Clustering O 0 3.7175726386173835e-10
of O 0 2.7602630264474994e-14
missense O 0 2.2997764803633913e-10
mutations O 0 1.0568176889158565e-10
in O 0 1.347756021369273e-11
the O 0 1.1291307373539894e-06
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999908208847046
telangiectasia I-Disease 1 0.9999963045120239
gene O 0 7.88320875244608e-08
in O 0 4.4366165472334296e-13
a O 0 3.384044075776388e-13
sporadic B-Disease 0 4.228182604038011e-07
T I-Disease 1 0.9993948936462402
- I-Disease 0 0.011779585853219032
cell I-Disease 0 0.007013771217316389
leukaemia I-Disease 1 0.9899953603744507
. O 0 1.0648144588287778e-09

Ataxia B-Disease 1 0.9999880790710449
- I-Disease 1 0.999970555305481
telangiectasia I-Disease 1 0.9999983310699463
( O 0 0.014778601936995983
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999969005584717
T I-Disease 1 0.9999995231628418
) O 0 9.407893301199843e-14
is O 0 9.48207641363315e-18
a O 0 1.0646436523378106e-17
recessive B-Disease 0 5.990732798721865e-09
multi I-Disease 0 0.003852848196402192
- I-Disease 1 0.999968409538269
system I-Disease 1 0.9998747110366821
disorder I-Disease 1 0.9999254941940308
caused O 0 1.6399976932035543e-09
by O 0 3.326913276847785e-16
mutations O 0 9.414444592827087e-14
in O 0 5.135221946023921e-16
the O 0 1.2917773900286234e-16
ATM O 0 5.024206051196245e-11
gene O 0 1.1600978858106181e-11
at O 0 9.499524777911716e-11
11q22 O 0 1.3584258717891373e-10
- O 0 1.7195956658611067e-08
q23 O 0 4.3490855361483227e-10
( O 0 4.62548768276165e-15
ref O 0 3.8130851254258857e-10
. O 0 4.2218032997483335e-14
3 O 0 1.3642347885048367e-13
) O 0 2.31548612748822e-13
. O 0 1.099208940015528e-12

The O 0 1.0748061468612846e-10
risk O 0 6.53812470829962e-09
of O 0 3.9765154331242863e-14
cancer B-Disease 0 6.826328835529694e-09
, O 0 6.722563478112065e-12
especially O 0 2.391176883234647e-12
lymphoid B-Disease 0 4.992265489889292e-10
neoplasias I-Disease 0 3.0092188296748645e-08
, O 0 7.835930594169739e-15
is O 0 1.408655363604406e-16
substantially O 0 6.833046633939258e-14
elevated O 0 3.75391362439359e-09
in O 0 5.994756246963107e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 8.314282951005225e-08
and O 0 7.557919567968696e-12
has O 0 1.2411535557990683e-12
long O 0 3.5586033360519853e-13
been O 0 3.6294345350310064e-13
associated O 0 5.29745138814347e-13
with O 0 4.791802510339949e-10
chromosomal O 1 0.9999996423721313
instability O 1 0.9999980926513672
. O 0 1.3602991622008176e-08

By O 0 2.3788932520911465e-13
analysing O 0 5.203794062325073e-10
tumour B-Disease 1 0.9999239444732666
DNA O 0 1.7134569318955073e-08
from O 0 6.709042365713944e-14
patients O 0 1.4472305410415673e-15
with O 0 2.0405318837398654e-16
sporadic B-Disease 0 1.7759038684062034e-09
T I-Disease 0 0.3475516140460968
- I-Disease 0 7.460921187885106e-05
cell I-Disease 0 6.722930265823379e-05
prolymphocytic I-Disease 0 0.0012105880305171013
leukaemia I-Disease 0 0.100712850689888
( O 0 1.634555229883261e-12
T B-Disease 0 1.3179187590139918e-06
- I-Disease 0 9.504713682773058e-10
PLL I-Disease 0 2.3351920397374215e-09
) O 0 3.383485389785038e-15
, O 0 2.856859530968534e-18
a O 0 1.400098312516443e-18
rare O 0 4.1432701318238827e-16
clonal B-Disease 0 7.147448323301109e-14
malignancy I-Disease 0 1.493516976758258e-09
with O 0 1.1313991659438693e-15
similarities O 0 3.2570983670571207e-13
to O 0 1.5123466647298626e-14
a O 0 2.2334167664155719e-13
mature B-Disease 0 2.4847926494153683e-10
T I-Disease 0 5.3799053603142966e-06
- I-Disease 0 6.493360515946733e-09
cell I-Disease 0 8.446901844649801e-09
leukaemia I-Disease 0 2.3170146960183047e-05
seen O 0 1.682968253646777e-08
in O 0 1.3984860144922173e-11
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999982118606567
T I-Disease 1 0.9999998807907104
, O 0 2.971102368038575e-13
we O 0 9.849655129208647e-17
demonstrate O 0 2.751493781529412e-19
a O 0 1.3142110670716824e-20
high O 0 2.1032572542875575e-17
frequency O 0 4.724893351869047e-15
of O 0 5.461092415996662e-19
ATM O 0 2.731500303720935e-10
mutations O 0 1.097906141001026e-11
in O 0 1.1104326659572283e-11
T B-Disease 0 0.004710211884230375
- I-Disease 0 1.3245098671177402e-06
PLL I-Disease 0 5.7848033065965865e-06
. O 0 1.7315972267173407e-10

In O 0 2.1566244883669539e-13
marked O 0 7.814773676263764e-13
contrast O 0 1.561770041938438e-15
to O 0 8.960103940416264e-18
the O 0 2.93532691785108e-18
ATM O 0 2.3324876752273127e-11
mutation O 0 1.1988625153377952e-12
pattern O 0 1.0771780978302559e-07
in O 0 3.849405239009229e-09
A B-Disease 1 1.0
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
, O 0 4.2951959941224874e-14
the O 0 1.6304112444453481e-19
most O 0 1.308437766448717e-21
frequent O 0 2.182555595794201e-19
nucleotide O 0 1.5863808753884874e-17
changes O 0 1.1231978488414183e-16
in O 0 3.095219524050539e-17
this O 0 4.89404784313898e-16
leukaemia B-Disease 0 2.3802593318578147e-07
were O 0 3.841038598295654e-12
missense O 0 9.421716185009643e-11
mutations O 0 1.8070445140239144e-10
. O 0 8.283140284781609e-10

These O 0 3.394684977998247e-13
clustered O 0 5.839775885085885e-11
in O 0 2.457357437652373e-14
the O 0 5.585688636340451e-14
region O 0 7.68810091544142e-13
corresponding O 0 1.343128921274593e-15
to O 0 1.2198902861303021e-15
the O 0 5.090960834935189e-18
kinase O 0 2.1375581426424928e-12
domain O 0 2.309753083240551e-12
, O 0 4.289071945913839e-14
which O 0 1.52857429133995e-15
is O 0 2.8856423143580823e-19
highly O 0 4.2262376480044646e-20
conserved O 0 6.7345802926066305e-18
in O 0 2.6510693609154983e-17
ATM O 0 8.907363735488616e-11
- O 0 2.4049169773665557e-12
related O 0 3.6502791688299875e-15
proteins O 0 2.903436454950478e-15
in O 0 1.389220060280758e-16
mouse O 0 2.2284514233916752e-09
, O 0 1.1326261143437908e-14
yeast O 0 6.5214509140099075e-12
and O 0 3.8300921679015887e-13
Drosophila O 0 4.011485588151231e-12
. O 0 1.92464013476501e-12

The O 0 1.0541265397460281e-13
resulting O 0 5.050189866989685e-13
amino O 0 3.822183455154393e-12
- O 0 2.9465199169464995e-09
acid O 0 3.776299151853069e-12
substitutions O 0 7.351964089602481e-13
are O 0 7.297596263443427e-15
predicted O 0 1.4980778865135956e-14
to O 0 1.2326796366008948e-15
interfere O 0 1.6475928260595296e-11
with O 0 2.3505661918163346e-15
ATP O 0 1.0986403572912223e-13
binding O 0 3.5471124735370063e-12
or O 0 7.63748710542328e-13
substrate O 0 6.57944143611644e-10
recognition O 0 2.3374446475599164e-11
. O 0 3.5555950544940984e-11

Two O 0 2.2377318910620642e-13
of O 0 6.105722121439153e-16
seventeen O 0 7.694736341157249e-12
mutated O 0 1.3844767554616055e-09
T B-Disease 0 9.450297511648387e-05
- I-Disease 0 4.963160904480901e-08
PLL I-Disease 0 1.4540089132708545e-08
samples O 0 1.0077957218745937e-10
had O 0 1.5381988217877396e-12
a O 0 1.2620362103659528e-16
previously O 0 3.4810006439844887e-12
reported O 0 1.1642779327303288e-06
A B-Disease 1 0.9999983310699463
- I-Disease 1 0.9999959468841553
T I-Disease 1 0.9999991655349731
allele O 0 1.1930501386814285e-06
. O 0 3.122827343937651e-11

In O 0 2.056924726032139e-12
contrast O 0 3.922552820750935e-12
, O 0 6.320028593347071e-14
no O 0 1.870457625862288e-14
mutations O 0 1.7052039034265443e-13
were O 0 3.3333242416278e-11
detected O 0 6.472678643065777e-11
in O 0 2.0965857448622968e-16
the O 0 1.3263155389559992e-17
p53 O 0 3.261965900651428e-17
gene O 0 3.019340081233078e-14
, O 0 1.6803865241686805e-15
suggesting O 0 1.0201152531204294e-13
that O 0 1.4628231894027455e-13
this O 0 7.563612279895549e-13
tumour B-Disease 1 0.9999996423721313
suppressor O 0 4.972613396603265e-07
is O 0 9.698232668331475e-12
not O 0 4.03928491132452e-13
frequently O 0 1.5383647133937473e-10
altered O 0 1.1207494932108375e-09
in O 0 2.7830561206282356e-12
this O 0 2.5292127767140293e-11
leukaemia B-Disease 0 0.005050651729106903
. O 0 1.3274700227938752e-09

Occasional O 0 3.0929209060559515e-07
missense O 0 1.3518045571814241e-09
mutations O 0 4.806360604653337e-12
in O 0 2.8089376477065256e-15
ATM O 0 5.092379851134865e-10
were O 0 7.115657368883532e-11
also O 0 3.0381753970271097e-12
found O 0 5.402575956048317e-12
in O 0 8.228891201257638e-14
tumour B-Disease 1 0.999998927116394
DNA O 0 2.397264609044214e-08
from O 0 1.5873065394630265e-14
patients O 0 6.769979122961368e-16
with O 0 5.975514205083972e-15
B B-Disease 0 1.0069340987683972e-06
- I-Disease 0 1.0113657481269911e-05
cell I-Disease 0 0.0501774437725544
non I-Disease 0 9.986227269109804e-06
- I-Disease 1 0.9998536109924316
Hodgkins I-Disease 1 0.9999678134918213
lymphomas I-Disease 1 0.997377872467041
( O 0 1.7291531704752283e-12
B B-Disease 0 1.8772682963685838e-08
- I-Disease 0 1.8499185516773764e-10
NHL I-Disease 0 4.5668174797341976e-10
) O 0 3.605614274488321e-14
and O 0 4.9361830947594956e-14
a O 0 2.586363943650992e-14
B B-Disease 0 6.971649035847349e-09
- I-Disease 0 5.469081298947742e-10
NHL I-Disease 0 3.205249121673859e-10
cell O 0 2.671118659591798e-09
line O 0 8.120470518235834e-09
. O 0 1.4174526353008532e-12

The O 0 1.4696462091994683e-14
evidence O 0 2.13559875892385e-15
of O 0 2.159599007350382e-18
a O 0 3.4920839074689854e-17
significant O 0 3.619424061432339e-17
proportion O 0 3.427016022307036e-14
of O 0 3.849909418498186e-14
loss O 0 1.751059991450532e-10
- O 0 1.7530817075783744e-10
of O 0 2.579576363712782e-13
- O 0 5.701890071208027e-10
function O 0 1.0672156382359951e-13
mutations O 0 6.007540927395472e-13
and O 0 3.353633560090885e-12
a O 0 4.140383104726461e-14
complete O 0 9.254784438805785e-13
absence O 0 3.295944517745647e-13
of O 0 7.421417306530849e-18
the O 0 1.120746032566252e-15
normal O 0 1.3947318624872194e-16
copy O 0 1.5468359828695738e-13
of O 0 1.6581671865019884e-18
ATM O 0 1.914175484785119e-10
in O 0 1.901112764662958e-14
the O 0 3.0123578870049073e-13
majority O 0 1.4744854642811944e-12
of O 0 3.526917120985282e-14
mutated O 0 1.5851804846533923e-06
tumours B-Disease 1 0.9999983310699463
establishes O 0 1.8733389839376002e-10
somatic O 0 5.956201677703721e-12
inactivation O 0 1.3105495355603125e-08
of O 0 3.283828945985695e-16
this O 0 1.2863920802814336e-17
gene O 0 1.3777420756311927e-15
in O 0 7.03281596112344e-17
the O 0 1.963528515551671e-16
pathogenesis O 0 2.0108623154189292e-13
of O 0 5.758113034775789e-16
sporadic B-Disease 0 7.496058174183418e-08
T I-Disease 1 0.5830382704734802
- I-Disease 0 1.6760248399805278e-05
PLL I-Disease 0 4.451760560186813e-06
and O 0 7.797599371750508e-11
suggests O 0 4.737219798833965e-15
that O 0 1.4294030055134816e-17
ATM O 0 1.018485209364206e-11
acts O 0 2.948128720314802e-12
as O 0 1.5732696788677177e-14
a O 0 3.7783648822523053e-13
tumour B-Disease 1 0.9999934434890747
suppressor O 0 9.524119377601892e-05
. O 0 2.2728632309565455e-09

As O 0 9.813103698770934e-14
constitutional O 0 1.521405173880979e-14
DNA O 0 2.0337674686704554e-12
was O 0 2.407202475546155e-12
not O 0 2.134074761363282e-16
available O 0 7.398521774355994e-18
, O 0 2.312339065511156e-17
a O 0 4.528015789872835e-16
putative O 0 7.219810527203663e-09
hereditary O 0 0.0002573571109678596
predisposition O 0 1.2806671293219551e-05
to O 0 8.159148023878515e-08
T B-Disease 0 0.0010556908091530204
- I-Disease 0 2.0227151509288888e-08
PLL I-Disease 0 2.0722707105846894e-08
will O 0 6.8321177776092985e-15
require O 0 5.801959587756928e-19
further O 0 9.56530360455548e-19
investigation O 0 5.750587147039434e-15
. O 0 4.0484824863449165e-15
. O 0 3.676427245318317e-14

Myotonic B-Disease 1 0.9998038411140442
dystrophy I-Disease 1 0.9997109770774841
protein O 0 1.2779698410625429e-09
kinase O 0 2.0904527886500546e-08
is O 0 2.251061377502462e-14
involved O 0 1.0654398963954541e-17
in O 0 5.1513787401862184e-20
the O 0 2.7950565376311784e-20
modulation O 0 2.578037683894865e-16
of O 0 3.277778915966209e-19
the O 0 9.065074715248794e-16
Ca2 O 0 5.450357387637439e-10
+ O 0 3.2955866924311294e-09
homeostasis O 0 1.5640270021322067e-06
in O 0 3.717129468810976e-12
skeletal O 0 6.801871677453164e-06
muscle O 0 1.8203785145942675e-08
cells O 0 9.690466311329526e-12
. O 0 9.470501639852191e-12

Myotonic B-Disease 1 0.9998408555984497
dystrophy I-Disease 1 0.9999431371688843
( O 0 1.1160255297681942e-07
DM B-Disease 1 0.9999884366989136
) O 0 8.75824759938304e-12
, O 0 2.479624631522532e-16
the O 0 2.3155169279884622e-17
most O 0 9.813254131822366e-14
prevalent O 0 3.681431735458318e-06
muscular B-Disease 0 6.905536429258063e-05
disorder I-Disease 0 1.1881813861691626e-06
in O 0 1.5018695109173669e-13
adults O 0 1.656038084441036e-09
, O 0 1.900732988970727e-13
is O 0 1.369554101203485e-12
caused O 0 5.948484760320838e-11
by O 0 1.5948173500129198e-14
( O 0 2.9956458380171204e-16
CTG O 0 1.5023904342825745e-10
) O 0 1.8251022980246556e-13
n O 0 8.437783249881647e-10
- O 0 3.454871944086335e-09
repeat O 0 4.170575440554103e-09
expansion O 0 2.642135578689354e-16
in O 0 8.533229449544272e-20
a O 0 3.809080286895029e-21
gene O 0 1.302587547722307e-19
encoding O 0 1.3370844172351893e-18
a O 0 7.196103233838755e-18
protein O 0 1.4675901214233032e-14
kinase O 0 9.035515113886561e-10
( O 0 1.7671883853725805e-14
DM B-Disease 1 0.99998939037323
protein O 0 7.183135922010642e-13
kinase O 0 7.046308536651225e-10
; O 0 5.3066312601752694e-14
DMPK O 0 1.7565661425411605e-10
) O 0 6.550755614206726e-17
and O 0 1.1625485842034645e-17
involves O 0 6.689283985660803e-19
changes O 0 1.0212632404472634e-18
in O 0 1.132097336159366e-17
cytoarchitecture O 0 1.5768297778606666e-10
and O 0 6.243587596802339e-14
ion O 0 1.8879533492111022e-09
homeostasis O 0 3.316636139061302e-06
. O 0 9.281185542331372e-11

To O 0 1.6394525982014324e-14
obtain O 0 5.935051335314516e-16
clues O 0 5.01276537639983e-12
to O 0 3.437162799388785e-14
the O 0 1.3639054748004384e-15
normal O 0 9.802953702963985e-16
biological O 0 5.439791700450518e-15
role O 0 1.9088755675146594e-16
of O 0 1.243157004024512e-17
DMPK O 0 1.3586796965281422e-10
in O 0 9.128638681501493e-18
cellular O 0 1.0626935495591707e-14
ion O 0 3.82921229447053e-11
homeostasis O 0 7.687589231863967e-09
, O 0 3.499332171686548e-13
we O 0 5.015430887440886e-13
have O 0 4.543677852584041e-15
compared O 0 4.580936820230508e-16
the O 0 6.94780627869912e-17
resting O 0 8.993832067982765e-11
[ O 0 2.786673016111032e-16
Ca2 O 0 2.941017113004818e-13
+ O 0 4.017000621026057e-11
] O 0 8.063833628613182e-11
i O 0 1.285508158255233e-11
, O 0 3.4200744023467022e-18
the O 0 5.681757837043785e-19
amplitude O 0 7.42468593388241e-15
and O 0 1.5778699527513318e-11
shape O 0 2.0846921411354913e-11
of O 0 3.881786230271703e-17
depolarization O 0 1.2453792337663305e-12
- O 0 3.1891410401385656e-08
induced O 0 7.579819794045761e-08
Ca2 O 0 5.083626297697208e-10
+ O 0 1.9254937921875381e-10
transients O 0 1.95384934897902e-08
, O 0 5.10563296759396e-15
and O 0 6.411105027495114e-16
the O 0 2.85607396788055e-19
content O 0 2.3631517779235534e-16
of O 0 9.575954912035292e-21
ATP O 0 1.4624694843258398e-16
- O 0 6.327148006912697e-13
driven O 0 2.11967401096691e-12
ion O 0 1.148219366808867e-11
pumps O 0 1.9201833179049999e-10
in O 0 1.5454182297103714e-16
cultured O 0 1.4257966335362582e-11
skeletal O 0 1.0170582953605845e-07
muscle O 0 6.997883609388689e-12
cells O 0 6.732815023004993e-16
of O 0 1.3264875925234103e-17
wild O 0 5.573168662675876e-12
- O 0 2.1521145754377358e-07
type O 0 3.0914089066413908e-09
and O 0 5.495725541315721e-10
DMPK O 0 2.079996441750609e-08
[ O 0 1.735423464004418e-13
- O 0 1.0404416217468793e-09
/ O 0 1.720891695811133e-08
- O 0 1.199160379883324e-07
] O 0 5.2428603680709784e-09
knockout O 0 4.4508841057222526e-08
mice O 0 9.345874296684542e-09
. O 0 2.202468893028331e-12

In O 0 1.6729689465352915e-13
vitro O 0 2.1544476272450375e-11
- O 0 1.607545208059946e-08
differentiated O 0 9.24756382580938e-10
DMPK O 0 9.510879863228183e-06
[ O 0 3.0236796400018306e-10
- O 0 2.2406590360901646e-08
/ O 0 1.1910796615666186e-07
- O 0 6.777444827577028e-09
] O 0 1.859798773318211e-11
myotubes O 0 5.147196037447177e-12
exhibit O 0 6.992692142760901e-16
a O 0 1.1789251886888505e-17
higher O 0 1.494428335210765e-17
resting O 0 2.6373667789611477e-13
[ O 0 2.537149285948532e-16
Ca2 O 0 1.0614340623885804e-13
+ O 0 3.1292132079974166e-11
] O 0 7.672786017653976e-11
i O 0 1.8391590334010388e-11
than O 0 3.825411886292744e-17
do O 0 5.5175997234688245e-15
wild O 0 8.634423471348684e-13
- O 0 7.43793134461157e-06
type O 0 8.411743834813024e-08
myotubes O 0 2.484422111592721e-06
because O 0 4.561144214057511e-13
of O 0 3.249666924354653e-19
an O 0 9.547772752243337e-18
altered O 0 3.3617158536058955e-12
open O 0 1.1820917508731377e-12
probability O 0 1.7012195112646369e-15
of O 0 2.611840982109661e-17
voltage O 0 5.98848444791078e-12
- O 0 2.096769202708515e-09
dependent O 0 2.782682140267667e-10
l O 0 3.8857286277504954e-09
- O 0 1.214678097688493e-11
type O 0 7.76049851550914e-13
Ca2 O 0 4.319174531919323e-11
+ O 0 1.356892792570008e-10
and O 0 7.50308062208438e-12
Na O 0 7.789156819537624e-11
+ O 0 1.0110676402011465e-12
channels O 0 5.942284442284063e-10
. O 0 2.0465943176284362e-11

The O 0 9.180902023862847e-14
mutant O 0 1.9971307593791288e-11
myotubes O 0 6.247325573527363e-11
exhibit O 0 2.5269859176089288e-14
smaller O 0 1.194289244695133e-15
and O 0 2.857476150770928e-14
slower O 0 7.502558416108002e-14
Ca2 O 0 1.4014873463141786e-11
+ O 0 1.1145859929451163e-10
responses O 0 8.799094130184856e-14
upon O 0 4.526876001163186e-16
triggering O 0 2.88328422823423e-14
by O 0 2.6825854385621362e-17
acetylcholine O 0 1.0880295969739606e-10
or O 0 2.0911377074384063e-09
high O 0 9.36292710029818e-10
external O 0 1.8760088948965858e-07
K O 0 4.020747113031575e-08
+ O 0 5.21244367113205e-11
. O 0 2.44959629837338e-12

In O 0 1.4865028424761867e-13
addition O 0 6.791425044273781e-15
, O 0 2.5544078469466342e-15
we O 0 1.2325660812464035e-16
observed O 0 3.255251841055458e-18
that O 0 7.896562258090496e-18
these O 0 2.0725076421965113e-16
Ca2 O 0 2.477628102681706e-10
+ O 0 5.383885692822332e-08
transients O 0 5.146797775523737e-06
partially O 0 5.9685385522811885e-09
result O 0 2.1582445235818724e-14
from O 0 1.0625049148255088e-18
an O 0 2.9879931843349044e-20
influx O 0 3.2127627783134825e-19
of O 0 4.168309801966464e-20
extracellular O 0 6.727067904457873e-15
Ca2 O 0 2.1520192312191044e-12
+ O 0 1.871894132754459e-12
through O 0 2.4681799776194412e-14
the O 0 1.03649066326289e-12
l O 0 4.152571064786059e-10
- O 0 1.8495567490756093e-12
type O 0 3.984958318729338e-14
Ca2 O 0 2.0166947972688476e-11
+ O 0 6.855994244547858e-11
channel O 0 1.2448715835944313e-07
. O 0 4.00300383118779e-11

Neither O 0 1.7686420383800083e-10
the O 0 5.265452838147796e-15
content O 0 1.8393254042244067e-13
nor O 0 1.826501189877705e-14
the O 0 7.417795082628479e-18
activity O 0 9.565135438736948e-16
of O 0 1.1484173614908535e-17
Na O 0 2.0667729680456937e-11
+ O 0 1.9698616002261637e-11
/ O 0 1.1558974610803574e-10
K O 0 3.3810779696830107e-12
+ O 0 4.993626836363209e-14
ATPase O 0 1.309458097509264e-11
and O 0 4.818483936505635e-13
sarcoplasmic O 0 6.369489380375626e-10
reticulum O 0 2.515729402574607e-09
Ca2 O 0 9.378301690787794e-09
+ O 0 2.1053340404364462e-08
- O 0 1.1770919794429346e-09
ATPase O 0 2.2879471650583127e-09
are O 0 3.940335606628445e-14
affected O 0 2.232937455881709e-15
by O 0 8.115874771479049e-16
DMPK O 0 1.346147797676167e-07
absence O 0 5.372785116114498e-12
. O 0 6.101514421746196e-14

In O 0 2.9192766910421386e-13
conclusion O 0 2.7314530642191283e-14
, O 0 1.7211458766454996e-14
our O 0 2.529469248803689e-14
data O 0 7.983229623697262e-15
suggest O 0 3.5552619774223155e-15
that O 0 2.6759242523509202e-15
DMPK O 0 2.460373293988738e-10
is O 0 2.0281618939875024e-16
involved O 0 2.983553822309606e-18
in O 0 3.75713214889222e-19
modulating O 0 4.274190508766823e-15
the O 0 1.8217456888314683e-17
initial O 0 5.4555985925608145e-18
events O 0 2.7469344653905964e-17
of O 0 3.509482907191487e-18
excitation O 0 4.954659599265554e-11
- O 0 1.3119046116116806e-06
contraction O 0 4.6723287461247764e-09
coupling O 0 2.622812800279206e-10
in O 0 2.5933600969821335e-13
skeletal O 0 6.659170594502939e-06
muscle O 0 3.382142566010771e-08
. O 0 2.7116872115817703e-13
. O 0 1.16798357010367e-12

Constitutional O 0 1.9265860018435887e-09
RB1 O 0 4.707576590590179e-05
- O 0 1.1851614800661991e-07
gene O 0 1.6440253602922894e-09
mutations O 0 2.5902028966129365e-08
in O 0 1.3345101933237569e-12
patients O 0 6.577047934053226e-13
with O 0 1.172692991975241e-13
isolated O 0 3.1808305323011155e-08
unilateral B-Disease 0 1.4539307358063525e-06
retinoblastoma I-Disease 0 0.00021483178716152906
. O 0 5.086053356251341e-09

In O 0 9.831913251210841e-14
most O 0 2.0286348030698663e-15
patients O 0 1.300044124544382e-14
with O 0 1.5662814876462802e-14
isolated O 0 9.466104566868694e-10
unilateral B-Disease 0 2.5066828612807512e-08
retinoblastoma I-Disease 0 5.26500002706598e-07
, O 0 1.5732794028059521e-13
tumor B-Disease 0 7.159052430733004e-12
development O 0 8.139899934585631e-17
is O 0 4.165579408011397e-18
initiated O 0 1.6647911454497365e-17
by O 0 5.2059865029652815e-18
somatic O 0 2.3350513010797144e-15
inactivation O 0 6.047223832794657e-10
of O 0 4.936192033604067e-18
both O 0 8.145615421746127e-17
alleles O 0 4.218740238028649e-16
of O 0 4.744648105727818e-17
the O 0 2.9410225340156804e-13
RB1 O 0 1.40399691872517e-07
gene O 0 2.5250782020869167e-10
. O 0 1.7288713516361298e-10

However O 0 3.878460400064121e-11
, O 0 1.0360824001585771e-14
some O 0 5.982644164474489e-18
of O 0 2.0938819892248815e-18
these O 0 5.436641669622974e-14
patients O 0 2.1476408145767274e-15
can O 0 7.462764300026226e-15
transmit O 0 4.194595781825683e-09
retinoblastoma B-Disease 0 3.4485054811739246e-09
predisposition O 0 1.2802003901413173e-08
to O 0 1.6762478557974525e-11
their O 0 5.381067258447558e-10
offspring O 0 6.385816764264973e-09
. O 0 6.647579708918272e-11

To O 0 7.72776279273947e-14
determine O 0 7.229544789428069e-15
the O 0 2.7596338715501025e-16
frequency O 0 3.628545380829351e-11
and O 0 4.816620626652002e-12
nature O 0 5.6728032644601245e-15
of O 0 1.3866937679719599e-17
constitutional O 0 3.603739214593643e-13
RB1 O 0 2.4363174588870606e-07
- O 0 4.03520244995903e-10
gene O 0 3.358814268383803e-11
mutations O 0 1.4023972261245632e-10
in O 0 3.116016017261358e-14
patients O 0 9.662435172179233e-15
with O 0 2.1569842232596528e-15
isolated O 0 4.413514276269126e-10
unilateral B-Disease 0 1.1516749776063762e-09
retinoblastoma I-Disease 0 1.230586690326163e-07
, O 0 1.8903963409835217e-13
we O 0 5.419865673882834e-15
analyzed O 0 8.265096777555075e-15
DNA O 0 1.3989035485550971e-09
from O 0 1.4185370543137732e-12
peripheral O 0 4.4510706231903896e-08
blood O 0 2.7662999855238013e-05
and O 0 1.0453435450585857e-08
from O 0 4.062092188224925e-13
tumor B-Disease 0 4.674015485761629e-08
tissue O 0 1.6267415503534721e-06
. O 0 9.131009282015157e-10

The O 0 1.7074724609471986e-13
analysis O 0 2.707099518509115e-12
of O 0 3.0277393005956332e-12
tumors B-Disease 1 0.9999991655349731
from O 0 8.031292991761418e-11
54 O 0 5.187348814383874e-12
( O 0 1.709611807826914e-15
71 O 0 1.8598945300540848e-11
% O 0 1.3239063132179565e-14
) O 0 3.484609053467703e-15
of O 0 6.34490013824433e-17
76 O 0 2.3598131912092035e-13
informative O 0 2.995596132260303e-11
patients O 0 2.7094473886712933e-10
showed O 0 5.426163056654332e-07
loss O 0 1.2444353880702863e-10
of O 0 1.3755312137597405e-15
constitutional O 0 6.281875464253517e-09
heterozygosity O 0 1.741514824971091e-05
( O 0 2.6485214021931824e-10
LOH O 0 0.000597739708609879
) O 0 6.489713627599869e-11
at O 0 6.206019725896184e-11
intragenic O 0 9.616390350686288e-09
loci O 0 2.0580166043560055e-11
. O 0 2.4200938128493554e-11

Three O 0 2.063031516452707e-11
of O 0 2.5886836280803426e-14
13 O 0 5.608369237769528e-12
uninformative O 0 9.778380416491927e-08
patients O 0 3.2093076026556977e-12
had O 0 6.544452913620491e-12
constitutional O 0 4.135967176382982e-12
deletions O 0 5.023342168897216e-07
. O 0 9.653806642972995e-09

For O 0 1.2028719119123055e-14
39 O 0 1.2153304621356775e-13
randomly O 0 3.31784556426018e-12
selected O 0 3.810540494253445e-10
tumors B-Disease 1 0.9999970197677612
, O 0 2.49844173128011e-10
SSCP O 0 9.710014637676068e-06
, O 0 6.9008067489495506e-12
hetero O 0 4.302815881374045e-09
- O 0 1.0070117656413302e-10
duplex O 0 3.6939226677468184e-10
analysis O 0 5.772055726483186e-16
, O 0 3.4808403179910694e-20
sequencing O 0 5.434373468914949e-17
, O 0 7.536656701487613e-16
and O 0 1.6163250750843294e-13
Southern O 0 5.0534705611196724e-15
blot O 0 4.494185645853577e-08
analysis O 0 1.0122359662978215e-14
were O 0 3.274409939612227e-16
used O 0 1.7426517043631073e-16
to O 0 1.839533215287686e-16
identify O 0 2.3743615580607003e-12
mutations O 0 8.358549963283224e-12
. O 0 2.4381075283685938e-11

Mutations O 0 2.0337151407368026e-10
were O 0 1.262294695852928e-11
detected O 0 7.187665046481939e-11
in O 0 3.0195243956024007e-14
21 O 0 1.5354785585369735e-12
( O 0 1.0280229240170998e-15
91 O 0 4.024514228817555e-12
% O 0 1.8902942904540365e-14
) O 0 5.369832183077516e-13
of O 0 1.5484249082584056e-12
23 O 0 2.46009290094662e-06
tumors B-Disease 1 0.9999996423721313
with O 0 1.2045950370520586e-06
LOH O 1 0.8734117746353149
. O 0 2.0510157128228457e-07

In O 0 2.430388518475518e-13
6 O 0 3.96851632502096e-13
( O 0 9.610268530540209e-16
38 O 0 1.9811788928153495e-13
% O 0 2.091929128295207e-15
) O 0 2.351734529771471e-13
of O 0 4.086768683880804e-12
16 O 0 4.3882168938580435e-06
tumors B-Disease 1 0.9999998807907104
without O 0 9.359431452082845e-09
LOH O 0 1.7763437654139125e-06
, O 0 2.8805042661013414e-13
one O 0 1.7197774102159155e-14
mutation O 0 2.341839846635484e-15
was O 0 4.195576178145366e-11
detected O 0 5.079475728919647e-11
, O 0 1.9431362714619066e-14
and O 0 5.867794314676211e-13
in O 0 7.101298071983137e-15
9 O 0 1.7957385795366876e-12
( O 0 5.088439257555882e-17
56 O 0 2.7876342185116643e-13
% O 0 4.795545322911594e-16
) O 0 1.0887504005990811e-13
of O 0 1.5934438013856522e-13
the O 0 0.0006600770866498351
tumors B-Disease 1 1.0
without O 0 2.0876332200714387e-06
LOH O 0 0.00011428484867792577
, O 0 4.157131236470768e-12
both O 0 6.507304867479566e-14
mutations O 0 1.17780047867444e-11
were O 0 4.424572652705905e-10
found O 0 1.8303455417978398e-09
. O 0 1.2322949605181321e-10

Thus O 0 3.907066510600021e-12
, O 0 2.335648247549292e-15
a O 0 1.431460799266942e-16
total O 0 4.248307643588234e-17
of O 0 7.31235800954104e-17
45 O 0 1.07260184451462e-15
mutations O 0 3.145430761014069e-14
were O 0 6.724935712465463e-12
identified O 0 3.530425951581151e-09
in O 0 1.1932910215506354e-09
tumors B-Disease 1 0.9999998807907104
of O 0 2.4697648440263897e-12
36 O 0 9.756941782290696e-11
patients O 0 8.880370397368331e-12
. O 0 3.298148906760723e-11

Thirty O 0 3.2463010057881547e-09
- O 0 2.654410913294214e-08
nine O 0 6.236622329680586e-11
of O 0 1.4249774238002004e-16
the O 0 5.794006585311282e-16
mutations O 0 8.726352804147141e-15
- O 0 2.2203539354337387e-11
including O 0 1.077445644775141e-14
34 O 0 4.749448731130831e-16
small O 0 2.9134618459243125e-18
mutations O 0 2.8364490660751085e-15
, O 0 1.0618299147661502e-15
2 O 0 1.4272086938717254e-15
large O 0 1.3476087726535025e-16
structural O 0 3.6476974218935254e-11
alterations O 0 4.936602775867938e-12
, O 0 2.2516981768722077e-13
and O 0 1.9005309478958843e-12
hypermethylation O 0 1.6283404624672926e-09
in O 0 1.485223402597491e-11
3 O 0 8.83869599732634e-09
tumors O 1 0.9999998807907104
- O 0 2.3092438823368866e-06
were O 0 4.407526787986171e-09
not O 0 1.3622852845784905e-12
detected O 0 1.4561326103224026e-11
in O 0 2.96646422949523e-17
the O 0 1.0023061964101814e-16
corresponding O 0 8.090192097243588e-15
peripheral O 0 1.8733355144906483e-10
blood O 0 8.300984788434107e-09
DNA O 0 4.4394892029231414e-07
. O 0 9.045753729397532e-11

In O 0 6.012997716929591e-13
6 O 0 2.9779687830272517e-12
( O 0 6.126139956511836e-15
17 O 0 2.0831407345628383e-12
% O 0 1.2010098158568854e-15
) O 0 3.8301156984768634e-16
of O 0 3.837614289253004e-18
the O 0 1.466001087614254e-14
36 O 0 9.35265828270939e-15
patients O 0 1.4912344585167999e-16
, O 0 4.426158258168158e-18
a O 0 8.544904106103844e-17
mutation O 0 1.498526644569051e-14
was O 0 3.6770397837671e-09
detected O 0 4.1727354210818746e-11
in O 0 5.30593514997037e-17
constitutional O 0 2.8544880620549873e-16
DNA O 0 7.510504995700273e-10
, O 0 8.949127246540844e-13
and O 0 5.694859731356083e-13
1 O 0 1.3913793060819869e-15
of O 0 1.7215150559555603e-16
these O 0 2.6924624435911183e-14
mutations O 0 1.0490714809981323e-14
is O 0 2.4906310305787137e-16
known O 0 1.536407969673513e-15
to O 0 1.8127686851610036e-13
be O 0 2.3303196395110803e-13
associated O 0 1.2340641204235114e-13
with O 0 4.1527943735707173e-13
reduced O 0 1.7821593159550453e-11
expressivity O 0 5.377893103286624e-05
. O 0 1.312199571223971e-09

The O 0 2.8686065025110286e-13
presence O 0 5.316153943381481e-14
of O 0 3.063339983242745e-17
a O 0 1.6004783888367755e-15
constitutional O 0 7.712209573761987e-15
mutation O 0 1.1284391119009002e-13
was O 0 1.6138854697089755e-09
not O 0 1.3602957464869253e-13
associated O 0 5.210641230251852e-16
with O 0 4.511582358079367e-17
an O 0 4.7282628489332245e-16
early O 0 8.81648309913885e-10
age O 0 8.077908342229989e-10
at O 0 4.075821169284566e-13
treatment O 0 2.5552959609918303e-14
. O 0 2.609459652210596e-14

In O 0 3.420311180547114e-13
1 O 0 2.3951457475885653e-14
patient O 0 1.3544401060786027e-12
, O 0 2.71048489066479e-15
somatic O 0 7.119093725985182e-14
mosaicism O 0 7.460619344534791e-10
was O 0 2.261660476954308e-11
demonstrated O 0 9.078293723181882e-16
by O 0 8.99938514504397e-20
molecular O 0 1.4862870581858957e-17
analysis O 0 3.631442003115999e-17
of O 0 7.47054922412769e-20
DNA O 0 7.792124584460325e-12
and O 0 3.545223468091885e-13
RNA O 0 2.263069509567117e-09
from O 0 2.212484481647209e-13
peripheral O 0 8.801398720947873e-09
blood O 0 1.9602848624344915e-06
. O 0 9.035683312674792e-11

In O 0 1.1601725439722155e-12
2 O 0 6.346720024530406e-12
patients O 0 6.225560025179336e-14
without O 0 1.3634640224041532e-14
a O 0 4.7781846838554354e-14
detectable O 0 8.676058982359791e-09
mutation O 0 4.38423269910615e-10
in O 0 4.379867649118019e-11
peripheral O 0 5.2548388339346275e-05
blood O 0 0.0912032201886177
, O 0 1.4206830156737738e-10
mosaicism O 0 8.93725204953455e-10
was O 0 3.961864517010305e-11
suggested O 0 7.579941990916439e-14
because O 0 1.7479847032083592e-16
1 O 0 2.793268573812448e-18
of O 0 2.120633837415459e-18
the O 0 2.619104748618345e-13
patients O 0 2.571869583620212e-12
showed O 0 1.0055352106519422e-07
multifocal O 0 0.16630853712558746
tumors B-Disease 1 1.0
and O 0 9.85941568387716e-08
the O 0 2.0125504182014892e-13
other O 0 3.446407384737754e-13
later O 0 2.8261294346410004e-11
developed O 0 7.641727962220957e-13
bilateral B-Disease 0 1.3737354136178492e-11
retinoblastoma I-Disease 0 5.752622378452088e-09
. O 0 5.138466041554324e-12

In O 0 1.6267889813015302e-12
conclusion O 0 6.207169923454908e-14
, O 0 6.225132442947562e-14
our O 0 3.0104510464340484e-13
results O 0 1.3224253912532236e-17
emphasize O 0 7.27738203391544e-16
that O 0 4.394701009606685e-16
the O 0 8.77742391454801e-17
manifestation O 0 1.5124568806569594e-13
and O 0 2.4668212351280916e-13
transmissibility O 0 3.339251618272865e-13
of O 0 2.071642824866087e-19
retinoblastoma B-Disease 0 1.0276783933658041e-14
depend O 0 4.601478030945915e-17
on O 0 3.7591219199939463e-13
the O 0 1.9137770930705358e-14
nature O 0 9.990096992923761e-14
of O 0 1.3324929403141575e-16
the O 0 4.137886390411134e-15
first O 0 6.427343602006044e-15
mutation O 0 1.0587558204423276e-15
, O 0 1.2105402070629171e-15
its O 0 3.983966263153602e-16
time O 0 5.683980711232092e-15
in O 0 3.931529067279824e-18
development O 0 6.3209290851575175e-19
, O 0 5.633935754777042e-17
and O 0 9.472764166498261e-15
the O 0 6.763370677786008e-16
number O 0 2.087499145981067e-13
and O 0 4.0258385514135853e-10
types O 0 5.14874492867079e-13
of O 0 5.1725549231741545e-17
cells O 0 1.3422077305928065e-14
that O 0 3.350683107166373e-14
are O 0 4.0435725010474794e-16
affected O 0 3.160148371401174e-16
. O 0 8.173668888261394e-15
. O 0 6.705121700922856e-12

Hereditary B-Disease 1 0.9996613264083862
deficiency I-Disease 1 0.9999198913574219
of I-Disease 0 1.209678380685239e-13
the I-Disease 0 1.292237665614579e-13
fifth I-Disease 0 2.4432841166932562e-11
component I-Disease 0 2.2852984492304808e-14
of I-Disease 0 5.730191123065143e-18
complement I-Disease 0 6.770579648145147e-14
in O 0 5.686846393099243e-14
man O 0 1.2449855546492472e-07
. O 0 2.0846682019515228e-11

I O 0 0.0001759612059686333
. O 0 1.4679634174896705e-09

Clinical O 0 6.142700237354859e-10
, O 0 1.27811728214966e-11
immunochemical O 0 2.573063113686658e-07
, O 0 1.2787390937796239e-11
and O 0 3.747886029303871e-11
family O 0 4.251565488555542e-10
studies O 0 3.4479608838206e-12
. O 0 8.566707456261757e-13

The O 0 1.9466390576306641e-13
first O 0 5.2137083577296836e-14
recognized O 0 6.600435259115911e-13
human O 0 4.629919364562696e-11
kindred O 0 5.607124421658227e-06
with O 0 6.312505718142347e-08
hereditary B-Disease 1 0.9999815225601196
deficiency I-Disease 1 0.9998292922973633
of I-Disease 0 7.137877295689433e-16
the I-Disease 0 1.7969290674033946e-14
fifth I-Disease 0 1.5381460211419395e-12
component I-Disease 0 2.3689656532548294e-15
of I-Disease 0 6.2474341911297575e-18
complement I-Disease 0 5.011736739588685e-14
( O 0 7.545628236236914e-17
C5 O 0 5.602158026363213e-08
) O 0 1.2393337495576057e-13
is O 0 7.133498876505957e-15
described O 0 1.4286284655273818e-10
. O 0 1.1369480010237076e-11

The O 0 8.780389067729322e-13
proband O 0 9.216783447563159e-10
, O 0 1.1169517484790263e-15
a O 0 2.882608629461544e-17
20 O 0 2.2156779155017614e-16
- O 0 2.2588497045061828e-11
year O 0 1.9698496306341795e-12
- O 0 2.5624588673167636e-08
old O 0 2.3651198262086837e-06
black O 0 5.365125730349973e-07
female O 0 6.498144955457974e-08
with O 0 3.7965119936700376e-09
systemic B-Disease 1 0.9999985694885254
lupus I-Disease 1 0.9995736479759216
erythematosus I-Disease 1 0.9999910593032837
since O 0 1.7236320104530023e-07
age O 0 2.5459325758703244e-09
11 O 0 4.962448637776951e-13
, O 0 2.9739568182488452e-15
lacked O 0 6.964405181025812e-13
serum O 0 1.4415637954179328e-11
hemolytic O 0 1.3569464128726505e-11
complement O 0 2.3866169728426617e-15
activity O 0 4.053008362953081e-12
, O 0 5.887634536806338e-14
even O 0 2.3703612857250977e-12
during O 0 2.169565048448785e-11
remission O 0 3.3746403449441686e-09
. O 0 2.230766786570637e-11

C5 O 0 0.0007341081509366632
was O 0 5.05486752899742e-07
undetectable O 0 2.1932616789399617e-07
in O 0 7.783623463646083e-13
her O 0 6.935203522573374e-09
serum O 0 2.912195762316827e-10
by O 0 1.9597655187439346e-15
both O 0 3.300844027363109e-14
immunodiffusion O 0 7.444393190780829e-08
and O 0 1.4406923570797758e-11
hemolytic O 0 2.1319750409531935e-09
assays O 0 1.2618427136512622e-10
. O 0 1.1381804353172154e-11

Other O 0 7.087789590540326e-16
complement O 0 4.627729355456559e-15
components O 0 1.0182666206537058e-13
were O 0 2.1056527561066213e-14
normal O 0 5.938153593483834e-16
during O 0 1.6025502526015832e-14
remission O 0 4.690411687519047e-12
of O 0 2.9815318868356996e-16
lupus O 0 4.778812068284566e-11
, O 0 3.5512497941094087e-15
but O 0 1.0932848051349586e-13
C1 O 0 3.426159009278784e-11
, O 0 3.268467540266095e-17
C4 O 0 2.3128986226250703e-10
, O 0 2.7173914702617596e-14
C2 O 0 6.414430764323242e-09
, O 0 4.7637705547854195e-14
and O 0 1.8202933604882787e-10
C3 O 0 0.00022228511807043105
levels O 0 5.673012615226014e-10
fell O 0 9.2885005642529e-07
during O 0 3.199902495754081e-11
exacerbations O 0 6.917555765539873e-06
. O 0 1.3369463522372449e-11

A O 0 5.434682703864269e-10
younger O 0 1.4488375832399925e-08
half O 0 8.106921384198884e-11
- O 0 1.2102009350201115e-07
sister O 0 4.220884875394404e-06
, O 0 4.2904780422903244e-11
who O 0 2.2903268170892943e-09
had O 0 1.6652680301376677e-07
no O 0 5.37692224078512e-10
underlying O 0 1.1015780509993078e-09
disease O 0 1.6799037161341346e-10
, O 0 2.2972555051271014e-14
was O 0 8.126618822323906e-10
also O 0 2.258127157483969e-10
found O 0 4.464483227550886e-10
to O 0 2.444217606090149e-10
lack O 0 5.207673875462504e-11
immunochemically O 0 2.890404857680551e-07
detectable O 0 8.429378084429118e-08
C5 O 0 6.9569996412610635e-06
. O 0 3.933570413838794e-10

By O 0 8.369025958354648e-13
hemolytic O 0 2.257258380211624e-09
assay O 0 8.051481703574837e-10
, O 0 3.227417985640635e-11
she O 0 8.896718084461241e-11
exhibited O 0 1.650118945293027e-14
1 O 0 1.9825016234362488e-17
- O 0 5.44924999221208e-12
2 O 0 8.174004008376645e-13
% O 0 2.873890807549725e-17
of O 0 8.261041145339723e-20
the O 0 8.835575373354978e-17
normal O 0 1.3597806361055468e-15
serum O 0 3.686050163015375e-12
C5 O 0 3.529516900968588e-09
level O 0 1.3145575123232889e-12
and O 0 5.266000851524011e-13
normal O 0 4.326765526165542e-16
concentrations O 0 4.125120333346591e-15
of O 0 2.4641271008254276e-20
other O 0 1.5952773683126177e-17
complement O 0 1.0989262520867443e-15
components O 0 9.578003537860647e-13
. O 0 3.0265831616090033e-13

C5 O 0 6.050490264897235e-05
levels O 0 5.867314190055595e-09
of O 0 4.976221685725672e-16
other O 0 3.5431849816603637e-15
family O 0 1.3625581782653051e-12
members O 0 6.884697691917244e-17
were O 0 4.295455270907642e-15
either O 0 1.9880905519630246e-17
normal O 0 3.559994774015099e-17
or O 0 1.9047023208868322e-14
approximately O 0 1.660733348089131e-15
half O 0 3.82273934729227e-11
- O 0 1.1906343644341177e-07
normal O 0 4.442633413925812e-11
, O 0 1.7511174259764173e-13
consistent O 0 5.7246590280668475e-12
with O 0 5.510432605007609e-13
autosomal O 0 7.329649776011138e-08
codominant O 0 1.6798196611489402e-07
inheritance O 0 5.44815130509857e-11
of O 0 1.2074542013382737e-16
the O 0 2.730774506125083e-15
gene O 0 5.227440702526565e-10
determining O 0 1.2232059987127286e-07
C5 B-Disease 1 0.9999957084655762
deficiency I-Disease 1 0.9999971389770508
. O 0 2.8139546248695524e-09

Normal O 0 1.9756706493012643e-08
hemolytic O 0 1.1056200492021162e-05
titers O 0 7.161197146388076e-08
were O 0 2.7198002964384793e-12
restored O 0 9.03607050295463e-13
to O 0 3.564362414704321e-14
both O 0 9.941914912853234e-13
homozygous O 0 3.7304866964404937e-06
C5 B-Disease 1 0.9999986886978149
- I-Disease 1 0.9999960660934448
deficient I-Disease 1 0.9999997615814209
( O 0 2.297468348899656e-08
C5D B-Disease 1 0.9999984502792358
) O 0 3.636249287786164e-11
sera O 0 1.7084199332995098e-10
by O 0 1.172435625911127e-17
addition O 0 2.9933707604603546e-17
of O 0 1.8433949493364205e-18
highly O 0 4.634318848269724e-15
purified O 0 8.904789882899222e-13
human O 0 3.0483799078745433e-12
C5 O 0 6.637984597546165e-07
. O 0 5.961566310053179e-12

In O 0 2.0698944132053337e-14
specific O 0 7.83488450847988e-15
C5 O 0 3.767041079072442e-08
titrations O 0 7.602226070879681e-10
, O 0 6.99304641429109e-14
however O 0 9.817666665257792e-15
, O 0 7.659752823338528e-16
it O 0 8.008885574043237e-14
was O 0 4.8695904947271273e-11
noted O 0 1.2391676125153312e-14
that O 0 1.7048706467837765e-15
when O 0 4.4049588432957306e-15
limited O 0 5.436479786117117e-20
amounts O 0 8.778850392684237e-20
of O 0 4.350907983482984e-19
C5 O 0 4.729557856464339e-10
were O 0 5.40856837194883e-15
assayed O 0 1.385755252951773e-13
in O 0 4.119470623588405e-17
the O 0 1.306545806510696e-16
presence O 0 6.4566856703318805e-15
of O 0 1.2885389448432538e-16
low O 0 6.481162828642084e-12
dilutions O 0 1.360814100292984e-10
of O 0 1.5790447495020975e-14
either O 0 1.9557376551571082e-10
C5D B-Disease 1 0.9999963045120239
serum O 0 5.395502000737906e-08
, O 0 5.143221113419554e-16
curving O 0 3.494183295569414e-13
rather O 0 1.416896279497141e-15
than O 0 3.521203229290751e-18
linear O 0 2.748613178812936e-16
dose O 0 3.320699021747836e-13
- O 0 1.047998243741688e-09
response O 0 6.94183263389575e-13
plots O 0 3.185453845144792e-10
were O 0 3.0012793465761245e-12
consistently O 0 2.6774177493138485e-13
obtained O 0 1.392769161416978e-17
, O 0 2.1630535203835565e-18
suggesting O 0 3.731198330628669e-17
some O 0 9.697526874508433e-20
inhibitory O 0 3.68459840275389e-14
effect O 0 3.2309641073702267e-12
. O 0 4.255779756379141e-12

Further O 0 1.666770833765735e-13
studies O 0 9.65299007719099e-14
suggested O 0 2.27176506501902e-14
that O 0 6.2151635427847365e-15
low O 0 3.740057308992961e-12
dilutions O 0 2.337818116870949e-08
of O 0 8.460062511650435e-12
C5D B-Disease 1 0.9999974966049194
serum O 0 3.580211682674417e-07
contain O 0 6.670371720252088e-13
a O 0 4.2199655770659705e-15
factor O 0 4.564283114872128e-14
( O 0 1.4605962180234277e-16
or O 0 1.80474168595679e-12
factors O 0 5.549240639213509e-15
) O 0 2.1129165400853597e-16
interfering O 0 3.7509071911835667e-13
at O 0 1.0326574224363543e-14
some O 0 1.9392954778212512e-19
step O 0 3.4931534983231307e-15
in O 0 6.37024073359183e-18
the O 0 3.4794668223240405e-16
hemolytic O 0 4.2134630745364887e-13
assay O 0 4.845438422241069e-14
of O 0 1.0045645980057981e-16
C5 O 0 5.672236458309499e-09
, O 0 1.0530443831581102e-15
rather O 0 1.798723101714525e-17
than O 0 6.449779526162785e-19
a O 0 1.2265477136328147e-17
true O 0 1.9232556628008546e-13
C5 O 0 1.4360738154195474e-09
inhibitor O 0 2.27602225261192e-12
or O 0 9.145820212275169e-11
inactivator O 0 1.6063061138993362e-06
. O 0 9.485257718155893e-11

Of O 0 1.253723253685779e-12
clinical O 0 1.2347946016372235e-12
interest O 0 1.5849756403174542e-12
are O 0 1.3230563834180226e-13
( O 0 1.8753628743926655e-17
a O 0 1.5529479820345477e-15
) O 0 1.8253648951789634e-15
the O 0 1.9422080345247902e-16
documentation O 0 2.0451652524289266e-12
of O 0 1.2067002467240108e-14
membranous O 0 0.0020050329621881247
glomerulonephritis B-Disease 1 0.9999985694885254
, O 0 8.017561015094543e-08
vasculitis B-Disease 1 0.9999973773956299
, O 0 2.1272155592555464e-08
and O 0 0.0006713676848448813
arthritis B-Disease 1 1.0
in O 0 5.1303937226993e-13
an O 0 4.761390392203635e-14
individual O 0 2.742163614233295e-11
lacking O 0 1.1344098577170669e-10
C5 O 0 2.0371732034618617e-07
( O 0 5.71090630043853e-16
and O 0 1.0314291399595409e-14
its O 0 5.598286917353967e-17
biologic O 0 5.909116774656365e-16
functions O 0 4.020297541125646e-18
) O 0 3.048582750242554e-16
, O 0 3.0565378719249296e-15
and O 0 8.203512522064749e-12
( O 0 2.925783089923178e-16
b O 0 4.786609043155865e-12
) O 0 8.267953945417617e-18
a O 0 2.315973883238352e-19
remarkable O 0 7.312581017434184e-17
propensity O 0 4.9148837777401866e-11
to O 0 1.1202232197415896e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.123675913601574e-12
the O 0 7.16079349679169e-14
proband O 0 6.38138475395067e-09
, O 0 5.922117671605534e-15
even O 0 1.505841621101539e-14
during O 0 6.05867251171361e-15
periods O 0 6.200721631034051e-14
of O 0 1.3779464487994974e-16
low O 0 1.3695658496182261e-10
- O 0 6.148865860922115e-10
dose O 0 8.150542957566231e-13
or O 0 2.5855650221751417e-14
alternate O 0 3.155153005182654e-14
- O 0 4.597546787721285e-10
day O 0 2.465025579490021e-12
corticosteroid O 0 4.2792097643129523e-10
therapy O 0 5.3155210268107655e-12
. O 0 2.9171045597521997e-14

Other O 0 6.254374053165854e-14
observations O 0 4.589689630955796e-13
indicate O 0 5.036741423242175e-13
that O 0 1.831385012444984e-14
the O 0 1.6119539513956282e-12
C5D B-Disease 1 0.9999986886978149
state O 0 2.3355213704841227e-13
is O 0 1.1383034903156167e-16
compatible O 0 4.723871033923688e-13
with O 0 8.525349344664854e-14
normal O 0 1.0582632707834992e-15
coagulation O 0 7.339312534451747e-13
function O 0 3.9045294910689324e-14
and O 0 5.090058488089501e-14
the O 0 2.9447958032154846e-16
capacity O 0 2.4551703271141574e-17
to O 0 1.7636307252331262e-16
mount O 0 1.3443158045078896e-11
a O 0 5.804304519657633e-12
neutrophilic O 0 0.00010918180487351492
leukocytosis O 0 0.00011863843246828765
during O 0 4.965279742918938e-09
pyogenic B-Disease 0 0.0006571962148882449
infection I-Disease 0 0.00045343852252699435
. O 0 9.618025993696211e-12
. O 0 1.7136929028604975e-11

Susceptibility O 0 1.8101660316460766e-05
to O 0 1.896961657621432e-05
ankylosing B-Disease 1 0.9999916553497314
spondylitis I-Disease 1 1.0
in O 0 1.8822380809524475e-07
twins O 0 3.0033444886612415e-07
: O 0 9.63559693324548e-16
the O 0 6.568865617024748e-19
role O 0 4.583014036184751e-17
of O 0 5.545037547991899e-20
genes O 0 1.3795453558363379e-16
, O 0 4.0747092336652005e-17
HLA O 0 1.3717918944874952e-12
, O 0 9.320607572424824e-14
and O 0 1.1443079990514082e-11
the O 0 9.66882390124324e-13
environment O 0 3.897389522222738e-09
. O 0 4.590129058096304e-12

OBJECTIVE O 0 4.113186527487933e-11
To O 0 3.214714329154503e-14
determine O 0 7.573438133134242e-14
the O 0 1.1003237505705955e-14
relative O 0 3.5123195584602085e-12
effects O 0 5.891445642967896e-13
of O 0 3.401741184840383e-18
genetic O 0 1.571285961586566e-12
and O 0 1.005924076674658e-12
environmental O 0 6.281182349484921e-16
factors O 0 9.228848303989842e-18
in O 0 8.903882955722872e-18
susceptibility O 0 1.4876680443087764e-10
to O 0 8.392817107960582e-08
ankylosing B-Disease 1 0.9999990463256836
spondylitis I-Disease 1 1.0
( O 0 3.628426270552154e-08
AS B-Disease 1 0.9999935626983643
) O 0 1.809927034635006e-11
. O 0 4.7060133567811135e-12

METHODS O 0 6.833329735389526e-11
Twins O 0 6.99350444222091e-09
with O 0 2.333229529721814e-12
AS B-Disease 1 0.9999825954437256
were O 0 7.186438401828033e-13
identified O 0 4.1400988404693626e-14
from O 0 4.131905861347486e-16
the O 0 5.206295125375314e-14
Royal O 0 9.398168354657344e-11
National O 0 1.0798213885554464e-11
Hospital O 0 2.7443611619326624e-11
for O 0 1.0004354420898535e-14
Rheumatic B-Disease 0 7.097959314705804e-05
Diseases I-Disease 0 1.7808968744148501e-09
database O 0 2.368345753886447e-12
. O 0 1.7713293332111135e-10

Clinical O 0 6.725096035609113e-10
and O 0 1.8119868105959114e-10
radiographic O 0 6.359637438890786e-08
examinations O 0 5.68724844995927e-10
were O 0 3.735907850438425e-12
performed O 0 1.50497507251518e-13
to O 0 7.87202827964552e-16
establish O 0 9.997105512935932e-15
diagnoses O 0 1.6666097835127403e-08
, O 0 2.1512076842089556e-11
and O 0 4.082724913700986e-08
disease O 0 9.549874668834946e-09
severity O 0 1.6322226556453323e-11
was O 0 2.1663787842622628e-13
assessed O 0 8.643225837736551e-16
using O 0 7.869927108540738e-16
a O 0 6.78495159497439e-15
combination O 0 3.6675323829326104e-14
of O 0 9.719503884651594e-17
validated O 0 3.2512905128595504e-12
scoring O 0 6.80932532581835e-11
systems O 0 8.776467330662285e-10
. O 0 3.2992813342458405e-11

HLA O 0 1.4753520183319324e-08
typing O 0 1.1402806476823457e-09
for O 0 4.141044129238498e-15
HLA O 0 1.3049408775778204e-10
- O 0 1.493254131457178e-10
B27 O 0 5.761838055284851e-12
, O 0 8.99205941640429e-16
HLA O 0 1.0090679377142142e-12
- O 0 1.2252695602912866e-12
B60 O 0 3.4905861838116503e-13
, O 0 2.1030095633249346e-16
and O 0 5.966630523533169e-15
HLA O 0 5.21893250837735e-10
- O 0 1.1716355174939963e-07
DR1 O 0 0.04377831891179085
was O 0 1.1918567695279325e-11
performed O 0 1.676601530974095e-16
by O 0 1.5774353668431844e-20
polymerase O 0 1.0985119470964186e-14
chain O 0 1.9130701254914395e-13
reaction O 0 5.537432811331604e-18
with O 0 3.8694358757191303e-20
sequence O 0 1.714809102729593e-17
- O 0 4.521405227115108e-16
specific O 0 1.5885307178005127e-17
primers O 0 1.40329765585534e-08
, O 0 4.0713746528872954e-14
and O 0 6.971577856023162e-14
zygosity O 0 7.774785155956199e-12
was O 0 3.577028183067909e-15
assessed O 0 7.235994018879124e-17
using O 0 1.7629986268962377e-16
microsatellite O 0 2.429782597346275e-08
markers O 0 2.869380068659666e-06
. O 0 4.1393571903469706e-10

Genetic O 0 6.8129444308340226e-09
and O 0 4.0111892973815344e-11
environmental O 0 6.612323315708648e-15
variance O 0 1.1228465948661038e-16
components O 0 1.3563188929182485e-13
were O 0 1.8499136040562875e-15
assessed O 0 1.862182743948368e-16
with O 0 2.3671124510453554e-16
the O 0 2.3786548631384713e-15
program O 0 1.824831735372512e-12
Mx O 0 4.458981361227243e-12
, O 0 1.7983979266759726e-20
using O 0 3.227908196835387e-20
data O 0 7.414944949109866e-16
from O 0 3.755358952832363e-17
this O 0 1.1360216629650524e-16
and O 0 4.0336877176090635e-13
previous O 0 2.8208812781309323e-13
studies O 0 4.2181787610637376e-15
of O 0 1.9479119080694864e-18
twins O 0 4.509512121358972e-12
with O 0 2.8075786256943035e-14
AS B-Disease 1 0.999995231628418
. O 0 3.419984018204758e-10

RESULTS O 0 1.3414683253110127e-10
Six O 0 1.9443940815072613e-13
of O 0 5.945020913103699e-16
8 O 0 1.3639500119622117e-11
monozygotic O 0 3.5749723181766058e-09
( O 0 1.1107811176934435e-13
MZ O 1 0.7183145880699158
) O 0 1.661422888155073e-09
twin O 0 0.031169045716524124
pairs O 0 9.840860002441332e-07
were O 0 2.3505879909180294e-08
disease O 0 7.779728250500995e-11
concordant O 0 1.896822542785115e-12
, O 0 6.73440185452838e-14
compared O 0 2.0096573263481653e-14
with O 0 2.4763647722854647e-15
4 O 0 7.00335040068785e-14
of O 0 1.1948908498459203e-15
15 O 0 7.366347386673217e-14
B27 O 0 3.0702970547913377e-12
- O 0 3.8824962689254505e-10
positive O 0 1.9316561967585438e-13
dizygotic O 0 7.688035624786593e-11
( O 0 4.2361565589131773e-16
DZ O 0 1.4290503713709768e-06
) O 0 3.4582224237023063e-12
twin O 0 1.7239970873106358e-07
pairs O 0 8.493485775806775e-11
( O 0 9.19610435944193e-16
27 O 0 2.5494165697796667e-13
% O 0 2.1551396766681085e-17
) O 0 3.3235372549829354e-17
and O 0 1.621703531011487e-14
4 O 0 1.3627204968830534e-14
of O 0 1.0482268832706014e-15
32 O 0 2.262670259489674e-11
DZ O 0 0.0015708392020314932
twin O 0 4.372046987555223e-06
pairs O 0 2.6105650974272976e-10
overall O 0 1.2398095787860552e-12
( O 0 1.5745768095240086e-16
12 O 0 3.944424065258252e-15
. O 0 3.10846353269046e-15
5 O 0 9.24553836267883e-13
% O 0 5.782659626070745e-15
) O 0 2.933207604756405e-13
. O 0 2.247598461513345e-11

Nonsignificant O 0 9.910415599279077e-08
increases O 0 1.719319998871871e-12
in O 0 3.690261492985665e-17
similarity O 0 3.619895091160351e-16
with O 0 5.565177193539184e-17
regard O 0 1.0554814028264792e-15
to O 0 3.875449440526868e-12
age O 0 1.6258444590633303e-10
at O 0 2.6481628001562285e-10
disease O 0 1.4519123403555767e-10
onset O 0 1.693454675533862e-13
and O 0 6.270323344749473e-13
all O 0 1.8262144692250595e-15
of O 0 3.4799975414050546e-16
the O 0 3.87542331559132e-10
disease O 0 1.788421002402174e-07
severity O 0 7.969461202073091e-11
scores O 0 6.270917623065267e-14
assessed O 0 3.80938287302692e-15
were O 0 8.224121389325059e-14
noted O 0 8.378816846073278e-13
in O 0 3.73811745446595e-12
disease O 0 1.6973804122244474e-06
- O 0 6.1020953580737114e-05
concordant O 0 0.006344802211970091
MZ O 1 0.9995575547218323
twins O 0 5.747071554651484e-06
compared O 0 1.1118951245836506e-11
with O 0 3.525015836950557e-13
concordant O 0 2.4156302060873713e-06
DZ O 1 0.6388450860977173
twins O 0 5.014075213694014e-06
. O 0 5.671819611197115e-11

HLA O 0 1.3379046777117765e-06
- O 0 1.3432624257347925e-07
B27 O 0 1.181838849007022e-09
and O 0 6.302532714469455e-12
B60 O 0 6.448827474629659e-13
were O 0 1.0541983173179784e-14
associated O 0 4.481344803874715e-16
with O 0 1.1222433750587607e-15
the O 0 8.74907730898794e-13
disease O 0 1.9964348230150364e-10
in O 0 4.041583032412616e-16
probands O 0 7.816156610829239e-10
, O 0 1.5782158218840907e-15
and O 0 7.426470632302274e-15
the O 0 3.322767315268771e-15
rate O 0 6.264731788885314e-12
of O 0 1.2139754285898457e-16
disease O 0 1.3382310125494012e-13
concordance O 0 2.3947425599056722e-15
was O 0 4.595330734859238e-13
significantly O 0 2.2155534175403828e-14
increased O 0 1.966865560666057e-15
among O 0 5.6568859839456476e-12
DZ O 1 0.9481313228607178
twin O 0 0.17737074196338654
pairs O 0 7.196699680633856e-09
in O 0 3.087007103934336e-13
which O 0 9.220079560945393e-12
the O 0 1.4580105785894082e-12
co O 0 1.409531250828877e-06
- O 0 1.4002798707224429e-06
twin O 0 0.00018933338287752122
was O 0 1.6562773375028428e-10
positive O 0 7.643107500959348e-18
for O 0 5.2264764000483764e-20
both O 0 3.722441134919693e-17
B27 O 0 1.3750139265036876e-12
and O 0 1.0799903506220065e-11
DR1 O 0 0.0009492730605416
. O 0 1.2057335165016614e-11

Additive O 0 2.4036342360922447e-11
genetic O 0 8.242286714255087e-11
effects O 0 1.1572734957832065e-11
were O 0 1.7767058169745192e-14
estimated O 0 1.5212663756211706e-17
to O 0 5.3039115353198203e-17
contribute O 0 3.531214712049766e-16
97 O 0 5.787476075637399e-13
% O 0 3.53178063593765e-16
of O 0 2.554150511058069e-18
the O 0 2.3958311666494835e-14
population O 0 4.468832009661401e-16
variance O 0 6.491383951499679e-15
. O 0 2.2403064126041983e-10

CONCLUSION O 0 7.073376715079072e-13
Susceptibility O 0 1.786945730275491e-10
to O 0 2.4008725563184896e-10
AS B-Disease 1 0.9999990463256836
is O 0 9.718832319873319e-14
largely O 0 7.734567537800356e-16
genetically O 0 1.2026824941694758e-16
determined O 0 1.0610217131973299e-12
, O 0 1.3399465761401112e-14
and O 0 4.042763086103962e-12
the O 0 1.9209459055976458e-13
environmental O 0 3.3511847810641093e-12
trigger O 0 1.50734945358888e-11
for O 0 5.68304579861656e-16
the O 0 7.919363081976272e-12
disease O 0 5.561037186296858e-10
is O 0 2.549570695894749e-14
probably O 0 4.401589336067158e-12
ubiquitous O 0 9.006660417476553e-10
. O 0 1.508212998935221e-10

HLA O 0 5.405493084253976e-07
- O 0 8.815461249866985e-09
B27 O 0 7.302174490075863e-12
accounts O 0 1.2451569824853664e-14
for O 0 6.27789429000641e-18
a O 0 4.958769630638681e-16
minority O 0 4.853411373966984e-14
of O 0 3.805017893046856e-19
the O 0 1.1745804556086403e-16
overall O 0 4.5111714809255e-16
genetic O 0 3.54153644378677e-15
susceptibility O 0 1.480868379311051e-13
to O 0 1.230564912121923e-12
AS B-Disease 1 0.9999933242797852
. O 0 8.549221885978397e-10

Cell O 0 9.597356438462157e-06
cycle O 0 7.5583902798825875e-06
- O 0 4.937375592817261e-07
dependent O 0 4.775351780672565e-10
colocalization O 0 6.752518544317354e-08
of O 0 6.11887336673646e-16
BARD1 O 0 7.783605981970254e-10
and O 0 5.636325049432789e-16
BRCA1 O 0 2.835657725544136e-16
proteins O 0 2.895613563052103e-17
in O 0 1.617705646838957e-18
discrete O 0 3.971408705366608e-13
nuclear O 0 8.771204562663115e-08
domains O 0 2.020203171415602e-10
. O 0 2.2764791787754923e-11

Germ O 0 0.0005969178746454418
- O 0 0.00030475505627691746
line O 0 3.4244530411342566e-07
mutations O 0 1.202995255494832e-11
of O 0 2.549547499103395e-17
the O 0 6.961973566486438e-17
BRCA1 O 0 9.805750775162408e-14
gene O 0 2.6007989097315103e-14
predispose O 0 1.4705009779292233e-11
women O 0 1.1941304471933464e-14
to O 0 2.3433321069303093e-15
early O 0 5.678587600144169e-10
- O 1 0.6687778830528259
onset O 1 0.8342009782791138
breast B-Disease 1 0.9999978542327881
and I-Disease 1 0.9999990463256836
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
by O 0 6.027945883332192e-14
compromising O 0 2.7323182605343277e-10
the O 0 7.141036199187099e-16
genes O 0 2.509150873186705e-12
presumptive O 0 1.8538132451340061e-07
function O 0 5.2619516274603206e-14
as O 0 1.1477664894627825e-14
a O 0 3.1022222551219114e-14
tumor B-Disease 0 5.911575584605089e-08
suppressor O 0 2.5023009584401734e-05
. O 0 1.7760038417691248e-07

Although O 0 6.7574270831705086e-12
the O 0 9.436660234154494e-15
biochemical O 0 5.225160039888654e-13
properties O 0 1.3265307092797524e-13
of O 0 3.2361363588438475e-17
BRCA1 O 0 6.84745706316936e-12
polypeptides O 0 8.676145739350272e-12
are O 0 8.456257714190268e-15
not O 0 6.6528051378402994e-15
understood O 0 9.549977995904069e-14
, O 0 2.367393771862962e-15
their O 0 1.139209386546991e-12
expression O 0 3.903087163366348e-13
pattern O 0 1.0553277141056583e-09
and O 0 2.0330538468005255e-12
subcellular O 0 1.2550390414423074e-12
localization O 0 8.45933132570531e-13
suggest O 0 2.828528884501807e-15
a O 0 8.826710313294125e-18
role O 0 1.0436753729043541e-13
in O 0 3.7243215374746855e-14
cell O 0 1.6751739906339935e-07
- O 0 4.291518052923493e-06
cycle O 0 3.5265517794869083e-07
regulation O 0 3.023946648639253e-09
. O 0 1.3751143453089032e-11

When O 0 6.967232346610785e-10
resting O 0 1.155563089660916e-09
cells O 0 8.675479497115279e-13
are O 0 1.1525087092971041e-15
induced O 0 4.640677165462792e-12
to O 0 1.5883241648458578e-14
proliferate O 0 1.053364839798121e-09
, O 0 1.9577256516487094e-15
the O 0 9.903913677529593e-16
steady O 0 2.7381130349168892e-11
- O 0 3.85685190382179e-12
state O 0 2.5601536949443338e-15
levels O 0 1.1795465833086126e-16
of O 0 2.2744191242294294e-21
BRCA1 O 0 9.950336906390642e-17
increase O 0 3.5675479101148066e-20
in O 0 1.4285619851353048e-19
late O 0 1.3457503611914029e-14
G1 O 0 2.1743508382687793e-10
and O 0 6.127697226585363e-14
reach O 0 4.050442202947508e-16
a O 0 7.497254052270323e-17
maximum O 0 4.438031774116867e-16
during O 0 2.3978737398455685e-11
S O 0 1.5355630239355378e-05
phase O 0 1.4485140517606077e-12
. O 0 1.4293438394680225e-12

Moreover O 0 1.0498222430266324e-10
, O 0 1.3539177916820078e-13
in O 0 1.8708063069750253e-15
S O 0 2.5832447292373217e-09
phase O 0 4.512978837476703e-16
cells O 0 1.9738029722623065e-15
, O 0 3.59900593519208e-17
BRCA1 O 0 6.987979124387436e-14
polypeptides O 0 1.7097838986637748e-12
are O 0 6.499613808318497e-14
hyperphosphorylated O 0 2.1643565162321465e-08
and O 0 2.3732033699319643e-11
accumulate O 0 1.0487154894489592e-10
into O 0 1.5201202248999943e-14
discrete O 0 6.714929307038986e-11
subnuclear O 0 4.447975243238034e-06
foci O 0 1.9151802632677573e-07
termed O 0 4.2969250380053836e-10
" O 0 3.3611616268025557e-10
BRCA1 O 0 9.332406847306629e-09
nuclear O 0 1.2558706430354505e-07
dots O 0 2.8459325562835147e-07
. O 0 3.690324157368252e-10

" O 0 1.5887167137407232e-08
BRCA1 O 0 2.7410747449607697e-08
associates O 0 1.909606766048455e-07
in O 0 4.3424868600072317e-14
vivo O 0 1.7628694337634698e-10
with O 0 1.232145082578212e-13
a O 0 2.7679444294329697e-14
structurally O 0 1.4961150540671042e-08
related O 0 5.62132426110834e-13
protein O 0 6.16200883721274e-12
termed O 0 8.933723760762291e-10
BARD1 O 0 4.364895721664652e-05
. O 0 1.406506439094457e-10

Here O 0 1.3021313194361284e-10
we O 0 1.0662741306219359e-12
show O 0 3.3505776278475174e-12
that O 0 5.613151816182688e-16
the O 0 2.325458811770737e-16
steady O 0 4.965082598534787e-12
- O 0 2.522764983026171e-12
state O 0 1.1350531517288764e-13
levels O 0 8.493326755874137e-14
of O 0 1.668433325084384e-18
BARD1 O 0 9.858669436368928e-11
, O 0 7.608374187038246e-18
unlike O 0 9.672561219453087e-18
those O 0 1.1704246671239494e-17
of O 0 7.161020953096732e-19
BRCA1 O 0 4.642341198957123e-12
, O 0 4.844421982704364e-14
remain O 0 1.29208492863353e-13
relatively O 0 2.7167671222763385e-16
constant O 0 1.408544640516332e-13
during O 0 2.7975213291731027e-12
cell O 0 2.2352649011736503e-06
cycle O 0 5.240123641669925e-07
progression O 0 1.7588131129286921e-07
. O 0 8.235820914137548e-09

However O 0 1.5831410626887532e-09
, O 0 1.6206855302236534e-11
immunostaining O 0 1.0874710199004767e-07
revealed O 0 3.594821995633879e-09
that O 0 3.6096828109032086e-13
BARD1 O 0 3.254844616051855e-09
resides O 0 1.0873765809212704e-13
within O 0 1.9740710813511696e-18
BRCA1 O 0 8.59966232339554e-13
nuclear O 0 5.653674056693703e-11
dots O 0 5.267934352626291e-11
during O 0 8.016688007872474e-12
S O 0 2.016959577133548e-08
phase O 0 1.258945175383185e-15
of O 0 4.7933458000319785e-18
the O 0 1.5048136619167513e-14
cell O 0 1.912723757158119e-09
cycle O 0 1.4100144662965164e-10
, O 0 5.3624443574764e-16
but O 0 7.514580375904206e-16
not O 0 7.044254214633823e-17
during O 0 1.9437930449273398e-17
the O 0 1.8116217591399828e-16
G1 O 0 6.18903539528759e-10
phase O 0 1.493434011439615e-13
. O 0 1.3391762742134827e-12

Nevertheless O 0 1.2119075520899969e-08
, O 0 1.5280256443830909e-12
BARD1 O 0 1.5465442260165219e-09
polypeptides O 0 3.0853488167115195e-12
are O 0 1.767410053894877e-15
found O 0 3.62000547014129e-16
exclusively O 0 1.1474419699648657e-15
in O 0 1.1589492566604502e-16
the O 0 2.65950822443754e-16
nuclear O 0 1.3428077009700057e-13
fractions O 0 1.2778129972378552e-18
of O 0 3.6953414986405674e-20
both O 0 2.6286729495222576e-17
G1 O 0 1.4928897007493447e-10
- O 0 2.0272796774634116e-09
and O 0 1.933101012596694e-09
S O 0 9.628855224264043e-08
- O 0 1.221959545268797e-13
phase O 0 5.168750686449799e-16
cells O 0 2.0687419401772995e-14
. O 0 2.2786739739565944e-14

Therefore O 0 1.2730681309483516e-12
, O 0 1.231049648748846e-14
progression O 0 2.1819233919639913e-11
to O 0 1.0753182198841582e-11
S O 0 2.284294851051527e-07
phase O 0 1.9507116259223807e-14
is O 0 6.108051991439694e-16
accompanied O 0 4.85085519793876e-15
by O 0 2.4089668201712703e-19
the O 0 8.044812772797123e-19
aggregation O 0 1.8265081355478725e-14
of O 0 1.1307384273054517e-16
nuclear O 0 8.456758904262784e-11
BARD1 O 0 3.439446535739854e-13
polypeptides O 0 7.0137710870489165e-16
into O 0 4.621537121095656e-15
BRCA1 O 0 1.5349772564121622e-09
nuclear O 0 8.394574813053168e-09
dots O 0 2.5811566217726067e-09
. O 0 3.7216996845446104e-11

This O 0 1.8831053524240998e-13
cell O 0 6.355269643876227e-09
cycle O 0 1.088074768063052e-07
- O 0 1.9531301020947467e-08
dependent O 0 8.958785796542301e-11
colocalization O 0 3.8414491143612395e-08
of O 0 2.3655430048732115e-15
BARD1 O 0 3.44134534202567e-08
and O 0 1.6233569393245273e-13
BRCA1 O 0 2.378122113295966e-13
indicates O 0 8.139034240443757e-16
a O 0 1.364350280628286e-19
role O 0 3.75855703160384e-16
for O 0 3.4166334550755735e-17
BARD1 O 0 1.1059491100695595e-08
in O 0 2.0257889841253287e-15
BRCA1 O 0 6.5724083953000445e-09
- O 0 7.844361959996604e-08
mediated O 0 2.067640423319972e-07
tumor B-Disease 0 6.287534779403359e-05
suppression O 0 2.610458977869712e-06
. O 0 2.702046919544898e-10

Ethnic O 0 2.097098139586251e-08
differences O 0 1.4489702770958957e-08
in O 0 2.5854466069691155e-14
the O 0 7.334242805093205e-14
HFE O 0 2.014230631175451e-07
codon O 0 1.0786548737540258e-10
282 O 0 2.2302373281490873e-09
( O 0 2.249621496031029e-12
Cys O 0 0.0001272401714231819
/ O 0 1.2961268680555804e-07
Tyr O 0 3.853754204641291e-09
) O 0 2.6916473607266345e-13
polymorphism O 0 2.9584343308464156e-10
. O 0 5.932372648675965e-11

Recent O 0 3.487373801194793e-12
studies O 0 8.430467153368315e-13
have O 0 3.739313817353179e-13
shown O 0 8.960887587505795e-11
that O 0 2.533345480060234e-07
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
( O 0 1.943319993813475e-08
HH B-Disease 0 0.2781984806060791
) O 0 3.641478936965148e-13
is O 0 7.207268669948228e-15
likely O 0 6.314052606497603e-14
to O 0 4.54933137399049e-15
be O 0 4.4778826371709435e-13
caused O 0 1.8760761173741702e-12
by O 0 3.258870590799255e-16
homozygosity O 0 4.88634022133283e-10
for O 0 3.356536798340126e-17
a O 0 4.546486613837136e-15
Cys282Tyr O 0 6.391711049325011e-10
mutation O 0 1.2878725321428808e-13
in O 0 8.652825897402495e-16
the O 0 8.670172602766671e-16
HFE O 0 4.470548237156535e-11
gene O 0 1.7283742525294604e-13
located O 0 8.541629860012168e-13
4 O 0 1.1726232485020915e-10
. O 0 8.619902708284499e-11

5 O 0 8.287166092246778e-11
Mb O 0 2.8381583305758795e-08
telomeric O 0 3.0027518960196176e-07
to O 0 1.1819969916032624e-12
HLA O 0 2.910322116633779e-08
- O 0 1.0470001399198736e-07
A O 0 3.4779115698491125e-10
. O 0 2.5153622240647877e-11

Population O 0 3.6533859271159486e-11
studies O 0 3.331007344953285e-13
of O 0 4.269474533718976e-18
this O 0 3.557562780296132e-18
polymorphism O 0 1.1334640205110384e-15
are O 0 1.0407982479860454e-18
facilitated O 0 3.3859354590547506e-17
by O 0 4.948036664405785e-16
the O 0 5.542679733762314e-16
fact O 0 2.1428451257876104e-15
that O 0 5.666463540487281e-16
the O 0 8.6002399744545795e-16
Cys282Tyr O 0 8.736967260780659e-10
mutation O 0 7.297766855879004e-14
creates O 0 8.650425617788213e-14
a O 0 3.92549541998596e-15
Rsal O 0 2.527930920148691e-10
restriction O 0 4.385614321786996e-13
site O 0 6.758413828578114e-10
. O 0 1.362670566662505e-11

We O 0 4.079013862789971e-11
have O 0 1.4344277650987607e-14
studied O 0 4.075941176912533e-15
the O 0 2.0586799087419236e-15
codon O 0 2.8050658584105603e-12
282 O 0 2.2549291600615362e-10
( O 0 1.2692173429872805e-13
Cys O 0 2.662623501237249e-06
/ O 0 1.1717293801893902e-09
Tyr O 0 3.2958094586810205e-11
) O 0 6.425942927148641e-16
polymorphism O 0 5.91424153574549e-14
in O 0 2.2152879494737794e-17
different O 0 7.242179344627551e-17
ethnic O 0 4.4702939673525385e-14
groups O 0 7.261707646874851e-14
. O 0 1.7997297445740412e-12

In O 0 8.585891193976444e-14
agreement O 0 1.3279452204203492e-14
with O 0 1.4060744383322544e-14
previous O 0 4.438529350916237e-13
observations O 0 9.168027665165668e-13
the O 0 1.525508201477479e-14
Tyr O 0 1.6353129787816112e-12
allele O 0 1.3271488942534493e-12
appeared O 0 1.5528808794407212e-10
to O 0 3.630392952810825e-15
be O 0 3.4801454015939096e-15
rare O 0 1.5681617313825953e-14
or O 0 8.04585478103581e-12
absent O 0 1.864206185253625e-11
in O 0 4.272657802648766e-15
Asiatic O 0 8.207421409167637e-09
( O 0 1.0786206224097926e-16
Indian O 0 5.693377271232458e-15
, O 0 1.3720350852699484e-16
Chinese O 0 1.7607326814134345e-17
) O 0 2.124182342981638e-16
populations O 0 4.355898271474288e-15
. O 0 7.504948404271974e-14

The O 0 4.48952805270561e-14
highest O 0 4.750988014459723e-13
allele O 0 3.887573856581339e-13
frequency O 0 7.824233448638918e-12
( O 0 2.8615854040595903e-16
7 O 0 2.8974506848704687e-15
. O 0 9.316651970912794e-16
5 O 0 7.564773324897009e-15
% O 0 5.120978226748003e-17
) O 0 2.5239919526019164e-16
was O 0 4.5841646451050266e-11
found O 0 6.228725001056201e-12
in O 0 2.4145482230915512e-14
Swedes O 0 1.7893731296680926e-07
. O 0 1.810296530735389e-11

Saamis O 0 1.7429421461656602e-07
( O 0 4.340543224325144e-13
2 O 0 6.1407493673337754e-12
% O 0 6.771432102103264e-14
) O 0 1.4237129677225832e-14
and O 0 1.857057693385733e-12
Mordvinians O 0 1.8844330609835147e-11
( O 0 4.839995064267213e-19
1 O 0 4.1209597865054265e-19
. O 0 3.995333312956857e-17
8 O 0 4.053891215229609e-15
% O 0 7.30073082797875e-18
) O 0 2.5409645076314224e-17
had O 0 1.453777961728242e-13
significantly O 0 2.7662317288136215e-16
lower O 0 2.096656518435507e-17
frequencies O 0 1.385120994680869e-13
of O 0 4.1044592807040376e-17
the O 0 2.1554072003777958e-13
Tyr O 0 3.8698391713332114e-10
allele O 0 6.886372722059164e-11
. O 0 1.9403392087502525e-11

Comparisons O 0 2.6824067056105405e-13
with O 0 1.3452209867751926e-15
allele O 0 6.249472781719861e-14
frequencies O 0 1.417968254749033e-13
based O 0 1.8648707235971408e-15
on O 0 3.0672315382007653e-11
prevalence O 0 9.18780962422261e-09
estimates O 0 5.106865451354192e-13
of O 0 4.304378763006966e-15
HH B-Disease 0 0.43160900473594666
showed O 0 6.825652043573882e-09
some O 0 5.844055843105517e-18
disagreements O 0 1.1601100126119174e-13
with O 0 2.819670441885854e-17
the O 0 1.6095874274736626e-17
RFLP O 0 1.1866159096984852e-13
data O 0 2.1881643361403719e-13
, O 0 3.422348479014927e-16
particularly O 0 3.104065525870079e-16
in O 0 7.280714049771701e-16
Finns O 0 8.783320737393296e-09
. O 0 1.3068157667106561e-11

The O 0 2.468187113024989e-12
newly O 0 3.2891011962632444e-12
described O 0 1.3273641083846877e-12
HFE O 0 4.1236420528223405e-11
marker O 0 4.046064698559615e-12
provides O 0 3.626029594931942e-17
a O 0 1.565489663876394e-18
new O 0 4.406665747033346e-18
approach O 0 1.3768593614210353e-15
to O 0 1.5165267961473643e-17
the O 0 9.890986325208686e-19
screening O 0 1.202746815733908e-16
of O 0 5.317340316256251e-18
HH B-Disease 0 4.1081413826304924e-09
as O 0 8.026677966968434e-16
well O 0 4.811487541770104e-16
as O 0 1.4351357575877232e-15
studies O 0 5.556315905421924e-15
of O 0 2.8467736143620983e-19
the O 0 1.9996909990479172e-16
relationship O 0 1.6072713093177177e-13
between O 0 1.2904081083298276e-16
the O 0 1.5223527284632487e-16
HFE O 0 1.3953532773669508e-10
Tyr O 0 4.0821464047588463e-13
allele O 0 1.582378672537743e-11
and O 0 1.0819928980554394e-10
different O 0 2.8228055309886813e-11
disorders O 0 1.629903294997348e-06
including O 0 3.2657967042465375e-12
cancer B-Disease 0 5.57569510419853e-05

Autosomal B-Disease 1 0.9995324611663818
dominant I-Disease 1 0.9995976090431213
neurohypophyseal I-Disease 1 0.9995400905609131
diabetes I-Disease 1 0.9998160004615784
insipidus I-Disease 1 0.9846353530883789
associated O 0 1.7610462421657758e-08
with O 0 3.666135320670727e-13
a O 0 7.185608343421041e-15
missense O 0 2.7360130220449586e-12
mutation O 0 6.80548197954994e-15
encoding O 0 2.955175709175306e-13
Gly23 O 0 1.2361931567284046e-06
- O 0 3.9269921217055526e-06
- O 0 4.566993538901443e-06
> O 0 2.365738716036958e-10
Val O 0 1.3381914243382198e-07
in O 0 1.5314941155530892e-13
neurophysin O 0 1.700196321507974e-07
II O 0 8.109436748782173e-07
. O 0 6.306272344602792e-12

Autosomal B-Disease 1 0.9993651509284973
dominant I-Disease 1 0.9996888637542725
neurohypophyseal I-Disease 1 0.9996337890625
diabetes I-Disease 1 0.9998676776885986
insipidus I-Disease 1 0.9990478157997131
( O 0 5.652016632495815e-10
ADNDI B-Disease 0 4.7123512558755465e-06
) O 0 2.437729705595526e-12
is O 0 9.921570943288716e-13
an O 0 1.9233401538087946e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 9.331573528470472e-05
by O 0 1.4494593676347978e-12
progressive O 0 2.3478770927454207e-08
degeneration O 0 7.908115549071226e-07
of O 0 8.135867925407802e-16
the O 0 1.9481200439169614e-14
magnocellular O 0 3.8089276177544207e-10
neurons O 0 5.741090654091952e-13
of O 0 8.22677573647187e-17
the O 0 1.636721933386074e-14
hypothalamus O 0 3.3088164153038946e-11
leading O 0 1.4184627084024015e-10
to O 0 2.3826361890411096e-12
decreased O 0 6.4433593009727286e-12
ability O 0 1.9114881118914573e-12
to O 0 3.830369723657745e-13
produce O 0 9.245816596061343e-14
the O 0 2.117812761097404e-14
hormone O 0 1.12154111952395e-12
arginine O 0 1.9072189574170784e-13
vasopressin O 0 1.8745156251873119e-13
( O 0 1.6460683755057417e-16
AVP O 0 8.948078389359182e-11
) O 0 2.760764707121499e-13
. O 0 9.819212500386532e-13

Affected O 0 2.0467972802751255e-11
individuals O 0 2.3059550840668188e-15
are O 0 2.427021503217876e-16
not O 0 3.9662872561763065e-15
symptomatic O 0 1.3866383356212625e-13
at O 0 5.908542752286472e-12
birth O 0 2.711929292242843e-10
, O 0 1.7052764365518835e-12
but O 0 4.898739400238661e-11
usually O 0 2.0214635521043078e-10
develop O 0 1.888716127940171e-10
diabetes B-Disease 0 5.487047616270502e-08
insipidus I-Disease 0 3.9016981645545457e-07
at O 0 2.3992383080262414e-10
1 O 0 8.880501043730116e-13
- O 0 1.163182560048881e-06
6 O 0 5.813243220131881e-09
yr O 0 4.898047336610034e-05
of O 0 2.1935746066250282e-14
age O 0 4.543582524108025e-11
. O 0 8.796245524501922e-13

The O 0 3.1515859800351764e-14
genetic O 0 7.258446881736047e-12
locus O 0 1.9465613565472495e-09
of O 0 1.998534936717769e-13
the O 0 1.6389618828771546e-10
disease O 0 5.629039456778173e-09
is O 0 9.425508198370944e-15
the O 0 8.128462231646663e-14
AVP O 0 2.4997893888212275e-06
- O 0 8.778450137469918e-06
neurophysin O 0 7.672827450733166e-06
II O 0 1.4310401184047805e-06
( O 0 7.678593483063424e-16
NPII O 0 1.4313560059431296e-10
) O 0 3.3076765630455987e-17
gene O 0 2.6317173063721867e-14
, O 0 8.406697647039829e-14
and O 0 5.620874317206759e-13
mutations O 0 8.855501510036945e-13
that O 0 2.1830556459767614e-11
cause O 0 2.0908006229114484e-11
ADNDI B-Disease 0 6.218457571094405e-08
have O 0 4.094945736665689e-12
been O 0 1.478146771649591e-11
found O 0 2.2826358858640816e-11
in O 0 7.850167418068071e-16
both O 0 7.869232541523989e-17
the O 0 9.140002985065114e-17
signal O 0 9.63800111768165e-13
peptide O 0 1.0441720306729766e-15
of O 0 1.8220636932480855e-19
the O 0 2.5237621949149736e-15
prepro O 0 9.670834799635486e-09
- O 0 4.5258366498934777e-10
AVP O 0 7.250809375136669e-08
- O 0 4.687056076591034e-09
NPII O 0 2.6895332627674406e-09
precursor O 0 1.318828672571687e-13
and O 0 6.024618304234508e-12
within O 0 1.0030601219076867e-15
NPII O 0 5.048921636330306e-08
itself O 0 3.9451417133129496e-10
. O 0 2.1348159785078424e-12

An O 0 2.019264963570855e-12
affected O 0 2.1021689597389148e-11
girl O 0 6.429768717453044e-08
who O 0 6.581678561531912e-13
presented O 0 3.644796748078884e-15
at O 0 2.465860123783501e-14
9 O 0 1.498889682890244e-14
months O 0 1.0299664834662221e-14
of O 0 2.412795187822046e-17
age O 0 4.7695056237806455e-11
and O 0 1.1680960365634263e-10
her O 0 6.122166240629667e-08
similarly O 0 7.582582131626658e-12
affected O 0 4.084284027926514e-15
younger O 0 3.2431381798841974e-13
brother O 0 1.7374729432972913e-10
and O 0 1.4261828697181844e-11
father O 0 7.547094615922845e-10
were O 0 2.449289957049544e-14
all O 0 6.686787451174542e-18
found O 0 1.2508645869454974e-15
to O 0 1.6385005331687186e-16
have O 0 5.83840222905484e-16
a O 0 1.2402113476887616e-16
novel O 0 1.1442435269692214e-13
missense O 0 1.0891502977283807e-11
mutation O 0 3.5199631837762313e-13
( O 0 1.2443729264377404e-15
G1758 O 0 5.1259170519291075e-12
- O 0 1.1044044612162907e-07
- O 0 1.2167573686383548e-06
> O 0 2.6435941977154265e-11
T O 0 4.041315546099433e-11
) O 0 1.2603504131756424e-19
encoding O 0 1.4644490867639471e-19
the O 0 1.2011814084779e-19
amino O 0 3.744814137101598e-18
acid O 0 1.9332838393219455e-18
substitution O 0 2.6651523589983974e-18
Gly23 O 0 3.926267644338566e-11
- O 0 8.52231440973128e-09
- O 0 1.5828977950604894e-07
> O 0 9.643430151640153e-12
Val O 0 1.5427415789304177e-08
within O 0 1.6803314382279888e-12
NPII O 0 6.468802439485444e-06
. O 0 1.1697364431240143e-11

The O 0 9.997802282238344e-13
mutation O 0 3.429111812211505e-12
was O 0 5.522622636977559e-11
confirmed O 0 1.1635929612690502e-14
by O 0 1.027535751032253e-17
restriction O 0 3.584595575418679e-15
endonuclease O 0 1.8537339441238032e-09
analysis O 0 5.521990850687608e-11
. O 0 1.1734055567480528e-11

A O 0 1.1620638262418992e-12
T1 O 0 3.454404096103758e-09
- O 0 6.0968326741350776e-12
weighted O 0 1.2463878907643163e-14
magnetic O 0 1.5464497358456258e-13
resonance O 0 3.952398304474247e-12
imaging O 0 1.47339973555205e-09
of O 0 4.8150543339835206e-14
the O 0 2.7211092754053645e-11
fathers O 0 2.1429535479455808e-07
pituitary O 0 5.062342101069817e-09
gland O 0 3.141492066482954e-10
demonstrates O 0 1.171140007888427e-12
an O 0 7.018564975893021e-15
attenuated O 0 3.060928429476917e-05
posterior O 0 0.0007378953159786761
pituitary O 0 0.009927231818437576
bright O 0 5.191261607251363e-06
spot O 0 1.6683241483406164e-05
. O 0 9.943541545709422e-10

This O 0 1.4351974469972717e-13
mutation O 0 1.5711231957354216e-13
may O 0 8.945875791988196e-15
be O 0 4.566289336003027e-20
valuable O 0 1.8823418954484731e-19
for O 0 1.0643790992984008e-18
developing O 0 2.6561434919336905e-15
models O 0 2.095434719837086e-12
of O 0 1.1127844522576535e-14
dominantly B-Disease 0 4.603523109381058e-07
inherited I-Disease 0 0.02045784890651703
neurodegeneration I-Disease 1 0.9999991655349731
, O 0 1.974609644089624e-14
as O 0 9.877267741544647e-18
the O 0 1.3170844845613157e-16
early O 0 4.208126902494058e-11
age O 0 1.3385648145458617e-10
of O 0 1.2750103198981653e-15
onset O 0 1.1856578219227032e-11
of O 0 2.5283164369624758e-14
symptoms O 0 3.541435547593785e-11
suggests O 0 8.498326029032126e-16
that O 0 8.563904590357975e-15
this O 0 2.2275778549079575e-15
mutation O 0 4.856654900291246e-13
may O 0 3.704843376528544e-11
be O 0 4.898965822309857e-14
particularly O 0 3.3635898564034553e-15
deleterious O 0 2.2286679609000853e-13
to O 0 6.3705571579694e-14
the O 0 1.8252404660390117e-14
magnocellular O 0 9.017988022996803e-10
neuron O 0 6.54233472952015e-11
. O 0 2.5280296519353262e-12
. O 0 1.4901473111006425e-10

Frequent O 0 1.9431227737953805e-09
inactivation O 0 4.059337399553442e-08
of O 0 1.8989719735920674e-13
PTEN O 0 8.527999284524412e-07
/ O 0 2.4722073703742353e-06
MMAC1 O 0 4.114693365409039e-05
in O 0 1.4517953679515916e-11
primary O 0 4.2063173168571666e-05
prostate B-Disease 1 0.9999946355819702
cancer I-Disease 1 0.9999921321868896
. O 0 2.471400932790857e-07

Sporadic B-Disease 0 0.00010015755833592266
prostate I-Disease 1 0.8188735842704773
carcinoma I-Disease 1 0.999998927116394
is O 0 3.2901601443313666e-09
the O 0 1.1250140359228555e-12
most O 0 3.5489530151450177e-12
common O 0 4.421200294757455e-09
male B-Disease 0 2.5267968339903746e-07
cancer I-Disease 0 3.720850016986077e-10
in O 0 1.460734236748227e-14
the O 0 2.658484326775734e-12
Western O 0 6.867776902730327e-10
world O 0 3.938947834569717e-09
, O 0 7.087928503943675e-15
yet O 0 5.932108425218399e-16
many O 0 4.144164787626953e-19
of O 0 4.7656282314009424e-20
the O 0 3.716594953222413e-17
major O 0 8.84538391562251e-18
genetic O 0 1.099479788117775e-15
events O 0 6.691182824251852e-16
involved O 0 4.657992664756763e-17
in O 0 5.5821836960610294e-18
the O 0 1.5925610659996712e-15
progression O 0 8.509214166618762e-11
of O 0 1.2321348673608682e-14
this O 0 2.2370101604440862e-10
often O 0 1.5941606761771254e-05
fatal O 0 0.00012609873374458402
cancer B-Disease 0 6.673428742942633e-07
remain O 0 9.29800056392871e-11
to O 0 6.544746434253637e-14
be O 0 5.336963510016446e-13
elucidated O 0 9.719787641415678e-08
. O 0 1.411308570009595e-10

Numerous O 0 1.1106111863501411e-10
cytogenetic O 0 2.7845301246998133e-06
and O 0 4.741356196547031e-09
allelotype O 0 2.203293405500517e-07
studies O 0 5.7586192758751764e-12
have O 0 7.976783838493928e-13
reported O 0 2.5934121170023694e-11
frequent O 0 7.481035235734623e-11
loss O 0 4.8930151597126326e-11
of O 0 2.5049040651355407e-16
heterozygosity O 0 6.881045733209135e-10
on O 0 2.869806969840738e-08
chromosomal O 1 0.9887858629226685
arm O 1 0.763799250125885
10q O 0 2.2228149987313373e-08
in O 0 3.0948599802696486e-13
sporadic B-Disease 0 1.3534431673178915e-06
prostate I-Disease 1 0.9999953508377075
cancer I-Disease 1 0.9999923706054688
. O 0 3.0932631034374936e-07

Deletion O 0 1.4726868613479382e-08
mapping O 0 6.116703588077144e-08
studies O 0 2.075521310374029e-09
have O 0 1.9438795191561997e-12
unambiguously O 0 1.8413580660237017e-09
identified O 0 1.4412880611214263e-12
a O 0 1.3760068862870949e-14
region O 0 5.162758241750165e-13
of O 0 1.3556210425900382e-16
chromosome O 0 3.509485591024486e-09
10q23 O 0 1.3724410063281622e-12
to O 0 3.548893771966621e-15
be O 0 2.48798167033838e-16
the O 0 3.8696630712141257e-17
minimal O 0 1.9131602836783453e-14
area O 0 8.529908008224341e-13
of O 0 1.1168001202641054e-12
loss O 0 9.657014032882216e-08
. O 0 1.3164800846676705e-11

A O 0 1.7215940045084421e-12
new O 0 8.103752247696182e-15
tumor B-Disease 0 1.0204213776038307e-12
suppressor O 0 1.5194153227260365e-11
gene O 0 1.0800068304950283e-11
, O 0 2.6632686399123695e-13
PTEN O 0 1.946079741799167e-08
/ O 0 2.5556457217135176e-07
MMAC1 O 0 1.1540058039827272e-05
, O 0 1.503501099661686e-12
was O 0 3.828876452005581e-11
isolated O 0 4.890403013102507e-11
recently O 0 8.594849831844442e-11
at O 0 1.8684046551673689e-13
this O 0 4.558394825049458e-17
region O 0 8.631402104825828e-15
of O 0 2.6448079676379414e-16
chromosome O 0 3.106471169189717e-08
10q23 O 0 1.729827045493515e-11
and O 0 8.034716555277432e-13
found O 0 4.107972151329428e-15
to O 0 4.241715179542309e-18
be O 0 3.7065952908743513e-19
inactivated O 0 2.4448441352192905e-16
by O 0 1.5277083703437935e-19
mutation O 0 9.279127352558245e-16
in O 0 8.871760070290266e-14
three O 0 9.267082390351788e-08
prostate B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999992847442627
cell O 0 2.3178723495220765e-05
lines O 0 2.5156211336252454e-07
. O 0 1.019673789848241e-09

We O 0 7.232601628714974e-09
screened O 0 9.983991589024299e-08
80 O 0 3.8813116609581755e-10
prostate B-Disease 0 0.003804105333983898
tumors I-Disease 1 0.999998927116394
by O 0 5.8773853839344525e-12
microsatellite O 0 3.2147030992746295e-07
analysis O 0 6.513473094216238e-11
and O 0 2.312654928671165e-11
found O 0 4.175695379748934e-12
chromosome O 0 7.043016170271699e-10
10q23 O 0 6.582281377939814e-13
to O 0 3.7415071583481174e-15
be O 0 1.441879833913762e-15
deleted O 0 1.098899183454849e-11
in O 0 4.492626753336551e-15
23 O 0 6.239729869947364e-14
cases O 0 3.048127004165284e-14
. O 0 4.2831149326023887e-13

We O 0 4.074649471996761e-12
then O 0 2.2675356601067898e-14
proceeded O 0 7.405140648624516e-15
with O 0 2.5964926458437396e-17
sequence O 0 8.457382573944221e-16
analysis O 0 2.6449998735400538e-16
of O 0 1.1100639743369748e-19
the O 0 2.275899112550235e-17
entire O 0 1.8544719118619366e-14
PTEN O 0 4.489006666386075e-10
/ O 0 9.529972297417366e-12
MMAC1 O 0 8.408447826901977e-10
coding O 0 1.930272475192396e-08
region O 0 9.346007995292283e-11
and O 0 1.2265093454755238e-11
tested O 0 3.6436885409926734e-13
for O 0 3.3455526669860343e-19
homozygous O 0 1.2141937778017801e-15
deletion O 0 1.192283034454067e-13
with O 0 5.951335480198008e-14
new O 0 4.831469425925494e-13
intragenic O 0 9.264723987989498e-10
markers O 0 6.223198067978331e-10
in O 0 3.0465136075710894e-16
these O 0 2.2085134726058681e-16
23 O 0 1.6338818213260185e-16
cases O 0 1.11043412111748e-16
with O 0 2.560052389803842e-14
10q23 O 0 9.699092640147455e-10
loss O 0 4.984175572264604e-11
of O 0 1.810648544753367e-15
heterozygosity O 0 4.3764978308047375e-09
. O 0 3.151995053851664e-10

The O 0 2.6921629327409692e-15
identification O 0 4.790394155570338e-14
of O 0 5.342883190350746e-16
the O 0 6.710821134903178e-14
second O 0 3.3380069541788515e-11
mutational O 0 3.142212490203633e-09
event O 0 3.5438462060721765e-12
in O 0 1.5336907938578396e-15
10 O 0 1.3289104991670402e-14
( O 0 8.509350559887335e-17
43 O 0 7.061410050440697e-12
% O 0 3.070008440173022e-13
) O 0 3.7573355538000897e-10
tumors B-Disease 1 0.9999979734420776
establishes O 0 2.7777253830407744e-09
PTEN O 0 1.5563344391011924e-07
/ O 0 1.612563238495568e-08
MMAC1 O 0 2.3371137913841267e-08
as O 0 1.7344687308179204e-15
a O 0 7.331686904350689e-17
main O 0 2.963720509784572e-14
inactivation O 0 8.623393665807555e-10
target O 0 6.412341577860525e-12
of O 0 3.0132728583472785e-16
10q O 0 1.8901144538396863e-10
loss O 0 1.8579666971607622e-10
in O 0 5.541871283165807e-14
sporadic B-Disease 0 3.913162072421983e-05
prostate I-Disease 1 0.9999995231628418
cancer I-Disease 1 0.9999992847442627
. O 0 1.11284306214543e-08
. O 0 1.3056829228919042e-10

Risk O 0 1.5106897954808574e-09
reversals O 0 4.871466771638744e-11
in O 0 5.132519381526588e-16
predictive O 0 1.1433147180731074e-12
testing O 0 3.358338563838603e-12
for O 0 1.0731935305707818e-11
Huntington B-Disease 1 0.9999779462814331
disease I-Disease 1 0.9999953508377075
. O 0 1.354871859149398e-08

The O 0 6.818808984183802e-16
first O 0 8.493556704143492e-17
predictive O 0 1.804252006045587e-13
testing O 0 6.907970289543597e-12
for O 0 1.3025984457737394e-10
Huntington B-Disease 1 0.9999984502792358
disease I-Disease 1 0.9999994039535522
( O 0 2.0864460722693932e-15
HD B-Disease 0 1.3797456510644679e-08
) O 0 3.81920813334255e-13
was O 0 2.1374521076700237e-12
based O 0 1.0097469838051164e-17
on O 0 3.888204049094096e-13
analysis O 0 8.89014652977302e-16
of O 0 1.0025303008346252e-19
linked O 0 1.5072180496408273e-14
polymorphic O 0 1.0948674819617385e-15
DNA O 0 1.8863235626276342e-12
markers O 0 4.5482822369491416e-11
to O 0 7.617767094209027e-15
estimate O 0 9.534280146050842e-16
the O 0 4.896753385486519e-17
likelihood O 0 9.117719930503017e-16
of O 0 1.564027973695467e-17
inheriting O 0 2.1726947498079685e-12
the O 0 1.6936693772101673e-15
mutation O 0 2.0885323144184805e-15
for O 0 1.5301727483905373e-15
HD B-Disease 0 3.437073019085801e-06
. O 0 5.815203318881856e-10

Limits O 0 2.0798814059919124e-12
to O 0 1.7180519617507111e-15
accuracy O 0 1.3736233355735213e-14
included O 0 1.098417581504958e-18
recombination O 0 5.286337917770009e-17
between O 0 1.9610357240576812e-16
the O 0 6.613725896390183e-18
DNA O 0 4.30051800377404e-13
markers O 0 2.7839031080389987e-10
and O 0 1.5080552908872114e-13
the O 0 2.0170206314042502e-16
mutation O 0 1.551554295198959e-14
, O 0 1.7652994680188855e-13
pedigree O 0 1.3542543086941805e-08
structure O 0 8.767168306438033e-13
, O 0 4.076983027437656e-15
and O 0 2.7145512840863213e-15
whether O 0 4.65736847426653e-18
DNA O 0 1.4648726025592862e-13
samples O 0 5.084665869771465e-13
were O 0 6.780756558423995e-16
available O 0 7.493618593478152e-18
from O 0 4.965145671149138e-17
family O 0 2.1100614745056534e-12
members O 0 6.867916778092054e-15
. O 0 4.402357181598239e-14

With O 0 8.934796262224931e-14
direct O 0 1.974677576131994e-14
tests O 0 1.1227583668555266e-13
for O 0 3.9504545978035194e-19
the O 0 1.967801465898324e-17
HD B-Disease 0 9.89401338635787e-10
mutation O 0 1.2666346378871485e-13
, O 0 2.6464847752361497e-15
we O 0 8.159987188580868e-16
have O 0 5.163719641615353e-18
assessed O 0 7.693655681011851e-18
the O 0 3.062698819006343e-16
accuracy O 0 6.887900805274683e-10
of O 0 1.918944671675145e-15
results O 0 3.162065577537725e-16
obtained O 0 3.627245302278211e-18
by O 0 6.922454309618196e-19
linkage O 0 2.679362909655241e-14
approaches O 0 3.97713749412075e-14
when O 0 1.0368019546472696e-14
requested O 0 2.6283119679029394e-17
to O 0 3.0336210567237856e-14
do O 0 3.797067437490316e-14
so O 0 8.039943429364723e-17
by O 0 3.6914423760281455e-18
the O 0 1.1329285898092553e-14
test O 0 5.585950105246873e-12
individuals O 0 4.0211889936717945e-17
. O 0 1.3585318342555861e-14

For O 0 1.1871004125443146e-13
six O 0 2.326108835442372e-14
such O 0 8.618326973379766e-18
individuals O 0 7.450837308505277e-17
, O 0 3.848363964534273e-16
there O 0 1.4640603180799018e-16
was O 0 7.488890014844748e-14
significant O 0 8.054090533945095e-18
disparity O 0 7.528902326613737e-15
between O 0 5.355741891643895e-15
the O 0 3.342120634061696e-12
tests O 0 6.426232324052705e-10
. O 0 1.9580113897431362e-13

Three O 0 8.144676599819434e-11
went O 0 1.4157828687189067e-08
from O 0 1.7789980575363788e-14
a O 0 1.7467000136312145e-14
decreased O 0 8.971652630876403e-13
risk O 0 1.6523329200105602e-14
to O 0 2.1103066198166324e-16
an O 0 5.258264069524449e-16
increased O 0 8.847427185407902e-14
risk O 0 3.454187890578053e-12
, O 0 1.918051687190502e-15
while O 0 2.3848934302015887e-14
in O 0 1.0156033398239306e-17
another O 0 3.476070220205551e-16
three O 0 3.7414072084603414e-15
the O 0 1.7939652584633703e-12
risk O 0 4.859755306507729e-11
was O 0 6.616601017084278e-11
decreased O 0 1.2018669046098829e-11
. O 0 1.4265085423667556e-12

Knowledge O 0 4.805022265491621e-12
of O 0 1.3851566844141016e-15
the O 0 3.2001937068671933e-16
potential O 0 2.844173053642002e-16
reasons O 0 6.835495913747794e-18
for O 0 1.796080528491117e-20
these O 0 7.729578646089926e-17
changes O 0 8.588137858871786e-17
in O 0 2.500885952592003e-15
results O 0 1.4346493489177624e-14
and O 0 2.5261353338995596e-12
impact O 0 2.469657118376158e-15
of O 0 1.9686565638565506e-18
these O 0 7.385026157226068e-15
risk O 0 4.670844603021224e-15
reversals O 0 6.580997411517048e-14
on O 0 2.6801885363858524e-12
both O 0 2.144584253834913e-14
patients O 0 1.256306455994251e-15
and O 0 3.920422539664854e-15
the O 0 2.753388062355286e-16
counseling O 0 6.223521047468705e-13
team O 0 1.3051807599766366e-16
can O 0 5.02558492541479e-19
assist O 0 3.590365041077228e-18
in O 0 2.9515404850377318e-18
the O 0 3.496589394829439e-17
development O 0 1.6980520003323113e-19
of O 0 7.860096362677614e-21
strategies O 0 7.20660131386491e-17
for O 0 1.8513342143154203e-21
the O 0 6.3488432255063085e-18
prevention O 0 4.7293857605113995e-14
and O 0 2.5396489331154385e-15
, O 0 1.3694558203147223e-18
where O 0 3.006942974515002e-18
necessary O 0 1.6748043322008134e-17
, O 0 4.0540419606244405e-17
management O 0 4.028174699380927e-17
of O 0 7.525063657669203e-20
a O 0 1.2947584695469257e-14
risk O 0 1.1504278161610787e-13
reversal O 0 1.0346487121920545e-14
in O 0 2.7455698758738254e-19
any O 0 1.8010832909864436e-19
predictive O 0 1.0720455556265107e-15
testing O 0 1.4062407108998004e-14
program O 0 3.8990243867755014e-13
. O 0 3.647507041751861e-16
. O 0 2.669619489662975e-14

A O 0 6.549473203359968e-12
novel O 0 1.431766814483093e-12
common O 0 7.51318712105542e-13
missense O 0 3.056182737437574e-11
mutation O 0 6.926384921342177e-13
G301C O 0 2.457117322107738e-11
in O 0 1.373775208580964e-14
the O 0 3.2732971606656835e-13
N O 0 1.2102586310902552e-07
- O 0 2.1005013195463107e-07
acetylgalactosamine O 0 8.044778951443732e-06
- O 0 1.2181880393313804e-08
6 O 0 1.0018538949829736e-11
- O 0 5.856474333265638e-11
sulfate O 0 6.527676316148145e-11
sulfatase O 0 2.3189282438718095e-10
gene O 0 2.6435526944562637e-12
in O 0 1.0410187387685857e-14
mucopolysaccharidosis B-Disease 0 3.6316802010105675e-08
IVA I-Disease 0 5.842920927534578e-06
. O 0 1.6072308761660992e-10

Mucopolysaccharidosis B-Disease 0 0.0005829022265970707
IVA I-Disease 1 0.8917161822319031
( O 0 4.4691401512864104e-07
MPS B-Disease 1 0.9999845027923584
IVA I-Disease 1 0.999993085861206
) O 0 3.4844334084738193e-09
is O 0 5.551261273578634e-12
an O 0 1.6074813355415607e-11
autosomal B-Disease 1 0.9999761581420898
recessive I-Disease 1 0.9999732971191406
lysosomal I-Disease 1 0.9999798536300659
storage I-Disease 1 0.9998948574066162
disorder I-Disease 1 0.9998764991760254
caused O 0 5.152284998644063e-08
by O 0 8.057963340633509e-14
a O 0 4.6121620411732067e-10
genetic B-Disease 1 0.9999994039535522
defect I-Disease 1 0.9999992847442627
in O 0 4.653671111659596e-12
N O 0 9.953683388630452e-08
- O 0 2.8312277322584123e-07
acetylgalactosamine O 0 8.65314868860878e-05
- O 0 5.107939955451002e-07
6 O 0 1.9400749895481795e-09
- O 0 1.014357735584781e-07
sulfate O 0 2.0944203527051286e-07
sulfatase O 0 8.517554874742927e-07
( O 0 1.3515020537164385e-14
GALNS O 0 5.4374642566301645e-09
) O 0 6.902747958729277e-14
. O 0 9.40902358196466e-14

In O 0 1.1997025768650804e-11
previous O 0 1.0372783361412008e-11
studies O 0 7.183971841885628e-13
, O 0 8.158218160270528e-15
we O 0 3.253135743641958e-14
have O 0 8.427335138931559e-16
found O 0 2.4065283880920054e-15
two O 0 1.2974325525614075e-15
common O 0 7.929594756323291e-16
mutations O 0 2.4956061844735302e-15
in O 0 4.874075335638316e-16
Caucasians O 0 1.492979242838366e-12
and O 0 5.8562586204014e-12
Japanese O 0 3.948815163745678e-10
, O 0 1.8948824985227236e-14
respectively O 0 6.740817756409334e-13
. O 0 1.7331154957347938e-12

To O 0 1.3924638894192987e-13
characterize O 0 3.3664191226301377e-12
the O 0 4.689268416656952e-15
mutational O 0 1.3405603016547474e-10
spectrum O 0 1.532926211097671e-13
in O 0 2.6467937056882424e-18
various O 0 9.056868769243636e-19
ethnic O 0 1.8735413763617094e-15
groups O 0 3.626086637306984e-16
, O 0 3.4439168495277775e-17
mutations O 0 1.018898380706811e-16
in O 0 2.0380338975516288e-17
the O 0 1.3988558541491638e-16
GALNS O 0 9.671637102304231e-11
gene O 0 4.2569768511028366e-14
in O 0 1.64644383874148e-14
Colombian O 0 1.0125733069799026e-06
MPS B-Disease 1 0.9999992847442627
IVA I-Disease 1 0.9999988079071045
patients O 0 4.669146180802386e-10
were O 0 1.973345803169685e-13
investigated O 0 1.262676920486816e-12
, O 0 9.009064111040188e-14
and O 0 5.106124941270385e-13
genetic O 0 2.7233522728598025e-11
backgrounds O 0 5.569686031825505e-11
were O 0 5.328231532066496e-15
extensively O 0 1.6012487017748323e-14
analyzed O 0 3.982703923599562e-13
to O 0 8.293679904360172e-15
identify O 0 3.896184861285762e-13
racial O 0 1.2447920298697124e-13
origin O 0 5.026362118675746e-15
, O 0 8.739097824354346e-18
based O 0 2.5936488505965706e-19
on O 0 1.2202632770886256e-14
mitochondrial O 0 9.320612857910415e-13
DNA O 0 4.3463985188729737e-10
( O 0 5.1160383041298364e-17
mtDNA O 0 6.88554844651551e-14
) O 0 3.0814408099807955e-14
lineages O 0 3.964099881681449e-12
. O 0 2.9335670177765838e-12

Three O 0 1.800541937768685e-10
novel O 0 6.23115914422101e-09
missense O 0 1.1026111224055057e-07
mutations O 0 5.0669040518869224e-08
never O 0 2.939149510439165e-07
identified O 0 9.44730058072274e-12
previously O 0 3.801317767504475e-12
in O 0 7.600433517855533e-16
other O 0 1.0159192551876389e-13
populations O 0 1.565130186911845e-12
and O 0 9.315082039051958e-10
found O 0 4.22538865008093e-10
in O 0 1.0838352378127539e-14
16 O 0 1.2028162194960236e-15
out O 0 1.2299982267514192e-14
of O 0 5.175808886267816e-18
19 O 0 8.224936573833497e-14
Colombian O 0 4.9251740463773785e-09
MPS B-Disease 1 0.9999958276748657
IVA I-Disease 1 0.9999892711639404
unrelated O 0 7.425313142128687e-10
alleles O 0 3.085007509867621e-12
account O 0 1.7617987147292014e-12
for O 0 9.865119145028873e-15
84 O 0 1.105123492717297e-10
. O 0 2.9707767496001125e-11

2 O 0 6.213519698761161e-10
% O 0 6.86399111919471e-14
of O 0 2.5960753332247066e-18
the O 0 3.63397992558421e-16
alleles O 0 2.2542053943960805e-15
in O 0 1.2204255050738484e-15
this O 0 4.2075861376022897e-16
study O 0 7.201386873162494e-15
. O 0 3.927179328261365e-12

The O 0 1.554541651654917e-12
G301C O 0 4.747525705894873e-10
and O 0 7.112532351277734e-12
S162F O 0 1.318301154004664e-12
mutations O 0 1.1535699695822133e-13
account O 0 6.21064004803322e-14
for O 0 3.6065269524889875e-15
68 O 0 3.263209702453196e-10
. O 0 1.9115108801370795e-11

4 O 0 3.1213951423580966e-09
% O 0 9.394507741178337e-12
and O 0 1.2885323884270772e-11
10 O 0 1.9930769274562055e-12
. O 0 1.3021102208618518e-12

5 O 0 3.238389556514676e-10
% O 0 7.744199297674351e-14
of O 0 2.40439715393504e-17
mutations O 0 3.0437637680473875e-14
, O 0 2.1106078310854232e-13
respectively O 0 1.5750306874701137e-12
, O 0 1.0713190046456739e-13
whereas O 0 2.4355859126398705e-13
the O 0 1.6070750687244978e-13
remaining O 0 4.80169237704331e-10
F69V O 0 1.1887668449617195e-07
is O 0 2.684715924947828e-16
limited O 0 3.269861246540428e-19
to O 0 2.978121520431817e-16
a O 0 1.3829551399050692e-15
single O 0 7.698729674598948e-12
allele O 0 2.1371956648863488e-08
. O 0 1.6342678321734638e-09

The O 0 1.4658061006297962e-13
skewed O 0 3.7183808809793106e-10
prevalence O 0 9.627110841847752e-08
of O 0 9.477964101761455e-16
G301C O 0 1.1436593859437405e-12
in O 0 7.927927292557282e-17
only O 0 3.090370591299753e-17
Colombian O 0 3.6311586875358015e-13
patients O 0 3.9914221118531306e-15
and O 0 8.389934399145546e-16
haplotype O 0 1.1261089716968486e-12
analysis O 0 2.173477807627266e-16
by O 0 4.4896389935076214e-18
restriction O 0 3.890727787995605e-16
fragment O 0 1.1682776057328481e-12
length O 0 9.979869578305434e-14
polymorphisms O 0 1.1212229929224993e-11
in O 0 1.4629453315537395e-14
the O 0 1.3395581268305003e-14
GALNS O 0 1.6126883162215222e-09
gene O 0 1.5867713501656333e-13
suggest O 0 1.3441144356383938e-13
that O 0 9.285540239001907e-15
G301C O 0 2.3760865237171247e-13
originated O 0 3.8778425999821953e-13
from O 0 1.4683615249162796e-16
a O 0 5.941711131862302e-16
common O 0 4.127624755661738e-14
ancestor O 0 2.601945325864108e-10
. O 0 1.1500665308972202e-08

Investigation O 0 3.976563002494604e-13
of O 0 1.3474339397592333e-16
the O 0 6.571328588657655e-17
genetic O 0 1.0355529198632484e-14
background O 0 5.984530904688812e-13
by O 0 3.1211875028054365e-16
means O 0 1.30666118827998e-15
of O 0 4.77276430562074e-18
mtDNA O 0 5.97032514572382e-13
lineages O 0 1.0406669449791739e-11
indicate O 0 2.958737421732138e-11
that O 0 1.4024545413882095e-12
all O 0 1.6397222934918382e-13
our O 0 2.0134893752299377e-11
patients O 0 1.9178971301474077e-16
are O 0 1.7771088309494836e-18
probably O 0 5.276269872400707e-15
of O 0 6.438179972432954e-18
native O 0 7.755969803034668e-13
American O 0 4.957153691975691e-07
descent O 0 0.251088410615921

Low O 0 7.693805037511936e-10
frequency O 0 1.0239122050226257e-10
of O 0 9.801351963660727e-15
BRCA1 O 0 6.55873078070357e-10
germline O 0 5.880909648148247e-11
mutations O 0 5.008555792329616e-10
in O 0 2.495896891940852e-11
45 O 0 1.7521175621482143e-08
German O 1 0.9998726844787598
breast B-Disease 1 0.9999971389770508
/ I-Disease 1 0.999996542930603
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999984502792358
families O 0 1.670762230787659e-06
. O 0 2.6424097285260295e-11

In O 0 6.427665474526001e-14
this O 0 8.916124236171922e-17
study O 0 5.396938913985494e-17
we O 0 1.2013082043883794e-14
investigated O 0 8.129399931000592e-12
45 O 0 2.190078847441601e-11
German O 0 0.12146659195423126
breast B-Disease 1 0.9999902248382568
/ I-Disease 1 0.999993085861206
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999990463256836
families O 0 8.11357300789517e-11
for O 0 1.3897651723044305e-17
germline O 0 1.2812133623994748e-13
mutations O 0 1.9698373249395218e-13
in O 0 2.72506010422555e-16
the O 0 3.2385483116309337e-15
BRCA1 O 0 3.6787917156999583e-10
gene O 0 4.361731420488013e-09
. O 0 2.195777781821562e-09

We O 0 1.6218575094040233e-11
identified O 0 5.098466137123947e-13
four O 0 4.647315044186036e-14
germline O 0 1.4576823905917968e-12
mutations O 0 1.8845634774944386e-10
in O 0 1.9443246925682223e-12
three O 0 4.7966006166966224e-11
breast B-Disease 0 1.5084956430655438e-06
cancer I-Disease 0 2.933042537733854e-07
families O 0 4.7454404988878096e-11
and O 0 1.5670001103987308e-12
in O 0 1.8503884676671772e-13
one O 0 9.120987670030445e-06
breast B-Disease 1 0.9999994039535522
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.4727548602877505e-07
. O 0 1.937384367178634e-15
among O 0 3.618400673578488e-18
these O 0 3.27026351481207e-17
were O 0 1.3329372599169692e-13
one O 0 5.019064591021971e-14
frameshift O 0 2.3815742780652904e-11
mutation O 0 8.96535314520372e-14
, O 0 3.3705934636245327e-13
one O 0 2.7307435826462445e-11
nonsense O 0 1.3937939513652964e-07
mutation O 0 3.1732010682267164e-12
, O 0 8.35693927253578e-12
one O 0 4.915422994848651e-13
novel O 0 1.3597361084305426e-12
splice O 0 9.645303862271248e-07
site O 0 4.8122778650849796e-08
mutation O 0 3.8739306207347113e-10
, O 0 5.3670600949629055e-12
and O 0 1.1079109851763747e-11
one O 0 3.951885693687096e-12
missense O 0 9.917953125437862e-10
mutation O 0 7.597688589378038e-10
. O 0 5.01467578573056e-09

The O 0 4.477492161758523e-12
missense O 0 3.259427450164054e-10
mutation O 0 6.86892626111657e-11
was O 0 8.736787293628367e-09
also O 0 4.184579419086454e-11
found O 0 1.0218358277580553e-11
in O 0 1.549303898064694e-14
2 O 0 6.8467384539694365e-12
. O 0 5.880345689546207e-12

8 O 0 3.3975353641579886e-09
% O 0 1.3613839873125033e-12
of O 0 2.2711984105652186e-17
the O 0 2.979792292920276e-16
general O 0 4.842363944105442e-17
population O 0 1.1285627702408698e-15
, O 0 4.789532977172864e-15
suggesting O 0 1.1782426163203796e-12
that O 0 7.23087605417061e-13
it O 0 4.260443733916652e-11
is O 0 3.5225709068414934e-12
not O 0 3.695839467798834e-10
disease O 0 2.3874620058705887e-09
associated O 0 1.4207202254923335e-11
. O 0 7.702287418975828e-11

The O 0 8.161592061906031e-12
average O 0 3.263914694073833e-09
age O 0 8.008321783492534e-10
of O 0 8.18540873102902e-13
disease O 0 4.089486935754394e-07
onset O 0 5.294651383991322e-10
in O 0 1.6304972237819737e-13
those O 0 4.141113667255336e-12
families O 0 2.820784513087038e-13
harbouring O 0 2.3852464892115677e-08
causative O 0 1.4995725147737282e-11
mutations O 0 3.703472598037827e-11
was O 0 4.4959662659493915e-09
between O 0 1.1237413083398096e-10
32 O 0 8.564645659348002e-10
. O 0 9.418985730258456e-11

3 O 0 1.1492393703349535e-09
and O 0 8.449503596796859e-11
37 O 0 7.056378398262453e-11
. O 0 1.1823471889049753e-11

4 O 0 6.846432309970396e-10
years O 0 5.95798896330102e-11
, O 0 1.717508886576579e-14
whereas O 0 5.471070509610251e-15
the O 0 1.4194280609764842e-15
family O 0 2.29836340931433e-11
harbouring O 0 4.921961949122533e-09
the O 0 5.203768087280475e-16
missense O 0 6.167317362099772e-14
mutation O 0 7.2796349297969e-15
had O 0 3.880539986567122e-11
an O 0 2.7815992781690668e-14
average O 0 1.7031792642896448e-09
age O 0 1.7151955411520703e-09
of O 0 4.654006130130894e-13
onset O 0 5.095336153004837e-09
of O 0 1.2352563633424851e-12
51 O 0 5.272121406107999e-09
. O 0 2.0707752179660588e-10

2 O 0 4.275263254527317e-09
years O 0 2.8415952924021326e-10
. O 0 8.767908274420755e-12

These O 0 1.7177532183124122e-12
findings O 0 5.444032269256993e-13
show O 0 2.005862559384397e-10
that O 0 2.2448700748778014e-14
BRCA1 O 0 2.3504306140287312e-12
is O 0 1.026212708729699e-15
implicated O 0 3.111224927861145e-13
in O 0 1.073927348506677e-17
a O 0 1.0293089781113829e-17
small O 0 3.704535652508125e-17
fraction O 0 1.1696013894803986e-13
of O 0 4.670947628682143e-09
breast B-Disease 1 0.9999986886978149
/ I-Disease 1 0.9999992847442627
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
families O 0 1.0484145995803829e-08
suggesting O 0 3.4673747705514513e-13
the O 0 4.850128523079355e-17
involvement O 0 9.331702687594319e-15
of O 0 2.618453670721563e-18
another O 0 7.650816625744995e-16
susceptibility O 0 1.1821841248982334e-12
gene O 0 1.4501114753429079e-09
( O 0 6.018856246736703e-11
s O 0 0.0005516106612049043
) O 0 2.1101611569207535e-09

Paternal O 0 0.0004690167843364179
transmission O 1 0.5705363750457764
of O 0 5.699877760889649e-07
congenital B-Disease 1 0.9999212026596069
myotonic I-Disease 1 0.9999817609786987
dystrophy I-Disease 1 0.9999635219573975
. O 0 2.31184390031558e-06

We O 0 1.6622216936212908e-09
report O 0 4.0494114273781703e-14
a O 0 3.040857545065799e-17
rare O 0 2.154229460356945e-15
case O 0 5.298906929560032e-13
of O 0 3.1581828081536645e-13
paternally O 0 0.35027167201042175
transmitted O 1 0.999915361404419
congenital B-Disease 1 0.9999891519546509
myotonic I-Disease 1 0.9999966621398926
dystrophy I-Disease 1 0.9999954700469971
( O 0 5.7311117416247725e-06
DM B-Disease 1 0.9999876022338867
) O 0 1.5672963371571313e-08
. O 0 9.800660977221654e-11

The O 0 1.4721586579988233e-12
proband O 0 5.520427226457514e-09
is O 0 1.7540080444935352e-14
a O 0 1.4216823332864831e-15
23 O 0 5.325165696313909e-14
year O 0 2.5462564253787325e-14
old O 0 1.4740756171249814e-07
, O 0 2.905571339084645e-10
mentally B-Disease 1 0.9999991655349731
retarded I-Disease 1 0.9999991655349731
male O 0 0.024864932522177696
who O 0 0.00014484372513834387
suffers O 1 0.9998250603675842
severe O 0 0.03908459469676018
muscular B-Disease 0 0.27911439538002014
weakness I-Disease 0 0.09868115931749344
. O 0 1.660568216266256e-08

He O 0 5.359782062619445e-10
presented O 0 4.609802123356488e-11
with O 0 1.7084956782653649e-09
respiratory O 0 0.00047424272634088993
and O 0 4.252751484301598e-09
feeding O 0 9.369040867568401e-07
difficulties O 0 2.121983033731567e-09
at O 0 3.295556535998223e-12
birth O 0 2.470605942050952e-10
. O 0 2.3675341201401245e-11

His O 0 1.429958160770184e-07
two O 0 7.167646742800571e-08
sibs O 1 0.9975926280021667
suffer O 0 7.345175254158676e-05
from O 0 2.0840598344284977e-11
childhood O 0 0.000480134243844077
onset O 0 0.0007412854465655982
DM B-Disease 1 0.9999896287918091
. O 0 1.8260544720760663e-07

Their O 0 2.478803620697967e-11
late O 0 2.5596658473348022e-11
father O 0 2.1483345657991038e-10
had O 0 9.97242991852311e-14
the O 0 1.6673779046613123e-17
adult O 0 2.2162940970307798e-13
type O 0 6.122556753035066e-14
of O 0 3.689844924829183e-14
DM B-Disease 1 0.9999998807907104
, O 0 3.917289669724822e-12
with O 0 2.656237317773258e-13
onset O 0 2.2687376283192506e-11
around O 0 2.5094919198220822e-11
30 O 0 2.1081695959247748e-13
years O 0 9.025098376969076e-13
. O 0 1.58486586484749e-13

Only O 0 4.825056776651057e-14
six O 0 8.948289650599414e-17
other O 0 8.211685604634157e-19
cases O 0 1.6020648815469828e-17
of O 0 7.69095659067309e-18
paternal O 0 7.217320785457559e-07
transmission O 0 0.08517291396856308
of O 0 4.111533336015327e-10
congenital B-Disease 1 0.9999760389328003
DM I-Disease 1 0.9999998807907104
have O 0 7.938364965376365e-10
been O 0 1.500900272122241e-11
reported O 0 1.0439318159916056e-10
recently O 0 1.4714049423325548e-10
. O 0 5.060480680330048e-12

We O 0 1.7401774465852782e-12
review O 0 1.6605994904136853e-16
the O 0 2.534478253576149e-17
sex O 0 2.6916834104488696e-13
related O 0 1.7678685104775783e-15
effects O 0 4.655972398533333e-15
on O 0 2.294865415319175e-13
transmission O 0 1.0396928473710432e-07
of O 0 3.674608360648701e-12
congenital B-Disease 1 0.9990750551223755
DM I-Disease 1 0.9999933242797852
. O 0 1.030529106493816e-09

Decreased O 0 8.278276397710727e-10
fertility O 0 2.9157196101969873e-10
of O 0 1.3225522145847402e-16
males O 0 3.0119027931430065e-14
with O 0 2.6491778741402974e-14
adult O 0 2.889778372150431e-08
onset O 0 2.334415512450505e-06
DM B-Disease 1 0.9999997615814209
and O 0 3.702101594171836e-07
contraction O 0 2.080025214568071e-11
of O 0 5.098715239587567e-18
the O 0 4.1715193582411714e-14
repeat O 0 7.577239946598979e-10
upon O 0 8.002442025006884e-14
male O 0 7.287415115797558e-11
transmission O 0 3.197675804700317e-11
contribute O 0 1.4192054236602543e-16
to O 0 2.444108698862837e-15
the O 0 3.649387666653002e-15
almost O 0 1.6629158174161912e-13
absent O 0 1.6112984427621435e-13
occurrence O 0 9.512633160292574e-15
of O 0 2.5026882798850826e-16
paternal O 0 8.908095878723543e-06
transmission O 0 0.06577138602733612
of O 0 1.4336525744340634e-08
congenital B-Disease 1 0.9999440908432007
DM I-Disease 1 0.9999954700469971
. O 0 7.034067266431521e-07

Also O 0 3.9968240522769705e-11
the O 0 2.4125410938197374e-14
fathers O 0 3.8311191025153235e-11
of O 0 2.7071133289578036e-17
the O 0 4.328769872934124e-13
reported O 0 6.840065847057986e-09
congenitally O 0 5.331300485522661e-07
affected O 0 6.55804837518259e-12
children O 0 8.964580466841454e-11
showed O 0 2.2854065861999118e-11
, O 0 1.17872286031102e-17
on O 0 5.289555685822345e-13
average O 0 6.149818067985313e-13
, O 0 5.860985186219823e-16
shorter O 0 1.820715236564019e-12
CTG O 0 8.878549562219007e-10
repeat O 0 1.5064147262933147e-08
lengths O 0 2.086636463616287e-08
and O 0 2.5099047840093647e-10
hence O 0 5.9750672291858375e-12
less O 0 5.966386239231181e-13
severe O 0 1.34963984432801e-10
clinical O 0 6.4388536169524e-11
symptoms O 0 1.044833286556468e-08
than O 0 3.1585591787734475e-15
the O 0 2.210102543684367e-12
mothers O 0 3.9955800446023204e-08
of O 0 7.125448675375252e-15
children O 0 1.4040071327769965e-08
with O 0 5.1336961348624754e-08
congenital B-Disease 1 0.9999676942825317
DM I-Disease 1 0.9999972581863403
. O 0 2.714017277583025e-08

We O 0 7.338276579275937e-13
conclude O 0 8.009893882063648e-14
that O 0 1.3700125188226709e-14
paternal O 0 9.27022938412847e-08
transmission O 0 0.0016512743895873427
of O 0 1.9950578966643207e-09
congenital B-Disease 1 0.9999521970748901
DM I-Disease 1 0.9999994039535522
is O 0 2.187030504613441e-12
rare O 0 3.4387345960773573e-15
and O 0 4.159694947704091e-15
preferentially O 0 2.532943039340596e-12
occurs O 0 2.059011869424282e-13
with O 0 2.3083106403414856e-14
onset O 0 8.889695229941097e-11
of O 0 6.3541329316241235e-12
DM B-Disease 1 0.9999997615814209
past O 0 6.530562473017198e-07
30 O 0 2.4289240323910333e-13
years O 0 4.4603033831462635e-14
in O 0 1.4415428736194323e-17
the O 0 5.710949710877077e-16
father O 0 9.076226992199565e-10
. O 0 9.105942149129683e-15
. O 0 1.1241319154827942e-13

The O 0 9.566390648391154e-13
RB1 O 0 1.7230529891776314e-08
gene O 0 3.9655466410604134e-11
mutation O 0 1.2194072140925272e-10
in O 0 5.615109072154567e-13
a O 0 4.6346197712932025e-11
child O 0 0.00023383376537822187
with O 0 1.3423058931039122e-07
ectopic B-Disease 1 0.9998589754104614
intracranial I-Disease 1 0.9995149374008179
retinoblastoma I-Disease 1 0.9394857287406921
. O 0 6.330809583232622e-07

The O 0 1.5374252218536277e-11
RB1 O 0 8.108325033617803e-08
gene O 0 1.6010158476742475e-11
mutation O 0 3.059248817813276e-12
was O 0 1.6088524609769728e-11
investigated O 0 8.330950512780433e-12
in O 0 1.496667068436649e-14
a O 0 1.3157069184144277e-11
child O 0 0.0005016020149923861
with O 0 6.32663272881473e-08
ectopic B-Disease 0 0.4587567150592804
intracranial I-Disease 0 2.5364945031469688e-05
retinoblastoma I-Disease 0 5.42219602550631e-10
using O 0 3.8966560657143195e-15
DNA O 0 7.817793634679049e-11
obtained O 0 1.7277643888074373e-13
from O 0 5.666809235808879e-16
both O 0 2.020809912703131e-16
the O 0 3.6389894901925086e-15
pineal B-Disease 0 1.3189754177744817e-08
and I-Disease 0 7.1377121990678916e-09
retinal I-Disease 0 6.410362857423024e-06
tumours I-Disease 1 0.9999995231628418
of O 0 1.609486198830834e-13
the O 0 7.671143234522226e-12
patient O 0 6.976703659233863e-09
. O 0 1.8896241515964363e-10

A O 0 3.247567145758801e-11
nonsense O 0 1.3598723536123458e-10
mutation O 0 3.4462348610670573e-14
in O 0 2.9461567734034855e-15
exon O 0 4.3395127768963704e-11
17 O 0 1.1207660494116922e-10
( O 0 2.128270203394426e-16
codon O 0 4.3074444293529635e-14
556 O 0 7.847668695437626e-12
) O 0 2.0389672751846416e-13
of O 0 5.032496040112186e-17
the O 0 5.653061636965058e-14
RB1 O 0 7.382989219983926e-10
gene O 0 1.9790297330589401e-13
was O 0 4.600491515516225e-11
found O 0 6.846392485056196e-14
to O 0 2.9061846533478446e-15
be O 0 6.512838872537157e-15
present O 0 2.713008837089371e-15
homozygously O 0 5.338275377297919e-10
in O 0 1.3234807744531678e-16
both O 0 3.410475988770178e-16
the O 0 8.365777654764563e-15
retinal B-Disease 0 7.917055899753223e-11
and I-Disease 0 1.2320040543301047e-09
the I-Disease 0 4.0678516111114504e-10
pineal I-Disease 0 0.031539395451545715
tumours I-Disease 1 0.9999963045120239
. O 0 2.263946896619018e-08

The O 0 3.249662908558215e-14
same O 0 3.578720554896523e-15
mutation O 0 1.8485743602633838e-14
was O 0 1.209772421129074e-10
present O 0 6.302165684929015e-14
heterozygously O 0 2.546183819340797e-10
in O 0 7.953735989413426e-17
the O 0 1.7178479326895413e-16
DNA O 0 9.284921442809235e-11
from O 0 1.1593085839185432e-14
the O 0 1.1244838830833668e-16
constitutional O 0 1.2638435669171566e-15
cells O 0 4.638034951215918e-14
of O 0 6.517156199469312e-17
the O 0 1.0211723502386028e-13
patient O 0 1.62415989945347e-12
, O 0 1.0962466633581054e-15
proving O 0 4.606949587440679e-13
it O 0 3.6163910746762375e-15
to O 0 1.4517037220360173e-15
be O 0 6.407074950611196e-15
of O 0 1.9031895941584189e-16
germline O 0 4.969535633697619e-12
origin O 0 8.696988441914133e-12
. O 0 1.293652684974944e-10

The O 0 4.0315954784667096e-13
initial O 0 1.2350053773158183e-14
mutation O 0 2.1431571727253788e-14
was O 0 3.537304130163399e-11
shown O 0 2.233699336606776e-12
to O 0 4.219885108935981e-15
have O 0 7.116881275926953e-14
occurred O 0 6.469977819559963e-14
in O 0 9.03347899665278e-18
the O 0 1.3939080170668962e-15
paternally O 0 1.939801208550307e-09
derived O 0 1.0097220910949833e-13
RB1 O 0 5.2842551667708904e-08
allele O 0 3.1969227265449263e-09
. O 0 1.1442894409796622e-09

The O 0 9.842989054029139e-13
mutation O 0 3.898513456501718e-12
is O 0 2.8523152806672614e-13
in O 0 3.9186711402277284e-16
an O 0 3.4607492470742926e-16
area O 0 1.6334737382162068e-12
of O 0 1.2634772251674691e-15
the O 0 1.4668401584518043e-14
gene O 0 1.170248522652101e-13
that O 0 1.5941170655237773e-15
encodes O 0 2.392176897108439e-15
the O 0 6.338783236876173e-16
protein O 0 8.170399171678402e-14
- O 0 4.879741142410632e-12
binding O 0 1.0377644923953433e-12
region O 0 1.4125883080438884e-13
known O 0 5.5837496085175964e-14
as O 0 7.91075321568413e-13
the O 0 1.2068172849932779e-11
pocket O 0 0.42998531460762024
region O 0 2.2206114280720612e-08
and O 0 6.321902112915723e-09
has O 0 2.695395122376265e-11
been O 0 6.591577869467791e-13
detected O 0 1.1087179351693122e-12
in O 0 1.8020601137416863e-18
other O 0 2.3351025796602478e-17
cases O 0 5.4728185076806984e-17
of O 0 4.973958618831401e-18
retinoblastoma B-Disease 0 4.937845705238475e-12
. O 0 3.557095210830058e-14
. O 0 7.997475078014293e-12

Low O 0 8.467745260531956e-07
levels O 0 2.3225935064097314e-10
of O 0 2.876930729388082e-16
beta O 0 3.1435249368827467e-13
hexosaminidase O 0 2.265152154734551e-08
A O 0 9.752880794633434e-12
in O 0 2.8167064221405053e-15
healthy O 0 7.592849417779879e-14
individuals O 0 5.268179648963245e-17
with O 0 8.806884800420522e-14
apparent O 0 5.108573191137111e-07
deficiency O 0 5.83199266657175e-07
of O 0 1.736789126912111e-19
this O 0 3.426657891482981e-17
enzyme O 0 3.0188864103865287e-13
. O 0 2.2943240189643443e-12

Appreciable O 0 6.934789409385189e-10
beta O 0 5.673823633145503e-10
hexosaminidase O 0 9.70495534602378e-07
A O 0 2.9126404066381895e-10
( O 0 3.67486853528878e-15
hex O 0 5.922652368539616e-10
A O 0 4.1641364835476313e-13
) O 0 3.580616585209393e-16
activity O 0 9.28578397273248e-16
has O 0 6.133081285635467e-16
been O 0 3.3764310876420673e-16
detected O 0 1.4718743801891976e-13
in O 0 5.959732419559628e-17
cultured O 0 4.78458717090291e-10
skin O 0 1.8712873497861437e-05
fibroblasts O 0 2.453138847613445e-07
and O 0 0.012732348404824734
melanoma B-Disease 1 0.9983006119728088
tissue O 0 0.0007103615789674222
from O 0 3.430659367698041e-10
healthy O 0 5.203203319592564e-12
individuals O 0 2.6037342812343964e-16
previously O 0 4.048563784567194e-13
reported O 0 9.887990426449278e-11
as O 0 1.7429810849831084e-12
having O 0 1.6373700617577924e-08
deficiency B-Disease 0 2.2675443688058294e-05
of I-Disease 0 3.704365915046429e-17
hex I-Disease 0 7.394718171127579e-09
A I-Disease 0 4.7558175930370594e-14
activity O 0 3.9930003883437495e-14
indistinguishable O 0 5.979715420739717e-13
from O 0 2.359106533855924e-17
that O 0 1.7708923122201578e-15
of O 0 6.313324073459669e-16
patients O 0 5.086841104590123e-12
with O 0 9.817689715418965e-06
Tay B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.7488844990730286
( O 0 9.204782931964556e-14
TSD B-Disease 0 1.1609407657431348e-08
) O 0 2.648709431039148e-13
. O 0 3.491798050789946e-13

Identification O 0 1.2505832307219134e-11
and O 0 1.4339894723047752e-11
quantitation O 0 3.665541647990267e-09
of O 0 1.405344444162487e-15
hex O 0 2.4669330467297357e-10
A O 0 1.9692238697978023e-14
, O 0 3.1495437835993463e-17
amounting O 0 3.012077483100466e-16
to O 0 1.373523004520919e-15
3 O 0 1.1867199931070438e-13
. O 0 3.658244280418943e-12

5 O 0 4.220396920828762e-09
% O 0 2.051542269398965e-11
- O 0 4.890027867077151e-07
6 O 0 1.0907110770119743e-08
. O 0 2.2468966964783732e-10

9 O 0 8.519778660343036e-09
% O 0 6.894553287659089e-13
of O 0 3.4260584833239007e-16
total O 0 1.0935574819813387e-14
beta O 0 4.7710631696481e-14
hexosaminidase O 0 6.80562883825786e-10
activity O 0 1.042013047028445e-12
, O 0 4.324257514548281e-16
has O 0 8.327724593730045e-16
been O 0 1.8427498229048843e-16
obtained O 0 4.5087067473978875e-18
by O 0 1.498035669862109e-17
cellulose O 0 7.732289808437542e-10
acetate O 0 1.2867850118780666e-09
gel O 0 1.525840787053312e-09
electrophoresis O 0 6.019157394732133e-10
, O 0 6.479487627865377e-14
DEAE O 0 1.2416123684744207e-09
- O 0 2.0798614566719387e-12
cellulose O 0 4.6514774254546865e-09
ion O 0 1.5771665917707622e-10
- O 0 3.814465410201251e-11
exchange O 0 9.594595456400689e-15
chromatography O 0 1.0375685770627752e-12
, O 0 4.845322802243769e-16
radial O 0 8.629402531087904e-13
immunodiffusion O 0 6.3865477351043864e-09
, O 0 2.0112754980906e-14
and O 0 4.695111053415468e-12
radioimmunoassay O 0 6.188238899085263e-08
. O 0 6.2915788030804e-12

Previous O 0 1.1907247632336748e-08
family O 0 4.692378485771087e-09
studies O 0 1.1694212221843858e-12
suggested O 0 7.034128189859282e-14
that O 0 5.154517356562374e-15
these O 0 9.615947489404855e-17
individuals O 0 4.957988656335146e-18
may O 0 2.4926840266846213e-16
be O 0 9.383555066775022e-18
compound O 0 5.001056162343576e-16
heterozygotes O 0 3.0737343348200864e-17
for O 0 2.5512948121648974e-20
the O 0 3.4192542941283865e-17
common O 0 6.909778416894783e-15
mutant O 0 1.493167243495075e-12
TSD B-Disease 0 1.0323945474552398e-12
gene O 0 3.710346510284526e-14
and O 0 3.679784341820147e-12
a O 0 5.516715844588365e-15
rare O 0 5.993600797962739e-13
( O 0 5.000445769225961e-16
allelic O 0 3.086156677434282e-11
) O 0 1.049797184946022e-12
mutant O 0 3.4980678076390603e-11
gene O 0 5.600136354644292e-09
. O 0 6.919067541133472e-10

Thus O 0 2.116810546293202e-11
, O 0 1.0085935552180385e-14
the O 0 1.2625273571264622e-16
postulated O 0 1.2157383932030752e-13
rate O 0 2.8631528571632092e-12
mutant O 0 3.4848916829512133e-13
gene O 0 3.5557537816921503e-13
appears O 0 4.777299042468819e-11
to O 0 9.172315439118293e-16
code O 0 2.6076622906481698e-15
for O 0 4.036142433913283e-17
the O 0 1.4885704499004344e-14
expression O 0 1.6335422597935079e-12
of O 0 2.6644346739378892e-15
low O 0 4.965385741462214e-12
amounts O 0 6.90600321751865e-17
of O 0 1.7669776965148628e-16
hex O 0 6.91796557816815e-08
A O 0 2.7707270505716863e-11
. O 0 4.823920343038912e-12

Heterozygotes O 0 5.400713903869203e-11
for O 0 7.229265268555475e-16
the O 0 5.118793742011924e-16
rare O 0 3.961586646835519e-14
mutant O 0 1.514252612189182e-09
may O 0 5.874923464377346e-11
be O 0 1.4857820174380733e-14
indistinguishable O 0 9.781825956872714e-13
from O 0 1.2477328679114818e-16
heterozygotes O 0 8.455898148704158e-16
for O 0 3.6978390671025947e-19
the O 0 8.875035461994004e-16
common O 0 1.6774973337491117e-12
TSD B-Disease 0 1.2339542720951613e-08
mutant O 0 2.1316903797696796e-09
. O 0 1.1970922517146043e-11

However O 0 4.9115212222804183e-14
, O 0 1.0383915039552764e-17
direct O 0 1.0967218612492242e-18
visualization O 0 2.5683695621669944e-12
and O 0 2.084087763476461e-11
quantitation O 0 1.8572695603680245e-09
of O 0 2.3860965769756924e-16
hex O 0 2.3859117806446228e-11
A O 0 1.257749164861662e-16
by O 0 1.1108603941704986e-19
the O 0 3.0501269723690987e-18
methods O 0 1.7677017889825702e-13
described O 0 2.1801678518063028e-11
may O 0 5.379783736005582e-14
prevent O 0 1.6936445803206364e-14
false O 0 1.3607330540121865e-11
- O 0 4.791897781353249e-12
positive O 0 3.6535230932597347e-16
prenatal O 0 4.1435136029742414e-13
diagnosis O 0 1.38052529477517e-11
of O 0 1.8081963049617272e-17
TSD B-Disease 0 3.917965951671931e-10
in O 0 5.396491376186878e-15
fetuses O 0 4.542802592433226e-11
having O 0 2.1412272928583546e-15
the O 0 1.2038667521088557e-16
incomplete O 0 6.036100785866694e-11
hex B-Disease 0 1.502947270637378e-06
A I-Disease 0 2.0045719750783064e-08
deficiency I-Disease 0 0.0005394163890741765
of O 0 8.090681364649745e-16
the O 0 9.226536201722979e-12
type O 0 9.593228433857348e-10
described O 0 1.2268177584928708e-08
in O 0 1.0552374946071197e-12
the O 0 2.7062336746541682e-11
four O 0 9.961519387147177e-10
healthy O 0 4.319687385567761e-10
individuals O 0 5.928339416594319e-13

The O 0 1.3744108932553512e-12
tumor B-Disease 0 9.39978761493876e-10
suppressor O 0 1.8295958525982314e-08
gene O 0 7.421341052804564e-08
Smad4 O 0 6.555165600730106e-05
/ O 0 2.2199769489361643e-07
Dpc4 O 0 9.388104738050629e-10
is O 0 9.460475915425308e-17
required O 0 3.0108766836167864e-20
for O 0 1.2264476079765896e-20
gastrulation O 0 2.133655882183283e-12
and O 0 6.470848596534795e-12
later O 0 4.906601600712657e-12
for O 0 1.1376262610045073e-16
anterior O 0 4.0640858733898e-12
development O 0 5.4417165166487045e-17
of O 0 1.2270197649288834e-18
the O 0 3.003130327018178e-15
mouse O 0 1.1247331954677975e-08
embryo O 0 2.2999400162149186e-09
. O 0 6.1546856500172e-10

Mutations O 0 1.8700262172099968e-10
in O 0 6.521198511744153e-13
the O 0 1.240706756083787e-11
SMAD4 O 0 0.0010733901290223002
/ O 0 1.3233899380793446e-06
DPC4 O 0 7.8095183653204e-08
tumor B-Disease 0 3.910990281630333e-11
suppressor O 0 4.309182784906218e-12
gene O 0 2.6167926874855196e-13
, O 0 5.301223992422411e-16
a O 0 4.993044984285449e-18
key O 0 1.378048472859203e-13
signal O 0 3.95944943498705e-10
transducer O 0 1.5045705792360309e-09
in O 0 1.7057593537520357e-14
most O 0 2.4442499416067916e-14
TGFbeta O 0 2.3755168498951207e-08
- O 0 1.2783275826766527e-10
related O 0 8.469175474855664e-14
pathways O 0 3.069848994691031e-14
, O 0 1.540761202861698e-17
are O 0 2.73794391686094e-20
involved O 0 7.614032102428109e-19
in O 0 8.403607099101006e-17
50 O 0 1.040727427197366e-13
% O 0 1.5252695075929426e-14
of O 0 3.46055622308869e-13
pancreatic B-Disease 0 0.027053531259298325
cancers I-Disease 0 0.0274171344935894
. O 0 2.4440801382752397e-08

Homozygous O 0 2.0050158866524725e-07
Smad4 O 0 3.028721403097734e-05
mutant O 0 0.00013083626981824636
mice O 0 0.0013297353871166706
die O 0 4.436835661181249e-05
before O 0 3.744020371510004e-11
day O 0 2.468932523702616e-11
7 O 0 8.638101518798624e-12
. O 0 2.0300391142397123e-12

5 O 0 1.9240060933345404e-11
of O 0 1.8027376805424856e-14
embryogenesis O 0 1.1412843115010674e-08
. O 0 1.0133899275288627e-09

Mutant O 0 4.741441961275683e-11
embryos O 0 1.0777555931040794e-11
have O 0 2.1214020123894173e-11
reduced O 0 4.85142416691009e-13
size O 0 1.3406300514162695e-09
, O 0 1.4441273732401783e-09
fail O 0 4.3595210996727474e-08
to O 0 1.890422497360933e-12
gastrulate O 0 2.8659560484811664e-06
or O 0 3.778421187039527e-10
express O 0 2.2176926839519683e-14
a O 0 3.54357184741541e-18
mesodermal O 0 2.419094926545823e-13
marker O 0 5.626745291920088e-08
, O 0 1.0891039589275286e-12
and O 0 1.2003320212783386e-11
show O 0 7.274965518888621e-09
abnormal O 0 2.341871314925914e-11
visceral O 0 1.431198800964928e-12
endoderm O 0 1.2175886965337668e-08
development O 0 1.0803111877288885e-12
. O 0 4.3999966864438633e-11

Growth B-Disease 1 0.9999772310256958
retardation I-Disease 1 0.9999861717224121
of O 0 1.2524702141299832e-13
the O 0 1.7488319820069265e-12
Smad4 O 0 7.719145287410356e-06
- O 0 2.6826442081073765e-06
deficient O 0 8.544695901946397e-07
embryos O 0 2.0372636910792608e-10
results O 0 7.261004406240723e-13
from O 0 1.5384086826707513e-14
reduced O 0 1.1196917010106514e-13
cell O 0 1.6744655662037644e-10
proliferation O 0 1.1893594442646815e-10
rather O 0 3.533505406776497e-16
than O 0 1.015258012597705e-18
increased O 0 9.78937339081114e-19
apoptosis O 0 4.07021015199141e-14
. O 0 7.879300510660325e-12

Aggregation O 0 6.160848914360528e-11
of O 0 1.3872071351860027e-13
mutant O 0 2.7238173938570753e-09
Smad4 O 0 2.2588530157463538e-08
ES O 0 1.5104462819381936e-11
cells O 0 7.916149696472405e-15
with O 0 1.6760478096546072e-13
wild O 0 3.975584750293137e-09
- O 0 0.0002457361260894686
type O 0 2.420712235107203e-07
tetraploid O 0 9.207827815771452e-07
morulae O 0 9.426369615539443e-06
rescues O 0 7.627010489841268e-08
the O 0 4.50170432072898e-14
gastrulation B-Disease 0 2.175822260142013e-07
defect I-Disease 0 8.432126037405396e-07
. O 0 3.0474496624105507e-12

These O 0 7.628687265226475e-11
results O 0 7.903634886320676e-13
indicate O 0 6.540833846768734e-12
that O 0 2.1825289242983353e-13
Smad4 O 0 2.77695061390304e-10
is O 0 5.543863991701694e-16
initially O 0 5.897069319168449e-16
required O 0 1.3824669577598752e-19
for O 0 6.729203140411244e-21
the O 0 1.816505582369006e-18
differentiation O 0 1.1639291486458155e-16
of O 0 8.244553005888492e-18
the O 0 1.4351740858285864e-15
visceral O 0 5.937288285800743e-14
endoderm O 0 1.1126063265143316e-10
and O 0 4.814753738931199e-13
that O 0 2.5373831199815332e-15
the O 0 4.3693596367094085e-16
gastrulation B-Disease 0 1.5018524202048411e-09
defect I-Disease 0 2.206946625449291e-09
in O 0 1.4153992017024283e-16
the O 0 1.933682367331012e-14
epiblast O 0 5.986360918086575e-08
is O 0 1.450308297935854e-12
secondary O 0 4.900129347423787e-12
and O 0 1.133419913479372e-09
non O 0 6.064558577545398e-11
- O 0 3.3889050428115297e-06
cell O 0 3.340536204632372e-05
autonomous O 0 3.0644626836107136e-09
. O 0 1.5766380423443138e-09

Rescued O 0 1.8450576817485853e-06
embryos O 0 2.2467537519332836e-07
show O 0 0.007330126129090786
severe O 0 6.759516054444248e-06
anterior O 0 1.0108789183504996e-06
truncations O 0 1.1618671180713136e-07
, O 0 2.5785276691614456e-10
indicating O 0 1.1083125736610633e-11
a O 0 2.3672762460415307e-15
second O 0 9.724260954032272e-15
important O 0 1.0506242644440169e-16
role O 0 1.187874939471284e-13
for O 0 2.7724131635044466e-15
Smad4 O 0 9.885341434312522e-09
in O 0 4.492267187850441e-15
anterior O 0 6.656324935683244e-10
patterning O 0 9.328211092451966e-08
during O 0 1.7733127466446064e-11
embryogenesis O 0 4.2672329669812825e-08
. O 0 1.0438203079665698e-10

Prevalence O 0 1.484131985307613e-06
of O 0 1.1061061056883217e-14
p16 O 0 1.973656307829863e-11
and O 0 1.3578034530059568e-11
CDK4 O 0 7.544089797306697e-09
germline O 0 7.2367160007524856e-12
mutations O 0 1.3073891795556403e-11
in O 0 4.513390529370387e-13
48 O 0 3.293002537319012e-10
melanoma B-Disease 1 0.9684702157974243
- O 1 0.9995619654655457
prone O 1 0.9999905824661255
families O 0 4.395483756525209e-06
in O 0 1.2948741037743794e-11
France O 0 2.1878861389268422e-08
. O 0 1.4794364344705713e-10

The O 0 5.743125974788654e-10
French O 0 7.830099093553144e-07
Familial B-Disease 0 0.002634533913806081
Melanoma I-Disease 1 0.7749122977256775
Study O 0 3.9231928816718664e-10
Group O 0 4.1636905034891925e-10
. O 0 1.0560716363905431e-11

Germline O 0 8.955424735113127e-10
mutations O 0 8.432615022924139e-11
in O 0 1.7170111700167724e-14
the O 0 1.401692991005992e-15
p16 O 0 4.465396151800971e-13
and O 0 1.6487268364798191e-12
CDK4 O 0 2.5414762308550998e-11
genes O 0 2.6723401594895557e-14
have O 0 5.866090762012693e-14
been O 0 5.598757677090227e-13
reported O 0 2.146415423870396e-12
in O 0 1.3502780514029866e-18
a O 0 1.0516943052844155e-17
subset O 0 3.82092168523001e-16
of O 0 7.915428024401344e-14
melanoma B-Disease 0 2.8796252081519924e-05
pedigrees O 0 2.1916581260938983e-07
, O 0 5.1277284501827225e-11
but O 0 2.484916161726858e-10
their O 0 2.095841500349138e-09
prevalence O 0 2.4495779626931835e-08
is O 0 3.893092513401926e-14
not O 0 8.829304746094807e-14
well O 0 3.587052733295369e-14
known O 0 2.564957361089748e-12
. O 0 2.3099657603387058e-11

We O 0 1.0603596180356473e-13
searched O 0 1.2470013967280126e-14
for O 0 2.1963364247993347e-19
such O 0 2.606881155458005e-19
germline O 0 2.0221922281214028e-14
mutations O 0 6.75497526837765e-13
in O 0 3.693649390252435e-13
48 O 0 9.009009510618782e-11
French O 0 1.4610278640247998e-06
melanoma B-Disease 1 0.9999836683273315
- O 1 0.9972713589668274
prone O 1 0.9999579191207886
families O 0 3.725506708684989e-11
selected O 0 1.5929917028440112e-16
according O 0 5.103602139928469e-17
to O 0 5.057189565153711e-16
two O 0 2.793869778607819e-15
major O 0 8.490937784149701e-16
criteria O 0 2.7645480306023873e-13
families O 0 1.4040028498531545e-14
with O 0 4.924214127462054e-17
at O 0 2.285943718929699e-14
least O 0 9.932507690031551e-18
three O 0 2.39055197027825e-16
affected O 0 5.0063793011959266e-17
members O 0 7.930585023865415e-18
( O 0 1.6952762665399189e-18
n O 0 9.728170526079882e-12
= O 0 2.6599462216170267e-11
20 O 0 1.9597814853149903e-14
) O 0 2.1106458035724486e-15
or O 0 1.95142079578714e-12
families O 0 4.806209277135112e-14
with O 0 3.264818350275756e-16
two O 0 1.409519490735327e-14
affected O 0 4.979962924374576e-16
members O 0 1.4463011060160517e-18
, O 0 4.035092907152076e-18
one O 0 1.622986065948572e-16
of O 0 4.919703222068588e-19
them O 0 5.399848167756847e-15
affected O 0 7.829046122132693e-18
before O 0 5.041683568263037e-16
the O 0 2.028426009448368e-15
age O 0 3.9627226196617404e-13
of O 0 6.257761954667788e-18
50 O 0 6.080665828068186e-16
( O 0 2.1412159522121565e-18
n O 0 1.3816448853065655e-11
= O 0 6.401382895981911e-11
28 O 0 3.6174850007869574e-13
) O 0 4.258728769347643e-15
, O 0 1.2780293570804164e-15
and O 0 8.033819513504972e-15
one O 0 2.28868964092602e-16
additional O 0 1.8655022197465434e-17
minor O 0 8.394296407065668e-14
criterion O 0 1.5912413053875696e-10
. O 0 1.517301839726315e-10

Sixteen O 0 3.5774175288771914e-11
different O 0 2.2385249510699194e-14
p16 O 0 5.184124397122902e-12
germline O 0 1.945022051405565e-12
mutations O 0 4.7612955245135424e-12
were O 0 8.909534568446453e-12
found O 0 1.3867105163808957e-12
in O 0 4.313318348732288e-16
21 O 0 1.5402995990222018e-14
families O 0 1.84440780519584e-14
, O 0 5.781021702578771e-17
while O 0 4.420546367107578e-15
one O 0 7.011660810339951e-15
germline O 0 1.4303384594360063e-13
mutation O 0 3.965202461080758e-13
, O 0 5.14839147876256e-13
Arg24His O 0 7.977681626414324e-09
, O 0 4.788542609310276e-13
was O 0 1.1168651420367937e-10
detected O 0 4.293492505968999e-10
in O 0 1.4777406678016672e-15
the O 0 1.7516844637126272e-14
CDK4 O 0 1.4288676197793393e-07
gene O 0 1.3934703391171865e-10
. O 0 1.0745253992139325e-10

The O 0 6.859930527948867e-15
frequency O 0 4.313242471520873e-13
of O 0 2.6004475617884782e-17
p16 O 0 5.519115488927936e-15
gene O 0 1.0815760315358372e-14
mutation O 0 5.3425220790295075e-14
in O 0 8.000179600004768e-15
our O 0 2.2149513126401565e-12
sample O 0 3.432722313866099e-13
( O 0 9.32885030414444e-16
44 O 0 1.0109437836554672e-13
% O 0 1.6802383463424702e-16
) O 0 2.0759098029687174e-16
is O 0 1.433160026768473e-16
among O 0 1.6301339652322142e-16
the O 0 2.3167042286290074e-14
highest O 0 9.42423805661008e-10
rates O 0 9.69513980209058e-09
yet O 0 1.385312697887997e-11
reported O 0 1.100388946628783e-10
and O 0 1.7420495655815632e-13
the O 0 1.2016244864908841e-14
CDK4 O 0 5.48305933989468e-09
mutation O 0 4.65089528304749e-15
is O 0 1.92319487124623e-15
the O 0 5.556143851854513e-16
second O 0 1.4874082868154836e-12
mutation O 0 1.3473632813295645e-14
detected O 0 8.723952983624716e-12
in O 0 7.378823626120901e-17
this O 0 9.709604021644436e-18
gene O 0 1.085530645407451e-12
worldwide O 0 5.695582547260436e-11
. O 0 4.552786619926863e-11

In O 0 1.094180301919323e-12
summary O 0 6.075954739337419e-10
, O 0 6.978473246314898e-13
our O 0 2.2329423032818596e-11
results O 0 1.864266153831038e-15
show O 0 3.1826021852643382e-12
frequent O 0 9.785548022930857e-15
involvement O 0 2.9926432120982224e-15
of O 0 6.885740932105796e-19
the O 0 2.9139412384483176e-17
p16 O 0 6.07042202336233e-16
gene O 0 1.141239507681125e-14
in O 0 7.242873382248707e-16
familial B-Disease 0 2.483421290833121e-08
melanoma I-Disease 0 0.012982294894754887
and O 0 1.622403655865412e-09
confirm O 0 1.9949529875273875e-11
the O 0 5.570981433870685e-15
role O 0 5.43834508676122e-13
of O 0 4.2311177716681983e-16
the O 0 1.3253212817563448e-14
CDK4 O 0 2.967867063219387e-10
gene O 0 6.2787655527281674e-15
as O 0 1.1808713322502065e-14
a O 0 5.125738158570647e-13
melanoma B-Disease 0 5.36528168595396e-05
- O 0 1.1007767142245939e-07
predisposing O 0 1.2406630167660637e-09
gene O 0 2.9276856494675485e-09
. O 0 2.0498769348620272e-10
. O 0 1.179001341000685e-10

Progression O 0 5.339112707503091e-09
of O 0 1.8585015864052042e-14
somatic O 0 5.830427113329151e-11
CTG O 0 2.046246692088971e-07
repeat O 0 2.494804505204229e-07
length O 0 4.8536411001443014e-11
heterogeneity O 0 9.513740489852651e-11
in O 0 8.804298300612787e-14
the O 0 2.176360084987436e-13
blood O 0 4.7416026660584976e-08
cells O 0 2.1951749307191903e-09
of O 0 3.692133265786879e-10
myotonic B-Disease 1 0.9999958276748657
dystrophy I-Disease 1 0.9999923706054688
patients O 0 5.278402781527802e-08
. O 0 1.7608194069484995e-10

The O 0 5.090929746179047e-15
genetic O 0 1.6992883608481918e-13
basis O 0 2.1862245629285237e-13
of O 0 1.35629257824732e-10
myotonic B-Disease 1 0.9999964237213135
dystrophy I-Disease 1 0.9999984502792358
( O 0 1.071261968021986e-09
DM B-Disease 1 0.9999990463256836
) O 0 4.390052123909305e-12
is O 0 1.304483943028622e-16
the O 0 3.4865315403252844e-18
expansion O 0 3.117094480785626e-16
of O 0 1.3386525903763704e-16
an O 0 7.614254956796532e-14
unstable O 0 8.75066780281486e-06
CTG O 0 4.320991564554788e-09
repeat O 0 1.0115708271030144e-09
in O 0 1.9130161027888548e-16
the O 0 9.918583229384854e-16
34 O 0 2.778341970618753e-15
UTR O 0 1.077663045606636e-11
of O 0 2.0962646002612792e-17
the O 0 3.2342241406725647e-13
DM B-Disease 1 0.9999945163726807
protein O 0 1.206576749320301e-13
kinase O 0 3.942715511712214e-12
gene O 0 4.854969508014118e-13
on O 0 2.3160462436777607e-10
chromosome O 0 1.0471713949300465e-06
19 O 0 3.3767554724617455e-11
. O 0 1.1932027631569864e-12

One O 0 1.2250224272480903e-11
of O 0 1.5817289439723871e-16
the O 0 2.9826240299420657e-16
principal O 0 4.9249548260106926e-14
features O 0 1.8133115993988758e-13
of O 0 4.560884373995446e-16
the O 0 2.536972021349726e-11
DM B-Disease 1 0.9999994039535522
mutation O 0 1.5078368241494555e-13
is O 0 1.2023798122397304e-16
an O 0 2.5089673417405237e-17
extraordinarily O 0 1.5201356839966707e-09
high O 0 5.604805952685865e-09
level O 0 5.7888264494432295e-12
of O 0 1.8460707214537132e-16
somatic O 0 6.801284253669937e-13
mosaicism O 0 2.533763421297408e-09
, O 0 1.4617744948514089e-13
due O 0 1.6826957477411326e-15
to O 0 7.723835100963052e-16
an O 0 3.425561645560777e-16
extremely O 0 3.020093203298657e-11
high O 0 3.485362276567372e-10
degree O 0 8.471554078896826e-13
of O 0 3.0846026145663064e-15
somatic O 0 3.837454243260652e-10
instability O 0 6.413038278196836e-08
both O 0 5.389808201529747e-14
within O 0 5.2044656189125394e-15
and O 0 1.7367074445218122e-10
between O 0 1.4637590185079263e-12
different O 0 3.2510655951188683e-13
tissues O 0 1.1544313061051525e-08
. O 0 1.7202851990139045e-11

This O 0 1.240293423521166e-10
instability O 0 1.3561697542741058e-08
appears O 0 1.3539010190743994e-11
to O 0 7.597766952258458e-16
be O 0 4.392501106223988e-18
biased O 0 3.3269654223136e-15
towards O 0 3.622919064956498e-17
further O 0 3.276803876819162e-19
expansion O 0 1.6423231002154486e-17
and O 0 8.197712765502154e-15
continuous O 0 1.0207078416054932e-15
throughout O 0 6.073992373114125e-15
the O 0 1.5844782964521444e-14
life O 0 3.4826988840573614e-13
of O 0 1.1511887060561206e-18
an O 0 2.5421860879600407e-17
individual O 0 4.4332264503279747e-16
, O 0 2.6442647018813962e-15
features O 0 2.345956328503318e-12
that O 0 3.110438642761615e-11
could O 0 9.045697350884563e-12
be O 0 1.8800575584732894e-14
associated O 0 3.2657375610180284e-14
with O 0 2.200872134278803e-13
the O 0 4.974922817452265e-12
progressive O 0 5.634453348335455e-09
nature O 0 1.4830076056071562e-10
of O 0 8.828475331432856e-15
the O 0 1.9465901113235873e-10
disease O 0 4.434090072891195e-08
. O 0 1.582167383218369e-11

Although O 0 9.261705985474933e-13
increasing O 0 1.9860999848323076e-14
measured O 0 6.750161627572249e-12
allele O 0 1.8844341365120698e-10
size O 0 4.841090195384368e-09
between O 0 2.0692828006652064e-10
patients O 0 1.0848077671614734e-13
clearly O 0 2.3976505934201857e-14
correlates O 0 2.1038763162579922e-16
with O 0 2.9354611279054666e-18
an O 0 1.9168208358215782e-17
increased O 0 1.7524371710708753e-13
severity O 0 2.010789756923259e-09
of O 0 3.4204876344506863e-13
symptoms O 0 3.98878574614514e-09
and O 0 7.378722199219423e-14
an O 0 4.96386294562964e-15
earlier O 0 4.934955768476357e-07
age O 0 1.415507995261578e-07
of O 0 7.827778410272185e-14
onset O 0 2.9227267307752047e-12
, O 0 2.1424847397383333e-16
this O 0 4.083292437102205e-20
correlation O 0 4.750733177186003e-17
is O 0 3.474108280141473e-16
not O 0 4.412442802901196e-15
precise O 0 4.580354151517696e-11
and O 0 6.969644061882718e-08
measured O 0 1.7607272084774195e-08
allele O 0 4.410058096482317e-09
length O 0 4.97715069158744e-09
cannot O 0 7.85495446464779e-10
be O 0 1.0175044688780959e-15
used O 0 8.617189739003848e-15
as O 0 9.466834088834534e-16
an O 0 2.3924037960591847e-16
accurate O 0 5.679205439257373e-10
predictor O 0 1.712169783729678e-08
of O 0 6.1658061469016534e-12
age O 0 4.000948905513724e-08
of O 0 9.844153487162388e-13
onset O 0 1.6270218949898663e-08
. O 0 9.255575195155075e-10

In O 0 2.372999647666128e-15
order O 0 1.5957772501003957e-16
to O 0 2.3241184483061562e-17
further O 0 2.142686679341276e-18
characterize O 0 1.0417497282020662e-14
the O 0 1.2323880455088025e-15
dynamics O 0 3.3591007579658605e-12
of O 0 5.4862042778722545e-14
DM B-Disease 1 0.9999940395355225
CTG O 0 4.49137473879091e-08
repeat O 0 1.2523914127982039e-09
somatic O 0 7.263861821066309e-12
instability O 0 9.093368724677475e-09
, O 0 2.666143944073801e-14
we O 0 4.9055387979805506e-14
have O 0 2.5936936585567623e-15
studied O 0 8.552152855247769e-15
repeat O 0 2.0189424784766707e-11
length O 0 4.9126271084963535e-14
changes O 0 4.981879534941086e-17
over O 0 1.8180541538112115e-15
time O 0 3.429297929066939e-14
in O 0 1.767353556797295e-14
111 O 0 3.025405419521121e-07
myotonic B-Disease 1 0.9999957084655762
dystrophy I-Disease 1 0.999997615814209
patients O 0 5.949071530536587e-12
with O 0 1.3447489776653352e-15
varying O 0 5.233954478048135e-14
clinical O 0 3.144619634132262e-11
severity O 0 1.2968983753580687e-07
and O 0 1.4744194754001683e-10
CTG O 0 6.689165221729354e-09
repeat O 0 1.1826234436185246e-09
size O 0 6.325531461473521e-13
over O 0 8.167038009418426e-13
time O 0 7.128224741156583e-14
intervals O 0 1.8534826451421793e-13
of O 0 7.208718234488556e-17
1 O 0 4.439100623817183e-15
- O 0 8.442098131666853e-10
7 O 0 1.480353166438686e-11
years O 0 2.971783843314091e-12
. O 0 1.0076865015161418e-13

We O 0 3.7967979454878176e-11
have O 0 1.1383394362763158e-14
found O 0 4.577303048886787e-16
a O 0 1.0558911715583258e-17
direct O 0 9.821364890514844e-17
progression O 0 7.868386497911217e-11
of O 0 1.9185044792403687e-16
the O 0 1.8256156169313507e-15
size O 0 8.424897166351124e-15
heterogeneity O 0 1.7550278086345583e-15
over O 0 3.88051712345381e-15
time O 0 4.47348804389334e-16
related O 0 5.1614184251512306e-17
to O 0 1.3239296191971513e-17
initial O 0 2.807565083755059e-16
CTG O 0 2.6645302717703823e-12
repeat O 0 9.143060440697237e-12
size O 0 2.988761853024019e-13
and O 0 2.2702295772447645e-12
the O 0 4.398645059706897e-15
time O 0 4.3222521915742274e-13
interval O 0 1.6706611137909388e-12
and O 0 5.890401014174707e-13
always O 0 5.490137644769419e-15
biased O 0 3.87924445645056e-15
towards O 0 3.637863571647371e-16
further O 0 7.899158612597178e-17
expansion O 0 5.853636751885919e-15
. O 0 7.449459885761067e-13

Attempts O 0 4.318952140369703e-11
to O 0 1.1320133198877702e-13
mathematically O 0 5.287528769860883e-13
model O 0 1.0917537490370832e-12
the O 0 1.8473144021424748e-12
dynamics O 0 2.6875026648554012e-09
have O 0 5.198863561872713e-10
proved O 0 1.5205067205315004e-09
only O 0 6.60136347170083e-14
partially O 0 1.1088206047782379e-10
successful O 0 5.258874390644264e-13
suggesting O 0 1.415226551400306e-12
that O 0 2.619084271861543e-17
individual O 0 3.036274359596432e-20
specific O 0 3.3940159383045973e-18
genetic O 0 8.510869786704234e-11
and O 0 5.954075010805582e-09
/ O 0 1.896116597066566e-09
or O 0 2.7753552928055925e-11
environmental O 0 2.1595140226818993e-13
factors O 0 3.866007872583817e-15
also O 0 6.066620052451108e-14
play O 0 5.601457001686537e-14
a O 0 2.4767590793573014e-17
role O 0 8.318616554327338e-15
in O 0 1.8021307549659983e-16
somatic O 0 3.698032006484164e-14
mosaicism O 0 7.032783383431607e-11
. O 0 5.764557939064857e-14
. O 0 2.0717923904234326e-12

Aspartylglucosaminuria B-Disease 1 0.9998132586479187
among O 0 1.358373968862736e-10
Palestinian O 0 2.6458279123176e-08
Arabs O 0 1.4996148323120906e-08
. O 0 1.7654602779693107e-10

Aspartylglucosaminuria B-Disease 1 0.9999654293060303
( O 0 2.532933862653408e-08
AGU B-Disease 1 0.9999595880508423
) O 0 3.845187189488453e-12
is O 0 4.688767820185125e-15
a O 0 1.9174310237984014e-14
rare O 0 1.034161506430209e-10
disorder B-Disease 0 2.721254077187041e-06
of I-Disease 0 1.2438739710922484e-16
glycoprotein I-Disease 0 2.7448782802252936e-08
metabolism I-Disease 0 4.108698703930713e-06
caused O 0 1.1762352869482129e-08
by O 0 2.9130636704927104e-13
the O 0 4.065130898567304e-09
deficiency B-Disease 0 0.010556942783296108
of I-Disease 0 2.684704675291497e-17
the I-Disease 0 2.9821719366943805e-14
lysosomal I-Disease 0 3.258062042377219e-09
enzyme I-Disease 0 2.3581972485864355e-10
aspartylglucosaminidase I-Disease 0 9.339194662061345e-08
( O 0 1.0534265008964403e-14
AGA O 0 1.414116324038872e-10
) O 0 1.0662028985392036e-12
. O 0 2.0001413719716865e-12

AGU B-Disease 1 0.9997932314872742
is O 0 2.9309932259025118e-09
inherited O 0 1.0794281024573138e-07
as O 0 4.711006324625844e-12
an O 0 2.6110654437194736e-12
autosomal O 0 0.020172152668237686
recessive O 0 0.006310201250016689
trait O 0 0.006103240419179201
and O 0 3.8837376337141905e-07
occurs O 0 6.520906731255494e-11
with O 0 2.6881520623291306e-14
a O 0 2.853102750257665e-14
high O 0 1.6308844899559638e-11
frequency O 0 9.236780229571195e-09
in O 0 1.0218694640462544e-10
Finland O 0 3.67083680430369e-06
because O 0 6.021080335705253e-12
of O 0 1.5862538204463992e-17
a O 0 6.354159531846799e-15
founder O 0 1.1363004287501255e-10
effect O 0 3.798874843169431e-12
. O 0 2.3318016354606508e-12

While O 0 1.3156674361081144e-10
very O 0 9.338437954777706e-14
few O 0 1.7638353885102154e-13
patients O 0 1.7838364791376848e-14
with O 0 1.52184504147862e-12
AGU B-Disease 1 0.9999986886978149
have O 0 6.504956295838582e-11
been O 0 1.906231769654987e-11
reported O 0 2.308989111021731e-10
from O 0 1.9373705181899466e-14
non O 0 1.0192206508028573e-13
- O 0 1.0406466799395275e-08
Finnish O 0 4.196762972696888e-07
origin O 0 2.0022196400848458e-10
, O 0 1.5026648328420045e-11
we O 0 1.181500036695482e-10
diagnosed O 0 1.57783758281127e-10
the O 0 1.8260771313029917e-13
disorder O 0 1.2983136343791557e-08
in O 0 4.169749440546236e-16
8 O 0 1.0440736139148352e-13
patients O 0 7.505552328175455e-17
originating O 0 1.0928979186011355e-15
from O 0 4.808278663328549e-15
3 O 0 7.905888739349366e-15
unrelated O 0 7.380668884220121e-13
families O 0 9.351561408924014e-13
, O 0 1.7008617457235403e-16
all O 0 4.615421649095599e-16
Palestinian O 0 1.307398078687072e-09
Arabs O 0 4.877998893704216e-09
from O 0 3.786769888543956e-13
the O 0 9.526338051735195e-12
region O 0 1.1997398907670487e-10
of O 0 2.5356232819786703e-14
Jerusalem O 0 1.9568783216072916e-07
. O 0 1.2401212279300466e-09

The O 0 2.0424948624780948e-12
clinical O 0 1.9661232711354337e-11
diagnosis O 0 4.446357593224093e-07
of O 0 2.762138573420003e-10
AGU B-Disease 1 0.9999977350234985
is O 0 4.16907036671077e-10
often O 0 8.731031869713135e-11
difficult O 0 3.320213244964454e-12
, O 0 5.275905118837796e-16
in O 0 2.5326033659997364e-17
particular O 0 8.417439676525261e-16
early O 0 9.015703765144489e-13
in O 0 2.6062512608129862e-14
the O 0 1.100252972497523e-13
course O 0 1.5202515912804415e-09
of O 0 6.759965605338046e-16
the O 0 1.8244279784834783e-12
disease O 0 7.731165013735719e-11
, O 0 1.1129324712651862e-15
and O 0 2.7286219074149076e-13
most O 0 4.729813978017884e-16
of O 0 4.6649631503426246e-17
the O 0 4.3151024203477717e-13
patients O 0 5.538616982582456e-14
are O 0 3.9086852041147514e-15
diagnosed O 0 6.97047142228513e-11
after O 0 4.77738126836158e-11
the O 0 3.6861156488265934e-11
age O 0 1.4830535688403756e-09
of O 0 2.4170167735613817e-15
5 O 0 1.0131932185603043e-12
years O 0 1.56467148265671e-11
. O 0 1.620916617074697e-12

However O 0 8.386276395544456e-11
, O 0 1.5037412504428915e-13
since O 0 3.72728479753736e-14
these O 0 2.3755445581561535e-15
patients O 0 6.1807530940003266e-18
excrete O 0 3.7313121506809565e-17
early O 0 8.089870231341076e-18
large O 0 2.633398963234018e-18
amounts O 0 8.412941666877544e-17
of O 0 2.6426108700518822e-15
aspartylglucosamine O 0 4.115593910114512e-08
in O 0 1.7047803530715992e-14
urine O 0 7.684377223080019e-13
, O 0 2.3912792688318372e-18
biochemical O 0 9.117710798429055e-18
screening O 0 7.193060698109662e-17
is O 0 9.876222052901482e-16
easy O 0 1.3823032345497421e-12
by O 0 3.0750528263057825e-14
urine O 0 2.738271276392368e-10
chromatography O 0 1.1857177462104573e-09
. O 0 1.1483326225678048e-12
. O 0 4.603333773195439e-12

Detection O 0 1.0367877563421946e-11
of O 0 3.1938535593778765e-15
heterozygous O 0 5.372321511265543e-13
carriers O 0 3.8391468823451014e-13
of O 0 3.871487006847085e-13
the O 0 4.7780780732864514e-05
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999986886978149
telangiectasia I-Disease 1 0.9999996423721313
( O 0 1.486183138360575e-12
ATM O 0 2.815585542492727e-10
) O 0 1.0683993170165974e-16
gene O 0 7.071932339674337e-17
by O 0 3.93150110857512e-17
G2 O 0 3.157711592205459e-10
phase O 0 1.0714708200548761e-12
chromosomal O 0 1.1359394193277694e-05
radiosensitivity O 0 7.72852945374325e-06
of O 0 4.0824480840133404e-14
peripheral O 0 2.548757436215965e-07
blood O 0 9.549006790621206e-06
lymphocytes O 0 2.4994317300297553e-06
. O 0 4.5718376306957964e-10

In O 0 3.563102950465691e-07
ataxia B-Disease 1 0.9999939203262329
- I-Disease 1 0.999980092048645
telangiectasia I-Disease 1 0.9999988079071045
( O 0 0.00445822486653924
A B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999986886978149
T I-Disease 1 0.9999997615814209
) O 0 2.033893609088011e-10
patients O 0 4.062322581186578e-14
, O 0 8.799176779424685e-18
mutations O 0 7.418340492437172e-16
in O 0 6.462247288663552e-17
a O 0 7.027559724639032e-17
single O 0 3.819102152580189e-15
gene O 0 2.0346821016231642e-13
, O 0 1.6021643020391668e-15
ATM O 0 1.4132373049591251e-10
, O 0 2.4069166256433794e-13
result O 0 6.601895137341163e-13
in O 0 2.3230364853965568e-10
an O 1 0.7363744974136353
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 1.935938342967347e-07
embraces O 0 5.535333302830736e-10
a O 0 7.464101765049941e-15
variety O 0 2.172873714317196e-15
of O 0 1.8982881850695727e-16
clinical O 0 1.1370402232604992e-13
features O 0 5.233466437992718e-10
and O 0 9.105518117280553e-09
manifests O 0 2.4544264398684845e-09
extreme O 0 2.008714722334659e-10
radiosensitivity O 0 3.5670595366354974e-08
and O 0 6.999194973600353e-11
a O 0 2.5696911504051456e-13
strong O 0 9.621214415445056e-13
pre O 0 1.353699108364026e-08
- O 0 7.613632988068275e-06
disposition O 0 7.691581771496203e-08
to O 0 2.671158294553777e-10
malignancy B-Disease 0 2.2629925297223963e-05
. O 0 3.145615712352168e-11

Heterozygotes O 0 4.125380245745269e-11
for O 0 8.83723132276686e-16
the O 0 8.0539406488181e-17
ATM O 0 3.1221660673486085e-11
gene O 0 3.536938103509968e-12
have O 0 1.3834584519645254e-12
no O 0 2.6491713519866036e-15
clinical O 0 1.7897987493473638e-16
expression O 0 3.5354591433264804e-13
of O 0 1.4642602408354577e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 2.906284635173506e-07
may O 0 6.1790390512572735e-12
be O 0 1.1429079931806266e-14
cancer B-Disease 0 6.814955266776224e-10
prone O 0 7.416586527142499e-07
with O 0 2.0407509741056287e-15
a O 0 1.4060529236953941e-14
moderate O 0 3.483472885146277e-11
increase O 0 7.921345396570863e-15
in O 0 3.74717956858929e-14
in O 0 2.972258398604988e-13
vitro O 0 1.3140360799468453e-08
radiosensitivity O 0 1.9948547560488805e-05
. O 0 1.7213520539516303e-11

We O 0 2.273764954097146e-09
performed O 0 1.4867624492653775e-11
a O 0 3.35518491787444e-14
blind O 0 4.9713771294035425e-11
chromosomal O 0 1.0128908128903547e-10
analysis O 0 3.478313904603709e-15
on O 0 3.451352295321189e-14
G2 O 0 2.4006562363010353e-11
- O 0 9.802258831015376e-13
phase O 0 2.1526603318221564e-15
lymphocytes O 0 5.298118714580635e-13
from O 0 1.6674114617244024e-15
7 O 0 9.222532676780859e-14
unrelated O 0 1.8044458371946348e-08
A B-Disease 1 0.9999992847442627
- I-Disease 1 0.9999973773956299
T I-Disease 1 0.9999997615814209
patients O 0 8.202100023474435e-13
, O 0 5.677925302470673e-18
13 O 0 3.185989361388433e-17
obligate O 0 7.77355749215225e-11
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999990463256836
T I-Disease 1 0.9999998807907104
heterozygotes O 0 4.592275004711155e-08
( O 0 2.968267297942138e-15
parents O 0 1.1665691470544998e-13
of O 0 5.818827351410533e-19
the O 0 2.188545941423769e-15
patients O 0 3.6342710931598285e-16
) O 0 1.3442450096053311e-17
, O 0 5.647409004943204e-16
and O 0 2.7632843929703554e-12
14 O 0 1.1753391906650992e-14
normal O 0 9.565094410578565e-17
controls O 0 6.835053763211071e-14
following O 0 4.758770328715364e-16
X O 0 1.0106214476390818e-10
- O 0 2.2116026187051635e-13
irradiation O 0 2.3908187644808114e-14
with O 0 4.415644079222049e-14
1 O 0 7.97856649556439e-16
Gy O 0 1.9414025644254665e-14
in O 0 3.2106431279938154e-19
order O 0 1.4535080205004965e-18
to O 0 1.6988628182783723e-18
evaluate O 0 7.161020953096732e-19
this O 0 2.144621440253753e-21
cytogenetic O 0 1.5916424058288147e-17
method O 0 8.993521209982793e-19
as O 0 2.204326989516597e-19
a O 0 1.0687722006017074e-20
tool O 0 3.381406347416002e-16
for O 0 8.633812350208733e-21
detection O 0 7.078008477581907e-16
of O 0 1.8904671096598225e-18
ATM O 0 1.746512090505803e-08
carriers O 0 1.2467534817039994e-11
. O 0 6.880146626031536e-12

Both O 0 4.7410782855195066e-08
A B-Disease 1 0.9999852180480957
- I-Disease 1 0.9999861717224121
T I-Disease 1 0.9999980926513672
homozygotes O 0 1.2164209692855366e-06
and O 0 2.9858973366742037e-12
heterozygotes O 0 4.958597551660282e-13
showed O 0 1.1948874235976487e-13
significantly O 0 2.965628578553204e-16
increased O 0 1.0479858891622177e-17
levels O 0 2.0238425024125383e-15
of O 0 1.0355444707095996e-15
radiation O 0 5.5631931900279596e-05
- O 0 0.002541050547733903
induced O 0 0.004365241155028343
chromatid O 0 0.0003727154980879277
damage O 0 2.136756052095734e-07
relative O 0 1.2412926318327439e-13
to O 0 2.898578297481501e-15
that O 0 3.1517708449759147e-15
of O 0 6.167213801734059e-17
normal O 0 5.498421813340815e-13
controls O 0 1.705122931738856e-09
. O 0 1.9443701856913798e-11

These O 0 7.827617677300114e-13
results O 0 3.0098623331247182e-15
show O 0 1.4124106344128723e-13
that O 0 9.628532049808114e-18
the O 0 2.5794825037271992e-17
G2 O 0 4.33613117634124e-10
- O 0 4.259828323416315e-10
phase O 0 1.3535363151476187e-12
chromosomal O 0 8.571223730768907e-08
radiosensitivity O 0 1.6612897724144204e-09
assay O 0 3.684918689628169e-12
can O 0 2.6833543194851165e-16
be O 0 6.136552465324008e-21
used O 0 2.3403974247997457e-19
for O 0 5.68515317919818e-22
the O 0 4.2156445662849574e-19
detection O 0 2.9622088202480024e-12
of O 0 3.521359907224936e-13
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999982118606567
T I-Disease 1 0.9999991655349731
heterozygotes O 0 2.6301897548819397e-08
. O 0 1.5568532791068734e-12

In O 0 2.8430654098327013e-13
combination O 0 4.922513338243527e-14
with O 0 2.1377506461263494e-15
molecular O 0 1.3925640087136641e-14
genetic O 0 3.202960032616664e-12
analyses O 0 5.105080802536577e-10
, O 0 3.7401982552753843e-13
this O 0 8.04025865797e-15
test O 0 2.1376518177101955e-12
may O 0 2.522597524612499e-15
be O 0 2.4861196619641046e-18
of O 0 1.0825261785486756e-20
value O 0 1.9949060569893185e-16
in O 0 9.162169440248065e-17
studies O 0 3.109633115784029e-14
of O 0 3.2870339813461235e-18
familial B-Disease 0 6.226783533236357e-10
and I-Disease 0 8.269501194924089e-10
sporadic I-Disease 0 1.7403858354470003e-09
cancers I-Disease 0 2.0295870228892454e-07
aimed O 0 6.764271809345246e-09
at O 0 8.92170226585165e-10
determination O 0 1.8724128150737762e-11
of O 0 6.195810779678512e-19
the O 0 4.503844579757301e-17
potential O 0 9.41928483554923e-16
involvement O 0 6.7794407986195536e-15
of O 0 2.994764394356384e-17
ATM O 0 9.073254148006527e-09
mutations O 0 8.002885576452456e-10
in O 0 2.970490335912207e-13
tumor B-Disease 0 1.0372585279583291e-07
risk O 0 1.2404713922720134e-09
or O 0 4.1809370093619236e-13
development O 0 2.548762584111421e-15
. O 0 1.091033513533901e-12
. O 0 5.7741408876488265e-11

Ataxia B-Disease 1 0.9999912977218628
- I-Disease 1 0.9999761581420898
telangiectasia I-Disease 1 0.9999971389770508
: O 0 5.3661412119376806e-11
identification O 0 7.521872800184473e-14
and O 0 2.932048592634018e-14
detection O 0 1.2100983735018056e-13
of O 0 1.863368590074524e-17
founder O 0 9.467034794985452e-12
- O 0 5.208987130522758e-10
effect O 0 2.930970624624024e-13
mutations O 0 7.163440644158449e-15
in O 0 3.495960985718083e-18
the O 0 8.984673479355773e-19
ATM O 0 1.489367006460296e-12
gene O 0 8.663110918731565e-13
in O 0 6.165714606356978e-15
ethnic O 0 2.3567167314886284e-11
populations O 0 5.490025656307296e-10
. O 0 1.017874451392231e-09

To O 0 1.596015478116811e-15
facilitate O 0 6.260462864803897e-17
the O 0 2.6738810169762407e-17
evaluation O 0 2.177219112450619e-17
of O 0 6.632946782091348e-20
ATM O 0 7.800894262152691e-13
heterozygotes O 0 6.6783342873540704e-15
for O 0 1.4613637547779126e-18
susceptibility O 0 2.6296014519512634e-13
to O 0 1.3397384330399165e-12
other O 0 2.0712284318213925e-11
diseases O 0 8.932842021636134e-09
, O 0 1.5896180923760835e-14
such O 0 1.6093863167056938e-15
as O 0 1.88781934529203e-10
breast B-Disease 0 2.5287542371188465e-07
cancer I-Disease 0 5.485527587723027e-09
, O 0 4.4330787277819736e-14
we O 0 5.540613608645724e-14
have O 0 6.931317194194039e-16
attempted O 0 1.693180968695418e-12
to O 0 6.408349057570456e-14
define O 0 7.563655105881362e-13
the O 0 2.5102335964396648e-15
most O 0 2.6254776169904142e-16
common O 0 5.970020031750725e-16
mutations O 0 5.250126729879295e-16
and O 0 4.235336853366384e-14
their O 0 2.7762685271374987e-13
frequencies O 0 1.417260087066552e-09
in O 0 4.9745123575917205e-09
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999977350234985
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.00029341565095819533
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999991655349731
T I-Disease 1 0.9999998807907104
) O 0 4.817468646223233e-11
homozygotes O 0 3.565884046374812e-11
from O 0 5.945451841115614e-16
10 O 0 1.1097020993625951e-15
ethnic O 0 1.0859028791183195e-13
populations O 0 7.308472403655397e-12
. O 0 1.8959916969762958e-11

Both O 0 1.2392817078533264e-13
genomic O 0 9.180075449810587e-11
mutations O 0 2.8262079343477353e-09
and O 0 4.014061583124118e-10
their O 0 3.1837499216841314e-12
effects O 0 1.6979729525624238e-13
on O 0 1.079786843841352e-14
cDNA O 0 8.457431803499116e-12
were O 0 1.2757857921139037e-12
characterized O 0 2.9233679279400127e-12
. O 0 1.5470838585912583e-13

Protein O 0 2.9604493856361103e-10
- O 0 2.3302755280951715e-09
truncation O 0 1.6246695655475207e-10
testing O 0 6.186504000055271e-12
of O 0 2.421839870152915e-18
the O 0 1.8413784897981694e-17
entire O 0 1.1852839080372804e-16
ATM O 0 6.636462755206518e-13
cDNA O 0 7.473415983283438e-12
detected O 0 6.5953389416506525e-09
92 O 0 1.096604404504653e-11
( O 0 7.041060900422674e-16
66 O 0 2.2409889915975256e-11
% O 0 3.0696247427182454e-15
) O 0 5.225012202993205e-16
truncating O 0 8.634341614084662e-13
mutations O 0 7.324544616660322e-13
in O 0 7.200999249710007e-16
140 O 0 4.709813200792605e-15
mutant O 0 2.835729914774099e-11
alleles O 0 3.414259847067669e-11
screened O 0 3.2150633160199504e-06
. O 0 1.3821478184183889e-08

The O 0 4.30753913441273e-12
haplotyping O 0 1.45353965308459e-07
of O 0 8.567372343244034e-14
patients O 0 9.18511035459535e-13
with O 0 3.1975016709893944e-13
identical O 0 1.958149864478287e-09
mutations O 0 3.3606037397326816e-10
indicates O 0 4.185291557767812e-10
that O 0 3.559693512178441e-11
almost O 0 5.522767139443108e-12
all O 0 6.108291362950588e-14
of O 0 1.408843431388476e-16
these O 0 2.531728285674016e-14
represent O 0 3.084081702538635e-17
common O 0 8.697382549403831e-13
ancestry O 0 1.691170403717024e-08
and O 0 4.009673304494754e-08
that O 0 8.020117903129176e-11
very O 0 2.316485545050817e-12
few O 0 1.6311707193295e-11
spontaneously O 0 4.8756498838287143e-11
recurring O 0 1.0357644603109506e-10
ATM O 0 6.368304070747399e-07
mutations O 0 9.540808143526647e-09
exist O 0 2.1761068502712533e-09
. O 0 7.628986331553733e-09

Assays O 0 1.8507785581878267e-11
requiring O 0 1.1098472130471188e-13
minimal O 0 2.1154097286260436e-15
amounts O 0 6.473124631000563e-18
of O 0 2.439018291825322e-19
genomic O 0 7.688680692553157e-15
DNA O 0 1.0659803595380879e-10
were O 0 2.390966114332316e-13
designed O 0 1.1111593136692278e-15
to O 0 3.478519365514519e-19
allow O 0 3.397276658429887e-20
rapid O 0 1.733902072703845e-20
screening O 0 5.508232922118176e-18
for O 0 2.320979618414005e-19
common O 0 8.478508634439928e-16
ethnic O 0 3.371775243992542e-14
mutations O 0 5.026312265704602e-12
. O 0 1.4791585924850414e-12

These O 0 5.345270870349937e-15
rapid O 0 6.552283714583132e-16
assays O 0 5.1605007973017786e-14
detected O 0 3.1723540894895708e-12
mutations O 0 5.004021827979821e-13
in O 0 5.0260959809237185e-14
76 O 0 1.4164378003833633e-10
% O 0 7.767883694132297e-14
of O 0 1.2851280225739995e-15
Costa O 0 8.147792662782649e-09
Rican O 0 1.3884090543925254e-09
patients O 0 4.448544871772479e-14
( O 0 8.185723119392502e-20
3 O 0 4.883322619316618e-17
) O 0 8.808282383607668e-17
, O 0 3.6421958804747805e-16
50 O 0 1.857635791678168e-15
% O 0 3.730303453554785e-16
of O 0 2.8272449943120065e-15
Norwegian O 0 2.06048644031398e-05
patients O 0 4.79979879626502e-13
( O 0 2.7384990326001455e-19
1 O 0 5.0378529444771405e-18
) O 0 9.072784303255585e-17
, O 0 1.1586051230558485e-15
25 O 0 8.54673862064892e-15
% O 0 1.0901617110139285e-16
of O 0 4.1519720718679405e-16
Polish O 0 4.942265832141857e-07
patients O 0 8.902946468155454e-15
( O 0 9.565439863174352e-21
4 O 0 2.0016055251192835e-17
) O 0 9.529838649382575e-17
, O 0 8.185989511874799e-16
and O 0 3.0020465280333752e-12
14 O 0 1.5595577130059213e-12
% O 0 1.8040848864450936e-15
of O 0 3.306166316535534e-15
Italian O 0 7.24328970136412e-08
patients O 0 4.6543942067460084e-14
( O 0 1.0752872334337142e-19
1 O 0 2.023539542550107e-17
) O 0 2.7496840931560615e-15
, O 0 2.0142679066745717e-16
as O 0 2.3384732083075034e-16
well O 0 1.1826334360662033e-15
as O 0 1.1951779940150395e-15
in O 0 6.801063114543233e-17
patients O 0 1.286500110069433e-17
of O 0 8.0561451471891e-19
Amish O 0 8.065780043864379e-09
/ O 0 7.347310759797665e-09
Mennonite O 0 1.1013353429234485e-07
and O 0 1.5804421593657025e-07
Irish O 0 1.1275355404904985e-07
English O 0 1.1150393941505854e-09
backgrounds O 0 1.1542017341881206e-09
. O 0 3.5825231670116864e-12

Additional O 0 5.374058132095322e-15
mutations O 0 8.680109040391792e-14
were O 0 7.047359115545937e-13
observed O 0 5.172780064531535e-14
in O 0 2.8683614029398287e-16
Japanese O 0 3.002573450289203e-12
, O 0 6.932632560260508e-18
Utah O 0 3.678611944459611e-16
Mormon O 0 2.1952027733562404e-14
, O 0 3.0463408657894087e-15
and O 0 6.918115846897901e-14
African O 0 5.224436961742901e-15
American O 0 5.901308630130997e-13
patients O 0 2.6936386335416757e-14
. O 0 2.6348011839265502e-14

These O 0 1.5698148961736634e-16
assays O 0 1.3160248992838598e-16
should O 0 1.777941879374507e-19
facilitate O 0 7.399526398134636e-21
screening O 0 3.79555728362448e-16
for O 0 1.2007315443578886e-13
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.9999979734420776
T I-Disease 1 0.9999998807907104
heterozygotes O 0 9.071630599488678e-12
in O 0 1.4627302571498502e-18
the O 0 1.5873069868023017e-17
populations O 0 1.707518762944469e-16
studied O 0 5.015387112778172e-15
. O 0 9.69344589541116e-15
. O 0 1.3216218484185527e-12

The O 0 1.0009065221083802e-07
von B-Disease 1 0.9991359114646912
Hippel I-Disease 1 0.999198853969574
- I-Disease 1 0.9998334646224976
Lindau I-Disease 1 0.9972992539405823
tumor I-Disease 0 1.899142807815224e-05
suppressor O 0 2.21902798358542e-08
gene O 0 9.2123669803712e-11
is O 0 3.3174560375246603e-14
required O 0 9.510808863082425e-17
for O 0 2.3802499320572696e-17
cell O 0 7.190264827983128e-09
cycle O 0 1.7902285209814295e-09
exit O 0 3.948722945845695e-11
upon O 0 1.3615572157146122e-13
serum O 0 6.332594004732073e-09
withdrawal O 0 2.699713508302892e-10
. O 0 6.24476373389804e-11

The O 0 4.3655844998019555e-13
inactivation O 0 1.2916791192196797e-08
of O 0 2.735164932000586e-14
the O 0 3.9383898919886917e-10
von B-Disease 1 0.9998020529747009
Hippel I-Disease 1 0.9998843669891357
- I-Disease 1 0.9999723434448242
Lindau I-Disease 1 0.9999276399612427
( I-Disease 0 4.185383417620869e-08
VHL I-Disease 0 0.00033854565117508173
) I-Disease 0 4.5630777802119216e-12
tumor I-Disease 0 2.909775198567388e-10
suppressor O 0 3.983091634296443e-09
gene O 0 3.961534433827296e-10
predisposes O 0 1.0177588194437703e-07
affected O 0 1.9697133193160438e-13
individuals O 0 3.4900745864994206e-16
to O 0 2.8193430662987184e-13
the O 0 1.3553408395594602e-10
human O 0 0.002920566825196147
VHL B-Disease 1 0.999975323677063
cancer I-Disease 1 0.999955415725708
syndrome I-Disease 1 0.9999681711196899
and O 0 5.245335416015351e-11
is O 0 2.2599763315096777e-13
associated O 0 4.367985573933142e-12
with O 0 7.376173283279996e-11
sporadic B-Disease 0 0.0035914841573685408
renal I-Disease 1 0.9997990727424622
cell I-Disease 1 0.9999722242355347
carcinomas I-Disease 1 0.9999997615814209
( O 0 6.773722915909275e-09
RCC B-Disease 0 0.00547260046005249
) O 0 1.1472469196860402e-08
and O 0 1.6555327420064714e-07
brain B-Disease 0 7.638027454959229e-05
hemangioblastomas I-Disease 0 0.0001936037588166073
. O 0 5.217837273363557e-10

VHL O 0 0.008897362276911736
- O 0 1.8749207811197266e-05
negative O 0 4.961152377802591e-09
786 O 0 1.1498713092805701e-08
- O 0 2.7686924752856612e-08
0 O 0 1.4945712039932807e-13
RCC B-Disease 0 4.347457810416344e-11
cells O 0 2.0162005203404332e-13
are O 0 1.1281420405056392e-13
tumorigenic O 0 1.303730300605821e-06
in O 0 1.3200770476728962e-09
nude O 1 0.9594894647598267
mice O 0 4.6977464080555364e-05
which O 0 5.825577433643536e-12
is O 0 6.78230530522849e-17
suppressed O 0 1.6960025559331588e-16
by O 0 1.5436844591464602e-18
the O 0 6.273037333603683e-17
reintroduction O 0 4.0485657361311045e-12
of O 0 1.4620861013320448e-14
VHL B-Disease 0 7.583116712339688e-08
. O 0 1.4952875092635876e-12

Remarkably O 0 5.754178244998798e-10
, O 0 9.107197282550925e-14
this O 0 2.1995845542017257e-16
occurs O 0 1.1848872848597286e-14
without O 0 4.776214231110238e-15
affecting O 0 2.1595200281454953e-15
the O 0 5.532608808480992e-14
growth O 0 1.5838341055340877e-11
rate O 0 5.925703261411286e-10
and O 0 2.059317438796171e-10
cell O 0 2.720833336411488e-08
cycle O 0 2.570166968141052e-09
profile O 0 1.1574191258190147e-11
of O 0 1.9098932395504772e-18
these O 0 1.5035087931031272e-17
cells O 0 4.84365732371123e-17
in O 0 1.2507870007127624e-17
culture O 0 2.112673092025119e-10
. O 0 1.3722951594519195e-11

The O 0 2.387429717896211e-13
786 O 0 8.193742212503352e-11
- O 0 1.7631268889317653e-08
0 O 0 4.5015006262458246e-13
cell O 0 2.429308754159365e-09
line O 0 7.751375363795887e-08
, O 0 3.246602409113196e-14
like O 0 7.329010174358247e-15
many O 0 3.7429329794961424e-16
cancer B-Disease 0 1.865763186309488e-12
cells O 0 2.0831556965528186e-13
, O 0 1.1012985499676137e-13
fails O 0 1.1970112678838518e-09
to O 0 9.19860569008682e-14
exit O 0 6.743297031874818e-10
the O 0 2.7833199070168013e-13
cell O 0 2.2524029308357285e-09
cycle O 0 1.0525805921313136e-11
upon O 0 1.6334400407044662e-15
serum O 0 3.5058711489455163e-10
withdrawal O 0 1.7112790351436757e-11
. O 0 2.6520383111794388e-11

Here O 0 2.2769752749951522e-10
, O 0 7.003854978214529e-15
it O 0 4.869262070915543e-16
is O 0 2.1941350386953896e-18
shown O 0 4.83436940892124e-18
that O 0 5.733921494370255e-21
reintroduction O 0 6.631489103736392e-17
of O 0 1.8590570196990468e-19
the O 0 4.1065443714177123e-16
wild O 0 1.3397952018656678e-11
- O 0 9.58943147111313e-08
type O 0 4.066646672185037e-11
VHL B-Disease 0 5.252105972353149e-10
gene O 0 1.6275082139177027e-13
restores O 0 9.307706688721495e-11
the O 0 2.92441195533981e-15
ability O 0 2.3660431253125225e-12
of O 0 7.806576159162873e-14
VHL O 0 0.08074785768985748
- O 0 0.0016476379241794348
negative O 0 1.5520865304097242e-07
RCC B-Disease 0 2.4454888603031577e-07
cancer I-Disease 0 7.677163071928561e-11
cells O 0 5.06622899488769e-15
to O 0 3.448549293892135e-14
exit O 0 2.2693433937570617e-11
the O 0 9.328997264360789e-15
cell O 0 1.5487404692038353e-09
cycle O 0 6.073915259641183e-10
and O 0 1.096014121473865e-12
enter O 0 6.095350054769258e-14
G0 O 0 7.458403672444547e-09
/ O 0 2.187054759517082e-09
quiescence O 0 2.355825934330369e-08
in O 0 1.084882238298196e-13
low O 0 5.49934264792995e-10
serum O 0 9.091876584932379e-09
. O 0 1.2143537911346591e-11

Both O 0 4.16167170169679e-11
VHL O 0 7.814754098944832e-06
- O 0 7.535464305874484e-07
positive O 0 6.209630726283777e-11
and O 0 1.7190340262374093e-09
VHL O 0 7.995065243449062e-05
- O 0 2.39799931023299e-07
negative O 0 3.100583956250347e-10
RCC B-Disease 0 7.51752771144254e-10
cells O 0 2.63555643238364e-13
exit O 0 3.051121161279369e-11
the O 0 1.900652148146241e-14
cell O 0 1.5112920914717165e-09
cycle O 0 2.250403682846347e-11
by O 0 5.30441995361152e-16
contact O 0 2.3231328319384126e-11
inhibition O 0 2.3093976384003234e-11
. O 0 7.541061525229154e-11

The O 0 3.0166086642524625e-12
cyclin O 0 1.006590277796704e-08
- O 0 1.667268753613449e-11
dependent O 0 1.1498963538086535e-14
kinase O 0 4.019128779786385e-12
inhibitor O 0 2.1737639899904737e-12
, O 0 3.8063738943609174e-16
p27 O 0 5.6457316679494034e-15
, O 0 2.2909935457271333e-18
accumulates O 0 3.204542691655752e-16
upon O 0 1.1029906702009726e-17
serum O 0 9.118081723685778e-13
withdrawal O 0 4.0112061756988546e-14
, O 0 2.315024689349544e-15
only O 0 3.752695431259942e-17
in O 0 1.5014568888756282e-17
the O 0 6.032402420129228e-16
presence O 0 2.8017798381374005e-14
of O 0 1.3645033741820816e-16
VHL B-Disease 0 9.483448748515144e-11
, O 0 1.2903391545539652e-16
as O 0 1.1929181895211038e-16
a O 0 2.836232649157085e-15
result O 0 8.47269354149879e-15
of O 0 6.984447567421136e-18
the O 0 7.354551605849753e-15
stabilization O 0 1.6295208997256505e-13
of O 0 3.845483672010527e-18
the O 0 2.820910670174202e-15
protein O 0 4.405519785782852e-12
. O 0 1.3005737979632226e-12

We O 0 2.7007703799070137e-13
propose O 0 2.3735392923568237e-14
that O 0 1.0927359447257968e-14
the O 0 2.7562491067170507e-14
loss O 0 1.82912495913512e-12
of O 0 2.166415637342309e-17
wild O 0 3.9672659601919236e-10
- O 0 0.00011078640818595886
type O 0 1.3900844031411452e-08
VHL B-Disease 0 5.066082664484384e-08
gene O 0 1.0428163324180395e-12
results O 0 4.3520597828551274e-16
in O 0 5.18517100691357e-20
a O 0 7.000845699281964e-20
specific O 0 1.2721716874987895e-17
cellular O 0 2.988247704838187e-10
defect O 0 2.8591310652359425e-08
in O 0 9.613944568827998e-14
serum O 0 1.7097588056458335e-07
- O 0 2.465332329393277e-07
dependent O 0 5.903637578796861e-10
growth O 0 4.435013467585236e-11
control O 0 2.3764175072216176e-09
, O 0 8.711290017246118e-14
which O 0 1.2996407335735816e-13
may O 0 5.628700376478961e-15
initiate O 0 2.7358105405129833e-15
tumor B-Disease 0 2.700650814091432e-10
formation O 0 7.727387306422084e-12
. O 0 7.909705529440814e-11

This O 0 1.2707459325252135e-13
is O 0 7.794814344360594e-16
corrected O 0 6.886861686396933e-14
by O 0 7.497442287558467e-20
the O 0 3.749457722265318e-19
reintroduction O 0 3.211337378200389e-14
of O 0 2.019106847083558e-16
wild O 0 3.7613367975808387e-10
- O 0 4.204897413728759e-05
type O 0 2.0343611240036807e-08
VHL B-Disease 0 4.57000851383782e-06
, O 0 1.0146798765792164e-13
implicating O 0 1.580835684578119e-09
VHL B-Disease 0 3.868628750680614e-10
as O 0 1.7032194619322227e-15
the O 0 3.522857673233918e-17
first O 0 2.8054668243260327e-16
tumor B-Disease 0 1.0624326125894396e-13
suppressor O 0 2.740058885081914e-13
involved O 0 3.795370830496966e-15
in O 0 8.597479705837715e-17
the O 0 2.383378130610598e-15
regulation O 0 6.059860946372453e-12
of O 0 8.455552474558384e-14
cell O 0 2.1443918285513064e-06
cycle O 0 1.0981528930642526e-06
exit O 0 3.9778291238690144e-07
, O 0 4.499704775451363e-10
which O 0 7.563287496292759e-11
is O 0 1.150204063937732e-13
consistent O 0 2.4829129637721215e-13
with O 0 1.3522904296320954e-15
its O 0 1.9807054013978344e-14
gatekeeper O 0 2.0085270946434974e-10
function O 0 5.125464397522095e-13
in O 0 7.705420096469975e-14
the O 0 1.498617549500203e-11
kidney O 0 2.0369633091377182e-07
. O 0 1.6690759885307216e-11
. O 0 1.0928840471491341e-10

Piebaldism B-Disease 1 0.9999669790267944
with O 0 0.17069926857948303
deafness B-Disease 1 0.9999995231628418
: O 0 5.181020543143511e-12
molecular O 0 7.398754443718692e-16
evidence O 0 6.081036934378202e-16
for O 0 6.625569054810411e-18
an O 0 4.5502017003437936e-14
expanded O 0 1.5579159935441567e-06
syndrome O 1 0.9997398257255554
. O 0 2.021243727945432e-10

In O 0 2.3202419464365097e-14
a O 0 1.159623341361743e-13
South O 0 9.649520765764308e-12
African O 0 2.1287372906075852e-12
girl O 0 1.1531460231140045e-08
of O 0 7.906578224168431e-16
Xhosa O 0 4.498565520094644e-09
stock O 0 1.8353979360646866e-12
with O 0 1.5010705894415166e-13
severe O 0 6.478657194053383e-11
piebaldism B-Disease 0 1.916890681741279e-07
and O 0 5.990044016357388e-10
profound O 0 7.528695000758034e-09
congenital O 1 0.9995598196983337
sensorineural B-Disease 1 0.9994388222694397
deafness I-Disease 1 0.9999997615814209
we O 0 3.305109241846793e-10
identified O 0 1.6137920738775423e-14
a O 0 5.813529900652105e-17
novel O 0 4.661410350054705e-15
missense O 0 9.24000351058829e-13
substitution O 0 2.906147341546518e-14
at O 0 1.4765651808884561e-12
a O 0 2.949032556138532e-17
highly O 0 8.038900520048416e-17
conserved O 0 1.503321867490047e-14
residue O 0 8.921225425062573e-10
in O 0 1.5468380852318187e-18
the O 0 3.783695374053741e-20
intracellular O 0 6.342943756833968e-16
kinase O 0 1.3909250270657814e-12
domain O 0 2.934931486210657e-13
of O 0 4.4025688868954934e-17
the O 0 1.6996278516534513e-14
KIT O 0 1.5717027679329476e-08
proto O 0 9.769050013375136e-10
- O 0 2.3299409623867007e-10
oncogene O 0 4.490650906685545e-10
, O 0 2.641525236393716e-13
R796G O 0 5.4427608253693194e-11
. O 0 1.215421426697949e-12

Though O 0 3.068114859394733e-11
auditory B-Disease 0 3.5945871279530195e-10
anomalies I-Disease 0 7.777911648076952e-09
have O 0 4.3769068230892216e-13
been O 0 1.45605898757388e-13
observed O 0 5.219900575149927e-13
in O 0 2.479821090226736e-14
mice O 0 8.843003412861705e-11
with O 0 3.8314073051368136e-13
dominant O 0 1.643822322705546e-08
white O 0 3.838494194496889e-06
spotting O 0 9.892934940580744e-06
( O 0 7.365705267936562e-13
W O 0 6.353848584694788e-05
) O 0 1.7505623144641047e-14
due O 0 3.6076141192767884e-15
to O 0 1.928699848484719e-13
KIT O 0 3.968034718582203e-07
mutations O 0 2.770846441180197e-09
, O 0 1.0466722599744571e-08
deafness B-Disease 1 1.0
is O 0 3.4977343937869776e-11
not O 0 2.7914719147315026e-12
typical O 0 1.4923243847261847e-12
in O 0 1.0535798308005523e-13
human O 0 7.584555761219747e-10
piebaldism B-Disease 0 2.3870228687883355e-05
. O 0 6.657683848665386e-10

Thus O 0 1.7995100852138957e-12
, O 0 7.563124363506942e-16
the O 0 7.76773466794965e-18
occurrence O 0 3.2465173670052916e-13
of O 0 6.846603904479831e-13
sensorineural B-Disease 1 0.995555579662323
deafness I-Disease 1 1.0
in O 0 1.6409911623993523e-11
this O 0 5.153770273502896e-15
patient O 0 1.218626572265305e-13
extends O 0 9.785921564460596e-15
considerably O 0 1.1218544810568526e-14
the O 0 1.8498977883629755e-17
phenotypic O 0 6.872551636500311e-16
range O 0 1.4881759713425424e-10
of O 0 9.233686576036893e-15
piebaldism B-Disease 0 4.599856051612505e-09
due O 0 2.97132614567291e-15
to O 0 1.0020581878102033e-15
KIT O 0 8.568134049480314e-12
gene O 0 1.3118352890382828e-15
mutation O 0 1.2184718235810064e-15
in O 0 2.3725729018793894e-16
humans O 0 1.2715962689009621e-14
and O 0 3.834977474470591e-12
tightens O 0 1.2629969887711923e-06
the O 0 2.6432762144319505e-15
clinical O 0 7.349415303936721e-16
similarity O 0 4.078025301479252e-15
between O 0 9.449845149011454e-15
piebaldism B-Disease 0 3.6777481060568107e-09
and O 0 1.6732338984411926e-13
the O 0 3.541640959711527e-17
various O 0 2.574560031311235e-15
forms O 0 1.3484792449336425e-10
of O 0 1.1725979476295834e-07
Waardenburg B-Disease 1 0.9999077320098877
syndrome I-Disease 1 0.9602781534194946
. O 0 6.920258094865461e-13
. O 0 1.1485565970525968e-11

Cycloheximide O 0 2.1359626567463152e-10
facilitates O 0 6.585442640424238e-14
the O 0 2.335023401932014e-16
identification O 0 6.773934660945927e-15
of O 0 7.295751531563425e-17
aberrant O 0 1.0649805343154739e-10
transcripts O 0 5.355738075252248e-09
resulting O 0 2.627468208282746e-11
from O 0 4.831537764543679e-15
a O 0 6.244343298422055e-16
novel O 0 2.6808198063245185e-14
splice O 0 2.098788399962359e-06
- O 0 1.5394698849036104e-08
site O 0 4.923011442947711e-10
mutation O 0 4.6935195313624334e-11
in O 0 4.457684018460174e-14
COL17A1 O 0 6.910777727853201e-08
in O 0 2.961536085928986e-16
a O 0 1.2315655765170186e-15
patient O 0 3.2113222671326103e-12
with O 0 1.6709415968929608e-12
generalized O 0 1.9111931592874498e-08
atrophic B-Disease 0 0.29274609684944153
benign I-Disease 1 0.998245358467102
epidermolysis I-Disease 1 0.9892557859420776
bullosa I-Disease 1 0.9784292578697205
. O 0 6.311651077339775e-07

Patients O 0 1.766788493284821e-09
with O 0 6.212379222159115e-11
generalized O 0 9.755783025866549e-08
atrophic B-Disease 0 0.4577856957912445
benign I-Disease 1 0.9825035929679871
epidermolysis I-Disease 1 0.834976077079773
bullosa I-Disease 0 0.07240427285432816
often O 0 5.550922423935845e-07
show O 0 1.671219074239616e-08
decreased O 0 1.3497626627501091e-11
expression O 0 2.013332771712891e-14
of O 0 1.898215657873464e-16
type O 0 2.041136530628318e-11
XVII O 0 2.547778654715671e-09
collagen O 0 3.7868122526596437e-10
, O 0 1.294665980325349e-12
a O 0 5.3855921797380836e-15
transmembrane O 0 4.325916794917228e-12
hemidesmosomal O 0 4.710649578743009e-11
protein O 0 2.710815657030693e-15
encoded O 0 1.0900963359522682e-14
by O 0 3.751141311090188e-14
COL17A1 O 0 1.3562909089159803e-06
. O 0 1.5434898151256427e-11

This O 0 3.274295981917086e-13
report O 0 4.46191799735032e-15
documents O 0 2.8749026678145592e-15
a O 0 5.643338482236055e-16
novel O 0 1.1339100468852389e-14
splice O 0 9.634235311750672e-07
- O 0 3.864230180283812e-08
site O 0 2.52082910101592e-10
mutation O 0 4.614180999090722e-12
in O 0 4.035930305099555e-15
COL17A1 O 0 3.5202392112410053e-09
in O 0 1.755072946226224e-17
a O 0 2.4633896569016274e-16
patient O 0 1.3985893606432986e-12
with O 0 1.6052561840548818e-12
generalized O 0 7.933465440146392e-09
atrophic B-Disease 0 0.06179988756775856
benign I-Disease 1 0.7357827425003052
epidermolysis I-Disease 0 0.00560971163213253
bullosa I-Disease 0 0.0003125067742075771
, O 0 2.882188758490667e-11
and O 0 2.3523031599296217e-14
applies O 0 1.5754592788887047e-17
a O 0 1.5467310687400696e-19
new O 0 1.2113651650411642e-18
methodology O 0 6.316287100588283e-16
to O 0 3.630086485702596e-16
define O 0 3.9047978311066225e-14
and O 0 4.188661272214525e-14
characterize O 0 1.2398587744596318e-13
the O 0 4.978213139594006e-17
resulting O 0 6.83187976135112e-16
mRNA O 0 1.5395834834872751e-13
splice O 0 3.3130384053947637e-06
variants O 0 3.313185104047989e-08
. O 0 1.085961098823418e-09

Mutational O 0 9.475900810684834e-07
analysis O 0 6.2536768298537826e-12
of O 0 5.160734578395221e-15
COL17A1 O 0 1.0928309812641146e-08
identified O 0 3.973911043980705e-12
a O 0 7.09809205227778e-14
maternally O 0 5.261154356617226e-08
inherited O 0 2.029100642175763e-06
G O 0 1.094291064873687e-06
- O 0 3.7844401390429994e-08
to O 0 3.4764804368592195e-09
- O 0 3.314199420856312e-05
T O 0 8.481678719363117e-07
transversion O 0 1.1499073915288704e-10
at O 0 2.4693180934390194e-15
the O 0 4.1169552500636924e-18
- O 0 1.0090361299329789e-14
1 O 0 1.811378096546943e-18
position O 0 2.069798486724057e-15
of O 0 9.74577993855383e-19
exon O 0 2.762829570158998e-13
32 O 0 1.4620959607955508e-12
. O 0 1.182603602718768e-12

This O 0 3.127613465320222e-15
acceptor O 0 1.1484568721367716e-13
splice O 0 2.1244421333221908e-08
- O 0 5.762088584049252e-09
site O 0 1.6628613763725042e-10
mutation O 0 5.8814225191439196e-12
led O 0 4.503939810083374e-13
to O 0 7.108724856864663e-15
the O 0 1.6389505194219474e-16
formation O 0 8.467260566295983e-16
of O 0 1.2695634215912873e-17
aberrant O 0 1.673611227902272e-12
transcripts O 0 7.50013731676269e-11
present O 0 1.965007746362185e-13
at O 0 3.450581140262976e-11
extremely O 0 4.252852583985778e-11
low O 0 1.3732083026241071e-08
levels O 0 2.2582390124537e-10
. O 0 4.970353295608021e-11

Based O 0 8.164915819191057e-14
on O 0 2.573444712536399e-12
our O 0 1.274097608016181e-13
recent O 0 2.0693238571060192e-16
finding O 0 6.227073355418724e-16
that O 0 1.8203860355150026e-15
cycloheximide O 0 1.4546454318864477e-10
stabilized O 0 6.172649058555635e-10
mutant O 0 3.000295107843942e-12
COL17A1 O 0 2.5000324727075807e-11
transcripts O 0 3.9533009027828414e-13
in O 0 4.548337632289793e-17
keratinocytes O 0 2.2549472597326037e-13
homozygous O 0 1.5992952743918744e-14
for O 0 3.9293421671763565e-17
a O 0 2.7183401471626845e-14
frameshift O 0 2.9556102010275254e-09
mutation O 0 4.490870869622299e-11
, O 0 2.805682595974357e-11
the O 0 1.1048469431007568e-11
effects O 0 2.001262489059741e-09
of O 0 8.841744817235644e-17
the O 0 5.060337880739537e-15
splice O 0 1.5594827118547983e-07
- O 0 2.480763094947491e-10
site O 0 9.072907355966997e-13
mutation O 0 2.296255498029573e-15
on O 0 1.4181001038976026e-14
splicing O 0 1.3583732229316414e-11
of O 0 1.0390859154620698e-15
COL17A1 O 0 4.2949730577612755e-11
transcripts O 0 1.0717154838276247e-13
were O 0 4.191803928561472e-17
determined O 0 2.727001894169906e-18
using O 0 2.986116014256989e-18
reverse O 0 9.640024238935507e-13
transcriptase O 0 3.305030077740967e-12
polymerase O 0 4.774158846032606e-10
chain O 0 1.5994944257968768e-09
reaction O 0 1.8724635692879757e-14
of O 0 1.5637341539720092e-19
total O 0 6.070296461481247e-19
RNA O 0 1.7073552315872986e-13
from O 0 5.505654864846644e-16
keratinocytes O 0 9.312113526029758e-14
incubated O 0 6.22803349691059e-13
for O 0 6.625619512827777e-18
2 O 0 7.715623116539422e-15
. O 0 8.035509513641334e-14

5 O 0 4.955560406472159e-10
h O 0 2.1349507051127148e-08
in O 0 1.4427773076730252e-14
the O 0 6.490022346036968e-15
presence O 0 1.1259714948613775e-12
or O 0 3.9368989838972634e-12
absence O 0 1.1273843356530023e-14
of O 0 5.8093374184354414e-18
10 O 0 8.072000052998052e-16
microg O 0 5.582544496118835e-11
cycloheximide O 0 2.756827821581709e-10
per O 0 3.436572925644317e-14
ml O 0 5.223536270193563e-09
. O 0 1.2551977686403593e-11

Using O 0 4.576207644703574e-14
this O 0 2.244834668900606e-15
approach O 0 1.6876717037761502e-11
, O 0 1.5828186200952943e-12
an O 0 7.157925104419108e-14
abnormally O 0 8.491667813359527e-08
spliced O 0 0.07505368441343307
transcript O 0 0.003926242236047983
was O 0 1.2288622563971785e-08
identified O 0 7.117183361757262e-13
that O 0 4.993676123092827e-17
contains O 0 1.1170559769585207e-19
an O 0 7.567578156215014e-21
extra O 0 2.0949366445058866e-18
264 O 0 1.23366682703114e-16
bases O 0 1.7358056664460429e-15
upstream O 0 1.7771869316885597e-14
from O 0 2.657633422887911e-15
exon O 0 5.831847591647454e-12
32 O 0 1.0185200773060732e-11
, O 0 7.356968360254859e-14
resulting O 0 1.5157491960789832e-13
in O 0 3.959499557653484e-15
a O 0 1.2617981746260165e-12
premature O 0 6.690641374262896e-10
termination O 0 2.4416755509820698e-12
codon O 0 9.273904344117567e-13
27 O 0 5.2925662984149024e-12
bp O 0 1.3197685999610798e-11
downstream O 0 5.475565205241562e-13
from O 0 1.3439182501023155e-15
the O 0 3.1323655319125555e-15
cryptic O 0 1.9510691673385594e-10
splice O 0 6.330833457468543e-08
site O 0 8.14327520970437e-08
. O 0 5.595894303489501e-10

Three O 0 1.8721493200645443e-14
other O 0 2.413273794524469e-17
splice O 0 8.555824798639478e-11
variants O 0 7.161538289474079e-12
, O 0 3.223641717605384e-14
including O 0 6.077671169552948e-17
one O 0 4.2150400275381276e-16
derived O 0 6.3631244987820366e-18
from O 0 2.2844930228062934e-17
the O 0 1.5865746010879473e-17
skipping O 0 1.3938377090971094e-13
of O 0 3.963135224895169e-18
exon O 0 1.1921874891376166e-13
32 O 0 1.0315083205994502e-13
, O 0 1.3275924311978177e-15
were O 0 1.6713296328504934e-13
also O 0 1.3712156952429277e-13
identified O 0 8.748702456928825e-11
. O 0 6.303329386225798e-11

These O 0 1.4941395343193165e-11
results O 0 1.9640510395889203e-14
indicate O 0 1.0942543359870448e-14
the O 0 1.8045787132707878e-17
usefulness O 0 1.893610763255716e-14
of O 0 5.465159146080702e-18
cycloheximide O 0 2.041339146330312e-11
treatment O 0 6.038848870253426e-16
in O 0 4.981472611193559e-20
evaluating O 0 1.1264706881966579e-18
the O 0 9.34950500403989e-18
abnormal O 0 9.960714436423046e-15
processing O 0 1.8455566783338482e-16
of O 0 1.4337484075760122e-19
mRNA O 0 1.1865367629398937e-13
due O 0 3.8667639511331953e-13
to O 0 2.9400171397886074e-14
splice O 0 7.007820386206731e-07
- O 0 3.1111302423170173e-09
site O 0 9.766754072160211e-11
mutations O 0 1.915905628591119e-11
, O 0 9.417319083836889e-14
because O 0 9.360800302211578e-14
( O 0 1.0624568349524042e-17
i O 0 7.555703979145179e-11
) O 0 5.3791806697229606e-17
aberrant O 0 1.3081380325751651e-14
splicing O 0 7.449118904177821e-13
often O 0 1.4951906900095846e-12
generates O 0 2.2164904053866355e-15
a O 0 2.8696650395852123e-15
premature O 0 1.477997238485962e-11
termination O 0 4.667216049400458e-13
codon O 0 1.4748820654358896e-12
, O 0 5.1970537248702264e-12
( O 0 3.775472332500068e-15
ii O 0 3.5863997993601515e-08
) O 0 1.453090306500343e-13
transcripts O 0 3.303336770787979e-11
with O 0 3.104637315461123e-14
premature O 0 2.3790022144094813e-13
termination O 0 6.237938670549629e-16
codons O 0 4.867630261942658e-15
can O 0 7.262334180205277e-13
occur O 0 1.5913884793272715e-12
at O 0 1.0611629353007856e-09
low O 0 2.2202277705218876e-06
or O 0 5.383740813158511e-07
undetectable O 0 5.658905593008967e-06
levels O 0 3.393123559902733e-10
due O 0 1.162562071350265e-13
to O 0 9.753935940187697e-13
nonsense O 0 3.207476950706223e-09
- O 0 2.7712635788587625e-13
mediated O 0 4.74996398550781e-13
mRNA O 0 1.1021444173975325e-11
decay O 0 1.9542444107401025e-08
, O 0 4.0994874222967815e-15
and O 0 2.6443868863840377e-14
( O 0 7.713606036615711e-19
iii O 0 7.071626704352463e-12
) O 0 3.07545770805457e-14
the O 0 2.71736046885589e-14
levels O 0 3.474960458813882e-14
of O 0 2.1884819248304888e-20
these O 0 8.029058394248015e-18
transcripts O 0 5.0335214105525286e-14
can O 0 3.0001401418956926e-16
be O 0 1.3999922679619136e-17
increased O 0 4.620101919719485e-18
by O 0 1.0858822115144065e-13
cycloheximide O 0 8.209339284803718e-06
. O 0 1.5529755259535705e-10

A O 0 2.2206579023548167e-12
deletion O 0 9.203849488104154e-11
mutation O 0 4.219408676620073e-12
in O 0 3.307462539525047e-13
COL17A1 O 0 1.272509507543873e-06
in O 0 2.2643072787316247e-14
five O 0 3.549804222270636e-13
Austrian O 0 4.1790656268858584e-08
families O 0 5.145706430398356e-11
with O 0 2.3430039917775314e-13
generalized O 0 1.5334147285273048e-09
atrophic B-Disease 0 0.006636986508965492
benign I-Disease 1 0.9795021414756775
epidermolysis I-Disease 1 0.6985028982162476
bullosa I-Disease 0 0.002173644956201315
represents O 0 1.1356947283644447e-12
propagation O 0 2.5511507836806224e-11
of O 0 1.269200917959642e-16
an O 0 1.0029033149333262e-15
ancestral O 0 1.569895289321721e-07
allele O 0 2.3651018636883236e-06
. O 0 1.1959849999243488e-08

Patients O 0 3.500594258909473e-09
with O 0 1.3956460986896957e-10
generalized O 0 4.5248918922879966e-07
atrophic B-Disease 1 0.8119266629219055
benign I-Disease 1 0.9800251126289368
epidermolysis I-Disease 0 0.2348794937133789
bullosa I-Disease 0 0.0004516282642725855
, O 0 7.715983884812316e-13
a O 0 8.537056610545329e-16
usually O 0 1.5942022982140948e-15
nonlethal O 0 1.4037713049266931e-12
form O 0 1.5125117683919415e-13
of O 0 3.539630828025553e-12
junctional B-Disease 0 0.27113527059555054
epidermolysis I-Disease 0 0.00029884351533837616
bullosa I-Disease 0 1.8236949472338893e-05
, O 0 1.38913728610357e-13
have O 0 7.162402181765115e-15
generalized O 0 8.238470805077905e-14
blistering B-Disease 0 7.229649327200605e-06
, O 0 1.0522730242712441e-08
nail B-Disease 1 0.9999867677688599
dystrophy I-Disease 0 0.3948558568954468
, O 0 1.3742714743969486e-09
patchy B-Disease 0 2.3033247998682782e-05
alopecia I-Disease 1 0.5643654465675354
, O 0 1.1407846889355255e-10
and O 0 3.3487125961073616e-08
dental B-Disease 0 0.00022699790133628994
abnormalities I-Disease 0 0.011078882031142712
. O 0 5.4377724545418e-10

Skin B-Disease 1 0.9996545314788818
fragility I-Disease 0 0.0013019063044339418
in O 0 2.5906394271555527e-14
most O 0 2.597880754173277e-16
cases O 0 1.0312323742058937e-14
is O 0 3.3020214031597925e-14
due O 0 2.318768786734645e-14
to O 0 2.007726260635015e-14
mutations O 0 1.3940994465129757e-15
in O 0 1.0302393908643826e-18
the O 0 7.370433098897954e-19
gene O 0 1.933773677482726e-15
encoding O 0 4.940459594703593e-14
type O 0 1.3580528368528633e-10
XVII O 0 5.4640794111548985e-09
collagen O 0 4.033342104747817e-09
( O 0 1.5222919496141185e-12
COL17A1 O 0 1.2010747923341114e-05
) O 0 3.108742430146805e-11
. O 0 2.0850102894209854e-11

Recently O 0 1.2252854286742831e-09
, O 0 6.39238445163115e-13
we O 0 8.667043862112256e-13
reported O 0 2.4037430032541884e-12
five O 0 6.543419303031879e-15
Austrian O 0 1.5695459154585478e-08
families O 0 2.869199018998292e-12
with O 0 6.787609076143106e-14
generalized O 0 6.167726745998081e-11
atrophic B-Disease 0 4.563229231280275e-05
benign I-Disease 0 0.005680377129465342
epidermolysis I-Disease 0 0.0030895802192389965
bullosa I-Disease 0 0.001463547581806779
who O 0 3.420037808510301e-09
share O 0 4.90661764690481e-13
the O 0 3.8163348959415096e-15
same O 0 7.600242592394058e-13
COL17A1 O 0 2.7605830155152944e-07
mutation O 0 7.676412457080506e-12
. O 0 7.315784089634292e-11

Affected O 0 1.2939858906602097e-10
individuals O 0 1.6416116851839836e-14
in O 0 1.06508695497169e-16
three O 0 3.2736120875154727e-15
families O 0 1.787957167371135e-15
are O 0 3.2090267653780985e-19
homozygous O 0 1.8229970476621385e-17
for O 0 2.7484437391362607e-17
4003delTC O 0 2.3099934465253824e-10
, O 0 1.6394026232575444e-14
whereas O 0 1.5082100946286515e-14
those O 0 6.481066243169175e-15
in O 0 7.819260906358436e-17
two O 0 5.3133157053818214e-14
others O 0 4.983220325098514e-13
are O 0 4.548754200446275e-17
compound O 0 2.6764528093803364e-13
heterozygotes O 0 1.8466237653586015e-12
. O 0 1.127544672213654e-12

To O 0 2.090432644694107e-12
determine O 0 1.680433136391768e-13
if O 0 9.74301172238564e-15
the O 0 1.0793080425860487e-16
occurrence O 0 8.512740073398847e-14
of O 0 6.203245789216869e-16
4003delTC O 0 6.056469770143735e-10
in O 0 1.7904611555818962e-16
these O 0 4.3203315830122064e-17
unrelated O 0 1.3949512863722056e-14
families O 0 2.78286983817786e-16
signifies O 0 6.147433431746078e-18
propagation O 0 1.1204382419690434e-15
of O 0 5.508461430762394e-19
an O 0 6.016679503394718e-17
ancestral O 0 1.137518079730171e-08
allele O 0 1.994313159059402e-08
or O 0 5.1225623742823245e-09
a O 0 2.7017570472520624e-11
mutational O 0 1.960873987627565e-06
hot O 0 4.1878975025611e-05
spot O 0 3.352027761138743e-06
, O 0 1.4602202910371509e-12
haplotypes O 0 4.945407625078779e-11
were O 0 9.075815186193603e-13
determined O 0 1.6337402080051494e-14
for O 0 2.6672678734150018e-18
polymorphisms O 0 7.469354128264438e-12
both O 0 1.032382838071777e-12
within O 0 2.2048455658343728e-14
and O 0 8.971803855395422e-10
flanking O 0 2.9723467378062196e-05
COL17A1 O 0 0.015767842531204224
. O 0 4.5762696410101e-10

Five O 0 4.038695419761318e-11
intragenic O 0 1.208568523036746e-10
polymorphisms O 0 1.9592090103048854e-11
were O 0 5.836785048340953e-13
chosen O 0 7.932347613401867e-16
based O 0 3.617201592562531e-17
on O 0 6.131787438912184e-11
their O 0 3.63196750452488e-10
informativeness O 0 1.0186075627416358e-07
. O 0 5.502513592339775e-13

One O 0 1.2235559787576733e-11
of O 0 2.5940979579703986e-16
these O 0 4.381061926271319e-15
, O 0 5.929600360661579e-15
not O 0 2.4733074068623503e-14
previously O 0 9.337231508810273e-13
reported O 0 3.413393526163766e-11
, O 0 2.2474552829602925e-16
was O 0 2.6453784909147293e-12
2988 O 0 2.3633640617443108e-12
A O 0 3.714589942062363e-13
or O 0 1.33814539310384e-11
C O 0 6.951224040818715e-10
that O 0 5.66990143546195e-16
introduces O 0 4.496070471662731e-16
a O 0 3.0331056633142887e-18
new O 0 4.3913786221327535e-18
restriction O 0 3.351495959687228e-17
site O 0 6.3128933572059905e-15
for O 0 3.14507767003605e-17
Eco0109 O 0 4.494656383191575e-12
I O 0 1.9946858387243083e-08
. O 0 6.536840296486601e-13

All O 0 7.073103225081062e-14
the O 0 2.1039495846079297e-15
4003delTC O 0 4.543825038449967e-11
alleles O 0 1.0767770139072375e-12
showed O 0 5.682171053122964e-11
the O 0 1.538235985887696e-17
same O 0 6.654346420166947e-17
haplotype O 0 1.894088591481921e-13
for O 0 4.627298391048696e-18
these O 0 5.819724093776698e-16
five O 0 1.9473797794727086e-15
polymorphic O 0 1.6837835379451827e-12
markers O 0 1.2325386933298432e-07
. O 0 1.798201310077019e-10

Fourteen O 0 7.163276916077876e-11
microsatellite O 0 4.905453127035386e-11
polymorphisms O 0 1.447531677856162e-11
were O 0 9.686428227443158e-14
selected O 0 2.362195226263197e-17
based O 0 4.033741294031164e-17
on O 0 8.277924179456164e-11
their O 0 4.436487843761938e-10
high O 0 1.404077288463812e-11
heterozygosity O 0 5.422639537378503e-14
and O 0 2.0711886795487383e-15
their O 0 2.451605840418544e-16
location O 0 5.834464584641291e-15
within O 0 2.4814888980998796e-16
10q23 O 0 9.940346289150082e-12
- O 0 6.9994157136932245e-09
q25 O 0 6.850481293341204e-10
near O 0 2.793131004263927e-10
COL17A1 O 0 4.835745130549185e-06
. O 0 9.472471418359163e-12

Three O 0 1.0107211075027767e-11
families O 0 2.1612128319609125e-12
shared O 0 4.489444840188872e-13
microsatellite O 0 1.0200570388363417e-09
polymorphisms O 0 3.6203775533039106e-09
covering O 0 4.249125218347416e-10
at O 0 3.807160836588608e-11
most O 0 4.914510909771047e-14
19 O 0 2.682452784202871e-13
cM O 0 6.341628611128414e-11
, O 0 7.497465376402751e-14
whereas O 0 1.1771031198370974e-13
the O 0 8.754135112122585e-13
others O 0 5.245158196665045e-10
shared O 0 1.8828093598100004e-11
smaller O 0 4.904930967137601e-14
regions O 0 7.402968347927988e-14
consistent O 0 5.6263045437876524e-12
with O 0 1.6130141927001018e-13
cross O 0 2.244653130034635e-09
- O 0 2.825734846112482e-08
over O 0 2.468390943033416e-11
events O 0 1.4806820320626551e-13
during O 0 1.2539514714668236e-14
passage O 0 3.4501101162100846e-17
of O 0 8.909004677130041e-20
this O 0 5.830400642155915e-20
mutation O 0 3.2651248620517377e-19
through O 0 1.49897395737454e-16
several O 0 3.880304687590638e-14
generations O 0 3.3035649216195395e-10
. O 0 6.326013931440277e-13

These O 0 2.2764097898364533e-11
results O 0 2.4048425468874146e-13
indicate O 0 1.2737774160095916e-12
that O 0 1.229790059934302e-13
4003delTC O 0 2.464882464803253e-10
occurs O 0 1.2213374842723335e-13
on O 0 1.2879709234900338e-13
a O 0 1.1602145121254113e-16
single O 0 1.6633264335780317e-15
ancestral O 0 1.0601529376597085e-10
allele O 0 1.0627889540648638e-10
. O 0 9.060166679397685e-12
. O 0 7.220685160902462e-11

The O 0 2.195632130969072e-12
haptoglobin O 0 5.7752288284973474e-08
- O 0 1.1512115705158976e-09
gene O 0 6.068515828738796e-11
deletion O 0 1.2482752609344061e-09
responsible O 0 1.3199145769415832e-11
for O 0 5.265553211552046e-15
anhaptoglobinemia B-Disease 0 4.2876951056314283e-07
. O 0 2.684272422392997e-11

We O 0 4.237393855938132e-12
have O 0 5.949377309430546e-16
found O 0 7.38552577431605e-17
an O 0 4.739399562023108e-18
allelic O 0 1.9138822471287398e-11
deletion O 0 1.0349473500426143e-09
of O 0 6.289316533932346e-14
the O 0 2.035859328342049e-12
haptoglobin O 0 1.0415480922176812e-08
( O 0 2.1944482787584737e-15
Hp O 0 1.1735918463982083e-14
) O 0 5.584337343503872e-17
gene O 0 6.995844164115871e-15
from O 0 8.587946350016367e-16
an O 0 1.3577326692577635e-16
individual O 0 1.4190065138544594e-14
with O 0 2.188592189422689e-11
anhaptoglobinemia B-Disease 0 9.538512131257448e-06
. O 0 4.7649769546742604e-11

The O 0 1.0708572700454666e-13
Hp O 0 2.2664515934595758e-13
gene O 0 7.350824322068655e-14
cluster O 0 1.866806188799419e-12
consists O 0 9.173890920400186e-16
of O 0 8.012078030633526e-18
coding O 0 3.989729435716072e-09
regions O 0 2.3902819827614774e-13
of O 0 1.8700846349039646e-16
the O 0 3.8180989267574614e-14
alpha O 0 3.5470477060097275e-14
chain O 0 7.885633812598769e-11
and O 0 2.5011806861763297e-12
beta O 0 1.0819716170980286e-15
chain O 0 4.000999564209712e-13
of O 0 6.051918472824274e-18
the O 0 5.849794292799818e-16
haptoglobin O 0 4.832519475729546e-13
gene O 0 1.33868212535645e-14
( O 0 2.0852981705722962e-17
Hp O 0 5.33811598304448e-16
) O 0 6.204781036433767e-17
and O 0 5.023719206473723e-14
of O 0 2.3857756226262157e-18
the O 0 2.50625317686228e-15
alpha O 0 1.1395161767982888e-15
chain O 0 5.597617855346293e-12
and O 0 1.8179797673777837e-13
beta O 0 6.440201138628891e-16
chain O 0 1.8343304306056574e-12
of O 0 5.714978278983557e-17
the O 0 1.7462536272680115e-14
haptoglobin O 0 4.3952677608594115e-10
- O 0 2.9099292420120548e-11
related O 0 2.527599440513284e-13
gene O 0 6.635998174575608e-12
( O 0 2.1640298168451344e-16
Hpr O 0 6.761200757252062e-13
) O 0 4.130851781784187e-15
, O 0 6.275820419170564e-15
in O 0 4.093531563067722e-16
tandem O 0 1.5510107642668913e-09
from O 0 3.631641564078372e-14
the O 0 1.4528583414455398e-12
5 O 0 2.6873767100532575e-11
side O 0 6.972369703817094e-08
. O 0 3.124115410813033e-10

Southern O 0 1.0387523063926096e-09
blot O 0 2.30365662901022e-06
and O 0 8.469712561506859e-13
PCR O 0 2.2064278182298835e-10
analyses O 0 1.4725554109418226e-11
have O 0 6.207631387004572e-14
indicated O 0 1.3257712256579263e-14
that O 0 2.8139985636872517e-16
the O 0 1.4188697868549048e-16
individual O 0 5.462288366134e-16
with O 0 1.5305888067390638e-13
anhaptoglobinemia B-Disease 0 5.913461387230257e-11
was O 0 1.1669385889447742e-13
homozygous O 0 6.06849740568749e-17
for O 0 1.0162456016256079e-19
the O 0 1.1651147466177877e-17
gene O 0 1.703656611401136e-13
deletion O 0 3.5472021153726274e-11
and O 0 2.545250295249435e-11
that O 0 2.928566270781266e-14
the O 0 2.5810094460507475e-16
gene O 0 8.509270761972165e-13
deletion O 0 3.7002371652827826e-12
was O 0 3.168775311590544e-11
included O 0 8.156781698271103e-16
at O 0 1.095754482158609e-13
least O 0 4.912504475992692e-18
from O 0 5.303423416040353e-18
the O 0 4.330776227170791e-17
promoter O 0 1.4656126312573292e-10
region O 0 6.1551016020122695e-12
of O 0 6.074498898816583e-16
Hp O 0 5.678262222398589e-14
to O 0 4.769859789939936e-15
Hpr O 0 9.657557956468943e-14
alpha O 0 1.7740423483416577e-16
but O 0 7.603021944663224e-14
not O 0 1.0694448934278969e-13
to O 0 5.247662113877505e-13
Hpr O 0 1.7091010551251173e-10
beta O 0 1.8443913388753452e-13
( O 0 1.0430215481723685e-15
Hpdel O 0 7.971415527663339e-09
) O 0 6.854365707832655e-13
. O 0 1.3250848985776886e-12

In O 0 2.6240182851014135e-14
addition O 0 1.4288428321852157e-15
, O 0 6.254120282094856e-15
we O 0 3.8978347459417417e-13
found O 0 1.5316109383371745e-13
seven O 0 6.0397968060005216e-15
individuals O 0 1.6095435455421666e-18
with O 0 4.1243786501221516e-16
hypohaptoglobinemia B-Disease 0 6.115154910224518e-11
in O 0 4.82455242941146e-17
three O 0 1.405950390357129e-15
families O 0 1.0954319658936125e-14
, O 0 3.7986532552211435e-18
and O 0 1.2877639255783838e-14
the O 0 6.441973131554547e-15
genotypes O 0 6.184029677225311e-11
of O 0 1.9493268964602094e-15
six O 0 6.716603401929477e-12
of O 0 5.12172341721824e-16
the O 0 1.2574826162986552e-13
seven O 0 1.0039110385010042e-13
individuals O 0 6.5321121212526385e-18
were O 0 8.375868358265204e-15
found O 0 4.185514714222065e-14
to O 0 1.4577317760007535e-13
be O 0 1.2125253058548058e-11
Hp2 O 0 1.0223577646684134e-06
/ O 0 3.9158855713594676e-08
Hpdel O 0 5.312673465596163e-07
. O 0 1.647184298680937e-11

The O 0 8.0891239886971e-12
phenotypes O 0 1.0479223044868036e-09
and O 0 2.840820079175188e-10
genotypes O 0 5.3705241642720836e-11
in O 0 1.264393397179043e-15
one O 0 7.436080221088874e-15
of O 0 3.4259635147177735e-18
these O 0 9.905468406504279e-15
three O 0 3.48611493405232e-13
families O 0 5.043155563294599e-12
showed O 0 3.527144201709298e-11
the O 0 1.8311176782589186e-16
father O 0 4.33169819458179e-11
to O 0 1.7103497641063857e-14
be O 0 5.6687181939621065e-14
hypohaptoglobinemic B-Disease 0 6.841484601061154e-10
( O 0 1.1867854724596357e-17
Hp2 O 0 1.3128041188859019e-11
) O 0 9.808719456235945e-15
and O 0 3.3491783565237077e-12
Hp2 O 0 1.1261541921214757e-08
/ O 0 6.940333863170167e-10
Hpdel O 0 6.006361630284118e-09
, O 0 4.8923454127941177e-14
the O 0 6.817304018394768e-15
mother O 0 1.3449474867144318e-10
to O 0 9.89043526575641e-16
be O 0 6.912042430083675e-16
Hp2 O 0 3.793842410365622e-12
- O 0 4.861393839566963e-12
1 O 0 3.429682143211814e-15
and O 0 1.5560871818517952e-12
Hp1 O 0 8.875264967400653e-10
/ O 0 1.8535437941447075e-12
Hp2 O 0 8.366349280031216e-12
, O 0 4.659698642052092e-17
one O 0 4.050270347903444e-17
of O 0 1.152919814132435e-19
the O 0 3.023787343019342e-15
two O 0 1.301080011957556e-12
children O 0 1.863387482509138e-12
to O 0 4.401062068221887e-15
be O 0 9.352626773083753e-14
hypohaptoglobinemic B-Disease 0 6.06775518718905e-10
( O 0 1.3460717552700932e-17
Hp2 O 0 1.3906923355955225e-11
) O 0 3.0906569943150433e-15
and O 0 4.2924382581341347e-13
Hp2 O 0 3.040798723930038e-10
/ O 0 2.8635459888709525e-12
Hpdel O 0 6.712879557779772e-11
, O 0 1.5064842014711499e-15
and O 0 3.3679040069620582e-15
the O 0 1.3898182772997564e-17
other O 0 7.846664936831174e-16
child O 0 1.1038479158509418e-12
to O 0 7.371396205964665e-17
be O 0 8.342350205751167e-16
Hp1 O 0 2.310838326247122e-11
and O 0 7.16333784823997e-13
Hp1 O 0 4.529783215190264e-10
/ O 0 2.7671662704287225e-12
Hpdel O 0 1.4067793804861672e-11
, O 0 3.779834896285562e-17
showing O 0 1.7302185841863943e-16
an O 0 8.856821212705309e-20
anomalous O 0 2.102665694418129e-15
inheritance O 0 2.1200428565459895e-11
of O 0 5.02146121992425e-13
Hp O 0 1.8477215590895213e-10
phenotypes O 0 4.739468366377064e-12
in O 0 3.687438673632623e-14
the O 0 1.2485549920338013e-11
child O 0 1.5764111367388978e-06
with O 0 5.5178004526590385e-11
Hp1 O 0 2.0996290004404727e-06
. O 0 3.548738039538257e-11

The O 0 1.2436736362975154e-10
Hp2 O 0 2.2605245248996653e-06
/ O 0 3.045132359602576e-07
Hpdel O 0 1.9736217993227e-08
individuals O 0 4.7582309593103764e-14
had O 0 7.997078693700033e-12
an O 0 9.726889085509365e-16
extremely O 0 6.503021038328782e-11
low O 0 1.1003034039447357e-09
level O 0 4.1922463764332285e-12
of O 0 4.0125793008096485e-16
Hp O 0 4.1855469014740604e-14
( O 0 3.55923244436257e-18
mean O 0 5.7185172091069655e-15
+ O 0 2.3392171446395826e-13
/ O 0 9.67724581024676e-11
- O 0 2.2904098617715363e-09
SD O 0 9.125121778197354e-07
= O 0 2.5531271541368028e-11
0 O 0 1.6514955405919266e-17
. O 0 4.332724072077231e-18
049 O 0 8.367091064052576e-14
+ O 0 1.0988897915535298e-13
/ O 0 8.673663350056149e-12
- O 0 8.563493664182076e-12
0 O 0 4.293585922132611e-16
. O 0 5.452147264172998e-17
043 O 0 2.2087949416542407e-13
mg O 0 4.5012257809950995e-13
/ O 0 5.515101179562332e-13
ml O 0 1.4769603942643705e-11
; O 0 1.6565385232969725e-15
n O 0 2.483604684758167e-13
= O 0 1.5795122100450282e-13
6 O 0 8.574528924615386e-15
) O 0 6.533614049634463e-16
, O 0 7.257449231084178e-16
compared O 0 2.797293062264147e-15
with O 0 3.1948403527614277e-15
the O 0 1.4917430626263523e-13
level O 0 5.694859731356083e-13
( O 0 2.8715427623231745e-19
1 O 0 4.035447354044555e-18
. O 0 2.3450747713401666e-16
64 O 0 8.166214998325556e-16
+ O 0 7.656514616381175e-15
/ O 0 2.0371440537063357e-13
- O 0 7.629548306065798e-14
1 O 0 1.14827770031623e-16
. O 0 3.6306823204414304e-16
07 O 0 1.436100316356409e-14
mg O 0 1.4618301957380203e-13
/ O 0 2.731048080826387e-13
ml O 0 1.019942593924461e-12
) O 0 4.343035043848827e-17
obtained O 0 1.6180468050748954e-16
from O 0 4.662634736179961e-16
52 O 0 1.3329366161719293e-14
healthy O 0 3.361215464233624e-16
volunteers O 0 7.680728006090505e-17
having O 0 3.716967766833213e-15
phenotype O 0 3.341620193443931e-14
Hp2 O 0 7.335740903613441e-10
, O 0 4.069837796307797e-14
whereas O 0 6.913970806467218e-15
the O 0 1.2194768069971e-14
serum O 0 9.353947616475011e-10
Hp O 0 6.456618009340054e-13
level O 0 1.9169263615684273e-14
of O 0 1.2189673684608328e-18
an O 0 9.852365369942065e-16
individual O 0 2.4428993983943714e-13
with O 0 7.371658145016724e-11
Hp1 O 0 1.7119890571848373e-06
/ O 0 3.383818558688745e-09
Hpdel O 0 5.964441385231112e-09
was O 0 1.955364620220834e-10
0 O 0 5.5228882583783015e-14
. O 0 9.710567988813548e-14

50 O 0 2.701200547960969e-11
mg O 0 9.934328915051083e-10
/ O 0 1.0226601787621803e-08
ml O 0 1.5852297252649805e-08
, O 0 1.6129957612631696e-13
which O 0 1.3025957265946908e-14
was O 0 9.240034410350206e-14
approximately O 0 1.9353573743224628e-18
half O 0 2.678966688818339e-16
the O 0 9.172836099683059e-17
level O 0 7.0251011056305084e-15
of O 0 4.0488158335143305e-18
Hp O 0 1.562402584967624e-14
in O 0 4.191693946627227e-16
control O 0 6.050422829417812e-09
sera O 0 2.389258781931858e-07
from O 0 1.3112005648992578e-14
the O 0 6.715661419976968e-14
Hp1 O 0 7.144355662624946e-10
phenotype O 0 1.464274156841392e-14
( O 0 2.2275051072682156e-19
1 O 0 2.3337033622950837e-18
. O 0 6.712756621069522e-17
26 O 0 6.529851635161878e-16
+ O 0 4.6770309081514954e-15
/ O 0 1.8161013871139525e-13
- O 0 6.328523859469581e-13
0 O 0 5.998026249709403e-17
. O 0 1.1894278182083751e-17
33 O 0 2.2137601799696185e-16
mg O 0 7.637436893310166e-15
/ O 0 1.5386381947181393e-13
ml O 0 7.64321852336769e-12
; O 0 2.593040807912666e-15
n O 0 4.448286357316977e-12
= O 0 1.894813125846717e-11
9 O 0 3.8059732774230193e-13
) O 0 2.7483207936274557e-15
, O 0 2.6093024640714093e-16
showing O 0 5.927884864833505e-14
a O 0 7.255590920207241e-17
gene O 0 4.662769302610226e-12
- O 0 2.2072169869602476e-08
dosage O 0 7.919438615999752e-08
effect O 0 6.51218468039616e-10
. O 0 4.186048035981216e-11

The O 0 3.2427917772900883e-13
other O 0 8.228702821130168e-14
allele O 0 1.6344914310906233e-10
( O 0 5.3222820573482765e-14
Hp2 O 0 1.415158545903239e-09
) O 0 8.134290326543541e-15
of O 0 2.584889163005999e-18
individuals O 0 7.555302278936844e-18
with O 0 1.3504867153225648e-14
Hp2 O 0 1.9185268484989138e-08
/ O 0 2.3052573738802096e-10
Hpdel O 0 7.636669074884139e-10
was O 0 9.700564136683187e-12
found O 0 2.0282878160230236e-14
to O 0 2.829261303303386e-16
have O 0 1.0681721586620115e-14
, O 0 8.344351188740157e-17
in O 0 4.233954984625643e-18
all O 0 1.0259656133371171e-16
exons O 0 5.0048670069413603e-11
, O 0 1.6159758942221533e-14
no O 0 8.597939618258294e-17
mutation O 0 3.816968067958833e-19
, O 0 5.375277597323114e-19
by O 0 5.628449665479922e-20
DNA O 0 7.453553291063286e-13
sequencing O 0 2.7562965798644257e-10
. O 0 5.283007711853749e-11

On O 0 2.3934507153988704e-11
the O 0 1.4638042229622554e-15
basis O 0 1.179727054265937e-15
of O 0 3.422751613758261e-17
the O 0 3.0909985603510236e-15
present O 0 2.377838323377318e-15
study O 0 1.705116034875574e-17
, O 0 7.238778308820978e-18
the O 0 1.019519440318425e-18
mechanism O 0 1.385839160035528e-14
of O 0 1.7766768855054146e-16
anhaptoglobinemia B-Disease 0 6.00793970129132e-10
and O 0 6.7404764360129085e-15
the O 0 8.315331852374934e-19
mechanism O 0 4.3671433220633584e-16
of O 0 1.979597785216366e-19
anomalous O 0 8.657547047292253e-16
inheritance O 0 2.7210768360763637e-12
of O 0 1.4823039985126935e-13
Hp O 0 9.76907790772863e-12
phenotypes O 0 9.156598005863326e-13
were O 0 8.5384746148498e-12
well O 0 1.4811553025739777e-11
explained O 0 5.1690247637736775e-09
. O 0 6.161388760306252e-11

However O 0 3.637789375288136e-11
, O 0 1.0599162132284186e-14
the O 0 1.9538598991565592e-16
mechanism O 0 2.371433127992817e-12
of O 0 9.515329062875777e-13
hypohaptoglobinemia B-Disease 0 8.836591405270156e-06
remains O 0 4.67103902224153e-08
unknown O 0 1.1621282602902738e-08

ATM O 0 1.7442216559970802e-08
mutations O 0 2.2662799636918862e-08
and O 0 3.0063041833727766e-08
phenotypes O 0 9.147034347734007e-07
in O 0 9.872134114630171e-07
ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.9999969005584717
telangiectasia I-Disease 1 0.9999997615814209
families O 0 0.003173249773681164
in O 0 9.11707449986754e-13
the O 0 2.0174903414549306e-12
British O 0 1.4851151419748021e-08
Isles O 0 6.579007845175511e-07
: O 0 2.0408987813549245e-15
expression O 0 2.9003768826094893e-18
of O 0 1.6471193557783816e-21
mutant O 0 1.761519627960993e-16
ATM O 0 1.7082257917216959e-12
and O 0 2.413473284071377e-12
the O 0 3.9966218268877585e-13
risk O 0 7.401516066707359e-10
of O 0 5.450733722885126e-13
leukemia B-Disease 1 0.8588153719902039
, O 0 1.3344539411264122e-06
lymphoma B-Disease 1 1.0
, O 0 5.353166798727216e-08
and O 0 2.355157675992814e-06
breast B-Disease 0 0.39968928694725037
cancer I-Disease 0 0.0010096682235598564
. O 0 2.229447204626922e-08

We O 0 9.520129823359369e-11
report O 0 1.3927552687531541e-14
the O 0 6.95700585059969e-18
spectrum O 0 2.1758690769285716e-14
of O 0 5.132086269757855e-17
59 O 0 9.889988032360259e-15
ATM O 0 7.592277501133893e-12
mutations O 0 1.6041236264655034e-12
observed O 0 6.189956880398029e-10
in O 0 2.7721217321641234e-08
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999979734420776
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.012291130609810352
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
) O 0 1.9036455745080616e-10
patients O 0 7.269866945849163e-15
in O 0 3.600967842168933e-18
the O 0 8.81467801175503e-15
British O 0 1.99579996973398e-09
Isles O 0 3.954264229832916e-06
. O 0 1.86041335115128e-10

Of O 0 7.236284596708054e-13
51 O 0 5.984176912679495e-13
ATM O 0 1.5309327416890284e-10
mutations O 0 1.2395376608811959e-12
identified O 0 5.8413326259332266e-12
in O 0 1.1103039162716193e-14
families O 0 4.802903409185932e-13
native O 0 2.4804017313120787e-15
to O 0 9.128245034850657e-13
the O 0 9.116643204243324e-12
British O 0 2.6253779594753723e-08
Isles O 0 9.071025885987183e-08
, O 0 1.2474159346523989e-13
11 O 0 3.902738979885467e-16
were O 0 3.5620458510619854e-17
founder O 0 1.2300350938604485e-15
mutations O 0 4.54244446673372e-16
, O 0 1.7938050828389786e-15
and O 0 2.612653474641513e-13
2 O 0 5.057288985645895e-15
of O 0 1.1314880555996748e-18
these O 0 7.276965928980101e-16
11 O 0 1.4835235470210295e-16
conferred O 0 3.621580157329795e-16
a O 0 1.2050200404061016e-16
milder O 0 7.840359898857521e-14
clinical O 0 3.3866250868106254e-14
phenotype O 0 1.634164808680949e-13
with O 0 3.202786072378089e-14
respect O 0 4.9609283999838775e-15
to O 0 2.4876295142729765e-13
both O 0 1.2990646752752966e-11
cerebellar B-Disease 0 3.516067579312221e-07
degeneration I-Disease 0 6.500997073999315e-08
and O 0 2.539266713563748e-11
cellular O 0 5.818898141107809e-10
features O 0 6.799481866437418e-09
. O 0 1.0826106677797043e-09

We O 0 5.745620992869682e-11
report O 0 8.016924255525859e-14
, O 0 3.053854206850232e-17
in O 0 4.3173821878200874e-17
two O 0 2.643716634498361e-10
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
families O 0 1.9126039727673794e-12
, O 0 6.710211913652336e-20
an O 0 3.497169380270749e-21
ATM O 0 2.349655409475404e-12
mutation O 0 2.517153220344022e-14
( O 0 2.965298897448265e-17
7271T O 0 5.038393747353043e-13
- O 0 1.1768158669767104e-09
- O 0 2.4331689019163605e-07
> O 0 3.871978085379091e-11
G O 0 6.650797956808674e-08
) O 0 3.884829198781692e-14
that O 0 5.0142229506954655e-14
may O 0 1.8449743008309635e-14
be O 0 2.339605254606619e-17
associated O 0 1.8483741216746528e-17
with O 0 2.7342427023799503e-17
an O 0 9.732307978789424e-16
increased O 0 1.7220177107174495e-12
risk O 0 2.0779762632816556e-10
of O 0 3.9246444906871486e-14
breast B-Disease 0 4.448942490853369e-06
cancer I-Disease 0 4.071698000984725e-08
in O 0 6.915922793894165e-15
both O 0 3.8964895220962303e-13
homozygotes O 0 2.4647803797961387e-09
and O 0 1.3476906257636756e-09
heterozygotes O 0 3.6366794992082063e-11
( O 0 7.394977947323359e-15
relative O 0 8.678429502806395e-12
risk O 0 5.799689721530665e-12
12 O 0 3.1491867592120786e-15
. O 0 1.179394170317666e-15
7 O 0 8.425451634118397e-13
; O 0 4.34022853464458e-13
P O 0 5.2857775045822564e-08
= O 0 1.1125909221698649e-11
. O 0 6.033924750093681e-15
0025 O 0 9.637302891482569e-13
) O 0 8.61038319399795e-16
, O 0 2.2644678073569972e-17
although O 0 1.3342370340921133e-17
there O 0 1.0156143206465622e-18
is O 0 2.2389219057814608e-18
a O 0 2.1430158558660413e-16
less O 0 8.41064793765528e-13
severe O 0 2.682391141206608e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
phenotype O 0 5.264366720325597e-08
in O 0 2.8069118095944894e-16
terms O 0 2.0398604777802684e-18
of O 0 6.880932298560478e-20
the O 0 1.6706458570334929e-15
degree O 0 5.677818038321049e-14
of O 0 1.6936832050230312e-14
cerebellar B-Disease 0 8.007540600374341e-06
degeneration I-Disease 0 9.520135790808126e-06
. O 0 7.58480567242259e-09

This O 0 2.5414432453592546e-14
mutation O 0 1.1747345446660312e-13
( O 0 2.129448664452073e-15
7271T O 0 3.8831884756340695e-12
- O 0 2.329409110046754e-09
- O 0 4.183883106634312e-08
> O 0 1.676366163938514e-11
G O 0 2.724023784317353e-10
) O 0 1.0918764233365264e-16
also O 0 4.066446361090286e-18
allows O 0 2.3892264133466338e-19
expression O 0 1.0367252313293496e-17
of O 0 4.800113585008734e-19
full O 0 1.1200622652195809e-15
- O 0 5.323300394238784e-13
length O 0 2.324741427803972e-15
ATM O 0 2.9350111750703345e-12
protein O 0 1.6034797865579e-14
at O 0 3.2790237810154804e-15
a O 0 3.09726299103579e-17
level O 0 1.2159226779262446e-15
comparable O 0 8.44036515263829e-16
with O 0 1.120964672945762e-14
that O 0 2.3572055765641586e-12
in O 0 7.888284345386812e-14
unaffected O 0 7.008630342753008e-10
individuals O 0 3.626074778845722e-15
. O 0 4.902146397145479e-13

In O 0 1.0247815406861944e-14
addition O 0 1.5533263410641744e-16
, O 0 1.502093553249498e-16
we O 0 2.023765422414338e-15
have O 0 6.591466929327524e-16
studied O 0 1.674852747809985e-13
18 O 0 2.5686022753212967e-10
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
patients O 0 6.612863468619112e-12
, O 0 1.9998718786324642e-18
in O 0 2.0092382515035553e-19
15 O 0 4.339342178722145e-17
families O 0 2.2199417999489008e-16
, O 0 2.0387025903588166e-17
who O 0 4.659515395050162e-12
developed O 0 1.3833022505238546e-09
leukemia B-Disease 1 0.8355867862701416
, O 0 4.2358831819910847e-07
lymphoma B-Disease 1 0.9999998807907104
, O 0 1.1560259416398821e-09
preleukemic O 0 0.00017097416275646538
T O 0 0.08017974346876144
- O 0 2.2286283183348132e-06
cell O 0 7.073055712680798e-06
proliferation O 0 0.0008480569231323898
, O 0 8.870560397333804e-10
or O 0 2.8506981834652834e-05
Hodgkin B-Disease 1 0.9999954700469971
lymphoma I-Disease 1 1.0
, O 0 3.8056199969105364e-08
mostly O 0 2.4026166473012367e-11
in O 0 3.5775111172087204e-12
childhood O 0 3.0124174372758716e-05
. O 0 8.000077822423179e-10

A O 0 8.865122178014495e-12
wide O 0 6.983422764757566e-14
variety O 0 3.783558797228827e-16
of O 0 8.572390325242246e-18
ATM O 0 1.6780472567035076e-09
mutation O 0 2.9391720719577907e-13
types O 0 7.973498163810211e-13
, O 0 4.567676837078597e-15
including O 0 3.1602931610955954e-16
missense O 0 2.950907747323317e-12
mutations O 0 4.5422138272854795e-11
and O 0 4.377647966347098e-10
in O 0 3.8233478882876426e-13
- O 0 2.98139042342882e-08
frame O 0 2.0105917997170764e-07
deletions O 0 6.883513758992876e-10
, O 0 1.312851086524014e-12
were O 0 8.588876680183655e-13
seen O 0 2.422018315073604e-12
in O 0 2.2636819857750718e-17
these O 0 3.6394772964668323e-14
patients O 0 3.3829323619737756e-14
. O 0 3.8399085343712724e-13

We O 0 4.062814754762778e-12
also O 0 4.932830199541084e-15
show O 0 1.0076984819501478e-12
that O 0 1.3857380666532733e-15
25 O 0 2.578273794328912e-16
% O 0 2.221361740256361e-19
of O 0 3.0436067211906494e-18
all O 0 3.036214890617117e-10
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 2.3192810519323537e-11
carried O 0 9.731432239895588e-13
in O 0 9.257377928752918e-17
- O 0 7.42645667184405e-11
frame O 0 4.1906876191433184e-08
deletions O 0 3.1007865164411896e-09
or O 0 6.376438960176145e-11
missense O 0 8.9648790778038e-13
mutations O 0 6.630377128412357e-13
, O 0 6.635649332526611e-14
many O 0 1.5500774932554213e-15
of O 0 1.1921408515035408e-15
which O 0 6.362653182101496e-10
were O 0 1.7599263713030666e-10
also O 0 2.432764276485977e-12
associated O 0 2.8350118205702074e-14
with O 0 3.95228664859114e-15
expression O 0 4.4577521199091336e-14
of O 0 1.6041387887787758e-16
mutant O 0 1.4744552800927124e-11
ATM O 0 2.8021274189882206e-10
protein O 0 6.338484598300553e-11
. O 0 7.380949692582794e-13

The O 0 3.7117569217856583e-13
DMPK O 0 1.679751804317675e-08
gene O 0 2.2870996763124651e-10
of O 0 4.575968510361905e-12
severely O 1 0.570552408695221
affected O 0 3.285350885562366e-06
myotonic B-Disease 1 0.9999934434890747
dystrophy I-Disease 1 0.9999964237213135
patients O 0 1.5673201403387793e-08
is O 0 2.2160786118489983e-13
hypermethylated O 0 3.809190740611257e-09
proximal O 0 1.221927004024792e-09
to O 0 8.200351855891519e-12
the O 0 4.4949605832161205e-14
largely O 0 7.937051623579938e-13
expanded O 0 2.9129858789868346e-13
CTG O 0 5.865974372909477e-08
repeat O 0 9.637545872465125e-08
. O 0 1.2201301601011405e-11

Using O 0 9.834182621883125e-14
methylation O 0 6.327275509088182e-11
- O 0 8.748006208314507e-10
sensitive O 0 2.053076805785814e-11
restriction O 0 1.1052040494808138e-13
enzymes O 0 4.87337655039749e-13
, O 0 3.6658658456088875e-15
we O 0 8.330520331851577e-16
characterized O 0 4.5612125330880585e-17
the O 0 4.540064544034313e-19
methylation O 0 5.77604844921413e-14
pattern O 0 4.36289164518211e-11
on O 0 1.623293513497437e-11
the O 0 4.4581346399881136e-14
5 O 0 2.032035936814624e-14
side O 0 2.4984198737643126e-12
of O 0 8.49274275842074e-18
the O 0 1.460620056706937e-14
CTG O 0 2.3081656030932152e-10
repeat O 0 1.889046558067875e-11
in O 0 8.701944014524791e-17
the O 0 2.6403941848289177e-15
DMPK O 0 1.019995288231712e-08
gene O 0 7.176083186878623e-13
of O 0 1.5102580244187434e-16
normal O 0 3.907179603051007e-15
individuals O 0 3.002178050227227e-16
and O 0 1.4529934059311772e-13
of O 0 4.883120059328216e-16
patients O 0 4.323676629940966e-14
affected O 0 1.6968390803779113e-14
with O 0 1.474923738697953e-09
myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 0.9999994039535522
, O 0 1.913406932896322e-12
showing O 0 1.7811717812482586e-13
expansions O 0 2.8077500651628277e-14
of O 0 1.986468450781808e-17
the O 0 4.454622079059145e-15
repetitive O 0 1.9751724700256545e-09
sequence O 0 7.743664737214218e-11
. O 0 2.7891700060678204e-10

The O 0 5.536958492071732e-14
gene O 0 3.7775793777783395e-13
segment O 0 2.3082822545733572e-12
analyzed O 0 9.714032692380997e-14
corresponds O 0 1.2754627413711175e-15
to O 0 5.232312568207353e-16
the O 0 5.507692508480383e-16
genomic O 0 6.91712742639794e-10
SacI O 0 3.16874150030344e-07
- O 0 1.2732060961084812e-09
HindIII O 0 1.3437071455513205e-09
fragment O 0 5.410333639432885e-11
carrying O 0 2.660487715550053e-12
exons O 0 9.8830366113134e-10
11 O 0 4.252941748772443e-11
- O 0 4.873748959965951e-09
15 O 0 1.981667217473837e-12
. O 0 9.6636988775739e-13

There O 0 2.7657452608513544e-13
is O 0 1.5291158895003803e-16
constitutive O 0 1.2764410644251962e-15
methylation O 0 3.083010531438647e-14
in O 0 3.405380026801259e-16
intron O 0 2.2946686772939984e-09
12 O 0 5.226156421685169e-13
at O 0 4.496482341433334e-16
restriction O 0 5.537432811331604e-18
sites O 0 2.3043954846526868e-14
of O 0 9.29670010984022e-16
SacII O 0 9.194909722509692e-09
and O 0 1.1860309609423858e-11
HhaI O 0 2.783068046852133e-11
, O 0 2.2644678073569972e-17
localized O 0 8.188328381600405e-17
1 O 0 9.27299973092935e-17
, O 0 1.0759330133379343e-16
159 O 0 5.029814624968754e-15
- O 0 1.2100064873676875e-12
1 O 0 5.175103433554206e-16
, O 0 1.1291694311195611e-16
232 O 0 4.532958756515656e-16
bp O 0 1.157143652408656e-14
upstream O 0 6.17580986265971e-16
of O 0 7.872381287243734e-18
the O 0 8.035167989957001e-15
CTG O 0 1.0471264827449644e-10
repeat O 0 6.968823434982951e-11
, O 0 4.189026428118086e-15
whereas O 0 5.514966933310521e-16
most O 0 1.4873322571381381e-15
, O 0 3.906955986352932e-15
if O 0 8.27869673855619e-15
not O 0 3.858127670965626e-14
all O 0 3.7621734917117015e-15
, O 0 4.938306373424202e-16
of O 0 6.36098207514613e-20
the O 0 7.102018056605748e-18
other O 0 2.6514825789904992e-18
sites O 0 1.1040700078897119e-14
of O 0 7.794542764421881e-17
SacII O 0 7.010471370083593e-11
, O 0 6.259678829932094e-16
HhaI O 0 1.4402967533910793e-11
, O 0 7.531775462370823e-15
and O 0 6.311912797984931e-13
HpaII O 0 8.289979813724813e-11
in O 0 1.5314274953529965e-16
this O 0 9.842255502320993e-17
region O 0 5.5881368156679e-15
are O 0 2.0298183727949766e-16
unmethylated O 0 3.59734915467147e-11
, O 0 4.3740418866110645e-14
in O 0 3.557580200719832e-16
normal O 0 8.49657531780927e-16
individuals O 0 3.141492669261245e-17
and O 0 2.580332899659952e-14
most O 0 1.0205009273383468e-16
of O 0 8.580966533833196e-17
the O 0 1.2202832060798086e-12
patients O 0 2.1256283679830373e-13
. O 0 3.0292053045631595e-13

In O 0 1.301110877838154e-14
a O 0 5.920985294434174e-16
number O 0 2.7547025516103064e-15
of O 0 1.6983876598933995e-13
young O 0 2.5208035481227853e-07
and O 0 4.239552708895644e-08
severely O 0 1.599807910679374e-05
affected O 0 1.827797489100183e-14
patients O 0 1.6127656869976628e-16
, O 0 3.288327154156758e-17
however O 0 2.047847416137725e-15
, O 0 1.0586462620245561e-16
complete O 0 9.220970070399764e-17
methylation O 0 3.0371308224440285e-13
of O 0 1.0623514521423649e-17
these O 0 1.1141293188934892e-17
restriction O 0 5.306762330582923e-18
sites O 0 3.420825227902144e-14
was O 0 2.0527399224867793e-11
found O 0 7.412802739258789e-14
in O 0 1.1033982427682928e-18
the O 0 4.176863392337539e-17
mutated O 0 1.1590539292227753e-11
allele O 0 3.4486483113660427e-10
. O 0 2.550023525671463e-10

In O 0 4.122243724754421e-14
most O 0 1.585063077411017e-16
of O 0 2.6820007873051838e-18
these O 0 1.8724055051794414e-15
patients O 0 6.72193038493498e-17
, O 0 7.202062242971587e-18
the O 0 1.9293453892344804e-15
onset O 0 3.3894994450056615e-11
of O 0 5.753518728069881e-14
the O 0 2.2140858035868405e-08
disease O 0 1.0604961971694138e-05
was O 0 5.362115189200267e-05
congenital O 1 0.9995558857917786
. O 0 5.553581061690238e-08

Preliminary O 0 3.4998312581357993e-10
in O 0 8.270277366585754e-13
vivo O 0 1.0469632938381324e-09
footprinting O 0 5.762542087950351e-08
data O 0 2.2748580905292137e-13
gave O 0 3.5215443486492004e-15
evidence O 0 1.6599716603287575e-17
for O 0 6.449948581200476e-20
protein O 0 2.1903406454203231e-16
- O 0 1.3833686800246436e-12
DNA O 0 1.1773502173184625e-09
contact O 0 9.946501400293073e-10
in O 0 9.434100500587891e-16
normal O 0 6.439362178964415e-17
genes O 0 6.3177117041264465e-15
at O 0 5.896152977750285e-14
an O 0 1.0317029215221726e-17
Sp1 O 0 1.78069815837123e-11
consensus O 0 1.0364325748286283e-17
binding O 0 1.1829802431185448e-16
site O 0 5.4375229227012975e-14
upstream O 0 8.459907579159986e-14
of O 0 1.1333120839761247e-16
the O 0 3.818186340557618e-14
CTG O 0 7.421444014887868e-11
repeat O 0 1.1280400225022191e-11
and O 0 5.590883849394964e-16
for O 0 6.273455703462936e-21
a O 0 4.248268763514505e-20
significant O 0 4.397174198471121e-20
reduction O 0 9.935999550269382e-17
of O 0 4.875181194950202e-20
this O 0 2.0475007315081144e-18
interaction O 0 3.951285449030041e-18
in O 0 1.0859690302739177e-17
cells O 0 1.0287604779559215e-15
with O 0 1.7181110422987821e-15
a O 0 1.0861826032788208e-13
hypermethylated O 0 7.306089599978804e-08
DMPK O 0 9.810546153232735e-09
gene O 0 4.605669578355842e-12
. O 0 1.0176225096955593e-12
. O 0 5.7868167722963104e-12

The O 0 3.720124208683728e-11
hemochromatosis B-Disease 1 0.9998188614845276
gene O 0 2.91713111999492e-11
product O 0 1.681298736301226e-13
complexes O 0 2.219706928300539e-14
with O 0 4.3025218550283477e-16
the O 0 1.5355164145569686e-16
transferrin O 0 8.384379887420301e-13
receptor O 0 2.9068387745413617e-15
and O 0 3.4055557852907814e-12
lowers O 0 3.7727303919821153e-11
its O 0 1.1688668999148742e-18
affinity O 0 4.727660318167332e-19
for O 0 1.0839512273749647e-21
ligand O 0 1.6220257423446224e-17
binding O 0 1.1757074805905654e-13
. O 0 2.0033445388700777e-12

We O 0 2.1216418899516754e-10
recently O 0 2.675305940322281e-12
reported O 0 2.578189127033087e-13
the O 0 2.2080899892194655e-18
positional O 0 8.339522174498522e-15
cloning O 0 1.2079006956981775e-13
of O 0 1.338467463219378e-18
a O 0 2.0797689644857468e-17
candidate O 0 6.908434599123964e-15
gene O 0 2.5959670524322576e-10
for O 0 1.1871524874251804e-09
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
called O 0 0.00023824737581890076
HFE O 0 0.0035931365564465523
. O 0 4.852590773651855e-09

The O 0 6.100979096923531e-14
gene O 0 5.823341483503219e-13
product O 0 1.4205821415036457e-11
, O 0 2.0833414000561747e-14
a O 0 3.853711389409408e-16
member O 0 3.854929661015576e-17
of O 0 3.529391231680472e-19
the O 0 8.890279143368825e-17
major O 0 4.032866269291981e-16
histocompatibility O 0 4.854442043657203e-13
complex O 0 5.796645715511195e-13
class O 0 3.7825255080892184e-13
I O 0 9.751778939914857e-09
- O 0 2.4960136180141035e-09
like O 0 7.707692123437582e-12
family O 0 1.5030546252070565e-11
, O 0 3.678022462467881e-16
was O 0 2.5333949077010337e-14
found O 0 4.598760511023107e-16
to O 0 4.752384759084251e-16
have O 0 4.675227469127673e-16
a O 0 2.1242621824543616e-17
mutation O 0 3.2047032043992568e-15
, O 0 7.912710742706552e-14
Cys O 0 1.1268825872434718e-08
- O 0 3.259265912713971e-10
282 O 0 7.779212829461812e-10
- O 0 5.251039851827954e-07
- O 0 9.17035549719003e-07
> O 0 1.4693645605801109e-12
Tyr O 0 7.9779741840591e-12
( O 0 5.706047375345945e-17
C282Y O 0 5.0638911839532685e-15
) O 0 5.812843009871441e-17
, O 0 7.300205733725901e-17
in O 0 7.14980973998498e-17
85 O 0 5.30946611004314e-14
% O 0 1.2859658175681728e-16
of O 0 3.0172511338725155e-17
patient O 0 2.925766399985985e-12
chromosomes O 0 2.1641788805482065e-08
. O 0 3.6576758288831e-10

This O 0 2.0537157450995977e-14
mutation O 0 1.1020171049574284e-13
eliminates O 0 1.321020931532857e-10
the O 0 4.400411513037078e-13
ability O 0 5.069252309586325e-12
of O 0 7.115228296424343e-17
HFE O 0 6.36205865767181e-10
to O 0 7.373291701587986e-14
associate O 0 1.0778229437430342e-12
with O 0 1.7055236346472102e-12
beta2 O 0 6.547114935528953e-06
- O 0 7.355702109634876e-06
microglobulin O 0 2.792889608826954e-05
( O 0 1.9318207583195364e-14
beta2m O 0 2.0075092699300967e-09
) O 0 1.858827694089897e-14
and O 0 9.816548073547648e-14
prevents O 0 3.2986048788263833e-13
cell O 0 3.208334931059653e-08
- O 0 1.681228241068311e-06
surface O 0 7.163455393310869e-06
expression O 0 3.79882521883701e-07
. O 0 1.437803209825006e-09

A O 0 1.5377478804201594e-11
second O 0 3.424077427843786e-13
mutation O 0 4.487852689298577e-13
that O 0 1.0250449794524386e-11
has O 0 5.187796373040676e-11
no O 0 9.64936897746016e-13
effect O 0 1.1098895646944815e-13
on O 0 1.3743658433540418e-09
beta2m O 0 2.6550748088993714e-07
association O 0 1.9441585131743004e-15
, O 0 1.1943381277606124e-17
H63D O 0 1.7492231621507592e-11
, O 0 3.2605371281229777e-16
was O 0 4.2058433016682606e-13
found O 0 3.704726683848719e-13
in O 0 5.355902616145636e-16
eight O 0 1.6104257955385642e-13
out O 0 3.73175067236442e-11
of O 0 1.974774519052807e-15
nine O 0 1.4163041399395393e-12
patients O 0 6.473103868767188e-17
heterozygous O 0 2.6843461752140166e-17
for O 0 1.146359625640036e-18
the O 0 3.6777740277044516e-14
C282Y O 0 8.217802549559394e-10
mutant O 0 1.8358180753352826e-08
. O 0 5.578566497632664e-10

In O 0 3.0920749359390765e-13
this O 0 9.873585662853153e-16
report O 0 1.1379051624842585e-14
, O 0 6.527208098273057e-17
we O 0 6.070144090676512e-16
demonstrate O 0 2.5037661954849128e-17
in O 0 1.2395380319759254e-19
cultured O 0 4.669261329036216e-14
293 O 0 3.511579048376401e-14
cells O 0 5.878744502508431e-15
overexpressing O 0 1.0497841484991e-10
wild O 0 2.762043649351398e-10
- O 0 5.81466508720041e-07
type O 0 1.242115121868892e-08
or O 0 2.344956728794756e-10
mutant O 0 1.1639677069408272e-11
HFE O 0 1.3734315768010319e-11
proteins O 0 4.129830090643209e-14
that O 0 1.9121635376576638e-15
both O 0 6.749217418981879e-17
the O 0 1.742593767309515e-14
wild O 0 8.389735572933432e-10
- O 0 1.169922779808985e-05
type O 0 5.115066770144949e-08
and O 0 7.714012539850046e-09
H63D O 0 1.1168069846689832e-07
HFE O 0 4.590028912510036e-10
proteins O 0 6.430247393579558e-12
form O 0 2.5275498721452107e-14
stable O 0 3.4939982764686794e-12
complexes O 0 4.889296975098267e-13
with O 0 3.056795878160663e-14
the O 0 1.2919117612177934e-14
transferrin O 0 2.2201984695158217e-10
receptor O 0 3.4794985902947273e-13
( O 0 2.4225737332118436e-15
TfR O 0 1.4011813931347206e-09
) O 0 4.57636749676138e-13
. O 0 4.163058786588181e-12

The O 0 2.4711500207219572e-12
C282Y O 0 1.0174143749708264e-09
mutation O 0 6.21660167787752e-10
nearly O 0 4.729810432202441e-10
completely O 0 2.9583189231630058e-08
prevents O 0 6.195082780102723e-10
the O 0 2.583743548972839e-12
association O 0 1.7148764352314548e-15
of O 0 1.3614446794797228e-18
the O 0 8.389390180476935e-16
mutant O 0 1.4565048819803472e-11
HFE O 0 1.188969339649404e-10
protein O 0 2.983612705856342e-13
with O 0 4.507211390138849e-14
the O 0 9.997745903725375e-13
TfR O 0 9.382596317664138e-07
. O 0 1.5109793624623613e-11

Studies O 0 8.016600577809285e-11
on O 0 1.9073300230876278e-11
cell O 0 2.521682773704015e-08
- O 0 1.0327397603759891e-07
associated O 0 2.1521312509875656e-11
transferrin O 0 4.2517600551406076e-10
at O 0 2.8236926685742958e-12
37 O 0 2.890464357121515e-14
degrees O 0 6.511243367396391e-13
C O 0 4.1659602850740995e-11
suggest O 0 1.4497888981796305e-15
that O 0 2.2502176691595256e-16
the O 0 6.978541927981426e-16
overexpressed O 0 2.2697081714095901e-10
wild O 0 3.679100080145048e-10
- O 0 4.354717830779009e-08
type O 0 3.9897859321902374e-11
HFE O 0 5.887658138803431e-10
protein O 0 4.31684771479493e-13
decreases O 0 4.913898589653477e-15
the O 0 6.31709975590928e-18
affinity O 0 1.8598277011874255e-14
of O 0 1.8832283363140852e-16
the O 0 1.6033153266408612e-13
TfR O 0 4.6230122507928684e-10
for O 0 1.0025394613429213e-16
transferrin O 0 1.084557554875687e-09
. O 0 6.179970164083004e-12

The O 0 1.3923325166420586e-11
overexpressed O 0 3.3999551618535406e-08
H63D O 0 1.0186890619934275e-07
protein O 0 2.025253437176744e-10
does O 0 7.846751677240138e-13
not O 0 7.999320390958897e-16
have O 0 1.4111677956748603e-15
this O 0 9.482324981407223e-19
effect O 0 2.4636432373902116e-16
, O 0 4.201519164855907e-18
providing O 0 4.417045273983147e-20
the O 0 8.585737711606402e-19
first O 0 2.8325412481400875e-18
direct O 0 5.688220185579355e-19
evidence O 0 7.071022573349427e-15
for O 0 4.25519863711723e-18
a O 0 6.103766004726587e-16
functional O 0 2.725310931857056e-15
consequence O 0 5.76152149535554e-15
of O 0 3.6829065338510883e-17
the O 0 6.4065918368994e-13
H63D O 0 1.3328919521882199e-05
mutation O 0 6.858950213350923e-11
. O 0 5.941624275918045e-11

Addition O 0 2.6517473655264523e-13
of O 0 2.978917202006644e-16
soluble O 0 1.4467250097557893e-12
wild O 0 1.444333985745061e-09
- O 0 0.002223500981926918
type O 0 1.6290796338580549e-06
HFE O 0 0.007974022068083286
/ O 0 1.021753519125923e-06
beta2m O 0 2.79114065193653e-09
heterodimers O 0 2.0721650090260724e-11
to O 0 1.3057343224774469e-15
cultured O 0 1.5398419301801414e-13
cells O 0 3.796533129107188e-13
also O 0 2.0740935011143158e-12
decreased O 0 2.2426244888906766e-13
the O 0 1.8188094954419256e-16
apparent O 0 1.688118286650997e-12
affinity O 0 5.3654787047791724e-14
of O 0 1.1286095952809852e-16
the O 0 6.13081557838068e-15
TfR O 0 2.5953605584105865e-12
for O 0 4.943140221502542e-20
its O 0 9.2121016188984e-19
ligand O 0 2.1909829015351338e-17
under O 0 8.211609188034808e-15
steady O 0 1.862720394596451e-11
- O 0 9.755229957164602e-11
state O 0 1.5285474708887081e-12
conditions O 0 1.9658634529268193e-12
, O 0 4.542405258372685e-18
both O 0 8.578699438569341e-19
in O 0 3.663580089564004e-19
293 O 0 1.762689195172694e-16
cells O 0 5.266471686434445e-17
and O 0 5.79393507455471e-14
in O 0 2.369507966099309e-15
HeLa O 0 8.909938564727327e-09
cells O 0 4.6020191130091703e-11
. O 0 3.492121522508107e-11

Furthermore O 0 2.064133586276995e-11
, O 0 2.5143749522770278e-14
at O 0 1.0032180977875144e-13
4 O 0 8.65613665273178e-14
degrees O 0 1.2154134643171943e-10
C O 0 2.7706205329991462e-08
, O 0 1.4686494208271395e-13
the O 0 2.2998157469134722e-14
added O 0 1.5169068258436003e-12
soluble O 0 4.3833349391852756e-15
complex O 0 1.0630051729804656e-15
of O 0 4.2822994728082433e-16
HFE O 0 3.1860074045653164e-07
/ O 0 8.425753983409834e-10
beta2m O 0 7.038912855361623e-12
inhibited O 0 1.2165212125825981e-15
binding O 0 2.3559602035035684e-16
of O 0 1.3239642987443326e-18
transferrin O 0 7.610077390300674e-13
to O 0 2.541383868349652e-15
HeLa O 0 4.9826455461587926e-11
cell O 0 6.546582165256609e-10
TfR O 0 5.203905750761351e-09
in O 0 7.162644009671556e-16
a O 0 1.8322385167239552e-13
concentration O 0 2.8471479396330324e-08
- O 0 4.594351992182055e-07
dependent O 0 3.128778902627971e-10
manner O 0 5.425653704094202e-09
. O 0 5.210078202200208e-11

Scatchard O 0 5.692050919492431e-08
plots O 0 1.6536803038036396e-09
of O 0 7.512835805670217e-15
these O 0 3.4049788508216158e-15
data O 0 1.424419799776408e-13
indicate O 0 2.9649825888759807e-13
that O 0 3.2066000923329854e-14
the O 0 6.942862083858525e-14
added O 0 1.1561615380351054e-11
heterodimer O 0 5.645928264296461e-14
substantially O 0 4.524809007837825e-14
reduced O 0 1.8611034386851089e-16
the O 0 1.9574398706732397e-17
affinity O 0 1.5842070765024335e-13
of O 0 1.677376486711494e-15
TfR O 0 4.33264847610193e-11
for O 0 3.4675795090027145e-17
transferrin O 0 4.308710610523292e-10
. O 0 1.1073569361821911e-12

These O 0 8.548675656250282e-12
results O 0 4.116882937934543e-15
establish O 0 9.47420433426683e-16
a O 0 1.4763714390424306e-15
molecular O 0 9.052466418070677e-15
link O 0 2.8606485236171153e-11
between O 0 2.185645978439177e-12
HFE O 0 1.2821803352380812e-07
and O 0 1.2525955966902202e-11
a O 0 5.445122184666708e-17
key O 0 1.6544987620808658e-15
protein O 0 1.3374427890996748e-16
involved O 0 2.263966866778035e-17
in O 0 6.305810891217524e-17
iron O 0 2.5709551154662336e-10
transport O 0 3.499143249457992e-14
, O 0 1.4950165929751883e-16
the O 0 2.2474651297183044e-15
TfR O 0 6.412274045075605e-10
, O 0 1.0034663800850135e-14
and O 0 4.96053427555352e-14
raise O 0 1.1751271889063133e-16
the O 0 1.8629412272110486e-18
possibility O 0 1.5628464082289808e-18
that O 0 2.6821875316002737e-16
alterations O 0 4.65666730436326e-14
in O 0 1.832480210163916e-16
this O 0 2.984134503099618e-18
regulatory O 0 5.8121168908774074e-15
mechanism O 0 1.0464546980684664e-12
may O 0 1.1157355421509418e-12
play O 0 6.5095323735484315e-16
a O 0 1.697929861944989e-18
role O 0 4.613273891178717e-16
in O 0 8.615368975509276e-18
the O 0 2.9738985317941623e-16
pathogenesis O 0 1.1754268391950262e-10
of O 0 2.284350876860519e-12
hereditary B-Disease 1 0.9999998807907104
hemochromatosis I-Disease 1 1.0
. O 0 4.208731070320937e-07
. O 0 1.6536699787295106e-10

Genomic O 0 2.8547183714144886e-11
organization O 0 1.9228741591614112e-13
of O 0 3.441134346296047e-16
the O 0 1.2365611227300403e-14
UBE3A O 0 5.365555466596561e-07
/ O 0 1.5476950832038483e-09
E6 O 0 7.682116347496049e-07
- O 0 4.3156731521776237e-07
AP O 0 2.9315803118379336e-09
gene O 0 1.584370113404121e-13
and O 0 8.769237235233679e-14
related O 0 4.118636042025475e-14
pseudogenes O 0 4.5603566062313305e-11
. O 0 2.4958672281694128e-12

The O 0 9.967181702381922e-14
UBE3A O 0 4.0661216060833283e-10
gene O 0 3.31633016133117e-14
encodes O 0 8.823400452113994e-13
the O 0 2.348749179089532e-13
E6 O 0 4.845712169299077e-07
- O 0 4.2866400917773717e-07
AP O 0 1.1856681192412566e-09
ubiquitin O 0 2.6871384349418104e-13
- O 0 7.034839019908617e-14
protein O 0 2.765948396292765e-15
ligase O 0 1.9406907602882413e-15
and O 0 2.0105543342393076e-14
has O 0 3.172299059029537e-16
recently O 0 5.778993455716791e-17
been O 0 2.4341307400796874e-18
shown O 0 3.172561903940982e-18
to O 0 3.0134866969433326e-19
be O 0 2.3538849727827954e-16
mutated O 0 7.653558675713157e-09
in O 0 3.1561677360514295e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 8.518998839690539e-09
who O 0 1.6966870963752712e-10
lack O 0 2.3355525412965816e-13
15q11 O 0 1.3949906334242979e-11
- O 0 2.9647566623935973e-09
q13 O 0 1.7337850599652427e-10
deletions O 0 1.1900436192036068e-08
or O 0 8.14897305190243e-09
chromosome O 0 5.279425749904476e-05
15 O 0 1.8851387117990726e-10
paternal O 0 1.590944521012716e-06
uniparental B-Disease 0 0.0017395289614796638
disomy I-Disease 0 0.002073536394163966
. O 0 1.916967695692051e-09

Previous O 0 2.6951586795664895e-11
UBE3A O 0 3.042105678474627e-09
cDNA O 0 1.8647040508912305e-11
analysis O 0 2.2984663217845425e-13
has O 0 1.2606998676608933e-14
shown O 0 2.3350157256959297e-15
a O 0 2.1102009392215726e-17
coding O 0 4.521729657369633e-10
region O 0 5.445756692812331e-13
of O 0 1.6999926105103186e-16
approximately O 0 2.813893933942442e-14
2 O 0 4.938898140287307e-13
. O 0 1.8245322787324714e-12

6 O 0 3.885193000652265e-10
kb O 0 8.028880671417937e-09
and O 0 3.950242910555346e-12
a O 0 1.6288248419309148e-13
3 O 0 3.3749475436550824e-10
- O 0 0.002613041317090392
untranslated O 1 0.9274762272834778
region O 0 5.8629762378359374e-08
( O 0 3.014987517730317e-15
UTR O 0 5.4123771436875856e-11
) O 0 2.8300816017732427e-16
of O 0 1.5282103914274308e-18
< O 0 1.4174692972859586e-15
50 O 0 2.422959417752975e-17
bp O 0 4.1160859985157894e-13
, O 0 1.4284170393105429e-16
whereas O 0 1.9841140631479107e-16
Northern O 0 4.765710175531337e-16
analysis O 0 5.950155055082715e-14
has O 0 5.87932263637625e-13
indicated O 0 4.637147938313553e-15
mRNA O 0 1.102705713097393e-15
sizes O 0 8.95899497708845e-14
of O 0 8.407359190359547e-17
5 O 0 9.914173431865847e-13
- O 0 2.0720415605524067e-08
8 O 0 1.1598130095213932e-10
kb O 0 3.911056012384506e-08
. O 0 1.4521711741086185e-12

We O 0 6.864178279594735e-13
have O 0 1.7926540775602233e-17
analyzed O 0 1.770904190533754e-17
additional O 0 2.1325091007832117e-19
cDNA O 0 8.268569612638818e-14
clones O 0 2.7474472696908947e-10
and O 0 3.970656675634718e-14
provide O 0 3.511729374638816e-20
evidence O 0 5.911249275226848e-19
for O 0 7.758775421420713e-22
an O 0 2.55683869941485e-20
additional O 0 5.63062703232683e-17
0 O 0 5.898061935903512e-15
. O 0 2.573031035197487e-13

5 O 0 1.8530461887156235e-11
kb O 0 5.918519563330449e-10
of O 0 1.8648495477734594e-15
5 O 0 8.422458558495979e-14
- O 0 4.032309208756857e-10
UTR O 0 2.660168618717762e-08
and O 0 3.6138592118817314e-12
> O 0 2.0050157128521538e-15
2 O 0 1.968817124576531e-15
kb O 0 3.9832168813314084e-11
of O 0 9.749991115052338e-17
3 O 0 5.098235202061208e-12
- O 0 9.264908840123098e-08
UTR O 0 7.962983545439783e-06
. O 0 3.05399143474272e-11

We O 0 4.7255518942357355e-11
have O 0 1.6678114465639636e-16
established O 0 1.6633240372357971e-18
the O 0 1.7189802643659682e-18
genomic O 0 1.0678911131301125e-14
organization O 0 5.691940703353915e-16
of O 0 4.79619915955498e-18
UBE3A O 0 5.756129253797759e-11
and O 0 3.166702765286587e-15
the O 0 7.177101344204763e-19
sequence O 0 9.8216269413329e-17
of O 0 4.715684707451519e-18
intron O 0 9.75404823577719e-09
- O 0 6.5008207705830046e-09
exon O 0 2.6269597608319373e-09
borders O 0 2.3751505295876996e-07
. O 0 3.238397550120453e-09

We O 0 4.280530443989683e-11
have O 0 2.8503001723450844e-15
also O 0 3.267983341822731e-16
mapped O 0 2.4495076106356706e-12
two O 0 2.7432392841581995e-16
highly O 0 3.176316063151054e-18
homologous O 0 3.342214000597648e-17
processed O 0 5.405162346588802e-16
pseudogenes O 0 1.683384470230545e-13
, O 0 1.125029478180517e-15
UBE3AP1 O 0 4.247885376784666e-10
and O 0 9.880001005692363e-14
UBE3AP2 O 0 1.6291318294392454e-10
, O 0 2.58456503228297e-17
to O 0 3.96126124721743e-18
chromosomes O 0 2.9178626203586744e-13
2 O 0 4.120622164880197e-15
and O 0 3.203728515116522e-13
21 O 0 9.531302613483006e-15
, O 0 7.587108630804039e-16
respectively O 0 2.015738175876504e-14
, O 0 2.6425667819869776e-14
and O 0 2.5440745430455047e-12
determined O 0 4.049274208040715e-13
their O 0 2.728365459719797e-14
genomic O 0 9.399921813146861e-12
organization O 0 1.4647447751231502e-12
. O 0 1.8187715873294041e-12

These O 0 1.0772921443802375e-09
results O 0 5.2995160343405345e-12
will O 0 4.645846966681855e-13
form O 0 3.8600356815007435e-17
the O 0 8.753749343672252e-17
basis O 0 1.6592634282882896e-16
for O 0 1.7131409896268032e-18
studies O 0 3.240869817181121e-16
of O 0 1.0427608761609952e-19
mutation O 0 1.8143190296813957e-16
and O 0 2.1269249721373763e-14
imprinting O 0 2.1038797370920292e-09
of O 0 3.5175723146979934e-14
UBE3A O 0 1.5907428405625978e-06
. O 0 3.8744459029960154e-11

Mutation O 0 1.3395192940968137e-11
spectrum O 0 1.08333307602404e-10
and O 0 9.165990882964437e-11
genotype O 0 3.285747425252339e-07
- O 0 2.2073049876780715e-06
phenotype O 0 2.5118649382704916e-09
analyses O 0 1.478365430074291e-09
in O 0 1.0036148344674811e-12
Cowden B-Disease 0 0.018169445917010307
disease I-Disease 0 0.0005867270519956946
and O 0 2.8218741476848663e-07
Bannayan B-Disease 1 0.9996163845062256
- I-Disease 1 0.9999825954437256
Zonana I-Disease 1 0.9999045133590698
syndrome I-Disease 1 0.9999911785125732
, O 0 9.639586871779127e-12
two O 0 2.4086550462487644e-11
hamartoma B-Disease 0 0.00477686058729887
syndromes I-Disease 0 7.240250124596059e-05
with O 0 7.976236316396823e-13
germline O 0 3.944978121950271e-09
PTEN O 0 2.3122586298995884e-06
mutation O 0 8.410572860384491e-08
. O 0 1.923744896714652e-08

The O 0 1.562501905638669e-09
tumour B-Disease 1 0.9997300505638123
suppressor O 0 1.1845049385783568e-07
gene O 0 4.004701015247747e-10
PTEN O 0 6.562112186969671e-09
, O 0 3.448095284232407e-14
which O 0 8.109716312556918e-16
maps O 0 1.3988907688472496e-12
to O 0 3.303649888375393e-12
10q23 O 0 1.880342104243482e-09
. O 0 1.4291291240697834e-11

3 O 0 1.166569770470749e-12
and O 0 7.927295591267087e-16
encodes O 0 6.229214972346738e-15
a O 0 9.927512677184588e-17
403 O 0 1.3657857397125772e-14
amino O 0 8.804063164266629e-14
acid O 0 1.4501775973639608e-13
dual O 0 2.8385299210946513e-13
specificity O 0 1.3543530012760652e-11
phosphatase O 0 1.4307492790521792e-07
( O 0 3.0768228287040124e-15
protein O 0 1.994414697411781e-13
tyrosine O 0 2.712622348965965e-10
phosphatase O 0 2.1710880560021906e-07
; O 0 2.793660918917751e-12
PTPase O 0 4.402198050534878e-10
) O 0 2.5455718533507615e-14
, O 0 5.979387157356174e-16
was O 0 7.052791510531176e-13
shown O 0 8.308535337595707e-14
recently O 0 1.7684436543190934e-13
to O 0 1.8076119316374605e-15
play O 0 9.017242552959107e-15
a O 0 1.7819370924567618e-16
broad O 0 1.531381676164506e-15
role O 0 6.529217271011856e-12
in O 0 2.2964010182899112e-14
human O 0 1.4814131865659164e-10
malignancy B-Disease 0 1.323051856161328e-05
. O 0 6.260076484965182e-11

Somatic O 0 6.417437692363137e-10
PTEN O 0 1.853031328380439e-08
deletions O 0 6.739121705123807e-09
and O 0 6.382327999432391e-11
mutations O 0 2.001602876500197e-12
were O 0 1.3376676068904692e-12
observed O 0 3.66576479457828e-13
in O 0 1.697311724762479e-14
sporadic B-Disease 0 8.772572002158086e-09
breast I-Disease 1 0.7946114540100098
, I-Disease 0 4.707082553068176e-06
brain I-Disease 0 0.026737622916698456
, I-Disease 0 6.876814495626604e-08
prostate I-Disease 1 0.9818591475486755
and I-Disease 1 0.6317741870880127
kidney I-Disease 0 0.00038907441194169223
cancer I-Disease 0 6.673434995718708e-07
cell O 0 7.573224138468504e-06
lines O 0 2.477362158970209e-06
and O 0 2.7343582953420764e-09
in O 0 4.1672411642311794e-14
several O 0 6.8382161912128314e-12
primary O 0 1.6941056628638762e-06
tumours B-Disease 1 0.9999997615814209
such O 0 5.159214526949396e-13
as O 0 3.6556202509530067e-09
endometrial B-Disease 1 0.9998408555984497
carcinomas I-Disease 1 0.9999998807907104
, O 1 0.9999052286148071
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9999676942825317
thyroid B-Disease 1 0.9999667406082153
tumours I-Disease 1 0.999995231628418
. O 0 1.3012971976422705e-05

In O 0 3.681621793451967e-13
addition O 0 1.1785852750288619e-14
, O 0 6.78427905081427e-15
PTEN O 0 2.320480092798949e-11
was O 0 7.21338191001647e-13
identified O 0 2.731076473370779e-15
as O 0 1.3223446584254384e-17
the O 0 1.2336944714072116e-17
susceptibility O 0 5.120839665392722e-14
gene O 0 2.607336547187644e-13
for O 0 2.9739015069973895e-14
two O 0 2.8416794251029387e-08
hamartoma B-Disease 1 0.9986005425453186
syndromes I-Disease 1 0.9990818500518799
Cowden B-Disease 1 0.9957834482192993
disease I-Disease 1 0.5264509916305542
( O 0 8.080812061161957e-12
CD B-Disease 0 1.9736722606467083e-05
; O 0 5.27897829616375e-11
MIM O 0 1.002429215191114e-07
158350 O 0 1.1320760995303658e-09
) O 0 8.374247476017338e-13
and O 0 1.893993989421361e-10
Bannayan B-Disease 0 1.0057507097371854e-05
- I-Disease 0 7.876528979977593e-05
Zonana I-Disease 0 1.6268304534605704e-05
( I-Disease 0 3.257569114087887e-14
BZS I-Disease 0 1.3644683993785378e-10
) I-Disease 0 1.9312376608386465e-15
or I-Disease 0 2.7680407879010493e-13
Ruvalcaba I-Disease 0 4.7579462147950835e-07
- I-Disease 0 0.00018288500723429024
Riley I-Disease 0 0.19573600590229034
- I-Disease 1 0.9999346733093262
Smith I-Disease 1 0.9998071789741516
syndrome I-Disease 1 0.9999277591705322
( O 0 9.49396743404711e-14
MIM O 0 3.907961243498903e-08
153480 O 0 2.7181239481421926e-09
) O 0 2.5099644584969383e-12
. O 0 2.212785293539965e-12

Constitutive O 0 7.389292303039419e-12
DNA O 0 4.391796301628226e-11
from O 0 9.804646921825547e-14
37 O 0 2.7915807144195115e-14
CD B-Disease 0 1.7253574124964643e-09
families O 0 6.891178166296141e-12
and O 0 7.81597686962468e-14
seven O 0 5.40623776079446e-15
BZS B-Disease 0 8.996023544149967e-12
families O 0 7.748235870242182e-17
was O 0 6.880001291271413e-16
screened O 0 9.534544377978738e-14
for O 0 2.6556443314474066e-17
germline O 0 3.3405910416367535e-12
PTEN O 0 7.735328488855941e-10
mutations O 0 4.146411686223317e-11
. O 0 2.9571522314197907e-11

PTEN O 0 8.705332454894688e-09
mutations O 0 1.4804293207992814e-11
were O 0 4.885381921053422e-13
identified O 0 1.548193946090612e-13
in O 0 1.0566940363695922e-15
30 O 0 9.894969433123062e-15
of O 0 4.2724442444669396e-16
37 O 0 5.495360568506802e-13
( O 0 1.926652539146261e-16
81 O 0 5.346907812342483e-13
% O 0 2.5204704131237066e-16
) O 0 3.7217470972985363e-16
CD B-Disease 0 2.7102966537739803e-09
families O 0 6.198524766382052e-13
, O 0 3.5591937323099025e-17
including O 0 7.356147098285025e-16
missense O 0 1.755316864082701e-10
and O 0 3.7606803005019174e-08
nonsense O 0 9.096044095713296e-08
point O 0 1.8041438135107946e-11
mutations O 0 2.375405305939625e-14
, O 0 4.417054738480318e-16
deletions O 0 1.7700229303085901e-13
, O 0 2.0395379382218658e-14
insertions O 0 4.1569453435030823e-10
, O 0 1.2079772945816636e-12
a O 0 9.278250504051247e-14
deletion O 0 2.1504439118302798e-08
/ O 0 1.1200923211163172e-07
insertion O 0 2.310173996544762e-10
and O 0 1.023057638604996e-09
splice O 0 1.5894493117230013e-06
site O 0 3.864215258886361e-08
mutations O 0 4.5020616568081095e-08
. O 0 6.206270497521871e-10

These O 0 1.2927209487329644e-13
mutations O 0 2.7303189548653906e-13
were O 0 5.974676591143091e-13
scattered O 0 4.89947275458813e-13
over O 0 1.29690019574219e-12
the O 0 2.066739384883401e-13
entire O 0 5.209876800804647e-12
length O 0 1.8655177229376374e-12
of O 0 1.4125941991580365e-16
PTEN O 0 8.005961345258772e-12
, O 0 1.1370064181755743e-15
with O 0 2.7532408903807007e-16
the O 0 4.992100059475783e-15
exception O 0 1.0544075344559502e-14
of O 0 2.742558018205701e-17
the O 0 4.296621381166127e-14
first O 0 5.593306200146753e-12
, O 0 4.201027112987754e-12
fourth O 0 2.3255988801373917e-10
and O 0 8.072128382385912e-11
last O 0 1.2211831545982932e-10
exons O 0 8.559558750675933e-08
. O 0 1.061258081413996e-09

A O 0 2.842710268569082e-11
hot O 0 2.0395158895070153e-09
spot O 0 1.3811186916345974e-10
for O 0 3.6967588312611464e-16
PTEN O 0 6.233553950796278e-11
mutation O 0 3.478914747424844e-13
in O 0 1.0372648581529441e-14
CD B-Disease 0 1.0526544969025053e-08
was O 0 5.09016336025514e-11
identified O 0 2.363609694522751e-14
in O 0 8.917174093805374e-18
exon O 0 5.357195400181383e-14
5 O 0 3.3460734183421437e-13
that O 0 2.5304210766671775e-13
contains O 0 1.5081731978734692e-13
the O 0 3.716632904215977e-12
PTPase O 0 2.6376298478680837e-08
core O 0 3.837540354933999e-11
motif O 0 1.001220148455495e-10
, O 0 5.271157499168436e-16
with O 0 3.533060714479188e-16
13 O 0 1.6228383645783945e-15
of O 0 1.3129503682086737e-17
30 O 0 8.796438851301804e-15
( O 0 3.3540790793041084e-17
43 O 0 2.9407097416889183e-12
% O 0 9.499432998842563e-15
) O 0 1.6162593114463046e-14
CD B-Disease 0 3.480293553348446e-10
mutations O 0 9.786780455869112e-15
identified O 0 4.1901794940691836e-14
in O 0 3.097192184375355e-17
this O 0 1.6276857753168533e-16
exon O 0 5.597495245091011e-10
. O 0 2.5079345267187136e-09

Seven O 0 3.576093934865021e-11
of O 0 3.787372721892517e-15
30 O 0 3.282179486963771e-14
( O 0 2.1295207681317082e-16
23 O 0 1.2622550032113933e-13
% O 0 2.958464797401801e-16
) O 0 1.0605587300705583e-15
were O 0 9.784247657950232e-14
within O 0 8.119113237343933e-19
the O 0 7.141985934879208e-17
core O 0 2.1542041154370972e-12
motif O 0 4.3735397248223506e-11
, O 0 1.2990817257097116e-15
the O 0 7.66417010015846e-15
majority O 0 2.940063557194117e-13
( O 0 1.7024586675269107e-16
five O 0 3.033732661784916e-13
of O 0 8.704343500045685e-15
seven O 0 3.254493202708986e-11
) O 0 3.73454835916995e-15
of O 0 4.048354597604771e-17
which O 0 2.594510543907358e-11
were O 0 1.6611424041856893e-11
missense O 0 1.4016577612116499e-12
mutations O 0 1.5522927995087477e-12
, O 0 8.110377603884333e-13
possibly O 0 7.444861567507122e-12
pointing O 0 3.125356862199169e-09
to O 0 1.247216739608259e-12
the O 0 2.18898978668813e-14
functional O 0 1.1459640033510254e-14
significance O 0 4.335824437657308e-14
of O 0 1.1345455757055638e-15
this O 0 2.211455031684434e-13
region O 0 3.400715473111937e-11
. O 0 1.5613153825366766e-10

Germline O 0 1.294663665163398e-08
PTEN O 0 4.620326343740544e-09
mutations O 0 1.7434874724497895e-11
were O 0 1.543012137332489e-12
identified O 0 1.0409940054065259e-12
in O 0 7.792350749033505e-15
four O 0 2.790288345429909e-13
of O 0 4.284899546318959e-15
seven O 0 1.6162164662159029e-10
( O 0 2.0151527914066564e-15
57 O 0 4.408144335665831e-11
% O 0 2.417248564127398e-14
) O 0 3.5067752196006607e-13
BZS B-Disease 0 3.6180027862542374e-09
families O 0 2.4692926739802723e-13
studied O 0 1.6753381993327154e-13
. O 0 6.970362221442317e-12

Interestingly O 0 1.0444107800822167e-08
, O 0 8.21630957714703e-11
none O 0 8.752620156426971e-12
of O 0 1.2040269769935072e-17
these O 0 1.243789871308498e-14
mutations O 0 2.7590050131142373e-14
was O 0 1.7357902615255938e-10
observed O 0 4.104501027252239e-12
in O 0 1.35702979073022e-14
the O 0 5.724874784299172e-13
PTPase O 0 1.4278131743594713e-07
core O 0 1.5562796606971574e-09
motif O 0 1.4648819046669814e-08
. O 0 6.326430351810686e-11

It O 0 2.2743090397070453e-11
is O 0 2.6521861963557658e-14
also O 0 2.5556664532029594e-14
worthy O 0 9.954001598672102e-13
of O 0 1.6261598984019339e-15
note O 0 2.745736797649112e-12
that O 0 3.463379019677721e-15
a O 0 2.2670805069525827e-15
single O 0 2.163779398711707e-11
nonsense O 0 3.135664172759789e-08
point O 0 2.205832088167381e-12
mutation O 0 4.498697861985996e-15
, O 0 6.4573751551509455e-15
R233X O 0 1.3154774036565342e-13
, O 0 4.544370725534895e-15
was O 0 4.3464771712353745e-12
observed O 0 8.991691804105181e-14
in O 0 8.917893079193805e-17
the O 0 4.2806826986701717e-16
germline O 0 1.1009031211065175e-14
DNA O 0 4.681505738624026e-10
from O 0 7.705798381384219e-15
two O 0 1.1595822814396248e-15
unrelated O 0 8.339176923869221e-14
CD B-Disease 0 4.9197095286501735e-09
families O 0 3.048519336273925e-12
and O 0 4.777348763980449e-13
one O 0 5.359875954527582e-13
BZS B-Disease 0 4.727017000050182e-09
family O 0 4.6663305164340585e-11
. O 0 3.809156115530676e-12

Genotype O 0 2.3900342057459056e-05
- O 0 1.9848181182169355e-05
phenotype O 0 2.1722348364505706e-08
studies O 0 1.3959282341158286e-10
were O 0 8.254444003319428e-12
not O 0 1.7923217163900995e-14
performed O 0 4.2176663908339435e-14
on O 0 4.244283147592648e-13
this O 0 6.117679579676423e-17
small O 0 1.411883088529037e-16
group O 0 7.59962974711606e-14
of O 0 4.569312881216219e-16
BZS B-Disease 0 1.4776775358882333e-09
families O 0 4.916882940836538e-14
. O 0 7.418290835130639e-14

However O 0 9.70694444962783e-13
, O 0 9.747806775900047e-15
genotype O 0 2.998158665779016e-10
- O 0 6.146781750260288e-09
phenotype O 0 5.3209405631582385e-11
analysis O 0 9.899429908623303e-14
inthe O 0 8.83746020807763e-10
group O 0 3.376980639568927e-11
of O 0 6.666392816863679e-16
CD B-Disease 0 1.7268156398131396e-06
families O 0 6.98860344594543e-11
revealed O 0 3.2347503581969805e-12
two O 0 8.015689170315688e-17
possible O 0 1.3153515908088539e-17
associations O 0 1.9356297752379342e-19
worthy O 0 1.792136216174651e-15
of O 0 5.595276641668764e-17
follow O 0 5.944432446280956e-12
- O 0 6.308943056865246e-08
up O 0 1.1877101968593706e-08
in O 0 4.200115359947066e-15
independent O 0 1.644106027807058e-14
analyses O 0 2.2650277486935266e-11
. O 0 9.450120265312723e-14

The O 0 3.059021135357054e-12
first O 0 2.040792881907727e-12
was O 0 3.137857196300331e-10
an O 0 1.901555085268014e-14
association O 0 4.108348233958009e-15
noted O 0 2.964591259654349e-14
in O 0 1.4719009050259409e-15
the O 0 1.6897796367449508e-13
group O 0 2.4680129901560877e-12
of O 0 3.5078119196360686e-17
CD B-Disease 0 8.436260827693332e-07
families O 0 5.146795836741269e-11
with O 0 4.378603816329596e-12
breast B-Disease 0 2.467579543008469e-05
disease I-Disease 0 3.491428742563585e-06
. O 0 8.741329882155924e-11

A O 0 1.943546018567943e-12
correlation O 0 8.13660987544762e-13
was O 0 1.0783724607721368e-11
observed O 0 7.69519810286251e-14
between O 0 5.486620340455946e-15
the O 0 1.5585213105967152e-14
presence O 0 1.1168645869252813e-11
/ O 0 6.737845836823908e-10
absence O 0 2.2502275159175375e-15
of O 0 1.0032341798371195e-19
a O 0 1.990754569843813e-17
PTEN O 0 7.820425080087845e-13
mutation O 0 5.066943890695173e-15
and O 0 4.237991901856475e-12
the O 0 9.2957874741912e-14
type O 0 3.33501753990717e-10
of O 0 2.1677852655305196e-12
breast O 0 0.0011021862737834454
involvement O 0 3.812456952800858e-06
( O 0 2.8185377209249962e-12
unaffected O 0 5.384091039672967e-08
versus O 0 1.5808366171654598e-08
benign O 0 0.00043401322909630835
versus O 0 2.5913104764185846e-06
malignant O 0 0.40250617265701294
) O 0 1.777385705281631e-08
. O 0 7.921213684980444e-10

Specifically O 0 5.707490383088931e-11
and O 0 1.7694162107728673e-12
more O 0 8.527868983132805e-18
directly O 0 6.31975144416673e-14
, O 0 1.1442341926661426e-14
an O 0 1.2188583035390149e-14
association O 0 3.7135821761430376e-14
was O 0 7.099744681049458e-10
also O 0 3.1352093230602174e-12
observed O 0 6.487376553922924e-14
between O 0 4.3808755790229227e-16
the O 0 1.1355277368776847e-16
presence O 0 1.1551936978607819e-15
of O 0 2.6678071951743863e-18
a O 0 1.2822687993330716e-14
PTEN O 0 2.6206160441688553e-07
mutation O 0 1.8293446757411402e-08
and O 0 1.505262844148092e-05
malignant B-Disease 1 0.9997559189796448
breast I-Disease 1 0.9998666048049927
disease I-Disease 1 0.9584251046180725
. O 0 2.7128925239594537e-07

Secondly O 0 1.0938094163748247e-07
, O 0 1.0070074114854055e-11
there O 0 9.669814862028892e-14
appeared O 0 9.204586398636749e-11
to O 0 1.6102347049056637e-14
be O 0 2.0908013886292327e-14
an O 0 7.705475661831315e-15
interdependent O 0 4.0411478039459325e-06
association O 0 5.2987321697223547e-14
between O 0 1.2436712019925876e-14
mutations O 0 7.03741915002859e-13
upstream O 0 2.22067156330219e-11
and O 0 6.454457801563507e-11
within O 0 4.1820631820169455e-16
the O 0 9.071760812169594e-14
PTPase O 0 4.638559758518568e-09
core O 0 7.065172058506874e-11
motif O 0 1.4047751850654322e-09
, O 0 4.697916623048418e-15
the O 0 4.1631537008650853e-16
core O 0 9.466636675947715e-12
motif O 0 2.8294628792724374e-11
containing O 0 6.921380244113984e-13
the O 0 1.2086543517333265e-13
majority O 0 2.2303549794804728e-14
of O 0 2.0332124602844042e-16
missense O 0 8.038767568274707e-12
mutations O 0 4.189344617738788e-12
, O 0 1.7347757345215209e-12
and O 0 1.1685790356208425e-11
the O 0 4.602169882163276e-14
involvement O 0 6.98935007092949e-11
of O 0 2.0087144092712818e-14
all O 0 8.521386721249691e-13
major O 0 6.872404663578469e-13
organ O 0 8.686989758643904e-07
systems O 0 1.1981675243077916e-06
( O 0 6.154464958496586e-13
central O 0 1.001048799409432e-09
nervous O 0 2.087799515493316e-07
system O 0 8.899220915736805e-09
, O 0 5.034028749406616e-11
thyroid O 0 1.3725160897593014e-05
, O 0 1.3389273023634019e-10
breast O 1 0.9116817712783813
, O 0 0.00047407159581780434
skin O 1 0.9999959468841553
and O 1 0.9676687121391296
gastrointestinal O 1 0.9665664434432983
tract O 1 0.7108752727508545
) O 0 9.528572775252542e-08
. O 0 1.0454870746912093e-08

However O 0 3.896961572880109e-11
, O 0 6.219361438071329e-15
these O 0 9.914531897267916e-17
observations O 0 3.9137475812273115e-13
would O 0 2.5209454207301973e-13
need O 0 1.282428925617794e-16
to O 0 1.1127919167355012e-16
be O 0 5.767169405168713e-16
confirmed O 0 4.734796119934515e-16
by O 0 2.6398347385924103e-19
studying O 0 1.3537283251355219e-18
a O 0 1.030852641891014e-18
larger O 0 1.5898507016027518e-19
number O 0 1.2460721539392714e-17
of O 0 1.3025148561240517e-16
CD B-Disease 0 7.661330982955405e-07
families O 0 2.617339331378865e-11
. O 0 1.455781296292452e-13

Molecular O 0 1.045519547915319e-05
defects O 0 0.11279580742120743
leading O 0 3.373124696226526e-11
to O 0 7.96935437698829e-15
human O 0 2.333975061016933e-14
complement B-Disease 0 2.5140993887423635e-12
component I-Disease 0 3.313842356078567e-08
C6 I-Disease 1 0.9999990463256836
deficiency I-Disease 1 0.9999997615814209
in O 0 7.472079121347182e-15
an O 0 1.0038416156806472e-14
African O 0 5.4613442240780685e-11
- O 0 2.235213116819068e-07
American O 0 1.6335385266685876e-09
family O 0 2.664839238164518e-09
. O 0 3.2523988927404823e-13

Complement B-Disease 0 4.88790874442202e-09
component I-Disease 0 1.8552063920651563e-05
C6 I-Disease 1 0.9999946355819702
deficiency I-Disease 1 0.9999996423721313
( O 0 1.492599238650527e-10
C6D B-Disease 0 7.825643479009159e-06
) O 0 2.7677587652319424e-11
was O 0 3.985789476246282e-09
diagnosed O 0 1.4965338968053743e-09
in O 0 1.3873241623167865e-16
a O 0 1.5388833175827453e-15
16 O 0 1.601120460986618e-14
- O 0 2.0691447166765187e-10
year O 0 2.2672742589630035e-12
- O 0 4.144612653078639e-09
old O 0 1.8331910212054936e-07
African O 0 2.5754873494293617e-12
- O 0 4.177910187946887e-12
American O 0 3.8970172575036877e-13
male O 0 2.1232559113681937e-11
with O 0 7.29042531639329e-13
meningococcal B-Disease 1 0.9999772310256958
meningitis I-Disease 1 0.9999841451644897
. O 0 9.242893993580137e-13

The O 0 9.384340526885637e-11
patients O 0 7.08627947987317e-11
father O 0 3.571443585315137e-08
and O 0 4.1026579356007176e-10
two O 0 2.2692136364410587e-11
brothers O 0 5.242430045626634e-09
also O 0 5.880362250734392e-14
had O 0 4.22857712387148e-12
C6D B-Disease 0 3.854178642903605e-10
, O 0 1.0759371161537726e-16
but O 0 1.470991509277945e-15
gave O 0 5.84314294540568e-14
no O 0 9.569799244496177e-14
history O 0 2.0541969167342522e-11
of O 0 5.660123845313558e-12
meningitis B-Disease 1 0.9999996423721313
or O 0 4.318400151359647e-11
other O 0 7.354815541316118e-12
neisserial B-Disease 0 0.0016359251458197832
infection I-Disease 0 0.0012173783034086227
. O 0 1.4934314895853618e-09

By O 0 1.4850693821497686e-16
using O 0 1.0442870683351256e-16
exon O 0 2.5808660221969537e-13
- O 0 1.618849477212636e-12
specific O 0 6.12929240138328e-16
polymerase O 0 4.7801061719976445e-11
chain O 0 1.310628272577219e-10
reaction O 0 3.3512548861695053e-16
( O 0 1.063939575587451e-20
PCR O 0 8.440116146127621e-14
) O 0 1.2314006168505408e-16
/ O 0 4.2484741649717085e-15
single O 0 1.0209648102258665e-15
- O 0 1.048568458623944e-12
strand O 0 1.927240918936368e-12
conformation O 0 1.211876126251503e-14
polymorphism O 0 3.7810769906933717e-16
as O 0 2.1135178094008184e-19
a O 0 3.1610927232460945e-21
screening O 0 2.556635103124237e-19
step O 0 2.3158600425065492e-18
and O 0 2.8451329533158877e-20
nucleotide O 0 6.22475706048601e-20
sequencing O 0 2.0533914982404108e-17
of O 0 4.759653079321469e-19
target O 0 1.1078797079765775e-14
exons O 0 2.1131707494959073e-12
, O 0 1.3799308511185451e-14
we O 0 7.777620846080753e-15
determined O 0 2.554378624309954e-15
that O 0 4.611378485552646e-14
the O 0 5.065931940433088e-14
proband O 0 4.6308098688996324e-08
was O 0 8.48208482617796e-12
a O 0 3.625351968574139e-17
compound O 0 2.004618030883418e-15
heterozygote O 0 4.305282123645213e-15
for O 0 2.7426089311724035e-18
two O 0 9.283343882569677e-15
C6 O 0 3.025102444098593e-07
gene O 0 3.012092519849574e-10
mutations O 0 1.7156471798784878e-09
. O 0 4.953019105968792e-10

The O 0 2.447624351462063e-13
first O 0 2.0603857907460464e-14
, O 0 1.2692209555828005e-15
1195delC O 0 2.376888833324764e-13
located O 0 1.9929438522274447e-16
in O 0 1.2759431347836638e-17
exon O 0 5.218922014926623e-14
7 O 0 2.722135667918013e-12
, O 0 1.9165607821483924e-14
is O 0 6.339218400052825e-16
a O 0 4.148520677305675e-16
novel O 0 8.506377839525431e-14
mutation O 0 2.4091948054583145e-13
, O 0 9.208509605881932e-13
while O 0 6.237686148852228e-13
the O 0 2.712201614690638e-15
second O 0 1.901426715730792e-12
, O 0 7.432847096329204e-15
1936delG O 0 8.595513623782525e-13
in O 0 1.0433434206923251e-16
exon O 0 3.404410813586528e-13
12 O 0 3.019573306672907e-12
, O 0 4.360322663370976e-14
has O 0 8.771718160854869e-13
been O 0 3.4985597318487605e-12
described O 0 3.8757320269811046e-11
before O 0 6.0798662111782864e-12
to O 0 5.619609053271468e-13
cause O 0 1.4705337642029193e-12
C6D B-Disease 0 5.1148587587590555e-09
in O 0 2.440110809230915e-16
an O 0 9.385569747874956e-16
unrelated O 0 1.5419052701304281e-09
African O 0 6.015140607829039e-10
- O 0 1.3936490006472013e-07
American O 0 1.3305929691398433e-09
individual O 0 8.669722925680468e-13
. O 0 3.9374246051104844e-12

Both O 0 4.591696814437718e-12
mutations O 0 1.3929601916373713e-10
result O 0 2.0210770557138602e-11
in O 0 1.0469970295476708e-13
premature O 0 4.229952776935164e-10
termination O 0 1.866823969715048e-12
codons O 0 5.099431293897894e-12
and O 0 1.834607812889466e-11
C6 O 0 3.189997869412764e-06
null O 0 1.40479528454307e-07
alleles O 0 3.1490748897411436e-10
. O 0 7.725950434966933e-10

Allele O 0 2.8426941356407553e-11
- O 0 8.957426814171221e-13
specific O 0 7.927961570921866e-16
PCR O 0 3.670703185854052e-10
indicated O 0 1.2077337394056364e-11
that O 0 3.1510495964213276e-15
the O 0 2.2456484558046807e-15
probands O 0 9.075868057095704e-09
two O 0 4.5149860412874165e-12
brothers O 0 4.735535519273526e-09
also O 0 6.024750197428791e-14
inherited O 0 7.53483213322692e-12
the O 0 7.866239127088392e-15
1195delC O 0 5.098969579897528e-10
mutation O 0 5.090080375420858e-13
from O 0 1.9672165372380812e-13
their O 0 4.707810877246921e-11
heterozygous O 0 1.7656977225818937e-12
mother O 0 2.8677644703378746e-09
and O 0 7.366182858993542e-13
the O 0 3.1008129193526223e-15
1936delG O 0 6.257632745310104e-10
mutation O 0 3.031864039340637e-13
from O 0 4.000341453491013e-14
their O 0 3.5270887772942405e-12
homozygous O 0 3.098133511889034e-12
father O 0 2.607376758945179e-09
. O 0 8.840797966749511e-14
. O 0 1.623540494752329e-12

PAX6 O 0 6.9008328864583746e-06
mutations O 0 5.091139509971754e-09
reviewed O 0 1.1190966375806966e-08
. O 0 1.200724741856618e-09

Mutations O 0 2.603932403033582e-09
in O 0 1.0884720994539313e-13
PAX6 O 0 8.858348082840806e-11
are O 0 7.554675739253672e-16
responsible O 0 5.8794170466685506e-15
for O 0 1.8521318986418518e-14
human O 0 1.8843532956225317e-08
aniridia B-Disease 1 0.9999998807907104
and O 0 1.3227442252627952e-08
have O 0 9.672212981709158e-14
also O 0 7.089628181431459e-16
been O 0 2.5730004742487503e-14
found O 0 1.1598003373664012e-13
in O 0 1.429823643398577e-16
patients O 0 1.3757037967227436e-16
with O 0 1.4372362891826307e-12
Peters B-Disease 1 0.9999998807907104
anomaly I-Disease 1 0.9999998807907104
, O 0 1.604396970833477e-07
with O 0 2.851213594112778e-07
congenital B-Disease 1 0.9999889135360718
cataracts I-Disease 1 0.999679684638977
, O 0 2.556951628207571e-08
with O 0 7.562253045989564e-10
autosomal B-Disease 0 0.0023744204081594944
dominant I-Disease 0 0.0004179101379122585
keratitis I-Disease 1 0.9797224402427673
, O 0 4.875654990854628e-09
and O 0 3.03639580145898e-09
with O 0 1.1816680967058346e-08
isolated B-Disease 1 0.7682982683181763
foveal I-Disease 1 0.999997615814209
hypoplasia I-Disease 1 0.9999961853027344
. O 0 4.6453044433292234e-07

No O 0 1.7725239678800797e-12
locus O 0 1.293045184813657e-11
other O 0 1.3798421498283087e-13
than O 0 1.1205200653517482e-14
chromosome O 0 1.7950975150782256e-09
11p13 O 0 4.498200423252996e-11
has O 0 2.129127169708811e-12
been O 0 5.532907031841061e-13
implicated O 0 1.140913696850987e-09
in O 0 1.253853011001782e-11
aniridia B-Disease 1 0.9999994039535522
, O 0 1.5142654491429042e-11
and O 0 4.020693066680847e-12
PAX6 O 0 8.479698609953346e-10
is O 0 6.326339192092023e-13
clearly O 0 9.558188442115867e-12
the O 0 3.314096027229492e-15
major O 0 5.178050981155709e-14
, O 0 1.1441960660191208e-12
if O 0 1.4044087073838973e-12
not O 0 3.544960006963971e-13
only O 0 8.078222039391227e-16
, O 0 1.1913355613987184e-16
gene O 0 1.0952697082622365e-13
responsible O 0 5.592370316831463e-11
. O 0 1.1647427813898936e-11

Twenty O 0 1.5940649689127895e-08
- O 0 1.4451840797846671e-05
eight O 0 2.1680708783833325e-08
percent O 0 3.6891049243203966e-11
of O 0 1.5451808288745687e-18
identified O 0 1.6400960256039905e-15
PAX6 O 0 6.510622661652643e-13
mutations O 0 6.2221529198523e-14
are O 0 1.449563058020069e-14
C O 0 5.385641799193763e-08
- O 0 5.72966882828041e-06
T O 0 2.244917141069891e-06
changes O 0 1.5903634390180199e-15
at O 0 7.074961700070633e-15
CpG O 0 2.323494912095936e-12
dinucleotides O 0 9.332748983348349e-12
, O 0 1.0071541034570077e-17
20 O 0 1.5802797566264187e-18
% O 0 7.235727067339056e-22
are O 0 1.3276333397365134e-22
splicing O 0 2.6466664638033358e-15
errors O 0 1.6022058124676164e-09
, O 0 3.1183687359756518e-15
and O 0 4.063366549294069e-15
more O 0 1.0603351993992669e-17
than O 0 1.615388577458395e-16
30 O 0 4.670717548079135e-16
% O 0 2.5157993159328135e-18
are O 0 3.972580386719606e-18
deletion O 0 1.8093032023232432e-14
or O 0 1.0597570726782884e-13
insertion O 0 3.920922180683517e-12
events O 0 6.648813721810143e-10
. O 0 2.9039312621215174e-10

There O 0 3.4651418019671087e-12
is O 0 2.998072439180238e-14
a O 0 1.8333875677388825e-14
noticeably O 0 1.3889679406631217e-09
elevated O 0 3.2293179241804637e-09
level O 0 9.488962567083536e-12
of O 0 2.804662738596182e-17
mutation O 0 1.913126614118692e-15
in O 0 5.528531636565207e-16
the O 0 3.0907848433505195e-16
paired O 0 2.285832547549438e-12
domain O 0 7.153374247115263e-12
compared O 0 1.8020174111579856e-12
with O 0 2.242135683117475e-14
the O 0 3.1788086702830287e-13
rest O 0 8.39279600678422e-13
of O 0 1.3050152452719678e-18
the O 0 6.481977332983065e-16
gene O 0 2.6313800097210738e-11
. O 0 2.3627523548785945e-11

Increased O 0 3.0042001872288004e-12
mutation O 0 9.10348966348673e-12
in O 0 9.092062497849385e-14
the O 0 2.2187673993554445e-14
homeodomain O 0 8.80149148008158e-11
is O 0 3.6881542470664636e-15
accounted O 0 9.755501858467615e-16
for O 0 1.0739179910259975e-19
by O 0 9.258861559899593e-17
the O 0 8.176588610830579e-14
hypermutable O 0 3.769412870724409e-08
CpG O 0 1.1504175390086857e-08
dinucleotide O 0 1.1075861061637937e-10
in O 0 2.667311250766324e-16
codon O 0 7.919988449789361e-14
240 O 0 2.7548930069684965e-14
. O 0 6.671703798146258e-14

Very O 0 6.569036222099645e-13
nearly O 0 7.134889874011938e-14
all O 0 1.0082699039288927e-15
mutations O 0 1.0061928503932172e-12
appear O 0 2.029585388640953e-09
to O 0 2.3769308299392833e-08
cause O 0 2.010259549933835e-06
loss O 0 7.084864361850407e-10
of O 0 3.7327643489643546e-17
function O 0 1.9582561060319274e-15
of O 0 1.0810875893250585e-17
the O 0 8.314170478387201e-16
mutant O 0 4.5412819013081196e-13
allele O 0 5.2158665976792876e-14
, O 0 2.7993303353209713e-16
and O 0 1.5069440344823905e-15
more O 0 1.3380488064318495e-18
than O 0 2.2243234087408186e-17
80 O 0 5.508091672756777e-16
% O 0 3.5447766359775933e-17
of O 0 7.101074243526825e-17
exonic O 0 2.35992736463686e-08
substitutions O 0 5.311256989770641e-11
result O 0 3.1229567543089587e-12
in O 0 1.010238306854358e-13
nonsense O 0 3.5042031498733195e-08
codons O 0 1.3141526755688915e-10
. O 0 1.5855032564626725e-10

In O 0 5.1451983000766824e-14
a O 0 4.719217066452141e-16
gene O 0 8.082634869288185e-15
with O 0 1.3358730252901758e-15
such O 0 7.924778215965292e-18
extraordinarily O 0 2.0518179169592976e-13
high O 0 8.673154899894835e-15
sequence O 0 1.2468383217098425e-16
conservation O 0 3.911649766490582e-17
throughout O 0 2.6662097026163933e-18
evolution O 0 1.1633255053219988e-16
, O 0 5.045474040702e-16
there O 0 1.6298674674911843e-15
are O 0 6.4008941511950815e-15
presumed O 0 9.960292857158493e-08
undiscovered O 0 1.9675421754072886e-06
missense O 0 3.625261202344632e-10
mutations O 0 4.01421451634576e-10
, O 0 1.919961802390735e-12
these O 0 1.3749076069281482e-14
are O 0 6.026491188948577e-16
hypothesized O 0 4.966628508202425e-15
to O 0 1.0821095538723902e-12
exist O 0 2.670905814225466e-12
in O 0 2.1582692569439323e-14
as O 0 9.772326003965048e-11
- O 0 0.0004312891105655581
yet O 0 2.972549673074809e-08
unidentified O 0 5.979605361972062e-07
phenotypes O 0 2.0309502343773822e-11
. O 0 3.035588883666847e-14
. O 0 1.2434827473262189e-12

Genetic O 0 6.790924489408212e-10
heterogeneity O 0 1.8754062747206035e-09
and O 0 6.151950615596036e-10
penetrance O 0 3.4165954510001484e-09
analysis O 0 3.7514702986869014e-14
of O 0 9.258327366660007e-18
the O 0 2.324191703421204e-15
BRCA1 O 0 9.81319914217238e-10
and O 0 1.650253544926983e-11
BRCA2 O 0 2.2516070952161016e-10
genes O 0 1.333763377520114e-10
in O 0 3.6072637932260676e-11
breast B-Disease 0 0.0008762768120504916
cancer I-Disease 0 5.69094336242415e-05
families O 0 5.091702615089844e-09
. O 0 7.66810434593701e-11

The O 0 5.818171189275745e-07
Breast B-Disease 1 0.9999852180480957
Cancer I-Disease 1 0.9999690055847168
Linkage O 0 3.741222099051811e-05
Consortium O 0 9.01904151362487e-09
. O 0 5.4408821198448365e-11

The O 0 1.096096103251731e-15
contribution O 0 2.8806534391912647e-16
of O 0 3.821050990103364e-17
BRCA1 O 0 2.2009354339047604e-09
and O 0 3.8854413020317224e-08
BRCA2 O 0 0.31728991866111755
to O 1 0.9317114353179932
inherited B-Disease 1 1.0
breast I-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999998807907104
was O 0 7.38197902805382e-09
assessed O 0 2.4446787096846917e-14
by O 0 1.7520100949412873e-16
linkage O 0 3.4131283910276977e-10
and O 0 2.0070937967187064e-11
mutation O 0 1.5346389413631724e-15
analysis O 0 1.2177469751363935e-15
in O 0 5.906049059549426e-17
237 O 0 1.0475438570777592e-14
families O 0 1.0903090089846648e-13
, O 0 1.1588343778169788e-16
each O 0 6.15304386696878e-17
with O 0 2.7134411796463087e-13
at O 0 3.960504493805139e-11
least O 0 1.484815298735372e-15
four O 0 2.1211761595243614e-14
cases O 0 1.5556362621682585e-12
of O 0 9.410140852303406e-13
breast B-Disease 0 4.389879904920235e-05
cancer I-Disease 0 1.5284571830420646e-08
, O 0 3.789237464925897e-15
collected O 0 1.4835704144127923e-14
by O 0 1.8955605314563417e-12
the O 0 4.4821067035627493e-07
Breast B-Disease 1 0.9999998807907104
Cancer I-Disease 1 0.9999985694885254
Linkage O 0 6.6307866291026585e-06
Consortium O 0 3.2679184358563873e-10
. O 0 7.832953903552653e-12

Families O 0 1.3439479529253617e-09
were O 0 3.354412559351816e-13
included O 0 3.131167469983113e-17
without O 0 1.0425949049560259e-17
regard O 0 3.99781642643768e-18
to O 0 5.805596245960987e-17
the O 0 2.6239071120270864e-15
occurrence O 0 5.3556506451890584e-11
of O 0 5.564087385279137e-12
ovarian B-Disease 0 0.0009665991528891027
or I-Disease 0 2.8972731769272286e-08
other I-Disease 0 4.6318385238386384e-10
cancers I-Disease 0 6.830904021626338e-05
. O 0 1.4126470826436588e-10

Overall O 0 3.2523566915187985e-06
, O 0 2.99494971045533e-08
disease O 0 1.2287286743628556e-08
was O 0 1.0501221420211593e-11
linked O 0 4.188348279310361e-11
to O 0 4.5952909581920345e-15
BRCA1 O 0 2.4114475065221963e-13
in O 0 1.0019272318843463e-17
an O 0 6.898285539685469e-18
estimated O 0 1.8268391560236595e-14
52 O 0 3.436141887518118e-13
% O 0 3.5392387610382243e-16
of O 0 2.776220298669669e-17
families O 0 4.293860392571257e-14
, O 0 3.711138787183952e-18
to O 0 2.0138376404071461e-16
BRCA2 O 0 8.850979844876594e-12
in O 0 2.1470399717555926e-14
32 O 0 9.666108245851707e-14
% O 0 1.9681703884515226e-16
of O 0 2.083540742642866e-17
families O 0 1.4991170197570236e-12
, O 0 2.269789106559665e-15
and O 0 3.3556154816621886e-13
to O 0 2.1434595634875486e-14
neither O 0 9.718031026705216e-15
gene O 0 2.2614833132371262e-15
in O 0 3.9793658683983865e-15
16 O 0 1.9334291383611008e-13
% O 0 1.113896103591586e-16
( O 0 2.1907574121001518e-17
95 O 0 6.440312259187175e-12
% O 0 2.5041355707772217e-12
confidence O 0 3.2458242760213807e-09
interval O 0 1.594290498230233e-11
[ O 0 2.0996061605906696e-13
CI O 0 8.094132586400349e-10
] O 0 1.539931550331719e-11
6 O 0 4.714152245649528e-12
% O 0 8.956739158943322e-14
- O 0 1.1621197870681499e-07
28 O 0 1.0421482343758726e-08
% O 0 8.83440930544814e-14
) O 0 5.616603051926275e-15
, O 0 2.5669097885503117e-16
suggesting O 0 1.9745042731909856e-14
other O 0 2.214892027745387e-16
predisposition O 0 2.299287496509983e-12
genes O 0 2.360140034796121e-11
. O 0 3.2625124823937313e-10

The O 0 1.2917831734848839e-11
majority O 0 3.0723706998664335e-12
( O 0 2.2266687767973168e-15
81 O 0 3.5385641899282616e-12
% O 0 1.558615691242863e-15
) O 0 5.355452629892407e-16
of O 0 3.2961786863566626e-16
the O 0 8.482829372269407e-08
breast B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.350506869840956e-09
were O 0 7.275863261489365e-14
due O 0 2.7519688520347167e-17
to O 0 1.5352470845495214e-16
BRCA1 O 0 1.41861284004563e-12
, O 0 2.918416444380907e-15
with O 0 1.3999723494527634e-15
most O 0 2.3772499742921553e-14
others O 0 1.3020313993639121e-11
( O 0 2.6638540328525464e-16
14 O 0 1.106706523298917e-12
% O 0 1.3964893499736537e-15
) O 0 7.263048330623766e-15
due O 0 6.133341854145866e-15
to O 0 1.115607823135023e-12
BRCA2 O 0 1.6162512395112572e-07
. O 0 3.6998740182703216e-10

Conversely O 0 9.857201860308251e-11
, O 0 1.9880025902384302e-14
the O 0 7.219482038014688e-16
majority O 0 1.7663315691947854e-15
of O 0 1.7148688913442683e-16
families O 0 3.9070535001739515e-11
with O 0 2.0932595934386455e-10
male B-Disease 0 7.742782145214733e-06
and I-Disease 0 1.2556255342133227e-06
female I-Disease 0 1.1151578291901387e-06
breast I-Disease 0 7.480545605176303e-07
cancer I-Disease 0 9.720266369583896e-09
were O 0 1.6267889813015302e-12
due O 0 7.254851592793186e-15
to O 0 2.6858571790244756e-13
BRCA2 O 0 6.321057899327798e-09
( O 0 1.0953573931129362e-13
76 O 0 2.1856733090075409e-10
% O 0 1.0664505303153993e-13
) O 0 5.417132671256542e-13
. O 0 7.360063947192685e-12

The O 0 1.8094939880242827e-13
largest O 0 5.649116835123105e-14
proportion O 0 2.597964161507593e-13
( O 0 8.275977233399912e-16
67 O 0 2.080314913388559e-11
% O 0 1.2609643960503208e-14
) O 0 1.843539088205136e-14
of O 0 2.0949955993225045e-15
families O 0 3.237268309322361e-12
due O 0 1.4614545006270128e-16
to O 0 3.130273519351515e-16
other O 0 1.7734934312871675e-17
genes O 0 2.3475016266131686e-15
was O 0 4.4395841169997396e-11
found O 0 2.807420745529199e-12
in O 0 2.1937774816038075e-16
families O 0 5.595431886926128e-15
with O 0 1.1259518970600769e-16
four O 0 5.738008707772708e-15
or O 0 8.328748931848984e-14
five O 0 1.1587603841950803e-14
cases O 0 1.6502897410165113e-13
of O 0 4.0122565643160857e-13
female O 0 3.598690454964526e-06
breast B-Disease 0 5.576796411332907e-06
cancer I-Disease 0 7.107880861667581e-08
only O 0 2.4373808093364202e-12
. O 0 1.245525349524712e-10

These O 0 4.598715071940651e-13
estimates O 0 1.7753322683472517e-12
were O 0 5.795893821304576e-13
not O 0 1.14072586690191e-14
substantially O 0 5.4252260371862385e-14
affected O 0 7.695039554176652e-17
either O 0 5.365672065857418e-18
by O 0 3.205347703827889e-17
changing O 0 1.4417761147293706e-14
the O 0 1.0688721996291817e-16
assumed O 0 8.073947868787734e-14
penetrance O 0 4.938716739711323e-14
model O 0 3.9002386445042907e-16
for O 0 1.504999031354945e-19
BRCA1 O 0 1.3910304386220013e-13
or O 0 1.1328772934939696e-13
by O 0 6.359196466207206e-17
including O 0 1.7687781709233702e-16
or O 0 2.603624509999597e-13
excluding O 0 2.9960243558654247e-15
BRCA1 O 0 2.4413450861598962e-12
mutation O 0 1.3100164128389963e-13
data O 0 6.390528661803785e-10
. O 0 3.9264941298355893e-10

Among O 0 1.1869470250419623e-12
those O 0 1.2353458100217152e-12
families O 0 3.6559023169902005e-11
with O 0 2.602420536013117e-11
disease O 0 8.641603543857457e-10
due O 0 1.1815968159695298e-14
to O 0 2.4509443818021212e-14
BRCA1 O 0 1.638629683331505e-11
that O 0 7.513416971915987e-13
were O 0 3.1510766760646514e-13
tested O 0 4.277566782094578e-15
by O 0 5.782427268555137e-19
one O 0 1.713443361363819e-16
of O 0 3.1244232493140576e-19
the O 0 2.0532660976595478e-17
standard O 0 4.0023328325822194e-18
screening O 0 3.123934437270827e-19
methods O 0 2.0172119417363214e-17
, O 0 1.8942850910240317e-19
mutations O 0 8.800951495428917e-19
were O 0 6.525344890486893e-16
detected O 0 3.5124769033004904e-14
in O 0 7.324050703807844e-18
the O 0 1.5041003595900006e-16
coding O 0 3.0696559183418515e-10
sequence O 0 3.690981981857577e-12
or O 0 4.530629479438178e-14
splice O 0 3.2130947208441896e-11
sites O 0 2.0971579507700344e-12
in O 0 1.9070850192735026e-16
an O 0 2.150819643200989e-17
estimated O 0 3.2094823760459024e-14
63 O 0 3.68653545190778e-12
% O 0 3.2469722660496145e-15
( O 0 1.9436014037230235e-16
95 O 0 1.5879348617270361e-12
% O 0 4.864792447459472e-14
CI O 0 1.2914011904285871e-07
51 O 0 4.1968126751612544e-09
% O 0 1.181869099114996e-11
- O 0 7.5795105658471584e-06
77 O 0 9.647072829466197e-08
% O 0 1.971262779745797e-12
) O 0 7.087746188572108e-13
. O 0 5.710285976706642e-12

The O 0 3.5393118557464076e-13
estimated O 0 3.0659750048034687e-14
sensitivity O 0 1.2025652012821048e-13
was O 0 2.1390417106852133e-13
identical O 0 1.827098639273095e-16
for O 0 3.5993403223084695e-22
direct O 0 1.2052245283715657e-20
sequencing O 0 5.060280282499123e-15
and O 0 6.114585834188224e-14
other O 0 1.8278297676729183e-17
techniques O 0 2.012851040358865e-12
. O 0 2.774759588763942e-13

The O 0 3.1025744039875347e-12
penetrance O 0 2.2834013790884455e-08
of O 0 2.6108871568366037e-15
BRCA2 O 0 1.3896270245616904e-10
was O 0 1.461263055002604e-11
estimated O 0 2.8995267890939686e-17
by O 0 1.05599128109196e-18
maximizing O 0 2.467510313371342e-15
the O 0 5.141404337861977e-13
LOD O 0 2.6645855541573837e-05
score O 0 1.950224703950454e-10
in O 0 2.651100893040449e-16
BRCA2 O 0 3.2612557099298556e-10
- O 0 1.3248652841468811e-08
mutation O 0 1.8922931277476351e-10
families O 0 3.360251521478119e-10
, O 0 7.13820837969269e-15
over O 0 1.0981814687217178e-13
all O 0 1.3403804052398711e-15
possible O 0 3.6662665768962335e-14
penetrance O 0 9.118177740630173e-11
functions O 0 1.4509578163523357e-13
. O 0 5.4651162068042325e-11

The O 0 6.540082603083419e-13
estimated O 0 2.1261970049174517e-12
cumulative O 0 1.6997642182658979e-10
risk O 0 9.083621632655081e-10
of O 0 1.0558207411658083e-13
breast B-Disease 0 3.585654485505074e-05
cancer I-Disease 0 1.3545716228691163e-06
reached O 0 2.2152886192117194e-09
28 O 0 2.0326592839459146e-11
% O 0 2.322897648836036e-15
( O 0 8.678635057479782e-18
95 O 0 1.7037662852271464e-14
% O 0 4.2376110733022905e-16
CI O 0 5.775729894352821e-10
9 O 0 2.9344308233314464e-11
% O 0 9.549391002071621e-15
- O 0 2.049173192242293e-10
44 O 0 1.01820149533971e-11
% O 0 1.4521739312008618e-16
) O 0 6.502477548627314e-18
by O 0 2.395279142042868e-17
age O 0 3.807024140378701e-14
50 O 0 1.6882556124499057e-17
years O 0 4.121958359354491e-15
and O 0 5.8023696592368786e-15
84 O 0 2.114925437538451e-15
% O 0 1.1172610660516456e-18
( O 0 1.1913972835480756e-19
95 O 0 1.2724836206165057e-15
% O 0 1.1783771484458097e-16
CI O 0 2.5814309023708404e-10
43 O 0 2.459357370532267e-12
% O 0 7.037331837872387e-15
- O 0 1.0561290730848327e-09
95 O 0 1.8125537182278606e-10
% O 0 1.357703554617784e-13
) O 0 1.431784514083559e-14
by O 0 9.746306002924102e-14
age O 0 1.1191126497722692e-10
70 O 0 3.9582330739907495e-14
years O 0 2.381835234686186e-13
. O 0 1.16589965221299e-13

The O 0 1.4767520895020425e-07
corresponding O 0 0.3873808681964874
ovarian B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999991655349731
risks O 0 4.9710317398421466e-05
were O 0 4.5434090517604275e-11
0 O 0 2.4266225422293897e-13
. O 0 1.1036858276261552e-12

4 O 0 1.3995947734102288e-09
% O 0 1.6247362613283634e-12
( O 0 1.4528448871742056e-15
95 O 0 1.6523841485632101e-13
% O 0 3.3748744528432507e-15
CI O 0 5.192243301976873e-10
0 O 0 6.594480143158263e-14
% O 0 1.8521874640031917e-15
- O 0 1.9168487977450077e-11
1 O 0 5.086469982186481e-13
% O 0 9.14698386003947e-16
) O 0 2.1226179128327287e-17
by O 0 8.21335489646932e-17
age O 0 1.225497347779594e-14
50 O 0 2.165034824745774e-18
years O 0 3.1081654300325857e-16
and O 0 8.989354840203707e-15
27 O 0 5.677760948300404e-15
% O 0 2.054580415274591e-19
( O 0 2.6584579992257028e-20
95 O 0 1.1078109659589519e-16
% O 0 1.6353837166206188e-17
CI O 0 3.1967546665345736e-11
0 O 0 2.4752845511678313e-14
% O 0 7.209055062433987e-15
- O 0 1.6588556306373903e-08
47 O 0 1.2880822630734201e-08
% O 0 2.2523424640132073e-13
) O 0 8.450872278711625e-15
by O 0 1.668618991894008e-13
age O 0 4.0796541145304843e-10
70 O 0 2.748942295582174e-13
years O 0 3.84270913700302e-12
. O 0 2.799665610019736e-13

The O 0 3.216663393978969e-11
lifetime O 0 7.567151527609894e-08
risk O 0 3.844007068209976e-08
of O 0 1.1622300344349412e-12
breast B-Disease 0 2.5840212401817553e-05
cancer I-Disease 0 1.373987004171795e-07
appears O 0 2.1950817552518487e-10
similar O 0 5.809368268963567e-15
to O 0 1.8500813674018207e-13
the O 0 2.167511233431424e-13
risk O 0 1.868640875715699e-12
in O 0 1.79532984140571e-17
BRCA1 O 0 1.352447234065357e-12
carriers O 0 3.363803647519342e-14
, O 0 2.4041793539710324e-15
but O 0 3.8561855938241615e-14
there O 0 1.1767691093350066e-16
was O 0 9.279701979709662e-14
some O 0 8.530793273393333e-19
suggestion O 0 8.224211344224058e-15
of O 0 9.133276352323833e-17
a O 0 4.0489365332740945e-12
lower O 0 4.3008119288145963e-10
risk O 0 2.78787097574007e-11
in O 0 2.917624309756547e-16
BRCA2 O 0 8.010211244302567e-11
carriers O 0 4.617776972436205e-14
< O 0 9.813478426146799e-14
50 O 0 4.423989725444756e-14
years O 0 3.172851564814394e-11
of O 0 6.179598662208602e-14
age O 0 5.093217847473852e-09
. O 0 4.171351111748045e-11

Eye B-Disease 0 0.010082016699016094
movement I-Disease 0 5.416505644006975e-08
abnormalities I-Disease 0 2.426759920126642e-06
correlate O 0 2.576669433373979e-10
with O 0 3.1401947014897402e-12
genotype O 0 2.0543841401376994e-06
in O 0 4.0106230836389756e-11
autosomal O 1 0.993125319480896
dominant O 1 0.9920902252197266
cerebellar B-Disease 1 0.9975292086601257
ataxia I-Disease 1 0.9995461106300354
type I-Disease 0 0.004251569975167513
I I-Disease 1 0.9472748041152954
. O 0 1.3973469492611912e-08

We O 0 1.073432631670812e-08
compared O 0 4.340020010040746e-10
horizontal O 0 8.804772369330749e-05
eye O 0 0.02182144671678543
movements O 0 4.2304113776481245e-06
( O 0 1.4092601868451182e-12
visually O 0 1.3277965393854174e-09
guided O 0 6.924731343893598e-10
saccades O 0 1.0009599549221093e-07
, O 0 2.2672730121305051e-13
antisaccades O 0 6.075444591857604e-10
, O 0 6.859066977859141e-15
and O 0 1.4740544397075228e-13
smooth O 0 4.001385334184704e-11
pursuit O 0 4.1729784072686016e-09
) O 0 3.964391003517288e-14
in O 0 1.248513726409732e-16
control O 0 4.417164550796215e-12
subjects O 0 4.800506346602784e-12
( O 0 2.4336862959365627e-17
n O 0 2.3599689910613897e-11
= O 0 5.2586383164632267e-11
14 O 0 2.6978033251367356e-14
) O 0 1.2035689141487774e-15
and O 0 6.338329926018627e-14
patients O 0 3.555324429558563e-18
with O 0 2.208149132633263e-18
three O 0 1.5632840074525367e-15
forms O 0 1.1309989809927742e-13
of O 0 6.059025893859205e-13
autosomal O 0 0.0037501438055187464
dominant O 0 0.006649573799222708
cerebellar B-Disease 0 0.0032113513443619013
ataxias I-Disease 0 0.0029831845313310623
type I-Disease 0 8.218184461838973e-07
I I-Disease 0 1.218932811752893e-05
spinocerebellar B-Disease 0 1.2534429515653756e-05
ataxias I-Disease 0 1.1322195803131763e-07
1 I-Disease 0 2.9256591181810176e-13
and I-Disease 0 1.7094970187689351e-12
2 I-Disease 0 3.8923522066060257e-13
( O 0 2.310920550022301e-16
SCA1 B-Disease 0 1.460863963131942e-08
, O 0 3.870584137487948e-14
n O 0 3.122297212443392e-11
= O 0 5.859457363754927e-11
11 O 0 5.543576123319405e-13
; O 0 1.8751145283029975e-15
SCA2 B-Disease 0 9.12449782397573e-10
, O 0 1.553218376127135e-14
n O 0 6.670785451801109e-11
= O 0 4.095457029062999e-10
10 O 0 3.103999262482615e-13
) O 0 6.624751745440416e-13
and O 0 6.94455124516935e-08
SCA3 B-Disease 1 0.999998927116394
/ O 0 6.557668257300975e-06
Machado B-Disease 0 1.9696337403729558e-05
- I-Disease 0 2.1871783246751875e-06
Joseph I-Disease 0 6.519771886814851e-07
disease I-Disease 0 0.0008320076740346849
( O 0 2.604086380125076e-13
MJD B-Disease 1 0.9999971389770508
) O 0 1.7981445325776502e-12
( O 0 4.348873350786675e-16
n O 0 6.311127731528643e-10
= O 0 5.801690239337631e-09
16 O 0 9.015790501318288e-13
) O 0 2.6751311669320765e-13
. O 0 9.241553919694945e-13

In O 0 7.979614148265202e-13
SCA1 B-Disease 0 5.816116033230401e-09
, O 0 9.508927391148336e-16
saccade O 0 1.4195160888755276e-13
amplitude O 0 2.914251413972668e-14
was O 0 1.4679723365704223e-12
significantly O 0 3.6689320201746534e-14
increased O 0 1.3769539114737725e-15
, O 0 9.493781595018482e-15
resulting O 0 3.0932900555238896e-13
in O 0 1.4363887141342901e-13
hypermetria B-Disease 0 7.4178838076477405e-06
. O 0 3.791348485160384e-11

The O 0 9.01450030073303e-13
smooth O 0 1.112099232147834e-10
pursuit O 0 1.853939113338754e-09
gain O 0 1.8041092925136226e-11
was O 0 3.0841104670109587e-10
decreased O 0 9.284815277732505e-11
. O 0 4.857658112561447e-12

In O 0 6.402829655360875e-13
SCA2 B-Disease 0 3.1562441549226605e-09
, O 0 5.8754266744540356e-15
saccade O 0 1.2457194997761434e-11
velocity O 0 4.0112427268645945e-11
was O 0 3.1263927557922955e-10
markedly O 0 1.146342909486009e-09
decreased O 0 3.656250996408872e-11
. O 0 8.352621545804073e-12

The O 0 6.442889299330956e-13
percentage O 0 3.016719166137882e-11
of O 0 1.024288461631774e-15
errors O 0 3.9449026267845966e-09
in O 0 2.0113637589237038e-14
antisaccades O 0 9.515742638299685e-10
was O 0 3.441909300974655e-12
greatly O 0 5.8184175454555585e-15
increased O 0 1.2384479309716966e-16
and O 0 3.870148762553059e-14
was O 0 6.019125085507393e-13
significantly O 0 7.206302734751003e-16
correlated O 0 4.720157844770832e-14
with O 0 1.0202655777516445e-12
age O 0 7.433744730889202e-10
at O 0 1.609210098507674e-09
disease O 0 3.2254030557510305e-09
onset O 0 9.815364493404033e-11
. O 0 6.629524013090915e-11

In O 0 2.1903596083704298e-14
addition O 0 6.507397321125759e-16
, O 0 1.1351812474626985e-16
a O 0 1.7049655500426354e-18
correlation O 0 1.2047724420877074e-15
between O 0 4.823547702752229e-14
smooth O 0 2.977971758078013e-10
pursuit O 0 4.351460525242601e-09
gain O 0 9.4027487618914e-13
and O 0 3.6145999388059735e-14
the O 0 2.1165790311399485e-16
number O 0 1.5091877188805488e-15
of O 0 4.687480330105298e-15
trinucleotide O 0 1.8114597821750067e-08
repeats O 0 2.6668898200910007e-08
was O 0 6.188398682382967e-10
found O 0 1.6297752036820157e-10
. O 0 3.147223801014398e-11

In O 0 3.854548236148503e-09
SCA3 B-Disease 1 0.9999409914016724
, O 0 6.835761734436119e-09
gaze B-Disease 0 0.0006119375466369092
- I-Disease 0 9.84117723419331e-05
evoked I-Disease 0 3.0348923019118956e-07
nystagmus I-Disease 0 1.3882562654998765e-08
was O 0 1.1250886888802825e-09
often O 0 2.647497293010309e-13
present O 0 4.944182598321329e-18
as O 0 3.2707379856114306e-17
was O 0 1.478695096056304e-13
saccade O 0 2.987915470598068e-11
hypometria O 0 3.6506244693867984e-09
and O 0 2.609650234623728e-13
smooth O 0 5.548169996344443e-12
pursuit O 0 3.6512490253493013e-10
gain O 0 5.501358917026078e-13
was O 0 4.452312477032372e-11
markedly O 0 7.441685462294956e-11
decreased O 0 1.3732324305459898e-11
. O 0 8.166820084781756e-13

Three O 0 1.800753014584433e-12
major O 0 2.1393097796723604e-14
criteria O 0 4.8982929393365585e-14
, O 0 7.533145749921244e-17
saccade O 0 4.666236472737617e-13
amplitude O 0 1.703090522341827e-14
, O 0 9.464338518013686e-17
saccade O 0 1.3050915599957524e-12
velocity O 0 2.18470935786641e-11
, O 0 1.2054724894076246e-13
and O 0 5.410245819056914e-13
presence O 0 9.793494140653003e-13
of O 0 9.21588977007004e-13
gaze B-Disease 0 0.0331544391810894
- I-Disease 0 3.338004262332106e-06
evoked I-Disease 0 2.367915641343643e-09
nystagmus I-Disease 0 2.4178779638173165e-12
, O 0 1.3236266229387731e-17
permitted O 0 1.2829755348383752e-18
the O 0 4.6767745450273305e-18
correct O 0 1.5430709010902377e-12
assignment O 0 9.347936921061395e-14
of O 0 8.057040260009459e-18
90 O 0 5.354656418921988e-16
% O 0 3.872245032778149e-18
of O 0 1.1662162254913421e-19
the O 0 3.7495798058519245e-15
SCA1 B-Disease 0 4.858480728842096e-09
, O 0 1.0491514409083531e-14
90 O 0 2.051630794675755e-16
% O 0 4.4042627873538795e-18
of O 0 3.344468026407824e-19
the O 0 9.916130010211369e-15
SCA2 B-Disease 0 1.5168520661745788e-08
, O 0 4.0128109643207226e-15
and O 0 5.693317995866809e-13
93 O 0 1.3728329183084614e-13
% O 0 2.455816520608684e-17
of O 0 1.4358344795326885e-18
the O 0 4.964587768663264e-13
patients O 0 1.1029050936417484e-12
with O 0 1.9408799220577144e-11
SCA3 B-Disease 1 0.9999998807907104
to O 0 2.2630078366780992e-10
their O 0 9.636015943503828e-13
genetically O 0 3.638128904718098e-15
confirmed O 0 1.1205852868886867e-12
patient O 0 1.265036794935448e-12
group O 0 6.805046977309548e-13
and O 0 1.3070974858031548e-11
, O 0 2.5357586378436416e-14
therefore O 0 1.7317720743753942e-14
, O 0 4.98635522791762e-14
may O 0 8.760683151143311e-13
help O 0 1.1238767891590812e-13
orient O 0 4.3327393756120713e-11
diagnoses O 0 1.0340570066880161e-10
of O 0 1.7640681383410443e-16
SCA1 B-Disease 0 9.241996501430094e-09
, O 0 4.613223492718355e-15
SCA2 B-Disease 0 2.1602724054048394e-09
, O 0 1.3876146596775857e-13
and O 0 7.932084433726061e-10
SCA3 B-Disease 1 0.9999991655349731
at O 0 2.109555412299624e-11
early O 0 2.114660273874313e-14
clinical O 0 4.65933274764168e-14
stages O 0 4.317695560893814e-13
of O 0 8.215238618334674e-16
the O 0 1.1489772674955212e-11
diseases O 0 1.2475189770100314e-08
. O 0 2.2553172437239644e-13
. O 0 5.265161917566985e-11

Genetic O 0 2.3271053053303126e-12
basis O 0 1.5098253864590655e-13
and O 0 1.0672405884384895e-12
molecular O 0 5.28264515464727e-11
mechanism O 0 3.5163159850526426e-07
for O 0 1.673807855695486e-05
idiopathic B-Disease 1 0.9999997615814209
ventricular I-Disease 1 0.9999803304672241
fibrillation I-Disease 1 0.9999957084655762
. O 0 0.0023989335168153048

Ventricular B-Disease 1 0.9729401469230652
fibrillation I-Disease 0 0.0011514301877468824
causes O 0 2.4561357392371974e-09
more O 0 4.620706075895281e-16
than O 0 8.776152041638149e-17
300 O 0 2.5148507465653683e-17
, O 0 3.891364320020577e-17
000 O 0 3.287302469283707e-15
sudden O 0 7.798558348572071e-13
deaths O 0 1.3251917792278523e-11
each O 0 1.5822908973933312e-15
year O 0 1.3601607633164509e-13
in O 0 5.140222828544511e-15
the O 0 3.4935320695345107e-12
USA O 0 8.303568392875604e-07
alone O 0 2.0902124475696837e-09
. O 0 6.08568439240155e-14

In O 0 1.971365846714819e-14
approximately O 0 3.1840485177386975e-15
5 O 0 8.958959740517844e-14
- O 0 1.0523272031548458e-08
12 O 0 1.0998811583728951e-10
% O 0 4.46537240946746e-16
of O 0 4.577765174532493e-20
these O 0 4.170158679882491e-18
cases O 0 9.584739453818332e-18
, O 0 7.111995509154363e-18
there O 0 1.6054541713888576e-17
are O 0 6.384914504068215e-17
no O 0 9.166553963362717e-14
demonstrable O 0 3.861642117186648e-09
cardiac O 0 6.900740572746145e-06
or O 0 3.6756434838025598e-06
non O 0 5.348117610992631e-06
- O 1 0.99996018409729
cardiac O 1 0.9384303092956543
causes O 0 1.7357012893626234e-06
to O 0 2.1998995507199748e-12
account O 0 8.311732717565003e-15
for O 0 1.649059162815713e-17
the O 0 1.2545543048153845e-14
episode O 0 4.343284842889261e-09
, O 0 7.302361840211269e-14
which O 0 7.753329635219394e-15
is O 0 3.5845388771507723e-16
therefore O 0 8.553490320271483e-15
classified O 0 2.626926516313688e-07
as O 0 0.07367273420095444
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999984502792358
fibrillation I-Disease 1 0.9999997615814209
( O 0 1.3409267921815626e-05
IVF B-Disease 1 0.9999940395355225
) O 0 6.890192594255495e-08
. O 0 2.4652116459300544e-10

A O 0 2.270710529328479e-12
distinct O 0 1.144758794051695e-13
group O 0 4.6729547314994235e-12
of O 0 8.967182736369789e-14
IVF B-Disease 1 0.999998927116394
patients O 0 1.7516169070752596e-11
has O 0 5.1650107395261394e-14
been O 0 6.590569561447379e-14
found O 0 1.0223455247518679e-13
to O 0 3.86680450707071e-15
present O 0 4.212675018905165e-17
with O 0 7.443280848173483e-17
a O 0 8.2710895356569e-15
characteristic O 0 7.462436918403981e-11
electrocardiographic O 0 2.0034792669321178e-07
pattern O 0 7.922309208652223e-08
. O 0 1.067824023648356e-10

Because O 0 4.45297227910646e-12
of O 0 4.0406406420843464e-17
the O 0 1.7283320829941814e-16
small O 0 3.2238783362591996e-16
size O 0 6.574928318806017e-13
of O 0 3.211418216907293e-17
most O 0 9.850410841416276e-16
pedigrees O 0 4.493364708091363e-11
and O 0 4.188793409354297e-12
the O 0 1.2801189958316223e-13
high O 0 1.6597308249988174e-10
incidence O 0 7.901978626989603e-09
of O 0 1.011379107768379e-14
sudden B-Disease 0 1.1357825097091379e-10
death I-Disease 0 4.828848432225641e-11
, O 0 6.327814689604822e-16
however O 0 2.917335259763296e-16
, O 0 3.979709442828894e-18
molecular O 0 3.8776596578062473e-16
genetic O 0 1.126106911712721e-12
studies O 0 1.0884773984920493e-11
of O 0 6.743386502406495e-14
IVF B-Disease 1 0.9999992847442627
have O 0 1.9020487962428945e-10
not O 0 7.370953551840385e-15
yet O 0 4.468746247575492e-16
been O 0 4.501747350002701e-14
done O 0 1.1194793356206212e-11
. O 0 1.6675690776152274e-13

Because O 0 8.875269408292752e-09
IVF B-Disease 1 0.9998669624328613
causes O 0 0.00012167744716862217
cardiac O 0 0.0003151738492306322
rhythm O 0 0.01531032845377922
disturbance O 0 2.1822560825057735e-07
, O 0 9.184199624770462e-13
we O 0 1.618388074649344e-14
investigated O 0 2.648910211728965e-14
whether O 0 3.355447498088089e-14
malfunction O 0 1.591053955252164e-09
of O 0 1.1682696755126109e-18
ion O 0 2.66908925516951e-11
channels O 0 1.7185655451612547e-05
could O 0 9.004077583085746e-05
cause O 0 8.47359160616179e-09
the O 0 7.985098693374937e-12
disorder O 0 6.396589924406726e-10
by O 0 1.2633699067547965e-17
studying O 0 4.06155156944634e-16
mutations O 0 9.980421843787043e-14
in O 0 2.0153448561274464e-15
the O 0 7.651200331670101e-15
cardiac O 0 1.1554627046828081e-11
sodium O 0 3.5038668472729684e-13
channel O 0 1.0735636379877178e-08
gene O 0 5.708835182360872e-09
SCN5A O 0 1.3086546459817328e-05
. O 0 1.4417177521264257e-11

We O 0 3.387504166063593e-10
have O 0 1.3158912978358805e-13
now O 0 3.247554389442615e-15
identified O 0 8.03431079261438e-15
a O 0 5.412528886251954e-16
missense O 0 6.7859975451389776e-12
mutation O 0 1.4905634235576337e-12
, O 0 5.994397957610059e-14
a O 0 2.757520206709348e-15
splice O 0 8.436955795332324e-06
- O 0 3.059909090552537e-07
donor O 0 9.773928888456851e-11
mutation O 0 8.243418447850814e-11
, O 0 1.343647957653682e-13
and O 0 7.463365185199008e-14
a O 0 1.2676725793552197e-15
frameshift O 0 3.85760217172515e-12
mutation O 0 4.414277476264949e-15
in O 0 1.2842304588174856e-16
the O 0 4.2871886528589136e-15
coding O 0 2.32411181855241e-07
region O 0 2.1964333130064517e-11
of O 0 2.0692144575069253e-15
SCN5A O 0 2.504814631265617e-07
in O 0 4.622524761512155e-15
three O 0 1.3493269002129438e-12
IVF B-Disease 1 0.9999927282333374
families O 0 9.330048539313296e-11
. O 0 1.8144603116006242e-13

We O 0 2.4748480174918708e-12
show O 0 7.483889301730749e-15
that O 0 8.600156762152908e-20
sodium O 0 1.1474839708876487e-18
channels O 0 4.263426414073115e-15
with O 0 6.60541173861729e-16
the O 0 7.913095613301961e-16
missense O 0 1.368640704241253e-11
mutation O 0 7.698710375800277e-13
recover O 0 3.75892705850589e-10
from O 0 2.6015502597194603e-16
inactivation O 0 1.0415605877778233e-11
more O 0 4.051921896714467e-18
rapidly O 0 1.7097422509007912e-15
than O 0 1.1586524808002784e-17
normal O 0 4.960661161089019e-16
and O 0 1.851748572187506e-12
that O 0 1.7844848862469398e-12
the O 0 2.3036201852316696e-12
frameshift O 0 2.1538058447845287e-08
mutation O 0 2.5469668149709357e-13
causes O 0 1.9194003754007677e-13
the O 0 2.7586536294370027e-17
sodium O 0 2.108457959821338e-14
channel O 0 1.0860071064655585e-08
to O 0 1.0921869962252084e-12
be O 0 8.071730675345001e-14
non O 0 5.877670718841196e-14
- O 0 1.3912985208364148e-09
functional O 0 1.7575044197748468e-10
. O 0 7.033467558370532e-11

Our O 0 1.536085214581817e-08
results O 0 1.8827284566438895e-13
indicate O 0 2.1276970257281397e-13
that O 0 1.8197967546935978e-14
mutations O 0 5.521224008043536e-14
in O 0 1.4871337337911254e-15
cardiac O 0 1.3702444560947935e-11
ion O 0 1.2309424590739582e-09
- O 0 6.924179896117266e-09
channel O 0 1.5876767678335568e-09
genes O 0 8.981103621213959e-13
contribute O 0 2.2471723210163504e-16
to O 0 5.60944869401641e-16
the O 0 1.5959181752069952e-15
risk O 0 4.570712433754967e-14
of O 0 1.1359771647840001e-18
developing O 0 4.018172259360369e-15
IVF B-Disease 1 0.9996706247329712
. O 0 5.129699291207823e-13
. O 0 5.72059354097057e-14

Molecular O 0 8.5976330221893e-12
heterogeneity O 0 6.90597162789075e-11
in O 0 7.157547124436725e-13
mucopolysaccharidosis B-Disease 0 6.352691173105995e-08
IVA I-Disease 0 3.5241046134615317e-06
in O 0 4.993879008236002e-12
Australia O 0 5.25272186857606e-12
and O 0 1.4229521207165252e-11
Northern O 0 2.0026723335231367e-12
Ireland O 0 8.213701718773336e-09
: O 0 1.9770367322966866e-14
nine O 0 1.8298328351570522e-16
novel O 0 2.884852935899523e-17
mutations O 0 4.9795806345826786e-17
including O 0 2.8581567569641702e-18
T312S O 0 4.365147024225358e-15
, O 0 4.077661689425586e-18
a O 0 9.584442495978425e-19
common O 0 2.9929501556624836e-16
allele O 0 1.0177816705744802e-12
that O 0 1.4129009648453789e-13
confers O 0 3.0380625792858496e-10
a O 0 5.728113469660734e-11
mild O 0 3.9571734333776476e-08
phenotype O 0 1.0657577931283413e-08
. O 0 1.5147355370004334e-08

Mucopolysaccharidosis B-Disease 0 0.0007052378496155143
IVA I-Disease 0 0.3324962556362152
( O 0 7.439623459504219e-07
MPS B-Disease 1 0.9999852180480957
IVA I-Disease 1 0.9999876022338867
) O 0 3.2032216878974396e-09
is O 0 1.0465988319052766e-11
an O 0 4.39464541146517e-11
autosomal B-Disease 1 0.9999790191650391
recessive I-Disease 1 0.999962568283081
lysosomal I-Disease 1 0.9999744892120361
storage I-Disease 1 0.9998877048492432
disorder I-Disease 1 0.9999455213546753
caused O 0 2.4190915937083446e-08
by O 0 2.2019387181659855e-13
a O 0 5.680527159768189e-10
genetic B-Disease 1 0.9999995231628418
defect I-Disease 1 0.9999994039535522
in O 0 9.0286493559244e-12
N O 0 4.0340363938184964e-08
- O 0 4.5306435936254275e-08
acetylgalactosamine O 0 3.6398894735611975e-05
- O 0 6.211878371686907e-07
6 O 0 2.315062586077943e-09
- O 0 2.5628798994148383e-07
sulfate O 0 1.4636481182606076e-07
sulfatase O 0 1.1322655382173252e-06
( O 0 3.196439085097723e-14
GALNS O 0 2.5744956388962237e-08
) O 0 8.251082109222985e-14
. O 0 2.473789673541199e-13

Previous O 0 2.890027626933911e-11
studies O 0 1.0844442748306204e-12
of O 0 1.6545924386308762e-16
patients O 0 3.877143391224896e-15
from O 0 3.7599051374789545e-16
a O 0 1.7151593188248493e-13
British O 0 3.8099560839555124e-08
- O 0 3.5146680602338165e-05
Irish O 0 9.585972975401091e-07
population O 0 9.195171750756015e-13
showed O 0 2.3104065535739515e-11
that O 0 8.348490400525373e-17
the O 0 1.0163242277277705e-17
I113F O 0 3.267049911514857e-15
mutation O 0 2.3748625047277117e-17
is O 0 9.036478353553897e-18
the O 0 1.5545815297410807e-18
most O 0 1.2318933683414387e-17
common O 0 2.2552116695374186e-15
single O 0 1.6645985805030517e-12
mutation O 0 2.4503418738497373e-10
among O 0 9.582082327597163e-08
MPS B-Disease 1 0.9999995231628418
IVA I-Disease 1 0.9999990463256836
patients O 0 2.3144021099597012e-07
and O 0 2.0269816936036023e-09
produces O 0 8.446027210951002e-10
a O 0 6.217831804988805e-11
severe O 0 6.886093473212895e-08
clinical O 0 8.156460229447049e-11
phenotype O 0 8.400756534854281e-09
. O 0 1.6372442290801814e-09

We O 0 2.624694628305946e-10
studied O 0 5.576653505298679e-13
mutations O 0 1.5197237457180435e-13
in O 0 2.595336690716199e-15
the O 0 4.92613567464246e-15
GALNS O 0 2.2413793043796204e-10
gene O 0 3.668371961989929e-14
from O 0 5.9359823304026664e-15
23 O 0 9.933469621674611e-15
additional O 0 5.113821828018131e-14
MPS B-Disease 1 0.9999959468841553
IVA I-Disease 1 0.9999974966049194
patients O 0 1.085315481930138e-08
( O 0 2.416371334455574e-15
15 O 0 8.957302266446657e-14
from O 0 1.680029271082517e-13
Australia O 0 2.18192841182005e-14
, O 0 7.499885148362732e-17
8 O 0 4.1132232262068124e-16
from O 0 7.621744866808452e-16
Northern O 0 5.352721710967165e-14
Ireland O 0 4.463187111558575e-11
) O 0 2.645374526800536e-15
, O 0 9.845024034472177e-19
with O 0 5.07941577172821e-19
various O 0 8.39524463398034e-17
clinical O 0 7.1231761808454586e-12
phenotypes O 0 7.165671944697749e-10
( O 0 7.009501486188174e-13
severe O 0 1.0903111746785044e-09
, O 0 3.6767640256181455e-14
16 O 0 6.180951035012188e-15
cases O 0 9.78976709404113e-15
; O 0 2.0985299501740415e-16
intermediate O 0 2.1782515264993137e-15
, O 0 3.9704031480856927e-16
4 O 0 2.974951150225627e-14
cases O 0 3.9656125605525006e-12
; O 0 2.1401049335456612e-11
mild O 0 1.582505480823837e-11
, O 0 3.0927104139374245e-14
3 O 0 1.889048406632579e-13
cases O 0 2.3963670674545523e-13
) O 0 2.3645317474840777e-12
. O 0 7.99762773368018e-12

We O 0 4.864608160737305e-10
found O 0 1.6805109821077524e-12
two O 0 5.340790066058962e-14
common O 0 8.2505439044883e-15
mutations O 0 9.431838075585775e-15
that O 0 1.0493921676719628e-13
together O 0 1.0160204925654948e-12
accounted O 0 1.0555947358348219e-14
for O 0 9.66430016667552e-18
32 O 0 2.7829153979625106e-14
% O 0 1.0990557554834456e-16
of O 0 8.167017231170834e-18
the O 0 2.422474655768003e-13
44 O 0 3.975772077009776e-14
unrelated O 0 1.850387349583687e-14
alleles O 0 2.5359619257509826e-14
in O 0 7.91237531765944e-15
these O 0 5.196815634073149e-12
patients O 0 3.4067252057540243e-12
. O 0 4.560337350800747e-12

One O 0 6.775982769671729e-13
is O 0 2.443157904379544e-15
the O 0 2.4387335865982387e-16
T312S O 0 2.9538570482830206e-13
mutation O 0 6.119509467304024e-14
, O 0 6.419747834051541e-15
a O 0 6.764299237654436e-16
novel O 0 3.449629904644924e-13
mutation O 0 9.612885574356023e-13
found O 0 5.47111054377547e-12
exclusively O 0 2.0744723213533822e-13
in O 0 4.708232213796555e-15
milder O 0 6.809205543162333e-12
patients O 0 9.728797628616448e-13
. O 0 2.261741141595941e-12

The O 0 3.679038410725477e-13
other O 0 2.5094401383263243e-14
is O 0 2.7132676056547574e-15
the O 0 9.605168995151044e-17
previously O 0 1.3976259114877737e-13
described O 0 1.9599095566966152e-13
I113F O 0 8.366516436901159e-14
that O 0 3.5370810504842124e-15
produces O 0 1.6902890762407474e-13
a O 0 9.889980544589005e-13
severe O 0 3.1410860579228483e-09
phenotype O 0 1.1306647840214623e-09
. O 0 2.55256482617483e-09

The O 0 3.8014409328712695e-12
I113F O 0 1.2757481182568142e-10
and O 0 4.1011418978713354e-13
T312S O 0 9.256650486269904e-14
mutations O 0 4.413132287720261e-15
accounted O 0 5.2706604814108104e-14
for O 0 1.5899614093879844e-17
8 O 0 1.2027991179008185e-13
( O 0 2.28972037414371e-16
18 O 0 5.937312815874896e-13
% O 0 5.1697339064131037e-17
) O 0 2.8578761938440045e-16
and O 0 5.034369188888776e-13
6 O 0 8.544949687064318e-14
( O 0 2.0200842436953506e-17
14 O 0 3.826519450692706e-14
% O 0 4.8271299242001755e-17
) O 0 1.965649406642257e-16
of O 0 2.9357076277280074e-18
44 O 0 1.888559085228071e-16
unrelated O 0 1.2272604256834802e-15
alleles O 0 1.334193189549181e-14
, O 0 3.4519598551135955e-13
respectively O 0 1.364746250037685e-11
. O 0 1.1764673957248561e-10

The O 0 9.23912205422206e-13
relatively O 0 6.409428109782622e-13
high O 0 7.184989148784071e-12
residual O 0 1.749336613066088e-11
GALNS O 0 4.2773273811747e-09
activity O 0 2.7956209938152787e-13
seen O 0 7.656579905680749e-13
when O 0 4.2102834081437026e-16
the O 0 6.062497699268521e-19
T312S O 0 6.9605160080726705e-16
mutant O 0 4.154285265907333e-16
cDNA O 0 5.900619213074568e-14
is O 0 2.343671978900395e-15
overexpressed O 0 1.87739342301374e-12
in O 0 5.563669739590868e-17
mutant O 0 4.611299203268783e-14
cells O 0 2.1792558958165205e-16
provides O 0 8.459789640575429e-19
an O 0 7.354368217426408e-19
explanation O 0 3.4265699324053647e-15
for O 0 2.5481306975327694e-15
the O 0 2.5878299503290236e-10
mild O 0 8.632382808571037e-09
phenotype O 0 2.183917803544322e-11
in O 0 7.425252598924122e-15
patients O 0 1.3386889863233227e-15
with O 0 6.063313961096988e-17
this O 0 1.2838931544160211e-15
mutation O 0 5.012334731296919e-12
. O 0 1.1668006560938693e-09

The O 0 6.257938283104605e-15
distribution O 0 3.4172627343809344e-15
and O 0 2.3841690476250968e-15
relative O 0 4.95284979677966e-17
frequencies O 0 1.0311413816915349e-15
of O 0 7.50680467962286e-19
the O 0 1.457963136697549e-16
I113F O 0 3.341613755993532e-14
and O 0 3.8743346299718005e-15
T312S O 0 6.471403185427779e-16
mutations O 0 5.978224604636067e-16
in O 0 6.301578373459212e-17
Australia O 0 6.901157262618069e-17
corresponded O 0 9.476584761546411e-17
to O 0 1.962607367221532e-16
those O 0 8.341204593690006e-16
observed O 0 1.6676794629489136e-14
in O 0 2.616370848137128e-15
Northern O 0 4.136464174658849e-12
Ireland O 0 4.013864352003793e-09
and O 0 1.189200040524474e-11
are O 0 3.406194932053522e-18
unique O 0 1.111424040209771e-19
to O 0 1.2142718901213848e-16
these O 0 2.0413572114678463e-16
two O 0 3.882945566913588e-15
populations O 0 1.3982330308230477e-14
, O 0 2.2001731626907287e-15
suggesting O 0 1.44760193957795e-13
that O 0 2.5093910104153835e-15
both O 0 2.0902040133492257e-17
mutations O 0 9.35864336457513e-17
were O 0 5.653188098984083e-15
probably O 0 4.616143215287541e-16
introduced O 0 1.238703099647057e-16
to O 0 4.907625887162585e-14
Australia O 0 1.3652603082347364e-13
by O 0 8.939526433015578e-16
Irish O 0 1.1316410482298256e-11
migrants O 0 1.1702998867300224e-13
during O 0 4.035930305099555e-15
the O 0 2.3524844567440696e-16
19th O 0 7.126485274296102e-14
century O 0 1.1137204873612472e-11
. O 0 1.3621145010522806e-11

Haplotype O 0 4.5506212131840584e-09
analysis O 0 2.1731618241038753e-13
using O 0 1.2517633143135226e-13
6 O 0 2.5274259681656863e-13
RFLPs O 0 2.8048622452425676e-12
provides O 0 1.6736349469688472e-18
additional O 0 2.739857159768381e-19
data O 0 4.751043800049629e-16
that O 0 1.4380943907329232e-16
the O 0 1.0094662717924404e-16
I113F O 0 3.660180814576801e-14
mutation O 0 6.016017097160186e-16
originated O 0 7.220893533717992e-14
from O 0 4.849166346590833e-17
a O 0 1.5903566362846622e-16
common O 0 4.667460282880469e-15
ancestor O 0 3.9853141620138643e-11
. O 0 2.4718092017650406e-09

The O 0 1.4533737711583394e-12
other O 0 2.354032225225511e-13
9 O 0 1.7151504825771435e-12
novel O 0 1.8865531153326037e-13
mutations O 0 1.5008185124364137e-13
identified O 0 2.687781767984898e-11
in O 0 2.553960867660368e-14
these O 0 1.7762321561504146e-13
23 O 0 2.2252685466322107e-14
patients O 0 2.031336414655134e-16
were O 0 1.0101866468443006e-16
each O 0 6.468308371883973e-19
limited O 0 1.1283980190239064e-17
to O 0 7.366235578324179e-14
a O 0 4.0805973509049076e-13
single O 0 8.919524008277335e-10
family O 0 2.6695572614698904e-06
. O 0 5.754024479109887e-10

These O 0 2.584992936122566e-14
data O 0 2.992004125739519e-15
provide O 0 3.8153395561278694e-18
further O 0 4.828414018703588e-19
evidence O 0 2.6014087870192954e-18
for O 0 7.691971095382644e-21
extensive O 0 4.9058187886917325e-18
allelic O 0 3.1451921687734863e-13
heterogeneity O 0 5.794503765699233e-12
in O 0 8.480952051748147e-12
MPS B-Disease 1 0.9999947547912598
IVA I-Disease 1 0.9999964237213135
in O 0 1.5839232148096016e-09
British O 0 2.647301516844891e-05
- O 0 0.394894003868103
Irish O 0 5.711359790439019e-06
patients O 0 1.8827472133414735e-12
and O 0 6.019687132101961e-17
provide O 0 3.3083262274675235e-21
evidence O 0 3.0360676936902646e-19
for O 0 4.778404698352549e-21
their O 0 1.908824613188926e-16
transmission O 0 4.0058407979604027e-13
to O 0 3.889230974898688e-15
Australia O 0 1.9976257739038336e-15
by O 0 6.316693279356271e-17
British O 0 1.769535386275667e-11
- O 0 1.7436619925703667e-09
Irish O 0 3.4812146221252505e-11
migrants O 0 1.3943827917393264e-13
. O 0 1.1151498116151959e-17
. O 0 2.1623463388624665e-16

Identification O 0 4.475920935970157e-12
of O 0 4.530385364542779e-15
constitutional O 0 8.082211115645332e-13
WT1 O 0 3.555923999698507e-09
mutations O 0 5.347239664943437e-11
, O 0 2.5872880227151285e-13
in O 0 7.397964585495378e-16
patients O 0 2.987819952386672e-14
with O 0 6.176737723725956e-13
isolated O 0 3.442348088356084e-06
diffuse B-Disease 0 0.37825968861579895
mesangial I-Disease 1 0.9999911785125732
sclerosis I-Disease 1 0.9999986886978149
, O 0 3.164066231242657e-10
and O 0 3.1350581310672643e-13
analysis O 0 5.865304207217873e-15
of O 0 2.1580612785916458e-16
genotype O 0 5.515922385512795e-09
/ O 0 5.637331157437586e-10
phenotype O 0 5.186390359334606e-15
correlations O 0 1.4829643199873845e-15
by O 0 3.737350486434532e-18
use O 0 7.38353008528298e-16
of O 0 5.667649651311233e-17
a O 0 2.645536098335225e-15
computerized O 0 1.564402773990281e-11
mutation O 0 8.03673967653129e-13
database O 0 4.5410876448048754e-11
. O 0 4.528435681994125e-10

Constitutional O 0 2.348912557514904e-11
mutations O 0 7.2217553118147926e-12
of O 0 1.3083262962356043e-16
the O 0 1.3139029494020898e-16
WT1 O 0 9.37463539955885e-13
gene O 0 1.66678825723346e-15
, O 0 5.25166341639046e-18
encoding O 0 6.003064904605484e-16
a O 0 1.970849265037211e-12
zinc O 0 3.875822585541755e-05
- O 0 7.011330467321386e-07
finger O 0 6.632494205405237e-06
transcription O 0 4.525049085435384e-11
factor O 0 4.2312694689163044e-13
involved O 0 3.1679608209714966e-14
in O 0 7.230292888927084e-14
renal O 0 6.783784556319006e-08
and O 0 5.595085728060667e-09
gonadal O 0 7.356820788118057e-07
development O 0 5.416830246613054e-14
, O 0 6.1764024680854325e-15
are O 0 1.0291171714709441e-16
found O 0 2.4350272774704973e-14
in O 0 4.5382678663848176e-17
most O 0 3.8214465809595117e-16
patients O 0 1.9597030500640746e-14
with O 0 7.10299180584073e-11
Denys B-Disease 1 0.9999841451644897
- I-Disease 1 0.9999972581863403
Drash I-Disease 1 0.9999884366989136
syndrome I-Disease 1 0.9999949932098389
( O 0 1.3827793077236805e-10
DDS B-Disease 1 0.9999954700469971
) O 0 2.940739665668879e-11
, O 0 3.7200919970371837e-13
or O 0 2.8257334250270105e-09
diffuse B-Disease 0 0.18190087378025055
mesangial I-Disease 1 0.9999960660934448
sclerosis I-Disease 1 0.9999982118606567
( O 0 2.1968180163867146e-08
DMS B-Disease 0 0.0009502427419647574
) O 0 1.67076628140167e-12
associated O 0 1.1993359864265196e-12
with O 0 1.4263196179697957e-10
pseudohermaphroditism B-Disease 1 0.999998927116394
and O 0 3.9880276858639263e-07
/ O 0 3.0104936854513653e-07
or O 0 2.811787247480879e-09
Wilms B-Disease 0 2.8775737064279383e-06
tumor I-Disease 0 0.0020645398180931807
( O 0 7.777511079609667e-09
WT B-Disease 1 0.9999858140945435
) O 0 1.1792329612791974e-10
. O 0 1.5245244303074834e-11

Most O 0 2.5949137586953053e-13
mutations O 0 2.0398853717296106e-09
in O 0 2.60316768141422e-09
DDS B-Disease 1 0.999998927116394
patients O 0 5.982148820748989e-08
lie O 0 8.389132055697246e-09
in O 0 2.6253373271585253e-16
exon O 0 3.8503667485270676e-13
8 O 0 3.6441959476093966e-13
or O 0 5.776841949679118e-14
exon O 0 2.1346887744879556e-13
9 O 0 3.7858312405131267e-13
, O 0 1.3516450169960673e-16
encoding O 0 4.070879917883463e-13
zinc O 0 0.0009794840589165688
finger O 0 0.30524954199790955
2 O 0 4.3573719632483687e-10
or O 0 1.3516241459399225e-09
zinc O 0 2.615782079828932e-07
finger O 0 5.684873940481339e-06
3 O 0 2.000969485591031e-12
, O 0 1.7165854512574824e-14
respectively O 0 7.209003901643973e-14
, O 0 1.3041015605924958e-15
with O 0 1.9257138201764223e-14
a O 0 2.4788732264774405e-12
hot O 0 1.1963146789639723e-05
spot O 0 1.1241667380090803e-05
( O 0 3.089701964667014e-15
R394W O 0 9.645867546544118e-14
) O 0 3.6747830908402256e-16
in O 0 3.093602220516875e-17
exon O 0 2.697277644292395e-11
9 O 0 1.0197652722254702e-09
. O 0 4.6879545384515e-11

We O 0 1.7068123173494265e-12
analyzed O 0 5.693925691184487e-13
a O 0 1.0412054248301605e-14
series O 0 2.059068887616533e-11
of O 0 2.1685015420017063e-15
24 O 0 2.015546881955696e-13
patients O 0 2.643053285948145e-16
, O 0 5.744989053351471e-17
10 O 0 1.939965276568918e-15
with O 0 1.4332613871778643e-12
isolated B-Disease 0 1.4712627489643637e-06
DMS I-Disease 0 0.0008179893484339118
( O 0 8.558185318018996e-16
IDMS B-Disease 0 6.449144551723407e-10
) O 0 2.4983876289140765e-15
, O 0 2.287991368140127e-16
10 O 0 1.9347771997669854e-15
with O 0 1.5535251036979947e-12
DDS B-Disease 1 0.9999997615814209
, O 0 7.196259105106406e-13
and O 0 3.4382265372452647e-13
4 O 0 3.298850179567908e-13
with O 0 9.724164182212114e-12
urogenital B-Disease 0 0.0010542686795815825
abnormalities I-Disease 1 0.6843693256378174
and O 0 8.335049983543286e-07
/ O 0 0.0008696039440110326
or O 0 0.0018808855675160885
WT B-Disease 1 0.9999921321868896
. O 0 2.7759032850127596e-09

We O 0 6.014753139993445e-09
report O 0 1.5353740848156328e-11
WT1 O 0 8.653632477262363e-09
heterozygous O 0 4.345981907682983e-11
mutations O 0 3.0810576312489957e-11
in O 0 6.05161049310049e-13
16 O 0 9.72234228888147e-13
patients O 0 4.009400979081666e-14
, O 0 1.001569026283164e-15
4 O 0 9.206644371569442e-14
of O 0 1.5563401372300644e-15
whom O 0 3.398594600190208e-11
presented O 0 1.3490780541303149e-11
with O 0 9.369317127694288e-11
IDMS B-Disease 0 6.115091673564166e-05
. O 0 1.0282019680118992e-10

One O 0 7.86520903961474e-10
male O 0 8.185147493122713e-08
and O 0 5.4920550746073715e-11
two O 0 3.6280471682470505e-11
female O 0 1.632184698507899e-08
IDMS B-Disease 0 3.330088986785995e-07
patients O 0 6.468522278143402e-14
with O 0 4.93981889898229e-14
WT1 O 0 2.3467141545552295e-06
mutations O 0 9.57817150037954e-08
underwent O 0 4.78912092205519e-08
normal O 0 5.808233893844772e-09
puberty O 0 3.142797504551709e-05
. O 0 1.4956436089619274e-09

Two O 0 6.065579150060785e-10
mutations O 0 8.073718360535054e-10
associated O 0 3.253166902528193e-10
with O 0 7.655679042095631e-12
IDMS B-Disease 0 3.7147347597965563e-07
are O 0 1.043225005486299e-14
different O 0 3.0469088013805427e-16
from O 0 4.0268132659717834e-14
those O 0 7.974896784612717e-13
described O 0 1.9171275678075972e-10
in O 0 6.553518578505946e-13
DDS B-Disease 1 0.999997615814209
patients O 0 1.8158469519691245e-11
. O 0 3.938684502245021e-13

No O 0 1.509155994616762e-11
WT1 O 0 4.4832393353289035e-10
mutations O 0 4.71871326734874e-12
were O 0 1.858195238305105e-12
detected O 0 1.2809416027881326e-10
in O 0 5.2718034676698354e-15
the O 0 2.959410467335763e-14
six O 0 2.4339707766635188e-12
other O 0 4.0349958075301673e-13
IDMS B-Disease 0 1.793129627003509e-07
patients O 0 2.1764709785408905e-14
, O 0 1.226740215104968e-16
suggesting O 0 1.472233047820383e-14
genetic O 0 3.2952530678101444e-13
heterogeneity O 0 8.262366485434214e-12
of O 0 6.316747780632471e-15
this O 0 6.389023424896445e-12
disease O 0 4.1860701571749814e-08
. O 0 2.0538845624251678e-10

We O 0 6.81474390806791e-11
analyzed O 0 2.946698163253103e-10
genotype O 0 3.510746751089755e-07
/ O 0 8.190830840248964e-07
phenotype O 0 1.2631160006826292e-11
correlations O 0 1.2006296998268162e-11
, O 0 8.624164885917898e-14
on O 0 9.068132529599371e-13
the O 0 4.442011770177778e-16
basis O 0 2.240504848232479e-16
of O 0 3.1042522949805872e-18
the O 0 6.1867777746563504e-15
constitution O 0 5.984570681356015e-15
of O 0 5.307286452898552e-19
a O 0 7.986605897025018e-16
WT1 O 0 8.235399341638416e-12
mutation O 0 2.5949889307517917e-16
database O 0 1.0934197544241152e-14
of O 0 7.854755054389519e-15
84 O 0 5.5908985774344444e-11
germ O 0 6.901539745740592e-05
- O 0 0.001639378140680492
line O 0 9.110860446526203e-06
mutations O 0 2.77853851038401e-11
, O 0 5.6805125348295595e-15
to O 0 5.734526872963901e-16
compare O 0 2.745167078206591e-15
the O 0 8.175468700925411e-17
distribution O 0 2.3573402344739813e-12
and O 0 1.4074195142654844e-09
type O 0 2.580128818929772e-12
of O 0 2.2997079513830223e-16
mutations O 0 7.668253645997172e-14
, O 0 6.782334157288256e-16
according O 0 2.4913993490188775e-17
to O 0 1.8808383534440684e-15
the O 0 3.158440170644358e-14
different O 0 1.5814984044570934e-10
symptoms O 0 7.974396254439853e-09
. O 0 2.0606618896055334e-13

This O 0 2.600542394273764e-13
demonstrated O 0 3.244140253742117e-13
( O 0 6.994235595609476e-17
1 O 0 6.1500703313376644e-15
) O 0 1.496545129573562e-13
the O 0 4.2584876190675594e-14
association O 0 1.3096595790341417e-16
between O 0 1.2245514786605405e-17
mutations O 0 4.511102659498535e-16
in O 0 1.6778738340178752e-17
exons O 0 2.924417999428108e-11
8 O 0 1.206209069258557e-12
and O 0 4.387708078812391e-12
9 O 0 2.4125619037251855e-12
and O 0 5.6630203998375706e-11
DMS B-Disease 0 2.604421354135411e-07
; O 0 3.822017216468165e-15
( O 0 8.144181256000083e-18
2 O 0 1.2567002627872532e-14
) O 0 1.3585732541667069e-14
among O 0 1.4352397308819986e-15
patients O 0 9.505259473788929e-17
with O 0 7.240829385867864e-16
DMS B-Disease 0 1.4842428619488146e-08
, O 0 1.2329275922613137e-17
a O 0 2.663331837867745e-19
higher O 0 4.661685426485868e-19
frequency O 0 4.533082317446837e-15
of O 0 8.092525481107371e-18
exon O 0 1.2051696446357951e-12
8 O 0 1.9792789640333402e-13
mutations O 0 1.406777933076267e-13
among O 0 1.1985372546860495e-13
46 O 0 1.7222606804243035e-12
, O 0 3.4782907890745784e-13
XY O 0 1.097056065191282e-05
patients O 0 1.5997025752667593e-12
with O 0 6.311900329659947e-13
female O 0 6.655541451294766e-09
phenotype O 0 2.0272802533916057e-12
than O 0 1.0152059179207792e-14
among O 0 3.398260947813647e-13
46 O 0 1.3265782916604962e-10
, O 0 4.075545456672103e-11
XY O 0 8.051996701397002e-05
patients O 0 9.978213459486962e-14
with O 0 3.549301491275782e-14
sexual O 0 1.5719957557891462e-09
ambiguity O 0 2.2256489984329164e-08
or O 0 2.6620769588703297e-08
male O 0 3.0333929146308947e-08
phenotype O 0 3.626220504426847e-11
; O 0 3.203589520398009e-12
and O 0 6.953093656392184e-10
( O 0 1.5118496257964138e-15
3 O 0 4.619986203769234e-15
) O 0 1.078949327441609e-17
statistically O 0 4.797219099099652e-20
significant O 0 1.1740725026060352e-19
evidence O 0 5.9613069214596755e-15
that O 0 3.1779829148034094e-14
mutations O 0 2.2960727083195555e-14
in O 0 6.84236391165576e-16
exons O 0 1.169686347779475e-09
8 O 0 5.93410459659438e-11
and O 0 1.795533860482479e-11
9 O 0 6.655829045461997e-14
preferentially O 0 3.1198368541374144e-12
affect O 0 6.693585962602331e-15
amino O 0 8.774515415165376e-16
acids O 0 2.1059869503089825e-17
with O 0 6.68602230910793e-18
different O 0 1.6747973425246373e-18
functions O 0 2.3791710238407044e-16
. O 0 4.905220652405562e-14
. O 0 2.8441242416743506e-12

The O 0 2.6047434608517106e-12
185delAG O 0 1.0919302129153152e-09
BRCA1 O 0 3.0641149340038254e-11
mutation O 0 5.6433658202244275e-14
originated O 0 1.3638764596868302e-12
before O 0 3.997443245558688e-14
the O 0 2.496452529206515e-16
dispersion O 0 4.011745796672628e-12
of O 0 1.6391381901593235e-16
Jews O 0 4.740408586501044e-12
in O 0 1.657372850750018e-15
the O 0 1.0210082630160607e-14
diaspora O 0 2.9841296100840964e-10
and O 0 5.139262626574492e-11
is O 0 7.936800359726465e-15
not O 0 5.537610453331234e-15
limited O 0 8.068086099037247e-17
to O 0 1.2701359061728645e-12
Ashkenazim O 0 8.106127324936097e-07
. O 0 8.254463779167054e-11

The O 0 4.592824601537537e-13
185delAG O 0 9.479764750963682e-10
mutation O 0 1.995572327176398e-12
in O 0 3.934115674290167e-15
BRCA1 O 0 7.555501363443184e-11
is O 0 1.5974362403605585e-13
detected O 0 4.727949975968926e-11
in O 0 1.7509152519174019e-15
Ashkenazi O 0 1.4814033555410333e-08
Jews O 0 3.588832564460631e-10
both O 0 9.583284686642823e-13
in O 0 8.601864880108945e-12
familial B-Disease 1 0.9987841248512268
breast I-Disease 1 0.9999990463256836
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 2.7726347440193422e-08
in O 0 7.786968172291059e-16
the O 0 9.596237429768941e-16
general O 0 1.1224660388447702e-15
population O 0 7.232651706278598e-14
. O 0 2.491996366205118e-11

All O 0 3.947849339103193e-11
tested O 0 4.444412893267469e-11
Ashkenazi O 0 2.71562522469182e-10
mutation O 0 6.307892576329355e-13
carriers O 0 1.0170088106083511e-13
share O 0 2.38257933618969e-14
the O 0 5.388774906037392e-16
same O 0 1.3396629895093704e-14
allelic O 0 9.894682295730206e-12
pattern O 0 6.011080522227985e-10
at O 0 1.386299793492904e-13
the O 0 2.363864079692635e-16
BRCA1 O 0 1.033928775928672e-10
locus O 0 2.4216307181745833e-08
. O 0 8.634606807333967e-09

Our O 0 2.1407928763039763e-09
previous O 0 2.7538347036754063e-12
study O 0 3.8230959129264934e-15
showed O 0 1.845912528733451e-12
that O 0 1.1780356882889478e-16
this O 0 4.971188804550267e-18
Ashkenazi O 0 2.2683621647701102e-10
mutation O 0 1.4020908999795578e-12
also O 0 3.4879490962147486e-10
occurs O 0 7.466273693051972e-13
in O 0 5.214339587857801e-16
Iraqi O 0 9.50049500875183e-13
Jews O 0 7.009872554381708e-14
with O 0 1.0897584439216966e-16
a O 0 2.0411148144611438e-17
similar O 0 1.7022517267899846e-15
allelic O 0 1.3863132863889405e-09
pattern O 0 1.9141500615660334e-06
. O 0 8.349140823149526e-10

We O 0 4.1679312778875044e-11
extended O 0 4.330816101246783e-14
our O 0 3.926186768277509e-14
analysis O 0 1.0774034095948086e-16
to O 0 3.538361287844428e-16
other O 0 1.5952478545083618e-16
non O 0 2.138769176775643e-16
- O 0 1.1824541996593996e-13
Ashkenazi O 0 1.2683668351720634e-11
subsets O 0 4.5261039518075877e-14
354 O 0 4.767133614399198e-14
of O 0 3.4734539182383976e-19
Moroccan O 0 1.277533580226059e-13
origin O 0 3.2969364949708355e-14
, O 0 2.349560869587062e-16
200 O 0 1.9407035253394543e-17
Yemenites O 0 8.216438461680284e-14
and O 0 3.222822509690447e-15
150 O 0 5.356614851740269e-17
Iranian O 0 2.2531888193341038e-13
Jews O 0 2.9289379081809397e-12
. O 0 2.9018133382296973e-12

Heteroduplex O 0 1.045955766443285e-08
analysis O 0 9.982395938773914e-15
complemented O 0 4.359505784796644e-15
by O 0 2.513026141230441e-19
direct O 0 7.709983761014553e-20
DNA O 0 3.691729573136824e-15
sequencing O 0 3.408535118650663e-14
of O 0 1.8547237254927324e-17
abnormally O 0 2.2859481235010248e-14
migrating O 0 1.5583949068112053e-16
bands O 0 3.597126123442568e-13
were O 0 1.6677504104285756e-13
employed O 0 1.5168191680979548e-13
. O 0 4.418221769887133e-14

Four O 0 5.847641815215354e-12
of O 0 4.076483701515249e-16
Moroccan O 0 6.160907201069321e-11
origin O 0 4.0820997840654294e-13
( O 0 1.149920327984347e-18
1 O 0 4.589395010827562e-19
. O 0 2.23261899630896e-18
1 O 0 1.4540189079263246e-17
% O 0 3.281220969591407e-18
) O 0 3.2163116850622586e-16
and O 0 2.4176934326075594e-12
none O 0 3.0372683805946626e-14
of O 0 2.36383225934694e-20
the O 0 3.627746821883602e-16
Yemenites O 0 8.492440691648673e-13
or O 0 1.4192656424088482e-15
Iranians O 0 1.5669687701796824e-14
was O 0 4.9229073779705895e-14
a O 0 7.221075651095608e-17
carrier O 0 7.305148239794557e-14
of O 0 2.4491648304309e-17
the O 0 8.944007643882368e-13
185delAG O 0 4.256462204921263e-08
mutation O 0 1.1717282526191308e-11
. O 0 3.928814565345995e-11

BRCA1 O 0 7.923911482521362e-08
allelic O 0 3.593178377059303e-08
patterns O 0 5.0372058524317254e-08
were O 0 3.207644913572061e-11
determined O 0 2.5270692656509386e-13
for O 0 2.4675560002109344e-16
four O 0 5.412080085844852e-14
of O 0 1.4851083258130076e-17
these O 0 1.5769882593852824e-15
individuals O 0 2.9318800562385714e-18
and O 0 4.053564578149324e-16
for O 0 3.7977673964838875e-19
12 O 0 2.3421767936949238e-17
additional O 0 1.2897916064833887e-18
non O 0 1.4268384345946569e-15
- O 0 1.1359521101539372e-09
Ashkenazi O 0 5.088534180686111e-06
185delAG O 0 1.8188551109687978e-08
mutation O 0 3.76581231475992e-12
carriers O 0 3.500313374652647e-13
who O 0 7.275211544310878e-10
had O 0 1.805101055651903e-05
breast B-Disease 1 0.9999798536300659
/ I-Disease 1 0.9999843835830688
ovarian I-Disease 1 0.9999994039535522
cancer I-Disease 1 0.9999969005584717
. O 0 1.3783034091829904e-07

Six O 0 1.0599436883751423e-08
non O 0 2.3543098026657105e-10
- O 0 3.6694018490379676e-06
Ashkenazi O 0 0.0002869768941309303
individuals O 0 5.242162606777789e-12
shared O 0 7.895709368439807e-13
the O 0 1.7362163715463428e-15
common O 0 4.05517735005672e-14
Ashkenazi O 0 6.150147058292532e-09
haplotype O 0 2.447131635108235e-07
, O 0 3.0313913271934334e-12
four O 0 1.729139157162149e-13
had O 0 8.741475425455558e-12
a O 0 6.15240991574732e-17
closely O 0 1.774815747656016e-14
related O 0 1.9192384227012527e-14
pattern O 0 3.026841832731719e-10
, O 0 3.176408517723689e-13
and O 0 1.9312454413444868e-11
the O 0 9.652829750794734e-13
rest O 0 1.3852659297430847e-10
( O 0 3.180999675584615e-16
n O 0 4.54559612173e-10
= O 0 1.749198341727265e-09
6 O 0 2.05198726933864e-12
) O 0 2.2430125316244727e-14
displayed O 0 1.0839314472030348e-12
a O 0 8.090310787735322e-16
distinct O 0 2.5716560635548683e-14
BRCA1 O 0 5.104742406558671e-09
allelic O 0 2.348334362523019e-07
pattern O 0 0.00010372456745244563
. O 0 3.141560966923862e-08

We O 0 7.700458109702324e-13
conclude O 0 6.252354641916305e-15
that O 0 1.6564871454547656e-16
the O 0 2.03398828952453e-16
185delAG O 0 3.905848700025416e-10
BRCA1 O 0 1.9073709278671913e-10
mutation O 0 4.505677515115325e-12
occurs O 0 3.523310115882694e-12
in O 0 4.968558155135389e-16
some O 0 6.183612624290698e-16
non O 0 1.8914458486864877e-13
- O 0 1.9786693883361295e-07
Ashkenazi O 0 0.015678033232688904
populations O 0 8.054161781956282e-08
at O 0 6.341801528364499e-10
rates O 0 7.155994546925726e-12
comparable O 0 5.695437890634891e-16
with O 0 1.1444338912713697e-16
that O 0 1.84973916609113e-13
of O 0 1.5302495531030295e-14
Ashkenazim O 0 7.60523391818424e-07
. O 0 4.419105012476443e-11

The O 0 2.1129339597414365e-11
majority O 0 3.8075125734574056e-13
of O 0 1.114393338401404e-16
Jewish O 0 1.747049206690665e-11
185delAG O 0 1.1530663091008364e-09
mutation O 0 1.918631811585747e-13
carriers O 0 5.812604781855026e-15
have O 0 4.919225579858759e-15
a O 0 3.2553419044805527e-16
common O 0 2.8939188285309614e-13
allelic O 0 9.916609755578065e-10
pattern O 0 3.937876442705601e-07
, O 0 2.4416045899498806e-13
supporting O 0 3.2798887710612165e-14
the O 0 1.2160571444066212e-15
founder O 0 2.453107812369626e-12
effect O 0 2.7588788052050964e-14
notion O 0 2.966174872452536e-14
, O 0 2.957091291126181e-14
but O 0 1.8024702553003785e-13
dating O 0 6.65883959083402e-10
the O 0 1.8145967770787563e-15
mutations O 0 7.724837246818772e-16
origin O 0 3.874657720101619e-16
to O 0 5.253735407871954e-15
an O 0 6.982772857552961e-17
earlier O 0 4.265987302992658e-12
date O 0 6.0182327871194374e-12
than O 0 2.5721157059836958e-15
currently O 0 1.942898128148786e-15
estimated O 0 4.347299616510236e-15
. O 0 2.0735002256855317e-12

However O 0 1.5990711359215037e-12
, O 0 2.159032984200824e-16
the O 0 8.557324057565205e-19
different O 0 1.0670424761142144e-17
allelic O 0 1.790020930959868e-12
pattern O 0 1.9836962628083654e-10
at O 0 5.966090252038092e-13
the O 0 1.1258231215823146e-16
BRCA1 O 0 7.813555358282542e-12
locus O 0 5.575354067310911e-10
even O 0 5.808717951083509e-10
in O 0 4.850189006525745e-15
some O 0 1.616202258483351e-16
Jewish O 0 8.640903097212327e-12
mutation O 0 1.8017812936088617e-11
carriers O 0 4.6347327017914886e-12
, O 0 1.4324305630530887e-12
might O 0 1.3017483792288065e-11
suggest O 0 2.532849960584088e-13
that O 0 4.9274166425685925e-14
the O 0 1.0363985975577871e-14
mutation O 0 1.2949733618056441e-14
arose O 0 6.35265689539837e-15
independently O 0 1.0066260840288152e-13
. O 0 4.858350592489014e-13
. O 0 3.6820047011332235e-11

Crystal O 0 1.3169749024655175e-07
structure O 0 7.250006584663682e-12
of O 0 5.9681989109141285e-16
the O 0 2.4852439984429653e-13
hemochromatosis B-Disease 1 0.9999444484710693
protein O 0 2.8771945763395035e-12
HFE O 0 4.616597382156584e-10
and O 0 2.337371019390383e-13
characterization O 0 4.522533335240414e-13
of O 0 3.556002717660857e-18
its O 0 5.526866158032668e-16
interaction O 0 1.0437767806152417e-17
with O 0 1.1126984784135072e-16
transferrin O 0 8.066856102377506e-13
receptor O 0 6.668561644725124e-14
. O 0 3.830720463060544e-13

HFE O 0 1.8084067505697021e-06
is O 0 4.526902724205639e-12
an O 0 3.5088325016932815e-15
MHC O 0 1.5773891914871996e-10
- O 0 2.7758226273100206e-10
related O 0 8.05817882581529e-14
protein O 0 3.4859139500745956e-14
that O 0 5.908169685942216e-16
is O 0 7.224047876472634e-18
mutated O 0 3.0487707915568445e-15
in O 0 5.142926769470383e-16
the O 0 1.1482630818404616e-11
iron B-Disease 1 0.9944607019424438
- I-Disease 1 0.9998906850814819
overload I-Disease 1 0.999742329120636
disease I-Disease 1 0.9992471933364868
hereditary B-Disease 1 0.9999988079071045
hemochromatosis I-Disease 1 0.9999998807907104
. O 0 0.00018577155424281955

HFE O 0 2.9056961281526128e-08
binds O 0 3.854487562460207e-10
to O 0 3.1614188805879906e-13
transferrin O 0 1.9174814513966965e-11
receptor O 0 3.773230100763414e-13
( O 0 2.1727576708034223e-15
TfR O 0 7.237910826241034e-10
) O 0 3.2965196700574916e-15
and O 0 1.1103203275349724e-15
reduces O 0 3.356229418024501e-17
its O 0 8.379558291036614e-19
affinity O 0 3.969161186026781e-16
for O 0 6.285301444237639e-17
iron O 0 6.587745460251426e-09
- O 0 8.038526788656242e-11
loaded O 0 3.413737174884357e-12
transferrin O 0 1.0197058475380771e-11
, O 0 7.683717105952026e-17
implicating O 0 3.2928687554445446e-11
HFE O 0 7.240189003887565e-10
in O 0 1.8257835835647912e-14
iron O 0 1.431695917375464e-08
metabolism O 0 4.965144406732236e-10
. O 0 6.268962779443221e-12

The O 0 4.990184914593909e-12
2 O 0 9.857201860308251e-11
. O 0 3.2999422638901876e-11

6 O 0 1.2395543258492125e-08
A O 0 3.402910175864804e-10
crystal O 0 1.2345279287728772e-07
structure O 0 1.3764787920589328e-11
of O 0 4.795545322911594e-16
HFE O 0 2.841871460379508e-10
reveals O 0 1.7933699230504585e-12
the O 0 9.473503100174345e-19
locations O 0 2.696798744061292e-15
of O 0 9.498454675788484e-15
hemochromatosis B-Disease 1 0.9999991655349731
mutations O 0 6.466484292477759e-11
and O 0 1.4792269839580818e-11
a O 0 5.3510476350502115e-14
patch O 0 0.0018708318239077926
of O 0 1.5194368387181495e-13
histidines O 0 2.524946118853677e-08
that O 0 1.0492666848230248e-12
could O 0 1.1944733396829221e-12
be O 0 2.5591088798038956e-15
involved O 0 1.1281974872823664e-14
in O 0 2.0807808872192607e-13
pH O 0 1.442650318494998e-05
- O 0 4.3586982201304636e-07
dependent O 0 8.69499784672545e-12
interactions O 0 2.9276646211495727e-12
. O 0 9.375962679858407e-12

We O 0 1.0037441017241022e-10
also O 0 4.7869782411006506e-14
demonstrate O 0 6.804027623979504e-15
that O 0 1.0041364678495864e-14
soluble O 0 4.1317409563146335e-12
TfR O 0 9.428705283198724e-08
and O 0 5.739815567284978e-11
HFE O 0 5.385444090677538e-09
bind O 0 2.032607193669378e-09
tightly O 0 2.7335969043917885e-09
at O 0 1.8686122527783455e-12
the O 0 7.79695522013478e-16
basic O 0 2.472882704542597e-14
pH O 0 4.1292060048991885e-11
of O 0 3.792357087270635e-17
the O 0 3.26037855296734e-14
cell O 0 3.5560443478743764e-10
surface O 0 6.301360544469503e-10
, O 0 2.766309859132676e-13
but O 0 1.9779063369779193e-12
not O 0 2.628679825894542e-12
at O 0 2.0878158576986827e-11
the O 0 1.0631649640518992e-12
acidic O 0 1.54161501342287e-08
pH O 0 1.8476070451356463e-08
of O 0 4.765240495762085e-15
intracellular O 0 4.8219779280600505e-09
vesicles O 0 2.6265000840908215e-08
. O 0 4.468591718875814e-09

TfR O 0 0.000122277153423056
HFE O 0 6.77635455303971e-07
stoichiometry O 0 2.360025286307632e-09
( O 0 1.8080345163748457e-13
2 O 0 1.7730233242956722e-13
1 O 0 4.04016894267091e-14
) O 0 1.5511783819769677e-14
differs O 0 1.4252683235016494e-12
from O 0 3.75477779293934e-14
TfR O 0 2.33002117600023e-10
transferrin O 0 3.499654342362102e-12
stoichiometry O 0 1.5390520888974857e-13
( O 0 1.462407346518225e-17
2 O 0 3.302017919736797e-16
2 O 0 4.525860091022073e-15
) O 0 3.050746654724993e-16
, O 0 7.551326021732302e-18
implying O 0 1.4456627624655384e-16
a O 0 3.19285868020044e-20
different O 0 1.2502131855218343e-19
mode O 0 9.60205972249013e-16
of O 0 4.448972506923133e-20
binding O 0 6.793132239178972e-16
for O 0 1.4962765875714536e-17
HFE O 0 2.0519423660214642e-10
and O 0 4.401253233393687e-12
transferrin O 0 2.3040529206763694e-10
to O 0 5.030052763199677e-12
TfR O 0 4.360899641397964e-09
, O 0 1.2730961101406653e-14
consistent O 0 1.6204821095015462e-14
with O 0 2.002096413799442e-15
our O 0 2.034433819325665e-13
demonstration O 0 5.717227283807416e-16
that O 0 8.442417089953014e-18
HFE O 0 5.526420792344167e-13
, O 0 1.3632026492124542e-16
transferrin O 0 4.511456312694673e-12
, O 0 2.5948232616952206e-14
and O 0 1.1105640712605336e-11
TfR O 0 4.02284694445143e-09
form O 0 7.351013549229072e-16
a O 0 1.3809471212486608e-14
ternary O 0 2.0299860750694343e-11
complex O 0 2.499500051378334e-10
. O 0 1.2623603551364937e-10

Identification O 0 4.338650098911767e-12
of O 0 5.424023335104432e-15
three O 0 4.2343834330809543e-14
novel O 0 3.0564477815006597e-13
mutations O 0 1.3141914856698578e-12
and O 0 2.1660164981063268e-12
a O 0 1.5719310491737006e-15
high O 0 4.565893832724627e-14
frequency O 0 8.810875640197224e-12
of O 0 1.0572055780952848e-16
the O 0 1.0164930014247911e-13
Arg778Leu O 0 3.965408623685107e-08
mutation O 0 5.83928305014636e-12
in O 0 6.768582005642343e-13
Korean O 0 1.9868034328851536e-08
patients O 0 5.522258540203995e-13
with O 0 1.3256993159488362e-12
Wilson B-Disease 0 7.563531198684359e-06
disease I-Disease 0 1.6761405277065933e-06
. O 0 1.4255091551618193e-10

Four O 0 1.4909985138894521e-12
mutations O 0 9.187322777548523e-12
- O 0 1.0097885194682021e-07
- O 0 6.677350938844029e-08
R778L O 0 5.297618593802511e-11
, O 0 2.306191459198662e-16
A874V O 0 9.055051139109224e-16
, O 0 4.800351916422726e-19
L1083F O 0 1.9696201382803075e-16
, O 0 1.936509430120596e-18
and O 0 7.538065423158015e-16
2304delC O 0 1.2333618501503274e-11
- O 0 4.651667592781017e-11
- O 0 1.086650491810559e-10
in O 0 1.7802258741450713e-15
the O 0 2.5397045461223816e-17
copper O 0 3.876670323323854e-15
- O 0 8.456885719637485e-19
transporting O 0 9.19963497309146e-19
enzyme O 0 1.727204999778741e-16
, O 0 5.156068485647034e-16
P O 0 9.428589020643585e-10
- O 0 3.005213633500148e-09
type O 0 1.233924767918282e-10
ATPase O 0 5.359559906992217e-09
( O 0 6.634275445086164e-16
ATP7B O 0 9.026661085265175e-10
) O 0 9.807329686927738e-16
, O 0 3.779690966858978e-17
were O 0 1.5921176442517835e-15
identified O 0 2.7879692369829623e-13
in O 0 4.873055507969822e-15
Korean O 0 9.269001677303379e-10
Patients O 0 1.1121309663388469e-14
with O 0 2.5639581603675854e-13
Wilson B-Disease 0 1.8859697092921124e-06
disease I-Disease 0 3.1032263336783217e-07
. O 0 9.534845135661385e-12

Arg778Leu O 0 2.9337195428524865e-07
, O 0 4.3293312186089283e-13
the O 0 2.185175809084881e-15
most O 0 4.262239297397538e-15
frequently O 0 5.304264250050039e-10
reported O 0 2.01441402621072e-12
mutation O 0 1.2600213307426716e-15
of O 0 9.301799016572119e-18
this O 0 2.2418200984936628e-17
enzyme O 0 6.494625123072348e-16
, O 0 8.397747748688374e-16
was O 0 2.25154582478293e-11
found O 0 8.162281267543037e-11
in O 0 9.34855525511289e-15
six O 0 1.8613263057590257e-13
of O 0 9.239244806236776e-17
eight O 0 5.257480106650447e-13
unrelated O 0 2.0809635752853245e-13
patients O 0 1.0936856989467514e-16
studied O 0 4.431482488898917e-17
, O 0 8.268900240038378e-18
an O 0 9.935343885556842e-19
allele O 0 4.76656561443356e-12
frequency O 0 1.0054006516213576e-08
of O 0 1.7895975500115124e-12
37 O 0 6.515551986829848e-10
. O 0 7.465198598177736e-11

5 O 0 3.155255501319232e-10
% O 0 8.335237339750223e-13
, O 0 1.90376516363399e-14
which O 0 2.3344468583685538e-14
is O 0 7.934401800647857e-17
considerably O 0 3.608467504971147e-15
higher O 0 1.244415013387307e-16
than O 0 1.3305419355777777e-17
those O 0 3.6748249130919963e-16
in O 0 4.8198616535937946e-17
other O 0 6.815825437682041e-14
Asian O 0 1.1270652380129809e-12
populations O 0 2.0748204857760216e-13
. O 0 8.701862472780542e-13

The O 0 6.8227932154094496e-15
novel O 0 2.1140220769002042e-15
single O 0 2.642932319055365e-16
nucleotide O 0 5.930293826535496e-14
deletion O 0 1.798602655700421e-10
, O 0 2.381735217035774e-13
2304delC O 0 6.646480588123893e-10
, O 0 1.2237087699488308e-13
was O 0 7.862835382788091e-11
found O 0 5.520029312117147e-12
in O 0 3.7542744859620815e-15
one O 0 6.454130849556372e-13
patient O 0 1.7990270731460534e-11
. O 0 4.6125265065755094e-12

Since O 0 1.8548843017107686e-12
a O 0 2.6213259908785657e-15
mutation O 0 8.937041238348334e-15
at O 0 7.669467952430356e-14
cDNA O 0 1.222184506377566e-11
nucleotide O 0 5.99372149134858e-11
2302 O 0 2.585157199419541e-09
( O 0 9.875134462597208e-15
2302insC O 0 1.8246454347448093e-10
) O 0 1.3638809320207917e-13
had O 0 8.092086896394068e-12
been O 0 4.056058941948222e-14
previously O 0 1.1699130976049882e-14
described O 0 6.953613574701978e-13
, O 0 1.3023508758394192e-16
this O 0 1.7910749897708596e-17
region O 0 2.0947131561862425e-14
of O 0 4.881034240695602e-16
the O 0 4.262603724852765e-12
ATP7B O 0 8.341269364109394e-08
gene O 0 1.5406250927774146e-11
may O 0 8.289735000874265e-13
be O 0 6.880578861862322e-16
susceptible O 0 1.7487552204931145e-12
to O 0 5.075615492136643e-13
gene O 0 1.6874125208232726e-07
rearrangements O 0 0.07326634973287582
causing O 0 0.3195691704750061
Wilson B-Disease 0 0.008264681324362755
disease I-Disease 0 0.00202194438315928
. O 0 9.967168423941075e-09

Disruption O 0 2.65182736880476e-10
of O 0 5.071618705235739e-17
splicing O 0 1.6634614421594945e-13
regulated O 0 1.6114081843507898e-14
by O 0 8.648371033495529e-16
a O 0 5.356661345908139e-15
CUG O 0 9.148203083952922e-09
- O 0 2.526887119685961e-12
binding O 0 5.425580774584549e-13
protein O 0 1.1048684883663284e-10
in O 0 6.328310271641602e-12
myotonic B-Disease 1 0.9999161958694458
dystrophy I-Disease 1 0.999936580657959
. O 0 4.4220077599632646e-10

Myotonic B-Disease 1 0.9998600482940674
dystrophy I-Disease 1 0.9999716281890869
( O 0 4.671957867685705e-06
DM B-Disease 1 0.9999977350234985
) O 0 1.2643440072679368e-07
is O 0 8.560657044354159e-11
caused O 0 1.347000549295485e-11
by O 0 3.128493029626607e-17
a O 0 1.944076006871282e-16
CTG O 0 1.7334591878234717e-12
expansion O 0 1.2463443956224748e-15
in O 0 2.051458741108344e-16
the O 0 1.426190877906481e-15
3 O 0 1.7684639831098276e-13
untranslated O 0 3.644420587534114e-08
region O 0 1.177561845776276e-12
of O 0 6.319082309314222e-16
the O 0 3.937315751212367e-10
DM B-Disease 1 0.999996542930603
gene O 0 9.466452510764611e-09
. O 0 1.534197907604451e-10

One O 0 5.223047471955566e-13
model O 0 2.6170734416380848e-12
of O 0 1.8995152944057542e-13
DM B-Disease 1 0.999995231628418
pathogenesis O 0 1.9964044306597373e-10
suggests O 0 1.281927174004785e-13
that O 0 2.3558702062529227e-16
RNAs O 0 1.7466318105383016e-12
from O 0 7.32296577371642e-17
the O 0 2.2213785423625533e-19
expanded O 0 9.04526756115258e-19
allele O 0 7.939825326139347e-16
create O 0 9.183584815434818e-17
a O 0 3.1176669691788516e-15
gain O 0 3.9929032844866763e-13
- O 0 6.135232766268928e-09
of O 0 5.140818760268617e-12
- O 0 1.468076149535591e-08
function O 0 1.1329486475494463e-13
mutation O 0 5.41327215766317e-16
by O 0 6.317196122450642e-18
the O 0 3.437063864947929e-18
inappropriate O 0 2.745279589592975e-13
binding O 0 3.2056552164924114e-16
of O 0 1.3919968215865676e-20
proteins O 0 4.133180645933104e-17
to O 0 6.233656919001258e-16
the O 0 6.671487635338119e-14
CUG O 0 1.1005788564943941e-06
repeats O 0 1.4285500071764545e-07
. O 0 2.5536029454181763e-12

Data O 0 1.1816437585354667e-11
presented O 0 4.3183490637532795e-12
here O 0 5.771379603608864e-14
indicate O 0 7.55531450797502e-15
that O 0 3.7714813647155116e-17
the O 0 1.0151500448482515e-17
conserved O 0 7.693906547024537e-14
heterogeneous O 0 5.998513491478619e-11
nuclear O 0 2.4617511584779095e-08
ribonucleoprotein O 0 4.592651346030374e-12
, O 0 1.5374213122460047e-16
CUG O 0 6.375733274666118e-11
- O 0 6.576132325318562e-13
binding O 0 1.3843181429721435e-13
protein O 0 1.199386293407323e-12
( O 0 3.6895858518613315e-17
CUG O 0 4.5110390423097613e-10
- O 0 3.503944009941584e-11
BP O 0 3.093506006912605e-11
) O 0 1.497585088038839e-16
, O 0 6.450081116214122e-17
may O 0 1.6759055081194685e-15
mediate O 0 3.5759010769825794e-12
the O 0 3.293266131803793e-14
trans O 0 1.7703422061643437e-11
- O 0 1.7314396583145708e-09
dominant O 0 2.1125763638440986e-10
effect O 0 9.315702235220685e-14
of O 0 3.8354170390521214e-19
the O 0 3.705242064751245e-17
RNA O 0 8.669798212679325e-11
. O 0 7.450629523064745e-12

CUG O 0 8.6197120253928e-05
- O 0 2.738802095336723e-06
BP O 0 1.3362194017929596e-08
was O 0 8.90105870954283e-12
found O 0 7.611201741834859e-15
to O 0 2.977120631890628e-17
bind O 0 2.416005221404782e-13
to O 0 8.325056439946194e-16
the O 0 3.387874767457269e-16
human O 0 1.3499525932866852e-12
cardiac O 0 3.2227340795998316e-09
troponin O 0 3.9187622036251923e-08
T O 0 1.1899937035764196e-08
( O 0 1.2246589294221111e-17
cTNT O 0 1.7601923336853925e-13
) O 0 3.1452712964738364e-16
pre O 0 8.647060525295361e-14
- O 0 1.2060985890571807e-12
messenger O 0 6.29479541408573e-12
RNA O 0 7.002239760245388e-11
and O 0 7.119172161236097e-15
regulate O 0 6.955306821621506e-18
its O 0 2.3616161584753794e-19
alternative O 0 1.4998703564607515e-18
splicing O 0 1.158368214716765e-12
. O 0 3.5404527074824055e-13

Splicing O 0 9.064268086111937e-11
of O 0 1.0027705255781852e-13
cTNT O 0 6.044698630525147e-10
was O 0 1.9910149917645725e-11
disrupted O 0 2.8571236487806573e-09
in O 0 2.7317163288353985e-12
DM B-Disease 1 0.9999978542327881
striated O 1 0.8956786394119263
muscle O 0 0.0004923013038933277
and O 0 5.061335239808784e-10
in O 0 1.853572786388426e-15
normal O 0 5.175718167715676e-15
cells O 0 1.1664016378188508e-14
expressing O 0 3.938199643645354e-15
transcripts O 0 9.94982633610586e-13
that O 0 5.478510982544205e-13
contain O 0 4.1220846180856086e-11
CUG O 0 1.5343304085035925e-06
repeats O 0 2.495304670446785e-06
. O 0 3.044941382368549e-11

Altered O 0 1.0615218037912655e-08
expression O 0 3.969413339688366e-11
of O 0 8.407940731417396e-16
genes O 0 5.6410625682342536e-14
regulated O 0 1.0450458044503758e-13
posttranscriptionally O 0 5.266613811727439e-09
by O 0 5.943329595831104e-13
CUG O 0 1.3934916751168203e-05
- O 0 5.566848315652351e-08
BP O 0 2.7956573167564613e-10
therefore O 0 2.3079703872065736e-15
may O 0 1.9361420874823673e-16
contribute O 0 6.075234626340612e-18
to O 0 7.303586988666178e-14
DM B-Disease 1 0.9999915361404419
pathogenesis O 0 9.997108002535171e-11
. O 0 4.253616840807668e-14
. O 0 9.270644825811261e-14

Identification O 0 1.283914706322331e-12
of O 0 1.1782653930363313e-15
a O 0 2.2225072192241617e-14
novel O 0 2.164603782675578e-12
nonsense O 0 9.464299344230653e-10
mutation O 0 3.009508061594529e-14
and O 0 5.187155230085977e-14
a O 0 4.120223027073583e-18
missense O 0 5.673384858457533e-16
substitution O 0 7.074523069352853e-17
in O 0 3.3637660260215944e-17
the O 0 3.8283041067609233e-16
vasopressin O 0 1.1216080147979923e-11
- O 0 3.0329692091157767e-09
neurophysin O 0 3.7640678129946537e-08
II O 0 9.77561143145067e-10
gene O 0 1.3971442275675927e-12
in O 0 1.4500819715793805e-15
two O 0 7.742279582202694e-14
Spanish O 0 4.936250297404854e-10
kindreds O 0 3.4662632970139384e-05
with O 0 2.285634459475716e-10
familial B-Disease 1 0.835560142993927
neurohypophyseal I-Disease 1 0.9996747970581055
diabetes I-Disease 1 0.9990227222442627
insipidus I-Disease 1 0.9924442172050476
. O 0 1.8756654185381194e-07

Familial B-Disease 1 0.9981393814086914
neurohypophyseal I-Disease 1 0.9991059899330139
diabetes I-Disease 1 0.999765932559967
insipidus I-Disease 1 0.9992039799690247
( O 0 6.874814175716892e-07
FNDI B-Disease 1 0.9999951124191284
) O 0 2.2462795512545597e-10
is O 0 8.327129404853834e-14
an O 0 2.1228651432211865e-13
autosomal B-Disease 1 0.9999414682388306
dominant I-Disease 1 0.9999953508377075
disease I-Disease 1 0.9999856948852539
caused O 0 0.0006139492033980787
by O 0 8.338609802649444e-09
deficiency O 1 0.9698989987373352
in O 0 6.46031080193954e-14
the O 0 1.8358986206279404e-12
antidiuretic O 0 4.4246782238133164e-08
hormone O 0 3.2676611416704304e-11
arginine O 0 2.356441430872991e-12
vasopressin O 0 1.5227886226293341e-12
( O 0 6.218524146002968e-17
AVP O 0 7.154868331919056e-14
) O 0 9.34094327110966e-19
encoded O 0 4.749408033844693e-18
by O 0 4.499840612002238e-18
the O 0 4.783852033074748e-16
AVP O 0 3.96798895963002e-08
- O 0 4.2562109570098983e-07
neurophysin O 0 2.3512393454439007e-06
II O 0 3.5577008929976728e-06
( O 0 3.1315053699546187e-15
AVP O 0 6.054417411860413e-09
- O 0 5.375943601393374e-08
NPII O 0 4.352890670134002e-08
) O 0 1.7557234079727113e-16
gene O 0 8.439077662558464e-16
on O 0 3.1164170636449606e-12
chromosome O 0 1.1012051004399837e-07
20p13 O 0 7.527111711702617e-10
. O 0 2.894240619735755e-12

In O 0 2.624700858131629e-13
this O 0 4.636969108482564e-16
study O 0 1.7765073465670657e-16
, O 0 7.661155192261826e-16
we O 0 1.6386575519013158e-15
analyzed O 0 9.268372151710483e-16
two O 0 1.4463198747441505e-15
families O 0 4.7106576926410175e-15
with O 0 1.3888173225841183e-16
FNDI B-Disease 1 0.9380955696105957
using O 0 5.886182083751311e-19
direct O 0 1.0789770405770689e-19
automated O 0 5.066557643671225e-15
fluorescent O 0 7.885621951427002e-14
, O 0 2.2130603454667292e-15
solid O 0 4.1363969676766824e-14
phase O 0 7.75237958188993e-16
, O 0 3.4815380825778733e-16
single O 0 2.3548919890779623e-15
- O 0 1.2463178275870512e-12
stranded O 0 9.684016512884089e-16
DNA O 0 1.3186430251842636e-16
sequencing O 0 3.8887544659262985e-16
of O 0 7.917280650893112e-19
PCR O 0 1.0171655878687957e-10
- O 0 1.3671118924418746e-11
amplified O 0 1.2549207506484805e-10
AVP O 0 1.3125350806220126e-09
- O 0 1.8938457746475734e-10
NPII O 0 2.8554021369586735e-09
DNA O 0 1.8317800054568067e-10
. O 0 1.5451973468111335e-12

In O 0 2.2234029396252242e-13
one O 0 1.6437172396842684e-14
of O 0 7.707109773675026e-18
the O 0 8.003754587261949e-14
families O 0 2.8515224036185227e-12
, O 0 1.5496745702703243e-16
affected O 0 4.6443441019315765e-19
individuals O 0 7.352484701322231e-20
presented O 0 1.2459213026653213e-15
a O 0 6.115772696753917e-15
novel O 0 2.6701622683755755e-12
nonsense O 0 5.208908304688009e-10
mutation O 0 4.153732682788368e-15
in O 0 2.0400961911676215e-16
exon O 0 1.4407047874576834e-13
3 O 0 1.215164037102201e-12
of O 0 2.0702634019329814e-16
the O 0 7.511489023284083e-15
gene O 0 1.1817913455561962e-13
, O 0 6.262022252459792e-15
consisting O 0 2.922022462160716e-17
in O 0 1.3658624650157307e-16
a O 0 6.142968891811179e-14
G O 0 9.201646555823118e-09
to O 0 1.7474748861476264e-12
T O 0 1.838017515964907e-09
transition O 0 5.781314114234031e-15
at O 0 2.1470090868167533e-16
nucleotide O 0 1.5603223038129028e-16
2101 O 0 3.05660254051876e-11
, O 0 4.7720980745030554e-15
which O 0 4.373795707072857e-16
produces O 0 6.100341212292822e-17
a O 0 5.998048749022064e-17
stop O 0 1.6615923914553576e-11
signal O 0 1.5779384909819782e-08
in O 0 1.1515600959236504e-14
codon O 0 3.2621483639361237e-12
82 O 0 1.55653337441386e-11
( O 0 3.197461707974943e-15
Glu O 0 1.508740354871918e-09
) O 0 4.1661463233248763e-13
of O 0 1.9824440212253686e-14
NPII O 0 2.7535270419321023e-05
. O 0 2.3603740489930303e-11

The O 0 1.0203512297232709e-12
premature O 0 3.073520951635267e-11
termination O 0 7.605226940831517e-14
eliminates O 0 6.15985263014221e-14
part O 0 1.547324424418608e-15
of O 0 6.121160885089638e-16
the O 0 1.8607238146117755e-12
C O 0 4.86487259365731e-08
- O 0 2.3096574999770247e-11
terminal O 0 3.3976479924213666e-15
domain O 0 9.588850031919463e-15
of O 0 7.766372301480775e-18
NPII O 0 8.402410711649821e-12
, O 0 1.5270209057065795e-19
including O 0 2.4947790498664364e-22
a O 0 3.198075734173206e-20
cysteine O 0 1.2795910740769165e-14
residue O 0 2.588264325087408e-10
in O 0 9.846761982298182e-17
position O 0 5.642744843430136e-13
85 O 0 7.356708257612581e-16
, O 0 1.5454543874293073e-15
which O 0 1.7226606426057334e-13
could O 0 1.0094491431980601e-12
be O 0 6.707899972377982e-15
involved O 0 1.1895106024440794e-15
in O 0 2.3543170654650135e-15
the O 0 6.254007186255739e-13
correct O 0 1.584290316714032e-07
folding O 0 3.9086529568521655e-09
of O 0 2.9713132284204646e-16
the O 0 2.0524715553440348e-13
prohormone O 0 6.345509717675668e-08
. O 0 6.05637415218574e-11

In O 0 5.853877495590187e-13
the O 0 4.093161017917034e-14
second O 0 2.4164257834274894e-12
family O 0 1.464231687287043e-11
, O 0 4.105962433313169e-17
a O 0 1.3659803434228983e-19
G279A O 0 1.3711763559888326e-17
substitution O 0 7.905088525651963e-19
at O 0 1.7909061125770008e-15
position O 0 6.671411063559687e-14
- O 0 1.5898866424779445e-12
1 O 0 1.0016224952379593e-15
of O 0 1.171286093013862e-18
the O 0 1.0707985378396952e-16
signal O 0 3.79601921727743e-13
peptide O 0 6.859769909326244e-16
was O 0 9.061483930827147e-15
observed O 0 3.764439940120317e-16
in O 0 8.086415097922442e-18
all O 0 1.215927230728336e-15
affected O 0 1.8738060741577264e-15
individuals O 0 1.0839498493114513e-16
. O 0 6.794282476040026e-13

This O 0 4.217563798203372e-13
missense O 0 1.0567774433312138e-10
mutation O 0 5.547051012966264e-11
, O 0 3.6801860170410094e-11
which O 0 4.11789630172521e-11
replaces O 0 1.2716292907555271e-08
Ala O 0 1.3114215269283136e-09
with O 0 3.6283981461743275e-12
Thr O 0 6.875449798826594e-06
, O 0 1.4074658322496547e-12
is O 0 4.326685375672908e-15
frequent O 0 1.5366395655913578e-11
among O 0 6.057763735078936e-10
FNDI B-Disease 1 0.9999997615814209
patients O 0 5.141824188648059e-10
and O 0 1.0294019326187454e-12
is O 0 3.1354019332702253e-15
thought O 0 1.4128767058217695e-13
to O 0 4.261914460262266e-15
reduce O 0 1.1942807108381893e-14
the O 0 6.697745741406297e-16
efficiency O 0 1.7127841579726182e-15
of O 0 1.6347512284748666e-20
cleavage O 0 2.740315027845164e-13
by O 0 1.2241598086404966e-16
signal O 0 3.0503821690786026e-11
peptidases O 0 3.955416549850099e-11
. O 0 5.592103047443418e-15
. O 0 2.386100486032744e-13

Genetic O 0 1.6107855049796171e-09
heterogeneity O 0 1.800612281499525e-08
of O 0 1.060351695336692e-09
Saethre B-Disease 1 0.9992107152938843
- I-Disease 1 0.9999796152114868
Chotzen I-Disease 1 0.9999445676803589
syndrome I-Disease 1 0.9999915361404419
, O 0 3.7540418907147655e-13
due O 0 2.2524948113591004e-15
to O 0 5.069766627991898e-15
TWIST O 0 3.0834723219186344e-08
and O 0 2.1807085651137648e-11
FGFR O 0 3.721066477169188e-08
mutations O 0 2.701194086116021e-12
. O 0 5.90371772735826e-13

Thirty O 0 9.837734182838176e-09
- O 0 3.694208317028824e-08
two O 0 2.1954226631093476e-12
unrelated O 0 3.8737641566699565e-12
patients O 0 2.398555055201264e-15
with O 0 1.2798576015964485e-17
features O 0 2.2878216248550798e-12
of O 0 1.3676483990449073e-12
Saethre B-Disease 1 0.9896939396858215
- I-Disease 1 0.9999302625656128
Chotzen I-Disease 1 0.9999030828475952
syndrome I-Disease 1 0.999962329864502
, O 0 4.462156437124972e-15
a O 0 2.526102758706474e-15
common O 0 4.156721494785742e-11
autosomal B-Disease 0 0.30319297313690186
dominant I-Disease 1 0.9886992573738098
condition I-Disease 0 0.02290426194667816
of O 0 1.5300716249555535e-10
craniosynostosis B-Disease 1 0.9965403079986572
and O 0 3.0745013646082953e-06
limb B-Disease 0 9.490493539487943e-06
anomalies I-Disease 0 1.985645894819754e-06
, O 0 2.0243581930114857e-13
were O 0 1.7853170927294854e-14
screened O 0 8.81919374768475e-13
for O 0 2.6474716215592602e-17
mutations O 0 1.7356411514718624e-14
in O 0 2.8220300242139985e-15
TWIST O 0 5.196982399979788e-09
, O 0 1.3386649644689386e-13
FGFR2 O 0 1.3822268662977422e-08
, O 0 2.286118038310244e-14
and O 0 1.4301265250163397e-12
FGFR3 O 0 2.511982302166871e-06
. O 0 5.739889466505055e-12

Nine O 0 6.011963149532562e-10
novel O 0 3.9757707542831255e-11
and O 0 4.534016911916794e-11
three O 0 6.736742782544047e-13
recurrent O 0 8.278630758695726e-08
TWIST O 0 1.1717930448185143e-07
mutations O 0 1.4434291435716506e-11
were O 0 4.962015173748391e-12
found O 0 1.1623520071793458e-12
in O 0 9.369900697141936e-16
12 O 0 3.8544376566342076e-13
families O 0 1.4715598260339052e-13
. O 0 1.8421553074198654e-13

Seven O 0 2.2318777034846526e-11
families O 0 5.543491555549951e-13
were O 0 4.18305442232347e-15
found O 0 7.110537719130024e-16
to O 0 9.520650327138336e-16
have O 0 6.39491452210394e-15
the O 0 4.724566608909644e-16
FGFR3 O 0 1.1556600121309657e-09
P250R O 0 1.186556447985588e-14
mutation O 0 7.0535381192522034e-15
, O 0 5.0325615528167e-14
and O 0 3.669313550919151e-12
one O 0 2.8816345468661575e-14
individual O 0 1.4838526457908174e-15
was O 0 6.168714844489998e-11
found O 0 2.9184971496801215e-13
to O 0 3.697635086845081e-15
have O 0 9.624282690652531e-16
an O 0 5.730346633020303e-17
FGFR2 O 0 3.361761855558143e-07
VV269 O 0 1.20090742905532e-10
- O 0 1.1527409027323188e-09
270 O 0 2.318949372803747e-11
deletion O 0 5.998176177968162e-09
. O 0 2.62798061090308e-10

To O 0 2.8962811017769e-14
date O 0 1.2920651419438822e-13
, O 0 1.622298910470112e-16
our O 0 9.310003821068032e-17
detection O 0 1.1769582094404811e-15
rate O 0 5.449655399121294e-16
for O 0 3.594227974537851e-19
TWIST O 0 1.280130723646522e-10
or O 0 3.2524175952279577e-13
FGFR O 0 1.4196456510351396e-10
mutations O 0 5.303130303597678e-14
is O 0 5.4934474260108154e-15
68 O 0 9.78742477689143e-13
% O 0 1.2233901203892385e-15
in O 0 4.500776989058326e-14
our O 0 7.047617145872209e-06
Saethre B-Disease 1 0.9993748068809509
- I-Disease 1 0.999993085861206
Chotzen I-Disease 1 0.9999836683273315
syndrome I-Disease 1 0.999991774559021
patients O 0 1.2584868043508113e-11
, O 0 1.0669783927777987e-15
including O 0 2.4858849990961294e-16
our O 0 2.1297293789634963e-11
five O 0 1.4163518448351287e-13
patients O 0 8.331156135957609e-16
elsewhere O 0 3.756120488391504e-16
reported O 0 1.3852742737630042e-13
with O 0 1.3238912360314953e-14
TWIST O 0 1.4693878824800777e-07
mutations O 0 1.4509414780761176e-09
. O 0 3.3099713941942e-11

More O 0 5.3715991954494426e-15
than O 0 4.3171043213087186e-16
35 O 0 2.21100877872892e-16
different O 0 2.97411267231114e-17
TWIST O 0 2.470587068259533e-10
mutations O 0 3.6370502421410877e-13
are O 0 4.841906718367492e-15
now O 0 4.0547573064181764e-15
known O 0 4.59951722908236e-15
in O 0 2.0575023211870033e-15
the O 0 2.601286428014632e-13
literature O 0 2.5371076767255474e-11
. O 0 1.0633303265672467e-10

The O 0 3.036492498414978e-14
most O 0 2.1689387698211671e-16
common O 0 1.0234404625375642e-16
phenotypic O 0 1.1190616314500204e-17
features O 0 6.942763204620395e-12
, O 0 3.8291262792911757e-14
present O 0 8.612153228159915e-17
in O 0 4.862127315531835e-19
more O 0 8.479978405141464e-20
than O 0 2.0667105536685865e-18
a O 0 9.291452740731979e-16
third O 0 2.0659375252196632e-11
of O 0 2.3544934177246318e-14
our O 0 6.830414567282617e-10
patients O 0 1.0216928615138112e-16
with O 0 1.0182101168063302e-17
TWIST O 0 1.1367339014523026e-10
mutations O 0 2.375791891776752e-13
, O 0 5.4122834584554875e-15
are O 0 4.2034793512970865e-16
coronal B-Disease 0 3.593204400687e-09
synostosis I-Disease 0 1.0518535873416113e-06
, O 0 9.130617269204055e-12
brachycephaly B-Disease 0 2.250008037663065e-05
, O 0 1.6723630258397293e-09
low B-Disease 0 0.1297258585691452
frontal I-Disease 1 0.9999879598617554
hairline I-Disease 1 0.9999949932098389
, O 0 6.540910817420809e-06
facial B-Disease 0 0.002858028281480074
asymmetry I-Disease 0 2.0205538930895273e-06
, O 0 1.7479242497842051e-09
ptosis B-Disease 0 0.01022407878190279
, O 0 3.376917911968036e-10
hypertelorism B-Disease 0 2.1431207642308436e-05
, O 0 1.839324664798525e-10
broad B-Disease 0 6.7929226688079325e-09
great I-Disease 0 1.5622321143382578e-06
toes I-Disease 1 0.9999775886535645
, O 0 8.815637803083476e-11
and O 0 7.583193101234897e-11
clinodactyly B-Disease 0 1.461540705349762e-06
. O 0 2.033609391993707e-11

Significant O 0 5.565326303101636e-13
intra O 0 2.0014313761862468e-08
- O 0 0.03669770061969757
and O 0 7.655780223103648e-07
interfamilial O 0 1.6371284345950698e-06
phenotypic O 0 3.9257393993560874e-13
variability O 0 1.03586271504863e-11
is O 0 1.2684030393931081e-15
present O 0 3.2781448916884755e-17
for O 0 1.0693604843447717e-18
either O 0 1.7829249022798498e-14
TWIST O 0 2.7391880763616427e-08
mutations O 0 9.002654177692193e-11
or O 0 3.223720596023938e-11
FGFR O 0 2.8982717026337923e-07
mutations O 0 3.199946696508249e-10
. O 0 1.3461151637805813e-10

The O 0 5.957604879260406e-14
overlap O 0 3.6294413112945845e-13
in O 0 2.66152913917057e-15
clinical O 0 1.9129294672002185e-15
features O 0 1.5378065140736474e-11
and O 0 3.256306682630772e-11
the O 0 3.3412997608799847e-15
presence O 0 2.2360797363577857e-14
, O 0 7.082383932150067e-16
in O 0 6.179076398898682e-19
the O 0 1.052240079052578e-17
same O 0 4.121073699615533e-17
genes O 0 2.252674064706563e-16
, O 0 8.50661954037693e-18
of O 0 2.5903140687258888e-21
mutations O 0 1.7699915621639243e-18
for O 0 7.27082245857067e-19
more O 0 1.4256780457790328e-17
than O 0 1.9071514319505233e-15
one O 0 1.9266978637522136e-11
craniosynostotic B-Disease 0 5.785217581433244e-06
condition I-Disease 0 4.184876611912358e-10
- O 0 5.094619170975534e-12
such O 0 7.984777894045724e-16
as O 0 9.70603697240946e-13
Saethre B-Disease 0 5.475380859820689e-08
- I-Disease 0 6.4020615475612885e-09
Chotzen I-Disease 0 1.5032460609631926e-08
, I-Disease 0 1.2373490327775762e-14
Crouzon I-Disease 0 2.4939994514028285e-10
, I-Disease 0 2.568812743357525e-14
and I-Disease 0 1.1751459180753265e-11
Pfeiffer I-Disease 0 1.718353814794682e-07
syndromes I-Disease 0 1.874584754091302e-08
- O 0 1.2371474287717343e-12
support O 0 7.567688812301458e-15
the O 0 1.387207695286539e-16
hypothesis O 0 1.8657317325880248e-15
that O 0 2.637323690395121e-15
TWIST O 0 5.064019759082328e-10
and O 0 9.387415324246806e-12
FGFRs O 0 4.1454149141140206e-11
are O 0 3.597715533436497e-17
components O 0 5.61690046636988e-16
of O 0 6.431128929795187e-20
the O 0 6.333534676627851e-17
same O 0 2.256913332258673e-17
molecular O 0 4.365423348872065e-18
pathway O 0 2.556470545881127e-18
involved O 0 7.610867102609328e-19
in O 0 5.810863670063178e-19
the O 0 3.558121375363789e-17
modulation O 0 1.2556287606879657e-11
of O 0 8.365036094359901e-13
craniofacial O 0 0.00017893922631628811
and O 0 3.5056186842297166e-09
limb O 0 8.978771059986457e-10
development O 0 2.1452498523248653e-15
in O 0 7.021801488784479e-16
humans O 0 2.1019612171158976e-14
. O 0 2.16627846167999e-14
. O 0 3.2685384347003188e-12

Mutation O 0 4.7053153040543805e-11
analysis O 0 1.859723312847006e-12
of O 0 1.3012015510210917e-12
UBE3A O 1 0.9740628600120544
in O 0 8.71244992595166e-05
Angelman B-Disease 1 0.9999986886978149
syndrome I-Disease 1 0.9999994039535522
patients O 0 1.5776443262893736e-07
. O 0 1.213622674578474e-10

Angelman B-Disease 1 0.9999945163726807
syndrome I-Disease 1 0.9999998807907104
( O 0 5.595202310360037e-06
AS B-Disease 1 0.9999990463256836
) O 0 1.925534176550059e-10
is O 0 3.8456252613762454e-13
caused O 0 1.0225098762486895e-12
by O 0 5.483897235409642e-16
chromosome O 0 2.5454532703861332e-08
15q11 O 0 1.7420388742639403e-10
- O 0 3.4294931477996116e-11
q13 O 0 3.3471521995037667e-13
deletions O 0 5.429268579854041e-12
of O 0 2.3295340990382143e-16
maternal O 0 5.209710440823301e-11
origin O 0 7.965604900943973e-14
, O 0 3.912952132586545e-15
by O 0 1.3009215871502664e-15
paternal O 0 1.6898420440725204e-08
uniparental B-Disease 0 3.4587679692776874e-05
disomy I-Disease 0 0.00020132525241933763
( O 0 3.281750522374227e-12
UPD B-Disease 1 0.9999375343322754
) O 0 3.774489943687842e-13
15 O 0 1.71447070644972e-15
, O 0 6.292546884659113e-17
by O 0 4.641410737499729e-16
imprinting O 0 0.0007938482449389994
defects O 1 0.9993529915809631
, O 0 1.001813215717462e-12
and O 0 6.712626331520366e-14
by O 0 2.431358311907818e-16
mutations O 0 6.347948154541289e-14
in O 0 2.2307495697789512e-15
the O 0 6.712229242474693e-14
UBE3A O 0 6.88047521180124e-08
gene O 0 9.52729228842486e-10
. O 0 2.63014693357988e-10

UBE3A O 0 6.99333355669296e-08
encodes O 0 5.2478347188633645e-12
a O 0 4.447219434616616e-15
ubiquitin O 0 3.9579806446199406e-12
- O 0 7.287536893385571e-12
protein O 0 2.1387152303060236e-13
ligase O 0 6.378597194704738e-13
and O 0 1.200977772092271e-11
shows O 0 1.3562097278541074e-10
brain O 0 1.9570660370060722e-10
- O 0 3.3290002156814713e-13
specific O 0 5.40673285155213e-15
imprinting O 0 8.193400731215661e-07
. O 0 1.4916372303996894e-10

Here O 0 6.934875850655997e-12
we O 0 1.572274347392058e-13
describe O 0 2.2357694851298654e-13
UBE3A O 0 3.7104356920281134e-08
coding O 0 2.263421720272163e-06
- O 0 5.916712780162925e-06
region O 0 1.8004629731560584e-10
mutations O 0 2.124016457508149e-12
detected O 0 3.2331481242264815e-11
by O 0 5.469401431187687e-15
SSCP O 0 1.774007940547051e-09
analysis O 0 2.310918485379492e-14
in O 0 4.849483322201564e-16
13 O 0 7.429363249817147e-14
AS B-Disease 1 0.9923651814460754
individuals O 0 3.881270400441715e-16
or O 0 2.612160162653032e-13
families O 0 8.003483943294643e-13
. O 0 1.271864341276241e-12

Two O 0 5.233326549891615e-10
identical O 0 1.2175926933366554e-09
de O 0 1.8815464464250198e-10
novo O 0 1.2966102636013943e-09
5 O 0 6.373663315878408e-12
- O 0 1.702366303479863e-10
bp O 0 2.9624122165755606e-12
duplications O 0 3.4003745999489077e-13
in O 0 2.597909275360798e-17
exon O 0 3.558364066185045e-14
16 O 0 1.4941007957756935e-13
were O 0 5.947545515978814e-14
found O 0 1.0448098115845017e-11
. O 0 1.599206010671761e-11

Among O 0 5.886268035493192e-13
the O 0 2.790014296390154e-15
other O 0 1.183680474668128e-15
11 O 0 7.635131163748622e-16
unique O 0 6.808093488005443e-18
mutations O 0 1.4081241945371387e-15
, O 0 5.399350641779454e-16
8 O 0 2.1089385292579187e-16
were O 0 1.556612431852827e-16
small O 0 2.537532659347032e-19
deletions O 0 8.52724032877894e-13
or O 0 7.990252903766759e-11
insertions O 0 1.0775926284622983e-06
predicted O 0 2.9359810582718637e-07
to O 0 2.6420432508444947e-10
cause O 0 7.596631101947082e-10
frameshifts O 0 4.041444867652899e-08
, O 0 8.392647742137133e-14
1 O 0 4.312495932680063e-16
was O 0 2.304850537857006e-12
a O 0 3.2839023996240896e-17
mutation O 0 1.2222559697426446e-16
to O 0 6.545466581665393e-15
a O 0 2.9460443297797375e-15
stop O 0 2.4619104498080358e-12
codon O 0 2.9073489001338456e-15
, O 0 2.3388924896163943e-16
1 O 0 4.189821342069305e-17
was O 0 2.3311389710928276e-12
a O 0 5.2692704156410714e-15
missense O 0 1.3262429349181204e-12
mutation O 0 3.2682876045277143e-13
, O 0 9.070969886684765e-13
and O 0 2.7902116381262054e-11
1 O 0 1.1735454459333577e-13
was O 0 5.030281080564691e-09
predicted O 0 1.7945410782371773e-11
to O 0 1.3990894658360165e-14
cause O 0 4.479144445211809e-14
insertion O 0 6.034793433203067e-13
of O 0 6.746345019084665e-14
an O 0 7.0265455780205155e-12
isoleucine O 0 5.850996603840031e-05
in O 0 5.733703984690808e-13
the O 0 1.1773096603509559e-13
hect O 0 7.466356422014542e-10
domain O 0 4.766372301186206e-13
of O 0 5.2043613412157985e-17
the O 0 2.4292551290997855e-15
UBE3A O 0 2.708780977300762e-10
protein O 0 5.210112397936728e-13
, O 0 2.3324415396296647e-16
which O 0 1.2939516838995557e-17
functions O 0 2.276218032035405e-19
in O 0 1.0397471702611896e-17
E2 O 0 1.48792558135602e-11
binding O 0 1.3048611162121224e-14
and O 0 8.828065896881977e-16
ubiquitin O 0 1.3919002736961957e-14
transfer O 0 1.569761691916664e-15
. O 0 9.586848459183783e-13

Eight O 0 3.8424034787265526e-11
of O 0 4.3855048126030145e-17
the O 0 1.2807179190643404e-16
cases O 0 1.8042500578698082e-15
were O 0 6.211705954294044e-14
familial O 0 9.787994720289461e-11
, O 0 3.3049862759731985e-12
and O 0 1.0825972063255307e-11
five O 0 1.8095008998131323e-13
were O 0 7.522221235657656e-13
sporadic O 0 2.264708039156904e-11
. O 0 1.684536191093322e-11

In O 0 7.250539009245535e-14
two O 0 8.012396356203016e-15
familial O 0 2.024435730163532e-09
cases O 0 5.2434449143712314e-11
and O 0 2.546157078578415e-12
one O 0 2.961978078308775e-15
sporadic O 0 1.161651070474834e-13
case O 0 9.73930070163713e-14
, O 0 9.7739777646296e-16
mosaicism O 0 6.963292789596842e-12
for O 0 7.336246985631571e-17
UBE3A O 0 3.922586699900421e-10
mutations O 0 9.728612230044953e-13
was O 0 3.558858416297106e-11
detected O 0 5.3907621422322194e-11
in O 0 8.854647802470066e-15
the O 0 2.8359107596964694e-13
mother O 0 2.204949822726121e-07
of O 0 7.580748366282225e-15
three O 0 3.445860541351209e-10
AS B-Disease 1 1.0
sons O 0 1.0862790134069655e-07
, O 0 1.7726555965883248e-16
in O 0 4.840348270388773e-18
the O 0 6.212887565255464e-15
maternal O 0 2.311881130978577e-09
grandfather O 0 2.962112866100597e-08
of O 0 8.291647210575219e-17
two O 0 8.773709840245725e-13
AS B-Disease 1 0.9999967813491821
first O 0 1.8961198442520727e-13
cousins O 0 2.238181728841937e-08
, O 0 3.833105274159143e-12
and O 0 1.0636041353206949e-10
in O 0 3.147999642536502e-14
the O 0 2.2233532289556157e-12
mother O 0 5.064237384999615e-08
of O 0 2.0955622908339972e-16
an O 0 8.544367470497694e-13
AS B-Disease 1 0.9999998807907104
daughter O 0 0.05787566304206848
. O 0 9.447022053521437e-10

The O 0 3.2076890378899756e-14
frequencies O 0 9.901554402780288e-12
with O 0 1.5174363501846422e-12
which O 0 9.856722642948013e-13
we O 0 2.6825268741747675e-15
detected O 0 3.293677027486506e-16
mutations O 0 3.322333210883303e-17
were O 0 3.634578142603208e-15
5 O 0 6.933879204161687e-17
( O 0 1.835892834770871e-18
14 O 0 1.805311305449423e-14
% O 0 1.4925433891181038e-16
) O 0 6.053794766607728e-16
of O 0 1.2131000729784176e-17
35 O 0 1.8364841084358074e-15
in O 0 6.6304742358428504e-18
sporadic O 0 4.242152080459992e-14
cases O 0 3.1118167667220503e-14
and O 0 8.154931591120018e-12
8 O 0 1.3067578703146454e-12
( O 0 1.9739225362567673e-16
80 O 0 1.2668804129671238e-14
% O 0 2.4648383479392282e-15
) O 0 7.794613343442211e-14
of O 0 6.604681702095875e-16
10 O 0 6.405587052536049e-14
in O 0 1.0657046934531446e-16
familial O 0 1.1073242323078603e-10
cases O 0 4.1348790710826755e-12
. O 0 4.1453318100174996e-13
. O 0 1.2088260080422852e-11

The O 0 1.522368342499192e-11
hemochromatosis B-Disease 1 0.999142050743103
845 O 0 5.990321572113544e-09
G O 0 7.503481924686639e-08
- O 0 1.1860615822811837e-09
- O 0 6.308696898216226e-10
> O 0 3.612821847243097e-14
A O 0 1.4612600536260587e-15
and O 0 1.0758555098232606e-15
187 O 0 1.6042436620455577e-15
C O 0 6.365863565449548e-12
- O 0 8.110498384006348e-10
- O 0 2.68737050390655e-08
> O 0 1.1823960864229544e-12
G O 0 2.42704301101071e-10
mutations O 0 1.0957967389382817e-12
: O 0 8.85100047859919e-15
prevalence O 0 4.424857355522782e-11
in O 0 1.065965447252001e-15
non O 0 9.045019507686325e-13
- O 0 1.6525655155419372e-06
Caucasian O 0 0.0022785323671996593
populations O 0 1.636786777226007e-07
. O 0 1.626238310681316e-10

Hemochromatosis B-Disease 0 0.0002572520752437413
, O 0 1.1503757946229598e-08
the O 0 9.801026408240432e-07
inherited B-Disease 1 0.9999997615814209
disorder I-Disease 1 0.9999997615814209
of I-Disease 0 5.360494687023376e-11
iron I-Disease 0 2.980604040203616e-05
metabolism I-Disease 0 2.2405650668133603e-08
, O 0 3.882699717294713e-12
leads O 0 3.581515639616839e-10
, O 0 2.8230046772437234e-11
if O 0 6.764087623345461e-10
untreated O 0 2.334249060709226e-08
, O 0 1.969598300712136e-15
to O 0 9.850802899086242e-13
progressive O 0 7.834296411601827e-07
iron B-Disease 1 0.999748170375824
overload I-Disease 0 0.07917053997516632
and O 0 9.283938950943593e-09
premature B-Disease 0 6.859218970589609e-09
death I-Disease 0 1.627734946829662e-09
. O 0 8.188691912047741e-12

The O 0 7.325394180135447e-10
hemochromatosis B-Disease 1 0.9998204112052917
gene O 0 3.646671409285318e-09
, O 0 4.67459491254596e-12
HFE O 0 1.1472272021251229e-08
, O 0 3.072152449969112e-13
recently O 0 4.025035946902955e-12
has O 0 1.263333919898288e-13
been O 0 4.259827625190116e-14
identified O 0 1.527334438393077e-13
, O 0 1.6407341590506282e-15
and O 0 6.409278083307005e-14
characterization O 0 1.538207712245554e-12
of O 0 2.912885425114455e-17
this O 0 3.1675347633990276e-16
gene O 0 1.4341303210090028e-13
has O 0 8.316571042943366e-11
shown O 0 3.731834286035962e-12
that O 0 9.82575921803586e-15
it O 0 6.21194015890396e-15
contains O 0 3.111178485044647e-16
two O 0 6.708667807744668e-15
mutations O 0 3.016881991620146e-14
that O 0 4.778068674222979e-13
result O 0 1.1896655671217796e-14
in O 0 1.977615599906796e-16
amino O 0 3.1174647400626946e-15
acid O 0 8.267547799736854e-17
substitutions O 0 2.0864917921962102e-17
- O 0 1.0485593648782224e-14
cDNA O 0 2.7769129836850877e-14
nucleotides O 0 1.3831041075895029e-13
845 O 0 3.2595113674122045e-12
G O 0 3.1999652927439115e-10
- O 0 6.446263661752383e-11
- O 0 2.5623878019409574e-10
> O 0 2.649102149394813e-14
A O 0 1.1786526141481686e-14
( O 0 7.389632477903192e-19
C282Y O 0 7.762910054308873e-17
) O 0 6.907761513987723e-19
and O 0 6.834557063752546e-18
187 O 0 1.2808155925510706e-16
C O 0 2.25598966591134e-12
- O 0 1.8688932623689425e-09
- O 0 1.0557891982898582e-06
> O 0 7.12208894290689e-12
G O 0 3.4537452897609455e-09
( O 0 1.653217068882772e-16
H63D O 0 9.974503445420169e-10
) O 0 8.475635286924604e-15
. O 0 1.4011350504036357e-14

Although O 0 7.1964247894129585e-09
hemochromatosis B-Disease 1 0.9999605417251587
is O 0 2.1618200285455913e-11
common O 0 5.759945471972561e-13
in O 0 1.1930513272185445e-14
Caucasians O 0 9.263319278307591e-12
, O 0 4.286796053087861e-15
affecting O 0 2.6843897113840165e-15
> O 0 1.0340483987665116e-15
= O 0 4.5183946644974937e-13
1 O 0 6.629975164692073e-16
/ O 0 3.2621360040313574e-12
300 O 0 9.048797388980527e-17
individuals O 0 1.532431824965534e-17
of O 0 1.0055575456131068e-16
northern O 0 1.251363422605234e-11
European O 0 1.8607611285137438e-10
origin O 0 6.021841358894164e-11
, O 0 4.599294035900758e-13
it O 0 2.685831700273422e-13
has O 0 9.437331423061898e-14
not O 0 2.3159331321854744e-16
been O 0 7.822217977786639e-16
recognized O 0 1.1045617343383946e-16
in O 0 9.626034791538817e-18
other O 0 1.0751381576202309e-14
populations O 0 3.4661051698074707e-13
. O 0 2.716368146041259e-12

The O 0 9.571564630564845e-15
present O 0 1.3350770360041609e-17
study O 0 4.827822519942127e-20
used O 0 6.471862146590654e-19
PCR O 0 1.673901794084498e-12
and O 0 5.748700381149425e-15
restriction O 0 5.460538184306736e-16
- O 0 3.4976287545483015e-14
enzyme O 0 2.3557264753496854e-16
digestion O 0 4.1047314879765276e-14
to O 0 4.043892040918109e-18
analyze O 0 6.6748855629308225e-18
the O 0 3.3373948566886714e-19
frequency O 0 1.6954017713455391e-15
of O 0 5.659021097697145e-20
the O 0 3.728734986764486e-18
845 O 0 1.818650888522552e-15
G O 0 5.030587491711147e-13
- O 0 2.951930692073057e-13
- O 0 7.153125205876243e-13
> O 0 4.1785845897561395e-17
A O 0 7.730049808166837e-17
and O 0 1.556517405344057e-16
187 O 0 1.7604045884952714e-16
C O 0 2.1610591463029627e-13
- O 0 4.112901859365525e-12
- O 0 1.20831261662957e-10
> O 0 7.576786793187917e-15
G O 0 1.3205075596357807e-13
mutations O 0 3.4354011905576666e-17
in O 0 2.579865074760505e-18
HLA O 0 4.481436922942894e-13
- O 0 1.6190935311216625e-12
typed O 0 3.641086737671273e-11
samples O 0 9.101219777818415e-11
from O 0 1.0652465068621952e-14
non O 0 6.704881570470441e-15
- O 0 4.020421218164927e-10
Caucasian O 0 1.5446737222646334e-07
populations O 0 2.1328432076028747e-11
, O 0 2.525003098182701e-16
comprising O 0 5.874831614783435e-19
Australian O 0 2.0317703866917037e-16
Aboriginal O 0 4.238553206873698e-14
, O 0 2.1535453687554738e-17
Chinese O 0 3.4557703477056624e-19
, O 0 3.923930534474124e-19
and O 0 3.0327514927001344e-15
Pacific O 0 1.5154180697240778e-15
Islanders O 0 4.895250329227385e-13
. O 0 3.075274028959958e-15

Results O 0 6.582284630546331e-12
showed O 0 9.739380526022079e-13
that O 0 5.0854679420775304e-18
the O 0 1.6251286622584314e-17
845 O 0 1.178444277924462e-13
G O 0 3.801959580496117e-10
- O 0 2.728667292117848e-10
- O 0 1.2116387893001956e-09
> O 0 1.5025192190692288e-14
A O 0 4.6755325068678025e-15
mutation O 0 3.387114290689312e-15
was O 0 2.6598601793326182e-11
present O 0 9.365183782416913e-16
in O 0 1.1835438343571016e-17
these O 0 5.714978278983557e-17
populations O 0 4.2216840083926025e-17
( O 0 4.572492463582964e-21
allele O 0 3.4155389296890433e-17
frequency O 0 4.1954575257701146e-14
0 O 0 2.543359691813131e-17
. O 0 4.486339121889964e-16
32 O 0 1.0321493720745912e-14
% O 0 1.971821729111454e-17
) O 0 3.4332280878268163e-16
, O 0 5.273815170919564e-15
and O 0 3.491786504036809e-12
, O 0 8.51445734799611e-15
furthermore O 0 1.4876224506258674e-14
, O 0 4.121470891893346e-15
it O 0 1.5187596189361607e-12
was O 0 3.457686581498365e-09
always O 0 3.265312326083958e-11
seen O 0 8.23689566260919e-15
in O 0 2.255128609953968e-20
conjunction O 0 1.8011536892264507e-17
with O 0 1.2863007608652968e-14
HLA O 0 9.943460638206503e-11
haplotypes O 0 8.719436839221828e-10
common O 0 1.5331917679883844e-10
in O 0 3.60221191254579e-14
Caucasians O 0 3.350007174874464e-13
, O 0 2.2392474013525004e-17
suggesting O 0 6.305309024196275e-16
that O 0 1.5615131791971832e-16
845 O 0 9.306294884020572e-13
G O 0 7.921610922778655e-09
- O 0 1.5159322686031373e-08
- O 0 3.199426146238693e-07
> O 0 5.538231765550572e-12
A O 0 1.8041461337034437e-12
may O 0 1.9523282730055103e-13
have O 0 1.2808148977193561e-17
been O 0 2.4845469848244882e-17
introduced O 0 4.340813484877693e-18
into O 0 9.503151321279777e-18
these O 0 4.7344866882109715e-17
populations O 0 2.4843764201821797e-17
by O 0 4.879880158304968e-16
Caucasian O 0 1.221328815859124e-08
admixture O 0 5.092773491810476e-08
. O 0 2.65491434392473e-10

187 O 0 1.7949639552483632e-09
C O 0 1.2696824569502496e-07
- O 0 5.676855039382644e-07
- O 0 1.3227187992015388e-05
> O 0 1.0381442372420224e-09
G O 0 1.9734448741814958e-08
was O 0 2.999024856578658e-12
present O 0 9.687960013736374e-18
at O 0 7.082967156520463e-19
an O 0 8.497652080203004e-22
allele O 0 2.3330646382414887e-16
frequency O 0 3.058548640050285e-12
of O 0 6.7792853680737324e-15
2 O 0 3.662008890570334e-11
. O 0 1.793767738511587e-11

68 O 0 1.8500743692584365e-07
% O 0 1.414954698547577e-11
in O 0 1.1438627263671243e-15
the O 0 4.985116272825671e-15
two O 0 8.609591988992249e-13
populations O 0 3.20003951722464e-13
analyzed O 0 6.190425949625933e-11
( O 0 1.064275722401347e-14
Australian O 0 4.141493138015706e-12
Aboriginal O 0 5.824994375736026e-10
and O 0 1.788602078944823e-11
Chinese O 0 1.7270212995083053e-15
) O 0 3.1700247755661593e-16
. O 0 6.547514707331854e-15

In O 0 2.4467591920097377e-14
the O 0 5.793409427083467e-16
Australian O 0 7.919230355301569e-15
Aboriginal O 0 1.0313661207082651e-14
samples O 0 3.1967057310695185e-15
, O 0 3.236639605188767e-19
187 O 0 1.559363336785158e-17
C O 0 1.8968434136769352e-13
- O 0 1.7000301166802956e-10
- O 0 4.773444572947483e-08
> O 0 1.5830450015089093e-12
G O 0 1.6561574334161833e-10
was O 0 6.520092083427131e-13
found O 0 6.54204361564642e-16
to O 0 8.12298599357433e-19
be O 0 1.1699464740118325e-18
associated O 0 2.9519797179429974e-18
with O 0 1.2852302223930416e-16
HLA O 0 8.92942230573679e-12
haplotypes O 0 1.514254555079475e-10
common O 0 4.93275559287909e-11
in O 0 1.9144645450105274e-13
Caucasians O 0 4.143294648345508e-12
, O 0 9.684723150120336e-15
suggesting O 0 1.2422493047246908e-13
that O 0 2.3053306090264555e-15
it O 0 2.0361088100382015e-15
was O 0 3.1193458731836043e-14
introduced O 0 3.231734037449391e-16
by O 0 2.0486345479737408e-17
recent O 0 2.3077834131537966e-13
admixture O 0 3.078544918988513e-10
. O 0 5.720383194907086e-11

In O 0 1.4044882336132491e-13
the O 0 4.3771004590561287e-16
Chinese O 0 3.917967110264772e-17
samples O 0 4.364326672815942e-17
analyzed O 0 2.24061575660901e-16
, O 0 6.515360473077521e-19
187 O 0 2.879004107224283e-17
C O 0 1.4300057448943249e-13
- O 0 1.3790962295756604e-11
- O 0 1.613374545073043e-09
> O 0 3.918370890341333e-13
G O 0 1.391792348037768e-09
was O 0 2.3834373710784895e-11
present O 0 3.0711707896052213e-15
in O 0 1.2247150122676422e-17
association O 0 3.236281332585955e-19
with O 0 2.9568695444353164e-19
a O 0 5.716524031394235e-18
wide O 0 4.4184531369366757e-16
variety O 0 6.387718977217014e-16
of O 0 1.6387318790424374e-16
HLA O 0 1.0430197504296412e-11
haplotypes O 0 8.204752849350072e-11
, O 0 1.0052178409320281e-13
showing O 0 9.699929661571849e-13
this O 0 3.3204564207914817e-18
mutation O 0 2.8904929841881545e-17
to O 0 1.1420277565418399e-14
be O 0 6.249186823396868e-14
widespread O 0 1.038900817587271e-13
and O 0 1.8008167179672796e-10
likely O 0 3.4434000789618224e-12
to O 0 2.5110571242226327e-15
predate O 0 4.198325172753703e-13
the O 0 3.1604827922510232e-18
more O 0 1.4574875541157465e-20
genetically O 0 1.0026985803904914e-19
restricted O 0 3.068554695260402e-18
845 O 0 5.773804286242357e-13
G O 0 1.1813074962674364e-08
- O 0 1.4221376964940191e-08
- O 0 2.625097828001799e-08
> O 0 9.724784589800264e-14
A O 0 2.855536445321716e-14
mutation O 0 1.6378352667156815e-12
. O 0 2.4129866507682785e-11

Genotype O 0 0.0016377095598727465
- O 0 0.0005306481616571546
phenotype O 0 6.632302529396839e-07
correlations O 0 6.929506639608007e-07
in O 0 4.488118321432921e-09
attenuated B-Disease 1 0.9987621307373047
adenomatous I-Disease 1 0.9999585151672363
polyposis I-Disease 1 0.9996393918991089
coli I-Disease 1 0.9999582767486572
. O 0 1.5637342585250735e-05

Germ O 0 0.0018920161528512836
- O 0 0.011521805077791214
line O 0 2.821749376380467e-06
mutations O 0 1.1370917402109271e-10
of O 0 3.7611529228893784e-16
the O 0 2.4618597565802085e-15
tumor B-Disease 0 7.799309809097821e-11
suppressor O 0 1.214100264768092e-09
APC O 0 4.5586565633470855e-09
are O 0 2.3651473981351964e-14
implicated O 0 2.6864059865516765e-09
in O 0 8.250213706650911e-11
attenuated B-Disease 1 0.9998266100883484
adenomatous I-Disease 1 0.9999899864196777
polyposis I-Disease 1 0.99996018409729
coli I-Disease 1 0.999998927116394
( O 0 1.6555105730731157e-06
AAPC B-Disease 1 0.9999712705612183
) O 0 2.7090121812456402e-11
, O 0 2.8247763167872338e-15
a O 0 1.2922764936048811e-14
variant O 0 1.0695372338886955e-06
of O 0 6.074998282201705e-07
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 0.9999257326126099
polyposis I-Disease 1 0.9999939203262329
( O 0 6.895314319521617e-10
FAP B-Disease 0 2.552289117829787e-07
) O 0 3.2174488767688914e-11
. O 0 2.165265709785924e-11

AAPC B-Disease 1 0.9997959733009338
is O 0 1.4232535289204762e-11
recognized O 0 3.028797754660588e-15
by O 0 5.976191990260453e-17
the O 0 3.342279513302162e-16
occurrence O 0 2.3238483077940575e-13
of O 0 5.685064913404578e-15
< O 0 4.717354545186181e-12
100 O 0 2.3552244495097597e-15
colonic B-Disease 0 3.442891249871849e-10
adenomas I-Disease 0 2.1805941496921832e-09
and O 0 4.271124686566763e-12
a O 0 1.2150424201116342e-14
later O 0 1.1628460416801545e-09
onset O 0 1.8111046529156738e-07
of O 0 2.5055832963971625e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 0 7.392601613330496e-13
age O 0 1.0194082557257733e-11
> O 0 3.531534805800533e-14
40 O 0 8.723361930810386e-14
years O 0 5.618926331163454e-12
) O 0 1.407145613138011e-13
. O 0 1.6899160022731952e-12

The O 0 9.824045873671472e-13
aim O 0 1.2030985582778264e-11
of O 0 3.379251177960832e-17
this O 0 4.3728568074467724e-18
study O 0 1.2602981715500808e-18
was O 0 5.253134437995877e-15
to O 0 4.746768401248363e-16
assess O 0 7.420640165713144e-14
genotype O 0 2.9644045551613374e-10
- O 0 1.3759815509217788e-09
phenotype O 0 5.6592411312728075e-11
correlations O 0 1.2999631371357623e-09
in O 0 2.831001058578586e-11
AAPC B-Disease 1 0.9999802112579346
families O 0 6.61370236354486e-10
. O 0 4.163715813104707e-13

By O 0 6.350709481949338e-14
protein O 0 9.048681942624981e-12
- O 0 7.697313342269752e-10
truncation O 0 1.5741621339770973e-09
test O 0 7.313663563657258e-11
( O 0 6.73182846950382e-19
PTT O 0 2.2738709583324836e-15
) O 0 7.143583468796232e-20
assay O 0 1.4793748061151576e-17
, O 0 1.148836773080691e-19
the O 0 1.7169600566655664e-20
entire O 0 7.265145848898963e-17
coding O 0 4.592373356593349e-11
region O 0 6.83747898794565e-14
of O 0 1.0875521505687676e-18
the O 0 9.170842263534561e-17
APC B-Disease 0 1.562220811697143e-14
gene O 0 3.0451211383453625e-15
was O 0 2.6584893141057275e-12
screened O 0 1.2199906015974982e-11
in O 0 1.0025093387337346e-15
affected O 0 1.3315789917640701e-15
individuals O 0 2.947830298749023e-16
from O 0 2.3398153531882515e-13
11 O 0 6.252302231501972e-09
AAPC B-Disease 1 0.9999898672103882
kindreds O 0 1.1605984582274687e-06
, O 0 6.208913591598808e-13
and O 0 8.372762119041033e-13
their O 0 1.1073659350602227e-11
phenotypic O 0 4.66834382294775e-14
differences O 0 3.2085797130321225e-08
were O 0 3.279857774263206e-10
examined O 0 1.1340108407864591e-08
. O 0 5.882163246068162e-12

Five O 0 5.712900204984939e-12
novel O 0 5.005761864046443e-12
germ O 0 5.301384589984082e-06
- O 0 0.00015488029748667032
line O 0 1.4786813835598878e-06
APC B-Disease 0 2.3971113982668157e-10
mutations O 0 9.52121085966151e-13
were O 0 1.6706604090595267e-13
identified O 0 3.15958657891649e-13
in O 0 3.968965997871998e-15
seven O 0 6.617485032167636e-11
kindreds O 0 2.1519185793295037e-06
. O 0 1.0295089780676392e-10

Mutations O 0 5.942044078999231e-11
were O 0 2.8768268149625964e-12
located O 0 1.9073562445171693e-14
in O 0 2.752401004273939e-16
three O 0 1.0064791703992787e-15
different O 0 1.9117905519932962e-16
regions O 0 1.5017561694386948e-15
of O 0 8.590099434976394e-18
the O 0 3.2202049661251946e-15
APC B-Disease 0 8.294321176063879e-13
gene O 0 2.468631954400096e-14
( O 0 5.828382424858862e-18
1 O 0 2.59922796669333e-17
) O 0 4.630693653134594e-16
at O 0 1.1958633410781572e-13
the O 0 2.125934324753915e-15
5 O 0 7.379928712949492e-15
end O 0 8.231072480503407e-14
spanning O 0 6.066327571974421e-15
exons O 0 8.051888149285258e-12
4 O 0 1.0266210082564287e-13
and O 0 1.0470576228965855e-12
5 O 0 6.400799622318168e-14
, O 0 2.1755287390903648e-14
( O 0 1.2802189968060729e-17
2 O 0 4.610461318277359e-15
) O 0 1.2071134029259018e-16
within O 0 2.388305916421227e-19
exon O 0 1.3996312281090804e-14
9 O 0 1.7699775672896934e-11
, O 0 2.2671002174092653e-13
and O 0 4.8869713831223294e-11
( O 0 4.72301706801176e-16
3 O 0 8.436028026310993e-14
) O 0 6.1030477207873156e-15
at O 0 1.354770110114853e-13
the O 0 2.2110255870389672e-16
3 O 0 2.031280383425673e-14
distal O 0 2.0355701846330732e-10
end O 0 1.1081064954510111e-09
of O 0 2.953909083634553e-16
the O 0 9.263220751435167e-14
gene O 0 4.197723280086052e-10
. O 0 1.695548285107762e-10

Variability O 0 1.3454509728560993e-09
in O 0 1.1218923857812422e-15
the O 0 9.319740067750026e-17
number O 0 1.1434015084570148e-13
of O 0 1.3797106790391922e-09
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
was O 0 2.2746785361960065e-06
most O 0 1.1211106506038918e-13
apparent O 0 7.74258643310155e-11
in O 0 3.2633119551186236e-16
individuals O 0 1.3531205748599639e-16
with O 0 1.2560286291875516e-15
mutations O 0 7.33830110935009e-14
in O 0 5.607397921371989e-15
region O 0 1.8895563553503886e-13
1 O 0 4.5284522659505555e-14
, O 0 1.9845193197087774e-12
and O 0 8.81082584669457e-08
upper O 0 0.017935359850525856
- O 1 0.9999657869338989
gastrointestinal O 0 0.11124997586011887
manifestations O 0 4.374648199245712e-07
were O 0 1.4767639888724204e-10
more O 0 3.909932544832878e-14
severe O 0 3.050516089730948e-11
in O 0 1.3394297166356966e-15
them O 0 2.0535779673980237e-11
. O 0 2.6335040051450598e-11

In O 0 2.7213867552673687e-13
individuals O 0 2.47095752570843e-15
with O 0 1.8015687750752747e-14
mutations O 0 7.220236778252009e-13
in O 0 8.478549080263159e-14
either O 0 8.301886738823483e-13
region O 0 1.2022950994158843e-12
2 O 0 4.070336461544505e-13
or O 0 2.432524147388815e-11
region O 0 1.3094293173625954e-13
3 O 0 7.814587057964825e-15
, O 0 5.7953544264886e-16
the O 0 1.0480584163583264e-16
average O 0 4.17594358073127e-15
number O 0 1.4750872312152747e-16
of O 0 3.4415020115347147e-16
adenomas B-Disease 0 8.626843683856578e-11
tended O 0 8.570164716781292e-11
to O 0 5.904708688143911e-13
be O 0 2.475457122272373e-12
lower O 0 1.075504377397174e-12
than O 0 1.225829299991623e-14
those O 0 4.781849626011615e-14
in O 0 1.335184652201854e-16
individuals O 0 2.2967437331143263e-17
with O 0 9.304079884393172e-16
mutations O 0 7.07264125331163e-15
in O 0 2.401429885024245e-15
region O 0 3.918152152553034e-14
1 O 0 5.056304733361185e-15
, O 0 2.7568550740875164e-13
although O 0 1.645839497674273e-12
age O 0 2.5448424617602328e-11
at O 0 2.7850740377116656e-12
diagnosis O 0 1.3384869384722164e-12
was O 0 4.359512317114733e-12
similar O 0 4.2989762682847654e-13
. O 0 6.275342745443169e-11

In O 0 3.2382953957244e-11
all O 0 1.8965821968475183e-10
AAPC B-Disease 1 0.9998779296875
kindreds O 0 2.9616225560857856e-07
, O 0 5.329878164115958e-15
a O 0 2.216996904619314e-16
predominance O 0 9.299034320342514e-10
of O 0 1.3628362761225477e-12
right O 1 0.994203507900238
- O 1 0.9999792575836182
sided O 1 0.9999964237213135
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999992847442627
and O 0 0.0011957103852182627
rectal B-Disease 1 0.9993434548377991
polyp I-Disease 0 0.0005262108752503991
sparing O 0 1.3287770883607664e-09
was O 0 7.312174754581235e-10
observed O 0 4.0759499941867006e-11
. O 0 4.563956851333373e-12

No O 0 1.5774843632243574e-05
desmoid B-Disease 1 0.9611313939094543
tumors I-Disease 1 0.9999990463256836
were O 0 5.643425993184792e-08
found O 0 1.1698887691924398e-10
in O 0 1.2774695106539287e-14
these O 0 1.793876137044792e-12
kindreds O 0 2.19983732563378e-07
. O 0 4.190010144400347e-11

Our O 0 1.888592580934212e-11
data O 0 8.932172492967516e-14
suggest O 0 2.0110463587377087e-13
that O 0 8.473602407851194e-14
, O 0 1.0917448314742145e-13
in O 0 6.887167160359031e-13
AAPC B-Disease 1 0.9999988079071045
families O 0 2.3437291604005983e-12
, O 0 4.2907794492746802e-19
the O 0 2.89639359436974e-20
location O 0 1.9003686038671476e-15
of O 0 2.2693971420633232e-17
the O 0 3.092080899051025e-13
APC B-Disease 0 2.8003887209138156e-08
mutation O 0 4.3264797994213566e-11
may O 0 4.900040928568217e-10
partially O 0 6.453180767529432e-10
predict O 0 1.6810366033209734e-12
specific O 0 2.7185890054425878e-14
phenotypic O 0 4.510475326569008e-12
expression O 0 2.141744204209317e-07
. O 0 1.8646467481175932e-07

This O 0 5.011277986544452e-14
should O 0 4.206595331400151e-14
help O 0 1.0063760229621268e-14
in O 0 4.434354790857946e-18
the O 0 3.631691480788745e-17
design O 0 8.484955359849833e-14
of O 0 1.2625935977499155e-18
tailored O 0 1.2840805350446127e-13
clinical O 0 2.8141608763757693e-15
- O 0 2.577935044253965e-12
management O 0 7.149213243501655e-16
protocols O 0 2.333537653202971e-15
in O 0 1.6159470867060635e-19
this O 0 1.6176670407688056e-20
subset O 0 3.890989100554965e-19
of O 0 1.3471859468756868e-18
FAP B-Disease 0 4.926161908946902e-12
patients O 0 5.807526289940644e-16
. O 0 6.257625304430595e-16
. O 0 1.4240972767351479e-12

Wilms B-Disease 0 8.743826583668124e-06
' I-Disease 0 1.11526547996732e-08
tumor I-Disease 0 3.154432715035682e-09
1 O 0 6.123660606371928e-12
and O 0 2.4557975097927454e-10
Dax O 0 3.602188007789664e-05
- O 0 1.8414704205937937e-09
1 O 0 6.293437857440506e-16
modulate O 0 2.4114670763714097e-12
the O 0 7.83499242047736e-14
orphan O 0 2.6004567943438417e-10
nuclear O 0 4.765472413383043e-13
receptor O 0 2.2149934070012615e-16
SF O 0 4.705214706746119e-08
- O 0 1.5691790922200965e-10
1 O 0 7.684252404304912e-15
in O 0 1.3427850523677873e-16
sex O 0 1.385904086805001e-12
- O 0 3.4711297946615717e-15
specific O 0 2.4163136832756015e-17
gene O 0 8.268270101788669e-14
expression O 0 6.964683820984141e-13
. O 0 2.49054927072348e-13

Products O 0 1.8737454296480216e-11
of O 0 1.2920194826328605e-15
steroidogenic O 0 7.369587579075798e-12
factor O 0 1.9710238148107177e-14
1 O 0 9.076740688273091e-15
( O 0 8.914393906679359e-16
SF O 0 4.630510011338629e-05
- O 0 2.9961782388454594e-07
1 O 0 3.2606617059172116e-12
) O 0 9.002971436931906e-13
and O 0 4.6664727637590886e-11
Wilms B-Disease 0 1.3840299739609208e-10
tumor I-Disease 0 4.560332944603118e-10
1 O 0 1.2186305363794982e-14
( O 0 1.7563722815324224e-17
WT1 O 0 7.046502270569022e-12
) O 0 6.744687777947538e-17
genes O 0 2.5654216575411043e-16
are O 0 2.814210305380453e-18
essential O 0 1.2219523944578376e-17
for O 0 2.4964023441587513e-18
mammalian O 0 1.0402179334914607e-12
gonadogenesis O 0 6.183489831279587e-10
prior O 0 1.8971814306448665e-15
to O 0 3.273724319380984e-15
sexual O 0 2.344559550844505e-13
differentiation O 0 2.3357932341788734e-13
. O 0 9.7700476181517e-12

In O 0 2.4045855909725355e-13
males O 0 1.180458291880071e-12
, O 0 3.546242685896657e-14
SF O 0 3.302166805951856e-05
- O 0 2.307701407744389e-08
1 O 0 5.963311848445826e-14
participates O 0 3.167886705588612e-15
in O 0 1.5487231140425413e-16
sexual O 0 7.463336724891981e-14
development O 0 1.3470625935668399e-18
by O 0 1.6232196328022355e-18
regulating O 0 1.0816667487644881e-14
expression O 0 8.209451456304973e-14
of O 0 4.8987124800492894e-18
the O 0 2.9493149886868823e-16
polypeptide O 0 1.7026642248896273e-11
hormone O 0 1.6334410359681792e-14
Mullerian O 0 6.174856632956693e-12
inhibiting O 0 4.1514816757903805e-12
substance O 0 1.5820551979572883e-08
( O 0 4.485086211930209e-14
MIS O 0 6.139203492239176e-07
) O 0 4.5087059086235115e-11
. O 0 3.630365799645041e-11

Here O 0 2.483943259412591e-11
, O 0 4.633894484763149e-15
we O 0 9.060792751942187e-15
show O 0 1.5206030878900378e-12
that O 0 9.346594373839997e-15
WT1 O 0 3.932627112845921e-09
- O 0 1.452209463792542e-09
KTS O 0 5.137043235237115e-09
isoforms O 0 2.1433919914341814e-16
associate O 0 4.8064840546232016e-14
and O 0 2.0776617053316557e-15
synergize O 0 1.304636607080134e-11
with O 0 1.6029553986246503e-12
SF O 0 0.0006208195118233562
- O 0 8.13214597883416e-08
1 O 0 1.9773999061431513e-13
to O 0 3.8782253911117184e-14
promote O 0 2.337152552652627e-13
MIS O 0 1.4158645456063823e-07
expression O 0 1.9763008937689897e-11
. O 0 1.5129134924019016e-12

In O 0 8.862568665057857e-12
contrast O 0 1.054063260286231e-11
, O 0 4.3387800405421395e-13
WT1 O 0 1.6772929711805773e-08
missense O 0 1.908895957969392e-10
mutations O 0 2.0903501152247372e-11
, O 0 6.89951351259821e-13
associated O 0 4.3116248418795244e-12
with O 0 8.930537975793129e-10
male B-Disease 0 0.0031204698607325554
pseudohermaphroditism I-Disease 1 0.999998927116394
in O 0 3.203235721116471e-08
Denys B-Disease 1 0.9999697208404541
- I-Disease 1 0.9999964237213135
Drash I-Disease 1 0.9999899864196777
syndrome I-Disease 1 0.9999985694885254
, O 0 4.038102491277229e-11
fail O 0 3.6584273804818324e-11
to O 0 4.522888593563987e-16
synergize O 0 5.343959719183999e-10
with O 0 2.223227157926999e-11
SF O 0 0.28041893243789673
- O 0 1.1274133612459991e-05
1 O 0 4.441768827745385e-11
. O 0 2.649950051059058e-11

Additionally O 0 2.886608174712535e-10
, O 0 8.826261661647183e-13
the O 0 1.7634854622590457e-13
X O 0 1.8777051081997342e-05
- O 0 4.3130603444296867e-07
linked O 0 5.441928863092471e-08
, O 0 1.4093608414643063e-14
candidate O 0 2.4714479577848903e-15
dosage O 0 1.0167087441045886e-12
- O 0 7.450966384679736e-13
sensitive O 0 2.9128498224562094e-11
sex O 0 4.270483619506216e-11
- O 0 1.1010947877218222e-13
reversal O 0 2.4782735610321023e-15
gene O 0 7.236521693935484e-16
, O 0 4.398120309561183e-17
Dax O 0 1.1070692140791039e-09
- O 0 1.0314188739202201e-11
1 O 0 3.225908038959058e-16
, O 0 1.2258934468555098e-16
antagonizes O 0 1.1464548928252771e-12
synergy O 0 4.796224960972647e-15
between O 0 3.3854608823762717e-15
SF O 0 1.6290174471578212e-06
- O 0 6.016793174801194e-10
1 O 0 6.984218213398332e-15
and O 0 1.655933690950656e-13
WT1 O 0 1.9253055746903946e-11
, O 0 2.014006649949903e-16
most O 0 7.101608188612228e-19
likely O 0 6.62084759059202e-17
through O 0 1.3231160250261594e-18
a O 0 7.419719104733277e-18
direct O 0 3.887415525212371e-18
interaction O 0 1.2082795820058138e-15
with O 0 1.9779063369779193e-12
SF O 0 0.49129942059516907
- O 0 4.629199338523904e-06
1 O 0 1.1980835594449513e-11
. O 0 8.599912448836733e-12

We O 0 1.3008485347937304e-13
propose O 0 2.9892219613209675e-14
that O 0 2.8796443582532888e-15
WT1 O 0 3.4576058682844746e-10
and O 0 1.2293480469716123e-11
Dax O 0 6.461660291279259e-07
- O 0 1.4240036927404276e-10
1 O 0 2.648088896819572e-16
functionally O 0 1.6233034068422608e-14
oppose O 0 4.223778098831342e-17
each O 0 3.09741523362753e-18
other O 0 8.564456008806638e-16
in O 0 2.8332465933202176e-16
testis O 0 1.6014779780082478e-10
development O 0 1.8464853374639493e-17
by O 0 9.178611805592149e-17
modulating O 0 1.2124705406346692e-10
SF O 0 0.000565697206184268
- O 0 2.8633005300093828e-08
1 O 0 6.340484777836441e-13
- O 0 3.3307058500131603e-11
mediated O 0 2.533080967204171e-10
transactivation O 0 7.054585182686424e-08
. O 0 1.9264056766877397e-13
. O 0 4.144523062959461e-14

A O 0 4.333858846881228e-13
mouse O 0 6.595486379268323e-10
model O 0 4.822784394065138e-10
for O 0 2.4795672182165163e-09
Prader B-Disease 1 0.9999990463256836
- I-Disease 1 0.9999991655349731
Willi I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999864101409912
imprinting O 0 0.020338887348771095
- O 0 6.417611439246684e-05
centre O 0 2.9148758962094234e-09
mutations O 0 9.890772645348989e-09
. O 0 4.6319951346740496e-11

Imprinting O 0 1.1543211719811097e-08
in O 0 1.5344707926176482e-13
the O 0 1.3354967732550054e-14
15q11 O 0 3.3558496259633586e-11
- O 0 6.209006087054547e-10
q13 O 0 6.684563493009055e-12
region O 0 4.348991564822376e-15
involves O 0 2.5227875445428146e-17
an O 0 8.349982965222663e-18
imprinting O 0 7.32553406823655e-10
centre O 0 4.0877058682387e-11
( O 0 9.44651426473827e-18
IC O 0 1.516187959145661e-14
) O 0 4.970695804905185e-18
, O 0 2.007759536911646e-19
mapping O 0 1.535483030870935e-14
in O 0 5.763449739390185e-17
part O 0 2.150146979926861e-17
to O 0 4.177455058086086e-16
the O 0 3.882924761666821e-18
promoter O 0 4.106237377031474e-13
and O 0 2.243004061295e-14
first O 0 2.083080995658409e-16
exon O 0 1.0816760898438305e-12
of O 0 2.855657604914491e-13
SNRPN O 0 0.00014482384722214192
. O 0 1.6769328980981157e-10

Deletion O 0 7.695492576509366e-10
of O 0 2.6183376586406525e-15
this O 0 5.304685710198721e-15
IC O 0 5.543328296386818e-11
abolishes O 0 1.2013678940547834e-10
local O 0 4.119176279639234e-15
paternally O 0 6.805115498886849e-12
derived O 0 1.0210110661657205e-16
gene O 0 3.0295908739607497e-14
expression O 0 1.6062861110666127e-11
and O 0 6.812927999533258e-10
results O 0 2.827511280667494e-10
in O 0 1.2950717120929767e-07
Prader B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999996423721313
Willi I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999977350234985
( O 0 7.85951481674374e-09
PWS B-Disease 1 0.9999428987503052
) O 0 1.1354727574852674e-10
. O 0 5.480040032868061e-12

We O 0 6.175186230417129e-12
have O 0 1.1348961414666086e-15
created O 0 1.6081336079162639e-16
two O 0 2.763501741624621e-15
deletion O 0 1.1431453006416348e-11
mutations O 0 7.390927279915527e-12
in O 0 4.73727882008973e-13
mice O 0 2.0232466813041583e-09
to O 0 2.4613106691662168e-11
understand O 0 9.602771910977026e-09
PWS B-Disease 1 0.9999984502792358
and O 0 1.3589893099741346e-12
the O 0 1.0817352717446875e-17
mechanism O 0 1.6488281941363534e-15
of O 0 3.8350384488255135e-18
this O 0 2.544875020520879e-16
IC O 0 1.1036385000329219e-10
. O 0 4.4504485274994565e-13

Mice O 0 3.020530243702524e-07
harbouring O 0 4.783533995578182e-07
an O 0 2.188398117233814e-13
intragenic O 0 4.4044659830433375e-07
deletion O 0 5.3535345045929716e-08
in O 0 4.840399782379823e-12
Snrpn O 0 4.1806765693763737e-07
are O 0 2.3883773105949635e-13
phenotypically O 0 1.7308162281876038e-12
normal O 0 1.6152609984146707e-14
, O 0 1.166410531664797e-14
suggesting O 0 4.10484536986222e-12
that O 0 2.693049234135658e-13
mutations O 0 3.344541982773508e-13
of O 0 7.537203037738592e-16
SNRPN O 0 3.679637217146592e-08
are O 0 1.53931098981177e-16
not O 0 3.293313068016983e-16
sufficient O 0 1.24723788303293e-16
to O 0 5.814307368900984e-13
induce O 0 3.00590308199844e-08
PWS B-Disease 1 0.9999759197235107
. O 0 1.1431116053728374e-09

Mice O 0 1.6830227878017467e-08
with O 0 4.329131183308105e-14
a O 0 7.804246056228271e-16
larger O 0 8.983312477734909e-17
deletion O 0 4.927691826632496e-13
involving O 0 2.761121409636247e-14
both O 0 1.9847582846438568e-15
Snrpn O 0 9.426713576399237e-11
and O 0 1.069640151462898e-14
the O 0 4.680813122019223e-16
putative O 0 5.588966445202459e-08
PWS O 1 0.9999959468841553
- O 0 6.719704401803028e-07
IC O 0 4.820619281531435e-08
lack O 0 2.776819030790578e-13
expression O 0 4.4657664915461696e-15
of O 0 4.918336099311191e-18
the O 0 2.1807788610556838e-15
imprinted O 0 8.477891277891558e-09
genes O 0 1.3819024050065742e-12
Zfp127 O 0 3.075117382955739e-10
( O 0 9.021775714474135e-17
mouse O 0 1.8985391384007677e-11
homologue O 0 1.512130420877611e-10
of O 0 6.760411864646307e-14
ZNF127 O 0 1.3230302329247934e-06
) O 0 5.843547217290745e-13
, O 0 1.679320406149619e-14
Ndn O 0 2.4141294518997825e-10
and O 0 6.846696061664492e-13
Ipw O 0 3.780870408420789e-11
, O 0 1.2618697048643462e-13
and O 0 9.775056198507714e-13
manifest O 0 4.407116598742489e-12
several O 0 2.699988458382415e-16
phenotypes O 0 2.801098762661436e-12
common O 0 5.2479170314922996e-11
to O 0 9.65588810686313e-07
PWS B-Disease 1 0.9999978542327881
infants O 0 0.0002638410951476544
. O 0 6.448474133141646e-12

These O 0 1.2490635153787621e-13
data O 0 8.957695289734183e-14
demonstrate O 0 2.994546410427408e-14
that O 0 1.6879354935528477e-15
both O 0 3.2138341136915397e-16
the O 0 3.4765232769532134e-15
position O 0 6.663737270318215e-12
of O 0 9.307407301125228e-18
the O 0 2.043516536678414e-15
IC O 0 5.480573026656055e-12
and O 0 3.828286361420678e-14
its O 0 8.447705751917433e-17
role O 0 3.566087905521173e-15
in O 0 9.216112204098363e-18
the O 0 2.180660349234962e-17
coordinate O 0 1.963127197694009e-13
expression O 0 3.646842756162977e-14
of O 0 1.2869951156275001e-18
genes O 0 1.5001873585412614e-15
is O 0 4.880880120403871e-18
conserved O 0 4.222876141091414e-17
between O 0 8.183780936992305e-14
mouse O 0 8.878539574652677e-07
and O 0 2.4647803797961387e-09
human O 0 3.4015440204121505e-12
, O 0 3.832399553412545e-14
and O 0 9.659975727313586e-13
indicate O 0 4.636566534898558e-14
that O 0 2.1393983369669958e-15
the O 0 2.902637914639454e-16
mouse O 0 6.237005911735594e-10
is O 0 1.1420227590474511e-15
a O 0 1.994775825673678e-17
suitable O 0 7.659322530601323e-14
model O 0 3.42008643627878e-11
system O 0 1.9789914151857602e-10
in O 0 3.711980013323306e-15
which O 0 5.818727983030727e-15
to O 0 2.0096847635982114e-17
investigate O 0 3.957489601409209e-16
the O 0 4.7150010426752436e-18
molecular O 0 2.2096669263392366e-17
mechanisms O 0 3.310832753390856e-17
of O 0 4.171318025209772e-19
imprinting O 0 9.038647608150541e-11
in O 0 3.89732522174265e-15
this O 0 1.0618658474919595e-16
region O 0 1.35629943657145e-15
of O 0 1.4310116029711981e-18
the O 0 3.185068980681902e-15
genome O 0 2.2617973032684757e-12
. O 0 7.844207596842401e-13
. O 0 2.4349181525218366e-12

Mutations O 0 2.5635694955727928e-11
of O 0 1.4348505192427353e-16
the O 0 5.819476998384116e-17
ATM O 0 9.216669094591623e-12
gene O 0 2.5966576978897482e-12
detected O 0 2.2755015649522647e-08
in O 0 2.241219883292178e-11
Japanese O 1 0.8088173866271973
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999995231628418
telangiectasia I-Disease 1 0.9999998807907104
patients O 0 0.00017727359954733402
: O 0 1.0255269127391192e-13
possible O 0 1.244078688367688e-15
preponderance O 0 3.912346575180026e-12
of O 0 6.449835609008317e-17
the O 0 7.0104309185005376e-15
two O 0 1.0279828339477062e-13
founder O 0 2.032477137980937e-11
mutations O 0 3.0644215463782043e-13
4612del165 O 0 2.822508069280638e-12
and O 0 2.0429584673270496e-12
7883del5 O 0 1.2129632021018466e-10
. O 0 4.066249073564343e-12

The O 0 1.8823908631924319e-13
ATM O 0 2.665354656983254e-07
( O 0 1.0417130269502195e-08
A O 1 0.9999994039535522
- O 1 0.9999990463256836
T O 1 0.9999998807907104
, O 0 4.30555157499013e-12
mutated O 0 2.5352376448184444e-13
) O 0 9.785948987152263e-17
gene O 0 8.641511654809545e-16
on O 0 2.4890213588119048e-12
human O 0 3.6370247091799257e-12
chromosome O 0 1.5719898271981947e-07
11q22 O 0 2.6097000116465097e-09
. O 0 7.333103742290792e-12

3 O 0 2.5734829822710026e-09
has O 0 2.756505614043281e-11
recently O 0 6.868752528560451e-12
been O 0 1.5819393321334085e-13
identified O 0 1.877033481445002e-14
as O 0 3.763217499523862e-17
the O 0 9.798896566107099e-20
gene O 0 2.3828846677443735e-17
responsible O 0 9.980330475401814e-17
for O 0 2.1256785276280843e-19
the O 0 2.4089716546283604e-15
human O 0 1.8409929136709025e-09
recessive B-Disease 0 0.49066588282585144
disease I-Disease 1 0.9999878406524658
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999982118606567
telangiectasia I-Disease 1 0.9999997615814209
( O 0 0.011408649384975433
A B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999983310699463
T I-Disease 1 0.9999995231628418
) O 0 7.978530058849742e-10
. O 0 1.7502635625554763e-12

In O 0 1.2328542524429713e-14
order O 0 3.4908205048885964e-16
to O 0 2.3360570468254605e-16
define O 0 2.0045503953025796e-14
the O 0 1.7080799487418047e-15
types O 0 3.4906411528617953e-12
of O 0 4.018551984230623e-13
disease O 0 2.5417078219902578e-08
- O 0 3.601370934802617e-08
causing O 0 1.426689599792752e-10
ATM O 0 1.982840454328727e-11
mutations O 0 8.552883228041264e-12
in O 0 1.7832725584827208e-13
Japanese O 0 5.9450409025885165e-05
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 8.65052875251987e-13
as O 0 2.4240686669544086e-17
well O 0 1.839721481595103e-17
as O 0 3.6573281240774786e-17
to O 0 2.2510247327395814e-16
look O 0 1.4007469610830274e-15
for O 0 4.816727232962049e-21
possible O 0 2.9089309641190533e-18
mutational O 0 2.0260847849711688e-13
hotspots O 0 1.0741472815378739e-12
, O 0 1.0589174978561347e-15
reverse O 0 2.3148007122220093e-10
- O 0 3.24415598551564e-11
transcribed O 0 1.4917916901779904e-09
RNA O 0 1.4874709464152147e-08
derived O 0 1.701072008947202e-13
from O 0 1.6743654963422418e-15
ten O 0 1.2021688480963049e-16
patients O 0 3.0691151101254066e-19
belonging O 0 1.3022197108436624e-19
to O 0 3.320519700108342e-18
eight O 0 5.652106861426913e-16
unrelated O 0 1.00587040866712e-12
Japanese O 0 2.5212800665030954e-06
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
families O 0 1.0790107696223572e-10
was O 0 3.6753054348829736e-14
analyzed O 0 3.864238420757003e-15
for O 0 4.588727579470808e-20
mutations O 0 2.603503415125433e-18
by O 0 6.046973974863344e-20
the O 0 1.0339437124425482e-19
restriction O 0 3.676475783614917e-18
endonuclease O 0 3.455252035010348e-14
fingerprinting O 0 1.4509363762543748e-12
method O 0 5.102259760525474e-13
. O 0 1.5977570828884513e-12

As O 0 6.352024808919943e-12
has O 0 6.264133742966971e-12
been O 0 3.679643829218593e-12
reported O 0 1.874870701398801e-12
by O 0 2.7527369057770844e-16
others O 0 5.736808462086448e-14
, O 0 6.765788989937644e-18
mutations O 0 3.1801368931184975e-17
that O 0 1.8816277881509094e-15
lead O 0 1.5733604469183454e-13
to O 0 1.9594440697404516e-15
exon O 0 6.152317153992892e-13
skipping O 0 2.0458899019359933e-09
or O 0 1.496404666845308e-10
premature O 0 4.2408519187672744e-13
protein O 0 7.810972556620654e-17
truncation O 0 9.202817137900568e-14
were O 0 1.3560228460940404e-11
also O 0 1.8639989725344197e-12
predominant O 0 1.5338644243634292e-10
in O 0 1.4728622238936034e-14
our O 0 2.78172151979561e-10
mutants O 0 1.4299049722055202e-09
. O 0 4.246793346672495e-13

Six O 0 6.008701348980683e-12
different O 0 1.2866626345161875e-16
mutations O 0 1.1002314239793448e-14
were O 0 6.47921522206954e-14
identified O 0 1.0848119684448917e-13
on O 0 5.940083147581987e-11
12 O 0 1.578711120164833e-13
of O 0 9.587848825740919e-18
the O 0 1.3881936575190108e-14
16 O 0 6.520275313594281e-14
alleles O 0 5.583195987783271e-14
examined O 0 1.3456433745062668e-09
. O 0 7.345762192967342e-11

Four O 0 1.3499879653825625e-13
were O 0 2.216862464608717e-15
deletions O 0 1.9332163907898048e-12
involving O 0 1.1867935453824252e-11
a O 0 1.0835516511820131e-11
loss O 0 1.0091146668278483e-11
of O 0 3.9388828580217854e-19
a O 0 5.054065072369527e-16
single O 0 3.69371755946403e-14
exon O 0 1.951484113194013e-12
exon O 0 2.5722682664430785e-11
7 O 0 7.623533748724043e-12
, O 0 6.1690078704559025e-15
exon O 0 1.0319495908836518e-12
16 O 0 1.2424585015338718e-12
, O 0 6.8970589466423385e-15
exon O 0 9.235144766972514e-12
33 O 0 2.8800456811084452e-11
or O 0 4.3706128993736826e-11
exon O 0 3.0509802684264287e-08
35 O 0 4.830006972156298e-08
. O 0 2.984633340474829e-08

The O 0 1.9136614222512588e-13
others O 0 2.7960462721174362e-14
were O 0 1.325370319670035e-16
minute O 0 2.622964840812825e-16
deletions O 0 2.5654537495018934e-14
, O 0 2.0094406129686103e-16
4649delA O 0 6.055083463709504e-14
in O 0 2.290958597346253e-18
exon O 0 4.074762107049955e-14
33 O 0 5.952038856357408e-14
and O 0 1.2019821038012149e-14
7883del5 O 0 1.370697988705566e-13
in O 0 4.56527094587104e-16
exon O 0 1.363568147283445e-10
55 O 0 4.926214436373755e-10
. O 0 1.867645066377932e-10

The O 0 1.97866760953333e-13
mutations O 0 1.2336646461330592e-12
4612del165 O 0 1.262301981691527e-11
and O 0 1.2540987128981107e-12
7883del5 O 0 4.904483937029358e-13
were O 0 5.326204429757786e-13
found O 0 6.646010239537425e-14
in O 0 2.068461488230208e-18
more O 0 6.861980815245064e-20
than O 0 1.2252839005640467e-19
two O 0 3.313421042886565e-18
unrelated O 0 1.9078510811649553e-14
families O 0 3.865110271769612e-14
; O 0 6.2970579968477325e-18
44 O 0 3.9485621388429446e-16
% O 0 2.6813663397753556e-18
( O 0 7.032540675415582e-19
7 O 0 3.2090476787373715e-14
of O 0 2.5974845015726397e-16
16 O 0 5.4361646206670805e-14
) O 0 3.869308707039708e-17
of O 0 6.800118045183754e-20
the O 0 1.9176410350297613e-16
mutant O 0 1.7460855894838034e-12
alleles O 0 9.953080128469443e-15
had O 0 4.6051470969921127e-10
one O 0 2.930501165083338e-13
of O 0 3.0531434932679264e-17
the O 0 4.4695946569512854e-14
two O 0 1.5081432630514868e-11
mutations O 0 2.1995200105706658e-10
. O 0 2.0463845895601906e-10

The O 0 4.2382482072500505e-13
4612del165 O 0 7.596479001392709e-12
mutations O 0 3.40280104441093e-13
in O 0 9.278135265218773e-16
three O 0 6.574416685494887e-16
different O 0 8.002219890616467e-16
families O 0 1.0832529534834934e-13
were O 0 3.967634038562441e-15
all O 0 4.708187452572068e-19
ascribed O 0 3.178487164104822e-17
to O 0 1.0966518362744685e-16
the O 0 3.049908886200599e-16
same O 0 2.183278379050066e-13
T O 0 2.0896624430832844e-09
- O 0 1.0946394615393706e-12
- O 0 3.868003194216346e-13
> O 0 2.855214475525319e-18
A O 0 2.6635957601819375e-19
substitution O 0 5.878081917602886e-19
at O 0 1.7537152781432286e-16
the O 0 1.0313556064775375e-19
splice O 0 6.3299040488351555e-12
donor O 0 2.7102367100112447e-15
site O 0 8.925768923886274e-14
in O 0 1.5190579026473275e-16
intron O 0 4.760587657415272e-08
33 O 0 2.0848522908067935e-10
. O 0 2.5883802479836904e-12

Microsatellite O 0 7.169027327336153e-08
genotyping O 0 1.5460251967525096e-09
around O 0 2.1470050130117935e-12
the O 0 3.8708902763709093e-16
ATM O 0 1.094340035256991e-10
locus O 0 6.873306923615985e-10
also O 0 4.385487251123976e-10
indicated O 0 9.111202244060923e-12
that O 0 5.323436902068563e-15
a O 0 2.615522544640453e-15
common O 0 4.802436118049591e-13
haplotype O 0 3.0619153879030137e-09
was O 0 4.5358095057679293e-10
shared O 0 1.3611988868966057e-13
by O 0 1.5175452209175396e-17
the O 0 7.46335420553443e-17
mutant O 0 4.49819001491214e-12
alleles O 0 3.675473486219709e-14
in O 0 5.87937257743882e-15
both O 0 1.8240964294591322e-13
mutations O 0 1.052412462732022e-10
. O 0 5.528791313658132e-10

This O 0 1.3370937386805726e-12
suggests O 0 3.766788964076895e-12
that O 0 1.2744960523145693e-13
these O 0 6.358939931691218e-14
two O 0 2.7835855365490603e-13
founder O 0 7.077836927660286e-11
mutations O 0 1.561712890084388e-12
may O 0 1.0048650008875198e-13
be O 0 6.119920908264197e-17
predominant O 0 4.0951465309080337e-13
among O 0 4.3760652259759063e-16
Japanese O 0 2.0134413613367291e-13
ATM O 0 8.431428333288693e-10
mutant O 0 4.986498436387876e-10
alleles O 0 1.9466633166542735e-11
. O 0 9.101288472868063e-11

W474C O 0 4.2528144894582454e-10
amino O 0 1.7192150481015744e-12
acid O 0 2.990944487522504e-14
substitution O 0 9.442520802176987e-17
affects O 0 2.0385091955316017e-16
early O 0 7.738631972458197e-18
processing O 0 4.857275363571813e-17
of O 0 6.977729232335375e-20
the O 0 6.25859430515917e-19
alpha O 0 1.027076665792286e-18
- O 0 2.5262832098114637e-17
subunit O 0 1.9391115335325347e-18
of O 0 3.2448620389714856e-18
beta O 0 2.9352082372855132e-15
- O 0 1.174435548811914e-11
hexosaminidase O 0 4.140154885590164e-10
A O 0 3.337186822998002e-14
and O 0 7.697190832574221e-15
is O 0 2.335377369059738e-18
associated O 0 3.6916131061065765e-17
with O 0 7.390719912697512e-15
subacute O 0 2.9500570875029553e-09
G B-Disease 0 5.288721993679246e-08
( I-Disease 0 6.52121348728666e-16
M2 I-Disease 0 2.544846466889794e-08
) I-Disease 0 7.250936656655327e-11
gangliosidosis I-Disease 0 6.385478172887815e-07
. O 0 4.19052188782576e-11

Mutations O 0 7.638358834327619e-10
in O 0 1.9560442404264328e-13
the O 0 3.0290980278403897e-15
HEXA O 0 6.851209877201114e-11
gene O 0 1.2673300180555264e-14
, O 0 7.588143003616424e-18
encoding O 0 8.840657198807228e-19
the O 0 3.3447122514836804e-18
alpha O 0 1.389881970206923e-17
- O 0 7.173855020124059e-16
subunit O 0 1.0556218250072662e-16
of O 0 9.1740960611921e-17
beta O 0 9.248197775082664e-14
- O 0 1.343569344669504e-08
hexosaminidase O 0 2.076924943139602e-07
A O 0 4.771195157710073e-12
( O 0 4.190090837512875e-18
Hex O 0 5.298129014501274e-13
A O 0 1.846698690504984e-15
) O 0 8.529366180041526e-18
, O 0 2.272747492377862e-19
that O 0 3.316745326672051e-19
abolish O 0 2.4855070106434172e-15
Hex O 0 1.1138340277232553e-13
A O 0 1.845302303751876e-17
enzyme O 0 2.121851922409681e-14
activity O 0 1.3124549225196347e-09
cause O 0 0.17761565744876862
Tay B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
Sachs I-Disease 1 0.9999998807907104
disease I-Disease 1 0.6112099885940552
( O 0 4.312779720481129e-14
TSD B-Disease 0 1.787533010499942e-09
) O 0 9.770801518132338e-14
, O 0 1.972666254047091e-15
the O 0 7.959483902053935e-14
fatal O 0 2.7604196475294884e-06
infantile B-Disease 0 0.0006776458467356861
form I-Disease 0 5.961887927785625e-11
of I-Disease 0 5.344423254644015e-12
G I-Disease 0 3.7839606648049084e-06
( I-Disease 0 4.643447322342283e-16
M2 I-Disease 0 1.3810719234896851e-09
) I-Disease 0 5.430926108135337e-12
gangliosidosis I-Disease 0 9.866297112637312e-09
, I-Disease 0 8.02818708321891e-14
Type I-Disease 0 1.6944183686348757e-12
1 I-Disease 0 3.27647804720943e-12
. O 0 2.2466137283849719e-10

Less O 0 2.9658313582814344e-09
severe O 0 7.074702779164e-08
, O 0 4.724537818259766e-13
subacute O 0 1.3868341852685262e-07
( O 0 8.540783098115456e-13
juvenile O 0 0.00018044871103484184
- O 1 0.9608378410339355
onset O 0 0.21426346898078918
) O 0 7.956986110002617e-07
and O 0 8.130133937811479e-05
chronic O 0 0.004307411145418882
( O 0 2.1574791446107335e-14
adult O 0 3.9683146724200924e-07
- O 0 0.00036042125429958105
onset O 0 2.4475002646795474e-07
) O 0 4.477752600672881e-14
variants O 0 1.6076629434712102e-14
are O 0 1.0018933340228439e-16
characterized O 0 1.7677741721830779e-15
by O 0 5.726850636879408e-17
a O 0 3.4717786218991685e-15
broad O 0 1.5263791207538457e-13
spectrum O 0 9.367565750872942e-11
of O 0 1.4047762968131161e-15
clinical O 0 9.037146980186636e-15
manifestations O 0 7.310950347720613e-13
and O 0 1.6695271467387363e-12
are O 0 1.1439106896077625e-15
associated O 0 3.007385058215531e-14
with O 0 2.591738130532095e-13
residual O 0 1.2391548231960314e-08
levels O 0 1.0260562365027592e-11
of O 0 9.733820561257539e-18
Hex O 0 1.6568650618165037e-10
A O 0 2.597277878473069e-15
enzyme O 0 8.91589506082013e-15
activity O 0 7.622687203667766e-13
. O 0 9.852869388427e-13

We O 0 7.395182556602098e-13
identified O 0 2.0833771448465488e-14
a O 0 5.0113903878165524e-15
1422 O 0 1.2819142969355823e-10
G O 0 1.108255087700627e-08
- O 0 2.673565369093467e-09
- O 0 2.97379720848312e-08
> O 0 7.743779575908327e-12
C O 0 6.027567334143669e-10
( O 0 1.2661779367802303e-17
amino O 0 2.6464932985051815e-16
acid O 0 3.448031245894616e-17
W474C O 0 1.0321005472426269e-17
) O 0 1.3260403152866875e-20
substitution O 0 3.87546298508083e-20
in O 0 1.8647959729395456e-19
the O 0 4.421987613519666e-19
first O 0 1.7340830727465685e-17
position O 0 1.665791087696305e-14
of O 0 1.8469624759207852e-19
exon O 0 7.193511330225513e-14
13 O 0 3.6280000000315366e-14
of O 0 3.3647047105807195e-16
HEXA O 0 4.2124213450733805e-07
of O 0 1.4765806985320498e-14
a O 0 9.807893212865348e-12
non O 0 1.4772259804285426e-10
- O 0 6.462143574026413e-06
Jewish O 0 0.00010213872883468866
proband O 0 0.023553986102342606
who O 0 3.7077133030472e-11
manifested O 0 1.59891780262926e-13
a O 0 4.958104709775087e-17
subacute O 0 4.19486390068613e-11
variant O 0 6.138518582332608e-10
of O 0 2.804029404501751e-11
G B-Disease 0 0.0008209175430238247
( I-Disease 0 1.6756187027635282e-14
M2 I-Disease 0 1.1820078071878015e-07
) I-Disease 0 2.2384612219372713e-10
gangliosidosis I-Disease 0 2.587640665296931e-06
. O 0 1.1066231958567485e-10

On O 0 1.2095883183960154e-09
the O 0 1.3783704212733117e-11
second O 0 3.920868074658301e-09
maternally O 0 2.4069104256341234e-06
inherited O 0 6.356642501259557e-08
allele O 0 3.680742655109981e-10
, O 0 1.1306070012498393e-12
we O 0 6.998143519754488e-14
identified O 0 1.7059978104673468e-13
the O 0 7.799971606103906e-13
common O 0 7.945839115564013e-07
infantile O 1 0.9999468326568604
disease O 1 0.9894545078277588
- O 0 0.00330769713036716
causing O 0 7.629554602317512e-05
4 O 0 1.6475678460414755e-11
- O 0 3.5947789189805235e-10
bp O 0 2.454745825011817e-12
insertion O 0 2.226050832380977e-13
, O 0 1.1982692195802204e-14
+ O 0 1.6214723248982044e-13
TATC O 0 2.1583684839399098e-10
1278 O 0 5.3762834462123266e-11
, O 0 5.870696418960094e-16
in O 0 1.0660415875730252e-17
exon O 0 2.3069102184081203e-11
11 O 0 2.4877236382003787e-10
. O 0 2.255104436521549e-11

Pulse O 0 2.253323509648908e-05
- O 0 3.609430265782976e-08
chase O 0 1.546139327679441e-10
analysis O 0 2.0351611919284607e-15
using O 0 3.876315416518955e-15
proband O 0 9.916944349042112e-11
fibroblasts O 0 1.219450213550688e-12
revealed O 0 2.6410139700172586e-11
that O 0 6.315226721217439e-16
the O 0 4.868554136660096e-17
W474C O 0 1.7941687564348822e-14
- O 0 8.93301952591477e-15
containing O 0 7.582768645740545e-16
alpha O 0 7.906087242844044e-18
- O 0 5.702782989776566e-17
subunit O 0 8.872752840550051e-19
precursor O 0 3.2964298845650827e-16
was O 0 4.522156087094498e-12
normally O 0 1.1977057785576628e-16
synthesized O 0 8.776925753295906e-16
, O 0 9.149177410675062e-17
but O 0 1.5101772915909582e-16
not O 0 2.149366989968254e-18
phosphorylated O 0 1.85694053644715e-16
or O 0 1.5867093388835648e-15
secreted O 0 8.065840747042974e-13
, O 0 9.321531854776868e-14
and O 0 2.500837427768521e-12
the O 0 2.6154939149268357e-14
mature O 0 5.172092138253093e-13
lysosomal O 0 1.1177974778425748e-12
alpha O 0 5.204720999346137e-16
- O 0 2.371545071867126e-13
subunit O 0 9.62454400031676e-15
was O 0 6.367715799093787e-10
not O 0 2.634330199726559e-13
detected O 0 3.785994087679434e-11
. O 0 2.334572964633741e-13

When O 0 3.301434126079528e-11
the O 0 6.575272400529851e-15
W474C O 0 1.1605199223482798e-12
- O 0 6.910866193546306e-13
containing O 0 1.546481414877853e-14
alpha O 0 2.7863543199646275e-16
- O 0 1.882368264353399e-14
subunit O 0 1.6062207692933472e-16
was O 0 5.1546458074147594e-11
transiently O 0 2.6172796568912915e-11
co O 0 3.117612071279474e-12
- O 0 5.589016120570445e-13
expressed O 0 4.2058851895650847e-16
with O 0 7.34355065956817e-18
the O 0 7.788531022524999e-19
beta O 0 6.950449720462171e-19
- O 0 4.269181298191826e-18
subunit O 0 6.325656939346141e-19
to O 0 1.7338127832096107e-16
produce O 0 1.5457535687307004e-17
Hex O 0 2.023157710156001e-13
A O 0 1.5095800857175407e-14
( O 0 2.8011648399398792e-18
alphabeta O 0 9.414454459066857e-12
) O 0 2.309950961995491e-16
in O 0 6.537674249127568e-17
COS O 0 4.2965995206145635e-09
- O 0 8.908923078421171e-12
7 O 0 2.2040552840945846e-14
cells O 0 1.9025964275733685e-14
, O 0 1.9032913704609874e-16
the O 0 1.924279192532724e-17
mature O 0 1.8819355522783383e-16
alpha O 0 5.29497025056552e-19
- O 0 1.3501505332397555e-16
subunit O 0 2.795967415997025e-17
was O 0 4.9923773448590225e-11
present O 0 3.764715014069938e-15
, O 0 2.51687687584498e-16
but O 0 1.9743526966450745e-15
its O 0 8.310333948531731e-16
level O 0 2.182226863879015e-15
was O 0 8.992725184300832e-13
much O 0 7.611720761273289e-16
lower O 0 9.594810179252818e-16
than O 0 1.3237175300880927e-17
that O 0 2.7596879757796084e-15
from O 0 7.83227675873308e-17
normal O 0 2.8832670652291362e-18
alpha O 0 8.112797713367091e-19
- O 0 4.7220412595867437e-17
subunit O 0 3.482929168757616e-18
transfections O 0 4.7135254033214835e-11
, O 0 1.7005559535946917e-17
although O 0 3.938539422971211e-18
higher O 0 4.359249686370275e-18
than O 0 4.123997038618356e-18
in O 0 1.2043025935736099e-17
those O 0 9.163188659111628e-16
cells O 0 4.004549428469678e-17
transfected O 0 1.6475841144950737e-14
with O 0 1.464171226456433e-17
an O 0 1.3949704544631042e-17
alpha O 0 2.903493417916181e-14
- O 0 1.8790637448806713e-11
subunit O 0 1.8017012578044889e-12
associated O 0 2.915665486824537e-09
with O 0 1.1670717170453315e-10
infantile O 0 0.032395146787166595
TSD B-Disease 0 2.1990454115439206e-05
. O 0 3.685862379199101e-11

Furthermore O 0 2.9950590618721407e-11
, O 0 7.580661968921605e-15
the O 0 1.0700750856759563e-17
precursor O 0 1.1432868498421097e-15
level O 0 2.5149183408533504e-13
of O 0 4.297776518377478e-18
the O 0 5.293221648653226e-16
W474C O 0 1.0072204301072446e-15
alpha O 0 1.7163200515159976e-18
- O 0 3.684269396628331e-17
subunit O 0 1.3841411713196825e-17
was O 0 3.989938240911428e-11
found O 0 6.444413145484384e-13
to O 0 3.969783808182572e-15
accumulate O 0 2.891772379279983e-13
in O 0 6.981034206623436e-19
comparison O 0 6.8028499901024696e-18
to O 0 1.6186084937980434e-16
the O 0 2.5596250405061287e-16
normal O 0 4.047075246982172e-16
alpha O 0 3.165950414740968e-17
- O 0 1.844304975396043e-15
subunit O 0 1.8765733043266266e-16
precursor O 0 1.58853385632228e-13
levels O 0 2.517890626899111e-12
. O 0 4.9659207274716996e-14

We O 0 2.1252726141451905e-12
conclude O 0 1.2763686219323823e-14
that O 0 1.889481424698292e-16
the O 0 4.402251514238069e-16
1422 O 0 1.0007161072023152e-10
G O 0 3.992317587631078e-09
- O 0 3.7568503863383285e-09
- O 0 4.146195919929596e-08
> O 0 5.3898031870946994e-12
C O 0 4.311651383148707e-11
mutation O 0 2.838505662071042e-15
is O 0 4.745609554297401e-16
the O 0 6.760762213355159e-17
cause O 0 3.630935138600362e-14
of O 0 1.6176871386727512e-18
Hex B-Disease 0 1.0168061947979368e-07
A I-Disease 0 3.087291844394713e-08
enzyme I-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
in O 0 8.462635025250145e-14
the O 0 2.8850693535587e-12
proband O 0 1.3963676792627666e-05
. O 0 6.985245021295938e-11

The O 0 6.399652400894407e-14
resulting O 0 1.5125543572085294e-14
W474C O 0 7.779107897122953e-14
substitution O 0 2.4178282311248514e-15
clearly O 0 1.6202727907196207e-13
interferes O 0 1.0051564479840111e-13
with O 0 3.835243589617427e-18
alpha O 0 2.6696904786340165e-18
- O 0 7.42000200050277e-18
subunit O 0 1.0580073270399049e-18
processing O 0 1.4672815049689711e-15
, O 0 3.506300164348567e-17
but O 0 1.508760066503859e-17
because O 0 3.9867407494542333e-20
the O 0 2.6429959417814267e-21
base O 0 1.1735402635806457e-18
substitution O 0 8.67648736573735e-17
falls O 0 9.144630365442996e-12
at O 0 2.203658915026917e-15
the O 0 4.167073709787974e-18
first O 0 2.510356575035694e-16
position O 0 2.5895344896165184e-13
of O 0 3.2941136134138117e-18
exon O 0 2.1464512838572508e-13
13 O 0 7.9494252163987e-14
, O 0 9.733008766204379e-17
aberrant O 0 4.742664526618916e-14
splicing O 0 9.469694473018819e-11
may O 0 4.513179760468056e-11
also O 0 4.00162123557102e-15
contribute O 0 2.7425383643943466e-16
to O 0 6.193466421146321e-13
Hex B-Disease 0 7.620141332154162e-06
A I-Disease 0 9.492654839959869e-08
deficiency I-Disease 0 1.7209600628120825e-05
in O 0 4.694008836546261e-16
this O 0 2.6607983614953265e-15
proband O 0 2.0260126021298674e-08
. O 0 4.677446581100031e-13
. O 0 5.104238212649825e-12

Two O 0 7.341570927577035e-12
frequent O 0 3.6319141027973956e-09
missense O 0 1.2332294545558398e-06
mutations O 0 9.546140790916979e-05
in O 0 0.00046848345664329827
Pendred B-Disease 1 0.9999973773956299
syndrome I-Disease 1 0.9999995231628418
. O 0 2.2294955215329537e-06

Pendred B-Disease 1 0.9999737739562988
syndrome I-Disease 1 0.9999986886978149
is O 0 1.2038407476211432e-05
an O 0 0.0010910793207585812
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.7203412652015686
by O 0 2.7066493490934818e-09
early O 0 1.1553316653589718e-05
childhood O 1 0.9998630285263062
deafness B-Disease 1 0.9999995231628418
and O 0 0.3464679419994354
goiter B-Disease 1 0.9999884366989136
. O 0 2.280837563262139e-08

A O 0 4.049871115546777e-12
century O 0 1.9342784752379716e-12
after O 0 2.1307754822716407e-13
its O 0 2.1674006109285125e-16
recognition O 0 3.455933864769152e-16
as O 0 8.483018432668687e-13
a O 0 3.954151450713539e-10
syndrome O 0 0.00011476427607703954
by O 0 3.0171638841849924e-14
Vaughan O 0 1.3892548444971453e-08
Pendred O 0 8.451286817034998e-07
, O 0 1.0761199873907112e-12
the O 0 3.962344233103543e-13
disease O 0 6.43714734294143e-11
gene O 0 5.977004915308504e-12
( O 0 1.8376623736170855e-14
PDS O 0 1.82233801382381e-08
) O 0 2.202516055822834e-15
was O 0 2.0372489502665236e-13
mapped O 0 2.423125033956808e-10
to O 0 6.586026429084013e-12
chromosome O 0 2.6180730401392793e-06
7q22 O 0 8.176441212981445e-08
- O 0 3.939393593554996e-07
q31 O 0 1.4931929470662908e-08
. O 0 4.078632570569951e-11

1 O 0 8.365934681120457e-12
and O 0 1.4163749166573592e-11
, O 0 8.122072723312345e-15
recently O 0 8.297707681549638e-13
, O 0 6.141974866883841e-17
found O 0 4.8518675875991864e-17
to O 0 4.2628975172709905e-19
encode O 0 6.572406570431934e-17
a O 0 5.3967741396074734e-17
putative O 0 3.97697456563928e-12
sulfate O 0 2.6989552953660123e-11
transporter O 0 1.8623394382188962e-08
. O 0 1.2372146362960024e-10

We O 0 2.5749777310402067e-11
performed O 0 6.73752367915878e-14
mutation O 0 1.3172107718797954e-15
analysis O 0 1.8539687742912675e-15
of O 0 1.4784157729129636e-17
the O 0 2.6602821372656224e-14
PDS B-Disease 0 1.064372323611451e-08
gene O 0 1.0075525483377312e-12
in O 0 1.400002482649862e-14
patients O 0 1.440368684784213e-14
from O 0 1.070950130267474e-15
14 O 0 2.0272512171021738e-14
Pendred B-Disease 0 4.896294480971619e-10
families O 0 1.3814009615017997e-13
originating O 0 2.356179216577575e-13
from O 0 2.4823212604364875e-13
seven O 0 1.828001725684425e-12
countries O 0 6.603554915341966e-14
and O 0 1.0899893184215803e-12
identified O 0 1.311122000899334e-12
all O 0 2.921211864865083e-15
mutations O 0 2.193225635827023e-12
. O 0 4.460487101204391e-12

The O 0 2.109826798945419e-13
mutations O 0 3.8072510096832934e-13
include O 0 3.253282661506659e-15
three O 0 9.4021610057293e-16
single O 0 2.680175553064837e-14
base O 0 1.921198795754378e-13
deletions O 0 1.4921999400008268e-11
, O 0 5.026556428033846e-14
one O 0 5.343820749944238e-16
splice O 0 9.25436083321074e-09
site O 0 3.7053418111554492e-09
mutation O 0 8.942038776105221e-11
and O 0 8.916360427768666e-10
10 O 0 1.0263904526644496e-12
missense O 0 5.877593411973692e-10
mutations O 0 2.4930162378922205e-09
. O 0 3.303717965863484e-09

One O 0 3.396968123459132e-11
missense O 0 1.5324381763548445e-09
mutation O 0 6.710421801559008e-11
( O 0 2.2473860337816898e-13
L236P O 0 9.52968173123514e-12
) O 0 2.9243588887256644e-13
was O 0 1.0093615526729494e-10
found O 0 1.3492626070241154e-12
in O 0 2.266524840104294e-17
a O 0 1.3290200886868026e-17
homozygous O 0 4.887166653354605e-15
state O 0 5.206111192170818e-16
in O 0 2.0226212066340507e-17
two O 0 7.911469839438825e-15
consanguineous O 0 5.665637958784941e-10
families O 0 2.3243915472925814e-11
and O 0 4.952028370697192e-13
in O 0 1.913643833612109e-16
a O 0 1.2846280613768826e-15
heterozygous O 0 7.725106497416881e-15
state O 0 9.459903241743626e-16
in O 0 9.995875515217401e-17
five O 0 6.455010662678685e-15
additional O 0 1.804291350725987e-15
non O 0 4.316076142318881e-12
- O 0 1.8919617161827773e-07
consanguineous O 0 1.1758743312384468e-05
families O 0 5.079732634527545e-09
. O 0 1.9878341594309346e-12

Another O 0 3.4290546097048846e-11
missense O 0 2.692248424196464e-09
mutation O 0 9.013822327430532e-11
( O 0 1.0022198186371983e-13
T416P O 0 6.61162704446161e-12
) O 0 2.0750935691982164e-13
was O 0 5.941228065076132e-11
found O 0 1.1595442488132601e-12
in O 0 3.901962488900851e-17
a O 0 1.206187655471557e-17
homozygous O 0 2.7184582235555317e-15
state O 0 2.2186054466559295e-15
in O 0 1.5801074582135464e-15
one O 0 3.7983876569232244e-13
family O 0 8.860921441034009e-10
and O 0 2.3696709525178328e-11
in O 0 6.295166863444089e-16
a O 0 6.086699349630597e-16
heterozygous O 0 1.868653276278047e-14
state O 0 3.97141942880372e-15
in O 0 1.6499103846055892e-15
four O 0 1.6342216208747873e-12
families O 0 2.2473999657796062e-12
. O 0 6.663276159134257e-13

Pendred B-Disease 0 3.196150282747112e-05
patients O 0 8.498063586159788e-09
in O 0 2.9940622463947575e-13
three O 0 1.1969158303370975e-12
non O 0 2.8664093668084867e-12
- O 0 5.1953993107645147e-08
consanguineous O 0 7.358799507528602e-07
families O 0 3.568096929029707e-10
were O 0 3.1039210644009246e-14
shown O 0 6.325642050095115e-16
to O 0 1.2200560415445292e-18
be O 0 6.83030907771678e-18
compound O 0 2.139830085542079e-16
heterozygotes O 0 6.604652717687211e-17
for O 0 1.3699574019586591e-18
L236P O 0 5.032660486264939e-13
and O 0 5.268562279156508e-13
T416P O 0 2.5299122172195432e-11
. O 0 5.160365949656576e-13

In O 0 8.509741305715024e-13
total O 0 1.5874639181846263e-14
, O 0 1.6040547525224963e-14
one O 0 5.0375553202605325e-14
or O 0 4.770458333913652e-12
both O 0 5.199544357488992e-15
of O 0 7.074006412342252e-18
these O 0 4.311311674740683e-16
mutations O 0 5.446142859368149e-16
were O 0 6.984128851422397e-14
found O 0 1.2215360016901156e-12
in O 0 2.991832813325937e-15
nine O 0 3.906401569407636e-13
of O 0 2.1731531888676758e-17
the O 0 1.084336206979078e-13
14 O 0 2.2529782130620984e-13
families O 0 1.7165854512574824e-14
analyzed O 0 2.171310874155008e-12
. O 0 7.610662100532295e-12

The O 0 2.0968825769707503e-15
identification O 0 2.436598828519515e-13
of O 0 3.809046812705097e-16
two O 0 1.0805008146888562e-12
frequent O 0 5.6153724031782204e-11
PDS B-Disease 0 4.3346467748506257e-08
mutations O 0 1.8048981227777525e-14
will O 0 4.3792192325643465e-17
facilitate O 0 2.4367227105291223e-18
the O 0 1.2470440871885542e-14
molecular O 0 1.302748020570732e-09
diagnosis O 0 3.864849531964865e-06
of O 0 1.4340223231101845e-07
Pendred B-Disease 1 0.9999996423721313
syndrome I-Disease 1 0.9999996423721313
. O 0 7.595956930117609e-08

Insertional O 0 3.6745018139328067e-09
mutation O 0 9.669814862028892e-14
by O 0 3.347676966060744e-16
transposable O 0 3.4393369229002158e-12
element O 0 1.9770680047530992e-13
, O 0 4.766276417056577e-15
L1 O 0 9.628138997186397e-08
, O 0 1.7502116428239414e-14
in O 0 1.8551491941126052e-16
the O 0 5.440928740538253e-13
DMD B-Disease 1 0.999988317489624
gene O 0 4.039134651745435e-11
results O 0 7.542280168471027e-12
in O 0 9.242475708381992e-12
X B-Disease 1 0.9999891519546509
- I-Disease 1 0.9999796152114868
linked I-Disease 1 0.9999706745147705
dilated I-Disease 1 0.999968409538269
cardiomyopathy I-Disease 1 0.9999986886978149
. O 0 2.417606879134837e-07

X B-Disease 1 0.9998496770858765
- I-Disease 1 0.999923586845398
linked I-Disease 1 0.9999347925186157
dilated I-Disease 1 0.9999773502349854
cardiomyopathy I-Disease 1 0.9999996423721313
( O 0 2.53069187827748e-09
XLDCM B-Disease 0 9.80132540462364e-07
) O 0 5.523520144956953e-14
is O 0 1.2026733620955132e-16
a O 0 1.452971730358057e-16
clinical O 0 8.400751475750104e-14
phenotype O 0 1.3103699549044112e-11
of O 0 5.2777394745641935e-15
dystrophinopathy B-Disease 0 1.0928955589406542e-06
which O 0 3.104861159841654e-11
is O 0 1.3066618235546903e-14
characterized O 0 2.57636062006919e-13
by O 0 7.735426746846227e-15
preferential O 0 1.4633501355110212e-10
myocardial B-Disease 0 1.0122161029357812e-06
involvement I-Disease 0 2.7067292851512548e-11
without O 0 7.29172463105306e-15
any O 0 3.3812370731754494e-17
overt O 0 5.1694911372413e-12
clinical O 0 1.3507953436353581e-11
signs O 0 4.9615778152656276e-09
of O 0 4.414185683643268e-11
skeletal B-Disease 1 0.9999992847442627
myopathy I-Disease 1 0.9999998807907104
. O 0 3.5211749604968645e-07

To O 0 1.723843168362736e-14
date O 0 3.518994652423023e-14
, O 0 6.283958764667343e-17
several O 0 9.811248802495565e-18
mutations O 0 7.019492138157085e-14
in O 0 5.590580759830613e-14
the O 0 1.9355879121718544e-09
Duchenne B-Disease 0 0.04966988041996956
muscular I-Disease 0 4.4851768166154216e-07
dystrophy I-Disease 0 7.0459220680163526e-09
gene O 0 1.5987137169659604e-09
, O 0 3.742146592600193e-09
DMD O 1 0.9999994039535522
, O 0 1.3536706477967897e-12
have O 0 6.520644704662579e-15
been O 0 6.016505517533396e-14
identified O 0 5.269690499937196e-12
in O 0 4.2215592695562295e-15
patients O 0 6.358378602957073e-15
with O 0 5.011295096609986e-15
XLDCM B-Disease 0 8.00258774802387e-08
, O 0 8.875614409013452e-15
but O 0 2.5553030548927636e-16
a O 0 8.498242940807547e-20
pathogenic O 0 7.322546227709733e-17
correlation O 0 9.811782962647927e-16
of O 0 3.617257179099695e-17
these O 0 3.132942310527659e-13
cardiospecific O 0 3.142780480303031e-10
mutations O 0 5.522575127238361e-13
in O 0 2.3787073114185653e-13
DMD O 1 0.9999967813491821
with O 0 3.1871645080061572e-12
the O 0 2.002610967680174e-12
XLDCM B-Disease 0 0.023629384115338326
phenotype O 0 1.4554073501926723e-08
has O 0 1.5813211851067877e-09
remained O 0 5.410436335062663e-11
to O 0 5.478965280195135e-15
be O 0 8.701791728588787e-14
elucidated O 0 7.831755688414432e-09
. O 0 3.028145442729446e-11

We O 0 6.930201967847438e-10
report O 0 9.772459669829883e-14
here O 0 3.689107410595031e-17
the O 0 3.675422214008466e-19
identification O 0 1.1028066158972347e-15
of O 0 8.911252928185566e-19
a O 0 7.481283510747639e-17
unique O 0 2.8324792344095644e-16
de O 0 3.431149543089637e-14
novo O 0 4.16130411379223e-12
L1 O 0 5.021028037788255e-10
insertion O 0 3.217185971294591e-14
in O 0 3.1423090634386105e-16
the O 0 3.9485754399071945e-17
muscle O 0 1.1586896569439845e-14
exon O 0 6.8965329391820936e-15
1 O 0 8.810846034701652e-15
in O 0 2.769350775175955e-13
DMD O 1 0.9999992847442627
in O 0 1.610002008014394e-13
three O 0 1.3176570565990448e-13
XLDCM B-Disease 0 5.477270406117896e-07
patients O 0 3.7194229765341244e-14
from O 0 7.755037280110838e-17
two O 0 2.02185680307429e-14
unrelated O 0 6.01128383181937e-11
Japanese O 0 9.308829818088782e-10
families O 0 1.051386300070234e-12
. O 0 2.5683535159748416e-13

The O 0 7.151127326204213e-15
insertion O 0 1.1057444022910534e-12
was O 0 3.2183693210452446e-11
a O 0 1.7675582846606464e-15
5 O 0 2.1384682947909106e-15
- O 0 9.9563612562803e-12
truncated O 0 1.774154174266629e-12
form O 0 6.25555219129219e-15
of O 0 8.875161590493806e-18
human O 0 2.3812696538466453e-15
L1 O 0 8.452127019109579e-12
inversely O 0 3.824919574861932e-15
integrated O 0 3.088003398909973e-16
in O 0 8.059565476983461e-17
the O 0 3.817441968003571e-15
5 O 0 2.62218876169798e-13
- O 0 1.1846914560464938e-09
untranslated O 0 1.9654908101074398e-06
region O 0 2.196081337613176e-11
in O 0 4.6577842020075096e-15
the O 0 2.27534585445189e-15
muscle O 0 9.307638481562824e-14
exon O 0 6.7645868053400286e-15
1 O 0 6.367675213069662e-15
, O 0 8.556394796247618e-15
which O 0 6.228683205062452e-14
affected O 0 2.086650776309943e-17
the O 0 6.722055537361659e-18
transcription O 0 2.3745347701997765e-11
or O 0 6.600168189763167e-10
the O 0 1.5423882874024408e-12
stability O 0 1.1155648627081405e-09
of O 0 3.2180683255157456e-15
the O 0 2.0731532809903364e-11
muscle O 0 4.444281831439412e-09
form O 0 5.621380741265263e-16
of O 0 1.5058047156113294e-17
dystrophin O 0 1.6130749757843968e-14
transcripts O 0 2.4072850917516986e-12
but O 0 7.134209537148703e-14
not O 0 2.070580298134373e-15
that O 0 3.4234212991821836e-15
of O 0 1.7638999228916755e-16
the O 0 7.488126438359721e-12
brain O 0 4.6220296212595713e-07
or O 0 2.3322174746986946e-10
Purkinje O 0 1.508059881416557e-07
cell O 0 1.1782177580244024e-06
form O 0 4.038435974518251e-10
, O 0 2.68056088437163e-09
probably O 0 1.5306452993968378e-08
due O 0 3.0233405839616423e-13
to O 0 9.865119145028873e-15
its O 0 7.814075873581157e-16
unique O 0 2.861474826555304e-17
site O 0 1.6647818648803103e-13
of O 0 1.3112835992743793e-17
integration O 0 9.439082545095734e-13
. O 0 4.2526802392084395e-12

We O 0 3.7346807504196056e-13
speculate O 0 4.753420998016098e-15
that O 0 1.3920513961199505e-18
this O 0 8.062409069312886e-21
insertion O 0 6.321948192351698e-17
of O 0 3.856190646160625e-19
an O 0 8.849539505583853e-17
L1 O 0 1.392010062772897e-06
sequence O 0 1.5015603205270622e-09
in O 0 1.613213590490048e-10
DMD O 1 0.9999991655349731
is O 0 2.0619494559183252e-15
responsible O 0 4.0583436306819613e-17
for O 0 2.9314983640846665e-19
some O 0 1.3551647242692202e-18
of O 0 4.192777106552141e-18
the O 0 6.350772772251156e-13
population O 0 1.4152332361843257e-14
of O 0 7.098613083419459e-16
Japanese O 0 5.426916249717806e-09
patients O 0 7.638684996357946e-16
with O 0 5.232032517939167e-16
XLDCM B-Disease 0 3.512139201689024e-08
. O 0 1.9775432918804625e-13
. O 0 1.2217014509416368e-12

Severe O 0 1.7295715224463493e-05
early O 0 1.0675118744529755e-07
- O 1 0.9996154308319092
onset O 1 0.9997286200523376
obesity B-Disease 1 0.9999997615814209
, O 0 0.003551364876329899
adrenal B-Disease 1 0.9999992847442627
insufficiency I-Disease 1 0.999998927116394
and O 0 1.4490028661384713e-06
red O 0 1.9129245629301295e-05
hair O 1 0.9887392520904541
pigmentation O 0 4.024502231914084e-06
caused O 0 1.4300850503801144e-09
by O 0 1.1168580454592363e-15
POMC O 0 4.033111622447905e-09
mutations O 0 8.57913913521191e-12
in O 0 1.0858920032152768e-14
humans O 0 1.1383578541607209e-12
. O 0 1.3296579982891021e-11

Sequential O 0 2.5881926810078504e-12
cleavage O 0 3.228905365304513e-09
of O 0 2.2187577008281984e-15
the O 0 3.024384077730683e-17
precursor O 0 2.2525880379228576e-16
protein O 0 2.8427778252064495e-13
pre O 0 5.908368794216301e-10
- O 0 7.233438168441353e-07
pro O 0 2.658175844771904e-06
- O 0 1.8057744455290958e-05
opiomelanocortin O 0 9.657052032707725e-06
( O 0 7.462190329325343e-16
POMC O 0 3.3455918591052125e-11
) O 0 1.3077376083372625e-16
generates O 0 5.014330161243786e-17
the O 0 1.8054599914954018e-17
melanocortin O 0 1.1807741416569595e-11
peptides O 0 8.963280118123862e-11
adrenocorticotrophin O 0 7.459626694128474e-09
( O 0 1.1527548782474e-15
ACTH O 0 1.4749454435580844e-10
) O 0 2.7102574623184524e-15
, O 0 1.6011134517889794e-15
melanocyte O 0 2.0341275330792996e-09
- O 0 1.9885649749085132e-07
stimulating O 0 1.4687475680119633e-09
hormones O 0 2.7300731120227795e-10
( O 0 1.1478960722688226e-17
MSH O 0 7.766480600995829e-13
) O 0 2.0460962615460606e-17
alpha O 0 1.4951924846606416e-17
, O 0 3.2732450873300176e-18
beta O 0 1.3124890289015375e-18
and O 0 1.672481377430193e-16
gamma O 0 2.816874033748027e-18
as O 0 1.5786899154890918e-17
well O 0 2.6936291269203317e-17
as O 0 3.1711099951707982e-18
the O 0 9.74600327731922e-19
opioid O 0 1.373181756122294e-16
- O 0 2.811101711007642e-16
receptor O 0 9.506637225817197e-17
ligand O 0 2.892593120324555e-14
beta O 0 1.750563994977472e-12
- O 0 1.7509590577446943e-07
endorphin O 0 3.2158641261048615e-05
. O 0 8.174074611622117e-11

While O 0 1.7267636973072875e-12
a O 0 6.244128893207281e-16
few O 0 3.783445453632572e-15
cases O 0 3.5444017444890945e-15
of O 0 2.536996025924638e-15
isolated O 0 3.5739080885832664e-06
ACTH B-Disease 1 0.6237448453903198
deficiency I-Disease 0 0.0021078987047076225
have O 0 1.1930479390867554e-12
been O 0 9.263058375896804e-11
reported O 0 8.954882169120992e-09
( O 0 5.923741857281895e-16
OMIM O 0 1.4420884930643751e-08
201400 O 0 1.9175298848761457e-10
) O 0 1.4297439100696696e-13
, O 0 1.3981530709128269e-14
an O 0 1.8082208636232416e-13
inherited O 0 0.0020182798616588116
POMC O 0 0.06538411229848862
defect O 0 0.00014546963211614639
has O 0 3.2398164706570753e-10
not O 0 9.895300724649392e-13
been O 0 6.541408040239283e-12
described O 0 6.620817782909683e-11
so O 0 1.6256978402351407e-11
far O 0 3.2684013915457166e-12
. O 0 3.615513921237379e-12

Recent O 0 2.4264907791393675e-11
studies O 0 2.5363320384913512e-12
in O 0 8.534809855652737e-16
animal O 0 5.814671118729853e-14
models O 0 5.25441684587802e-15
elucidated O 0 3.0824989235385056e-14
a O 0 4.309662690189559e-18
central O 0 4.4772052281300306e-18
role O 0 4.2231014650902734e-17
of O 0 5.974271132121498e-19
alpha O 0 3.9343536905483457e-16
- O 0 7.67676460594613e-12
MSH O 0 4.5888189081910724e-11
in O 0 1.3974951751287386e-17
the O 0 8.166456402715523e-18
regulation O 0 2.8046962890418273e-16
of O 0 1.1611291939711117e-19
food O 0 1.783010475106835e-17
intake O 0 5.530105128477727e-19
by O 0 1.1361797464858932e-20
activation O 0 7.933493887207519e-17
of O 0 5.575908703934202e-17
the O 0 6.463342502264352e-14
brain O 0 2.0396588584770114e-10
melanocortin O 0 4.60964166143496e-12
- O 0 4.681732865968735e-12
4 O 0 6.790492460998854e-15
- O 0 5.074365000455952e-14
receptor O 0 1.1249785926762106e-14
( O 0 2.664361987923103e-16
MC4 O 0 1.3109544561018538e-08
- O 0 2.3359538747769193e-09
R O 0 3.3097791174441227e-09
; O 0 2.743186873994588e-16
refs O 0 2.226366226792953e-12
3 O 0 6.559006906253065e-17
- O 0 5.649493934191223e-14
5 O 0 1.243717958211276e-15
) O 0 7.64430691284755e-17
and O 0 3.511950800549039e-16
the O 0 4.4350148809867634e-18
linkage O 0 8.34055394194344e-12
of O 0 5.937315560261645e-16
human O 0 1.649253789093308e-10
obesity B-Disease 1 0.9999995231628418
to O 0 4.765381340400554e-13
chromosome O 0 5.644241074520551e-09
2 O 0 2.8123822173008184e-13
in O 0 4.591886375434995e-17
close O 0 2.2889190068602246e-14
proximity O 0 2.163510823876484e-15
to O 0 2.363495726239698e-15
the O 0 4.6098259376878e-16
POMC O 0 5.1891522329094997e-11
locus O 0 4.685475965549024e-12
, O 0 2.971661951884849e-14
led O 0 3.4773055118800028e-15
to O 0 8.669945492057688e-15
the O 0 6.868912041805078e-15
proposal O 0 8.57459855072365e-14
of O 0 2.685544429049361e-17
an O 0 3.6806630876809465e-15
association O 0 1.597794247306045e-15
of O 0 2.1985192779216554e-16
POMC O 0 5.973961947347561e-08
with O 0 2.255121610283961e-11
human O 0 3.554461898147565e-07
obesity B-Disease 1 0.9999960660934448
. O 0 2.961354494956936e-09

The O 0 3.325996840138415e-14
dual O 0 7.751470228493582e-14
role O 0 2.3802718490347798e-14
of O 0 3.395236542560093e-16
alpha O 0 1.0162060944248971e-13
- O 0 4.855949531368253e-10
MSH O 0 2.4592718972371586e-09
in O 0 1.1466443825659074e-17
regulating O 0 3.462375073876988e-15
food O 0 1.965104070948947e-14
intake O 0 6.58526645757121e-14
and O 0 3.811477839615364e-14
influencing O 0 1.442867613582477e-11
hair O 0 1.403067017236026e-06
pigmentation O 0 4.612476373067054e-11
predicts O 0 1.4934853755175365e-13
that O 0 1.5769091941536122e-16
the O 0 6.954995470838941e-16
phenotype O 0 1.1323679624183902e-12
associated O 0 8.773726103278312e-13
with O 0 4.359180117569084e-12
a O 0 8.251378746937377e-11
defect O 0 6.118004876043415e-07
in O 0 1.607454403959596e-14
POMC O 0 1.4580175955458685e-10
function O 0 7.922976782027275e-15
would O 0 1.8151941809461253e-13
include O 0 2.125263533951996e-13
obesity B-Disease 1 0.999998927116394
, O 0 2.874759024579232e-12
alteration O 0 8.008775587153849e-11
in O 0 2.1738314273656023e-11
pigmentation O 0 0.00015081455057952553
and O 0 2.1194504370214418e-05
ACTH B-Disease 1 0.9881298542022705
deficiency I-Disease 0 0.06781400740146637
. O 0 1.0469886763120329e-10

The O 0 3.554194427917573e-13
observation O 0 3.6124986335650533e-10
of O 0 1.631286522963543e-14
these O 0 6.293934817769298e-11
symptoms O 0 6.937816293683952e-11
in O 0 1.449289916364359e-17
two O 0 6.492798920038068e-14
probands O 0 2.1886195078479886e-09
prompted O 0 2.1358443984785536e-14
us O 0 7.230888660138447e-17
to O 0 2.0011453231854896e-19
search O 0 6.992182202456875e-17
for O 0 6.103876582230873e-18
mutations O 0 2.849116613207886e-14
within O 0 1.0848889309172705e-16
their O 0 3.1872112371197914e-13
POMC O 0 1.5712403600431912e-09
genes O 0 5.494252622306739e-12
. O 0 4.9885954742090455e-12

Patient O 0 3.3688203338044787e-09
1 O 0 3.1615899134807e-12
was O 0 1.342699562645322e-10
found O 0 7.484324575021684e-13
to O 0 3.0797351397349095e-15
be O 0 1.4016174462550088e-16
a O 0 4.300466096139194e-18
compound O 0 9.15228840387165e-16
heterozygote O 0 1.700187163390391e-16
for O 0 5.744148322486509e-20
two O 0 1.5880944627454522e-17
mutations O 0 3.2194295604015424e-16
in O 0 7.791807112700046e-17
exon O 0 5.230265005817802e-13
3 O 0 9.080234827929523e-12
( O 0 3.723893531726438e-15
G7013T O 0 3.4729646242182e-11
, O 0 1.6586150855535386e-12
C7133delta O 0 4.747274129357493e-09
) O 0 4.3227445548858073e-14
which O 0 1.6475580682319456e-15
interfere O 0 3.044853899450504e-15
with O 0 7.725856064499739e-19
appropriate O 0 4.840917887638092e-19
synthesis O 0 4.314239761760223e-16
of O 0 1.6683077549314954e-16
ACTH O 0 2.376583929653009e-10
and O 0 4.5408900977480376e-14
alpha O 0 3.6782158400897394e-14
- O 0 6.481481573672454e-09
MSH O 0 2.393395561739453e-07
. O 0 2.1196458217104253e-12

Patient O 0 2.975304891350561e-09
2 O 0 3.4632520375804665e-12
was O 0 1.4509363762543748e-12
homozygous O 0 7.906673091858524e-15
for O 0 1.1842070677722467e-18
a O 0 1.4333997767972153e-17
mutation O 0 1.2386470895934198e-15
in O 0 4.3328627869572336e-15
exon O 0 2.743340797584093e-11
2 O 0 1.3853716784861803e-10
( O 0 1.35205381097828e-14
C3804A O 0 7.637786236802668e-11
) O 0 3.530694887930036e-13
which O 0 1.2793337353031453e-12
abolishes O 0 9.276615031694746e-08
POMC O 0 6.890441568430106e-07
translation O 0 8.212788227268675e-10
. O 0 9.348110480145166e-11

These O 0 8.7079018854571e-14
findings O 0 1.0106881829933037e-15
represent O 0 7.659035897629822e-20
the O 0 7.744504851409747e-19
first O 0 3.2743080971352095e-17
examples O 0 5.562506128079577e-16
of O 0 1.1417129302772132e-16
a O 0 5.211770459645493e-10
genetic B-Disease 1 0.9999998807907104
defect I-Disease 1 0.9999992847442627
within O 0 1.4414729404617246e-15
the O 0 2.3176830493149426e-16
POMC O 0 4.722305879667488e-12
gene O 0 1.8440737354014428e-14
and O 0 2.2683618560435416e-14
define O 0 1.0279925917672586e-13
a O 0 6.579428706498733e-14
new O 0 3.0910890513879963e-10
monogenic B-Disease 0 0.0864209532737732
endocrine I-Disease 0 0.038631945848464966
disorder I-Disease 0 0.00283593381755054
resulting O 0 4.053357996469664e-11
in O 0 2.1389723217461742e-13
early O 0 6.84878898482566e-07
- O 1 0.9999523162841797
onset O 1 0.9999302625656128
obesity B-Disease 1 0.9999998807907104
, O 0 0.0012523141922429204
adrenal B-Disease 1 0.999998927116394
insufficiency I-Disease 1 0.9999974966049194
and O 0 3.704899427248165e-06
red O 0 9.033194032781466e-07
hair O 0 0.002451152540743351
pigmentation O 0 7.258115175545754e-08
. O 0 1.7393478150828923e-12
. O 0 1.5768280778316601e-12

A O 0 1.841484409403904e-09
European O 0 1.0899950941833936e-09
multicenter O 0 1.2736633081544824e-08
study O 0 5.5844186913622806e-11
of O 0 4.000845765794736e-10
phenylalanine B-Disease 1 0.9999969005584717
hydroxylase I-Disease 1 0.9999831914901733
deficiency I-Disease 1 0.9999998807907104
: O 0 1.610391542339329e-10
classification O 0 3.476407258850428e-13
of O 0 9.127633657057241e-17
105 O 0 7.402545509080719e-14
mutations O 0 1.6661215999523235e-14
and O 0 1.4918512117930577e-13
a O 0 9.3291968928211e-18
general O 0 4.220327184033832e-19
system O 0 9.301103622374757e-15
for O 0 2.7194093687634044e-17
genotype O 0 1.9335231332684444e-11
- O 0 3.554794653082283e-11
based O 0 1.454104984208518e-13
prediction O 0 7.398072154884971e-10
of O 0 2.580832098527416e-16
metabolic O 0 8.161510578474918e-09
phenotype O 0 1.1195182975098916e-10
. O 0 6.279617104087976e-11

Phenylketonuria B-Disease 0 2.0500592654570937e-05
( O 0 1.596518056645735e-11
PKU B-Disease 0 7.249813194221133e-08
) O 0 7.079295483158887e-11
and O 0 7.969047288725051e-08
mild B-Disease 0 7.743624337308574e-06
hyperphenylalaninemia I-Disease 1 0.9999984502792358
( O 0 1.1643374042691335e-09
MHP B-Disease 1 0.9999992847442627
) O 0 9.837856224104158e-11
are O 0 8.440490602452944e-13
allelic B-Disease 0 0.00010751654917839915
disorders I-Disease 1 0.7177926301956177
caused O 0 7.97115318196262e-10
by O 0 1.2135455858388938e-15
mutations O 0 1.6025916487957814e-12
in O 0 1.5280146143200517e-15
the O 0 1.4548692959181434e-15
gene O 0 3.557752009664128e-11
encoding O 0 9.802909595180154e-10
phenylalanine O 0 0.001141060027293861
hydroxylase O 0 0.003937203902751207
( O 0 5.514757053792785e-12
PAH O 0 5.722637475003012e-09
) O 0 3.375486695711416e-11
. O 0 2.488326211746994e-10

Previous O 0 1.0562655611279226e-10
studies O 0 1.2256084818904056e-12
have O 0 2.818135790238997e-15
suggested O 0 1.368314281290897e-15
that O 0 8.009301350753308e-17
the O 0 4.931341115619811e-16
highly O 0 1.1136768184082449e-13
variable O 0 3.2551003992936645e-12
metabolic O 0 3.9954074964043684e-06
phenotypes O 0 3.4711554519617493e-08
of O 0 1.218925793633474e-10
PAH B-Disease 0 0.0001615856890566647
deficiency I-Disease 0 0.006669391877949238
correlate O 0 2.2373951580334506e-09
with O 0 2.74607603323318e-09
PAH O 0 1.7049542293534614e-05
genotypes O 0 1.3741819202550687e-05
. O 0 7.385640543589034e-09

We O 0 3.967740719312829e-11
identified O 0 4.5575583508972867e-14
both O 0 2.565353100811936e-16
causative O 0 9.24596228572827e-13
mutations O 0 2.6078268017259987e-11
in O 0 1.425996500785745e-13
686 O 0 8.320847122433861e-09
patients O 0 4.509617679282485e-11
from O 0 5.391774808745364e-13
seven O 0 5.563644336903373e-11
European O 0 2.856875326584518e-11
centers O 0 5.3997251114878964e-11
. O 0 5.841800567590871e-12

On O 0 1.4680283898227398e-12
the O 0 5.5013688119590886e-17
basis O 0 6.630626023485254e-18
of O 0 1.6350888215623648e-19
the O 0 1.809666204910234e-17
phenotypic O 0 8.427009692991356e-17
characteristics O 0 2.3088665311241097e-13
of O 0 6.139702436305035e-17
297 O 0 1.8725119111523414e-12
functionally O 0 1.694125222051479e-11
hemizygous O 0 3.497484302172893e-09
patients O 0 6.340243542853063e-13
, O 0 1.4232016986356205e-15
105 O 0 6.176782447065571e-14
of O 0 3.002624595409108e-16
the O 0 4.4361405824797084e-14
mutations O 0 4.462660506431883e-14
were O 0 7.137527365203098e-15
assigned O 0 3.747046912641838e-16
to O 0 8.051272627383147e-16
one O 0 5.999791122264346e-16
of O 0 5.1153527368381525e-18
four O 0 1.325436838226174e-15
arbitrary O 0 6.508574061647732e-13
phenotype O 0 7.565855580926595e-11
categories O 0 6.605129776460217e-10
. O 0 1.0165764896541418e-09

We O 0 1.204232135017247e-12
proposed O 0 3.709205133388101e-15
and O 0 8.98367318036275e-13
tested O 0 6.193912163764484e-14
a O 0 3.815150545357901e-18
simple O 0 7.310708280527364e-18
model O 0 3.9339915839633945e-17
for O 0 2.1662719638247267e-20
correlation O 0 1.1114258114102576e-16
between O 0 1.1584857972894041e-15
genotype O 0 4.146047741238057e-11
and O 0 1.5422167395136993e-13
phenotypic O 0 1.0202919272525677e-14
outcome O 0 1.8869138022903353e-12
. O 0 1.9276205631690857e-11

The O 0 3.715338922475643e-14
observed O 0 3.0163827165197166e-13
phenotype O 0 4.3249570049440356e-13
matched O 0 2.893557615735176e-11
the O 0 2.0757943703774567e-13
predicted O 0 1.0758214458173043e-10
phenotype O 0 6.210003214782156e-13
in O 0 8.188746582942288e-14
79 O 0 9.612680651471806e-10
% O 0 7.080540851984313e-14
of O 0 5.2539504880661075e-17
the O 0 4.495474901621693e-14
cases O 0 3.659226242326563e-13
, O 0 1.4533536321029855e-13
and O 0 6.588501879484232e-12
in O 0 7.944369657901366e-16
only O 0 1.6612023925836731e-15
5 O 0 2.6142843412902447e-16
of O 0 4.801764430716237e-18
184 O 0 5.0232568958911115e-15
patients O 0 5.4639319409239187e-17
was O 0 5.4548396642749644e-14
the O 0 1.5627712348820926e-15
observed O 0 5.178823949542055e-13
phenotype O 0 8.835179597210373e-15
more O 0 3.4947358485128304e-17
than O 0 7.251863260555273e-15
one O 0 3.707034679223398e-11
category O 0 4.98861263409367e-09
away O 0 3.841296063455957e-07
from O 0 6.105499135780623e-13
that O 0 4.20236545214947e-12
expected O 0 1.6785248321479762e-12
. O 0 3.7334003076539e-12

Among O 0 1.9552731829464154e-12
the O 0 5.901123112974889e-15
seven O 0 2.254540819443193e-15
contributing O 0 3.10199400091845e-16
centers O 0 5.390831078516851e-16
, O 0 2.1850914234275106e-16
the O 0 2.2367569391991155e-15
proportion O 0 3.204588558489846e-14
of O 0 6.801426412268266e-17
patients O 0 4.907561989114627e-17
for O 0 7.292905595986421e-19
whom O 0 1.6801567664817378e-14
the O 0 1.253673454077711e-15
observed O 0 3.2147236261881318e-12
phenotype O 0 9.079312822402041e-13
did O 0 2.409106247824866e-10
not O 0 1.6191244308835784e-12
match O 0 7.28386795323388e-12
the O 0 7.092854000531959e-14
predicted O 0 5.482862427963475e-12
phenotype O 0 4.455029925423248e-15
was O 0 3.870294709718003e-11
4 O 0 5.285020684975272e-12
% O 0 5.978709552174194e-14
- O 0 1.4919311297489912e-07
23 O 0 1.0608013134572047e-08
% O 0 2.4735446438502173e-13
( O 0 1.6461172228370187e-14
P O 0 1.1016168599553566e-07
< O 0 2.1416298367962078e-13
. O 0 5.2341343878461316e-14
0001 O 0 4.642786155528711e-11
) O 0 1.1848744099589303e-13
, O 0 3.727531538234895e-15
suggesting O 0 9.713958153481639e-14
that O 0 5.493172246182076e-16
differences O 0 8.483167315649826e-16
in O 0 4.0536006113000295e-21
methods O 0 5.514600144883303e-19
used O 0 1.1726949470331624e-17
for O 0 3.77356208843254e-20
mutation O 0 4.515783773846646e-17
detection O 0 8.021740216523909e-11
or O 0 3.911755364072178e-09
phenotype O 0 2.423495015779764e-10
classification O 0 1.1699741175874578e-09
may O 0 6.477458847076178e-11
account O 0 5.6227342999149756e-15
for O 0 1.5837688044501674e-17
a O 0 8.898221930133906e-16
considerable O 0 1.1762984766536884e-15
proportion O 0 2.2492888763570376e-14
of O 0 1.769792503465619e-14
genotype O 0 2.8113974622101523e-05
- O 0 0.001044241595081985
phenotype O 0 5.454148208627885e-07
inconsistencies O 0 1.8405415175948292e-05
. O 0 4.017747468054722e-09

Our O 0 2.268479015743452e-10
data O 0 1.206319441039716e-12
indicate O 0 3.695595912622807e-12
that O 0 1.7125662799227608e-14
the O 0 7.52465648926233e-14
PAH O 0 4.890852722816419e-10
- O 0 8.524363437345528e-09
mutation O 0 1.0360272362230916e-10
genotype O 0 2.262702691879781e-09
is O 0 2.8326211124282295e-15
the O 0 1.3502323083151125e-17
main O 0 8.893175096075928e-14
determinant O 0 2.332534393498925e-13
of O 0 3.2595048067185115e-16
metabolic O 0 3.895003874987424e-09
phenotype O 0 1.710502399443481e-11
in O 0 2.439862141533425e-14
most O 0 4.509219386772401e-12
patients O 0 1.1679714140289121e-10
with O 0 6.707971955677294e-09
PAH B-Disease 0 0.06496832519769669
deficiency I-Disease 1 0.9964847564697266
. O 0 2.4208950399895457e-09

In O 0 2.745070338573685e-13
the O 0 1.6810148108573064e-15
present O 0 7.78818631154833e-16
study O 0 4.9084794978500706e-17
, O 0 6.903368812703791e-17
the O 0 1.130717410300448e-15
classification O 0 1.1697447481126555e-12
of O 0 5.002468060387531e-16
105 O 0 2.767609709117269e-12
PAH O 0 5.746930166992958e-13
mutations O 0 1.9699537411477924e-13
may O 0 4.492322854855735e-13
allow O 0 2.602920335511644e-16
the O 0 4.1262711970120255e-14
prediction O 0 1.2556652939643698e-10
of O 0 2.6963627106906357e-18
the O 0 3.848498007498176e-15
biochemical O 0 1.3697735437231962e-12
phenotype O 0 3.2282979424197358e-15
in O 0 9.357501193585317e-17
> O 0 2.629618655190422e-15
10 O 0 2.5777945113236202e-14
, O 0 2.7426352543756007e-14
000 O 0 1.2873641768492566e-13
genotypes O 0 1.096400054079183e-10
, O 0 1.2903622614857113e-11
which O 0 4.987142643297915e-11
may O 0 5.365539691151375e-14
be O 0 1.5566583734640482e-18
useful O 0 2.3200513666703554e-18
for O 0 6.077969699036019e-18
the O 0 2.3054296102373306e-13
management O 0 3.328508302313793e-11
of O 0 2.884780088419081e-14
hyperphenylalaninemia B-Disease 1 0.9999990463256836
in O 0 2.1157771715185625e-11
newborns O 0 4.520507079774916e-09
. O 0 1.8572551266013426e-13

Somatic O 0 4.8612340819431665e-09
instability O 0 5.188838372305327e-07
of O 0 1.2494625356595547e-15
the O 0 1.1268469779512642e-14
CTG O 0 3.9760530978760755e-10
repeat O 0 4.8150063797214315e-11
in O 0 2.937580075121613e-17
mice O 0 3.642364492970843e-15
transgenic O 0 1.055980834628004e-15
for O 0 5.1948600138277694e-17
the O 0 2.2780843877967527e-09
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.9999996423721313
region O 0 6.289455427577195e-07
is O 0 1.4111498081170737e-10
age O 0 5.7271930253843806e-12
dependent O 0 1.2525268467528366e-14
but O 0 9.775959609967938e-15
not O 0 1.1543076484583947e-16
correlated O 0 2.2777253817589643e-15
to O 0 1.8715413198150052e-15
the O 0 4.184235186251942e-15
relative O 0 6.646774059967941e-13
intertissue O 0 1.6904205812906525e-10
transcription O 0 8.861745365296159e-11
levels O 0 8.477479135349242e-11
and O 0 7.438289567618384e-12
proliferative O 0 2.8451394129547225e-08
capacities O 0 4.414709708910891e-10
. O 0 5.164051044420637e-12

A O 0 1.4863889286065302e-10
( O 0 2.6703069416029665e-14
CTG O 0 9.362189495876194e-11
) O 0 1.3863739258164476e-13
nexpansion O 0 1.1198690863523098e-09
in O 0 1.1780677167222658e-15
the O 0 3.53239030907726e-14
3 O 0 1.7958216511071434e-11
- O 0 6.624741786254162e-07
untranslated O 0 0.004936734214425087
region O 0 3.839623285983862e-09
( O 0 4.747166506733572e-16
UTR O 0 1.612604494383163e-10
) O 0 7.604320340292247e-16
of O 0 2.1152048442601203e-18
the O 0 1.7442938640786082e-13
DM O 1 0.9999955892562866
protein O 0 6.812579471902891e-13
kinase O 0 7.025195702947684e-11
gene O 0 1.5817269369278186e-11
( O 0 3.3051320893069365e-15
DMPK O 0 1.8286286929125595e-09
) O 0 7.150932190988989e-16
is O 0 9.04951720154957e-18
responsible O 0 1.5380742740631753e-14
for O 0 2.9638121926307825e-13
causing O 0 0.014884875155985355
myotonic B-Disease 1 0.9999984502792358
dystrophy I-Disease 1 0.9999991655349731
( O 0 1.752429312773529e-07
DM B-Disease 1 0.9999978542327881
) O 0 5.688813420334782e-09
. O 0 5.97589061568371e-11

Major O 0 1.5732135594248575e-09
instability O 0 2.223410092483391e-06
, O 0 2.9602698330827293e-13
with O 0 2.133758368087703e-15
very O 0 4.3431842672313315e-17
large O 0 2.8913940630486814e-19
expansions O 0 1.2237828683910566e-14
between O 0 3.56570350502905e-13
generations O 0 6.071412816943678e-10
and O 0 3.335079434840793e-11
high O 0 1.863053331399578e-12
levels O 0 9.048594630468778e-16
of O 0 7.811675923805145e-20
somatic O 0 4.928520495905454e-16
mosaicism O 0 6.903715880218764e-12
, O 0 1.6427194983998738e-15
is O 0 1.8631774782657998e-16
observed O 0 1.4342341333670183e-13
in O 0 7.63656580462721e-14
patients O 0 2.5477116076533246e-12
. O 0 3.8325497289659616e-12

There O 0 9.618062422889206e-12
is O 0 1.0216822471321909e-14
a O 0 5.281281131074901e-16
good O 0 3.1889001530539807e-14
correlation O 0 5.288685681341561e-14
between O 0 6.3978158708344335e-12
repeat O 0 3.4873739451768415e-08
size O 0 1.2081299502475495e-11
( O 0 2.6401611978288636e-16
at O 0 2.088813334539391e-13
least O 0 4.842474786307524e-17
in O 0 7.690402710534925e-17
leucocytes O 0 9.093641395452323e-10
) O 0 1.3913367426763874e-15
, O 0 8.102506738686804e-17
clinical O 0 2.7321408549722988e-14
severity O 0 1.750012579293525e-09
and O 0 9.444751647436078e-10
age O 0 3.419383942659948e-10
of O 0 7.65487814872708e-15
onset O 0 5.515067846850741e-10
. O 0 1.0825027679794985e-10

The O 0 8.152607477995844e-10
trinucleotide O 0 1.8824257494998164e-05
repeat O 0 2.147663309415293e-07
instability O 0 1.4143457238713353e-10
mechanisms O 0 2.202399504089292e-14
involved O 0 6.602018736388826e-14
in O 0 5.756628355425841e-13
DM B-Disease 1 0.9999992847442627
and O 0 1.5923951046659113e-10
other O 0 3.4551086492730365e-13
human O 0 4.798033081954145e-09
genetic B-Disease 1 0.9999996423721313
diseases I-Disease 1 0.9999998807907104
are O 0 6.116432230487967e-13
unknown O 0 6.229061710882888e-11
. O 0 1.3828048081587774e-11

We O 0 9.690896696223916e-11
studied O 0 2.533464757425996e-12
somatic O 0 1.468555659023263e-11
instability O 0 1.955447803680954e-09
by O 0 9.279272195192225e-15
measuring O 0 2.879497751351323e-10
the O 0 1.8509778670731947e-13
CTG O 0 1.862076715042349e-08
repeat O 0 1.4623052102535894e-08
length O 0 5.455781659780001e-12
at O 0 7.708658472833918e-13
several O 0 1.0424527655482872e-15
ages O 0 4.7640429605812565e-14
in O 0 6.802041110860969e-19
various O 0 4.0555557011454126e-18
tissues O 0 8.274312496021202e-14
of O 0 6.942133143185986e-18
transgenic O 0 2.1904036744124777e-12
mice O 0 1.772849402004173e-11
carrying O 0 1.5419941799127423e-12
a O 0 4.40420472986279e-14
( O 0 1.5684560700378103e-16
CTG O 0 6.035640043311474e-11
) O 0 7.747948434905488e-15
55expansion O 0 1.4537294111549581e-11
surrounded O 0 4.403131776287844e-13
by O 0 1.4258753581336287e-15
45 O 0 1.3038528505433583e-15
kb O 0 4.016906599013659e-12
of O 0 1.0155645450532018e-17
the O 0 1.2562982609504864e-13
human O 0 9.06341224293783e-09
DM B-Disease 1 0.9999996423721313
region O 0 4.371969366395723e-12
, O 0 1.6978077287275456e-17
using O 0 2.3626559989516137e-16
small O 0 7.650940970181652e-14
- O 0 1.432734535455893e-07
pool O 0 4.327274094606537e-10
PCR O 0 7.746763230898068e-08
. O 0 1.3464552823388987e-12

These O 0 1.985640991908344e-11
mice O 0 6.402616631318025e-11
have O 0 1.8201855428163875e-14
been O 0 6.394234778163768e-14
shown O 0 2.5145250465152813e-13
to O 0 1.2615988237278143e-15
reproduce O 0 1.3298551712961904e-12
the O 0 2.947232941997862e-17
intergenerational O 0 7.117390878053076e-12
and O 0 8.226352541870763e-13
somatic O 0 1.2844970042041187e-13
instability O 0 3.3751130362746906e-11
of O 0 1.0847931103151123e-17
the O 0 2.0898325523441633e-14
55 O 0 1.9461045459596288e-13
CTG O 0 6.047970457778717e-11
repeat O 0 7.630724524476662e-11
suggesting O 0 3.5925114879459263e-13
that O 0 5.320736561032716e-15
surrounding O 0 1.1242964770437867e-14
sequences O 0 4.058324856726081e-11
and O 0 6.299287480526772e-12
the O 0 1.6671244234344016e-16
chromatin O 0 1.7935264005290025e-13
environment O 0 5.463255173775161e-13
are O 0 9.879711853459588e-19
involved O 0 4.672334239499146e-18
in O 0 5.823473935103973e-17
instability O 0 2.6766444963244318e-11
mechanisms O 0 3.116203042136112e-12
. O 0 5.991318118708788e-12

As O 0 1.1329853071354035e-13
observed O 0 5.092350220431592e-14
in O 0 7.432215156810993e-17
some O 0 2.2732168139779093e-18
of O 0 4.193768896106592e-18
the O 0 4.942601774908517e-13
tissues O 0 9.893184049758474e-10
of O 0 3.430014735780751e-12
DM B-Disease 1 0.9999998807907104
patients O 0 2.639169698753774e-12
, O 0 2.660949239239056e-16
there O 0 1.9828051325466067e-16
is O 0 8.301335282258338e-16
a O 0 2.8322755229857497e-15
tendency O 0 1.8768715748240794e-11
for O 0 2.010929061615173e-15
repeat O 0 4.339169468181581e-09
length O 0 6.492223425524912e-12
and O 0 1.6415028245096025e-13
somatic O 0 7.810768209922129e-16
mosaicism O 0 1.5517888894440307e-13
to O 0 1.210826504199089e-15
increase O 0 1.0913803631231784e-17
with O 0 7.202458369840771e-15
the O 0 4.508015922360942e-12
age O 0 2.906447027495318e-10
of O 0 3.884927200493689e-17
the O 0 4.3853775591375793e-14
mouse O 0 7.588512289657956e-07
. O 0 5.289369636729546e-11

Furthermore O 0 2.721091130197806e-09
, O 0 3.8874571964275795e-12
we O 0 4.4268958616054677e-13
observed O 0 6.0619318944946446e-15
no O 0 4.482849346147276e-16
correlation O 0 3.3839357995547404e-16
between O 0 1.9722364112961392e-16
the O 0 2.228809176115469e-16
somatic O 0 4.537446807173495e-13
mutation O 0 3.187348301958437e-11
rate O 0 9.21076015458766e-09
and O 0 3.763914957488623e-09
tissue O 0 2.530331926209328e-07
proliferation O 0 4.994650680600898e-06
capacity O 0 3.0268849492837147e-12
. O 0 1.478927223741433e-12

The O 0 5.4571083573208903e-14
somatic O 0 8.689112797333198e-12
mutation O 0 5.187502094550211e-10
rates O 0 1.6227269838964276e-07
in O 0 1.0749214696516643e-13
different O 0 3.143067877904408e-14
tissues O 0 7.181700980435357e-12
were O 0 1.533699057511273e-12
also O 0 3.075743285212737e-15
not O 0 6.206532674098909e-17
correlated O 0 3.791492690147962e-15
to O 0 5.051111913174748e-14
the O 0 1.6213989786212357e-12
relative O 0 8.786919525327619e-10
inter O 0 1.3638063123266875e-08
- O 0 6.216471319930861e-07
tissue O 0 3.415815967855451e-07
difference O 0 3.826019796121516e-12
in O 0 3.6779327071675646e-19
transcriptional O 0 7.097266025747617e-14
levels O 0 1.2382036890213558e-14
of O 0 1.1910468626987342e-20
the O 0 6.87278430586301e-17
three O 0 4.647576607960148e-16
genes O 0 1.2373254852616426e-14
( O 0 2.759673253619066e-18
DMAHP O 0 1.3057382952652574e-09
, O 0 2.0603464884172938e-14
DMPK O 0 2.4656984010107408e-08
and O 0 9.852202387250486e-11
59 O 0 8.447416485930781e-13
) O 0 2.017183129381225e-15
surrounding O 0 7.34315969033554e-14
the O 0 3.0956172954871297e-12
repeat O 0 2.6617520632044034e-08
. O 0 2.704636644854097e-13
. O 0 2.8016330574920367e-12

A O 0 2.021038371380346e-11
novel O 0 1.0712261806766765e-11
missense O 0 1.4699415018526452e-09
mutation O 0 3.8965475290808627e-10
in O 0 1.3974346853296016e-12
patients O 0 8.41629663097393e-13
from O 0 6.5253478551022086e-15
a O 0 6.462183761192508e-14
retinoblastoma B-Disease 0 4.0382239774316986e-08
pedigree O 0 1.8429263946018182e-05
showing O 0 1.0722829557607838e-07
only O 0 6.433980431763686e-11
mild O 0 1.9322217437167666e-11
expression O 0 1.1740268316979413e-13
of O 0 2.3482437333540817e-16
the O 0 9.829856113113822e-13
tumor B-Disease 0 5.211025495555077e-07
phenotype O 0 2.048799130349721e-09
. O 0 2.182398983752165e-10

We O 0 2.261650502294321e-12
have O 0 1.1707513372914588e-16
used O 0 7.405047898516792e-17
single O 0 1.1839966297156907e-15
strand O 0 3.122970285152071e-11
conformation O 0 2.2868879099441353e-12
polymorphism O 0 1.880535522224766e-13
analysis O 0 7.101863042958956e-16
to O 0 2.1127553391275854e-16
study O 0 4.3706221790219604e-18
the O 0 7.363751733615695e-17
27 O 0 1.5752805350844994e-15
exons O 0 4.2386523436098444e-13
of O 0 1.491956223232089e-17
the O 0 1.4982771933660845e-15
RB1 O 0 5.4836600538177294e-11
gene O 0 5.692619769667728e-14
in O 0 7.965125670878241e-16
individuals O 0 5.649606526045737e-16
from O 0 2.7836463026926963e-15
a O 0 2.8607617576920097e-12
family O 0 3.5233520065958146e-06
showing O 0 0.00020530499750748277
mild O 0 1.6686693693479526e-10
expression O 0 4.83147559232535e-14
of O 0 9.769314054161577e-17
the O 0 2.3497615528680904e-13
retinoblastoma B-Disease 0 3.1424541191427124e-08
phenotype O 0 2.08083980601792e-10
. O 0 4.844170897744249e-11

In O 0 2.096100934967024e-13
this O 0 1.0784278430049535e-15
family O 0 1.041901807885548e-12
affected O 0 1.1708724894726958e-15
individuals O 0 1.3413253101972027e-17
developed O 0 1.6780340680346006e-13
unilateral B-Disease 0 8.477053370370413e-07
tumors I-Disease 1 1.0
and O 0 2.5549237392397117e-08
, O 0 3.123829387980011e-14
as O 0 3.65153235407545e-15
a O 0 2.8286690684545777e-15
result O 0 2.418787495937617e-15
of O 0 4.2055115520823945e-18
linkage O 0 3.261926145858851e-11
analysis O 0 3.17764065928261e-12
, O 0 2.231695324416208e-14
unaffected O 0 1.7262697347975031e-12
mutation O 0 6.312174226233772e-14
carriers O 0 3.254428248156832e-13
were O 0 9.920761261106303e-12
also O 0 1.4209634987757958e-12
identified O 0 3.6752160559663793e-13
within O 0 5.093782447266281e-16
the O 0 2.018548739615711e-12
pedigree O 0 0.00012049925135215744
. O 0 2.73877226453223e-10

A O 0 6.462634247195176e-12
single O 0 4.4656520235136776e-13
band O 0 2.4410109350503362e-11
shift O 0 1.0385877542099659e-13
using O 0 1.9760630679238177e-15
SSCP O 0 1.5831944089050864e-10
was O 0 7.677341293081674e-14
identified O 0 6.614716924938471e-16
in O 0 3.2479459750902364e-18
exon O 0 3.3290256944325247e-13
21 O 0 9.575372179188024e-13
which O 0 2.5441302032745347e-14
resulted O 0 5.3188290428355e-15
in O 0 1.666608626691638e-17
a O 0 1.0983479403420065e-15
missense O 0 1.0264375070387355e-12
mutation O 0 2.791623404880053e-14
converting O 0 2.371288278582573e-12
a O 0 4.8316003975479305e-12
cys O 0 3.6125306905887555e-06
- O 0 6.352049126689963e-07
- O 0 2.1230553670648078e-07
> O 0 1.3516117478712397e-12
arg O 0 1.0287227883779004e-12
at O 0 4.09675150587715e-15
nucleotide O 0 4.593115036429657e-16
position O 0 6.373586554364596e-13
28 O 0 6.935125666083131e-16
in O 0 8.086473207360474e-19
the O 0 5.352083026949111e-16
exon O 0 2.1174333120210775e-10
. O 0 6.125921991895211e-10

The O 0 1.2636791569750616e-12
mutation O 0 6.446346494798361e-12
destroyed O 0 1.7231647220228297e-08
an O 0 3.0157598423716236e-14
NdeI O 0 1.0066646405348934e-09
restriction O 0 4.926232151695152e-14
enzyme O 0 4.655249167921649e-13
site O 0 6.140849495572809e-10
. O 0 1.58518788373474e-11

Analysis O 0 1.0957680943168846e-11
of O 0 5.030485898579453e-15
all O 0 1.0652992770148091e-14
family O 0 7.0752079325484e-14
members O 0 1.5043053887125311e-18
demonstrated O 0 2.2990829585275956e-18
that O 0 1.1181645282263125e-19
the O 0 6.411881419218056e-18
missense O 0 1.0626783741168877e-12
mutation O 0 4.907984283743227e-13
co O 0 7.160237736059116e-09
- O 0 4.193276392783218e-09
segregated O 0 1.4877878928842847e-09
with O 0 8.297620923691795e-11
patients O 0 1.674567845499908e-10
with O 0 2.116652275674369e-08
tumors B-Disease 1 1.0
or O 0 4.181673318726098e-08
who O 0 1.0590404109223073e-08
, O 0 6.026658393252365e-14
as O 0 3.701341533615676e-14
a O 0 3.612174036445037e-14
result O 0 2.3238248958033954e-14
of O 0 8.284654721985063e-18
linkage O 0 1.6395176882788576e-11
analysis O 0 4.4249033690629824e-13
had O 0 4.125461361415006e-10
been O 0 1.089609392296298e-11
predicted O 0 4.699731814654384e-13
to O 0 4.3073663540910503e-16
carry O 0 1.468632615693466e-13
the O 0 7.458864560337067e-15
predisposing O 0 2.4679874810473734e-10
mutation O 0 2.5087465438389245e-10
. O 0 3.9436915955093355e-09

These O 0 6.696398535503689e-14
observations O 0 4.0315954784667096e-13
point O 0 5.947003414892571e-13
to O 0 5.314691286888162e-15
another O 0 6.095067399874759e-15
region O 0 8.726723635171449e-14
of O 0 3.980607181947698e-17
the O 0 3.09629336330431e-14
RB1 O 0 1.9187225419603493e-10
gene O 0 1.0491720746309482e-13
where O 0 3.165635546124694e-14
mutations O 0 2.3057177030833508e-15
only O 0 2.515110812149955e-16
modify O 0 2.0198610579252874e-13
the O 0 1.2322907722451398e-13
function O 0 3.1967088481507644e-13
of O 0 3.676495262063982e-15
the O 0 4.865500363715469e-13
gene O 0 1.4281209027855457e-11
and O 0 1.939614094337294e-11
raise O 0 3.197131153367277e-16
important O 0 1.993146900252408e-18
questions O 0 9.759671378150475e-16
for O 0 3.0722761032880955e-20
genetic O 0 1.0602316482979761e-14
counseling O 0 2.297721203841502e-13
in O 0 1.109599429704965e-17
families O 0 5.848299279647914e-16
with O 0 4.4571502341786824e-17
these O 0 2.7849540368599622e-14
distinctive O 0 1.5776954395696485e-11
phenotypes O 0 2.421514811584702e-12
. O 0 2.0751450688014095e-13
. O 0 1.6064453586817073e-11

Maternal B-Disease 0 0.0008066645823419094
disomy I-Disease 1 0.8515974879264832
and O 1 0.9017941355705261
Prader B-Disease 1 0.9999977350234985
- I-Disease 1 0.9999991655349731
Willi I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999954700469971
consistent O 0 6.675112546039585e-11
with O 0 3.2623922890961422e-15
gamete O 0 1.1125230077457804e-11
complementation O 0 1.7587804990171207e-08
in O 0 1.9754525689270842e-15
a O 0 1.0412718295662473e-16
case O 0 5.594980312486123e-16
of O 0 1.78605251452756e-18
familial O 0 1.3571793862354742e-11
translocation O 0 3.0674787709905615e-10
( O 0 9.654697526206065e-15
3 O 0 2.1577887859749317e-13
; O 0 4.150361152845117e-14
15 O 0 6.66616750609971e-15
) O 0 3.242897931694203e-16
( O 0 4.726470212061021e-19
p25 O 0 6.078462483614141e-16
; O 0 6.192175631079071e-18
q11 O 0 8.542334155202315e-16
. O 0 1.3996458447213764e-16
2 O 0 5.825138413078843e-14
) O 0 8.917685519064036e-14
. O 0 2.2779636250219726e-12

Maternal B-Disease 0 0.0011691900435835123
uniparental I-Disease 0 0.016186818480491638
disomy I-Disease 0 0.09150929003953934
( I-Disease 0 3.3872669114032306e-09
UPD I-Disease 1 0.9999357461929321
) I-Disease 0 1.6166564614783496e-11
for I-Disease 0 1.839162003098552e-15
chromosome I-Disease 0 1.2742489730044326e-08
15 I-Disease 0 2.3110023416412703e-14
is O 0 5.903613260799641e-18
responsible O 0 6.811678488780248e-18
for O 0 1.6537435861447682e-20
an O 0 2.3201131984211438e-18
estimated O 0 5.4934059213964e-15
30 O 0 1.9029376124445226e-14
% O 0 4.64016923866196e-17
of O 0 9.89189725785826e-18
cases O 0 4.794311649070071e-12
of O 0 1.47458763422037e-07
Prader B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999991655349731
( O 0 4.531533548401967e-08
PWS B-Disease 1 0.9999603033065796
) O 0 7.525415013365233e-11
. O 0 1.0438237947607565e-11

We O 0 6.100712157675048e-10
report O 0 1.1882821929123238e-14
on O 0 3.647618479523984e-16
an O 0 4.2031039912107706e-19
unusual O 0 2.1371450241865074e-17
case O 0 3.1171659491905507e-16
of O 0 1.3736893306897687e-17
maternal B-Disease 0 3.529252445844122e-10
disomy I-Disease 0 3.4580576624421155e-08
15 I-Disease 0 1.0363363812937454e-12
in O 0 3.726881542091831e-13
PWS B-Disease 1 0.9999992847442627
that O 0 5.539414846961188e-12
is O 0 2.433280229665138e-15
most O 0 5.729909881656875e-17
consistent O 0 1.678830482292927e-14
with O 0 1.5470234100849775e-15
adjacent O 0 3.8910676980821735e-13
- O 0 1.4155669525450776e-08
1 O 0 5.18238121686998e-13
segregation O 0 1.4486924160284076e-10
of O 0 1.709492647496592e-17
a O 0 2.883349957990937e-14
paternal O 0 2.1470752287200412e-08
t O 0 1.0168561992429659e-08
( O 0 4.770179366206512e-18
3 O 0 8.048815702440518e-16
; O 0 1.1557225640572238e-15
15 O 0 1.6740142953064864e-15
) O 0 2.6135463638349494e-16
( O 0 1.4697321859387468e-19
p25 O 0 4.0332330742628116e-17
; O 0 2.866225697044472e-18
q11 O 0 1.5741564694239337e-16
. O 0 4.7118212776825285e-17
2 O 0 2.5424297422812743e-16
) O 0 2.9356084074135317e-17
with O 0 1.5120327238793637e-17
simultaneous O 0 6.985221185111176e-14
maternal O 0 2.5886504051442216e-09
meiotic O 0 8.1743003477186e-09
nondisjunction O 0 2.1346696854607217e-08
for O 0 1.4468717167092867e-15
chromosome O 0 3.694757921834935e-08
15 O 0 1.5285191515279628e-11
. O 0 1.105998105599415e-11

The O 0 8.069029819313123e-12
patient O 0 2.853739744512751e-10
( O 0 4.214144089026081e-14
J O 0 2.3294102646786996e-08
. O 0 3.43429413596566e-13
B O 0 2.1780242887015078e-10
. O 0 8.353814796692254e-16
) O 0 1.1327972136756472e-17
, O 0 1.9790021117777513e-18
a O 0 3.7185929252739736e-18
17 O 0 2.328938793694972e-16
- O 0 1.389249392608205e-12
year O 0 3.638111947118494e-13
- O 0 1.4703853246089693e-08
old O 0 7.855504372855648e-05
white O 0 4.729697877792205e-07
male O 0 6.263686791463385e-10
with O 0 2.578995773449416e-13
PWS B-Disease 1 0.9999936819076538
, O 0 6.110289217211629e-16
was O 0 2.613110364213262e-14
found O 0 3.851611700612283e-15
to O 0 4.854668540267299e-15
have O 0 8.055796291541253e-14
47 O 0 9.863458325177544e-16
chromosomes O 0 7.110819637105859e-13
with O 0 2.1527396564576667e-14
a O 0 3.819288364303314e-13
supernumerary O 0 4.132010360535787e-07
, O 0 3.2296261220920996e-09
paternal O 0 0.0002160602161893621
der O 1 0.9639037847518921
( O 0 3.641286491079532e-12
15 O 0 4.2222562252058893e-13
) O 0 7.138072007388183e-15
consisting O 0 1.0978536966172836e-15
of O 0 2.23492311286831e-15
the O 0 7.735742046932614e-10
short O 0 0.0002309217961737886
arm O 1 0.928561806678772
and O 0 4.942600217994197e-10
the O 0 4.9862983073035647e-14
proximal O 0 1.3846523927441012e-07
long O 0 4.396791609906359e-06
arm O 0 0.00046146876411512494
of O 0 2.108489257688739e-15
chromosome O 0 3.36889072194424e-09
15 O 0 5.1005738939098946e-14
, O 0 1.534439994499686e-15
and O 0 3.281393603019045e-12
distal O 0 4.653787527786335e-06
chromosome O 1 0.9334695339202881
arm O 1 0.9990422129631042
3p O 0 0.007774737197905779
. O 0 6.984759437500543e-09

The O 0 9.672153356010682e-11
t O 0 1.009566652498961e-08
( O 0 5.368420704314871e-16
3 O 0 5.738402578093181e-15
; O 0 1.0666772725650498e-15
15 O 0 4.207072623878017e-16
) O 0 7.032386488949402e-17
was O 0 1.8948193708512306e-12
present O 0 6.37666625604653e-16
in O 0 4.3986718735936336e-18
the O 0 9.576668321709407e-17
balanced O 0 5.439875133195823e-15
state O 0 2.470062423641419e-15
in O 0 1.2251368082055953e-15
the O 0 9.820186113937424e-13
patients O 0 2.2073463120265285e-13
father O 0 3.6281319615305563e-10
and O 0 9.042091728139745e-12
a O 0 4.645279386844559e-13
sister O 0 4.239566806063522e-06
. O 0 7.873434682004188e-10

Fluorescent O 0 7.308612048895213e-12
in O 0 5.4951426565756265e-16
situ O 0 4.2422552490729674e-15
hybridization O 0 2.1553145095623777e-15
analysis O 0 7.10248614157078e-16
demonstrated O 0 7.602960958291022e-15
that O 0 6.268929382628177e-15
the O 0 5.621627729296419e-12
PWS B-Disease 1 0.999997615814209
critical O 0 8.130086881497078e-11
region O 0 1.747870647045638e-13
resided O 0 5.859071366097479e-13
on O 0 1.4193443295673625e-11
the O 0 3.993874272235432e-15
derivative O 0 2.4282569770044116e-13
chromosome O 0 1.0888704521372361e-10
3 O 0 4.0417952459296386e-14
and O 0 8.145518764698934e-14
that O 0 2.3376804913479918e-15
there O 0 1.3873876897878306e-16
was O 0 7.010196459780738e-13
no O 0 2.1517050904158903e-14
deletion O 0 2.4935403134668244e-12
of O 0 8.003232306746672e-15
the O 0 3.068229004199452e-09
PWS B-Disease 1 0.9999996423721313
region O 0 3.887162466909011e-11
on O 0 1.4117582103345683e-10
the O 0 3.6175541186754534e-13
normal O 0 1.1112028045759045e-13
pair O 0 6.651990590300638e-12
of O 0 1.776357461440071e-17
15s O 0 3.3371708458390344e-16
present O 0 3.224802449204654e-15
in O 0 1.14311365278022e-13
J O 0 4.79760674352292e-05
. O 0 3.412848614825492e-10

B O 0 0.0018179179169237614
. O 0 2.1425003993158498e-09

Methylation O 0 3.640583385970675e-13
analysis O 0 1.9244471671070983e-14
at O 0 1.367427226036885e-15
exon O 0 3.591987208432894e-15
alpha O 0 6.205758088938425e-15
of O 0 3.1159635594521436e-17
the O 0 1.7486132916524726e-14
small O 0 1.5645989278473271e-12
nuclear O 0 6.173361839501013e-07
ribonucleoprotein O 0 1.437275992666187e-10
- O 0 2.902032225637896e-10
associated O 0 3.918021723031684e-12
polypeptide O 0 4.15758139027389e-09
N O 0 7.179192351713937e-09
( O 0 2.2172252064683786e-16
SNRPN O 0 8.803824336212074e-11
) O 0 4.7404145953527715e-17
gene O 0 3.065168290624504e-14
showed O 0 4.24870971738045e-11
a O 0 8.750381858311325e-16
pattern O 0 5.866651053842986e-10
characteristic O 0 8.733442788400048e-12
of O 0 3.7811041222174634e-17
only O 0 7.089226158418869e-15
the O 0 3.948136780072657e-14
maternal O 0 2.0091542296540865e-07
chromosome O 0 5.1943270591436885e-06
15 O 0 1.9208169776963047e-10
in O 0 1.6420704856620616e-12
J O 0 0.00024971060338430107
. O 0 1.5451458168502796e-10

B O 0 0.0016254375223070383
. O 0 2.625236694697719e-09

Maternal B-Disease 0 5.345986573956907e-05
disomy I-Disease 0 1.6920663483688259e-06
was O 0 2.3008416352721106e-11
confirmed O 0 1.2388218960179094e-15
by O 0 2.9399534424146655e-19
polymerase O 0 3.708437907885137e-13
chain O 0 1.5276738207781193e-11
reaction O 0 3.6932629674691503e-16
analysis O 0 1.2158518547221978e-17
of O 0 2.7132312498260647e-19
microsatellite O 0 1.12428321860647e-11
repeats O 0 1.109218827899383e-09
at O 0 1.7818166443716622e-14
the O 0 2.075576151396838e-17
gamma O 0 1.5693982300789971e-13
- O 0 1.6666733770875908e-08
aminobutyric O 0 1.6004450742457266e-07
acid O 0 5.208453026511739e-13
receptor O 0 5.1294489929719096e-15
beta3 O 0 1.0864322462500464e-11
subunit O 0 5.4152805151327574e-14
( O 0 8.173356333103857e-15
GABRB3 O 0 3.7609172665042934e-08
) O 0 1.7730572056135624e-13
locus O 0 1.4000620662812935e-09
. O 0 3.647893931368884e-10

A O 0 1.4407179615982812e-10
niece O 0 1.143816987791979e-07
( O 0 2.4499830332883055e-13
B O 0 2.299488155443896e-09
. O 0 5.339730597248536e-14
B O 0 3.48161326158003e-11
. O 0 3.333137645521124e-16
) O 0 7.894936021006217e-18
with O 0 2.51940222516788e-17
45 O 0 1.9630770238297273e-18
chromosomes O 0 4.192274037141154e-14
and O 0 5.643018621419348e-15
the O 0 9.512509215549589e-18
derivative O 0 3.2882553813493682e-15
3 O 0 1.7283526235431523e-15
but O 0 1.7853826869609207e-13
without O 0 6.042450475520975e-14
the O 0 5.065557890683581e-13
der O 0 5.731939018005505e-05
( O 0 1.4805392646593954e-15
15 O 0 1.53385266185406e-14
) O 0 2.886749270614858e-15
demonstrated O 0 1.674743209509246e-14
a O 0 8.298106498542523e-16
phenotype O 0 7.118985983394291e-14
consistent O 0 3.7544500928327063e-13
with O 0 3.5178357080632716e-13
that O 0 2.104764626476019e-11
reported O 0 1.1872403060664283e-10
for O 0 1.6510994865146363e-16
haploinsufficiency O 0 2.241632435229235e-09
of O 0 1.0046186625306346e-15
distal O 0 1.4103521017716503e-08
3 O 0 2.198872017800113e-08
p O 0 9.746195246407297e-06
. O 0 7.467054197185519e-10

Uniparental B-Disease 1 0.9992493987083435
disomy I-Disease 1 0.9997937083244324
associated O 0 1.993499232355589e-08
with O 0 1.8539080860746626e-12
unbalanced O 0 1.43257500440086e-06
segregation O 0 1.7293223208980635e-07
of O 0 7.271201869774035e-14
non O 0 6.717064404693218e-12
- O 0 4.6917548957026156e-08
Robertsonian O 0 6.647271675319644e-07
translocations O 0 4.3571108676587755e-07
has O 0 2.9856284111673403e-09
been O 0 1.348006151147274e-10
reported O 0 6.151005919885488e-12
previously O 0 2.2720523108320928e-13
but O 0 5.478155906332716e-13
has O 0 4.1580809433637567e-13
not O 0 2.6799097541259885e-14
, O 0 1.879826043192981e-16
to O 0 2.330370808771424e-15
our O 0 2.514470836406657e-14
knowledge O 0 1.0757889184752276e-17
, O 0 2.664623790586976e-18
been O 0 8.596861371786219e-16
observed O 0 2.718425453968385e-16
in O 0 2.4350209415151593e-19
a O 0 2.266740899680293e-17
case O 0 7.557176455799675e-14
of O 0 6.636602075185682e-13
PWS B-Disease 1 0.9999886751174927
. O 0 4.957079885459237e-11

Furthermore O 0 4.955952803697983e-08
, O 0 8.827752417950308e-11
our O 0 2.5159332950330793e-11
findings O 0 4.0371009046326605e-15
are O 0 3.866783572783767e-18
best O 0 3.2288506843573784e-16
interpreted O 0 1.0914189990752295e-15
as O 0 4.9359498351207116e-17
true O 0 2.4068602132490922e-14
gamete O 0 1.4778387931804748e-12
complementation O 0 1.7477784552966114e-08
resulting O 0 1.5299067351523532e-12
in O 0 8.791662601918826e-14
maternal B-Disease 0 3.642180672613904e-05
UPD I-Disease 1 0.9999856948852539
15 I-Disease 0 2.3467130461085617e-08
and O 0 1.8836998094684532e-07
PWS B-Disease 1 0.9999349117279053

Schwartz B-Disease 1 0.996553897857666
- I-Disease 1 0.9998511075973511
Jampel I-Disease 1 0.9997115731239319
syndrome I-Disease 1 0.9999737739562988
type I-Disease 0 1.672555072218529e-08
2 I-Disease 0 1.1057124105207095e-09
and O 0 9.757811625377144e-08
Stuve B-Disease 1 0.9985529780387878
- I-Disease 1 0.9999889135360718
Wiedemann I-Disease 1 0.9999860525131226
syndrome I-Disease 1 0.9999932050704956
: O 0 1.8336325296672285e-14
a O 0 8.252450926377148e-18
case O 0 1.1872478333348283e-16
for O 0 1.567163319089288e-17
" O 0 9.011268836157937e-13
lumping O 0 2.487757999602991e-09
" O 0 5.346383058491e-11
. O 0 8.398497283908235e-13

Recent O 0 2.712553966166542e-11
studies O 0 1.0749794067052565e-12
demonstrated O 0 1.3146721124929206e-13
the O 0 4.839097639477042e-16
existence O 0 2.946675157567205e-14
of O 0 6.969543427144156e-18
a O 0 4.476014319658526e-16
genetically O 0 1.1174248163800678e-15
distinct O 0 2.9300171958682652e-15
, O 0 1.6348686252974816e-14
usually O 0 5.345291622657145e-15
lethal O 0 6.786630731913203e-16
form O 0 5.566790526605908e-17
of O 0 9.623625816601936e-15
the O 0 6.401404561984236e-08
Schwartz B-Disease 1 0.9999765157699585
- I-Disease 1 0.9999909400939941
Jampel I-Disease 1 0.999963641166687
syndrome I-Disease 1 0.999990701675415
( O 0 1.4307819685976941e-11
SJS B-Disease 0 0.04353421553969383
) O 0 2.2307613655597747e-12
of O 0 1.784027061550817e-14
myotonia B-Disease 0 6.401799328159541e-05
and O 0 8.209535273806523e-09
skeletal B-Disease 0 2.6831950890482403e-05
dysplasia I-Disease 0 6.880159162392374e-06
, O 0 1.2482060469855977e-13
which O 0 5.371461196841676e-13
we O 0 1.4208361050205287e-12
called O 0 4.831566050023106e-11
SJS B-Disease 0 0.07692911475896835
type I-Disease 0 1.5360718252921401e-10
2 I-Disease 0 3.5495623367659546e-12
. O 0 2.9361534904792652e-12

This O 0 1.4460367625535042e-10
disorder O 0 9.040700774676225e-07
is O 0 1.9817316190828826e-12
reminiscent O 0 3.159882355774357e-09
of O 0 5.683392552729343e-16
another O 0 3.985703368909743e-14
rare O 0 8.997375327418622e-13
condition O 0 9.957619451217425e-11
, O 0 1.9237681854965792e-14
the O 0 2.714391211799949e-11
Stuve B-Disease 1 0.9999352693557739
- I-Disease 1 0.9999961853027344
Wiedemann I-Disease 1 0.9999934434890747
syndrome I-Disease 1 0.9999951124191284
( O 0 6.380762888544278e-13
SWS B-Disease 0 1.9841369066853076e-05
) O 0 2.7999985142967976e-12
, O 0 2.3714398364937592e-14
which O 0 1.1749318694614236e-13
comprises O 0 6.497602443881947e-15
campomelia B-Disease 0 1.923531911529608e-08
at O 0 7.40236951596307e-12
birth O 0 3.0093746938852917e-11
with O 0 1.2848658768882526e-11
skeletal B-Disease 0 2.1295076294336468e-05
dysplasia I-Disease 0 1.8630682461662218e-05
, O 0 8.062903101256624e-13
contractures B-Disease 0 2.7787494971676097e-08
, O 0 2.403145770487475e-13
and O 0 9.522304819653549e-12
early B-Disease 0 1.690291656641918e-10
death I-Disease 0 2.3706560625669226e-07
. O 0 1.8613709532044886e-11

To O 0 2.8981515538123448e-12
test O 0 7.801842261427258e-14
for O 0 1.0477815135123712e-18
possible O 0 4.475999496581949e-15
nosologic O 0 2.399222509552601e-08
identity O 0 4.4549949507199926e-08
between O 0 1.5614554094156574e-10
these O 0 2.096720019828524e-10
disorders O 0 8.059256040304774e-10
, O 0 6.2625380955246696e-18
we O 0 6.497468556427999e-18
reviewed O 0 5.5356825798735034e-17
the O 0 4.91391500091683e-16
literature O 0 6.45190882802584e-15
and O 0 9.642919533074494e-15
obtained O 0 2.2742154691314446e-17
a O 0 2.402261042721183e-17
follow O 0 3.9406510416980026e-14
- O 0 4.79170203515622e-10
up O 0 6.943670638470678e-10
of O 0 3.89593895968024e-17
the O 0 4.3223445435764665e-16
only O 0 2.558180319935468e-16
two O 0 2.868308092803711e-15
surviving O 0 1.0245401532368859e-12
patients O 0 6.27112356853848e-17
, O 0 3.969656716844537e-18
one O 0 7.918595080591128e-15
with O 0 2.3514768257570928e-11
SJS B-Disease 0 0.011233178898692131
type I-Disease 0 2.2226337090258674e-11
2 I-Disease 0 5.939839006936787e-13
at O 0 4.219909491287588e-11
age O 0 2.7376627440706125e-12
10 O 0 1.6561026189664918e-15
years O 0 3.563872829660808e-14
and O 0 3.05869729772066e-14
another O 0 1.7610299899779207e-15
with O 0 2.0940961638349354e-12
SWS B-Disease 0 0.001142124179750681
at O 0 1.1094266838540534e-08
age O 0 7.999401835379061e-11
7 O 0 1.3091901694683994e-12
years O 0 6.985134692882866e-12
. O 0 7.132090599527852e-13

Patients O 0 7.545226665683913e-09
reported O 0 1.0105718484254567e-09
as O 0 1.4626334540225605e-13
having O 0 1.3389011253861494e-11
either O 0 1.013903683233508e-10
neonatal O 0 0.0031375533435493708
SJS B-Disease 1 0.8930540680885315
or O 0 1.0734259037192828e-09
SWS B-Disease 0 1.4148118907542084e-06
presented O 0 2.5646317887298778e-14
a O 0 9.714314484360681e-17
combination O 0 1.8258313985746637e-15
of O 0 3.760893122002588e-17
a O 0 1.5134503893177165e-12
severe O 0 5.811419401258178e-11
, O 0 5.4387368903213024e-14
prenatal O 0 1.3905984133089078e-06
- O 1 0.9942413568496704
onset O 0 0.04605451226234436
neuromuscular B-Disease 1 0.9999289512634277
disorder I-Disease 1 0.9999394416809082
( O 0 8.92186324819022e-12
with O 0 1.0846114006923813e-09
congenital B-Disease 1 0.9997894167900085
joint I-Disease 0 7.532379822805524e-05
contractures I-Disease 1 0.9998455047607422
, O 0 2.1500630964510492e-07
respiratory O 0 0.09196942299604416
and O 0 1.937206484114995e-08
feeding O 0 6.854291768831899e-06
difficulties O 0 1.55256838496598e-08
, O 0 3.277850132163765e-14
tendency O 0 1.5762457311607747e-11
to O 0 4.811898492509958e-13
hyperthermia B-Disease 0 6.167135779833188e-07
, O 0 3.6580609960416843e-13
and O 0 4.081144276690818e-12
frequent O 0 9.137890999433296e-10
death O 0 4.99713848967076e-07
in O 0 1.9660959058726e-12
infancy O 0 2.8096872384253402e-08
) O 0 9.137318287669012e-17
with O 0 1.063417770670007e-17
a O 0 5.947698066612614e-16
distinct O 0 3.294500523082222e-12
campomelic B-Disease 0 0.01748322695493698
- I-Disease 0 0.042733512818813324
metaphyseal I-Disease 0 0.051790013909339905
skeletal I-Disease 1 0.9488939642906189
dysplasia I-Disease 1 0.9068642854690552
. O 0 1.183571241014647e-09

The O 0 3.999649461454424e-13
similarity O 0 9.313255461967929e-13
of O 0 7.790856185867855e-17
the O 0 3.264807391787001e-15
clinical O 0 3.014402895590122e-14
and O 0 1.97166892187961e-12
radiographic O 0 2.385507902324946e-10
findings O 0 1.9608518639097766e-13
is O 0 6.288686532002002e-16
so O 0 3.5564147892635286e-15
extensive O 0 8.386419000656203e-15
that O 0 2.0028442904163057e-08
these O 0 4.0613976182157785e-08
disorders O 0 1.1993994064596336e-07
appear O 0 2.2310836988656546e-13
to O 0 2.4375177237420144e-14
be O 0 5.1884911704503864e-14
a O 0 1.2859180713797273e-14
single O 0 1.9195488948353656e-11
entity O 0 1.0352005475056103e-08
. O 0 1.0051210352912676e-07

The O 0 7.43401705211727e-13
follow O 0 1.2766401434258223e-12
- O 0 1.8123808009917752e-10
up O 0 1.1102103611437819e-11
observation O 0 3.4533051331692155e-12
of O 0 4.498328112252185e-19
an O 0 1.0738080277033162e-18
identical O 0 9.18832948637073e-14
and O 0 6.459494008068502e-15
unique O 0 7.150168273149684e-16
pattern O 0 1.7320811451781992e-08
of O 0 1.9618330397708217e-12
progressive O 0 2.1845435185241513e-06
bone B-Disease 1 0.9995937943458557
dysplasia I-Disease 0 0.02304825559258461
in O 0 1.6989910997175506e-12
the O 0 2.2712910111716278e-12
two O 0 1.51665374703569e-10
patients O 0 6.042257080958457e-13
( O 0 3.418250096864747e-17
one O 0 1.7849103271794231e-12
with O 0 1.4508888535047504e-09
SJS B-Disease 0 0.060061875730752945
type I-Disease 0 1.668347057726116e-11
2 I-Disease 0 1.2470115272420618e-13
, O 0 6.551212006146619e-15
one O 0 7.596934149464718e-14
with O 0 8.292901955420096e-12
SWS B-Disease 0 0.009277037344872952
) O 0 2.279225072565616e-11
surviving O 0 2.7632689025836044e-08
beyond O 0 5.594232632688545e-09
infancy O 0 3.5517750802682713e-06
adds O 0 3.5848199408938797e-12
to O 0 8.281030314325876e-16
the O 0 2.0287112742631356e-16
evidence O 0 1.0239379466927059e-13
in O 0 4.858259642326302e-16
favor O 0 4.016118627979751e-15
of O 0 5.224630574945798e-17
identity O 0 4.3092880375183995e-09
. O 0 9.522522527449784e-12

The O 0 7.522837604592714e-13
hypothesis O 0 1.7061296819775862e-11
that O 0 1.1155876916690843e-10
SWS B-Disease 0 0.008350733667612076
and O 0 8.284570185423945e-08
SJS B-Disease 0 0.010634087957441807
type I-Disease 0 1.831437640431588e-10
2 I-Disease 0 1.4540337250207314e-12
are O 0 5.301209232873305e-14
the O 0 3.732382458654371e-12
same O 0 8.749611701830418e-09
disorder O 0 6.539334407307251e-09
should O 0 5.913919980862889e-16
be O 0 1.214140976381739e-18
testable O 0 1.7649616836541424e-18
by O 0 5.743842007165923e-20
molecular O 0 1.1229364597678516e-16
methods O 0 1.8262026277044568e-13
. O 0 9.385011214349537e-13
. O 0 5.1375054384295016e-12

A O 0 1.4004712103540817e-12
mouse O 0 1.5836249644962663e-08
model O 0 3.1751796747414573e-09
of O 0 1.0263724314896194e-09
severe O 1 0.9994046688079834
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 0.9999984502792358
disease I-Disease 1 1.0
: O 1 0.9996933937072754
defects O 1 0.9999710321426392
in O 0 6.283514264460166e-10
hemostasis O 0 0.029173556715250015
and O 0 8.832141702441731e-07
thrombosis B-Disease 0 0.00023875036276876926
. O 0 1.2230958468251174e-08

von B-Disease 0 0.1019844263792038
Willebrand I-Disease 0 0.002385152503848076
factor I-Disease 0 3.49411948263878e-07
( I-Disease 0 7.532306722790594e-11
vWf I-Disease 0 1.302925193158444e-05
) I-Disease 0 1.8673263184609823e-05
deficiency I-Disease 1 0.9999226331710815
causes O 1 0.9935632944107056
severe O 1 0.9999563694000244
von B-Disease 1 0.9999998807907104
Willebrand I-Disease 1 0.9999940395355225
disease I-Disease 1 0.9999998807907104
in O 0 2.1758118862180709e-07
humans O 0 2.6282540588340453e-08
. O 0 6.539742636313406e-10

We O 0 5.00551097966373e-13
generated O 0 1.937110775536671e-15
a O 0 1.563134188499991e-16
mouse O 0 3.362289890951331e-10
model O 0 4.969080702466044e-12
for O 0 5.29596868238029e-16
this O 0 1.1640229575447239e-15
disease O 0 4.9894539285485606e-15
by O 0 6.925752563063781e-20
using O 0 1.935011364672232e-17
gene O 0 1.6805838404937434e-13
targeting O 0 4.606798831296999e-10
. O 0 3.2160238014333764e-12

vWf B-Disease 0 6.769164610886946e-05
- I-Disease 1 0.9602823853492737
deficient I-Disease 1 0.9842128157615662
mice O 0 0.001159305451437831
appeared O 0 2.220833266619593e-06
normal O 0 3.1388893220740677e-12
at O 0 1.122772361195068e-11
birth O 0 2.88465813735872e-11
; O 0 5.228703890214695e-15
they O 0 2.0391168357921383e-15
were O 0 7.847832254111609e-16
viable O 0 3.662678884144843e-15
and O 0 2.1617983011340547e-12
fertile O 0 5.589770868397181e-10
. O 0 2.799863896285615e-09

Neither O 0 5.408288572539277e-08
vWf O 0 3.696689816479193e-07
nor O 0 6.157885223956328e-08
vWf O 0 1.7799121110328997e-07
propolypeptide O 0 0.00016806328494567424
( O 0 1.2354461897956526e-10
von B-Disease 0 9.7788950370159e-05
Willebrand I-Disease 0 1.1535964404174592e-05
antigen O 0 3.0874384719936643e-06
II O 0 0.04477333649992943
) O 0 1.9701745790356995e-10
were O 0 1.160535990224476e-11
detectable O 0 1.7961735614482888e-12
in O 0 6.556077197959525e-18
plasma O 0 1.9989552547949874e-12
, O 0 4.1020392784569745e-14
platelets O 0 1.1948003697526133e-10
, O 0 1.639791140329791e-13
or O 0 5.360469013115932e-13
endothelial O 0 2.5386927260916126e-13
cells O 0 4.3634512642649545e-14
of O 0 1.7179388232952486e-17
the O 0 7.18029626099563e-14
homozygous O 0 3.8224423626331827e-10
mutant O 0 3.640891463874141e-07
mice O 0 9.537188816466369e-07
. O 0 2.2016437284388957e-10

The O 0 1.4148872178043614e-11
mutant O 0 5.794333446829114e-06
mice O 0 0.00014066537551116198
exhibited O 0 1.3597074257631903e-06
defects O 0 0.02163790352642536
in O 0 6.35156938979739e-14
hemostasis O 0 1.5837042610655772e-07
with O 0 3.8508831540218225e-12
a O 0 2.0329530159984843e-12
highly O 0 1.104247582262019e-09
prolonged O 0 1.4546907323165215e-06
bleeding O 1 0.7645480036735535
time O 0 2.911350236445287e-07
and O 0 1.0200656674896891e-07
spontaneous O 0 2.0842240433527337e-10
bleeding O 0 0.0019547699484974146
events O 0 1.0300289267350937e-11
in O 0 2.9812830179678845e-15
approximately O 0 1.0358452309333459e-14
10 O 0 8.276495266044959e-13
% O 0 2.7954367895602393e-15
of O 0 2.0494585575066976e-14
neonates O 0 9.954252533361796e-08
. O 0 9.738270953518757e-12

As O 0 3.648838869940718e-11
in O 0 3.725429795382873e-14
the O 0 2.3515640389798476e-13
human O 0 2.61203801643628e-11
disease O 0 1.757531342683194e-10
, O 0 9.14478078028322e-17
the O 0 6.947222620058902e-17
factor O 0 1.1734127836331588e-14
VIII O 0 4.503012185352873e-09
level O 0 3.6668383607274535e-11
in O 0 1.0270553159298038e-14
these O 0 2.745295310524476e-13
mice O 0 3.3625882026738774e-12
was O 0 4.989176172892629e-12
reduced O 0 4.736024847103626e-16
strongly O 0 1.3781342942374188e-14
as O 0 1.2713877293893481e-14
a O 0 2.5788778664631584e-13
result O 0 4.0981546498355947e-13
of O 0 2.2587071627525003e-15
the O 0 3.902225764740308e-12
lack O 0 4.67432252030265e-14
of O 0 4.248835834598501e-20
protection O 0 3.2298957774305024e-17
provided O 0 4.727229667260921e-18
by O 0 7.853672546282928e-16
vWf O 0 4.755860982808002e-11
. O 0 5.175255016198754e-11

Defective O 0 8.715772855794057e-05
thrombosis B-Disease 0 2.591686643427238e-05
in O 0 1.9242730239094064e-12
mutant O 0 1.1198355132080451e-08
mice O 0 8.151619823593137e-08
was O 0 1.6973547012355539e-09
also O 0 1.3282892147303826e-11
evident O 0 1.4160831361686999e-11
in O 0 1.541355118541511e-17
an O 0 1.0018431076160497e-17
in O 0 1.2613871713701191e-15
vivo O 0 1.614913064384993e-10
model O 0 8.272821663823926e-12
of O 0 6.485360615508459e-14
vascular B-Disease 0 8.369763963855803e-05
injury I-Disease 0 0.2802135944366455
. O 0 1.0627123625539525e-09

In O 0 8.372290491096002e-15
this O 0 8.171228242233219e-17
model O 0 1.3452217279290215e-14
, O 0 9.790620903251963e-16
the O 0 1.4546805134500241e-15
exteriorized O 0 1.951770078889581e-09
mesentery O 0 1.1460412618902183e-09
was O 0 1.5727559879441522e-11
superfused O 0 2.719282958529856e-11
with O 0 2.293216767331298e-16
ferric O 0 2.2406704855253146e-13
chloride O 0 3.0346440638151506e-11
and O 0 2.1171063513403254e-10
the O 0 3.40266470598774e-13
accumulation O 0 6.68854915897299e-10
of O 0 7.745111721565133e-15
fluorescently O 0 6.411277553297623e-08
labeled O 0 2.1533941296780768e-09
platelets O 0 8.361172865178901e-10
was O 0 1.7376045047257094e-11
observed O 0 2.4537041845508652e-14
by O 0 2.26780704946309e-15
intravital O 0 6.197091728665782e-10
microscopy O 0 7.023989723187185e-11
. O 0 1.3084095439042098e-11

We O 0 3.483152568456438e-12
conclude O 0 3.5058436188839526e-14
that O 0 9.818223589420612e-16
these O 0 1.56824740876521e-15
mice O 0 3.515145802473335e-13
very O 0 2.5408313911098055e-15
closely O 0 2.037104512853105e-10
mimic O 0 7.634019311808515e-06
severe O 0 4.038929910166189e-05
human O 1 0.9884527325630188
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999997615814209
disease I-Disease 1 1.0
and O 1 0.9826745390892029
will O 0 1.9802723905115727e-09
be O 0 5.316475985308027e-15
very O 0 1.092046016041615e-18
useful O 0 1.778362449017202e-19
for O 0 3.504166488147638e-21
investigating O 0 6.165117312471543e-18
the O 0 5.580328950332532e-19
role O 0 1.0666075776353585e-16
of O 0 2.303515250743596e-19
vWf O 0 1.0337841244869683e-15
in O 0 9.971729120520243e-17
normal O 0 7.649157288201324e-15
physiology O 0 1.949434320566712e-12
and O 0 3.3405164051591996e-11
in O 0 1.0517773717938494e-12
disease O 0 1.1211321870874258e-09
models O 0 2.896350043482543e-12
. O 0 1.8257742323210535e-13
. O 0 1.8713489091659596e-11

Oral O 0 8.188458622271355e-08
contraceptives O 0 4.7225905291270465e-05
and O 0 7.274299385073846e-09
the O 0 5.900639699074617e-11
risk O 0 1.9600066991642962e-07
of O 0 1.3283353583748436e-10
hereditary B-Disease 1 0.9999938011169434
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999983310699463
. O 0 1.002303022801243e-07

Hereditary B-Disease 1 0.9996919631958008
Ovarian I-Disease 1 0.9992287158966064
Cancer I-Disease 0 0.0005216810386627913
Clinical O 0 3.1703624170376088e-09
Study O 0 5.243594794479556e-11
Group O 0 1.2119762970996817e-09
. O 0 9.052346372495634e-11

BACKGROUND O 0 4.288105992600322e-05
Women O 0 8.731236289527544e-10
with O 0 2.222833496315444e-14
mutations O 0 4.381999930557108e-14
in O 0 7.188511337089518e-16
either O 0 2.1759924896289865e-15
the O 0 2.055305752996536e-15
BRCA1 O 0 1.6957747706047854e-10
or O 0 2.935895667202648e-12
the O 0 2.364686019288827e-15
BRCA2 O 0 2.908540379029101e-12
gene O 0 1.8896943471818917e-12
have O 0 2.155441190115903e-12
a O 0 1.2785524592176523e-13
high O 0 1.2923938363940124e-08
lifetime O 0 3.5002230447389593e-07
risk O 0 1.5902613085927442e-05
of O 0 2.591745555946545e-07
ovarian B-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999974966049194
. O 0 3.0682429041917203e-07

Oral O 0 7.3520764090062585e-06
contraceptives O 1 0.5296646356582642
protect O 1 0.5553009510040283
against O 1 0.9819803237915039
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999995231628418
in O 0 1.0638262189568981e-12
general O 0 1.4852571322964835e-15
, O 0 3.0425464122955936e-13
but O 0 7.476481239665489e-12
it O 0 3.6227344908656978e-12
is O 0 2.278212002187162e-15
not O 0 9.676959007897786e-17
known O 0 1.2104836179828511e-17
whether O 0 1.0846246301679475e-15
they O 0 3.215137168001772e-14
also O 0 3.2796888712856645e-14
protect O 0 5.435330571040842e-12
against O 0 1.106751912338666e-10
hereditary B-Disease 0 0.05407622829079628
forms I-Disease 0 8.434378173660662e-07
of I-Disease 0 0.00013082691293675452
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999972581863403
. O 0 4.014660603957054e-09

METHODS O 0 7.228559656229094e-13
We O 0 1.8912619408929798e-13
enrolled O 0 1.404185046640109e-14
207 O 0 1.6338252972758482e-09
women O 0 9.714237192426367e-10
with O 0 1.1468841876194347e-07
hereditary B-Disease 1 0.9999971389770508
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
and O 0 1.321810549903546e-09
161 O 0 7.466302424409543e-13
of O 0 2.536578597500319e-16
their O 0 4.4449131875179404e-11
sisters O 0 3.278932125816425e-10
as O 0 2.1596860042515098e-14
controls O 0 1.5401657813690628e-12
in O 0 4.463581728877405e-17
a O 0 1.2334321194954118e-15
case O 0 1.6632213184833433e-12
- O 0 7.385358546940779e-09
control O 0 1.524113812934047e-08
study O 0 4.3255015454851664e-13
. O 0 1.008429234214403e-12

All O 0 4.1866821966739243e-13
the O 0 1.6838012104405942e-14
patients O 0 2.0460046959609735e-15
carried O 0 6.811433063630759e-14
a O 0 6.800959220658296e-17
pathogenic O 0 1.5604606772327487e-14
mutation O 0 1.9131895910183203e-14
in O 0 2.688490367288264e-14
either O 0 9.374039765990341e-14
BRCA1 O 0 5.4469043858640376e-11
( O 0 2.1766900212610504e-15
179 O 0 1.3550706780621202e-12
women O 0 1.6273412738881943e-12
) O 0 7.590647809743375e-14
or O 0 1.3515022434518187e-10
BRCA2 O 0 1.3209850635576004e-07
( O 0 1.2186318577508959e-12
28 O 0 2.4843188617396095e-10
women O 0 2.0281901158547555e-11
) O 0 9.33060811773856e-13
. O 0 3.617957669566074e-11

The O 0 1.0941015454735137e-11
control O 0 6.979778088833655e-09
women O 0 2.8031204094003392e-11
were O 0 2.5752894283227745e-13
enrolled O 0 2.997108822735706e-16
regardless O 0 1.4560796001206514e-15
of O 0 1.1505389556849602e-18
whether O 0 1.8335449464604824e-14
or O 0 2.1981379390301203e-12
not O 0 4.735418329161745e-13
they O 0 3.8667765549834504e-14
had O 0 2.060725938848873e-12
either O 0 7.72142359816222e-15
mutation O 0 3.668457681724191e-13
. O 0 3.413712715283346e-11

Lifetime O 0 1.4381872359692238e-09
histories O 0 7.678997437920998e-10
of O 0 2.057039205923092e-15
oral O 0 7.869376678071305e-11
- O 0 1.1261273163976071e-10
contraceptive O 0 3.934742753841647e-09
use O 0 3.244745035266457e-14
were O 0 1.0592129217723133e-14
obtained O 0 3.168159855516128e-18
by O 0 1.319331653044214e-17
interview O 0 2.8374341071168985e-11
or O 0 3.86198573663378e-14
by O 0 7.162175759270402e-17
written O 0 5.982310373936267e-15
questionnaire O 0 1.0608627725469753e-14
and O 0 1.681442223682491e-14
were O 0 2.7684673875746045e-14
compared O 0 3.52766035004485e-16
between O 0 5.365329563452985e-16
patients O 0 6.735207467564513e-15
and O 0 4.4238739191002074e-13
control O 0 8.77499461982012e-10
women O 0 1.0963549946368945e-12
, O 0 3.0885219418923704e-16
after O 0 6.788472710936126e-15
adjustment O 0 4.684117079909106e-16
for O 0 1.5527314886023176e-19
year O 0 1.2438170610661048e-16
of O 0 1.9958480585427e-18
birth O 0 2.2898046306285558e-11
and O 0 8.074880174235854e-12
parity O 0 2.2421774506509173e-11
. O 0 9.864038839207945e-13

RESULTS O 0 2.8121704617745102e-11
The O 0 4.343572078619254e-14
adjusted O 0 8.623233682669706e-09
odds O 0 5.4098400141811e-05
ratio O 0 1.2287646313779987e-05
for O 0 0.0001174812568933703
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 6.30148662139618e-08
with O 0 9.155685514209908e-14
any O 0 1.5583065242171152e-15
past O 0 3.0897597848300595e-12
use O 0 1.2440217254019851e-15
of O 0 3.5909971725013414e-17
oral O 0 4.441605937210991e-12
contraceptives O 0 8.005423879353657e-09
was O 0 4.5651979418970257e-10
0 O 0 3.4967014228776475e-14
. O 0 7.727732299553369e-14

5 O 0 3.998455733178474e-11
( O 0 3.1958539547377596e-14
95 O 0 2.7316239548103027e-11
percent O 0 2.5114290647110238e-09
confidence O 0 2.5588895585793026e-11
interval O 0 9.99577685705487e-14
, O 0 2.0645063572185103e-16
0 O 0 2.621691876024555e-18
. O 0 5.010254476929615e-18
3 O 0 2.1071119159420546e-17
to O 0 8.265187092443076e-16
0 O 0 2.68666128831243e-17
. O 0 3.221198535772324e-16
8 O 0 3.4779576001944465e-14
) O 0 6.751232907410091e-15
. O 0 3.7247069035843683e-13

The O 0 5.438267544621844e-11
risk O 0 2.913757013445206e-10
decreased O 0 8.705282046432561e-13
with O 0 8.084264560678702e-16
increasing O 0 2.9071351963682313e-17
duration O 0 8.448612077170995e-16
of O 0 8.652350566335297e-19
use O 0 1.2041475435308705e-15
( O 0 2.719575466630405e-17
P O 0 7.62024904982228e-12
for O 0 1.3453620911731898e-19
trend O 0 2.4122636481778642e-15
, O 0 2.421368790794066e-18
< O 0 1.581546273541814e-18
0 O 0 4.481677806626802e-20
. O 0 1.5445849227914066e-19
001 O 0 3.7661619316323056e-17
) O 0 1.114510716364301e-19
; O 0 3.3293169452530153e-21
use O 0 6.237069773150833e-20
for O 0 1.7420592445211724e-17
six O 0 2.7423096125590287e-15
or O 0 9.558246731535165e-15
more O 0 3.2610947140302875e-17
years O 0 6.492897853486307e-14
was O 0 1.0363681484173992e-12
associated O 0 5.1458482390450225e-17
with O 0 5.711684611220494e-18
a O 0 1.6565321705498681e-15
60 O 0 4.342925961887088e-14
percent O 0 1.2554461593580757e-12
reduction O 0 8.434966863434673e-14
in O 0 8.319413951143884e-14
risk O 0 1.3661279885113231e-09
. O 0 6.852578400551312e-12

Oral O 0 1.1416130263341984e-08
- O 0 5.717135653782179e-10
contraceptive O 0 1.4971776352012967e-07
use O 0 6.281510034344961e-11
protected O 0 3.0886676540831104e-05
against O 1 0.6606875061988831
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999994039535522
both O 0 6.063088941500594e-15
for O 0 1.2124238528276555e-18
carriers O 0 2.8153820067181344e-17
of O 0 1.3832115237087494e-18
the O 0 3.240596538941348e-13
BRCA1 O 0 9.643242648849082e-09
mutation O 0 2.4196091311101675e-11
( O 0 5.833841168392112e-15
odds O 0 2.8787165359811517e-11
ratio O 0 3.0156776378240926e-15
, O 0 1.994326997473307e-17
0 O 0 2.205901062523497e-18
. O 0 6.015440717709359e-17
5 O 0 2.095699060185199e-15
; O 0 1.8542525303285977e-14
95 O 0 3.5962359392488485e-12
percent O 0 2.898709050569437e-09
confidence O 0 5.124616443002994e-12
interval O 0 1.5607822109395264e-14
, O 0 3.9259110219954865e-17
0 O 0 1.6305730616526788e-19
. O 0 1.8528134345861024e-18
3 O 0 1.279974730371186e-17
to O 0 2.9123981164719877e-16
0 O 0 6.797402178588195e-18
. O 0 8.677844603686426e-17
9 O 0 2.3430820204526324e-15
) O 0 6.8172416919899734e-18
and O 0 9.569108552655162e-17
for O 0 4.676038431830341e-20
carriers O 0 4.628481259324647e-18
of O 0 1.8363200735572545e-18
the O 0 4.689863406480421e-13
BRCA2 O 0 1.593794252130465e-08
mutation O 0 1.0805878761233068e-11
( O 0 2.7366247509335315e-15
odds O 0 5.938870922816974e-11
ratio O 0 6.074525156837948e-15
, O 0 8.689372192702965e-17
0 O 0 3.715203966304344e-18
. O 0 4.852904541215083e-17
4 O 0 2.5189926370922794e-14
; O 0 6.220503577297407e-14
95 O 0 8.939203544056085e-12
percent O 0 9.80878667178331e-09
confidence O 0 3.6022448912653715e-11
interval O 0 1.5985579830332663e-13
, O 0 1.1721595560360487e-15
0 O 0 2.603056530799501e-18
. O 0 7.459650421623662e-18
2 O 0 2.097984639627022e-17
to O 0 1.4840726625988667e-16
1 O 0 2.1729541692122955e-17
. O 0 4.290344168224791e-16
1 O 0 6.629772406180324e-16
) O 0 5.35286197962323e-15
. O 0 1.0611547448038938e-13

CONCLUSIONS O 0 1.6272189151678162e-10
Oral O 0 2.8026300724626196e-10
- O 0 2.8480684477472096e-10
contraceptive O 0 9.185549210144472e-09
use O 0 2.382717937884915e-12
may O 0 4.5760205520661845e-12
reduce O 0 2.3405919129942943e-13
the O 0 1.8727645031534762e-13
risk O 0 1.594007059679825e-08
of O 0 1.9501650294628803e-10
ovarian B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
in O 0 7.62647150293061e-12
women O 0 1.4129198028581258e-13
with O 0 6.606265389009445e-17
pathogenic O 0 2.028071144995116e-14
mutations O 0 4.8953320509661363e-14
in O 0 3.225477640342734e-16
the O 0 1.5901822163189548e-14
BRCA1 O 0 7.83028042405931e-08
or O 0 2.6585593726480283e-09
BRCA2 O 0 1.5858880715313717e-06
gene O 0 1.1390829968149774e-05

A O 0 2.5642149861782038e-11
Japanese O 0 1.401824906155369e-10
family O 0 7.648994285180954e-12
with O 0 4.724691232867173e-13
adrenoleukodystrophy B-Disease 1 0.9999572038650513
with O 0 6.130087553562515e-16
a O 0 7.492164575397407e-17
codon O 0 9.09261323867169e-15
291 O 0 1.325463447766212e-13
deletion O 0 6.606940688991259e-11
: O 0 8.195273310614062e-15
a O 0 3.343057460124656e-16
clinical O 0 2.6896906129745234e-14
, O 0 4.6557792750213586e-14
biochemical O 0 1.3263347885261734e-11
, O 0 2.3341989148842335e-13
pathological O 0 3.625100220006061e-11
, O 0 3.097471714882949e-12
and O 0 4.4382822417254886e-10
genetic O 0 1.2239453006657186e-08
report O 0 1.3670956811040469e-08
. O 0 4.452847465752363e-11

We O 0 1.4447300300535204e-10
report O 0 1.408345079553959e-14
a O 0 1.2527310240447722e-16
Japanese O 0 5.7825914195897e-12
family O 0 6.812456154747792e-11
with O 0 5.036345784859009e-10
adrenoleukodystrophy B-Disease 1 0.9999984502792358
( O 0 1.2395943646548169e-12
ALD B-Disease 1 0.9999983310699463
) O 0 2.4778860434587335e-15
with O 0 1.4876703730037834e-18
a O 0 1.6660037922277392e-18
three O 0 5.33377771851666e-17
base O 0 7.742810841267211e-14
pair O 0 8.579029153743534e-11
deletion O 0 3.343434036573445e-12
( O 0 1.436826951511145e-17
delGAG O 0 9.12244889003655e-13
291 O 0 6.413830512704e-13
) O 0 8.865125600027602e-15
in O 0 1.919932947366354e-15
the O 0 1.3084269778751434e-11
ALD B-Disease 1 0.999995231628418
gene O 0 3.1700256641897795e-08
. O 0 2.7123225887493163e-10

A O 0 5.076431462691655e-12
variety O 0 5.0947205574311885e-14
of O 0 2.024475659540611e-15
phenotypes O 0 4.231110253827275e-12
were O 0 7.690125120897451e-13
observed O 0 1.3395793534761585e-13
within O 0 7.076898070327615e-17
this O 0 6.5421716235005735e-15
family O 0 1.5233283523485852e-09
. O 0 1.1620355719332842e-11

While O 0 2.5417210558487113e-09
the O 0 1.4597977340824464e-11
proband O 0 6.219169108589995e-07
( O 0 4.636405090418811e-15
patient O 0 2.0538030911371186e-13
1 O 0 5.972505967571798e-15
) O 0 5.6312126762005175e-15
was O 0 2.641666182676139e-13
classified O 0 9.674089498500505e-15
as O 0 1.588186114357323e-16
having O 0 1.9486347646631842e-16
a O 0 2.063953147096641e-18
rare O 0 6.66031800244509e-16
intermediate O 0 6.944331855428601e-14
type O 0 9.019694171240322e-13
of O 0 3.688507968025237e-14
adult O 0 9.400163980899379e-05
cerebral O 0 0.004124857950955629
and O 0 3.818074958417128e-07
cerebello O 1 0.7412949204444885
- O 1 0.7518780827522278
brain O 0 0.004479223862290382
stem O 0 1.1955725653933769e-07
forms O 0 3.9389008721357754e-10
, O 0 3.1674113332158527e-10
his O 0 8.480457154291798e-07
younger O 0 4.139747744602573e-08
brother O 0 6.755478842990215e-09
( O 0 2.0919349714990542e-17
patient O 0 2.6556485282309625e-14
2 O 0 1.323005968017002e-13
) O 0 1.339927517898798e-12
and O 0 1.06779196595852e-09
nephew O 0 1.6631460653115937e-07
( O 0 9.510414992761952e-16
patient O 0 3.525042670954326e-13
3 O 0 4.973876128674948e-13
) O 0 3.020689167548829e-13
had O 0 4.079018012248525e-09
a O 0 1.9457288558122343e-10
childhood O 0 0.11146056652069092
ALD B-Disease 1 0.999998927116394
type O 0 3.9721277289572754e-07
. O 0 2.5052607210973576e-10

Another O 0 2.6677263176289046e-10
nephew O 0 1.0956673577311449e-06
( O 0 8.016317102309267e-13
patient O 0 6.265905849733855e-11
4 O 0 5.752265677672064e-11
) O 0 1.5699140121575028e-12
of O 0 5.654242443245178e-16
patient O 0 5.094295753467482e-13
1 O 0 5.818369899852275e-16
was O 0 6.088567150452917e-13
classified O 0 1.3639954508752605e-13
as O 0 1.1721869575518924e-14
having O 0 4.778013922013269e-13
an O 0 1.3949785608331072e-13
adolescent O 0 2.0359688278404064e-05
form O 0 2.0325779254148912e-11
. O 0 2.073092142396149e-09

The O 0 2.961403705267242e-14
tau O 0 3.7893277925193924e-13
level O 0 6.901991131402774e-12
in O 0 1.288182207388397e-13
the O 0 2.3827853024016576e-09
cerebrospinal O 1 0.7312042117118835
fluid O 0 3.6348519643070176e-06
( O 0 7.626184406195335e-11
CSF O 0 7.328313949983567e-05
) O 0 1.2417744783832507e-11
in O 0 1.0037459009576075e-14
patient O 0 3.542472576129746e-13
1 O 0 3.7435611073660907e-16
was O 0 1.1420337765744026e-11
as O 0 1.8374170728755607e-14
high O 0 1.4366188360454002e-13
as O 0 9.63677325025098e-16
that O 0 2.6929142509651838e-14
of O 0 1.3952379646732039e-15
patients O 0 2.2024427366509197e-13
with O 0 4.681181831056591e-11
Alzheimers B-Disease 0 0.2734104096889496
disease I-Disease 0 5.50335585103312e-07
( O 0 1.4994207937239963e-15
AD B-Disease 0 3.931166503434724e-08
) O 0 1.8893636655192836e-11
. O 0 9.659077357393464e-12

His O 0 1.1162863966518444e-09
brain O 0 4.471164272157324e-10
magnetic O 0 1.0869463315521521e-11
resonance O 0 1.5759457627773088e-10
image O 0 1.262855846562161e-07
( O 0 1.2622349454712023e-14
MRI O 0 4.772750195058961e-09
) O 0 1.9745913237834145e-10
showed O 0 1.7007332075991144e-07
abnormalities B-Disease 0 6.364030014083255e-08
in I-Disease 0 4.6933976493352574e-17
the I-Disease 0 1.1204553943862253e-15
bilateral I-Disease 0 9.39617095241374e-09
cerebellar I-Disease 0 0.04070832207798958
hemispheres I-Disease 1 0.5246248841285706
and O 0 1.2272761523490772e-05
brain O 0 7.409177555928181e-07
stem O 0 2.057069181660154e-09
, O 0 4.1065192695963204e-13
but O 0 4.179137504806141e-12
not O 0 5.402102376539375e-12
in O 0 1.2516439165492776e-13
the O 0 2.6582802625796376e-09
cerebral O 0 5.221889296080917e-05
white O 0 1.196469128217359e-07
matter O 0 1.5869529540295246e-13
, O 0 2.6104961518697723e-17
where O 0 3.723165083391799e-17
marked O 0 3.0485844443084486e-15
reductions O 0 3.445236039815655e-14
of O 0 1.09140168783937e-16
the O 0 3.3165961643710773e-10
cerebral O 0 0.00026951642939820886
blood O 0 0.00011169397475896403
flow O 0 4.84948429857468e-07
and O 0 1.3970556267395295e-07
oxygen O 0 1.2962874697264315e-11
metabolism O 0 2.639985018787483e-12
were O 0 7.367809026726999e-14
clearly O 0 7.48454575226487e-15
demonstrated O 0 8.199822283686498e-19
by O 0 2.7446573276371174e-20
positron O 0 7.789326909174443e-13
emission O 0 1.0071605008321605e-12
tomography O 0 2.274804927759888e-10
( O 0 3.6157515648010605e-14
PET O 0 1.2735807963792922e-08
) O 0 1.2980040219739974e-12
. O 0 2.0690794997474393e-12

In O 0 1.6000778176386565e-12
patients O 0 5.800458583501283e-14
2 O 0 4.033077921649676e-14
and O 0 1.5094288666195332e-12
3 O 0 2.2799433375313496e-14
, O 0 3.7251841981798166e-16
the O 0 1.29980488008843e-16
autopsy O 0 1.5719905377409304e-08
findings O 0 3.2244033831840824e-11
showed O 0 2.5278648063675746e-09
massive O 0 8.036012133505466e-11
demyelination B-Disease 1 0.9999954700469971
of I-Disease 0 3.035300960227416e-13
the I-Disease 0 1.7225393333930583e-09
cerebral I-Disease 0 3.672461389214732e-05
white I-Disease 0 3.5899244466008895e-08
matter I-Disease 0 4.723127288174022e-15
with O 0 8.509865397100588e-18
sparing O 0 5.022506742337199e-16
of O 0 3.114632460410423e-17
the O 0 6.130237376750225e-13
U O 0 6.127995533233843e-08
- O 0 3.36941958778425e-08
fibers O 0 7.09882730376421e-09
, O 0 1.6597264376730825e-15
compatible O 0 8.431749493487822e-14
with O 0 1.9001376603340787e-14
the O 0 2.975399400061314e-14
findings O 0 1.919247746839936e-12
of O 0 1.4901732734058648e-13
childhood O 0 0.0001278928975807503
ALD B-Disease 1 0.9999881982803345
. O 0 9.244067317171201e-11

Oleic O 0 0.00028213844052515924
and O 0 6.7040319962075046e-09
erucic O 0 2.4729131837375462e-05
acids O 0 1.5143536424844228e-09
( O 0 1.85029319340127e-13
Lorenzos O 0 1.5967337674283044e-08
Oil O 0 5.173784317635821e-11
) O 0 7.588208185448694e-16
were O 0 7.731971381817022e-16
administered O 0 1.1513298644276528e-17
to O 0 2.513039287198326e-16
patients O 0 1.537520309221715e-17
1 O 0 1.4583231422437443e-18
and O 0 7.780087744836336e-14
4 O 0 1.0847244530007814e-14
, O 0 1.7618421622254396e-16
but O 0 2.1975381755407185e-16
sufficient O 0 2.3946372085284962e-19
effectiveness O 0 1.9907620144693258e-17
was O 0 2.0786627627500387e-13
not O 0 3.4628242130972696e-15
obtained O 0 7.483721080987424e-14
. O 0 1.2795270919185864e-11

The O 0 3.155717354097476e-11
findings O 0 2.376277776980351e-12
in O 0 1.842251555773662e-15
this O 0 4.510913135876587e-16
family O 0 2.4182561335350794e-12
suggest O 0 1.0158566933341547e-14
that O 0 7.308596786208537e-16
delGAG291 O 0 1.7428115157633317e-12
is O 0 1.7997467542661715e-16
part O 0 4.109315823516459e-17
of O 0 1.8216215124779118e-16
the O 0 3.021899137173323e-13
cause O 0 1.6498476196336043e-11
of O 0 3.603900303319552e-15
Japanese O 0 6.026475034559553e-07
ALD B-Disease 1 0.9999954700469971
with O 0 1.375616607386318e-13
phenotypic O 0 5.3188722415158096e-14
variations O 0 8.11158140656687e-10
. O 0 6.473611424695491e-09

Moreover O 0 3.642830481709325e-11
, O 0 1.5294004872767018e-14
although O 0 4.974115220664969e-16
the O 0 1.4756058271372312e-15
scale O 0 7.987418365607013e-11
of O 0 1.0720619668898638e-15
the O 0 1.995373538708073e-13
study O 0 4.61288690300094e-16
is O 0 7.91807391710055e-17
limited O 0 7.50179858255569e-18
, O 0 3.4252614782600936e-16
there O 0 4.4215702181825715e-17
is O 0 2.6275989795739494e-18
a O 0 2.357485838881749e-18
possibility O 0 3.6343801486517875e-17
that O 0 1.4770490061079278e-13
PET O 0 2.0669929767791473e-08
can O 0 3.806614311957501e-12
detect O 0 3.073201693126748e-09
an O 0 7.34628666492626e-13
insidious B-Disease 0 9.075037814909592e-05
lesion I-Disease 1 0.9952312111854553
which O 0 5.262487320578657e-06
is O 0 1.489947401567271e-11
undetectable O 0 6.342281561044771e-11
by O 0 1.0682653534620332e-15
computed O 0 2.845030417850114e-12
tomogram O 0 6.100974587752717e-07
( O 0 7.157485155506304e-15
CT O 0 4.676677378689931e-10
) O 0 4.244912052615325e-14
or O 0 6.238203685983001e-15
MRI O 0 6.742511686778571e-14
analysis O 0 2.572732610667093e-16
, O 0 3.083822960443028e-17
and O 0 3.708130248578035e-15
that O 0 5.105516077047239e-15
the O 0 2.3306463062375184e-15
higher O 0 1.4545481857278393e-14
level O 0 2.4229987319931284e-15
of O 0 8.767404927192888e-20
tau O 0 8.347589828312971e-19
reflects O 0 2.1052871555107626e-18
the O 0 7.69934415038559e-20
process O 0 3.7858365052199406e-18
of O 0 1.8040616840289115e-18
neuronal B-Disease 0 5.6298712219904345e-11
degeneration I-Disease 0 3.036664111277787e-07
in O 0 4.270198430966765e-11
ALD B-Disease 1 0.9999942779541016
. O 0 2.183108982478643e-08

Lorenzos O 0 7.828367074580456e-07
Oil O 0 3.766001052674106e-11
should O 0 2.3628644749357566e-15
be O 0 2.3817110638912832e-18
given O 0 5.469199949222418e-20
in O 0 6.260790986673381e-19
the O 0 6.229283052619874e-16
early O 0 1.3172385925075414e-11
stage O 0 3.481175070429998e-11
. O 0 3.612654388829425e-15
. O 0 1.3585940911772093e-14

Nonsense O 0 5.841500083647588e-08
mutation O 0 2.1772993564345144e-12
in O 0 1.6899078097705293e-14
exon O 0 1.810686843517484e-11
4 O 0 3.6907938510966076e-11
of O 0 7.22185108328904e-16
human O 0 1.1961872464771872e-13
complement O 0 1.1089626395996421e-13
C9 O 0 1.931274758171231e-11
gene O 0 1.4928169377731448e-12
is O 0 3.239834954677813e-14
the O 0 4.652791683937274e-16
major O 0 1.8229721118062647e-14
cause O 0 5.930559428962701e-12
of O 0 1.7762024147060542e-16
Japanese O 0 2.7485282938499722e-09
complement B-Disease 0 2.2352188155938535e-10
C9 I-Disease 0 1.5951796740409918e-05
deficiency I-Disease 0 5.83908476983197e-05
. O 0 1.0529535143105617e-12

Deficiency B-Disease 1 0.9990938901901245
of I-Disease 0 4.6950971891801876e-14
the I-Disease 0 3.2305911147178373e-14
ninth I-Disease 0 6.526829771091869e-11
component I-Disease 0 8.556039720036129e-14
of I-Disease 0 2.8941779083809557e-17
human I-Disease 0 2.1581952262643422e-14
complement I-Disease 0 4.808226231989114e-14
( O 0 9.283436434154054e-18
C9 O 0 6.372808639305838e-13
) O 0 3.880542812374913e-17
is O 0 2.4551677008157126e-19
the O 0 1.0562244038530322e-19
most O 0 1.0601213566673097e-16
common O 0 7.37994457211677e-11
complement B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9999998807907104
in O 0 1.507870603823392e-14
Japan O 0 3.0036502798869158e-12
but O 0 1.6663123517720452e-14
is O 0 9.022459296532349e-18
rare O 0 4.558464308220912e-17
in O 0 3.946512451459487e-17
other O 0 1.642789399793846e-14
countries O 0 8.877210896712437e-14
. O 0 4.238215952235419e-13

We O 0 8.4066113445469e-12
studied O 0 4.7027040532663e-15
the O 0 1.2063164474929315e-17
molecular O 0 1.3262106028234908e-15
basis O 0 2.152233638974977e-15
of O 0 2.1753461187869368e-14
C9 B-Disease 0 1.6883534044609405e-05
deficiency I-Disease 0 0.000216905667912215
in O 0 1.0730229257685238e-16
four O 0 1.900253534441263e-14
Japanese O 0 1.9414879426360443e-10
C9 B-Disease 0 2.7638495225801307e-07
- I-Disease 0 3.12115516862832e-05
deficient I-Disease 0 0.0001010674677672796
patients O 0 9.292735331234425e-11
who O 0 1.0470571076837132e-09
had O 0 2.3048039565765066e-06
suffered O 0 4.330417141318321e-05
from O 0 7.181489292129584e-10
meningococcal B-Disease 1 0.9999961853027344
meningitis I-Disease 1 0.999996542930603
. O 0 8.647753624302368e-10

Direct O 0 3.216889890927878e-15
sequencing O 0 2.3403688383973054e-13
of O 0 1.521778863641484e-15
amplified O 0 5.5335881710139034e-11
C9 O 0 5.285484723505096e-12
cDNA O 0 1.608449809974155e-12
and O 0 2.945238183112847e-13
DNA O 0 8.77978625132142e-13
revealed O 0 7.139058766890416e-13
a O 0 1.3662682798242492e-17
nonsense O 0 1.6502322783013695e-14
substitution O 0 6.141995132808848e-18
( O 0 1.9648967177797674e-19
CGA O 0 5.899598301203901e-13
- O 0 1.0061688288098836e-10
- O 0 2.997529724435566e-10
> O 0 4.311362973173551e-15
TGA O 0 7.426145115507765e-11
) O 0 3.1281130559404245e-16
at O 0 1.223673591876438e-17
codon O 0 1.2033421334848593e-18
95 O 0 4.960370005921109e-19
in O 0 5.592024637959179e-20
exon O 0 2.39914077848429e-15
4 O 0 1.7562451601511875e-13
in O 0 1.2003227662575437e-15
the O 0 1.97392544475615e-13
four O 0 6.394390572594943e-11
C9 B-Disease 0 2.914858214353444e-06
- I-Disease 0 0.00014996706158854067
deficient I-Disease 0 5.369022983359173e-05
individuals O 0 6.225978391692644e-13
. O 0 5.436646792478239e-12

An O 0 1.6543345435682168e-15
allele O 0 1.5518961983540525e-12
- O 0 1.3233774969964585e-12
specific O 0 1.980130308378296e-15
polymerase O 0 1.5899467298297054e-09
chain O 0 3.4730362585833063e-08
reaction O 0 4.210049192945875e-13
system O 0 2.230054113377608e-13
designed O 0 2.5530285351071935e-12
to O 0 1.4205548265545692e-15
detect O 0 5.329799644161748e-14
exclusively O 0 4.017800531010532e-17
only O 0 1.0835896452419089e-17
one O 0 8.883870809727254e-17
of O 0 4.319717070535141e-19
the O 0 1.181258278076336e-15
normal O 0 5.21752559640978e-15
and O 0 1.726344490537296e-13
mutant O 0 5.909463456771347e-13
alleles O 0 4.3499868285354e-15
indicated O 0 2.088316715734284e-12
that O 0 2.9999257472688307e-14
all O 0 3.12952288934157e-15
the O 0 5.069411551780409e-14
four O 0 2.63336553084359e-13
patients O 0 5.453645122826209e-17
were O 0 4.566191829503383e-17
homozygous O 0 1.1510225668300893e-17
for O 0 9.99475923498076e-19
the O 0 1.4916954297285634e-16
mutation O 0 1.4786824625598956e-15
in O 0 1.2461685304068011e-15
exon O 0 4.5226455501652663e-13
4 O 0 4.6684312665634664e-11
and O 0 5.664052338261172e-09
that O 0 6.958091741671169e-11
the O 0 1.3358656195117113e-11
parents O 0 4.2580253212243235e-10
of O 0 1.0186340799574881e-16
patient O 0 1.6535602368698138e-13
2 O 0 2.2850631434777335e-14
were O 0 1.1125181722040911e-12
heterozygous O 0 1.4533579201225777e-11
. O 0 8.115117085261137e-12

The O 0 4.167686025935077e-14
common O 0 2.056279205611168e-14
mutation O 0 9.038698744546006e-15
at O 0 2.8164672200362006e-13
codon O 0 7.225298613263483e-15
95 O 0 3.4707854757685128e-15
in O 0 1.6039798377522676e-16
exon O 0 5.553301958907686e-13
4 O 0 5.0705672299811155e-12
might O 0 3.1913965285561285e-13
be O 0 2.862359248066246e-17
responsible O 0 2.6208144359179833e-16
for O 0 1.3486313829575773e-17
most O 0 1.3769966442859615e-14
Japanese O 0 3.04589882205164e-08
C9 B-Disease 0 1.1551754823813098e-06
deficiency I-Disease 0 5.777773708359746e-07
. O 0 3.656536201211355e-15
. O 0 6.901263957005688e-13

BRCA1 O 0 2.8124080841962495e-10
required O 0 7.833331050054616e-15
for O 0 2.8270251942252776e-18
transcription O 0 4.5883657984191473e-10
- O 0 7.6153901318321005e-06
coupled O 0 1.0779668713212232e-08
repair O 0 2.4056454606125044e-09
of O 0 1.5409493037329924e-17
oxidative O 0 7.06223418300519e-15
DNA O 0 3.839623285983862e-09
damage O 0 6.082557888476003e-07
. O 0 1.8881821453597958e-11

The O 0 1.5883749426848226e-07
breast B-Disease 1 0.999849796295166
and I-Disease 1 0.9999475479125977
ovarian I-Disease 1 0.9999984502792358
cancer I-Disease 1 0.9999833106994629
susceptibility O 0 3.038910234565151e-09
gene O 0 2.1810496117491418e-11
BRCA1 O 0 1.5087058269358522e-09
encodes O 0 5.9886198222613984e-09
a O 0 1.0134653116722347e-09
zinc O 0 0.0026855780743062496
finger O 0 0.015891268849372864
protein O 0 7.274573166071718e-10
of O 0 4.758007999062835e-16
unknown O 0 2.526063126034872e-12
function O 0 3.4477946214174493e-13
. O 0 3.3541981692142286e-11

Association O 0 1.3849158365247805e-12
of O 0 2.9091985156881836e-17
the O 0 2.2030096113332873e-17
BRCA1 O 0 4.4278393207834374e-14
protein O 0 1.3387196912676607e-15
with O 0 1.8086585334880218e-17
the O 0 3.3795218314572594e-17
DNA O 0 4.108497569932368e-11
repair O 0 1.9323775912738483e-10
protein O 0 1.7755640165616204e-14
Rad51 O 0 1.0716104219266054e-11
and O 0 2.6734157219259792e-14
changes O 0 6.082256976150881e-19
in O 0 1.76029931244323e-21
the O 0 1.0352371353460713e-21
phosphorylation O 0 1.7178264508090333e-18
and O 0 2.096130835230062e-15
cellular O 0 5.637747111872111e-15
localization O 0 1.426474633943811e-14
of O 0 6.24152388225549e-19
the O 0 2.1219309558776156e-16
protein O 0 2.5774699282982323e-14
after O 0 2.411784313927079e-12
exposure O 0 1.5179659829459013e-12
to O 0 2.5775572573950942e-15
DNA O 0 3.982407736913274e-09
- O 0 6.817740594300403e-09
damaging O 0 6.676147967787927e-10
agents O 0 1.0470555629124578e-12
are O 0 1.5791175678657817e-17
consistent O 0 7.116259294339829e-17
with O 0 2.117513712144909e-18
a O 0 4.2248371278298357e-19
role O 0 7.06573047031366e-17
for O 0 7.077969951644877e-19
BRCA1 O 0 2.188815535070221e-13
in O 0 4.1815046696673497e-16
DNA O 0 2.375145236044318e-08
repair O 0 5.341623364074621e-06
. O 0 9.203177282757213e-12

Here O 0 4.464608890919486e-11
, O 0 2.5382350233682342e-15
it O 0 2.396230796793998e-16
is O 0 4.550556709719089e-18
shown O 0 1.8241387885180332e-16
that O 0 4.86268909524485e-17
mouse O 0 1.1765476613800896e-11
embryonic O 0 5.4368441172736315e-12
stem O 0 4.375310946880262e-10
cells O 0 3.353070859163365e-12
deficient B-Disease 0 6.908478233924598e-10
in I-Disease 0 1.1543869254483017e-16
BRCA1 I-Disease 0 1.368599678031046e-10
are O 0 4.6643119461188196e-14
defective O 0 2.1183706178096173e-10
in O 0 2.4202642978811547e-15
the O 0 7.59672351354656e-16
ability O 0 1.7547485545773428e-13
to O 0 3.8937435429251856e-15
carry O 0 6.841706021165628e-14
out O 0 3.690958942561412e-13
transcription O 0 7.485616293489983e-11
- O 0 6.63944135226302e-08
coupled O 0 2.438694524098395e-10
repair O 0 6.8444216960728e-10
of O 0 2.8122786318549885e-18
oxidative O 0 1.218992537085331e-15
DNA O 0 1.644044234083708e-09
damage O 0 8.556098407552781e-08
, O 0 4.8342501334473764e-14
and O 0 2.3931743631071256e-13
are O 0 3.531228211637363e-16
hypersensitive O 0 2.8890811964998875e-10
to O 0 1.2645224765298752e-13
ionizing O 0 2.4223751476926125e-11
radiation O 0 4.839167955239532e-10
and O 0 3.7652216414163497e-13
hydrogen O 0 1.1655643897962031e-12
peroxide O 0 8.420006913922862e-09
. O 0 3.3564127172036606e-11

These O 0 1.884030605137088e-11
results O 0 1.1709005347335794e-13
suggest O 0 4.3488446893093224e-14
that O 0 6.1897991411792065e-15
BRCA1 O 0 1.0317056453948426e-12
participates O 0 1.3431092277585693e-14
, O 0 2.2797245912727212e-15
directly O 0 4.305694798097115e-14
or O 0 4.698207968500956e-13
indirectly O 0 2.078402120547773e-12
, O 0 1.7708113146945766e-15
in O 0 9.567753299939555e-18
transcription O 0 1.4397186776093918e-09
- O 0 7.716465916018933e-06
coupled O 0 5.33760591281407e-09
repair O 0 2.4979949220238495e-09
of O 0 1.6529197801706204e-17
oxidative O 0 6.410301722623761e-15
DNA O 0 1.9321426680818377e-09
damage O 0 1.5006907716497153e-08
. O 0 1.5220008413308062e-13
. O 0 3.70475698729944e-12

Truncation O 0 7.770670773510346e-10
mutations O 0 8.097061909850822e-11
in O 0 1.9513814595770694e-14
the O 0 1.3523633168172067e-14
transactivation O 0 3.354069377792257e-08
region O 0 6.271214103570344e-11
of O 0 3.079476794685997e-15
PAX6 O 0 1.351060241461255e-08
result O 0 2.7402537704224184e-12
in O 0 4.459263819610098e-15
dominant O 0 8.156561648320348e-09
- O 0 1.4407530215976294e-05
negative O 0 1.457866858345369e-07
mutants O 0 2.329983495030774e-08
. O 0 4.428046471161018e-12

PAX6 O 0 5.277114496493596e-07
is O 0 2.2909263461962093e-12
a O 0 2.1239879224504635e-16
transcription O 0 3.141211520497206e-13
factor O 0 1.958641717781165e-14
with O 0 1.98990512152917e-16
two O 0 3.3520219803823625e-16
DNA O 0 2.474133398155942e-10
- O 0 9.828708957826393e-10
binding O 0 4.80612208017539e-12
domains O 0 1.9859601463334542e-10
( O 0 2.518029370048838e-16
paired O 0 8.035885325219372e-12
box O 0 6.748331227157678e-09
and O 0 8.35423784729776e-14
homeobox O 0 4.671022479940147e-15
) O 0 5.703043717105642e-17
and O 0 3.4811659174766735e-16
a O 0 6.81796961092902e-18
proline O 0 9.347174726934138e-13
- O 0 3.237538546713853e-13
serine O 0 2.5808978218466727e-11
- O 0 1.271132591545987e-11
threonine O 0 2.891771266888554e-10
( O 0 1.3287621572281963e-16
PST O 0 4.461429448099352e-09
) O 0 8.56991852428348e-15
- O 0 7.427100384357899e-13
rich O 0 8.208007603943083e-15
transactivation O 0 3.419710070673432e-10
domain O 0 2.6678777242938878e-11
. O 0 1.2839098274125549e-12

PAX6 O 0 1.2059558684995864e-06
regulates O 0 4.8633275184784e-10
eye O 0 1.948360228709589e-08
development O 0 2.5384591482860777e-14
in O 0 2.148607702686018e-15
animals O 0 7.958326008015038e-15
ranging O 0 5.7271624508831165e-15
from O 0 3.4650668651740234e-17
jellyfish O 0 5.3174898837458906e-15
to O 0 2.4889866286081828e-17
Drosophila O 0 1.908307658393305e-16
to O 0 1.3254309354653228e-16
humans O 0 1.834145662226675e-15
. O 0 7.697370572965628e-14

Heterozygous O 0 1.8404802126781306e-09
mutations O 0 1.316453196453793e-10
in O 0 1.3812113616468863e-13
the O 0 1.7163496372849668e-14
human O 0 7.815231480631096e-14
PAX6 O 0 1.9490607738870125e-10
gene O 0 2.518026412379193e-11
result O 0 4.5046266521596434e-13
in O 0 9.83996024155728e-18
various O 0 3.0304933028627544e-17
phenotypes O 0 3.44115252785826e-13
, O 0 3.222195493551242e-15
including O 0 1.4157476189644025e-12
aniridia B-Disease 1 0.9999996423721313
, O 0 2.376623342570383e-07
Peters B-Disease 1 0.9999992847442627
anomaly I-Disease 1 0.9999994039535522
, O 0 2.8535562801579317e-09
autosomal B-Disease 0 2.2477390302810818e-05
dominant I-Disease 0 0.00017183578165713698
keratitis I-Disease 1 0.9946185350418091
, O 0 2.95679569717322e-08
and O 0 4.749722393171396e-08
familial B-Disease 1 0.778331458568573
foveal I-Disease 1 0.9990498423576355
dysplasia I-Disease 1 0.9990434050559998
. O 0 5.555297022397099e-08

It O 0 2.5464047103546106e-12
is O 0 3.0233821965727585e-16
believed O 0 2.564816399560732e-15
that O 0 4.289998208205397e-17
the O 0 1.643927665167679e-17
mutated O 0 9.630339060928694e-13
allele O 0 5.5468685200565915e-12
of O 0 1.1850269394169072e-15
PAX6 O 0 6.616679981696905e-10
produces O 0 3.9194525175336586e-14
an O 0 4.45274632459745e-18
inactive O 0 3.3682559779507626e-12
protein O 0 7.808677038312339e-10
and O 0 2.3680088361288654e-06
aniridia B-Disease 1 0.9999998807907104
is O 0 1.2475903865549753e-08
caused O 0 9.065966866117492e-10
due O 0 1.9866305662704677e-14
to O 0 2.38285330052615e-13
genetic O 0 7.872086982274595e-09
haploinsufficiency O 0 1.4406541595235467e-05
. O 0 7.776865262876242e-11

However O 0 1.2436470256393939e-11
, O 0 1.3888232782845286e-15
several O 0 2.087415091195942e-17
truncation O 0 4.1617544913746807e-13
mutations O 0 1.962102355590467e-12
have O 0 3.4632371840107035e-13
been O 0 1.0770311237914137e-13
found O 0 1.354258637739983e-13
to O 0 1.0260532928938609e-13
occur O 0 4.803182489601394e-15
in O 0 1.2961055794965826e-17
the O 0 6.867081773012651e-14
C O 0 9.309228232723399e-08
- O 0 5.868117103347004e-10
terminal O 0 1.1174606162275835e-12
half O 0 2.456287550336696e-15
of O 0 3.2392827057398154e-19
PAX6 O 0 2.896249321100719e-13
in O 0 2.2033793610670985e-17
patients O 0 1.2973435082228274e-15
with O 0 5.515837894938536e-13
Aniridia B-Disease 1 0.9999995231628418
resulting O 0 3.6176422968381416e-10
in O 0 2.0864539073241553e-15
mutant O 0 9.294658142103285e-13
proteins O 0 3.227882642165697e-13
that O 0 4.0822302271393066e-14
retain O 0 1.0514106683610935e-15
the O 0 9.628757539243096e-17
DNA O 0 1.115787739980334e-10
- O 0 3.5334336151437995e-11
binding O 0 2.2370876039210646e-13
domains O 0 1.296797530470073e-10
but O 0 2.1070352407281945e-10
have O 0 2.7537453654163935e-12
lost O 0 7.945628530126037e-12
most O 0 1.3746433180902261e-17
of O 0 6.761038801872481e-19
the O 0 1.4045251303684315e-14
transactivation O 0 1.9867265610429286e-09
domain O 0 3.7261410623656843e-10
. O 0 2.523171671597879e-10

It O 0 9.490795649380601e-11
is O 0 2.893509271160305e-14
not O 0 6.333804271333094e-16
clear O 0 4.4010092874813614e-16
whether O 0 6.683472111279429e-18
such O 0 5.695823009384483e-18
mutants O 0 1.9163297684809955e-11
really O 0 9.629076182238183e-12
behave O 0 5.925258893290427e-15
as O 0 6.61499739872313e-15
loss O 0 3.1332231188903326e-13
- O 0 4.025501043614099e-10
of O 0 1.4414888553637706e-12
- O 0 5.250908685638933e-08
function O 0 1.6992082654126994e-12
mutants O 0 9.246500787263301e-11
as O 0 5.814467830822512e-15
predicted O 0 1.8326299137082225e-13
by O 0 6.639241599255916e-15
haploinsufficiency O 0 1.4868830930936383e-06
. O 0 5.3636550062519106e-11

Contrary O 0 8.092924247415922e-11
to O 0 1.0329022657800876e-13
this O 0 1.3840362186435618e-16
theory O 0 4.9187753818472936e-15
, O 0 2.018214603752744e-15
our O 0 2.426321947177068e-13
data O 0 1.4232357154787822e-13
showed O 0 4.583373611199981e-13
that O 0 1.6941328961382175e-17
these O 0 1.7067950460829342e-17
mutants O 0 8.209733348869819e-14
are O 0 4.7097007174641875e-17
dominant O 0 6.296429089919231e-12
- O 0 2.9533529755099153e-07
negative O 0 1.5229353889090191e-10
in O 0 3.9730675961003996e-17
transient O 0 1.6261280287872934e-16
transfection O 0 8.421334376368383e-14
assays O 0 1.2234474772252618e-13
when O 0 2.137499975195939e-13
they O 0 4.2040405106246424e-16
are O 0 5.006794483824882e-19
coexpressed O 0 8.569273220702944e-13
with O 0 5.755546524945608e-15
wild O 0 1.4492920752395833e-10
- O 0 1.4638033007940976e-06
type O 0 3.5801035469518183e-09
PAX6 O 0 6.455205721067614e-07
. O 0 2.93669290274412e-11

We O 0 3.90816242215597e-12
found O 0 1.3514247196083542e-14
that O 0 8.378900206820782e-16
the O 0 1.6879010193118944e-14
dominant O 0 2.279167610197419e-08
- O 0 0.001745273475535214
negative O 0 9.51873346366483e-07
effects O 0 5.304246819548553e-09
result O 0 1.2340015373942036e-15
from O 0 4.137499004359483e-19
the O 0 2.7001475789809486e-20
enhanced O 0 1.261967628821366e-18
DNA O 0 8.091765884459586e-15
binding O 0 3.603280010504366e-16
ability O 0 8.437432168709524e-17
of O 0 7.880932589943427e-21
these O 0 8.08342798329439e-17
mutants O 0 6.808006849240433e-13
. O 0 1.9525281727810623e-14

Kinetic O 0 1.3000542309349328e-10
studies O 0 8.644265858670508e-12
of O 0 4.4225678641757595e-16
binding O 0 8.885745611530993e-11
and O 0 7.572688587309528e-10
dissociation O 0 1.9395105313457783e-11
revealed O 0 3.375867768380496e-14
that O 0 4.690189553406562e-19
various O 0 9.573543648237958e-21
truncation O 0 1.1123982052337056e-14
mutants O 0 3.992819529868852e-13
have O 0 6.591392284549047e-16
3 O 0 5.783139284946907e-17
- O 0 4.539961462324271e-11
5 O 0 2.0601363497074754e-12
- O 0 1.803966642732746e-09
fold O 0 4.4860448689121313e-10
higher O 0 3.959629633459169e-18
affinity O 0 8.085824904555385e-19
to O 0 9.457033804931443e-20
various O 0 2.811534193537498e-21
DNA O 0 3.4421206102840064e-15
- O 0 2.647765700810635e-16
binding O 0 2.7919051733678075e-18
sites O 0 7.750221236061208e-16
when O 0 7.0527575783913086e-15
compared O 0 1.1864136754538084e-18
with O 0 4.471329324799366e-20
the O 0 6.187078047836152e-17
wild O 0 2.3545556129822565e-11
- O 0 1.9058643374592066e-07
type O 0 1.0678571360500655e-09
PAX6 O 0 1.1260762278197944e-07
. O 0 2.2039660027561858e-11

These O 0 1.7184338804362986e-13
results O 0 4.754814684851687e-16
provide O 0 4.296546914396918e-18
a O 0 1.7536073476169027e-17
new O 0 2.227211195520915e-16
insight O 0 8.375795963417993e-17
into O 0 3.714991380886918e-18
the O 0 1.33787520190079e-18
role O 0 6.15194073890388e-17
of O 0 4.273790451962548e-19
mutant O 0 1.0682670026351815e-12
PAX6 O 0 8.088145153628545e-10
in O 0 3.5358705980509386e-13
causing O 0 1.549855994653626e-07
aniridia B-Disease 1 0.9999874830245972
. O 0 6.694186871492036e-11
. O 0 2.795762406304636e-11

Reversal O 0 4.052410815802432e-07
of O 0 2.145035482570279e-09
severe O 0 0.0011596151161938906
hypertrophic B-Disease 1 0.9987562894821167
cardiomyopathy I-Disease 1 0.999997615814209
and O 0 4.0917532828643743e-07
excellent O 0 1.3244243202148454e-10
neuropsychologic O 0 1.2804104443375763e-08
outcome O 0 2.071554326731409e-13
in O 0 2.259637840203296e-15
very B-Disease 0 2.1338349923821776e-12
- I-Disease 0 1.5418347629747586e-06
long I-Disease 0 1.2504727919804282e-06
- I-Disease 0 4.9684462766208526e-08
chain I-Disease 0 4.940940989683895e-10
acyl I-Disease 0 4.968682583428308e-12
- I-Disease 0 1.5310684577801714e-12
coenzyme I-Disease 0 5.0643862747109386e-14
A I-Disease 0 3.57624032384235e-13
dehydrogenase I-Disease 0 2.0620655050151981e-07
deficiency I-Disease 0 0.00022255955263972282
. O 0 2.0841423205297804e-12

Very B-Disease 0 1.4884378174429003e-09
- I-Disease 0 1.4872609426674899e-05
long I-Disease 0 3.6456165730669454e-07
- I-Disease 0 1.1782922193503964e-08
chain I-Disease 0 4.724202140593547e-10
acyl I-Disease 0 2.1437194467482934e-12
- I-Disease 0 2.2059405083846295e-13
coenzyme I-Disease 0 1.5922390876005961e-15
A I-Disease 0 1.2576107808539043e-15
dehydrogenase I-Disease 0 1.5906236831148002e-12
( I-Disease 0 8.391951396351195e-16
VLCAD I-Disease 0 1.9292239983315085e-07
) I-Disease 0 7.625245920794832e-13
deficiency I-Disease 0 3.1737158678879496e-08
is O 0 6.1614087143696105e-16
a O 0 6.873528710180793e-14
disorder O 0 8.929848149819009e-08
of O 0 3.0532252187124467e-17
fatty O 0 7.185431416534271e-11
acid O 0 6.832701505282701e-12
beta O 0 1.5053467421021057e-15
oxidation O 0 2.1901267420725706e-13
that O 0 3.7119023132969886e-11
reportedly O 0 2.8407743712932643e-08
has O 0 3.694836797629719e-11
high O 0 1.3439474533250007e-10
rates O 0 1.128355298085637e-09
of O 0 4.3903072908905993e-14
morbidity O 0 2.546737414377276e-05
and O 0 1.0049251208954502e-08
mortality O 0 5.22628965882177e-07
. O 0 4.660957383939568e-11

We O 0 5.9606338961848415e-12
describe O 0 7.897813804856602e-14
the O 0 1.7308788728385586e-16
outcome O 0 1.9459753459066017e-16
of O 0 1.1237624988711593e-18
a O 0 2.5538803042391724e-16
5 O 0 2.629558515851167e-15
- O 0 8.896344771969211e-11
year O 0 9.70093363278357e-12
- O 0 1.4167067519110788e-08
old O 0 8.886078830983024e-06
girl O 0 0.0008908341405913234
with O 0 2.0082291385392637e-09
VLCAD B-Disease 1 0.9999991655349731
deficiency I-Disease 1 0.9999997615814209
who O 0 2.8883729175782635e-12
was O 0 2.7632090409193677e-13
first O 0 1.0360106564679446e-15
seen O 0 1.5866029193581377e-12
at O 0 2.84972003947951e-14
5 O 0 1.083326234538925e-15
months O 0 2.3546282653698347e-14
of O 0 2.176573554230803e-15
age O 0 1.3494113204615132e-07
with O 0 3.485825175175705e-07
severe O 0 0.010601162910461426
hypertrophic B-Disease 1 0.9998949766159058
cardiomyopathy I-Disease 1 0.9999998807907104
, O 0 0.28627097606658936
hepatomegaly B-Disease 1 0.9999994039535522
, O 0 7.597506055390113e-07
encephalopathy B-Disease 0 0.0034846889320760965
, O 0 1.9760164615689746e-09
and O 0 4.354368599024383e-08
hypotonia B-Disease 0 0.00019262968271505088
. O 0 8.118867383943851e-11

Biochemical O 0 2.050366418870908e-07
studies O 0 6.251875674934126e-07
indicated O 0 0.088047094643116
VLCAD B-Disease 1 0.9999985694885254
deficiency I-Disease 1 0.9999998807907104
caused O 0 0.00022592995082959533
by O 0 1.0042026888854028e-12
a O 0 8.683491751169947e-13
stable O 0 1.4073811560599836e-10
yet O 0 4.783695141397093e-13
inactive O 0 9.514457364329099e-13
enzyme O 0 3.682719060260631e-12
. O 0 3.782181165479237e-12

Molecular O 0 2.2952880915361185e-11
genetic O 0 2.530777254428074e-10
analysis O 0 3.196394884885656e-11
of O 0 5.525293222084782e-13
her O 0 1.3933860145698418e-06
VLCAD O 0 9.94722768155043e-07
gene O 0 7.063380436100886e-11
revealed O 0 3.635837186877211e-09
a O 0 2.2160816272862906e-14
T1372C O 0 4.585736738255131e-12
( O 0 4.577128348341416e-16
F458L O 0 5.974493903077027e-13
) O 0 3.2698947987231525e-14
missense O 0 2.868292235669312e-11
mutation O 0 6.819893261234e-11
and O 0 4.617621840452557e-09
a O 0 1.8044681027173937e-10
1668 O 0 4.318523497204296e-05
ACAG O 0 0.0009037205018103123
1669 O 0 2.862710779538702e-08
splice O 0 5.175198793949676e-07
site O 0 2.3175509511474957e-08
mutation O 0 6.13392181492145e-09
. O 0 1.7433693377810755e-09

After O 0 1.030046057129419e-12
initial O 0 6.604256597435472e-15
treatment O 0 1.4295959503544432e-14
with O 0 2.326959595334594e-15
intravenous O 0 3.657365642978361e-12
glucose O 0 7.891480358068748e-09
and O 0 2.0974880166058085e-10
carnitine O 0 4.692877197953749e-10
, O 0 3.0319881042564214e-15
the O 0 6.695622070988853e-17
patient O 0 8.854343717642002e-15
has O 0 8.46949429805701e-15
thrived O 0 3.820403195187172e-13
on O 0 4.025627487608263e-12
a O 0 1.7770386670414723e-13
low O 0 1.0160158131489183e-10
- O 0 2.3514072911012818e-09
fat O 0 1.1489910411999205e-10
diet O 0 1.6827544471243773e-14
supplemented O 0 1.215444369008842e-16
with O 0 1.056657825711097e-15
medium O 0 6.805284634425757e-12
- O 0 1.2616796496445204e-09
chain O 0 4.3475759103905887e-10
triglyceride O 0 7.83209122556805e-11
oil O 0 2.4004523412404777e-13
and O 0 1.3166927318232106e-16
carnitine O 0 1.8691057612784702e-14
and O 0 2.1583813974887038e-17
avoidance O 0 3.550806296128556e-13
of O 0 1.59340413509743e-17
fasting O 0 6.384564751882316e-12
. O 0 1.5697694337978019e-13

Her O 0 0.003569961292669177
ventricular O 0 0.00014031144382897764
hypertrophy O 0 2.706568302812684e-08
resolved O 0 3.206947554734718e-11
significantly O 0 6.159934622931504e-14
over O 0 1.814414368533565e-14
1 O 0 1.6964887263751032e-15
year O 0 3.1845359004965476e-14
, O 0 1.4284893865121502e-14
and O 0 1.8215011096667233e-11
cognitively O 0 2.5508017920117254e-10
, O 0 4.789862049472873e-15
she O 0 2.6390009622012656e-10
is O 0 1.6365023824461457e-15
in O 0 1.7581017507571483e-17
the O 0 2.709295868165082e-15
superior O 0 1.4208271603526057e-13
range O 0 1.798471441216698e-11
for O 0 1.2281702618886087e-13
age O 0 1.443507757770135e-09
. O 0 2.0978630291268452e-11

Clinical O 0 1.0973896097388192e-10
recognition O 0 1.5564101119025509e-09
of O 0 1.1145751841468154e-06
VLCAD B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
is O 0 2.875087971518364e-12
important O 0 3.394499994472896e-15
because O 0 1.8046065401559896e-13
it O 0 3.661451702810861e-14
is O 0 1.7540431063635956e-16
one O 0 2.585069380846056e-16
of O 0 8.914181354349157e-18
the O 0 1.9928251215016457e-13
few O 0 2.1604031064104134e-10
directly O 0 3.589233088518995e-08
treatable O 0 0.00028443767223507166
causes O 0 1.1427169255284753e-07
of O 0 1.9188123090430054e-08
cardiomyopathy B-Disease 1 1.0
in O 0 7.193611484268558e-09
children O 0 7.098911680714082e-08
. O 0 1.0155941842712735e-12
. O 0 1.503559256266218e-11

Cloning O 0 8.430089959432507e-11
of O 0 1.953951357539039e-14
a O 0 2.8518311843972466e-13
novel O 0 4.424838100092199e-12
member O 0 1.3321850946598074e-13
of O 0 3.172312876254489e-15
the O 0 6.806663566116811e-11
low O 0 9.53731500885624e-07
- O 0 5.6154976846301e-07
density O 0 1.0769577504093908e-12
lipoprotein O 0 1.1682609046825831e-10
receptor O 0 2.7969506051495063e-12
family O 0 2.0405558132097212e-08
. O 0 8.386564359641469e-11

A O 0 6.383389368307124e-14
gene O 0 2.4416498892718998e-14
encoding O 0 8.059274276585315e-13
a O 0 3.60087421035285e-13
novel O 0 3.1029473695348697e-12
transmembrane O 0 3.463914571844029e-11
protein O 0 9.8939606507642e-13
was O 0 2.3565256191716843e-13
identified O 0 2.0416843779437233e-16
by O 0 5.98587893180806e-20
DNA O 0 4.0325009228060066e-14
sequence O 0 7.426275306504637e-14
analysis O 0 4.389342096847203e-15
within O 0 2.956985401419862e-17
the O 0 2.2228602964378952e-13
insulin B-Disease 0 0.054805051535367966
- I-Disease 1 0.9999672174453735
dependent I-Disease 1 0.9986311793327332
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999995231628418
( O 0 2.857788450327803e-09
IDDM B-Disease 0 2.4876011593732983e-05
) O 0 4.073039106509968e-13
locus O 0 3.8861044937554823e-10
IDDM4 O 0 5.48569744296401e-07
on O 0 3.6589317686797074e-10
chromosome O 0 3.3766684737202013e-06
11q13 O 0 3.276322146916755e-08
. O 0 2.9457471184546336e-11

Based O 0 5.765683069869354e-13
on O 0 9.252622279465328e-11
its O 0 2.499330386748766e-12
chromosomal O 0 3.2709149166976204e-08
position O 0 1.3991917624522898e-09
, O 0 5.933737904850679e-16
this O 0 5.2252010555648816e-20
gene O 0 8.127767511105193e-17
is O 0 6.768709764680568e-17
a O 0 5.230487902901832e-19
candidate O 0 3.098113663577739e-17
for O 0 4.246909666993989e-19
conferring O 0 5.38518925632947e-12
susceptibility O 0 1.240888991560496e-07
to O 0 8.219033276191112e-08
diabetes B-Disease 0 0.023239975795149803
. O 0 3.807173598602276e-08

The O 0 1.1258334352672386e-13
gene O 0 7.251956847531549e-12
, O 0 4.596928306760395e-12
termed O 0 1.5605599035239948e-09
low O 0 3.3531517829032964e-07
- O 0 1.9949634406657424e-06
density O 0 4.32383772883127e-12
lipoprotein O 0 5.8072865960490105e-11
receptor O 0 1.4797645259741893e-13
related O 0 1.6455592314126855e-13
protein O 0 4.248026843484132e-12
5 O 0 1.9300025173949603e-13
( O 0 1.478821918593727e-17
LRP5 O 0 7.5457085024766e-11
) O 0 5.908866105843537e-17
, O 0 2.4481617072095872e-20
encodes O 0 1.0933352390648249e-16
a O 0 3.704181950078197e-17
protein O 0 5.864289631153652e-14
of O 0 1.6291074010048114e-17
1615 O 0 4.54569324889742e-13
amino O 0 1.5351893010206509e-15
acids O 0 1.3166927318232106e-16
that O 0 2.421408057057744e-16
contains O 0 1.774372103892852e-18
conserved O 0 6.745460033767418e-17
modules O 0 1.983542887232237e-12
which O 0 1.5513568348782952e-13
are O 0 5.808191210804239e-16
characteristic O 0 5.053899464722844e-13
of O 0 3.698100531449597e-15
the O 0 6.797754026344194e-10
low O 0 0.0004803915217053145
- O 0 0.058084916323423386
density O 0 4.872700998248547e-08
lipoprotein O 0 6.678221689071506e-05
( O 0 3.417398308780406e-12
LDL O 0 7.980407872310025e-07
) O 0 1.953676749457539e-13
receptor O 0 1.0272830492080026e-13
family O 0 4.750952076193471e-09
. O 0 9.159087377419439e-11

These O 0 1.4294487360282104e-14
modules O 0 2.1003832624977986e-13
include O 0 5.925588968133338e-18
a O 0 4.2205062686364495e-18
putative O 0 2.5980325001257777e-14
signal O 0 3.922488961242976e-14
peptide O 0 2.4312749321020726e-16
for O 0 1.5968823507325634e-20
protein O 0 7.338201282546789e-18
export O 0 3.156606185494875e-16
, O 0 2.780917427234439e-16
four O 0 6.114139617231611e-15
epidermal O 0 4.246564766496874e-10
growth O 0 2.249630169648409e-12
factor O 0 4.2000392963884026e-13
( O 0 5.43825380625566e-16
EGF O 0 4.743253567696115e-10
) O 0 8.232003403593757e-13
repeats O 0 5.981510042829541e-08
with O 0 6.469583441019722e-14
associated O 0 8.234967476808061e-14
spacer O 0 5.4999883758455326e-08
domains O 0 6.700251020674841e-08
, O 0 5.2705049526091674e-12
three O 0 4.227969970654888e-13
LDL O 0 2.0185227356250834e-07
- O 0 3.838934947708594e-09
receptor O 0 1.1803598029547224e-11
( O 0 2.0634771221903457e-14
LDLR O 0 1.1651960107883497e-07
) O 0 5.146326886775604e-14
repeats O 0 2.2231924745597098e-08
, O 0 3.729851984993898e-14
a O 0 3.6441416739733013e-16
single O 0 1.2227738353104423e-12
transmembrane O 0 2.2778993968852745e-11
spanning O 0 5.1194092368089805e-12
domain O 0 4.626884708702761e-10
, O 0 6.107074481537245e-12
and O 0 1.6213866187164694e-12
a O 0 1.317643690419137e-14
cytoplasmic O 0 2.764490636408823e-09
domain O 0 1.1552727663399764e-08
. O 0 5.583165041400662e-10

The O 0 3.5574444107504754e-16
encoded O 0 9.158160883294963e-15
protein O 0 6.645861161738709e-13
has O 0 1.2971264348542698e-14
a O 0 4.399561092752128e-18
unique O 0 1.9201351830999557e-18
organization O 0 3.6677787239364735e-17
of O 0 5.512545014651415e-17
EGF O 0 1.4811935011849187e-09
and O 0 1.9117014915526198e-10
LDLR O 0 1.0240112402470913e-07
repeats O 0 2.3299255857978096e-08
; O 0 3.305170205789563e-15
therefore O 0 1.468697691117221e-16
, O 0 5.482600216209158e-16
LRP5 O 0 3.195167019853784e-09
likely O 0 4.220225107961009e-14
represents O 0 1.2089363559675554e-19
a O 0 2.171197568463478e-17
new O 0 1.5832705968759492e-13
category O 0 6.009999442557756e-11
of O 0 2.062555084475612e-15
the O 0 1.0579834924806519e-10
LDLR O 0 0.0003986020165029913
family O 0 6.307689481843681e-09
. O 0 1.2405080435096139e-11

Both O 0 3.8827941513039366e-13
human O 0 1.1137411522546548e-12
and O 0 3.988355826156642e-11
mouse O 0 1.3722583958042378e-07
LRP5 O 0 4.0110967347573023e-07
cDNAs O 0 5.319593099351039e-10
have O 0 2.5557943890593127e-13
been O 0 3.446552125727781e-13
isolated O 0 2.928090409026751e-11
and O 0 4.794637993923989e-13
the O 0 6.0087632194964634e-18
encoded O 0 1.5308384104079607e-15
mature O 0 2.640129401006117e-17
proteins O 0 6.003173546507136e-18
are O 0 3.3578030050627915e-18
95 O 0 1.6564491613210372e-16
% O 0 8.148816279844462e-17
identical O 0 1.5218748136702764e-11
, O 0 1.138837288361394e-13
indicating O 0 3.5755396039782728e-12
a O 0 1.6045145897689017e-13
high O 0 1.143920097534945e-10
degree O 0 7.290584524706056e-15
of O 0 4.355540711901164e-19
evolutionary O 0 5.627687960348756e-16
conservation O 0 7.971482123751792e-15
. O 0 8.183749766179846e-14
. O 0 2.3407862453916906e-11

The O 0 3.852039536953941e-14
APC B-Disease 0 1.1834436208779664e-11
variants O 0 5.677376429223668e-13
I1307K O 0 1.1994051585251242e-11
and O 0 5.256895857204749e-14
E1317Q O 0 2.893631786005796e-13
are O 0 2.7255603830600222e-15
associated O 0 9.347540796955656e-11
with O 0 0.22141112387180328
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 6.283154334596475e-07
but O 0 3.6742317521820667e-11
not O 0 1.1077962549024822e-12
always O 0 1.0715940287897574e-11
with O 0 3.1966078987641106e-15
a O 0 1.441996885396743e-13
family O 0 2.1987702769621364e-09
history O 0 3.429540540444975e-10
. O 0 6.112563146615235e-12

Classical O 1 0.9670794606208801
familial B-Disease 1 0.999968409538269
adenomatous I-Disease 1 0.9993791580200195
polyposis I-Disease 1 0.999976396560669
( O 0 9.55345913489225e-10
FAP B-Disease 0 2.9965836034762106e-08
) O 0 9.946030544299989e-13
is O 0 2.692010297403874e-14
a O 0 4.5332509447659763e-13
high O 0 3.4865608995460207e-06
- O 1 0.999992847442627
penetrance O 1 0.9999717473983765
autosomal B-Disease 1 0.9999904632568359
dominant I-Disease 1 0.9914708733558655
disease I-Disease 0 5.3598356316797435e-05
that O 0 2.7983830666123213e-14
predisposes O 0 1.4847786194982504e-11
to O 0 3.760507589662689e-16
hundreds O 0 3.030067404108963e-16
or O 0 1.5655974238380777e-14
thousands O 0 3.381500198666558e-14
of O 0 3.014982014049039e-11
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
and I-Disease 0 0.09422982484102249
carcinoma I-Disease 1 0.9999998807907104
and O 0 4.77770697671076e-07
that O 0 2.63249089194062e-10
results O 0 1.955152890715378e-13
from O 0 4.675762158675627e-16
truncating O 0 8.242656232039514e-13
mutations O 0 1.267504710130568e-13
in O 0 6.572883026464765e-17
the O 0 3.672947146927052e-16
APC B-Disease 0 2.978901847416893e-11
gene O 0 5.319387985647239e-11
. O 0 7.143043795343473e-11

A O 0 1.633124841957101e-12
variant O 0 7.710092286838943e-11
of O 0 2.6495165179126097e-14
FAP B-Disease 0 1.4723447350206698e-07
is O 0 8.894579517360057e-11
attenuated B-Disease 0 0.026742586866021156
adenomatous I-Disease 1 0.9999644756317139
polyposis I-Disease 1 0.9998867511749268
coli I-Disease 1 0.9999988079071045
, O 0 1.0612059675452201e-08
which O 0 1.0586369454668176e-11
results O 0 3.6166277356817003e-14
from O 0 6.423891095713036e-14
germ O 0 3.4275028156116605e-05
- O 0 5.438801508717006e-06
line O 0 7.961178027926508e-08
mutations O 0 8.021333705761358e-13
in O 0 9.868647857817355e-17
the O 0 1.0786247252256309e-16
5 O 0 8.393296061154961e-16
and O 0 1.4480431420995157e-14
3 O 0 3.752225195625318e-16
regions O 0 1.135150377082238e-17
of O 0 1.2423267421641772e-18
the O 0 3.656787346480216e-15
APC B-Disease 0 3.509562432335578e-11
gene O 0 1.1481842386584784e-11
. O 0 5.0984612365301274e-11

Attenuated B-Disease 1 0.9917104840278625
adenomatous I-Disease 1 0.9998002648353577
polyposis I-Disease 1 0.9996706247329712
coli I-Disease 1 0.9999903440475464
patients O 0 1.7400137721779174e-06
have O 0 9.151932545137242e-10
" O 0 1.9825323605004996e-09
multiple O 0 2.475298060744535e-06
" O 1 0.9824345707893372
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999991655349731
( O 0 1.2707828496091866e-12
typically O 0 1.1216106202713381e-14
fewer O 0 5.757429188019779e-17
than O 0 7.848786622015148e-17
100 O 0 6.18496088898449e-15
) O 0 1.2235540847920032e-14
without O 0 1.1576690669458378e-14
the O 0 1.11375269561966e-14
florid O 0 1.9809804996384628e-07
phenotype O 0 6.978716216021752e-12
of O 0 1.5751243633848493e-15
classical O 0 7.528063505901628e-09
FAP B-Disease 0 2.3739592336369242e-07
. O 0 1.3977393027719831e-11

Another O 0 2.090872440463354e-11
group O 0 6.334182484080131e-11
of O 0 2.41404961714715e-15
patients O 0 5.910926587603116e-14
with O 0 1.483194162377622e-14
multiple O 0 4.1163572550573235e-11
adenomas B-Disease 0 4.539353710697469e-07
has O 0 3.279198068639744e-08
no O 0 1.7094676368900608e-12
mutations O 0 3.0745835700530036e-14
in O 0 1.7320148234301655e-16
the O 0 9.274202782412247e-17
APC B-Disease 0 1.0914449818108865e-13
gene O 0 1.1650282247168547e-13
, O 0 1.0911702043227972e-13
and O 0 1.2717292496855492e-11
their O 0 2.081546462973094e-10
phenotype O 0 7.4040209727122e-12
probably O 0 3.296897477245153e-11
results O 0 4.730809029972671e-15
from O 0 1.1132340149944088e-15
variation O 0 3.839218168637942e-14
at O 0 1.1457237936163267e-10
a O 0 1.566155957363497e-14
locus O 0 3.958526215153135e-11
, O 0 5.205264930023545e-13
or O 0 4.272888534423598e-14
loci O 0 1.786969484602989e-14
, O 0 2.3674595270306575e-13
elsewhere O 0 1.2385998675066103e-15
in O 0 1.7629698327391147e-18
the O 0 1.016038360725517e-15
genome O 0 7.368695098541878e-10
. O 0 4.2230519081698503e-10

Recently O 0 6.045620670747098e-10
, O 0 5.263045655214994e-14
however O 0 4.076639079121511e-16
, O 0 1.6681351057940433e-17
a O 0 2.674533662479545e-17
missense O 0 3.075740617058953e-13
variant O 0 3.435240980564913e-11
of O 0 8.298509855632005e-14
APC B-Disease 0 3.4278762939266016e-08
( O 0 1.4557638474137387e-14
I1307K O 0 1.371804904913565e-12
) O 0 8.28093968180052e-15
was O 0 8.194531208108313e-13
described O 0 8.344996548436626e-15
that O 0 9.301088468425935e-18
confers O 0 1.85519273690005e-15
an O 0 6.60697147038032e-17
increased O 0 1.8985103419910665e-11
risk O 0 2.2543611066794256e-06
of O 0 0.00011416286724852398
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.986310475629807e-09
including O 0 3.738539578417412e-15
multiple O 0 1.1207275385505255e-10
adenomas B-Disease 0 1.5861936617511674e-06
, O 0 5.570102712404434e-10
in O 0 1.3611750615538654e-10
Ashkenazim O 0 0.0009696650668047369
. O 0 1.618294120930841e-08

We O 0 3.281670768462419e-11
have O 0 6.1048641829427024e-15
studied O 0 7.086220991401129e-16
a O 0 4.3742104885192154e-17
set O 0 5.235312102455994e-14
of O 0 7.64071694898907e-18
164 O 0 1.0029393765140227e-12
patients O 0 2.869707655930371e-16
with O 0 1.6736224155134392e-14
multiple O 0 0.006307424511760473
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
and I-Disease 0 0.005492409225553274
/ I-Disease 0 0.0010849678656086326
or I-Disease 0 1.7275371646974236e-05
carcinoma I-Disease 1 0.9999997615814209
and O 0 9.897415331749926e-09
analyzed O 0 1.0965877511592836e-11
codons O 0 1.505992270993406e-12
1263 O 0 1.1484789785853877e-09
- O 0 5.382607137782713e-10
1377 O 0 4.1849004817073876e-10
( O 0 1.7339923806642082e-15
exon O 0 1.352096494662558e-12
15G O 0 5.721103799039007e-11
) O 0 1.3032866513697661e-14
of O 0 7.4704671523012885e-19
the O 0 4.088769318845132e-17
APC B-Disease 0 3.030538534422138e-14
gene O 0 2.241967674132387e-15
for O 0 1.512841210210073e-16
germ O 0 1.1417616008202458e-07
- O 0 5.692224647191324e-08
line O 0 1.1124360099756814e-07
variants O 0 3.700875994550046e-10
. O 0 1.1912573705252782e-10

Three O 0 5.466927258113152e-12
patients O 0 1.311101157112568e-13
with O 0 1.3181860244394403e-15
the O 0 6.996134272900306e-16
I1307K O 0 1.0038766150820277e-13
allele O 0 1.6868685539118272e-13
were O 0 3.0880009107506906e-14
detected O 0 4.2475628591644166e-13
, O 0 2.809481231100426e-17
each O 0 7.258687718984517e-18
of O 0 1.5817780189437687e-15
Ashkenazi O 0 0.0001972278842004016
descent O 0 0.00024618403404019773
. O 0 1.3271566956518654e-08

Four O 0 1.7824176162806182e-11
patients O 0 2.4450810842159554e-13
had O 0 7.494109499628365e-13
a O 0 8.006071561185869e-15
germ O 0 1.5583439108013408e-06
- O 0 2.8196136554470286e-06
line O 0 1.803307583259084e-07
E1317Q O 0 1.9472687351473894e-11
missense O 0 6.272069452348261e-13
variant O 0 6.319404634996806e-13
of O 0 9.347440692103202e-17
APC O 0 8.645766394477228e-12
that O 0 2.1796500964798432e-13
was O 0 7.454836227493988e-12
not O 0 2.794714600799081e-13
present O 0 5.15803847252411e-15
in O 0 1.5121495813388603e-15
controls O 0 1.9402773832055686e-10
; O 0 2.827931641570698e-14
one O 0 1.3357617251609066e-14
of O 0 5.180094922611759e-18
these O 0 2.301850785920898e-15
individuals O 0 1.226369952519177e-17
had O 0 6.138169399844129e-13
an O 0 1.7100273370445464e-17
unusually O 0 2.673487042100138e-14
large O 0 2.52289451553963e-16
number O 0 4.977947307832631e-13
of O 0 3.2952782755106547e-13
metaplastic B-Disease 0 1.17279805635917e-05
polyps I-Disease 0 1.3934817388872034e-06
of I-Disease 0 1.0898052954315916e-14
the I-Disease 0 5.068188924095551e-12
colorectum I-Disease 0 3.9126412048062775e-06
. O 0 2.2275228536705605e-11

There O 0 1.7779016106556078e-11
is O 0 4.261784017188389e-15
increasing O 0 2.27149305229941e-17
evidence O 0 1.2941702051650576e-15
that O 0 1.3425764440347463e-14
there O 0 1.0599722656337031e-15
exist O 0 1.2161777407224865e-15
germ O 0 3.624046174266482e-09
- O 0 3.845090468246326e-09
line O 0 1.2028709583944419e-08
variants O 0 2.8442585743235216e-13
of O 0 9.537653024629363e-18
the O 0 7.010102243247223e-17
APC B-Disease 0 9.153830003835652e-15
gene O 0 4.13296028501792e-17
that O 0 7.268860882466061e-17
predispose O 0 1.3861662418081103e-15
to O 0 6.128096761438671e-17
the O 0 8.553774790992863e-17
development O 0 3.2293803446472084e-16
of O 0 1.7938299432559805e-14
multiple O 1 0.6220384240150452
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
and I-Disease 0 0.30889302492141724
carcinoma I-Disease 1 0.9999996423721313
, O 0 2.912673435773172e-10
but O 0 9.271290332679705e-12
without O 0 2.6983040910151523e-13
the O 0 8.363133726123004e-14
florid O 0 4.154982434556587e-06
phenotype O 0 1.3434167667192298e-10
of O 0 2.597466131545596e-15
classical O 0 1.3096861095629464e-10
FAP B-Disease 0 2.281036470819231e-09
, O 0 7.207845499385308e-15
and O 0 4.709182373005137e-16
possibly O 0 2.9429077800109446e-17
with O 0 9.704345634490437e-18
importance O 0 2.723048295096703e-13
for O 0 1.0169884490096592e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 2.6466254965384906e-08
in O 0 5.513362682686924e-18
the O 0 5.660710846742832e-18
general O 0 4.608836546957125e-18
population O 0 5.752730802140478e-17
. O 0 1.2042354655507955e-14
. O 0 8.191472673779732e-12

Genomic O 0 1.2685277273050133e-09
structure O 0 5.71429847884275e-11
of O 0 3.3769370627731096e-14
the O 0 2.141677113431939e-11
human O 0 2.0447212989438412e-07
congenital B-Disease 1 0.999963641166687
chloride I-Disease 1 0.9999263286590576
diarrhea I-Disease 1 0.9999998807907104
( O 0 4.633038050427807e-11
CLD B-Disease 0 2.264989461764344e-06
) O 0 1.330706920522895e-13
gene O 0 2.6480755088709174e-11
. O 0 1.5229964511753735e-10

Congenital B-Disease 1 0.9995809197425842
chloride I-Disease 1 0.9996767044067383
diarrhea I-Disease 1 0.9999996423721313
( O 0 1.9598772382778407e-08
CLD B-Disease 0 0.009532222524285316
) O 0 4.1704639741624305e-09
is O 0 1.5040706180524666e-10
caused O 0 4.1221576152494777e-10
by O 0 2.747670907598675e-15
mutations O 0 4.300413757735155e-12
in O 0 3.1219394033648023e-15
a O 0 6.451216272712341e-16
gene O 0 8.080546323209481e-13
which O 0 1.846362418424924e-13
encodes O 0 1.2389940419119116e-12
an O 0 1.4103781619152767e-13
intestinal O 0 6.091078103054315e-05
anion O 0 1.5188785340569666e-08
transporter O 0 0.0007898192852735519
. O 0 2.8882023883625152e-08

We O 0 2.3642241497867644e-09
report O 0 8.380478928003698e-13
here O 0 3.486056209258087e-16
the O 0 1.3803545452705679e-18
complete O 0 2.255949501408926e-17
genomic O 0 5.699758563347188e-14
organization O 0 6.730272865372046e-16
of O 0 2.3476144722466943e-18
the O 0 1.2960920170432592e-15
human O 0 5.044933112756389e-13
CLD B-Disease 0 3.2010594175346796e-09
gene O 0 3.844490698012848e-12
which O 0 5.9470974152209255e-12
spans O 0 3.5722015623296244e-11
approximately O 0 1.0124677145121903e-14
39kb O 0 6.883964065451664e-09
, O 0 7.259007305839005e-14
and O 0 5.782886105740181e-13
comprises O 0 1.7910504893428603e-14
21 O 0 8.624757131354618e-14
exons O 0 1.620103873278822e-08
. O 0 6.045459133297015e-10

All O 0 7.147124688952622e-13
exon O 0 2.428316159264199e-10
/ O 0 2.942775090275518e-08
intron O 0 5.43809974828946e-08
boundaries O 0 3.5363073580541027e-10
conform O 0 1.8581358673941395e-11
to O 0 1.959810411490139e-15
the O 0 1.1717354042877111e-14
GT O 0 5.310753503628973e-10
/ O 0 5.065664332448705e-09
AG O 0 1.5594902436077973e-07
rule O 0 4.4221321049420226e-11
. O 0 7.228421420452102e-13

An O 0 6.2247731315713366e-15
analysis O 0 5.234171487889221e-15
of O 0 1.3136410846996708e-18
the O 0 1.4091650392106367e-17
putative O 0 2.7164483837782867e-14
promoter O 0 9.638331799344257e-13
region O 0 4.0910670677681265e-15
sequence O 0 2.9072601734326207e-15
shows O 0 8.488844935143625e-13
a O 0 2.9839443425485983e-16
putative O 0 3.2447020070769383e-10
TATA O 0 3.16376791431594e-08
box O 0 2.28999306273181e-05
and O 0 2.114602182246017e-08
predicts O 0 1.0325447094561291e-11
multiple O 0 2.5117470325581714e-15
transcription O 0 2.4146704601102353e-12
factor O 0 4.747117209416042e-14
binding O 0 1.4990706430090955e-13
sites O 0 7.143074465254529e-10
. O 0 1.601386245830838e-10

The O 0 5.3012495516415944e-14
genomic O 0 8.451353332439293e-12
structure O 0 6.0992287609362705e-12
was O 0 6.567457623736506e-13
determined O 0 2.349372669454094e-16
using O 0 7.234527427653068e-18
DNA O 0 1.5360761707744475e-12
from O 0 1.9180288173009262e-16
several O 0 1.2319255663467823e-18
sources O 0 1.1512421005646609e-17
including O 0 5.726800923324594e-19
multiple O 0 8.802408739514052e-16
large O 0 1.4286738491122385e-15
- O 0 1.1366505070498079e-08
insert O 0 1.297249241360987e-08
libaries O 0 5.40473554799803e-10
and O 0 6.639563710003889e-17
genomic O 0 1.6690670723231056e-14
DNA O 0 4.0293726688567233e-10
from O 0 8.947552578410581e-14
Finnish O 0 1.0676499684336704e-08
CLD B-Disease 0 5.237255891188397e-07
patients O 0 5.643131903605714e-13
and O 0 3.8948526478663203e-14
controls O 0 3.598709941154965e-10
. O 0 2.487494411840263e-11

Exon O 0 1.9036383580584015e-10
- O 0 3.4949196314748576e-11
specific O 0 1.9812041343971777e-14
primers O 0 6.641823091513288e-08
developed O 0 8.754139774191927e-12
in O 0 4.273764292375676e-16
this O 0 4.375574509349315e-19
study O 0 1.919151917383223e-20
will O 0 5.110761264053024e-21
facilitate O 0 1.5036957695257766e-20
mutation O 0 1.2569571890559792e-17
screening O 0 5.14744336090338e-15
studies O 0 3.5772820388422014e-14
of O 0 2.5016454284714187e-18
patients O 0 8.606865227939986e-17
with O 0 3.7700160638912106e-16
the O 0 4.2190222669657995e-12
disease O 0 6.864090096314612e-08
. O 0 1.0457652105388959e-10

Genomic O 0 2.0802263991231973e-12
sequencing O 0 1.593183267603604e-12
of O 0 5.416662618792792e-15
a O 0 2.1134920799147777e-13
BAC O 0 8.671952045347098e-10
clone O 0 6.724909553668112e-07
H O 1 0.9999979734420776
_ O 0 6.067451402413937e-11
RG364P16 O 0 7.058120906310028e-13
revealed O 0 1.2315916515792669e-11
the O 0 3.1303928980575186e-16
presence O 0 2.4787368880542504e-15
of O 0 6.394904777916324e-18
another O 0 1.2383399342709217e-15
, O 0 8.754446160620267e-18
highly O 0 1.174412939126889e-19
homologous O 0 2.64481670266521e-17
gene O 0 2.1583775077545914e-13
3 O 0 8.557308744797706e-15
of O 0 4.411745463175034e-18
the O 0 2.569743801973147e-14
CLD B-Disease 0 1.0159523222696976e-09
gene O 0 3.103869158221917e-13
, O 0 9.781890534664613e-15
with O 0 1.139337399906859e-16
a O 0 7.874998321265729e-17
similar O 0 9.472139162062306e-17
genomic O 0 1.834128335320706e-11
structure O 0 7.823103276294319e-11
, O 0 4.7685858523872655e-15
recently O 0 3.714276404346607e-14
identified O 0 6.142737685697897e-13
as O 0 8.55112161635141e-12
the O 0 1.462801378693257e-06
Pendred B-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999998807907104
gene O 0 9.138576118061792e-09
( O 0 3.9495024004715384e-13
PDS B-Disease 0 8.226812298062214e-08
) O 0 3.0031332238708575e-13
. O 0 9.419726012659807e-14
. O 0 2.2790859477428427e-11

The O 0 1.2907702250791742e-12
APCI1307K O 0 3.513567889967817e-06
allele O 0 5.711626727133989e-06
and O 0 5.904717454541242e-06
cancer B-Disease 0 3.163809196848888e-06
risk O 0 4.243822182559143e-09
in O 0 3.796427927615139e-15
a O 0 5.716859565629189e-15
community O 0 8.945500556392563e-15
- O 0 3.953922952937283e-11
based O 0 1.1265417919803684e-14
study O 0 1.8726198045150967e-15
of O 0 5.293642915195587e-17
Ashkenazi O 0 1.1877753225419951e-09
Jews O 0 4.6615180465670036e-11
. O 0 1.8478359033874403e-12

Mutations O 0 2.9593445471931545e-09
in O 0 7.681417351149133e-13
APC O 0 5.0038053700518503e-08
are O 0 7.288152026330152e-11
classically O 0 7.930085303087253e-06
associated O 0 4.5539621851276024e-07
with O 0 7.139510853448883e-05
familial B-Disease 1 0.9999992847442627
adenomatous I-Disease 1 0.9999362230300903
polyposis I-Disease 1 0.999994158744812
( O 0 4.687024726668376e-11
FAP B-Disease 0 3.527087288901498e-09
) O 0 2.7740437442795585e-14
, O 0 2.031413971109367e-16
a O 0 2.143173435757966e-14
highly O 0 1.777349183385013e-07
penetrant O 1 0.9999591112136841
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999997615814209
disorder I-Disease 1 1.0
characterized O 0 0.00011566781904548407
by O 0 2.4360853612126476e-11
multiple O 0 1.8913448229795904e-07
intestinal O 1 0.9400306344032288
polyps B-Disease 0 0.2553551197052002
and O 0 2.4898147543694904e-08
, O 0 4.051448795726201e-15
without O 0 3.296415657058547e-17
surgical O 0 9.406901425618609e-15
intervention O 0 1.7250600158947617e-14
, O 0 1.578864616034463e-17
the O 0 9.891596164115291e-18
development O 0 1.7372474647530355e-14
of O 0 2.7764699428445283e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 0 1.6587913768267848e-13
CRC B-Disease 0 7.389191036821785e-09
) O 0 1.8048510277458851e-13
. O 0 4.872670192682116e-13

APC B-Disease 0 5.001744440846778e-08
is O 0 1.2986162492567566e-11
a O 0 2.9343673758203126e-12
tumour O 1 0.9999881982803345
- O 0 4.299438316479609e-08
suppressor O 0 6.007321307066604e-10
gene O 0 3.68647404269673e-11
, O 0 7.055546603776733e-14
and O 0 7.041443844018128e-14
somatic O 0 7.51425588418897e-11
loss O 0 5.767740507423014e-09
occurs O 0 1.714213493375638e-10
in O 0 2.811443966521665e-09
tumours B-Disease 1 0.9999991655349731
. O 0 3.1697222766524646e-06

The O 0 1.9222592267942318e-12
germline O 0 5.513111078769839e-10
T O 0 1.265492755919695e-06
- O 0 9.050071803073934e-10
to O 0 3.9235030155349016e-12
- O 0 1.3709981760978707e-10
A O 0 7.14265072868786e-14
transversion O 0 9.78440202123454e-13
responsible O 0 2.2852775208992387e-17
for O 0 3.798719930502159e-21
the O 0 1.5433716814773386e-19
APC O 0 3.4575971727797633e-15
I1307K O 0 5.556670468119689e-17
allele O 0 1.8004874779611005e-17
converts O 0 2.957731319809038e-16
the O 0 2.5192686851297896e-16
wild O 0 8.956743224701469e-13
- O 0 1.1558738410855085e-09
type O 0 2.5552693641572866e-12
sequence O 0 6.369823071783465e-12
to O 0 5.3133617297640434e-12
a O 0 1.3187268117775819e-11
homopolymer O 0 3.033542998309713e-05
tract O 0 7.816982542863116e-05
( O 0 1.3566888769096092e-13
A8 O 0 1.5304201951948926e-05
) O 0 3.6264402938912532e-12
that O 0 1.1022236725763412e-12
is O 0 1.8780371138435448e-13
genetically O 0 3.630462944159696e-11
unstable O 0 0.0016318904235959053
and O 0 1.423599655936414e-07
prone O 0 4.426152372616343e-05
to O 0 7.637643908162475e-14
somatic O 0 6.7014137294929554e-12
mutation O 0 6.612588948629039e-11
. O 0 2.8980551292079326e-10

The O 0 1.734946821624339e-13
I1307K O 0 1.649171250950321e-11
allele O 0 9.957828311923933e-11
was O 0 2.2350918893465632e-09
found O 0 2.546988835117059e-11
in O 0 1.9623847563750817e-14
6 O 0 1.1094927927779441e-11
. O 0 8.399751380561149e-12

1 O 0 5.2754453583325756e-11
% O 0 9.602618721883671e-14
of O 0 4.0743829936316095e-17
unselected O 0 6.51218176606072e-11
Ashkenazi O 0 2.4120422992268686e-08
Jews O 0 8.298958853458771e-09
and O 0 4.306691447908406e-09
higher O 0 2.7821446535458705e-11
proportions O 0 4.551202525959752e-09
of O 0 3.148313315777529e-13
Ashkenazim O 0 2.2011943201505346e-06
with O 0 2.539515264743386e-10
family O 0 4.913070394962915e-09
or O 0 1.7187045189825945e-11
personal O 0 1.5729156865873506e-10
histories O 0 8.112355232015034e-10
of O 0 9.89047846443672e-15
CRC B-Disease 0 6.64438175590476e-08
( O 0 1.137886723635788e-16
ref O 0 1.6329271268489265e-10
. O 0 5.259964488166062e-14
2 O 0 4.2497426476321987e-13
) O 0 9.964634504902939e-14
. O 0 2.763885257814347e-12

To O 0 4.414633399509385e-14
evaluate O 0 6.9567239474469314e-15
the O 0 5.506954266327292e-17
role O 0 5.992314256559814e-15
of O 0 5.727486970381033e-16
I1307K O 0 1.0359964839126712e-12
in O 0 6.026260901866043e-16
cancer B-Disease 0 8.671641421424681e-13
, O 0 3.352215474471251e-15
we O 0 6.025393942468704e-14
genotyped O 0 6.797799302626917e-12
5 O 0 1.2090403234715666e-15
, O 0 5.891964886870057e-16
081 O 0 1.3161235989933573e-11
Ashkenazi O 0 7.787734346287323e-10
volunteers O 0 9.527568621200966e-13
in O 0 1.7605925239304435e-16
a O 0 1.7548681217481772e-14
community O 0 7.211304578653988e-13
survey O 0 1.2243556168911596e-09
. O 0 1.5179088888594983e-11

Risk O 0 2.1888800461056235e-07
of O 0 1.252326828392672e-13
developing O 0 3.1102267983307286e-10
colorectal B-Disease 1 0.9999974966049194
, I-Disease 0 2.7277387459889724e-08
breast I-Disease 0 0.00010215909424005076
and I-Disease 0 7.077807140376535e-08
other I-Disease 0 8.206861405735122e-12
cancers I-Disease 0 2.3096168533243144e-08
were O 0 8.982816660646487e-13
compared O 0 2.37918129411519e-15
between O 0 6.547910906992932e-16
genotyped O 0 5.065507457935325e-10
I1307K O 0 3.7701943346804545e-13
carriers O 0 3.735189563111021e-15
and O 0 1.248608557042133e-13
non O 0 1.4924814763036154e-15
- O 0 1.287884382472626e-10
carriers O 0 1.8874744161286733e-13
and O 0 4.650581135468013e-13
their O 0 1.0878370280313979e-13
first O 0 4.218261685589274e-14
- O 0 3.130342929313912e-10
degree O 0 3.6637430963397735e-14
relatives O 0 4.1944673103734564e-13
. O 0 7.545751506000519e-15

Sperm O 0 4.512437298820338e-12
DNA O 0 1.8504538179531238e-11
analysis O 0 2.5705685410132295e-13
in O 0 2.803446121351239e-15
a O 0 4.36618406360334e-13
Friedreich B-Disease 0 1.8784463463816792e-05
ataxia I-Disease 0 0.000789774174336344
premutation O 0 2.870217713279999e-06
carrier O 0 1.2423176376508138e-10
suggests O 0 9.892176765495964e-15
both O 0 8.2707928292799e-18
meiotic O 0 9.85516702967093e-12
and O 0 8.273491890501902e-14
mitotic O 0 1.216370493911656e-11
expansion O 0 1.0059466280798457e-13
in O 0 1.2649385687597196e-15
the O 0 8.029836764586983e-15
FRDA B-Disease 0 4.257850605426938e-08
gene O 0 1.974266410076364e-11
. O 0 1.4021853123047379e-11

Friedreich B-Disease 1 0.5538545846939087
ataxia I-Disease 1 0.9988574981689453
is O 0 2.5229082893929444e-06
usually O 0 5.6626614508559214e-08
caused O 0 2.2253612147471458e-11
by O 0 1.0102790925495595e-16
an O 0 5.789186967841405e-17
expansion O 0 6.75211229701593e-14
of O 0 2.3127573939079812e-14
a O 0 9.807785139592795e-11
GAA O 0 7.322857982217101e-07
trinucleotide O 0 1.2427881834753407e-08
repeat O 0 1.6567640315212628e-10
in O 0 2.2946944758647874e-17
intron O 0 6.5832166107338e-11
1 O 0 2.7029073762703006e-14
of O 0 8.16328399963026e-17
the O 0 1.94493929967475e-13
FRDA B-Disease 0 1.6693560667135898e-07
gene O 0 2.3737842247406604e-10
. O 0 1.3767342821324746e-10

Occasionally O 0 2.501761287021509e-07
, O 0 7.068090145286032e-13
a O 0 1.1107015982403552e-15
fully O 0 1.5629382062518201e-15
expanded O 0 6.779666268202201e-17
allele O 0 1.5454567963910093e-12
has O 0 1.7405990928101578e-12
been O 0 7.992408818102703e-13
found O 0 2.2457404859344e-13
to O 0 2.4219048736450442e-14
arise O 0 9.442021317435903e-16
from O 0 1.4437545271027306e-18
a O 0 1.3427235101302133e-16
premutation O 0 4.9604091667543315e-11
of O 0 1.1446297841840345e-17
100 O 0 8.735973298482937e-16
or O 0 2.789707077540185e-14
less O 0 1.7179144247759007e-15
triplet O 0 8.415290153607202e-08
repeats O 0 5.3588537411997095e-05
. O 0 1.5186344404227725e-09

We O 0 1.9380914928479598e-10
have O 0 1.9417347283957323e-15
examined O 0 1.7634768564043016e-15
the O 0 8.709971967805741e-19
sperm O 0 3.848382387500876e-14
DNA O 0 5.878327338781908e-12
of O 0 1.2482945566346298e-16
a O 0 2.997111903818052e-14
premutation O 0 3.0816028839808496e-08
carrier O 0 4.20903589759547e-10
. O 0 1.363720941727209e-11

This O 0 2.0994219817466186e-13
mans O 0 1.7846491645601148e-11
leucocyte O 0 1.8268506707386223e-09
DNA O 0 4.40344294361239e-09
showed O 0 1.479107170077043e-09
one O 0 8.394320441625547e-16
normal O 0 3.146781992970154e-17
allele O 0 3.8720091857184086e-14
and O 0 2.0067241867770952e-13
one O 0 1.5252077588910878e-15
allele O 0 5.098414637520754e-14
of O 0 1.1017421734152219e-16
approximately O 0 9.450277135814554e-15
100 O 0 1.8664099942205387e-13
repeats O 0 1.526958754993757e-07
. O 0 3.770516676659952e-10

His O 0 1.264502669240386e-10
sperm O 0 1.032257820887672e-10
showed O 0 1.186487540161263e-12
an O 0 2.3831925443683657e-18
expanded O 0 1.9728318489882794e-15
allele O 0 5.278759651616838e-10
in O 0 9.495897124178754e-12
a O 0 1.0585076218316836e-11
tight O 0 1.0643007586352837e-09
range O 0 1.711772779457773e-14
centering O 0 2.970973510610375e-12
on O 0 5.687828246586646e-12
a O 0 1.5885444357637913e-15
size O 0 4.737195065471905e-14
of O 0 1.1788718686265654e-16
approximately O 0 1.7928995622667164e-14
320 O 0 2.8292114744726815e-13
trinucleotide O 0 1.297459562010772e-08
repeats O 0 9.354077974421671e-07
. O 0 2.5804364200965324e-10

His O 0 1.05080928847201e-07
affected O 0 1.2772729540699856e-09
son O 0 4.872673571298947e-07
has O 0 2.396530751624937e-10
repeat O 0 4.766034233938399e-10
sizes O 0 1.2815604426199417e-13
of O 0 9.419598634786408e-18
1040 O 0 4.608323271593218e-12
and O 0 1.3152452217612964e-11
540 O 0 4.715323964621376e-11
. O 0 2.336614408904314e-12

These O 0 1.6164012741682644e-14
data O 0 4.155444112858295e-15
suggest O 0 3.2355474856570485e-15
that O 0 1.4751322298405976e-16
expansion O 0 3.690136621800394e-16
occurs O 0 5.2264124966857825e-14
in O 0 3.365821735279911e-16
two O 0 4.297673057273438e-13
stages O 0 2.085184238817539e-12
, O 0 4.729669453021259e-16
the O 0 1.0406914796484801e-17
first O 0 7.436671873602531e-16
during O 0 2.537983242824663e-15
meiosis O 0 4.109177055696897e-16
followed O 0 2.403563984534852e-16
by O 0 8.009934702268825e-19
a O 0 1.9388387293665147e-17
second O 0 2.738650641985127e-15
mitotic O 0 7.542921287573279e-10
expansion O 0 1.385534742492922e-11
. O 0 2.376546529014867e-11

We O 0 2.3085662548272268e-10
also O 0 3.3831146434640247e-13
show O 0 1.5233559205740654e-11
that O 0 1.1716319603890277e-15
in O 0 3.5090260449994163e-19
all O 0 1.4500688103086542e-18
informative O 0 4.0547748400001846e-14
carrier O 0 7.577026029173539e-13
father O 0 8.453258926177654e-11
to O 0 1.6949435900485456e-14
affected O 0 9.43964433122767e-16
child O 0 1.7536618858449149e-12
transmissions O 0 6.766730231699825e-11
, O 0 3.6275670920801067e-16
with O 0 4.775116476410596e-17
the O 0 3.879434985924133e-16
notable O 0 1.6921129541695875e-15
exception O 0 1.9604984140015463e-15
of O 0 2.043958661407101e-17
the O 0 6.072165068937013e-14
premutation O 0 4.869613601243827e-09
carrier O 0 1.53850695204516e-12
, O 0 4.414778072736776e-17
the O 0 1.0642091343620365e-17
expansion O 0 1.5352420288216174e-15
size O 0 7.758963610493552e-12
decreases O 0 7.516574168642265e-12
. O 0 1.24970747725911e-12
. O 0 1.428007295745104e-10

The O 0 6.109040140075961e-13
R496H O 0 1.0046826565135447e-10
mutation O 0 1.3369253620831856e-12
of O 0 8.963296718614375e-15
arylsulfatase O 0 9.813562229510353e-08
A O 0 3.329194211976194e-11
does O 0 7.423369557946202e-11
not O 0 1.9678272900058857e-10
cause O 0 6.249014177228673e-07
metachromatic B-Disease 1 0.9999923706054688
leukodystrophy I-Disease 1 0.9999780654907227
. O 0 1.2492017731347005e-07

Deficiency B-Disease 1 0.9993732571601868
of I-Disease 0 1.8510316977110586e-12
arylsulfatase I-Disease 0 2.5759602522157365e-06
A I-Disease 0 2.591089565129323e-10
( O 0 1.2681859448487268e-14
ARSA O 0 1.7535353435960133e-06
) O 0 4.069077160721163e-14
enzyme O 0 5.1582228072222236e-12
activity O 0 6.80371181616124e-09
causes O 0 2.153992681996897e-05
metachromatic B-Disease 1 0.9999866485595703
leukodystrophy I-Disease 1 0.9999821186065674
( O 0 8.20036802906543e-08
MLD B-Disease 1 0.9999361038208008
) O 0 9.444044157813636e-11
. O 0 4.270912616621825e-12

A O 0 1.3905862572549665e-11
number O 0 1.0086556427330723e-13
of O 0 2.182611120375537e-14
ARSA O 0 5.45898983546067e-05
gene O 0 8.906259063579114e-11
mutations O 0 1.087904506064108e-11
responsible O 0 2.8916650324228854e-11
for O 0 3.1204973501008926e-12
MLD B-Disease 1 0.9999963045120239
have O 0 6.1784379695728475e-12
been O 0 4.342480964657919e-13
identified O 0 1.011990977128896e-10
. O 0 9.062361971956534e-12

Recently O 0 1.6888897225175725e-10
, O 0 2.0472550859977102e-14
the O 0 6.675477774618574e-16
R496H O 0 1.096390556468152e-12
mutation O 0 7.377146040311172e-14
of O 0 2.1355500545293827e-15
ARSA O 0 9.1399741108944e-08
was O 0 2.828542521732258e-13
proposed O 0 5.496161772041613e-19
to O 0 8.389930163980809e-17
be O 0 1.2020639483597433e-15
a O 0 4.271144662991791e-14
cause O 0 1.0738661071485467e-09
of O 0 8.15219905470066e-11
MLD B-Disease 1 0.999998927116394
( O 0 4.784139664287812e-14
Draghia O 0 3.353829158836419e-10
et O 0 1.0309546619180487e-11
al O 0 3.0308858200989164e-10
. O 0 1.9506616374259655e-12
, O 0 4.332304914117513e-13
1997 O 0 6.245376936962754e-13
) O 0 1.1485954331744153e-12
. O 0 6.900780294416542e-12

We O 0 1.3258693622175688e-11
have O 0 4.2585481395716407e-16
investigated O 0 1.663954826145776e-15
the O 0 7.016523811778595e-17
R496H O 0 9.147900264985104e-14
mutation O 0 2.049958815165346e-14
and O 0 1.200370423719288e-12
found O 0 2.4519928730655505e-13
this O 0 7.837237857174928e-17
mutation O 0 3.722272257725834e-16
at O 0 5.787561998659568e-14
a O 0 9.322300357182e-17
relatively O 0 2.0712745475137662e-16
high O 0 1.9051819109415676e-14
frequency O 0 2.6640727384535934e-12
in O 0 7.359262591344145e-16
an O 0 2.9476854561150427e-15
African O 0 3.1676499531035907e-12
American O 0 2.3749061744959832e-11
population O 0 5.885007379417134e-14
( O 0 5.196128578015181e-17
f O 0 2.548671551583226e-10
= O 0 1.7060377633174029e-12
0 O 0 5.774456006097468e-16
. O 0 5.230339087319369e-15
09 O 0 3.2190001532372836e-12
, O 0 2.0792586402640367e-12
n O 0 4.751715465545203e-08
= O 0 8.163865317101227e-08
61 O 0 1.2292689088866382e-10
subjects O 0 2.134758148031324e-09
) O 0 2.380983778194068e-11
. O 0 1.0642128844828846e-10

The O 0 1.199962980542868e-12
ARSA O 0 2.6402421582361058e-08
enzyme O 0 1.7453330447558812e-12
activity O 0 3.520173302157259e-12
in O 0 2.436010852128849e-15
subjects O 0 6.293451003391848e-12
with O 0 8.042348118844286e-14
and O 0 3.1505614089821776e-12
without O 0 2.2092141806114842e-15
the O 0 2.2296243129783035e-17
R496H O 0 1.7838831506530786e-15
mutation O 0 8.978447993988607e-17
was O 0 2.055873483605697e-12
determined O 0 1.3061349961665525e-12
and O 0 4.662411407473088e-13
found O 0 3.8091470082324275e-13
to O 0 3.94163597160907e-14
be O 0 7.89663880075217e-14
normal O 0 9.01353373449626e-14
. O 0 4.2037606035050246e-12

It O 0 4.9610145852474474e-11
is O 0 4.4777071150036134e-15
therefore O 0 4.109817425839911e-17
concluded O 0 2.4878011464414963e-16
that O 0 1.592833810608687e-16
the O 0 1.483094339544788e-15
R496H O 0 3.022269934316313e-12
mutation O 0 1.9541909323378404e-13
of O 0 2.1335316597193704e-14
ARSA O 0 0.00044273637467995286
does O 0 5.3935595573095796e-11
not O 0 9.074866416119054e-16
negatively O 0 2.6313933480335975e-16
influence O 0 3.00075969355705e-15
the O 0 2.2349656762739095e-15
activity O 0 2.550040257079389e-12
of O 0 2.1409659831941267e-15
ARSA O 0 1.9342258383403532e-05
and O 0 1.5152795684869602e-11
is O 0 3.299614728446759e-15
not O 0 4.386747634929763e-15
a O 0 4.013555506281359e-14
cause O 0 2.9439861659597e-09
of O 0 4.846809620318027e-09
MLD B-Disease 1 0.9999812841415405

Down O 0 1.642917050048709e-05
- O 0 1.119367798452231e-08
regulation O 0 3.2822595336101656e-11
of O 0 1.4846680208816681e-15
transmembrane O 0 4.804862063778614e-10
carbonic O 0 2.7073310260306016e-09
anhydrases O 0 2.51326173383859e-06
in O 0 3.353053598664779e-11
renal B-Disease 0 0.00022807632922194898
cell I-Disease 0 0.0072637638077139854
carcinoma I-Disease 1 0.999998927116394
cell O 0 0.00012044572940794751
lines O 0 4.170824041693777e-08
by O 0 1.6501961472639715e-12
wild O 0 3.1524828614237776e-07
- O 1 0.9931325316429138
type O 0 0.217910498380661
von B-Disease 1 0.9999552965164185
Hippel I-Disease 1 0.9997153878211975
- I-Disease 1 0.9995272159576416
Lindau I-Disease 1 0.9983956217765808
transgenes O 0 0.06188385933637619
. O 0 1.1968114677074482e-07

To O 0 4.536563995554549e-13
discover O 0 7.059184508641236e-13
genes O 0 1.5236215880534004e-13
involved O 0 5.135360019170587e-12
in O 0 9.881447743387284e-11
von B-Disease 1 0.9997542500495911
Hippel I-Disease 1 0.9998942613601685
- I-Disease 1 0.9999756813049316
Lindau I-Disease 1 0.9999028444290161
( O 0 2.7870671104324174e-08
VHL B-Disease 0 0.00023150358174461871
) O 0 4.302335571138016e-11
- O 0 4.797334751671656e-10
mediated O 0 9.523658528465262e-10
carcinogenesis O 0 7.079048600644455e-07
, O 0 2.63659238755945e-13
we O 0 7.744706026664716e-13
used O 0 2.6167153513445562e-11
renal B-Disease 0 1.0404617569292895e-05
cell I-Disease 0 0.3483244776725769
carcinoma I-Disease 1 0.9999995231628418
cell O 0 0.4639347493648529
lines O 0 4.895066467724973e-06
stably O 0 2.9017890028626425e-06
transfected O 0 1.3896634243337758e-07
with O 0 5.810654388205272e-11
wild O 0 9.863102690133019e-08
- O 1 0.5601581335067749
type O 0 0.00014542802819050848
VHL O 1 0.891753077507019
- O 0 5.396029337134678e-06
expressing O 0 3.6945002612753797e-10
transgenes O 0 6.379245576226822e-08
. O 0 2.956328931658092e-11

Large O 0 1.4394137737207963e-13
- O 0 1.246214520467248e-10
scale O 0 8.621378784490208e-12
RNA O 0 2.8196053825091383e-10
differential O 0 1.6429820828486874e-12
display O 0 1.252307719329382e-13
technology O 0 1.286472539147e-14
applied O 0 4.36336118760497e-17
to O 0 6.545014054313322e-16
these O 0 1.654713273174758e-15
cell O 0 7.305521465550413e-11
lines O 0 2.2299447444834586e-12
identified O 0 1.7090901414105238e-15
several O 0 1.3099737587744016e-17
differentially O 0 8.716808606304069e-14
expressed O 0 6.3412435036284776e-18
genes O 0 1.8934137751559202e-16
, O 0 1.1858395914291813e-17
including O 0 6.224594080055943e-19
an O 0 1.549360572509799e-17
alpha O 0 3.358668256166729e-14
carbonic O 0 6.208511352592816e-13
anhydrase O 0 1.8073320617872923e-12
gene O 0 2.4641137654629608e-12
, O 0 7.911598893378669e-13
termed O 0 9.594326444428702e-10
CA12 O 0 5.378965215641074e-05
. O 0 4.4459078085701265e-10

The O 0 8.932338511425178e-15
deduced O 0 1.6488172589410044e-13
protein O 0 5.575831883339842e-14
sequence O 0 1.8451584119123787e-13
was O 0 4.692906219877502e-13
classified O 0 1.8059450555005588e-14
as O 0 8.390446854078634e-16
a O 0 4.554265086798362e-14
one O 0 6.895182758093199e-10
- O 0 0.46531835198402405
pass O 0 0.0010366529459133744
transmembrane O 0 2.3474671252188273e-05
CA O 0 1.7704435606447078e-07
possessing O 0 4.1925139168718165e-14
an O 0 8.591025844175229e-16
apparently O 0 1.3069935411724742e-10
intact O 0 5.346477045266827e-14
catalytic O 0 7.840680119663231e-16
domain O 0 7.641640141844985e-13
in O 0 6.987386010741945e-16
the O 0 1.3933903740570054e-14
extracellular O 0 6.138676411637789e-08
CA O 0 0.00011060726683354005
module O 0 3.0705555786880723e-07
. O 0 9.033615522291427e-11

Reintroduced O 0 9.592936445201872e-10
wild O 0 9.851423676821014e-09
- O 0 2.256106017739512e-05
type O 0 2.0655624766163783e-08
VHL B-Disease 0 1.1541184221641743e-06
strongly O 0 1.2317924458216112e-13
inhibited O 0 9.045562252517608e-15
the O 0 2.0673660529450042e-17
overexpression O 0 7.203231202701846e-14
of O 0 1.592851082139877e-17
the O 0 4.612359095595682e-16
CA12 O 0 4.2320969645404105e-11
gene O 0 5.3288613010627796e-15
in O 0 2.4246514984140135e-17
the O 0 1.467164741477192e-14
parental O 0 1.583348603162449e-05
renal B-Disease 0 0.0003050631785299629
cell I-Disease 0 0.05136055126786232
carcinoma I-Disease 1 0.999998927116394
cell O 0 0.19256709516048431
lines O 0 0.0005815731710754335
. O 0 8.904709858370552e-08

Similar O 0 1.0525158218935293e-12
results O 0 2.8830860225245725e-14
were O 0 3.563993193042613e-15
obtained O 0 2.4228681301005737e-16
with O 0 4.845288497409405e-15
CA9 O 0 6.617736914016348e-11
, O 0 1.837316040373799e-17
encoding O 0 5.067640151777816e-15
another O 0 1.0832664626425625e-11
transmembrane O 0 9.77897656184723e-08
CA O 0 8.378228812944144e-07
with O 0 3.7569676272178765e-15
an O 0 1.6586694464340275e-15
intact O 0 9.189465854930745e-11
catalytic O 0 1.0228921659347079e-12
domain O 0 6.118238138341781e-10
. O 0 1.3395558273732178e-10

Although O 0 7.56573297934493e-13
both O 0 2.2294735146439126e-15
domains O 0 1.3582586661300966e-12
of O 0 1.7165900887628686e-16
the O 0 3.0871454074739638e-15
VHL B-Disease 0 2.1893606719225467e-11
protein O 0 1.342601325627572e-15
contribute O 0 1.9062540584455502e-18
to O 0 8.986328709120522e-17
regulation O 0 8.463604030941804e-14
of O 0 2.8946556879027663e-15
CA12 O 0 1.045359923068645e-07
expression O 0 4.624681171870593e-13
, O 0 1.6731076524155691e-15
the O 0 3.757279335342466e-17
elongin O 0 2.260357049102546e-12
binding O 0 1.5775726062397695e-14
domain O 0 3.971852013950894e-11
alone O 0 3.4062237475041e-09
could O 0 5.821476113665458e-13
effectively O 0 3.3732836402650124e-12
regulate O 0 5.022512961083692e-10
CA9 O 0 2.4644823497510515e-05
expression O 0 7.174482785643477e-09
. O 0 7.184585704145263e-10

We O 0 8.578178445350915e-11
mapped O 0 1.7164270005309845e-08
CA12 O 0 1.4680064850836061e-05
and O 0 2.6666058250413016e-11
CA9 O 0 6.964308574275435e-10
loci O 0 6.308590802528435e-13
to O 0 5.447852320086474e-14
chromosome O 0 2.669050980230736e-09
bands O 0 4.823723087632459e-10
15q22 O 0 2.999714365792272e-10
and O 0 5.911022539495381e-12
17q21 O 0 4.362627759046944e-10
. O 0 2.0924592353949167e-12

2 O 0 4.091761998670229e-11
respectively O 0 6.573251491726051e-12
, O 0 2.9924281504329145e-14
regions O 0 1.594854619462599e-13
prone O 0 5.369885798245377e-07
to O 0 2.497703920859712e-13
amplification O 0 1.878621258555313e-09
in O 0 9.410562302016642e-15
some O 0 1.0882219790949365e-15
human O 0 3.0934230871304536e-11
cancers B-Disease 0 1.984793698284193e-06
. O 0 2.2156593226796417e-10

Additional O 0 1.3790809382592702e-14
experiments O 0 4.665404867987277e-11
are O 0 3.1907117024182734e-15
needed O 0 1.5128477482456346e-15
to O 0 1.205539642179683e-16
define O 0 5.856539957312633e-15
the O 0 1.415831188505528e-16
role O 0 2.717180592939211e-13
of O 0 1.1262968300520225e-14
CA O 0 1.0209723733112241e-08
IX O 0 9.494308117474759e-11
and O 0 1.7256831519318894e-09
CA O 0 6.131418928134735e-09
XII O 0 7.199142540784131e-13
enzymes O 0 1.6839489329865953e-14
in O 0 5.946245934503665e-16
the O 0 1.723162662092912e-14
regulation O 0 1.3965720940811721e-11
of O 0 8.011845784787301e-15
pH O 0 3.198789011449321e-09
in O 0 1.5178066761655553e-16
the O 0 7.749419069390378e-17
extracellular O 0 6.271997352903791e-13
microenvironment O 0 1.169505603471066e-09
and O 0 4.791973415296802e-11
its O 0 6.652719418106037e-14
potential O 0 9.362800655219813e-14
impact O 0 1.7982182515491156e-14
on O 0 4.3024034335203964e-10
cancer B-Disease 0 1.4547857141167242e-08
cell O 0 1.918709813253372e-08
growth O 0 2.2641551827851103e-11
. O 0 1.0218494453373417e-11

A O 0 2.522242702510894e-14
gene O 0 5.6524981906485444e-15
encoding O 0 3.6307274461216954e-14
a O 0 4.157489697425914e-15
transmembrane O 0 2.959722039935081e-13
protein O 0 3.7413537437407107e-13
is O 0 1.3341415840668696e-15
mutated O 0 4.277230913202201e-12
in O 0 1.4624640474331096e-12
patients O 0 5.112508194571319e-09
with O 0 4.4160296965856105e-05
diabetes B-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999998807907104
and O 0 0.19874794781208038
optic B-Disease 1 0.9999779462814331
atrophy I-Disease 1 0.9992443323135376
( O 0 4.2346086956968065e-06
Wolfram B-Disease 1 0.9999984502792358
syndrome I-Disease 1 0.9999997615814209
) O 0 2.8901862236807574e-08
. O 0 3.724982544639488e-10

Wolfram B-Disease 1 0.9999300241470337
syndrome I-Disease 1 0.9999983310699463
( O 0 8.338595876011823e-07
WFS B-Disease 0 0.0018267513951286674
; O 0 9.815127599566154e-10
OMIM O 0 2.226614242317737e-06
222300 O 0 2.111522068304339e-09
) O 0 6.05327257503091e-13
is O 0 7.894956390031016e-13
an O 0 1.0957268425926259e-10
autosomal B-Disease 1 0.9999912977218628
recessive I-Disease 1 0.999994158744812
neurodegenerative I-Disease 1 0.9999911785125732
disorder I-Disease 1 0.9998162388801575
defined O 0 4.05260297542398e-10
by O 0 3.222681496661828e-11
young O 0 1.3420502682492952e-06
- O 0 0.07104167342185974
onset O 0 0.20229722559452057
non O 0 8.029127457120921e-06
- O 0 0.1279008537530899
immune O 0 0.17387337982654572
insulin B-Disease 1 0.9953813552856445
- I-Disease 1 0.9967663288116455
dependent I-Disease 1 0.7932018637657166
diabetes I-Disease 1 0.9999996423721313
mellitus I-Disease 1 0.9999991655349731
and O 0 2.979623445753532e-07
progressive O 0 1.059345436260628e-06
optic B-Disease 1 0.998582124710083
atrophy I-Disease 0 0.0014690831303596497
. O 0 9.242079324067731e-10

Linkage O 0 8.394490103036389e-10
to O 0 2.0807583087090187e-12
markers O 0 4.560135380415886e-09
on O 0 5.339275688243106e-09
chromosome O 0 1.668639379204251e-05
4p O 0 3.0698738555656746e-05
was O 0 2.756948835891393e-10
confirmed O 0 1.4168775527845234e-11
in O 0 5.435788622741794e-15
five O 0 5.30066604758489e-13
families O 0 2.138634755399771e-12
. O 0 1.3106068964471862e-12

On O 0 1.3843024220406425e-13
the O 0 7.418700018218612e-18
basis O 0 4.018641525539315e-18
of O 0 1.282897366270489e-18
meiotic O 0 1.616674438764676e-08
recombinants O 0 0.0006890472723171115
and O 0 2.0185842686260003e-07
disease O 0 1.386256371915806e-07
- O 0 2.0030397251957766e-07
associated O 0 2.274372246091616e-09
haplotypes O 0 9.070679851674868e-08
, O 0 1.0223499564282479e-12
the O 0 4.831555975752045e-15
WFS B-Disease 0 2.0424061747403854e-11
gene O 0 7.942733296126389e-16
was O 0 3.424520324431246e-14
localized O 0 5.6623394429462185e-15
to O 0 1.5324926657539484e-14
a O 0 7.736065070875278e-14
BAC O 0 1.7157256726463288e-09
/ O 0 5.837417771381581e-10
P1 O 0 1.7968854137961898e-07
contig O 0 1.6198178909299088e-10
of O 0 3.5470203633891434e-18
less O 0 1.6759861044624526e-18
than O 0 1.4765551335226021e-18
250 O 0 1.5324443319363957e-16
kb O 0 6.634182092568608e-10
. O 0 4.25261518707809e-12

Mutations O 0 1.0795465632540413e-09
in O 0 2.7663730139092235e-13
a O 0 1.9248437479330027e-14
novel O 0 3.4958095988281424e-13
gene O 0 1.761397278032817e-10
( O 0 5.616777117196936e-14
WFS1 O 0 5.363749444597943e-10
) O 0 5.191690588592711e-17
encoding O 0 6.490386649613626e-17
a O 0 6.618726037756944e-17
putative O 0 2.5874707107811923e-13
transmembrane O 0 3.831727348065604e-14
protein O 0 8.132462937663135e-14
were O 0 1.1433562430163136e-12
found O 0 1.092272322936183e-12
in O 0 9.314733441287263e-16
all O 0 2.1778360568386855e-15
affected O 0 3.7698146288684417e-16
individuals O 0 9.353071806841218e-18
in O 0 7.162807592909495e-16
six O 0 4.758317871667028e-12
WFS B-Disease 0 4.48315802259458e-08
families O 0 3.391696428919899e-12
, O 0 5.5063295265891325e-15
and O 0 8.030518524465569e-13
these O 0 8.492464137520653e-15
mutations O 0 9.332632729770404e-14
were O 0 8.70242680001132e-13
associated O 0 5.985601012233055e-14
with O 0 1.0234810232396391e-13
the O 0 9.345722112863442e-11
disease O 0 2.2559689227819035e-07
phenotype O 0 1.9901236214536766e-10
. O 0 2.0789514554309108e-10

WFS1 O 0 1.7589568415132817e-06
appears O 0 9.478263729434389e-10
to O 0 3.104933438179483e-14
function O 0 1.5073530666926196e-14
in O 0 1.710330282348599e-14
survival O 0 2.0110697551700696e-09
of O 0 3.1816794195247864e-16
islet O 0 7.614713837256204e-08
beta O 0 2.366713491852579e-10
- O 0 2.1009014972150908e-08
cells O 0 1.710613248273596e-11
and O 0 7.254097496300904e-13
neurons O 0 4.834379221268538e-14
. O 0 5.557650829346797e-15
. O 0 4.738706714350893e-13

Stable O 0 7.828536430221078e-11
interaction O 0 1.0065832919243199e-14
between O 0 1.6165832168453347e-14
the O 0 4.443316730312142e-16
products O 0 9.287453686429754e-15
of O 0 3.1455786519740427e-19
the O 0 1.5278389873323944e-16
BRCA1 O 0 4.56169615969948e-11
and O 0 2.0168708283335723e-12
BRCA2 O 0 3.126363913846103e-13
tumor B-Disease 0 2.7350866661562598e-14
suppressor O 0 4.5579933870189965e-14
genes O 0 7.046411184034006e-15
in O 0 2.877137656890118e-17
mitotic O 0 3.9680225771832056e-10
and O 0 4.185872481965447e-11
meiotic O 0 3.8229053700433724e-08
cells O 0 3.2125218041301196e-09
. O 0 4.0843411985846956e-10

BRCA1 O 0 1.0493547506484902e-06
and O 0 1.7690612308385312e-09
BRCA2 O 0 8.640990006858473e-11
account O 0 9.592911554901547e-15
for O 0 2.414607623262211e-18
most O 0 7.742706664155633e-18
cases O 0 3.874643161722838e-16
of O 0 4.3380825480853494e-18
familial O 0 3.3454661263476737e-10
, O 0 4.2039023087289684e-13
early O 0 5.4666382531820545e-11
onset O 0 2.7396100943377633e-09
breast B-Disease 0 0.0024837269447743893
and I-Disease 0 0.10249143093824387
/ I-Disease 1 0.998012900352478
or I-Disease 1 0.9974982142448425
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999994039535522
and O 0 6.054854968101653e-13
encode O 0 3.404199580510142e-15
products O 0 2.446625259160118e-13
that O 0 2.3467301913564567e-16
each O 0 3.0957494986690015e-18
interact O 0 2.682064711822922e-16
with O 0 1.2203889767779981e-14
hRAD51 O 0 3.287514616090448e-08
. O 0 7.964138896976447e-12

Results O 0 3.1744238314368456e-12
presented O 0 6.69982258148967e-14
here O 0 4.177345420258976e-15
show O 0 5.523080907551825e-13
that O 0 4.504929377499827e-16
BRCA1 O 0 1.4217794693308083e-12
and O 0 5.291385385408631e-12
BRCA2 O 0 1.7394956308702803e-10
coexist O 0 1.8942973578628397e-10
in O 0 7.49065050400419e-17
a O 0 2.226667506247896e-16
biochemical O 0 5.556300320015695e-13
complex O 0 1.0593467699186385e-13
and O 0 7.112508498829939e-11
colocalize O 0 1.8437140170135535e-07
in O 0 3.204486372435089e-13
subnuclear O 0 2.493112738477521e-08
foci O 0 1.965199114550842e-09
in O 0 4.64110759234884e-17
somatic O 0 3.646978440253215e-16
cells O 0 7.620963796551965e-15
and O 0 2.6920717919958446e-14
on O 0 6.819625701821874e-13
the O 0 6.26579440781127e-16
axial O 0 3.2346992922746565e-13
elements O 0 5.022150772505951e-13
of O 0 4.014677030843083e-16
developing O 0 1.1524131258641712e-13
synaptonemal O 0 7.392781942172633e-10
complexes O 0 5.071495740721632e-12
. O 0 1.840607310663045e-12

Like O 0 2.012706147580534e-11
BRCA1 O 0 2.7603594965341927e-09
and O 0 1.8627568931783856e-10
RAD51 O 0 1.3442311797007278e-07
, O 0 6.047984649985155e-14
BRCA2 O 0 6.157603073264628e-12
relocates O 0 7.697496286207528e-12
to O 0 2.1242747415706892e-13
PCNA O 0 3.336401732667582e-08
+ O 0 7.408421207229232e-14
replication O 0 5.186848604159071e-14
sites O 0 5.746735986383866e-12
following O 0 8.561986840002755e-13
exposure O 0 9.813455603691068e-11
of O 0 4.5516178997269334e-17
S O 0 1.6682141779078563e-10
phase O 0 3.0591577167066463e-18
cells O 0 2.392722161333344e-17
to O 0 3.8273388862477474e-17
hydroxyurea O 0 7.886437813561797e-13
or O 0 8.199213707884689e-15
UV O 0 5.483053941435223e-11
irradiation O 0 1.113686486781118e-11
. O 0 4.084882172100679e-12

Thus O 0 6.577942184005092e-12
, O 0 5.0086213524086834e-14
BRCA1 O 0 8.12817608358829e-12
and O 0 2.599304018552351e-12
BRCA2 O 0 1.0037967635920242e-12
participate O 0 2.0957380501705525e-16
, O 0 1.5155221488974717e-15
together O 0 6.975735527409155e-12
, O 0 6.6448663215421585e-15
in O 0 4.230454108119135e-17
a O 0 2.6974674765731493e-15
pathway O 0 7.161674898947812e-12
( O 0 2.7903989340515023e-14
s O 0 1.7261720586247975e-07
) O 0 5.811939437474958e-15
associated O 0 1.6560124430448337e-17
with O 0 5.507662684483397e-19
the O 0 2.529067241259376e-19
activation O 0 8.971189318677332e-17
of O 0 2.5792662787150778e-17
double O 0 3.01742453245879e-09
- O 0 8.328986496053403e-07
strand O 0 0.0008854150073602796
break O 0 0.0004628378082998097
repair O 0 1.3295809822011506e-06
and O 0 8.253451741491169e-12
/ O 0 3.112121020956704e-13
or O 0 7.196903448363338e-17
homologous O 0 8.190011711352307e-14
recombination O 0 8.399947404313934e-11
. O 0 5.980121259296922e-11

Dysfunction O 0 8.922621054807678e-05
of O 0 5.3661336306539895e-14
this O 0 4.58819705725878e-15
pathway O 0 1.4963489431904509e-12
may O 0 3.4885512447541123e-12
be O 0 1.390046976195515e-16
a O 0 5.658443958274131e-18
general O 0 2.913706277795322e-18
phenomenon O 0 1.2429469346125765e-12
in O 0 4.621678152081374e-15
the O 0 8.818555152605156e-13
majority O 0 8.09610828356698e-14
of O 0 3.2913394150754313e-17
cases O 0 1.230181863494384e-13
of O 0 2.0057665652082474e-14
hereditary B-Disease 0 0.04623499885201454
breast I-Disease 1 0.9999294281005859
and I-Disease 1 0.9940067529678345
/ I-Disease 1 0.9994679093360901
or I-Disease 1 0.9950919151306152
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.999998927116394
. O 0 7.882930974645319e-10
. O 0 2.172927809906966e-11

A O 0 4.0546108137640147e-11
novel O 0 1.8989884317810457e-11
Arg362Ser O 0 5.545501835513278e-09
mutation O 0 2.7322894381037743e-12
in O 0 3.882088877790735e-14
the O 0 1.215338966346468e-14
sterol O 0 2.621963979265729e-09
27 O 0 6.998297340937709e-12
- O 0 5.140213601984023e-11
hydroxylase O 0 4.224262273311297e-09
gene O 0 9.046214298480404e-12
( O 0 2.6054945215779092e-15
CYP27 O 0 4.757183802439613e-08
) O 0 5.705013826802496e-13
: O 0 1.0896550529625724e-15
its O 0 1.6102644781137597e-15
effects O 0 4.224735388998549e-14
on O 0 1.7303202599038003e-13
pre O 0 2.0863685941657079e-13
- O 0 1.1074608501841603e-15
mRNA O 0 6.215061898831066e-17
splicing O 0 1.0188260689747083e-13
and O 0 4.2373060355621606e-15
enzyme O 0 3.141865694630282e-16
activity O 0 1.6482002462609065e-14
. O 0 2.7267577911859082e-14

A O 0 6.80219595927678e-12
novel O 0 2.591423169800988e-12
C O 0 5.61115909292198e-09
to O 0 7.050874624149562e-15
A O 0 9.751451558672082e-15
mutation O 0 9.710725579293385e-16
in O 0 8.439077662558464e-16
the O 0 1.8503309371893997e-14
sterol O 0 4.14617806754336e-09
27 O 0 2.4991016200903715e-12
- O 0 5.504954478374735e-11
hydroxylase O 0 1.0736025402025007e-08
gene O 0 2.663281747916635e-11
( O 0 5.152079595740176e-15
CYP27 O 0 1.412701733372046e-09
) O 0 4.76156712562808e-16
was O 0 2.0325853647358604e-15
identified O 0 1.3819411190444752e-17
by O 0 8.327104441949154e-20
sequencing O 0 8.764384583478859e-15
amplified O 0 4.838512368543491e-10
CYP27 O 0 1.3006791477199187e-10
gene O 0 3.842998646088128e-14
products O 0 8.523776844938935e-13
from O 0 4.394734890924575e-16
a O 0 1.3293155079707698e-15
patient O 0 4.515366899826567e-11
with O 0 1.5226726546302416e-08
cerebrotendinous B-Disease 1 0.9999983310699463
xanthomatosis I-Disease 1 0.9999954700469971
( O 0 4.206567819770024e-12
CTX B-Disease 0 8.803652917777072e-08
) O 0 8.688461733928621e-13
. O 0 3.7121417051366734e-12

The O 0 2.5851408280751567e-14
mutation O 0 6.675255237887506e-14
changed O 0 6.165885402080462e-13
the O 0 2.3292484570290875e-17
adrenodoxin O 0 5.10363236047584e-13
cofactor O 0 3.2458327949773207e-15
binding O 0 7.93773971926497e-15
residue O 0 6.327662005478629e-11
362Arg O 0 2.2853717182580446e-11
to O 0 6.770657575176295e-14
362Ser O 0 3.8747730024546456e-10
( O 0 9.515308725614713e-17
CGT O 0 9.919659494858624e-13
362Arg O 0 1.1944921614326365e-11
to O 0 5.9032390012771305e-15
AGT O 0 9.429734770804998e-11
362Ser O 0 2.0871200601124684e-10
) O 0 2.6636825086807274e-15
, O 0 2.472663079487286e-16
and O 0 8.311194004610549e-15
was O 0 2.2406875617095312e-13
responsible O 0 1.783077876430124e-14
for O 0 1.8701354568808e-15
deficiency O 0 1.219868428492532e-09
in O 0 3.8685078824694224e-19
the O 0 2.928631873483031e-15
sterol O 0 1.4166953166139251e-09
27 O 0 9.138052727702961e-13
- O 0 2.6109611434704805e-12
hydroxylase O 0 5.688550186455643e-10
activity O 0 2.8475751487691547e-13
, O 0 2.7138548509501108e-17
as O 0 6.567742098957748e-18
confirmed O 0 5.531485134573164e-16
by O 0 6.5159849944399984e-18
expression O 0 2.2380360118890287e-16
of O 0 7.3170933910732375e-19
mutant O 0 2.6724777176401898e-14
cDNA O 0 8.668251663332405e-13
into O 0 9.310382326210842e-12
COS O 0 3.052785473300901e-07
- O 0 5.8073861691765316e-11
1 O 0 5.29292169311078e-15
cells O 0 1.5114072374287219e-13
. O 0 3.1818558204887992e-12

Quantitative O 0 2.151703294706042e-12
analysis O 0 4.268526938161488e-12
showed O 0 2.0406315526244612e-10
that O 0 6.706467639664175e-15
the O 0 5.303488746765132e-16
expression O 0 5.757745761289859e-14
of O 0 4.383765417210938e-17
CYP27 O 0 3.0060072486737255e-11
gene O 0 7.180316293324833e-16
mRNA O 0 6.727918325536916e-14
in O 0 1.7998573450053474e-15
the O 0 2.8974506848704687e-15
patient O 0 1.0319968620983722e-12
represented O 0 7.0237073129158015e-15
52 O 0 1.4342438695025272e-11
. O 0 3.839705463304366e-12

5 O 0 4.958085053630157e-10
% O 0 3.651034552812349e-13
of O 0 1.5278389873323944e-16
the O 0 2.0594988117249996e-13
normal O 0 1.1943736798192273e-11
level O 0 6.486829823293405e-11
. O 0 1.926322990009055e-11

As O 0 4.0187488346875647e-14
the O 0 5.284566560119063e-16
mutation O 0 2.171332537869667e-15
occurred O 0 9.291461507522983e-14
at O 0 2.1460017793540107e-16
the O 0 1.586034426298556e-19
penultimate O 0 6.645775505531918e-16
nucleotide O 0 7.772155286579256e-17
of O 0 4.4993600200663446e-18
exon O 0 7.880238887640612e-14
6 O 0 3.822853925777858e-12
( O 0 6.407780423177141e-16
- O 0 7.197639012579415e-11
2 O 0 1.2073663195524137e-13
position O 0 6.501439469251691e-13
of O 0 1.0465356761122898e-17
exon O 0 2.794341635251746e-13
6 O 0 1.1118903107260047e-12
- O 0 8.290691744239354e-11
intron O 0 5.033652428210189e-08
6 O 0 1.140001027605253e-11
splice O 0 6.521077722254631e-08
site O 0 1.0643033121482404e-08
) O 0 3.455181290818593e-13
of O 0 7.183487075136096e-18
the O 0 4.563773285741176e-16
gene O 0 1.18174391171115e-13
, O 0 7.100756394413368e-15
we O 0 2.78826808502983e-16
hypothesized O 0 3.9628201517998476e-17
that O 0 7.941438034519271e-14
the O 0 3.784476204637954e-12
mutation O 0 2.52350984553118e-09
may O 0 8.814132534951113e-09
partially O 0 9.245337134755616e-11
affect O 0 2.8795785014416398e-15
the O 0 8.06294384804125e-18
normal O 0 1.9834233921518473e-18
splicing O 0 2.4320286114306276e-14
efficiency O 0 8.356942254091754e-15
in O 0 5.655185280250978e-18
exon O 0 1.7475906518345935e-13
6 O 0 5.999516855537124e-12
and O 0 1.1775572921271515e-12
cause O 0 1.8147145146584246e-15
alternative O 0 5.2866783853101356e-18
splicing O 0 5.996831503596312e-11
elsewhere O 0 4.159973060469113e-11
, O 0 8.315471203356828e-16
which O 0 3.025231364787821e-14
resulted O 0 1.891395433285467e-13
in O 0 2.549355718932736e-15
decreased O 0 1.848293246968849e-13
transcript O 0 2.1163271135549167e-10
in O 0 1.0858179725356867e-13
the O 0 1.9502188492587225e-12
patient O 0 9.418433810637339e-10
. O 0 1.6655839901735803e-11

Transfection O 0 6.092133908452979e-09
of O 0 3.6198437503758354e-14
constructed O 0 4.270222717095429e-11
minigenes O 0 6.57795453662402e-08
, O 0 1.4488007961301758e-13
with O 0 4.4380359034024847e-14
or O 0 2.1087498067173804e-12
without O 0 3.323464846900835e-15
the O 0 5.633957592345213e-17
mutation O 0 1.4541867991208933e-15
, O 0 2.7482684893429627e-15
into O 0 9.854705891381918e-14
COS O 0 1.754224996375342e-07
- O 0 1.4063555008048123e-11
1 O 0 8.071533787830368e-17
cells O 0 4.517560756325757e-16
confirmed O 0 1.2679537731178844e-14
that O 0 5.854728259717574e-16
the O 0 1.7129410708260971e-15
mutant O 0 4.985164711590606e-11
minigene O 0 1.0500631475451883e-09
was O 0 5.026232793685359e-13
responsible O 0 2.4811289090972966e-16
for O 0 1.5293644117795188e-19
a O 0 7.942149008828906e-18
mRNA O 0 1.8543950012703259e-13
species O 0 2.793731288720943e-15
alternatively O 0 2.0358400295433787e-12
spliced O 0 3.704930804815376e-06
at O 0 1.8984495919749378e-10
an O 0 2.0596371089118802e-16
activated O 0 3.551541699620131e-11
cryptic O 0 3.463795916758272e-11
5 O 0 3.1239154782911874e-16
splice O 0 1.5532370944981722e-09
site O 0 2.605363258467719e-09
88 O 0 4.167626747181297e-12
bp O 0 2.153698877224719e-12
upstream O 0 1.5978903855455584e-13
from O 0 4.824409982292534e-15
the O 0 1.2156305574385603e-15
3 O 0 1.6941387393420645e-14
end O 0 3.770436721628641e-14
of O 0 3.043618301719225e-18
exon O 0 8.417874904076417e-12
6 O 0 3.463491993205281e-11
. O 0 1.9800173653439224e-11

Our O 0 1.5499978037181172e-11
data O 0 3.3789472413635335e-14
suggest O 0 1.7681458714161567e-14
that O 0 5.26025036178576e-16
the O 0 1.936615684779001e-15
C O 0 1.8706326765371983e-10
to O 0 1.0431090043241725e-15
A O 0 1.0041891241821481e-16
mutation O 0 1.5721205504617722e-18
at O 0 1.1886437171621238e-16
the O 0 1.4085832468966763e-19
penultimate O 0 2.601074068384426e-16
nucleotide O 0 3.675790464477417e-17
of O 0 8.523409135462648e-19
exon O 0 2.220511440193841e-14
6 O 0 2.323414084823977e-13
of O 0 4.6957259973234717e-17
the O 0 4.588181302445961e-14
CYP27 O 0 3.114336122322925e-09
gene O 0 5.425891398506966e-13
not O 0 4.532671980805869e-13
only O 0 1.4578199351899038e-14
causes O 0 3.3378558250696244e-10
the O 0 2.508412810797722e-09
deficiency B-Disease 0 0.00241671409457922
in I-Disease 0 3.386326126531892e-15
the I-Disease 0 2.426710633655904e-13
sterol I-Disease 0 1.5490424942754544e-08
27 I-Disease 0 2.104579097800263e-12
- I-Disease 0 1.092054138090992e-11
hydroxylase I-Disease 0 1.8306423044123221e-09
activity I-Disease 0 5.502054974820814e-12
, O 0 8.353409110262167e-14
but O 0 1.6332432368343364e-12
also O 0 2.41331672527767e-12
partially O 0 6.46944775528624e-10
leads O 0 1.6436748880369056e-12
to O 0 5.855914846997559e-15
alternative O 0 1.9338253464925084e-15
pre O 0 1.5009223247944292e-12
- O 0 4.107997985834319e-14
mRNA O 0 2.1596354363845587e-15
splicing O 0 2.140903990546783e-12
of O 0 2.7526196777406734e-17
the O 0 1.2317670909491263e-16
gene O 0 5.531008051735953e-13
. O 0 2.9815475717683004e-13

To O 0 4.086277323456233e-12
our O 0 2.2348358515340838e-13
knowledge O 0 1.8740409405121323e-16
, O 0 1.379282113878199e-16
this O 0 6.018513197376626e-18
is O 0 8.63126110030989e-17
the O 0 4.094000078166672e-16
first O 0 1.0945303501432371e-13
report O 0 2.8229358412477923e-14
regarding O 0 4.823816569538533e-17
effects O 0 3.2428749559255086e-15
on O 0 1.1763303886199762e-14
pre O 0 7.872757892650462e-14
- O 0 1.246976917475837e-15
mRNA O 0 9.355395522618002e-17
splicing O 0 2.1984471805947675e-13
of O 0 1.160532496896489e-17
a O 0 1.2553759505970228e-17
mutation O 0 1.7954129896008837e-16
at O 0 1.5450757806425436e-13
the O 0 7.686774868421835e-15
- O 0 1.5963673716257176e-09
2 O 0 9.891960297755964e-13
position O 0 6.126149067198217e-12
of O 0 2.5117622609532485e-18
a O 0 2.658311261003951e-16
5 O 0 4.883864918926208e-16
splice O 0 2.3271631732768583e-08
site O 0 6.018152731712689e-08
. O 0 1.287825540652321e-10

ATM O 0 1.0431590169446281e-07
germline O 0 3.216742072709167e-08
mutations O 0 7.723924966285267e-08
in O 0 8.704946763415933e-10
classical O 1 0.9893527030944824
ataxia B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999988079071045
telangiectasia I-Disease 1 0.9999998807907104
patients O 0 0.003582950448617339
in O 0 3.396454558574069e-12
the O 0 1.0301110008395509e-12
Dutch O 0 4.374372508664237e-08
population O 0 1.0631325464069419e-12
. O 0 5.4693784223847075e-12

Germline O 0 1.6435716787555066e-08
mutations O 0 5.52709378265348e-10
in O 0 4.0787902569339174e-14
the O 0 9.479296590466605e-17
ATM O 0 4.804637590560823e-12
gene O 0 2.525747555440043e-14
are O 0 2.716050353731949e-17
responsible O 0 4.554940426167208e-15
for O 0 1.0524189213243634e-13
the O 0 0.0001839051692513749
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999980926513672
telangiectasia I-Disease 1 0.9999992847442627
( O 0 0.11523233354091644
A B-Disease 1 0.9999995231628418
- I-Disease 1 0.999997615814209
T I-Disease 1 0.9999995231628418
) O 0 2.9718678629109263e-09
. O 0 4.313458878274501e-12

In O 0 7.841089583182637e-11
our O 0 1.0633115048175323e-11
study O 0 1.0089931641867294e-15
, O 0 4.44759001153104e-16
we O 0 4.889553168683494e-15
have O 0 1.2409680359695129e-17
determined O 0 1.0157693136138393e-18
the O 0 7.097055205574977e-20
ATM O 0 2.7400014223667724e-13
mutation O 0 1.8269870691520738e-16
spectrum O 0 1.4326478100634005e-14
in O 0 2.1110242155416344e-15
19 O 0 8.435807391168892e-13
classical O 0 3.8250723832788935e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 3.2882104157583303e-12
, O 0 5.180784170857169e-19
including O 0 2.6368631730211703e-21
some O 0 1.5224774546334186e-20
immigrant O 0 1.6916587962790934e-14
populations O 0 8.338758997813046e-15
, O 0 1.2033302626158885e-15
as O 0 8.619847728392332e-16
well O 0 9.21552957777955e-15
as O 0 7.155359611028464e-14
12 O 0 1.2244972559787709e-14
of O 0 1.7601895215360076e-16
Dutch O 0 1.4887721611067661e-10
ethnic O 0 5.56014088937129e-12
origin O 0 5.699263543740285e-12
. O 0 4.6468613679184756e-11

Both O 0 1.1116558655587319e-14
the O 0 1.9735008726677123e-16
protein O 0 8.537354342626289e-15
truncation O 0 9.770997379254798e-12
test O 0 6.473296204623225e-11
( O 0 7.443873605800438e-18
PTT O 0 1.6954690689602314e-12
) O 0 7.599129616512354e-16
and O 0 8.484813735941052e-17
the O 0 9.603139104267597e-20
restriction O 0 2.273615721828313e-18
endonuclease O 0 2.5600964355170994e-14
fingerprinting O 0 9.338317879387104e-13
( O 0 1.8513218469959103e-19
REF O 0 2.878216472462455e-15
) O 0 6.028131220562041e-21
method O 0 4.444344237525443e-19
were O 0 3.5540803664608957e-16
used O 0 3.648803213919397e-15
and O 0 2.7677599456570577e-14
compared O 0 2.1962548544511793e-17
for O 0 5.413813300576995e-22
their O 0 7.018229416842649e-19
detection O 0 6.94067647812728e-18
efficiency O 0 1.5088620940625385e-19
, O 0 3.6224690677172764e-21
identifying O 0 9.762310150478968e-17
76 O 0 1.810874109627221e-14
% O 0 7.436072465443451e-17
and O 0 4.06593118548737e-12
60 O 0 1.5408240005079787e-12
% O 0 6.799380165956157e-16
of O 0 1.1225591165160171e-17
the O 0 1.788702649538343e-13
mutations O 0 4.158082732297341e-12
, O 0 7.591984224446235e-13
respectively O 0 1.594856191555749e-11
. O 0 1.2457439246826851e-10

Most O 0 2.067884058432057e-12
patients O 0 9.660271714506674e-13
were O 0 7.935200483895691e-14
found O 0 5.780787767960607e-14
to O 0 6.31221954249645e-15
be O 0 5.9418048348820925e-15
compound O 0 1.0293233279612402e-12
heterozygote O 0 6.695144438850775e-11
. O 0 1.6566801099363038e-12

Seventeen O 0 4.772474082592737e-10
mutations O 0 2.0631968355999675e-11
were O 0 4.027063404965503e-12
distinct O 0 1.2635598744072975e-14
, O 0 1.7581655532492024e-13
of O 0 4.65332425590286e-16
which O 0 6.532243929796566e-12
10 O 0 6.834414761555663e-14
were O 0 5.3896487967053375e-12
not O 0 7.215693971149295e-13
reported O 0 1.199869630735817e-11
previously O 0 7.0443525145014174e-12
. O 0 2.55134411861202e-12

Mutations O 0 1.5097816052911384e-10
are O 0 6.94246118316459e-15
small O 0 4.990460309569017e-16
deletions O 0 2.3633586199167667e-09
or O 0 1.5848010548324964e-07
point O 0 3.74420459081648e-08
mutations O 0 1.278734895748812e-10
frequently O 0 5.966410032698377e-09
affecting O 0 2.827700909795866e-13
splice O 0 1.5359042038198822e-07
sites O 0 3.135563133582764e-07
. O 0 1.2791727677097242e-08

Moreover O 0 3.464299680455696e-10
, O 0 1.0632455609308963e-13
a O 0 1.896784595709078e-14
16 O 0 9.183481882932276e-13
. O 0 1.449666667090177e-12

7 O 0 5.868192737290556e-11
- O 0 2.645421381952673e-10
kb O 0 6.326816848201133e-11
genomic O 0 1.714660705087745e-11
deletion O 0 1.7629846471578503e-09
of O 0 2.4897296816437167e-15
the O 0 8.845296558732379e-15
3 O 0 5.5932363775268445e-14
end O 0 9.009704874524127e-13
of O 0 5.2520416447255495e-19
the O 0 1.8839961584458814e-17
gene O 0 3.410178574326573e-15
, O 0 5.290456086080441e-16
most O 0 4.01292942981933e-17
likely O 0 7.921257643957527e-14
a O 0 9.288263661685566e-16
result O 0 1.1992151647998903e-15
of O 0 8.31955150747472e-19
recombination O 0 7.28708475397459e-14
between O 0 8.445144540278338e-13
two O 0 8.081409890239866e-13
LINE O 0 2.1533949734475755e-08
elements O 0 1.8043526742173022e-12
, O 0 3.274861037596199e-15
was O 0 7.916036532870652e-13
identified O 0 4.428865694322548e-12
. O 0 9.022103268467585e-13

The O 0 1.357649886610246e-12
most O 0 3.1216552238109985e-14
frequently O 0 7.849499522594172e-11
found O 0 1.1528484330364241e-13
mutation O 0 2.9080589255018816e-15
, O 0 3.5103702900090216e-16
identified O 0 4.705754642425836e-15
in O 0 7.75054204978998e-17
three O 0 9.915070371994354e-15
unrelated O 0 1.3075177607291266e-09
Turkish O 0 0.0046979994513094425
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
individuals O 0 4.417569175046987e-12
, O 0 9.450020484831536e-16
was O 0 4.811752125216673e-13
previously O 0 5.209789220986033e-15
described O 0 1.0377120068457996e-14
to O 0 1.5114741784425434e-16
be O 0 1.4324174171017473e-15
a O 0 1.119085293183053e-13
Turkish O 0 1.8468146663508378e-05
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999991655349731
T I-Disease 1 0.9999994039535522
founder O 0 1.7502361782106846e-09
mutation O 0 6.237166165490304e-12
. O 0 6.637349090482525e-13

The O 0 1.229084244320014e-13
presence O 0 1.1507240744047104e-13
of O 0 8.3064947716983e-17
a O 0 3.4974733663541277e-15
founder O 0 8.247152960549897e-13
mutation O 0 1.8389737500260246e-14
among O 0 1.8722402014058288e-16
relatively O 0 1.2717786112717043e-17
small O 0 2.953287573209505e-17
ethnic O 0 8.925904449157834e-14
population O 0 7.278135681480259e-15
groups O 0 1.0145399806176479e-14
in O 0 1.0940629234816243e-13
Western O 0 4.0892209063336793e-10
Europe O 0 1.1746283234970178e-07
could O 0 1.2474797583816866e-10
indicate O 0 9.21475538966576e-15
a O 0 6.845102210355556e-17
high O 0 6.000895716755036e-14
carrier O 0 3.602541577768861e-14
frequency O 0 7.999622557257335e-13
in O 0 3.1098599591482373e-17
such O 0 5.2115528494613345e-17
communities O 0 4.255939947250126e-13
. O 0 4.4133416539360315e-12

In O 0 2.3893807939157075e-12
patients O 0 1.7345011061112303e-12
of O 0 1.3482315536279712e-15
Dutch O 0 5.290734517160445e-10
ethnic O 0 2.3565907905642725e-11
origin O 0 2.4227403069843056e-11
, O 0 7.456056171778469e-13
however O 0 3.1713900169177967e-13
, O 0 5.0549164463606355e-15
no O 0 2.155848987352095e-15
significant O 0 1.4505335824153324e-18
founder O 0 1.8721092384654803e-11
effect O 0 7.810348505096765e-13
could O 0 1.1653132885730555e-12
be O 0 9.803702268331121e-16
identified O 0 6.786061729907589e-12
. O 0 4.505299345397562e-12

The O 0 2.5137803351480553e-14
observed O 0 1.7754388250920163e-14
genetic O 0 2.6851694899152588e-14
heterogeneity O 0 6.185179321840928e-13
including O 0 1.0528761835906092e-14
the O 0 3.568933682114063e-14
relative O 0 9.11589970176152e-11
high O 0 1.0778013204149062e-10
percentage O 0 4.532950837604632e-12
of O 0 6.801815518028411e-17
splice O 0 4.854939106735401e-05
- O 0 2.3945560769789154e-06
site O 0 2.2427157020388222e-08
mutations O 0 9.803849287948196e-09
had O 0 1.2430820817144195e-08
no O 0 4.618966545507329e-14
reflection O 0 1.3837630822818078e-14
on O 0 4.60187617179475e-12
the O 0 4.5258127757616395e-13
phenotype O 0 8.648954469281378e-11
. O 0 2.3211219404850603e-11

All O 0 2.435967877065237e-12
patients O 0 7.446874605680776e-13
manifested O 0 2.3328793757881883e-11
classical O 0 5.294263587529713e-07
A B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999982118606567
T I-Disease 1 0.9999997615814209
and O 0 1.3173943706756841e-11
increased O 0 9.219769996767072e-18
cellular O 0 9.993364591924384e-16
radioresistant O 0 1.8731073820905247e-13
DNA O 0 5.472127267915246e-14
synthesis O 0 4.930267890994322e-13
. O 0 1.1751342086918637e-12

Determination O 0 1.756083750636961e-10
of O 0 6.942163583432528e-17
the O 0 4.457830507514446e-17
genomic O 0 2.8615898171012455e-13
structure O 0 5.301818554494242e-13
of O 0 1.2362714698875593e-17
the O 0 1.6920863520410878e-16
COL4A4 O 0 4.270532191763543e-11
gene O 0 6.757597089459286e-15
and O 0 9.935743058105042e-15
of O 0 1.8063153624232306e-16
novel O 0 1.306979191539881e-09
mutations O 0 0.0016685858136042953
causing O 1 0.8985874652862549
autosomal B-Disease 1 0.9999887943267822
recessive I-Disease 1 0.9999897480010986
Alport I-Disease 1 0.9999903440475464
syndrome I-Disease 1 0.9999896287918091
. O 0 3.1337323889601976e-05

Autosomal B-Disease 1 0.9997722506523132
recessive I-Disease 1 0.999908447265625
Alport I-Disease 1 0.9999579191207886
syndrome I-Disease 1 0.9999798536300659
is O 0 5.509844580586787e-09
a O 0 2.2614113359686883e-10
progressive O 0 7.087745325407013e-05
hematuric B-Disease 1 0.9996877908706665
glomerulonephritis I-Disease 1 0.9999964237213135
characterized O 0 3.6892262869514525e-05
by O 0 5.687964543810153e-10
glomerular B-Disease 1 0.65317302942276
basement I-Disease 1 0.9998553991317749
membrane I-Disease 1 0.7800862193107605
abnormalities I-Disease 1 0.9988918900489807
and O 0 2.386015474087344e-08
associated O 0 1.948966855958023e-11
with O 0 4.0870447624115e-14
mutations O 0 1.3653859943715818e-12
in O 0 1.1055239399436739e-14
either O 0 3.807822723041372e-14
the O 0 8.18871541212983e-14
COL4A3 O 0 1.8992018624430784e-07
or O 0 4.1857562880186217e-13
the O 0 6.658565173639865e-16
COL4A4 O 0 5.435674826914649e-11
gene O 0 4.692256748894865e-15
, O 0 2.0483923494903853e-17
which O 0 3.5191471167818854e-19
encode O 0 1.3056439811196663e-16
the O 0 3.037929066293521e-14
alpha3 O 0 4.7347526788144023e-07
and O 0 1.1924629061965675e-09
alpha4 O 0 3.571396689494577e-07
type O 0 2.1559780349900137e-10
IV O 0 6.446334310794555e-08
collagen O 0 3.850763707902161e-09
chains O 0 6.38657468243764e-07
, O 0 3.863728781361431e-12
respectively O 0 4.577845481162912e-12
. O 0 7.046301042645808e-12

To O 0 1.606651416725599e-14
date O 0 2.2458722842609927e-14
, O 0 1.1267291821380807e-17
mutation O 0 1.4766507762809286e-18
screening O 0 2.465487386935062e-15
in O 0 1.904845675919199e-16
the O 0 7.199484913618994e-17
two O 0 1.3295538418663035e-15
genes O 0 9.47676250082248e-14
has O 0 8.926118524876792e-12
been O 0 1.46109582765952e-11
hampered O 0 5.602900365886399e-10
by O 0 7.306510438180331e-15
the O 0 1.0344084258855774e-13
lack O 0 7.31247693826079e-15
of O 0 8.357080045631398e-20
genomic O 0 7.691793030414548e-14
structure O 0 1.0620051658829371e-13
information O 0 5.155250141705703e-13
. O 0 8.680113919301569e-13

We O 0 4.0331399331350326e-10
report O 0 1.290055708742452e-13
here O 0 9.75330248448051e-17
the O 0 2.3228143567114357e-18
complete O 0 3.4117513027513875e-16
characterization O 0 1.6195806631577603e-13
of O 0 3.452701921223397e-18
the O 0 1.0470519426936413e-15
48 O 0 4.608489213817914e-16
exons O 0 6.836386925307414e-13
of O 0 1.3863876615144785e-16
the O 0 2.7892496797486677e-14
COL4A4 O 0 4.1448164345148086e-10
gene O 0 5.113041880080299e-14
, O 0 2.559751830750421e-16
a O 0 2.2824100993058236e-18
comprehensive O 0 9.380692194674976e-18
gene O 0 4.47080133331168e-12
screen O 0 3.835692041320726e-05
, O 0 6.556360055559596e-12
and O 0 3.3654928345040747e-13
the O 0 4.1676006238381704e-17
subsequent O 0 4.358605494652831e-16
detection O 0 1.1170337793848031e-13
of O 0 2.5184220161420048e-17
10 O 0 7.854750925103901e-16
novel O 0 1.3832986541168282e-14
mutations O 0 1.1718802143956264e-11
in O 0 1.9321989754711444e-12
eight O 0 3.777961499196181e-09
patients O 0 4.876322123870125e-10
diagnosed O 0 7.664629265491385e-06
with O 0 4.482658084725699e-07
autosomal B-Disease 1 0.9999933242797852
recessive I-Disease 1 0.9999934434890747
Alport I-Disease 1 0.9999961853027344
syndrome I-Disease 1 0.9999939203262329
. O 0 2.127165498677641e-05

Furthermore O 0 3.2348335121668015e-10
, O 0 8.023564316205975e-14
we O 0 4.939588040152516e-16
identified O 0 6.811522565234782e-18
a O 0 3.5067627366718034e-20
glycine O 0 6.084239248314415e-16
to O 0 1.7493647382551182e-17
alanine O 0 1.1449890684287357e-15
substitution O 0 5.772955698989644e-17
in O 0 1.8119803253919123e-17
the O 0 4.844728688040609e-17
collagenous O 0 3.8742225573484834e-12
domain O 0 3.0917328701536573e-13
that O 0 8.137060361450288e-13
is O 0 4.1704060181353003e-14
apparently O 0 3.5272068599212503e-10
silent O 0 7.093379356115648e-11
in O 0 5.300189884307822e-17
the O 0 5.59344400647804e-16
heterozygous O 0 6.575627222631455e-14
carriers O 0 7.148781044940319e-15
, O 0 1.2657887569047024e-14
in O 0 7.184734713639243e-14
11 O 0 2.52529025468462e-10
. O 0 2.8498167367607685e-11

5 O 0 3.56831481029829e-10
% O 0 2.472572927653127e-13
of O 0 1.2283082848485726e-17
all O 0 2.6247579566226033e-15
control O 0 9.094252044136719e-13
individuals O 0 3.225820423988576e-17
, O 0 1.6432773754747592e-15
and O 0 1.179967581976804e-12
in O 0 9.576891197253653e-16
one O 0 1.5176577307157366e-14
control O 0 1.7925756907490042e-13
individual O 0 3.5469644253002195e-19
homozygous O 0 6.0216593788364714e-18
for O 0 3.3496357807391995e-21
this O 0 2.4051549392640787e-20
glycine O 0 6.612323315708648e-15
substitution O 0 9.920253366598603e-15
. O 0 9.079416363709514e-13

There O 0 1.0509797025715084e-11
has O 0 2.6011389223090653e-12
been O 0 6.060068679508701e-12
no O 0 9.642777570352534e-14
previous O 0 2.4338290646633114e-14
finding O 0 3.990872228651685e-16
of O 0 7.557423383284932e-21
a O 0 3.921549546779678e-20
glycine O 0 3.5931502905485924e-16
substitution O 0 1.4251513302521835e-16
that O 0 2.3750383712668743e-14
is O 0 1.7173901113815503e-15
not O 0 2.852488143151137e-14
associated O 0 2.297482213495434e-15
with O 0 1.4771884023200574e-15
any O 0 7.103143756775204e-14
obvious O 0 4.34605074151051e-10
phenotype O 0 1.7940302021735022e-12
in O 0 5.164358185343575e-15
homozygous O 0 3.707359766402796e-11
individuals O 0 1.0629135375680998e-12
. O 0 5.573692549165621e-11

Founder O 0 4.606695469533406e-09
BRCA1 O 0 4.7259558044743244e-08
and O 0 1.1140482286675635e-10
BRCA2 O 0 2.6221937954318264e-09
mutations O 0 2.355535766440653e-10
in O 0 8.711465576682897e-12
French O 0 3.7571858229057398e-06
Canadian O 0 0.005326283164322376
breast B-Disease 1 0.9999918937683105
and I-Disease 1 0.9999909400939941
ovarian I-Disease 1 0.9999997615814209
cancer I-Disease 1 0.9999984502792358
families O 0 1.0850567555564794e-08
. O 0 2.307489919625705e-12

We O 0 1.1752429585065727e-10
have O 0 3.278963133456457e-14
identified O 0 1.2781037350435148e-13
four O 0 8.413399541125095e-15
mutations O 0 2.4385036700926184e-14
in O 0 6.542941999966101e-16
each O 0 5.168279947889362e-15
of O 0 8.91572565423068e-15
the O 0 5.343857578665734e-10
breast B-Disease 0 0.003826187690719962
cancer I-Disease 0 8.626410021861375e-07
- O 0 4.278045029337818e-09
susceptibility O 0 5.889418119853218e-11
genes O 0 1.7744993842383483e-12
, O 0 1.5501316186607508e-14
BRCA1 O 0 1.0067428835025538e-10
and O 0 1.0615024831350794e-10
BRCA2 O 0 1.9087158520392222e-08
, O 0 1.4383284493990622e-11
in O 0 3.530196697031779e-13
French O 0 3.801818238002852e-08
Canadian O 0 9.731834325066302e-07
breast B-Disease 1 0.9994413256645203
cancer I-Disease 1 0.8069009184837341
and O 0 0.0008888383745215833
breast B-Disease 1 0.9999899864196777
/ I-Disease 1 0.9999933242797852
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
families O 0 9.801609479609397e-08
from O 0 1.3982506558846142e-12
Quebec O 0 1.957343398473199e-09
. O 0 1.2311514030471926e-09

To O 0 1.4503893745743124e-11
identify O 0 3.430456474440291e-10
founder O 0 1.5894229932200687e-08
effects O 0 3.78323505856315e-08
, O 0 8.966212646475957e-13
we O 0 3.362740316238677e-13
examined O 0 1.2975873901841656e-13
independently O 0 1.8121983948182763e-13
ascertained O 0 2.576590607539231e-10
French O 0 1.0603677935705491e-09
Canadian O 0 3.3142186217638425e-10
cancer B-Disease 0 2.780806696023319e-08
families O 0 4.646428708910029e-14
for O 0 2.0175552294453492e-20
the O 0 7.816479387471634e-19
distribution O 0 4.0580512057918116e-16
of O 0 1.6205469088455001e-18
these O 0 1.4150598061883754e-15
eight O 0 4.14879151609056e-15
mutations O 0 3.012172827246591e-14
. O 0 1.0913915170912558e-12

Mutations O 0 7.904125270963291e-11
were O 0 8.846558902098067e-12
found O 0 1.2336976058791027e-12
in O 0 1.5001187488725338e-15
41 O 0 3.5503982295358866e-14
of O 0 1.509112015310888e-16
97 O 0 2.0977110673503496e-11
families O 0 1.2865432677533484e-11
. O 0 4.845110423978838e-12

Six O 0 4.1058986766095984e-10
of O 0 8.819118158464537e-15
eight O 0 1.3427640618325631e-13
mutations O 0 6.005636390754229e-14
were O 0 1.8937644421374022e-12
observed O 0 5.647611284881338e-13
at O 0 1.0941411839049398e-11
least O 0 2.577576950911118e-15
twice O 0 1.3265960552288902e-10
. O 0 3.711720097943072e-10

The O 0 6.125714085286615e-13
BRCA1 O 0 4.716711465846402e-10
C4446T O 0 1.8300154794315127e-11
mutation O 0 4.041435155283102e-13
was O 0 4.794204269686908e-11
the O 0 4.6944950334579846e-15
most O 0 1.8741205351393946e-15
common O 0 9.168232443850996e-14
mutation O 0 4.649372317808327e-14
found O 0 1.233171897929708e-10
, O 0 1.3200685763405367e-14
followed O 0 1.677683642033992e-15
by O 0 1.3279564171371207e-16
the O 0 3.632417785071236e-14
BRCA2 O 0 3.685396876562663e-08
8765delAG O 0 4.102443185161064e-08
mutation O 0 5.41256310604421e-11
. O 0 8.073051949164523e-11

Together O 0 3.519371183369202e-10
, O 0 6.821336318740172e-15
these O 0 7.736481302865559e-17
mutations O 0 4.713012020717911e-15
were O 0 2.9614403377481446e-12
found O 0 8.372527497690907e-12
in O 0 3.1829069290840355e-15
28 O 0 1.0678054780991451e-14
of O 0 6.130666067139322e-18
41 O 0 1.2043404552846077e-15
families O 0 3.8911118644976257e-17
identified O 0 1.3644409055022216e-16
to O 0 8.927734675598614e-16
have O 0 8.120326649594875e-14
a O 0 3.150516346829384e-14
mutation O 0 1.6252110768277817e-11
. O 0 9.55812540226475e-10

The O 0 6.076106956985627e-13
odds O 0 2.609817049969987e-11
of O 0 3.558160418288701e-18
detection O 0 3.5330592618176837e-13
of O 0 3.061202217667663e-17
any O 0 4.845156042632278e-16
of O 0 1.8068379089597926e-17
the O 0 1.2065161864645724e-14
four O 0 1.625986976625752e-14
BRCA1 O 0 2.6471754475954068e-12
mutations O 0 3.0978659307928647e-13
was O 0 2.325307280059974e-09
18 O 0 1.2100763099875955e-11
. O 0 6.592939302135781e-12

7x O 0 9.348316325485939e-07
greater O 0 1.2195007102668715e-13
if O 0 4.6310516727855744e-14
one O 0 3.982355841762635e-16
or O 0 4.618506013693907e-15
more O 0 6.77155063377632e-17
cases O 0 9.361381461681084e-12
of O 0 1.0358957247547096e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
were O 0 6.2183835858320435e-09
also O 0 3.794095679993115e-12
present O 0 9.986662443729234e-15
in O 0 7.418198614418507e-16
the O 0 2.2469958565248666e-13
family O 0 3.4252231273512734e-08
. O 0 9.282725976778039e-11

The O 0 1.0988357576277585e-12
odds O 0 4.667968442340076e-11
of O 0 7.775739294737326e-18
detection O 0 8.144652487163118e-13
of O 0 5.488812872005024e-17
any O 0 6.366603504633149e-16
of O 0 4.6638246189475066e-17
the O 0 1.5322011508948213e-13
four O 0 4.5138984780881963e-13
BRCA2 O 0 2.9724527960545144e-12
mutations O 0 6.419481781002809e-14
was O 0 4.336445369457209e-10
5 O 0 3.049827968296115e-12
. O 0 1.4655169439103943e-11

3x O 0 2.2255811416016513e-08
greater O 0 4.98961115480423e-13
if O 0 3.2098694362214797e-13
there O 0 2.4363915934386398e-15
were O 0 3.409906973212036e-14
at O 0 6.070656333851364e-15
least O 0 4.272682029941727e-19
five O 0 2.956297187150218e-17
cases O 0 2.930465996275368e-14
of O 0 1.5040797925712501e-13
breast B-Disease 0 7.269832713063806e-05
cancer I-Disease 0 3.413419165099185e-07
in O 0 4.9284503615774217e-14
the O 0 1.080010430046241e-12
family O 0 2.335669968545062e-08
. O 0 4.602949618681684e-11

Interestingly O 0 1.1321236170758198e-09
, O 0 2.3241055347594797e-13
the O 0 1.4689504775124173e-15
presence O 0 9.617575968479466e-14
of O 0 3.0486426778235723e-15
a O 0 2.504660975150008e-12
breast B-Disease 0 1.1581673398097792e-08
cancer I-Disease 0 5.380171655411381e-11
case O 0 4.016733912712636e-14
< O 0 2.6082206124153524e-14
36 O 0 4.790995379556299e-15
years O 0 2.762755844411269e-13
of O 0 2.491353126166248e-16
age O 0 9.176110392361547e-13
was O 0 3.9117174126593324e-13
strongly O 0 2.4308587742271747e-15
predictive O 0 5.461270338410519e-15
of O 0 2.117450184673865e-17
the O 0 1.4708295142267826e-14
presence O 0 2.308226953486297e-14
of O 0 2.2177570836022502e-17
any O 0 2.3877462795195885e-15
of O 0 1.2969716872287623e-16
the O 0 2.40702694321443e-13
eight O 0 2.862195615065122e-13
mutations O 0 5.635599544537642e-14
screened O 0 2.9125084566317128e-09
. O 0 4.2863636251500026e-11

Carriers O 0 4.551770765859331e-11
of O 0 6.450404709269753e-16
the O 0 1.5444819936058594e-15
same O 0 1.3220132369324905e-15
mutation O 0 1.011868629284421e-15
, O 0 2.0003250561484963e-15
from O 0 2.892478217658282e-17
different O 0 2.8234824210207436e-16
families O 0 3.5800738594363515e-14
, O 0 3.0759848451126595e-18
shared O 0 4.476902645461959e-16
similar O 0 1.6348045578429336e-16
haplotypes O 0 1.2654623876562354e-11
, O 0 2.5971653077943788e-14
indicating O 0 2.2772575654621957e-14
that O 0 7.548684039943032e-16
the O 0 4.359318259643056e-17
mutant O 0 3.3021111886522014e-13
alleles O 0 1.2805481366040192e-14
were O 0 9.36981308513607e-12
likely O 0 7.216846071482833e-14
to O 0 3.0189794781316083e-16
be O 0 5.18789468984893e-15
identical O 0 3.195855309990475e-13
by O 0 2.7756315922424814e-14
descent O 0 9.221460817165905e-10
for O 0 1.859890593383759e-15
a O 0 1.699268201464047e-14
mutation O 0 6.048884537788318e-14
in O 0 4.8927625765206404e-15
the O 0 7.925036088528639e-14
founder O 0 4.507557882504898e-09
population O 0 3.656805218875403e-13
. O 0 5.932980235573426e-12

The O 0 7.905673487101645e-16
identification O 0 7.816733439453168e-15
of O 0 1.2449413980419114e-17
common O 0 2.875068686272221e-14
BRCA1 O 0 3.0375078008404444e-09
and O 0 4.2021533475100625e-10
BRCA2 O 0 3.707607484915165e-11
mutations O 0 5.30703368552851e-15
will O 0 8.532684828659088e-18
facilitate O 0 2.105560125112905e-18
carrier O 0 1.187599064228495e-12
detection O 0 9.846604781538204e-11
in O 0 1.151350390894701e-12
French O 0 3.368494105870923e-08
Canadian O 0 5.447639637168322e-07
breast B-Disease 1 0.831626296043396
cancer I-Disease 0 0.017042361199855804
and O 0 1.2316297215875238e-05
breast B-Disease 1 0.9999837875366211
/ I-Disease 1 0.999991774559021
ovarian I-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999992847442627
families O 0 7.440617366683e-08
. O 0 1.566510809958288e-11

Are O 0 7.665530710188051e-11
Dp71 O 0 2.6279590770172945e-07
and O 0 1.4995332753287016e-10
Dp140 O 0 2.9011520963351245e-10
brain O 0 6.543034170025663e-11
dystrophin O 0 4.072650691081675e-13
isoforms O 0 3.607889404984646e-15
related O 0 1.7536174606608973e-13
to O 0 1.918910993645162e-12
cognitive B-Disease 0 9.771533804325827e-09
impairment I-Disease 0 1.0145202367084494e-07
in O 0 4.262398878296381e-09
Duchenne B-Disease 1 0.9981714487075806
muscular I-Disease 1 0.9142151474952698
dystrophy I-Disease 1 0.9879052639007568
? O 0 4.649363472708501e-05

Molecular O 0 2.7327522467146537e-09
study O 0 3.1333774463959685e-10
and O 0 9.615399143569903e-09
neuropsychological O 0 2.0854050430951787e-10
analysis O 0 2.4581342939199472e-15
were O 0 1.7549943508331418e-15
performed O 0 3.5089647447121715e-16
concurrently O 0 1.6222006546482304e-15
on O 0 2.6832792932030003e-11
49 O 0 2.9728171313525564e-11
patients O 0 1.8865422733108789e-13
with O 0 1.721835590773324e-10
Duchenne B-Disease 0 0.006673752795904875
muscular I-Disease 0 0.00010588678560452536
dystrophy I-Disease 0 0.001141548273153603
( O 0 3.247754565283145e-10
DMD B-Disease 1 0.9999991655349731
) O 0 1.4474599470404304e-11
in O 0 9.911959696435121e-17
order O 0 2.4118852891482376e-16
to O 0 2.6718735819784725e-16
find O 0 6.166581968094966e-16
a O 0 1.2487737620090213e-19
molecular O 0 7.648853097494141e-18
explanation O 0 8.353742501106717e-18
for O 0 1.5773647721477819e-18
the O 0 8.253475485518746e-14
cognitive B-Disease 0 2.8690910758299992e-11
impairment I-Disease 0 1.0474365380033421e-13
observed O 0 8.764087274914373e-14
in O 0 1.2610131851480827e-13
most O 0 3.5207073367793384e-10
DMD B-Disease 1 0.9999957084655762
patients O 0 1.3476751936636333e-09
. O 0 1.2568723839478935e-11

Complete O 0 4.751832607952089e-12
analysis O 0 5.786877596038187e-14
of O 0 1.2620170197757415e-16
the O 0 1.6217676090539467e-15
dystrophin O 0 1.697532630955123e-13
gene O 0 1.2619924907603802e-13
was O 0 9.319981592037507e-11
performed O 0 1.218733989595544e-12
to O 0 4.940680712654474e-16
define O 0 5.9094126009131935e-15
the O 0 7.66068442723161e-17
localization O 0 1.763303045243525e-14
of O 0 5.204037768839683e-19
deletions O 0 1.4886968610974827e-12
and O 0 2.293279455223285e-11
duplications O 0 9.173000033169121e-12
in O 0 5.916311790147698e-16
relation O 0 6.9503309662775296e-15
to O 0 1.0097677122895225e-14
the O 0 2.0067960490523402e-14
different O 0 3.297746450914296e-11
DMD B-Disease 1 0.9999830722808838
promoters O 0 3.8177574990250207e-10
. O 0 6.086105469420289e-13

Qualitative O 0 2.5131214383827816e-12
analysis O 0 2.1756916743480986e-13
of O 0 6.010786668710891e-16
the O 0 3.67526342204879e-14
Dp71 O 0 1.3554707356533413e-09
transcript O 0 6.3107217229685375e-09
and O 0 2.981083045347499e-12
testing O 0 1.7818681386808994e-17
for O 0 4.129750200139904e-22
the O 0 9.75763132031257e-22
specific O 0 1.8796501657246946e-20
first O 0 7.685677524003777e-18
exon O 0 1.1033837417958464e-14
of O 0 2.004227257527158e-16
Dp140 O 0 2.909831663816531e-13
were O 0 4.093044127370313e-14
also O 0 1.586129163666343e-14
carried O 0 2.349133387813396e-10
out O 0 3.2710443242933707e-09
. O 0 2.3064085363788678e-11

Neuropsychological O 0 4.976619116803249e-09
analysis O 0 3.8145490455568365e-13
assessed O 0 4.212461109098786e-12
verbal O 0 2.630227147193409e-10
and O 0 6.284451583259132e-13
visuospatial O 0 6.230858606848244e-10
intelligence O 0 5.694767921116117e-11
, O 0 7.054846615749122e-14
verbal O 0 2.2184533723934585e-11
memory O 0 9.649014920398713e-10
, O 0 6.765494062329833e-14
and O 0 3.1737822005911687e-12
reading O 0 8.872310872098943e-12
skills O 0 1.762968460453096e-12
. O 0 4.1815411132599054e-14

Comparison O 0 7.587312722545647e-12
of O 0 4.651321340619959e-15
molecular O 0 6.146467449591464e-12
and O 0 1.2523376433093425e-11
psychometric O 0 2.3734705173472648e-11
findings O 0 8.029898597992132e-15
demonstrated O 0 1.1954190542978722e-16
that O 0 4.119720101261151e-18
deletions O 0 4.058241576446707e-14
and O 0 3.291170233479107e-13
duplications O 0 2.4726776615829893e-12
that O 0 7.593834008877767e-14
were O 0 1.0762625091544162e-14
localized O 0 1.5417132970111692e-14
in O 0 2.680174028405532e-15
the O 0 1.2802062741065073e-14
distal O 0 4.992875002329811e-10
part O 0 1.6959550083739394e-11
of O 0 2.1099465355228428e-14
the O 0 7.676887961048304e-14
gene O 0 4.199400809729026e-12
seemed O 0 1.1893451501432395e-11
to O 0 6.470683869167103e-17
be O 0 2.9754176324455037e-17
preferentially O 0 2.3540186726983547e-13
associated O 0 8.810451283466914e-13
with O 0 3.105021101346139e-11
cognitive B-Disease 0 3.056420538882776e-08
impairment I-Disease 0 1.1365291818776768e-08
. O 0 3.328497477639303e-10

Two O 0 7.50298087548451e-12
altered O 0 3.8261113721738127e-10
Dp71 O 0 4.170631395794544e-09
transcripts O 0 2.11286654838716e-10
and O 0 1.6240722417078246e-13
two O 0 1.1167721774942084e-16
deleted O 0 3.631960387279719e-14
Dp140 O 0 9.851688802375446e-16
DNA O 0 6.630484125614254e-15
sequences O 0 5.4665673436494686e-14
were O 0 9.627775431010534e-15
found O 0 1.3415627150034724e-14
in O 0 4.2245516781402013e-17
four O 0 1.0905335743596409e-13
patients O 0 1.360425444171809e-13
with O 0 2.0578136417093162e-10
severe O 0 6.146304804133251e-05
cerebral B-Disease 0 0.2675129771232605
dysfunction I-Disease 0 0.005786930676549673
. O 0 2.759013639774821e-08

These O 0 1.8160261705882363e-12
findings O 0 3.525457513810573e-14
suggest O 0 4.648979718037275e-15
that O 0 7.518332599511644e-17
some O 0 2.1268952586103615e-19
sequences O 0 7.252938251244457e-16
located O 0 1.3814786555988866e-15
in O 0 2.9067820233338957e-16
the O 0 7.959840714682966e-16
distal O 0 9.700822610481108e-12
part O 0 1.2221366767987268e-13
of O 0 1.4593883225708635e-15
the O 0 9.155401249952809e-15
gene O 0 2.8680700934861914e-13
and O 0 4.524807264982833e-11
, O 0 1.1705821689300244e-15
in O 0 3.230584488008514e-18
particular O 0 1.353058635575696e-16
, O 0 1.7421399111745085e-16
some O 0 2.1555107829781243e-16
DMD B-Disease 1 0.9999861717224121
isoforms O 0 9.257104495929633e-15
expressed O 0 9.418472945998957e-13
in O 0 6.402292433184409e-13
the O 0 3.960491656851417e-10
brain O 0 7.790386916894931e-06
may O 0 9.233700609678763e-12
be O 0 6.086719201965298e-17
related O 0 1.026408479219633e-15
to O 0 1.7084293710083708e-14
the O 0 4.097070339242892e-12
cognitive B-Disease 0 1.262982274319313e-09
impairment I-Disease 0 7.03767447964021e-13
associated O 0 6.243971268846127e-13
with O 0 5.626846766304539e-10
DMD B-Disease 1 0.9999964237213135
. O 0 3.463414277593557e-10
. O 0 2.6644806153108824e-11

I1307K O 0 1.368535063051013e-09
APC O 0 4.09185973992976e-09
and O 0 2.9701421877526e-11
hMLH1 O 0 1.3356172834377844e-09
mutations O 0 2.194181780712512e-10
in O 0 1.5607649992300382e-13
a O 0 1.8581631459207992e-12
non O 0 1.3405007139033476e-11
- O 0 2.257660440818654e-07
Jewish O 0 2.1232042399788043e-06
family O 0 7.481002626263944e-07
with O 0 2.8674840280018543e-10
hereditary B-Disease 1 0.995884358882904
non I-Disease 0 8.58651110320352e-05
- I-Disease 1 0.9998962879180908
polyposis I-Disease 1 0.9999561309814453
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999971389770508
. O 0 1.2142345440224744e-07

We O 0 4.521158100678768e-11
describe O 0 2.730664002206784e-12
a O 0 1.7450360004656745e-13
French O 0 7.249699951472621e-09
Canadian O 0 6.950931492610835e-07
hereditary B-Disease 1 0.9999738931655884
non I-Disease 1 0.8161255121231079
- I-Disease 1 0.999977707862854
polyposis I-Disease 1 0.9999803304672241
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
( O 0 2.103249796547857e-09
HNPCC B-Disease 0 9.970206883735955e-05
) O 0 2.098175279352521e-11
kindred O 0 1.9974194742644613e-08
which O 0 4.680179421095998e-12
carries O 0 3.025049611846131e-12
a O 0 3.729279073084199e-16
novel O 0 7.992831250374158e-14
truncating O 0 3.1367022867989647e-10
mutation O 0 1.4596927833121498e-10
in O 0 2.7434333017134493e-12
hMLH1 O 0 2.1665182430297136e-06
. O 0 2.2146283418233992e-10

Interestingly O 0 7.698629927999079e-11
, O 0 2.1405996414444392e-14
the O 0 9.089031453975106e-17
I1307K O 0 6.991032508755698e-14
APC O 0 3.246802241126112e-13
polymorphism O 0 3.2701159488612852e-12
, O 0 3.2076750194946985e-15
associated O 0 1.5000893938869555e-16
with O 0 5.3996160013199606e-17
an O 0 1.616381961817067e-15
increased O 0 2.0247385365546045e-11
risk O 0 3.5960414379587746e-07
of O 0 8.536016338211994e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 2.1760135360260335e-11
is O 0 1.4042036813649485e-14
also O 0 5.081233827794462e-13
present O 0 1.2656196891284305e-14
in O 0 5.1548714163343265e-15
this O 0 5.2302221120693534e-14
family O 0 1.75427017357066e-09
. O 0 4.290355223868225e-11

The O 0 5.576206814003615e-13
I1307K O 0 7.839085630623188e-11
polymorphism O 0 2.4594501990549134e-09
has O 0 1.323686854570738e-10
previously O 0 4.818171144178873e-13
only O 0 5.683435963167889e-16
been O 0 4.10828767110228e-14
identified O 0 8.349621449972588e-13
in O 0 2.2174714812977928e-15
individuals O 0 2.1198375086545207e-14
of O 0 1.2186101737074462e-13
self O 0 2.761525365713169e-06
- O 0 7.911758439149708e-05
reported O 0 4.6517466216755565e-06
Ashkenazi O 0 1.4401638281924534e-06
Jewish O 0 2.8776451443945916e-08
origins O 0 2.041856816958898e-07
. O 0 1.255509585185166e-10

In O 0 7.24079541984668e-14
addition O 0 6.563419021465974e-15
, O 0 5.935620223817715e-15
in O 0 3.292471064327853e-16
this O 0 5.443757085193089e-15
family O 0 9.899676634006482e-10
, O 0 1.1129739843499312e-13
there O 0 5.728604524475817e-15
appears O 0 4.971732660979944e-13
to O 0 6.149882290023374e-15
be O 0 9.605073084551635e-14
no O 0 2.0972196960837575e-14
relationship O 0 2.4129552929309447e-14
between O 0 1.853974994689474e-16
the O 0 2.204110754164718e-17
I1307K O 0 8.761337700088467e-16
polymorphism O 0 7.180898670827718e-14
and O 0 4.430223549123369e-13
the O 0 1.1446663488758318e-14
presence O 0 4.39244734334876e-12
or O 0 3.76723846562399e-10
absence O 0 5.966602537564591e-13
of O 0 2.7900979408936955e-16
cancer B-Disease 0 7.228318638086151e-11
. O 0 1.7389953680616715e-13
. O 0 3.8254508068213955e-12

Identification O 0 1.7180612401496154e-12
of O 0 5.633401726973578e-16
a O 0 2.0989713602186794e-15
novel O 0 2.014062405893656e-14
mutation O 0 5.386878822784963e-14
of O 0 1.887716419794451e-16
the O 0 2.843676967620619e-14
CPO O 0 1.4329026853943105e-09
gene O 0 2.507530926063213e-14
in O 0 1.1113797539937507e-15
a O 0 1.6387498996683902e-13
Japanese O 0 2.458391357151868e-08
hereditary B-Disease 0 0.3182903528213501
coproporphyria I-Disease 0 0.01107723731547594
family O 0 1.784310654784349e-07
. O 0 2.4841849063927945e-11

Hereditary B-Disease 1 0.9975554943084717
coproporphyria I-Disease 0 0.05325587838888168
( O 0 4.3524524262483766e-11
HCP B-Disease 0 1.777413103809522e-06
) O 0 1.0323006338630591e-11
is O 0 2.8712722846026273e-13
an O 0 9.218949388600794e-13
autosomal B-Disease 1 0.9987359642982483
dominant I-Disease 1 0.999940037727356
disease I-Disease 1 0.7237184643745422
characterized O 0 5.465559560491329e-09
by O 0 6.711016833395311e-13
a O 0 1.2756508349642814e-10
deficiency B-Disease 0 0.0012673953315243125
of I-Disease 0 1.0080006533307842e-15
coproporphyrinogen I-Disease 0 1.2663677750879287e-07
oxidase I-Disease 0 1.2734733267905085e-09
( O 0 3.2775374075996386e-14
CPO O 0 4.2562840008031344e-07
) O 0 2.9152258406751896e-13
caused O 0 1.0151754247346781e-13
by O 0 1.8307945070654002e-18
a O 0 8.589939789118171e-17
mutation O 0 3.800180707087949e-15
in O 0 1.376932947408328e-15
the O 0 8.323853759040212e-15
CPO O 0 3.297235551258382e-08
gene O 0 2.2631436655262682e-12
. O 0 2.042179142805467e-12

Only O 0 2.3339519553133847e-11
11 O 0 1.5882923231833046e-12
mutations O 0 2.301984828884801e-13
of O 0 5.812022446703789e-17
the O 0 4.207714780731154e-16
gene O 0 2.0318831252946756e-12
have O 0 7.403658242033373e-11
been O 0 1.2078034405949012e-10
reported O 0 5.011317472103372e-10
in O 0 2.64240567632041e-14
HCP B-Disease 0 4.571830231725471e-06
patients O 0 4.112054446947511e-12
. O 0 2.754601451451788e-12

We O 0 1.8630269549291256e-10
report O 0 6.24745887618447e-14
another O 0 8.030318355757056e-17
mutation O 0 1.1021469042862657e-14
in O 0 2.265335407323002e-14
a O 0 1.278587262107389e-12
Japanese O 0 1.0233547342863858e-08
family O 0 2.4736248604995126e-09
. O 0 4.241881585570484e-12

Polymerase O 0 1.911731661863314e-09
chain O 0 1.6638338706798095e-08
reaction O 0 6.96233652328071e-12
- O 0 1.0804565575561753e-10
single O 0 1.7832522296919867e-13
strand O 0 3.1284193985348097e-11
conformational O 0 4.435120627756272e-16
polymorphism O 0 1.8698296356351937e-14
and O 0 1.1340732224885715e-16
direct O 0 2.8574688011884676e-19
sequence O 0 3.101569955049231e-15
analyses O 0 2.4203947833066793e-14
demonstrated O 0 3.028875668456846e-17
a O 0 1.109984048010287e-18
C O 0 7.282777083218034e-14
to O 0 7.228544761154717e-17
T O 0 2.6468900381497636e-14
substitution O 0 2.3289161902092523e-20
in O 0 1.2384456042677298e-20
exon O 0 6.244483058858352e-17
1 O 0 5.2462001365987307e-17
of O 0 1.1332288571987927e-18
the O 0 1.205603963744115e-16
CPO O 0 7.571337654055377e-12
gene O 0 3.992164549466289e-17
at O 0 3.488941613758019e-17
nucleotide O 0 8.054063733293248e-17
position O 0 2.9665848770565884e-12
85 O 0 2.930320984234798e-14
, O 0 2.1214241030086817e-13
which O 0 3.537535264719338e-10
lies O 0 6.42989164134633e-08
in O 0 6.536982699665694e-15
the O 0 5.21076034426006e-16
putative O 0 7.188223974385899e-12
presequence O 0 7.210441878985341e-12
for O 0 5.161373860795729e-19
targeting O 0 1.0759716549809881e-13
to O 0 3.5525610773447236e-13
mitochondria O 0 4.4754819295000914e-10
. O 0 6.669068075559892e-11

This O 0 4.260613841171757e-15
mutation O 0 5.857880810468136e-15
changes O 0 8.19088933277687e-17
the O 0 4.457811151488112e-18
codon O 0 4.266676347142832e-17
for O 0 1.927104483491096e-20
glutamine O 0 4.1971022519954456e-16
to O 0 4.295809896471133e-18
a O 0 3.2503749909589984e-18
termination O 0 5.050037430705332e-16
codon O 0 2.6803173887318546e-15
at O 0 4.009026251705801e-14
amino O 0 1.5470241935904537e-14
acid O 0 1.9044017935971463e-13
position O 0 2.850849591118365e-11
29 O 0 2.685061027685176e-11
. O 0 3.1948269984399813e-12

MaeI O 0 1.548475303536634e-08
restriction O 0 1.8918076740565004e-12
analysis O 0 3.1416308356874145e-13
showed O 0 1.0735825423102696e-11
two O 0 9.66920997991939e-17
other O 0 1.0745139022790384e-16
carriers O 0 1.0550426397598015e-15
in O 0 1.545677633550468e-16
the O 0 2.775389510226156e-13
family O 0 3.1545830392332164e-09
. O 0 2.7657310035927862e-12

The O 0 2.394859421883666e-09
C O 1 0.8403182625770569
- O 1 0.9934138655662537
T O 0 0.012198325246572495
mutation O 0 4.843798973030999e-12
is O 0 1.5111010180776305e-14
located O 0 1.88922903534979e-16
within O 0 7.0972210294384e-19
a O 0 2.110932456396284e-18
recently O 0 6.787252242338251e-16
proposed O 0 8.801988185380993e-20
putative O 0 1.7636787678831033e-15
alternative O 0 6.380653531296832e-17
translation O 0 4.176548785772083e-15
initiation O 0 8.256588331599906e-15
codon O 0 4.753081608854792e-13
( O 0 1.9899810897966268e-16
TIC O 0 3.5369820960973186e-10
- O 0 7.904740230435525e-12
1 O 0 2.5395909113585515e-15
) O 0 5.258043311562571e-16
, O 0 1.1612986315798356e-17
supporting O 0 4.414763779055791e-16
that O 0 4.4811529297363387e-14
TIC O 0 3.1391813593018014e-09
- O 0 4.200738715209873e-12
1 O 0 3.1692510639084017e-16
is O 0 1.0736662472919634e-15
the O 0 1.774652397352138e-15
real O 0 6.034969399215662e-12
TIC O 0 1.9632573344807724e-10
rather O 0 2.6403020170563446e-16
than O 0 1.0618328098982942e-17
TIC O 0 4.771091299815566e-10
- O 0 2.287213057838855e-10
2 O 0 3.640479031511573e-13
. O 0 6.030073630095695e-14
. O 0 3.994503295842722e-13

Human B-Disease 0 4.9151438127892355e-12
complement I-Disease 0 2.508880603269148e-10
factor I-Disease 0 1.255952247447567e-05
H I-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.9998955726623535
associated O 0 3.3107771741924807e-06
with O 0 0.001400879817083478
hemolytic B-Disease 1 0.9999700784683228
uremic I-Disease 1 0.9999891519546509
syndrome I-Disease 1 0.9999744892120361
. O 0 7.130529979804123e-07

This O 0 3.753761014589456e-14
study O 0 2.968027799376302e-16
reports O 0 1.2294111482156773e-15
on O 0 1.0748066119840166e-13
six O 0 1.6832038828061904e-14
cases O 0 1.3072550007276525e-14
of O 0 8.978456914304333e-15
deficiency B-Disease 0 8.47815062599011e-09
in I-Disease 0 6.396588090462869e-18
the I-Disease 0 4.602320762553984e-17
human I-Disease 0 7.661035151811332e-17
complement I-Disease 0 8.655986025127468e-18
regulatory I-Disease 0 6.928832211285031e-16
protein I-Disease 0 6.249663194726404e-14
Factor I-Disease 0 1.2772459955998072e-13
H I-Disease 1 0.9999845027923584
( O 0 5.172813797618659e-16
FH O 0 3.3955255274165097e-10
) O 0 4.617992394090515e-16
in O 0 1.5919565224965528e-19
the O 0 5.553995138544024e-19
context O 0 1.7161196678397873e-15
of O 0 1.9725375050391085e-16
an O 0 3.0124661098973604e-10
acute B-Disease 0 0.28883373737335205
renal I-Disease 1 0.9999982118606567
disease I-Disease 1 0.9999983310699463
. O 0 1.985873041121522e-06

Five O 0 2.033208887711191e-12
of O 0 8.673736493892243e-18
the O 0 3.095656275413967e-17
cases O 0 3.414303254202787e-16
were O 0 5.7625328526945616e-15
observed O 0 1.6332667165876343e-14
in O 0 6.556083716142752e-16
children O 0 4.133964004449098e-12
presenting O 0 6.362762539069422e-10
with O 0 1.295097945330781e-06
idiopathic O 1 0.9999816417694092
hemolytic B-Disease 1 0.9999945163726807
uremic I-Disease 1 0.9999970197677612
syndrome I-Disease 1 0.9999960660934448
( O 0 2.6611360226524994e-07
HUS B-Disease 1 0.9988916516304016
) O 0 8.798549799848843e-08
. O 0 6.53356257984683e-09

Two O 0 4.0632005138957483e-13
of O 0 1.8177967616743646e-16
the O 0 8.220686501317354e-14
children O 0 3.57389812188913e-11
exhibited O 0 1.8147035523580213e-12
a O 0 3.9944574883009343e-13
homozygous O 0 2.1314440346031915e-07
deficiency O 0 0.0039481245912611485
characterized O 0 4.857382551737288e-11
by O 0 1.771231951256183e-13
the O 0 5.754301115462601e-13
absence O 0 1.0967622480779343e-13
of O 0 2.201646148850101e-19
the O 0 5.9800885899720065e-18
150 O 0 1.8283239253708575e-18
- O 0 4.6510572357470054e-14
kD O 0 7.451080225907847e-13
form O 0 1.3190354396668588e-16
of O 0 8.697098721368701e-17
Factor O 0 1.689400355719961e-12
H O 1 0.9999996423721313
and O 0 8.652442911455394e-13
the O 0 5.1595284828876694e-17
presence O 0 1.7310975396878482e-15
, O 0 2.0573432708988216e-17
upon O 0 1.544492118296557e-17
immunoblotting O 0 3.309149178634674e-12
, O 0 3.961110286755639e-18
of O 0 6.338334774703223e-20
the O 0 2.2260391136801516e-16
42 O 0 8.146897564930474e-15
- O 0 7.790842623811578e-13
kD O 0 1.2967771821636997e-11
Factor O 0 1.6676375558244416e-11
H O 1 0.999990701675415
- O 0 9.024212627162242e-11
like O 0 7.150717362257742e-15
protein O 0 5.647325783956136e-15
1 O 0 7.289019604866224e-17
( O 0 1.614746304799972e-18
FHL O 0 1.0884020464410615e-12
- O 0 4.7088458891668405e-14
1 O 0 4.931774161214095e-16
) O 0 2.931637146379889e-16
and O 0 1.678695973460903e-14
other O 0 1.4079523527279645e-15
FH O 0 8.709613585899945e-10
- O 0 2.2795879225066817e-13
related O 0 1.4022980266402158e-14
protein O 0 5.308797970454346e-14
( O 0 2.358709239007715e-18
FHR O 0 5.926107521370128e-11
) O 0 2.552127475433948e-16
bands O 0 1.442580863791898e-12
. O 0 4.1377169160590477e-13

Southern O 0 2.0774847120375028e-10
blot O 0 2.9656982292181056e-07
and O 0 1.9962897911877768e-14
PCR O 0 7.015561092130196e-13
analysis O 0 6.024672053345451e-17
of O 0 2.9137241187240415e-21
DNA O 0 1.2565754948341227e-14
of O 0 8.466698666641778e-19
one O 0 1.206188787054635e-15
patient O 0 5.5963737875634745e-14
with O 0 4.872521656984485e-13
homozygous O 0 1.0318061072212004e-08
deficiency O 0 7.794651173753664e-05
ruled O 0 5.7003644859943137e-11
out O 0 2.659394648940605e-10
the O 0 7.918228632962322e-16
presence O 0 1.0461256062867003e-15
of O 0 2.391788863787958e-19
a O 0 1.0527219117593901e-17
large O 0 2.6231136340614112e-17
deletion O 0 1.523951624615716e-11
of O 0 2.66152913917057e-15
the O 0 1.0414627060056914e-12
FH O 0 3.1075539919100947e-09
gene O 0 2.2387128229776204e-14
as O 0 1.317347228887598e-14
the O 0 2.6414632674632947e-14
underlying O 0 1.5608665471233962e-09
defect O 0 2.484102257227505e-09
for O 0 2.1192794833488696e-14
the O 0 5.103583777810172e-09
deficiency O 0 0.0034897627774626017
. O 0 1.237800140163614e-10

The O 0 2.5857029191389547e-14
other O 0 8.951098597140966e-15
four O 0 3.750054059599092e-14
children O 0 3.4070093751434327e-13
presented O 0 4.223107730487105e-14
with O 0 2.1658924653777945e-12
heterozygous O 0 5.217004162005878e-09
deficiency O 0 7.976977030921262e-06
and O 0 1.3315201805724763e-12
exhibited O 0 3.0941651150973026e-12
a O 0 1.7059058904519107e-14
normal O 0 1.0129124915127935e-13
immunoblotting O 0 3.263777692552594e-09
pattern O 0 1.4559667360636297e-10
of O 0 6.502080088342982e-18
proteins O 0 1.2740530879644732e-14
of O 0 2.834738430098569e-16
the O 0 2.3926563855192207e-11
FH O 0 2.750981002463959e-05
family O 0 3.6839120642895296e-09
. O 0 1.5530932442886503e-11

Factor B-Disease 0 0.0006999672623351216
H I-Disease 1 0.9999977350234985
deficiency I-Disease 1 0.950390636920929
is O 0 4.6981515899879867e-14
the O 0 4.8241460468261693e-14
only O 0 2.1407754735580653e-10
complement B-Disease 1 0.999997615814209
deficiency I-Disease 1 0.9999995231628418
associated O 0 8.653904676192425e-11
with O 0 4.35633924766865e-11
HUS B-Disease 1 0.9977763295173645
. O 0 2.201843329885378e-08

These O 0 2.959784381559999e-13
observations O 0 7.466814709936043e-13
suggest O 0 1.5689933483302096e-14
a O 0 4.4870875549082016e-18
role O 0 6.314166871242187e-16
for O 0 1.6388138294800843e-15
FH O 0 8.613686475200666e-08
and O 0 7.22549312048848e-11
/ O 0 3.923424640728257e-10
or O 0 3.785775512521461e-12
FH O 0 2.7510341227277024e-10
receptors O 0 2.9065061023513276e-15
in O 0 2.828418042299725e-17
the O 0 2.663173230121191e-16
pathogenesis O 0 1.3783836051717291e-11
of O 0 1.0354501747667465e-14
idiopathic O 0 1.2406405858200742e-07
HUS B-Disease 0 0.4995907247066498
. O 0 1.9848402921240904e-09
. O 0 1.7732637580536448e-09

Further O 0 4.8702890136607946e-14
evidence O 0 3.1793637902656708e-15
for O 0 1.2077016855057434e-18
a O 0 4.588172334484632e-18
major O 0 3.3743304459328766e-17
ancient O 0 5.580487027340153e-12
mutation O 0 2.743225309131958e-07
underlying O 0 0.0023101598490029573
myotonic B-Disease 1 0.9999960660934448
dystrophy I-Disease 1 0.9999921321868896
from O 0 8.256286279650915e-12
linkage O 0 1.8570331050682398e-08
disequilibrium O 0 5.239703781967364e-08
studies O 0 2.9917691587999506e-12
in O 0 5.21107798161528e-16
the O 0 8.833056932644554e-15
Japanese O 0 6.714752642800192e-10
population O 0 7.375510589096614e-15
. O 0 3.2595096326887285e-13

The O 0 3.6883017173749977e-07
myotonic B-Disease 1 0.9999279975891113
dystrophy I-Disease 1 0.9999784231185913
( O 0 4.777019171342545e-07
DM B-Disease 1 0.9999972581863403
) O 0 1.1473354905033872e-10
mutation O 0 1.2794367995616618e-11
is O 0 2.7360078178745306e-12
an O 0 1.6786328186843558e-13
unstable O 0 0.00067271658917889
( O 0 1.1927054836661805e-14
CTG O 0 9.012709467626223e-10
) O 0 2.121684121794698e-12
n O 0 5.489023457982967e-09
repeat O 0 5.468669428410067e-08
, O 0 7.262053913943689e-14
present O 0 1.6056334313537652e-15
at O 0 1.0811428588866114e-14
a O 0 1.0075878769702305e-18
copy O 0 1.885595121069259e-14
number O 0 2.244422640311326e-16
of O 0 1.0805727686554178e-16
5 O 0 1.4004437529340635e-13
- O 0 1.2684310268795684e-09
37 O 0 4.543777463658638e-13
repeats O 0 4.121782026800247e-09
on O 0 1.811308568411274e-11
normal O 0 2.8229990299056575e-15
chromosomes O 0 1.1876037262978367e-12
but O 0 1.0328898482770809e-14
amplified O 0 9.202571837159043e-14
to O 0 1.543915540322383e-16
50 O 0 1.9516019607820854e-17
- O 0 1.2320415412707397e-13
3000 O 0 7.72287033043613e-14
copies O 0 6.3771774319598684e-12
on O 0 7.028475579318183e-07
DM B-Disease 1 0.9999967813491821
chromosomes O 0 1.083692723113927e-06
. O 0 5.7651390605872876e-11

Previous O 0 5.019519522253546e-12
findings O 0 2.848417302806633e-13
in O 0 4.676407068385843e-15
Caucasian O 0 7.216261366238541e-08
populations O 0 1.4140859490308078e-11
of O 0 1.1102192129768939e-14
a O 0 2.6218940352151776e-09
DM B-Disease 1 0.9999996423721313
founder O 0 1.377079605902054e-08
chromosome O 0 4.148917298607557e-08
raise O 0 2.7070365263628937e-13
a O 0 9.297870074098614e-16
question O 0 9.37945416999578e-15
about O 0 8.68257938551268e-17
the O 0 7.198464834487594e-18
molecular O 0 1.1768324250478138e-15
events O 0 3.476059102898118e-15
involved O 0 3.306353934333351e-16
in O 0 5.6617042906585084e-18
the O 0 7.700119104882218e-17
expansion O 0 1.8892454942587462e-14
mutation O 0 2.2800587373000836e-12
. O 0 2.8967384047007272e-11

To O 0 9.134231186095493e-14
investigate O 0 1.7368068382138738e-14
whether O 0 3.2754467608792255e-16
a O 0 6.944067091458135e-18
founder O 0 3.783892687028723e-15
chromosome O 0 1.504735572255278e-11
for O 0 1.1701708550247936e-16
the O 0 1.384107780645627e-12
DM B-Disease 1 0.9999991655349731
mutation O 0 3.452117877580235e-13
exists O 0 1.0137740087234458e-14
in O 0 2.2094310144285364e-17
the O 0 3.056351312918297e-15
Japanese O 0 5.163602878610618e-10
population O 0 3.025089497357068e-16
, O 0 5.525579726744026e-16
we O 0 3.38191287311846e-14
genotyped O 0 9.49447985509888e-13
families O 0 5.0781014851324394e-18
using O 0 2.44234340279142e-18
polymorphic O 0 8.742350376608754e-14
markers O 0 1.7362721038693962e-08
near O 0 1.4812048254597698e-09
the O 0 9.143091015198501e-13
( O 0 4.509470427009176e-15
CTG O 0 4.1557324248486793e-10
) O 0 2.8647587774210947e-12
n O 0 1.8616931996007224e-08
repeat O 0 2.7501826593834267e-07
region O 0 9.431120467917609e-11
and O 0 3.3393315890251074e-11
constructed O 0 2.739583671029777e-09
haplotypes O 0 1.1387052154532284e-06
. O 0 4.5488396382964424e-10

Six O 0 3.6385215044891506e-13
different O 0 3.346464120759394e-16
haplotypes O 0 1.3064693424325036e-11
were O 0 3.1152940470347e-12
found O 0 6.518171419278573e-11
and O 0 1.5724576085673903e-09
DM B-Disease 1 0.9999960660934448
alleles O 0 3.104461403658637e-13
were O 0 2.925485916883963e-13
always O 0 1.7832191886307802e-12
haplotype O 0 2.000737422958032e-11
A O 0 6.5865294988920464e-12
. O 0 3.060814796063127e-11

To O 0 1.4364517333855659e-13
find O 0 2.0456155690250048e-14
an O 0 9.473255359580885e-18
origin O 0 4.299701447072228e-15
of O 0 4.2156353328813697e-16
the O 0 3.8960655990467885e-13
( O 0 5.230793070509318e-17
CTG O 0 7.005255316799852e-12
) O 0 2.211264042695487e-14
n O 0 5.20660112246496e-11
repeat O 0 1.4851872509602515e-10
mutation O 0 5.707307998599476e-14
and O 0 3.6507147131714657e-13
to O 0 6.352504905923897e-17
investigate O 0 2.6178969368102843e-16
the O 0 2.24911711362633e-18
mechanism O 0 2.3433399419850714e-16
of O 0 3.309844572411827e-19
the O 0 4.203971755372127e-18
expansion O 0 4.466185528009599e-18
mutation O 0 4.2399213556659266e-17
in O 0 3.413897803353738e-17
the O 0 6.010675389757445e-15
Japanese O 0 1.5249002061068495e-10
population O 0 1.6961763631234685e-17
we O 0 4.1625658070601316e-16
have O 0 3.161521358869114e-17
studied O 0 2.4039581195531214e-16
90 O 0 6.887455842951741e-17
Japanese O 0 8.036104420794388e-11
DM B-Disease 1 0.9999983310699463
families O 0 1.5142804409484442e-14
comprising O 0 5.443122951164713e-19
190 O 0 1.9541283027217204e-16
affected O 0 1.2214635968902678e-16
and O 0 2.255634508384688e-14
130 O 0 4.865182421428388e-14
unaffected O 0 1.4068357589991365e-11
members O 0 3.543680241824623e-14
. O 0 1.2667221872125767e-12

The O 0 1.5881265053030447e-11
results O 0 7.645748319401804e-14
suggest O 0 9.570382680790246e-14
that O 0 1.399502457925274e-15
a O 0 1.0579681062711607e-16
few O 0 2.5982689070213564e-15
common O 0 2.06387637646399e-16
ancestral O 0 3.1212712536116127e-12
mutations O 0 2.5738753576393103e-13
in O 0 1.6565259236818821e-15
both O 0 1.0598243203180369e-12
Caucasian O 0 2.279847194586182e-06
and O 0 2.418758082711747e-09
Japanese O 0 2.897590778427883e-10
populations O 0 5.445519231360733e-16
have O 0 9.62710516325146e-17
originated O 0 5.5502065479409545e-18
by O 0 2.0876269592926806e-20
expansion O 0 5.743778805397245e-19
of O 0 3.6042899158312196e-20
an O 0 5.4337279371649124e-18
ancestral O 0 5.87932325046836e-09
n O 0 8.90501095085483e-09
= O 0 8.018649633179109e-11
5 O 0 4.9538586394896195e-14
repeat O 0 1.571170693548396e-10
to O 0 6.077976663632079e-12
n O 0 1.0233665470593678e-08
= O 0 3.040684370958502e-09
19 O 0 3.037851003737102e-12
- O 0 3.0479876955702423e-10
37 O 0 2.26831113571066e-13
copies O 0 1.1264876184635675e-11
. O 0 2.7557907344988308e-11

These O 0 4.805214204004502e-16
data O 0 1.1772045372094545e-16
support O 0 1.773351321657931e-17
multistep O 0 4.0682255199146755e-13
models O 0 2.5357578883888898e-11
of O 0 2.6588806789027428e-15
triplet O 0 6.221026183084177e-07
repeat O 0 5.235222810817675e-10
expansion O 0 1.730416710486713e-16
that O 0 9.147083651108568e-17
have O 0 1.7512534397477605e-18
been O 0 1.7016777139028902e-18
proposed O 0 2.763779093836444e-20
for O 0 8.619707537822117e-18
both O 0 2.8016452005563686e-11
DM B-Disease 1 0.9999996423721313
and O 0 1.311439667972536e-08
Friedreichs B-Disease 0 2.1232551716821035e-08
ataxia I-Disease 0 1.7830798171303286e-08
. O 0 3.6572375444916816e-13
. O 0 2.3842364714476982e-12

The O 0 3.432586195671475e-16
molecular O 0 7.410504908279478e-16
basis O 0 2.632661239888607e-14
of O 0 6.371065480736959e-11
C6 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
in O 0 3.4976734778879165e-15
the O 0 1.709937915511607e-15
western O 0 1.3975100590646328e-11
Cape O 0 1.6006533598567074e-10
, O 0 8.387958567741133e-14
South O 0 9.892148948933976e-13
Africa O 0 3.080390218075657e-13
. O 0 2.151463008399565e-14

Deficiency B-Disease 1 0.9996532201766968
of I-Disease 0 3.1134671257164806e-14
the I-Disease 0 5.350741686749663e-14
sixth I-Disease 0 3.9910647703367275e-11
component I-Disease 0 3.4461444657109264e-13
of I-Disease 0 1.5199554597863966e-17
human I-Disease 0 9.384465216911737e-15
complement I-Disease 0 1.7833091164247243e-14
( O 0 7.38555075517055e-18
C6 O 0 7.457792605691793e-09
) O 0 6.777298313482769e-14
has O 0 5.748837820715447e-13
been O 0 1.8046177616484749e-12
reported O 0 4.383874719401243e-13
in O 0 5.818272106424356e-19
a O 0 2.448014759866237e-18
number O 0 7.346267947880406e-18
of O 0 3.2538750816439246e-17
families O 0 7.942831911937273e-14
from O 0 1.3863341098416218e-17
the O 0 2.6070752968157225e-15
western O 0 7.114842742739214e-11
Cape O 0 4.0324632522015236e-10
, O 0 2.128533216653669e-13
South O 0 2.1227002360707514e-12
Africa O 0 2.987663285172748e-12
. O 0 5.3055585776508665e-14

Meningococcal B-Disease 0 0.0005665016360580921
disease I-Disease 0 2.2409500161302276e-05
is O 0 1.594108178792908e-11
endemic O 0 4.105918804953035e-08
in O 0 1.4950586883950845e-13
the O 0 4.62006344639776e-12
Cape O 0 2.0356556718059693e-10
and O 0 7.449527377346304e-14
almost O 0 3.457171591663327e-17
all O 0 2.5591439936208985e-18
pedigrees O 0 2.3461354387022126e-12
of O 0 4.545480338695798e-15
total O 0 3.344638344060513e-09
C6 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 1.0
( O 0 3.953753286139311e-13
C6Q0 O 0 5.660998567691422e-07
) O 0 3.328365415309481e-13
have O 0 3.2513613790240495e-14
been O 0 1.3647969473312704e-13
ascertained O 0 1.4667137296364707e-11
because O 0 7.015627228462717e-13
of O 0 4.629470770492819e-14
recurrent O 0 0.29294025897979736
disease O 0 0.00039187626680359244
. O 0 7.441721461276529e-09

We O 0 9.001962369969974e-12
have O 0 2.91963971877542e-16
sequenced O 0 6.912837052867318e-15
the O 0 1.906540509437316e-15
expressed O 0 1.8769600278066074e-16
exons O 0 1.846489974810517e-12
of O 0 2.22595414568763e-16
the O 0 6.186352987633302e-15
C6 O 0 4.670484443636269e-09
gene O 0 1.6891859682928792e-14
from O 0 3.773855703945784e-17
selected O 0 2.093993658607576e-18
cases O 0 7.884797433674277e-17
and O 0 3.4057992022310316e-14
have O 0 4.0631594497384654e-14
found O 0 7.128989781314543e-13
three O 0 5.564700176347026e-13
molecular O 0 8.256199612866055e-10
defects O 0 1.6820922610349953e-05
leading O 0 8.756047276126111e-11
to O 0 2.4035162748958783e-10
total O 0 2.1416207696134393e-10
deficiency O 0 8.354706437785353e-07
879delG O 0 9.709032466886924e-10
, O 0 1.9623532399731802e-12
which O 0 6.301314721748885e-13
is O 0 7.106066867476179e-15
the O 0 2.5799097219995036e-14
common O 0 2.130916831877272e-10
defect O 0 2.6697703603417722e-08
in O 0 1.178126056116508e-15
the O 0 7.653250862910133e-13
Cape O 0 1.915424346909944e-10
and O 0 3.532863834376093e-13
hitherto O 0 8.081775130846722e-14
unreported O 0 9.992421928957385e-14
, O 0 1.0086704658096492e-14
and O 0 3.963873500267834e-12
1195delC O 0 3.863189323993765e-09
and O 0 4.5586871083580505e-11
1936delG O 0 1.8727637496329663e-10
, O 0 2.4926377575098775e-15
which O 0 1.6310366905957505e-15
have O 0 3.482217032424657e-15
been O 0 1.518335966937262e-13
previously O 0 2.7583291553612277e-12
reported O 0 6.152218318122848e-11
in O 0 6.240536414719739e-15
African O 0 9.523866070781928e-12
- O 0 2.364383959729821e-07
Americans O 0 1.5525195018462057e-10
. O 0 3.498024081765444e-13

We O 0 1.7447349121013644e-11
also O 0 1.451732309397987e-14
show O 0 2.9318778307918514e-12
that O 0 9.632509498152739e-16
the O 0 2.0759661571294894e-15
879delG O 0 6.363131177522519e-08
and O 0 2.7542168545835466e-09
1195delC O 0 1.0973990356433205e-06
defects O 0 3.4649158351385267e-06
are O 0 1.9540750653774965e-17
associated O 0 2.919784243772045e-16
with O 0 7.162402181765115e-15
characteristic O 0 1.6152619242149058e-09
C6 O 0 0.0015140458708629012
/ O 0 5.720163187561411e-08
C7 O 0 3.213149000202975e-07
region O 0 4.4829247193740873e-13
DNA O 0 8.703829323941648e-11
marker O 0 3.27349241047159e-08
haplotypes O 0 4.767573003050529e-09
, O 0 1.0760927468111275e-13
although O 0 2.090675704821728e-16
small O 0 6.263138297777138e-17
variations O 0 3.815465738493673e-13
were O 0 2.5427659977594885e-11
observed O 0 4.242749554461689e-11
. O 0 1.473291280640332e-11

The O 0 2.7266683702564798e-11
1936delG O 0 6.283411835283914e-08
defect O 0 1.5757128934978937e-08
was O 0 6.3410448766787475e-12
observed O 0 2.4975359372856124e-14
only O 0 1.8935953049044286e-15
once O 0 7.585012479216502e-12
in O 0 1.1354900174417523e-14
the O 0 6.105199245459714e-12
Cape O 0 3.3941591204289523e-10
, O 0 1.9570098241049848e-14
but O 0 2.3315190042830745e-14
its O 0 5.44718418049768e-15
associated O 0 9.313814198781255e-15
haplotype O 0 4.7371662148520954e-11
could O 0 6.062195884171118e-12
be O 0 3.898618641053108e-15
deduced O 0 2.349678784874243e-11
. O 0 1.917675220008963e-11

The O 0 6.945925497096883e-13
data O 0 1.8077113157072278e-12
from O 0 1.880903913794186e-14
the O 0 1.6748574107263597e-15
haplotypes O 0 2.0151645976906885e-11
indicate O 0 1.2776998426292097e-12
that O 0 3.1833578470735063e-14
these O 0 5.496993105928022e-14
three O 0 2.705535665295522e-12
molecular O 0 7.365692056282569e-09
defects O 0 1.8814080249285325e-05
account O 0 6.829127649661537e-13
for O 0 1.6311317531034208e-13
the O 0 1.7105760141689075e-09
defects O 0 0.35667258501052856
in O 0 2.722496368428272e-14
all O 0 5.627884683750755e-15
the O 0 2.7569956815567606e-14
38 O 0 3.258650266941762e-14
unrelated O 0 1.881278065187647e-13
C6Q0 O 0 2.885866212665178e-09
individuals O 0 1.4825851668643698e-15
we O 0 1.1083431535833382e-13
have O 0 1.8375630166523726e-15
studied O 0 7.102218373280329e-15
from O 0 4.782613565026744e-15
the O 0 2.3075426118512876e-12
Cape O 0 2.2915547237545297e-09
. O 0 3.3089850304257595e-12

We O 0 5.477628420291758e-11
have O 0 4.797798324672172e-15
also O 0 1.5429676575148463e-16
observed O 0 2.139692257399693e-15
the O 0 3.3440922167488453e-15
879delG O 0 3.248927127330603e-09
defect O 0 1.0978506992387338e-09
in O 0 1.950657717569244e-16
two O 0 5.86249798706362e-11
Dutch O 1 0.632472574710846
C6 B-Disease 1 0.9999997615814209
- I-Disease 1 0.9999954700469971
deficient I-Disease 1 0.9999992847442627
kindreds O 0 4.858358693127229e-07
, O 0 3.2430604561409573e-15
but O 0 3.853446691613391e-16
the O 0 2.0007744071270147e-16
879delG O 0 2.2291730961132572e-10
defect O 0 3.5229844042028446e-10
in O 0 3.3767143142838054e-16
the O 0 2.1309625071463945e-13
Cape O 0 2.1712717734878595e-10
probably O 0 1.642202866747322e-11
did O 0 1.2863413676247881e-12
not O 0 1.30511825847425e-13
come O 0 6.88845139783234e-14
from O 0 2.2379420441714427e-16
The O 0 4.079925958709596e-14
Netherlands O 0 1.9148007623925878e-09
. O 0 6.279610620558984e-13
. O 0 2.0658960111184788e-13

Complement B-Disease 0 0.0015237745828926563
C7 I-Disease 1 0.9999781847000122
deficiency I-Disease 1 0.9999991655349731
: O 0 6.011645403702914e-09
seven O 0 1.6695779958206258e-12
further O 0 3.8863581948954395e-13
molecular O 0 7.180194216971358e-08
defects O 1 0.9109817743301392
and O 0 1.2389651526945045e-09
their O 0 1.1674146371820626e-10
associated O 0 1.7393047722566446e-12
marker O 0 1.8613208396800474e-07
haplotypes O 0 3.0924068141757743e-06
. O 0 2.1788303106173856e-10

Seven O 0 5.737376990600646e-14
further O 0 7.333672799565306e-17
molecular O 0 5.4030242871991666e-14
bases O 0 7.56453233385912e-10
of O 0 1.943307958995888e-09
C7 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999998807907104
are O 0 6.0740245298729345e-12
described O 0 3.804541681695639e-10
. O 0 4.3189108539509746e-11

All O 0 4.8303608969667636e-14
these O 0 4.470846148130854e-15
new O 0 2.4995327327554696e-14
molecular O 0 1.1307801917048721e-11
defects O 0 2.7059281038077643e-08
involve O 0 8.815812374159861e-17
single O 0 3.553038515935773e-15
- O 0 2.560342075071803e-13
nucleotide O 0 6.496264131825285e-15
events O 0 8.229326576192526e-15
, O 0 3.330249205268344e-18
deletions O 0 3.1349714287747833e-15
and O 0 4.812042623636263e-14
substitutions O 0 3.52234585357554e-14
, O 0 2.8851860713107e-15
some O 0 2.259256569497913e-17
of O 0 8.71503265879334e-17
which O 0 9.977267493091468e-13
alter O 0 3.065153816525501e-12
splice O 0 8.853049404677904e-10
sites O 0 1.2991246967075654e-10
, O 0 1.1611837793384927e-13
and O 0 3.4327748976714645e-13
others O 0 1.128822309606238e-13
codons O 0 1.4927969884531711e-12
. O 0 2.2907559096146946e-12

They O 0 1.518735766488366e-13
are O 0 9.338414166386778e-19
distributed O 0 7.478625944875629e-18
along O 0 1.2845600234553944e-14
the O 0 2.808264214161811e-14
C7 O 0 2.5239577094993138e-09
gene O 0 8.819395951389919e-13
, O 0 1.5672257599758793e-14
but O 0 9.161300834430435e-16
predominantly O 0 1.8599515896821288e-18
towards O 0 9.448903460132344e-16
the O 0 2.3265035527957924e-14
3 O 0 1.263312913481196e-12
end O 0 6.329593099652087e-11
. O 0 7.871650380131268e-13

All O 0 1.3310377106057203e-12
were O 0 2.047147607681099e-12
found O 0 4.395177255998861e-13
in O 0 6.712069068544367e-16
compound O 0 2.1596799869294525e-12
heterozygous O 0 3.05530503241086e-13
individuals O 0 5.119948671435505e-15
. O 0 4.490954483293841e-12

The O 0 3.8931377566164826e-10
C6 O 0 0.06282007694244385
/ O 0 0.00010002613271353766
C7 O 0 1.817808697524015e-05
marker O 0 8.3445797827153e-08
haplotypes O 0 3.8258814782921036e-08
associated O 0 2.361266737693768e-10
with O 0 3.475878872921667e-12
most O 0 1.2688224082513244e-10
C7 B-Disease 1 0.9568846821784973
defects I-Disease 1 0.9989855885505676
are O 0 1.104998644668731e-11
tabulated O 0 6.854461531702327e-08
. O 0 8.869531628249994e-13
. O 0 1.3358198228119456e-11

A O 0 2.8897945234668265e-12
genome O 0 2.1017559220792847e-11
- O 0 3.0082587532120897e-09
wide O 0 1.6349387121916692e-12
search O 0 4.813991544803942e-13
for O 0 2.603714693597491e-16
chromosomal O 0 9.51654088865439e-10
loci O 0 7.53986456603073e-12
linked O 0 7.770930210426741e-08
to O 0 1.053975309805999e-10
mental O 0 7.412213953728042e-09
health O 0 2.1687104965594645e-13
wellness O 0 1.75420129810977e-11
in O 0 3.3597684672619175e-15
relatives O 0 7.783271423200677e-12
at O 0 2.5157783842266745e-12
high O 0 1.1196202819030443e-11
risk O 0 9.919252225154551e-11
for O 0 1.4814023488810002e-13
bipolar B-Disease 1 0.7704499959945679
affective I-Disease 0 0.0016933339647948742
disorder I-Disease 0 0.0036163553595542908
among O 0 4.905700411866887e-13
the O 0 1.0767154312238403e-12
Old O 0 2.239737568743294e-06
Order O 0 1.0296326985459459e-10
Amish O 0 1.8792822231716855e-07
. O 0 4.044120507223914e-12

Bipolar B-Disease 1 0.9951991438865662
affective I-Disease 1 0.7833922505378723
disorder I-Disease 1 0.9972999691963196
( O 0 9.953605513146613e-07
BPAD B-Disease 1 0.999992847442627
; O 0 0.003436945378780365
manic B-Disease 1 0.9999352693557739
- I-Disease 1 0.9999903440475464
depressive I-Disease 1 0.999990701675415
illness I-Disease 1 0.999956488609314
) O 0 2.434241523630032e-11
is O 0 2.6362778164634986e-15
characterized O 0 2.4884587934096564e-14
by O 0 2.8538019653677113e-16
episodes O 0 1.1472479216623199e-10
of O 0 5.405474584108984e-15
mania B-Disease 0 0.00012526821228675544
and O 0 2.004095639440706e-10
/ O 0 2.860951697769565e-09
or O 0 2.5304962986139046e-11
hypomania B-Disease 0 4.820270191885356e-07
interspersed O 0 8.675066887064986e-09
with O 0 1.0374122351095028e-12
periods O 0 3.744663260030201e-11
of O 0 2.631507750421036e-13
depression B-Disease 0 6.902847360379383e-08
. O 0 2.7839798608791932e-12

Compelling O 0 8.964776078597414e-13
evidence O 0 5.152551393091797e-15
supports O 0 1.0393515661701524e-15
a O 0 6.0971280292033594e-18
significant O 0 3.3824718056758073e-19
genetic O 0 1.1896746303743152e-14
component O 0 2.219152291126677e-14
in O 0 1.9607355236697734e-17
the O 0 1.4338053599951623e-16
susceptibility O 0 2.919801553313839e-12
to O 0 2.9169847960697215e-12
develop O 0 4.595138047847058e-09
BPAD B-Disease 1 0.9999916553497314
. O 0 1.0939377181884424e-09

To O 0 1.3567665328902134e-13
date O 0 5.300170567192064e-13
, O 0 1.3389247155925436e-14
however O 0 8.032375322329904e-16
, O 0 4.9165564202232833e-17
linkage O 0 6.837130145896653e-13
studies O 0 3.1029324075448894e-14
have O 0 1.0939406161592055e-15
attempted O 0 9.149685132811558e-13
only O 0 1.0267016717333913e-16
to O 0 1.0708884027414429e-16
identify O 0 1.8578290761264021e-13
chromosomal O 0 4.8714112604875126e-11
loci O 0 9.212340092157323e-13
that O 0 4.385342783352897e-11
cause O 0 1.0308504917733163e-11
or O 0 2.0964460636235804e-12
increase O 0 7.064359600428088e-16
the O 0 7.630076583574341e-13
risk O 0 8.910783777515974e-10
of O 0 6.389918975890918e-14
developing O 0 1.6439070549267853e-08
BPAD B-Disease 1 0.9999817609786987
. O 0 5.012990023089969e-10

To O 0 3.4813590812227124e-12
determine O 0 3.851275513235518e-14
whether O 0 9.41271630680151e-15
there O 0 4.782339973384781e-15
could O 0 7.188788952137981e-15
be O 0 7.438877434900618e-18
protective O 0 8.47330764038555e-15
alleles O 0 5.50760833458125e-16
that O 0 7.096778812396357e-14
prevent O 0 5.668748109810551e-11
or O 0 5.812982734054728e-11
reduce O 0 7.866671723755214e-12
the O 0 2.2136029717133993e-13
risk O 0 1.4268222887914295e-11
of O 0 1.9923660169387397e-16
developing O 0 1.8759258469530637e-12
BPAD B-Disease 1 0.9999992847442627
, O 0 1.6025616663705475e-15
similar O 0 8.546850917034518e-19
to O 0 2.3428292737621056e-17
what O 0 3.6493842123467643e-17
is O 0 4.223451341809868e-19
observed O 0 1.1849313305729858e-16
in O 0 5.659162116481949e-16
other O 0 2.1238535374834555e-09
genetic B-Disease 1 0.9999998807907104
disorders I-Disease 1 1.0
, O 0 1.423524167466772e-12
we O 0 1.0997708820015273e-12
used O 0 7.683066682862005e-11
mental O 0 4.214173188188397e-08
health O 0 8.874815812798253e-12
wellness O 0 5.005273084890405e-09
( O 0 5.3152008619092306e-14
absence O 0 2.6617364996123216e-12
of O 0 1.899369401450919e-14
any O 0 8.369374082661807e-10
psychiatric B-Disease 0 3.130933328066021e-05
disorder I-Disease 0 2.3568107110349956e-07
) O 0 3.012803231517585e-15
as O 0 7.292527512407939e-16
the O 0 7.461255734347166e-15
phenotype O 0 1.0675275767535464e-12
in O 0 1.0094398681872877e-15
our O 0 1.08554723370069e-12
genome O 0 2.406082277861543e-12
- O 0 1.7889587589081657e-09
wide O 0 1.8279747507343735e-11
linkage O 0 1.4048938901112251e-08
scan O 0 1.3051107972117393e-09
of O 0 6.963514107659257e-17
several O 0 1.4903651644849005e-15
large O 0 2.9062178993910243e-15
multigeneration O 0 5.234529609765559e-08
Old O 0 2.075624339070714e-09
Order O 0 2.0579948877864906e-13
Amish O 0 1.4556668370691028e-10
pedigrees O 0 1.1541697285399888e-11
exhibiting O 0 5.561362951238139e-15
an O 0 4.640647349056016e-17
extremely O 0 1.0577932627042763e-11
high O 0 2.035497548291687e-09
incidence O 0 1.4948201169318054e-05
of O 0 1.4552676841361745e-09
BPAD B-Disease 1 0.9999957084655762
. O 0 3.0099648995474126e-08

We O 0 4.639604256340135e-09
have O 0 2.997537764878877e-12
found O 0 2.6878662056500913e-13
strong O 0 6.519195695987623e-17
evidence O 0 7.917978791330107e-18
for O 0 5.2283113839150517e-20
a O 0 1.0039243767552944e-17
locus O 0 1.8091911432524532e-12
on O 0 8.178277610682017e-09
chromosome O 0 5.072862404631451e-05
4p O 0 2.516259655749309e-06
at O 0 1.6152409271219526e-12
D4S2949 O 0 6.494684889717106e-13
( O 0 5.50817253793346e-17
maximum O 0 2.99258487270398e-16
GENEHUNTER O 0 2.0489878238549863e-08
- O 0 5.299847671835778e-09
PLUS O 0 2.336605301606065e-12
nonparametric O 0 1.371483916018379e-11
linkage O 0 1.4602051512380143e-10
score O 0 5.871719083172522e-11
= O 0 1.26485288714194e-13
4 O 0 9.236535359596746e-16
. O 0 5.229099666359299e-16
05 O 0 7.348950007562971e-13
, O 0 3.718458375413791e-14
P O 0 2.6766471261652214e-09
= O 0 5.779379253813277e-13
5 O 0 3.489382666460632e-16
. O 0 4.507610766173479e-16
22 O 0 2.4652898165001148e-15
x O 0 5.2916202669672785e-11
10 O 0 1.031334695785922e-14
( O 0 1.288376072980642e-17
- O 0 1.3329234417602809e-11
4 O 0 1.3966939584053595e-12
) O 0 1.6882647352594454e-14
; O 0 1.34569765456626e-16
SIBPAL O 0 3.073507594264502e-12
Pempirical O 0 7.058925248796741e-14
value O 0 4.357454290850729e-18
< O 0 1.09215131199769e-16
3 O 0 5.698327861171804e-16
x O 0 2.2199189708693723e-10
10 O 0 7.684754525436044e-14
( O 0 4.913200383042033e-17
- O 0 2.578472331482562e-11
5 O 0 5.165427547498824e-13
) O 0 1.2542816449096633e-14
) O 0 1.1037704335120917e-15
and O 0 2.9943789943653832e-15
suggestive O 0 7.194276031570294e-15
evidence O 0 6.717642321998535e-19
for O 0 1.4633977151637917e-21
a O 0 9.38673702379636e-19
locus O 0 4.560050254065473e-12
on O 0 4.954167138748744e-07
chromosome O 0 0.05759800598025322
4q O 0 8.242443982453551e-06
at O 0 4.764011667796053e-12
D4S397 O 0 3.0741335583887863e-13
( O 0 6.085790774445769e-17
maximum O 0 2.2616459965025583e-16
GENEHUNTER O 0 1.2364657742125473e-08
- O 0 7.00283475651986e-09
PLUS O 0 7.156049190715219e-12
nonparametric O 0 9.917299620409992e-12
linkage O 0 2.3625235101576436e-10
score O 0 9.707527837132801e-11
= O 0 2.004455900306984e-13
3 O 0 3.6792292197199226e-16
. O 0 8.838614104053253e-16
29 O 0 3.113058855835904e-13
, O 0 7.218769683306047e-15
P O 0 8.111782356934327e-10
= O 0 2.9388636164397186e-13
2 O 0 6.58782204067637e-16
. O 0 1.0728310728059707e-15
57 O 0 4.19659424398533e-14
x O 0 7.897830167635789e-10
10 O 0 1.2662481198126574e-13
( O 0 1.1973174668909059e-16
- O 0 1.1816736478209577e-10
3 O 0 3.5724244742962874e-12
) O 0 3.550303361845794e-14
; O 0 1.3948168304797409e-16
SIBPAL O 0 5.035946919890177e-12
Pempirical O 0 9.341538095364657e-14
value O 0 4.276776884166594e-18
< O 0 5.0614910366878846e-17
1 O 0 5.12435907934763e-17
x O 0 3.607795451276985e-10
10 O 0 3.559384232666718e-13
( O 0 1.360563612186165e-16
- O 0 5.903704747289851e-10
3 O 0 2.2824431147178137e-12
) O 0 4.447830145371586e-15
) O 0 1.57928614727462e-17
that O 0 2.6098800346623183e-16
are O 0 9.422078522262842e-18
linked O 0 3.753062964573228e-12
to O 0 1.8991756951802774e-12
mental O 0 4.117130636416277e-09
health O 0 3.367631152238759e-13
wellness O 0 6.152921921964705e-11
. O 0 9.71954179466994e-13

These O 0 1.899165893992638e-11
findings O 0 2.50982568061886e-12
are O 0 6.6208796190253376e-15
consistent O 0 2.1805721426649063e-14
with O 0 6.654860886803286e-15
the O 0 3.389206197371234e-16
hypothesis O 0 3.674924862979772e-15
that O 0 1.6525235606572075e-16
certain O 0 3.620680714218929e-17
alleles O 0 2.2895392043842042e-14
could O 0 4.5241862339784333e-11
prevent O 0 2.6663414531835627e-11
or O 0 5.852350722090893e-12
modify O 0 4.923877061288606e-13
the O 0 1.2437518395291662e-14
clinical O 0 2.4600411768424535e-13
manifestations O 0 2.6663427021844655e-10
of O 0 4.078994357992888e-13
BPAD B-Disease 1 0.9999997615814209
and O 0 8.405236229247492e-11
perhaps O 0 2.7751641147588917e-15
other O 0 2.2854890739952604e-15
related O 0 2.393899245500819e-10
affective B-Disease 0 1.1151886610605288e-05
disorders I-Disease 0 0.0007027612300589681
. O 0 8.947041441054182e-10

Segregation O 0 0.00011008106230292469
distortion O 0 0.16762639582157135
in O 0 7.570196913775362e-08
myotonic B-Disease 1 0.9998834133148193
dystrophy I-Disease 1 0.9998859167098999
. O 0 6.826799676673545e-07

Myotonic B-Disease 1 0.9997817873954773
dystrophy I-Disease 1 0.9999682903289795
( O 0 7.782374268572312e-06
DM B-Disease 1 0.9999969005584717
) O 0 1.0747580603265305e-08
is O 0 1.120889405598069e-11
an O 0 2.2016542235159253e-12
autosomal B-Disease 1 0.9316164255142212
dominant I-Disease 1 0.9998716115951538
disease I-Disease 1 0.9970355033874512
which O 0 1.184126685593867e-09
, O 0 4.428785287178931e-14
in O 0 7.206271103364379e-17
the O 0 3.799107939860252e-15
typical O 0 8.964481040081226e-14
pedigree O 0 2.798977494222754e-09
, O 0 1.942601666617247e-15
shows O 0 5.71714875961804e-13
a O 0 1.3218057667999724e-16
three O 0 4.431689509045182e-15
generation O 0 1.6410873311320517e-12
anticipation O 0 1.0966697351394352e-14
cascade O 0 2.8785479555537563e-10
. O 0 8.728064278262782e-12

This O 0 1.594247195195464e-12
results O 0 3.983549167613232e-12
in O 0 4.240144693690162e-11
infertility B-Disease 1 0.9986466765403748
and O 0 0.2995336055755615
congenital B-Disease 1 0.9999933242797852
myotonic I-Disease 1 0.9999988079071045
dystrophy I-Disease 1 0.9999988079071045
( O 0 1.6026872537433512e-11
CDM B-Disease 0 1.465987997661955e-09
) O 0 1.3378627056832761e-14
with O 0 4.909659057403571e-17
the O 0 3.386569807322905e-16
disappearance O 0 2.3979207508517675e-10
of O 0 2.1818671543973045e-13
DM B-Disease 1 0.9999995231628418
in O 0 1.5401818614425335e-14
that O 0 1.9150425602937338e-12
pedigree O 0 1.1135165323139518e-07
. O 0 3.898863003282127e-12

The O 0 8.302511916901192e-15
concept O 0 1.2702248378560627e-13
of O 0 7.333203834480103e-15
segregation O 0 7.086513598153488e-10
distortion O 0 2.2096518392800135e-08
, O 0 1.3318991702181322e-15
where O 0 1.039378843278032e-16
there O 0 1.0803032437435387e-19
is O 0 1.2636523986275062e-20
preferential O 0 2.0495646298544955e-17
transmission O 0 4.963719105882669e-12
of O 0 1.8964685893472303e-19
the O 0 2.448137472110109e-17
larger O 0 4.139727118736971e-18
allele O 0 2.560750853172148e-14
at O 0 1.2120836452578221e-11
the O 0 1.3069329472814584e-11
DM B-Disease 1 0.9999996423721313
locus O 0 6.374961447619398e-09
, O 0 3.2080590354338634e-12
has O 0 1.2808426194665934e-12
been O 0 3.921161572523202e-12
put O 0 9.225748637264886e-11
forward O 0 3.0216167025073903e-13
to O 0 1.5468058284966515e-14
explain O 0 1.223116117936296e-13
partially O 0 7.791938074581603e-14
the O 0 2.506968972642269e-16
maintenance O 0 1.185914430892887e-13
of O 0 2.0094721649458955e-15
DM B-Disease 1 0.9999996423721313
in O 0 2.5622848298396256e-14
the O 0 9.165330170160524e-14
population O 0 7.906857406227846e-14
. O 0 1.6070153888159133e-11

In O 0 6.67790407932016e-14
a O 0 3.1974636561507216e-14
survey O 0 8.288505298770232e-12
of O 0 5.2501619452740775e-14
DM B-Disease 1 0.9999991655349731
in O 0 2.040568235217588e-11
Northern O 0 1.2353236489293096e-10
Ireland O 0 2.6258840435389175e-08
, O 0 2.065581863539001e-12
59 O 0 4.878426222015841e-13
pedigrees O 0 5.5879453841889415e-11
were O 0 1.047197376556619e-12
ascertained O 0 8.22771087372054e-11
. O 0 5.4660199977352164e-12

Sibships O 0 4.774601052304206e-07
where O 0 4.528295446948327e-11
the O 0 8.073204851486403e-15
status O 0 8.510300957323934e-15
of O 0 2.46606103999859e-15
all O 0 7.513011480303478e-14
the O 0 3.788962602734513e-15
members O 0 2.0823263422419647e-16
had O 0 8.972097695868209e-13
been O 0 1.529122427535942e-15
identified O 0 9.695142290646274e-16
were O 0 1.1030206637699838e-16
examined O 0 1.286407465840827e-16
to O 0 2.1444119713039083e-18
determine O 0 7.405895593208536e-17
the O 0 1.2955179669330372e-16
transmission O 0 1.3225303664710086e-11
of O 0 2.7589904573824343e-17
the O 0 6.134474438840298e-12
DM B-Disease 1 0.9999996423721313
expansion O 0 7.82264335773275e-14
from O 0 1.8002086095685738e-14
affected O 0 8.379575821475336e-15
parents O 0 4.941436901318135e-15
to O 0 2.2552718088766736e-15
their O 0 1.5583921956704994e-12
offspring O 0 1.444745798689917e-11
. O 0 1.1034352685040938e-12

Where O 0 6.542297953382459e-11
the O 0 6.477313124883186e-14
transmitting O 0 2.281999940123569e-07
parent O 0 6.234864846632604e-10
was O 0 6.845913169684081e-09
male O 0 3.201114484596701e-09
, O 0 1.1223430496608289e-13
58 O 0 2.3233088630031373e-12
. O 0 1.0710049383813591e-12

3 O 0 3.831910344587186e-10
% O 0 3.9232991313163657e-13
of O 0 3.44090955169278e-17
the O 0 3.3579748749961065e-15
offspring O 0 2.5572976895815724e-12
were O 0 1.466407941255743e-12
affected O 0 7.976436737097638e-16
, O 0 2.621354419421858e-16
and O 0 2.7586803284448957e-13
in O 0 8.644442388807045e-17
the O 0 1.2432950770123593e-16
case O 0 4.904684988769718e-15
of O 0 5.29624596986523e-18
a O 0 3.0883251549628996e-14
female O 0 2.4646473750777886e-10
transmitting O 0 2.0122990918025607e-07
parent O 0 2.20900381320277e-11
, O 0 2.6977879091370956e-14
68 O 0 2.28145176361938e-11
. O 0 1.5488069160518592e-11

7 O 0 7.606291596573556e-09
% O 0 8.339213109116728e-13
were O 0 1.2501580716819949e-12
affected O 0 1.861276567984363e-13
. O 0 5.863900944674816e-13

Studies O 0 4.622247137993363e-13
on O 0 4.012560411974925e-14
meiotic O 0 2.512654251329849e-10
drive O 0 4.157359789758175e-09
in O 0 2.7818022950258647e-13
DM B-Disease 1 0.9999961853027344
have O 0 5.968025010814892e-13
shown O 0 6.664387889877528e-15
increased O 0 1.5066485845927407e-18
transmission O 0 7.712713388959014e-14
of O 0 4.131582336534256e-20
the O 0 5.0915435836767324e-18
larger O 0 1.0093112043789081e-18
allele O 0 9.702695495195177e-15
at O 0 2.29734417253602e-13
the O 0 2.3925228118115704e-12
DM B-Disease 1 0.9999986886978149
locus O 0 1.5264994601693616e-08
in O 0 6.577942184005092e-12
non O 0 2.9259941136672296e-09
- O 0 0.04164452850818634
DM O 1 0.9999954700469971
heterozygotes O 0 1.3639182228075697e-08
for O 0 2.4241278269118184e-14
CTGn O 0 1.3994812775308674e-07
. O 0 1.1172140469695169e-11

This O 0 1.588139342256767e-14
study O 0 3.009377036185501e-17
provides O 0 5.759004615534932e-19
further O 0 5.73874179245468e-19
evidence O 0 2.1999203233559732e-16
that O 0 6.578462411312505e-14
the O 0 4.884229305723853e-12
DM B-Disease 1 0.9999990463256836
expansion O 0 1.1570714004982552e-13
tends O 0 6.021927206022182e-13
to O 0 1.7841945014356435e-17
be O 0 4.557788468573232e-16
transmitted O 0 9.487940433317021e-10
preferentially O 0 3.2418751017004865e-10
. O 0 1.0027447622240615e-11

Diagnosis O 0 3.290899621788412e-05
of O 0 2.0296551106468996e-09
hemochromatosis B-Disease 1 0.9998968839645386
. O 0 5.28352018136502e-07

If O 0 1.5046480257296935e-06
untreated O 0 0.003583282232284546
, O 0 5.260191215938903e-08
hemochromatosis B-Disease 1 0.9999995231628418
can O 0 0.10190679877996445
cause O 0 0.00030724413227289915
serious O 0 0.001299356110394001
illness O 0 0.0156972985714674
and O 0 1.628218393445735e-10
early B-Disease 0 1.1800586896537624e-10
death I-Disease 0 1.8283981262356974e-07
, O 0 5.4081996585068903e-14
but O 0 2.2320040780898776e-12
the O 0 1.1395092768679005e-12
disease O 0 7.577876104392089e-10
is O 0 7.978225014231705e-14
still O 0 4.607163175268658e-12
substantially O 0 1.7659973960623687e-12
under O 0 4.793618627041418e-11
- O 1 0.5963974595069885
diagnosed O 0 0.01600188948214054
. O 0 8.448637345281895e-10

The O 0 2.4082286796786763e-14
cornerstone O 0 7.40702638113433e-13
of O 0 4.547849347574203e-18
screening O 0 3.7046079150064375e-16
and O 0 5.609341756106819e-16
case O 0 1.1534740251428456e-19
detection O 0 4.4491322070650834e-17
is O 0 9.801181394055335e-19
the O 0 9.666986849305092e-19
measurement O 0 1.3763830027969937e-13
of O 0 1.561994929185934e-17
serum O 0 1.5622461007128163e-12
transferrin O 0 9.228431820801353e-13
saturation O 0 1.1795181151241785e-11
and O 0 7.359779018861756e-13
the O 0 6.726452111505219e-15
serum O 0 3.7814928965929084e-10
ferritin O 0 4.371494810584409e-08
level O 0 1.3768306807160346e-11
. O 0 1.668737522296515e-12

Once O 0 2.0780575482604036e-08
the O 0 6.999214575975632e-13
diagnosis O 0 3.3911437546940704e-10
is O 0 2.530743355762949e-14
suspected O 0 1.0423844010176708e-09
, O 0 1.2244226323761178e-14
physicians O 0 1.9377824197242845e-16
must O 0 6.728754955860787e-17
use O 0 4.000841277045276e-16
serum O 0 8.483064251052497e-10
ferritin O 0 1.5661405541322893e-06
levels O 0 3.6989160623335238e-09
and O 0 1.1888837692097809e-09
hepatic O 0 5.74839805267402e-06
iron O 0 0.0008820090442895889
stores O 0 2.113871300224446e-09
on O 0 5.550112591734546e-10
liver O 0 1.4248893731583223e-10
biopsy O 0 1.720628306500771e-09
specimens O 0 6.514411406144394e-13
to O 0 2.1566727692449474e-14
assess O 0 1.6206366083111254e-14
patients O 0 6.793491434088167e-17
for O 0 3.4726854157505476e-19
the O 0 1.9344072581272721e-16
presence O 0 3.037455269944145e-13
of O 0 7.093774217125856e-14
iron B-Disease 0 5.618352224701084e-05
overload I-Disease 0 4.115343585908704e-07
. O 0 1.385454793424723e-12

Liver O 0 0.00012581025657709688
biopsy O 0 2.164444822483347e-06
is O 0 2.4928805547608235e-11
also O 0 7.336593490928425e-14
used O 0 1.1205969759433589e-14
to O 0 7.910801742201678e-16
establish O 0 1.2149815184427266e-15
the O 0 7.015192090697054e-15
presence O 0 1.5924724646593225e-12
or O 0 1.7484769188058635e-10
absence O 0 5.823066855092929e-12
of O 0 4.3482138191702074e-14
cirrhosis B-Disease 0 3.927708576156874e-07
, O 0 3.33977393266946e-13
which O 0 2.3802754905988266e-11
can O 0 7.050011182480054e-12
affect O 0 1.6320599385832857e-12
prognosis O 0 1.2773314628233834e-09
and O 0 3.962839778548499e-11
management O 0 3.1274885459176005e-11
. O 0 1.9116923755807536e-12

A O 0 5.425125409672105e-13
DNA O 0 1.2972051384452232e-11
- O 0 2.6633642513651523e-10
based O 0 2.6789437977529397e-14
test O 0 4.179151057333297e-13
for O 0 2.625743975351511e-19
the O 0 1.5822461717376104e-18
HFE O 0 1.6739576711539625e-14
gene O 0 1.4796345408274992e-17
is O 0 5.68984520774211e-20
commercially O 0 1.1875870104731996e-17
available O 0 2.7807596144084536e-15
, O 0 1.1248412886354607e-14
but O 0 1.731679578377554e-14
its O 0 7.468741070381171e-16
place O 0 1.5234996153089958e-13
in O 0 1.3172402592142717e-16
the O 0 7.096287872100128e-15
diagnosis O 0 1.2203850152658902e-09
of O 0 5.160375707476128e-13
hemochromatosis B-Disease 1 0.9999997615814209
is O 0 2.8369756543966673e-10
still O 0 4.4439361045200965e-12
being O 0 6.15570623445881e-14
evaluated O 0 3.391681737980462e-13
. O 0 1.4376968582655025e-12

Currently O 0 3.5935979886270175e-11
, O 0 7.708797725050447e-15
the O 0 5.094243914786412e-18
most O 0 5.608260642419946e-20
useful O 0 3.736436089966143e-19
role O 0 2.4812236709082706e-16
for O 0 3.026022887960273e-17
this O 0 3.3818190112799927e-16
test O 0 6.195989257957741e-15
is O 0 1.2610093142323292e-19
in O 0 5.481140874898054e-22
the O 0 1.1546714983264868e-19
detection O 0 3.4272007432521734e-13
of O 0 6.2223514643751365e-15
hemochromatosis B-Disease 1 0.9999997615814209
in O 0 5.170392786872993e-14
the O 0 4.313386534884542e-15
family O 0 2.7692268617096616e-11
members O 0 1.8975723363500244e-15
of O 0 5.822718884640834e-17
patients O 0 2.9119759234873407e-16
with O 0 9.625599694536614e-17
a O 0 8.411533209904938e-16
proven O 0 2.788253829211218e-11
case O 0 1.0083819663878144e-14
of O 0 2.5163106872593e-16
the O 0 5.7202523967569974e-11
disease O 0 3.931549130697931e-08
. O 0 3.785661714661437e-11

It O 0 5.657939936877521e-13
is O 0 4.134888317294328e-15
crucial O 0 1.8796435762025165e-12
to O 0 3.119572378196267e-10
diagnose O 1 0.5603461861610413
hemochromatosis B-Disease 1 0.9999973773956299
before O 0 0.000608893926255405
hepatic B-Disease 1 0.9996302127838135
cirrhosis I-Disease 1 0.9997132420539856
develops O 0 4.777178673975868e-06
because O 0 1.3259661424402935e-10
phlebotomy O 0 3.2586336601525545e-05
therapy O 0 1.0451500429553562e-06
can O 0 1.5083935522852698e-07
avert O 0 0.0039636665023863316
serious O 1 0.9787282347679138
chronic O 1 0.9999666213989258
disease O 0 0.10867399722337723
and O 0 2.55643300306474e-07
can O 0 4.408468701200263e-09
even O 0 9.641802911630748e-10
lead O 0 1.956626638488501e-09
to O 0 5.422087258344366e-12
normal O 0 3.9224630488110535e-12
life O 0 4.473433568019658e-10
expectancy O 0 9.41492647732467e-11
. O 0 1.3976864404621845e-14
. O 0 1.065930438533258e-12

Prevalence O 0 1.953195578607847e-06
of O 0 4.363097151553443e-16
the O 0 5.320794688668722e-16
I1307K O 0 1.5898918195433182e-13
APC B-Disease 0 2.2976553385595233e-13
gene O 0 4.7768816083693794e-14
variant O 0 7.057131962140417e-11
in O 0 3.2507786203563385e-14
Israeli O 0 1.6244350309335687e-09
Jews O 0 9.199615028099295e-12
of O 0 1.8200855373420744e-17
differing O 0 1.4202846018685714e-14
ethnic O 0 2.2818249026390625e-12
origin O 0 1.9748097601635095e-10
and O 0 2.007303656625936e-08
risk O 0 2.8690498865557856e-09
for O 0 7.168371365245951e-12
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999988079071045
. O 0 3.926900582484905e-09

BACKGROUND O 0 1.1055832146666944e-05
& O 0 8.056310321080673e-07
AIMS O 0 1.297867258109875e-09
Israeli O 0 7.056173245700847e-08
Jews O 0 3.090785583026445e-08
of O 0 1.7283684249427833e-12
European O 0 7.158568182674685e-10
birth O 0 8.04516098185104e-09
, O 0 1.435422635788497e-12
i O 0 1.428485975341065e-11
. O 0 6.16801385082252e-17
e O 0 3.670133621113628e-15
. O 0 2.9765997728025155e-16
, O 0 2.1319754431430715e-16
Ashkenazim O 0 8.159906669628902e-13
, O 0 2.036830217411466e-16
have O 0 2.237159025739177e-14
the O 0 1.7345978819971464e-11
highest O 1 0.6322442889213562
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.0036440992262214422
of O 0 3.9961451675670206e-15
any O 0 1.0452093156905137e-13
Israeli O 0 1.527990093563858e-06
ethnic O 0 4.57154563093809e-08
group O 0 6.214035153107034e-08
. O 0 2.0296270220043766e-10

The O 0 2.2362173961523735e-13
I1307K O 0 1.0344607982715193e-11
APC B-Disease 0 5.446029478078929e-12
gene O 0 5.777439616126701e-13
variant O 0 7.848395267018304e-10
was O 0 5.577742001605657e-08
found O 0 7.011611291574127e-10
in O 0 1.6901730666082915e-13
6 O 0 3.751103941351808e-11
. O 0 7.0128620792420104e-12

1 O 0 1.7237307067818897e-11
% O 0 3.643283523718614e-14
of O 0 3.5355647390858965e-18
American O 0 1.7846337743102764e-13
Jews O 0 2.695177848260899e-12
, O 0 8.160677096916407e-15
28 O 0 1.690210878159057e-14
% O 0 1.7368901928733285e-17
of O 0 1.8466693355194056e-16
their O 0 6.61143758406979e-07
familial O 1 0.9999581575393677
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
cases O 0 2.056633530145291e-09
, O 0 4.453437130787913e-13
but O 0 1.93119756297655e-11
not O 0 2.5658735552935852e-11
in O 0 1.7814707499973215e-13
non O 0 1.1085155363077526e-11
- O 0 1.7773898264294985e-07
Jews O 0 1.6340698039130075e-07
. O 0 3.5921537966387973e-10

We O 0 1.0234016325355588e-12
assessed O 0 5.460013002703615e-14
the O 0 9.891007012995806e-15
I1307K O 0 2.775404350785493e-10
prevalence O 0 2.98909469620412e-07
in O 0 6.0477970321873385e-15
Israeli O 0 4.1474892964465937e-10
Jews O 0 9.758984419183658e-12
of O 0 6.101152676473736e-18
differing O 0 1.4011477135461971e-15
ethnic O 0 1.3170866307310458e-13
origin O 0 9.715561688494745e-12
and O 0 9.961461655549897e-10
risk O 0 8.441518040136486e-10
for O 0 2.5164308570940763e-12
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999980926513672
. O 0 1.7483476888457972e-09

METHODS O 0 9.497046568216969e-14
DNA O 0 1.4796495192287429e-12
samples O 0 9.179996172947735e-13
from O 0 4.438031774116867e-16
500 O 0 8.024924972727088e-18
unrelated O 0 1.885277864878865e-15
Jews O 0 9.045990519152003e-12
of O 0 3.176988836936512e-14
European O 0 1.149872974615107e-09
or O 0 1.4679074622492294e-09
non O 0 5.991817827490087e-13
- O 0 7.012855296473219e-10
European O 0 8.61921228834106e-11
origin O 0 2.9580194630535184e-12
, O 0 1.24503287098277e-15
with O 0 1.4380505832476824e-16
or O 0 2.033205816369724e-15
without O 0 1.2557973164010573e-17
a O 0 4.289177975909989e-18
personal O 0 6.78146904950494e-12
and O 0 4.137486186994721e-10
/ O 0 1.519964598628576e-09
or O 0 1.5379951479044252e-10
family O 0 2.948598309959749e-10
history O 0 1.72009489984859e-11
of O 0 2.2966660443111953e-16
neoplasia B-Disease 0 2.632604897967461e-11
, O 0 6.078671594872995e-16
were O 0 5.296251379626436e-16
examined O 0 1.550042023750755e-15
for O 0 8.447470853302983e-19
the O 0 1.4998662536449132e-16
I1307K O 0 1.2588496935942058e-14
variant O 0 2.5028519160625803e-15
by O 0 5.2503641638023226e-17
the O 0 1.8974772833714747e-16
allele O 0 6.855097544299082e-13
- O 0 5.076818739707667e-12
specific O 0 2.4314721107842815e-14
oligonucleotide O 0 9.27679195683595e-08
( O 0 4.171631166590209e-14
ASO O 0 3.3602552207412373e-07
) O 0 1.2125315021125732e-16
method O 0 1.3729893314125014e-14
. O 0 1.0605643967209755e-12

RESULTS O 0 7.265971851966313e-11
In O 0 8.04476370857909e-16
persons O 0 9.161440594866732e-16
at O 0 2.1475293331824075e-12
average O 0 7.854107988980452e-12
risk O 0 3.389617475590967e-10
for O 0 1.289905848800288e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, O 0 5.182028417483053e-12
I1307K O 0 5.727342428443749e-13
was O 0 2.1675465242121383e-11
found O 0 4.51591585307054e-12
in O 0 6.314169835857503e-15
5 O 0 1.6918638798962826e-12
. O 0 5.8466495533870955e-12

0 O 0 2.6267077402053474e-10
% O 0 3.8304868174923734e-13
of O 0 1.8365742909749104e-16
120 O 0 1.2981171584706963e-13
European O 0 1.395203570730974e-11
and O 0 1.1350959755462853e-10
1 O 0 3.341456072340071e-13
. O 0 1.2719880487441215e-12

6 O 0 1.993927911669857e-09
% O 0 4.340973923638164e-13
of O 0 2.1251385637697492e-16
188 O 0 1.1972058544182373e-12
non O 0 3.4652476200991433e-12
- O 0 3.2605928481643787e-06
European O 0 2.5041316575880046e-07
Jews O 0 3.117535811725247e-07
( O 0 6.262622798819395e-14
P O 0 4.419480337247705e-09
= O 0 2.9398505114672235e-13
0 O 0 3.3881966399772255e-17
. O 0 1.5513483867834376e-16
08 O 0 3.910803209999361e-15
) O 0 1.3415518518059238e-15
. O 0 7.414697382555208e-14

It O 0 6.28335508623401e-11
occurred O 0 8.355589137254427e-11
in O 0 2.774647001144593e-14
15 O 0 1.0622569447324426e-12
. O 0 2.005179442626792e-12

4 O 0 6.429984322764426e-10
% O 0 5.133369315561687e-13
of O 0 4.1700517254292875e-16
52 O 0 2.74837227628999e-12
Ashkenazi O 0 3.044293066523096e-07
Israelis O 0 1.8051483721137629e-06
with O 0 3.422333250124865e-10
familial O 0 0.00014045255375094712
cancer B-Disease 0 0.006537663284689188
( O 0 2.361986300991603e-11
P O 0 8.850693120621145e-06
= O 0 1.141372885093972e-09
0 O 0 2.849616701459945e-14
. O 0 8.599887566396874e-14
02 O 0 1.70788123227128e-11
) O 0 2.3089535383484516e-14
and O 0 8.413615941102459e-13
was O 0 1.8755118985636088e-11
not O 0 4.753432348257591e-14
detected O 0 1.971316339333118e-11
in O 0 1.5333173370313952e-14
51 O 0 1.0580791885012042e-12
non O 0 6.324614226435599e-13
- O 0 1.8778848698275397e-07
European O 0 2.6898321792145907e-08
Jews O 0 2.4754575278507218e-08
at O 0 6.549454867332827e-10
increased O 0 1.606301930931562e-14
cancer B-Disease 0 3.7299807686963504e-10
risk O 0 1.9407991880271425e-10
. O 0 1.2352469307835845e-12

Colorectal B-Disease 0 0.00010546646808506921
neoplasia I-Disease 0 0.00018394937796983868
occurred O 0 1.3832738510188847e-08
personally O 0 7.294413961744795e-10
or O 0 1.202772777209038e-11
in O 0 2.5512026213346647e-16
the O 0 5.2309578448873385e-15
families O 0 3.009130759238504e-13
of O 0 1.23788066705122e-17
13 O 0 1.4701894749560135e-15
of O 0 1.6746822610219159e-18
20 O 0 7.223941666481982e-17
Ashkenazi O 0 3.5722726859921394e-13
I1307K O 0 1.259820139241875e-14
carriers O 0 8.018564450124922e-17
, O 0 4.465813131297828e-17
8 O 0 2.0568431177958027e-15
of O 0 4.1488057568319855e-16
whom O 0 8.287086988856274e-11
also O 0 4.2958168272599906e-11
had O 0 1.0370676539750434e-09
a O 0 6.380930262254655e-14
personal O 0 1.1814719869107648e-08
or O 0 5.518416390515313e-09
family O 0 9.2572038923322e-09
history O 0 5.634901989459706e-10
of O 0 6.910391312994757e-13
noncolonic O 0 1.02861195045989e-05
neoplasia B-Disease 0 7.345512926804076e-07
. O 0 1.150666575910897e-10

CONCLUSIONS O 0 1.8061002693414707e-10
The O 0 5.249971532267535e-14
I1307K O 0 1.2932771173423951e-11
APC O 0 2.242674934649358e-10
variant O 0 1.4531874592549343e-09
may O 0 2.3505798002476652e-11
represent O 0 4.2803354151617974e-18
a O 0 7.402590179480774e-17
susceptibility O 0 9.070583775186089e-14
gene O 0 8.658093339497519e-12
for O 0 4.342301258147829e-12
colorectal B-Disease 1 0.9999996423721313
, I-Disease 0 6.403046981517946e-10
or I-Disease 0 5.942452085960781e-11
other I-Disease 0 3.8214049979945486e-11
, I-Disease 0 7.03101687982155e-10
cancers I-Disease 0 2.794077317957999e-06
in O 0 9.067267878366814e-13
Ashkenazi O 0 1.5731320672784932e-05
Jews O 0 7.981183784977475e-07
, O 0 5.760808149957164e-11
and O 0 2.2505594610144897e-10
partially O 0 2.828364875639977e-09
explains O 0 4.793015637161169e-11
the O 0 8.471432309440328e-15
higher O 0 1.3518747753182847e-12
incidence O 0 3.622020813054405e-06
of O 0 2.3309107177738042e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.0446155052079575e-09
European O 0 1.654746895063397e-09
Israelis O 0 2.1871981914500793e-07
. O 0 1.0084494350692808e-10

Systematic O 0 5.675625767975756e-12
analysis O 0 6.773450615497889e-13
of O 0 7.451982417640626e-15
coproporphyrinogen O 0 2.471061577580258e-07
oxidase O 0 6.736322433198438e-08
gene O 0 8.75158584676683e-05
defects O 1 0.9998028874397278
in O 0 3.3482587362410055e-12
hereditary B-Disease 0 0.0009611551649868488
coproporphyria I-Disease 0 6.587387179024518e-05
and O 0 7.138998420197495e-11
mutation O 0 6.5013311574546595e-12
update O 0 1.0874788181070016e-08
. O 0 1.0672152050972272e-10

Hereditary B-Disease 1 0.996051013469696
coproporphyria I-Disease 0 0.149919793009758
( O 0 6.227520166213196e-10
HC B-Disease 0 0.0002456700603943318
) O 0 2.5837412764850853e-10
is O 0 1.1580020796431167e-11
an O 0 4.1772926784311437e-10
acute O 0 0.0293410737067461
hepatic B-Disease 1 0.9993151426315308
porphyria I-Disease 1 0.9999614953994751
with O 0 6.928125912963878e-06
autosomal O 1 0.9994369149208069
dominant O 0 0.07851754128932953
inheritance O 0 0.032026257365942
caused O 0 0.0004862547211814672
by O 0 1.9665536560298236e-12
deficient B-Disease 0 2.877238713949737e-08
activity I-Disease 0 6.509293971890262e-13
of I-Disease 0 1.3270152841233823e-15
coproporphyrinogen I-Disease 0 4.721360724602164e-08
III I-Disease 0 3.084954869336798e-08
oxidase I-Disease 0 1.0380036830071049e-09
( O 0 1.4046322800362592e-14
CPO O 0 2.6550083020993043e-08
) O 0 3.131495036152662e-14
. O 0 5.733133016721723e-14

Clinical O 0 1.4589139896159509e-09
manifestations O 0 9.831904890234e-08
of O 0 4.562405683285198e-13
the O 0 6.643134931039185e-10
disease O 0 2.9087237507496866e-08
are O 0 9.114698775738398e-15
characterized O 0 9.365810210715253e-12
by O 0 2.8594321355157604e-11
acute O 0 1.568088737258222e-05
attacks O 0 0.07989107072353363
of O 0 6.767007842967132e-09
neurological B-Disease 1 0.6347731351852417
dysfunction I-Disease 0 4.6019208639336284e-06
often O 0 1.080297865052593e-10
precipitated O 0 3.0631275294012994e-11
by O 0 7.838407953782221e-16
drugs O 0 5.222400203258593e-13
, O 0 2.879710215064938e-15
fasting O 0 2.6209463419024637e-11
, O 0 2.060142184070416e-14
cyclical O 0 1.6362904087241503e-11
hormonal O 0 2.295898804405283e-09
changes O 0 2.9114137858367306e-13
, O 0 3.024793956973859e-13
or O 0 2.9545617064030694e-09
infectious B-Disease 0 1.273835550819058e-06
diseases I-Disease 0 2.910875309680705e-07
. O 0 3.718054752965827e-10

Skin O 1 0.9998669624328613
photosensitivity O 1 0.5197890400886536
may O 0 4.237547557295329e-08
also O 0 3.1979041810459297e-13
be O 0 6.860352265653305e-14
present O 0 1.8251893052489976e-13
. O 0 1.2971432955533047e-11

The O 0 1.3449197268020074e-13
seven O 0 2.146723266136614e-15
exons O 0 1.5337341856616615e-12
, O 0 8.091637982484551e-16
the O 0 1.2805224397419818e-16
exon O 0 6.145951369357361e-12
/ O 0 1.0582867915331917e-09
intron O 0 2.6049820078810626e-08
boundaries O 0 2.2005828270721395e-09
and O 0 2.0755498014723983e-12
part O 0 4.7121627378393904e-17
of O 0 1.9177487670327402e-18
3 O 0 8.160916939589378e-17
noncoding O 0 2.5693629081974256e-13
sequence O 0 2.484571250994938e-13
of O 0 6.527830799838187e-17
the O 0 1.3010754295093114e-15
CPO O 0 1.0110128706442012e-10
gene O 0 7.867615767385918e-16
were O 0 1.5092797278344443e-15
systematically O 0 1.3817699968162594e-13
analyzed O 0 1.6326980927822306e-16
by O 0 1.033218249195945e-19
an O 0 2.5355779281619924e-19
exon O 0 4.703740110086063e-13
- O 0 2.1760188095854005e-10
by O 0 1.49035590726182e-12
- O 0 4.166570022334781e-08
exon O 0 2.2006844346833532e-08
denaturing O 0 1.5982066543074325e-05
gradient O 0 2.5706583528517513e-08
gel O 0 5.568217602558434e-07
electrophoresis O 0 1.6388298718084116e-07
( O 0 1.0269871975401856e-13
DGGE O 0 6.779535821621607e-10
) O 0 1.8167013098455484e-16
strategy O 0 5.9741890220379925e-16
followed O 0 2.3421836179349774e-19
by O 0 2.1479598554284378e-23
direct O 0 5.114249619597686e-22
sequencing O 0 2.6810740009119895e-15
in O 0 5.956576030691023e-16
seven O 0 1.7259543556321201e-15
unrelated O 0 1.3829352431011382e-13
heterozygous O 0 1.2755570254555093e-12
HC B-Disease 0 3.4654934211175714e-07
patients O 0 1.588809084296372e-10
from O 0 1.7868220791861233e-11
France O 0 8.431995546231974e-09
, O 0 1.7898920193215595e-11
Holland O 0 8.949421470560992e-08
, O 0 4.207677262169085e-11
and O 0 2.043468061430076e-09
Czech O 0 2.737940121733118e-06
Republic O 0 2.466115756050158e-09
. O 0 7.349405806156284e-11

Seven O 0 4.83368588211075e-11
novel O 0 5.793959604628862e-13
mutations O 0 1.917447537552741e-12
and O 0 2.381709413024069e-12
two O 0 7.377311381142476e-15
new O 0 1.0486627876010821e-15
polymorphisms O 0 3.978129631265759e-11
were O 0 8.74049183724468e-12
detected O 0 1.0623678603494113e-09
. O 0 3.1108169425836385e-12

Among O 0 2.1731587883377923e-12
these O 0 4.901000395449162e-15
mutations O 0 7.017912591117045e-14
two O 0 5.154227739057049e-13
are O 0 6.648749205275667e-14
missense O 0 6.8434485508972465e-12
( O 0 2.560142524697342e-16
G197W O 0 4.783512453331029e-13
, O 0 2.635091335062632e-15
W427R O 0 5.563063369879752e-14
) O 0 4.628170659622078e-15
, O 0 8.014990500483101e-16
two O 0 1.748873500173869e-14
are O 0 1.1128147421558474e-13
nonsense O 0 3.9221378922427164e-10
( O 0 1.9386021557113245e-17
Q306X O 0 3.1001046727537757e-14
, O 0 4.923258833116229e-16
Q385X O 0 4.165222854124462e-14
) O 0 4.9388341808294595e-16
, O 0 2.2392305268680043e-17
two O 0 6.895289574224863e-17
are O 0 1.7069642872362625e-17
small O 0 2.214088372149455e-17
deletions O 0 5.5336308452114125e-11
( O 0 5.8590874089015e-15
662de14bp O 0 8.569550776459101e-13
; O 0 5.529080090398554e-16
1168del3bp O 0 7.459754385388817e-13
removing O 0 4.672056283652271e-15
a O 0 3.578646786929496e-18
glycine O 0 5.012587838294086e-14
at O 0 1.1070057224409416e-13
position O 0 9.476847712336974e-15
390 O 0 3.131290223586016e-15
) O 0 2.031949666508946e-15
, O 0 1.5723328604280544e-15
and O 0 7.713683749903388e-14
one O 0 3.1794605637798946e-15
is O 0 9.94111284994394e-18
a O 0 1.629187430729076e-18
splicing O 0 3.3612623101531014e-11
mutation O 0 7.520187597642725e-12
( O 0 2.5663332238110275e-15
IVS1 O 0 1.3629768425005295e-08
- O 0 1.6846342099086087e-09
15c O 0 4.512269724532558e-10
- O 0 8.341330293148985e-09
- O 0 1.836238823216263e-07
> O 0 7.437882948435615e-11
g O 0 1.1044771763835115e-09
) O 0 2.13367684116653e-15
which O 0 4.0676431260005275e-17
creates O 0 6.290812473030227e-19
a O 0 2.0057221846005794e-20
new O 0 2.1872156728713835e-18
acceptor O 0 1.2835938606180647e-16
splice O 0 2.6058804003525893e-09
site O 0 1.032485297258745e-08
. O 0 4.979291978735034e-11

The O 0 1.0847069770170137e-12
pathological O 0 3.049624355128122e-12
significance O 0 1.2587207751796337e-13
of O 0 5.55110135884039e-16
the O 0 2.1129509613867538e-14
point O 0 3.0399027479283136e-12
mutations O 0 9.619730947352224e-16
G197W O 0 3.3829323619737756e-14
, O 0 4.963782146627406e-17
W427R O 0 4.645026615272439e-15
, O 0 4.335489171428873e-16
and O 0 3.085063400489613e-14
the O 0 6.533741951609499e-15
in O 0 1.32627781912302e-13
- O 0 2.3574440177753786e-08
frame O 0 1.9250737750553526e-06
deletion O 0 1.0232366343121413e-10
390delGly O 0 1.5408424536289544e-11
were O 0 1.419309052847395e-15
assessed O 0 4.971213074029439e-16
by O 0 1.56813909442708e-16
their O 0 1.2635135125671493e-11
respective O 0 1.851144888417866e-12
expression O 0 2.6178012665564743e-13
in O 0 1.222745660665276e-16
a O 0 8.84130177929956e-18
prokaryotic O 0 3.1073337495575004e-17
system O 0 1.0237762316918117e-16
using O 0 1.295047863647311e-17
site O 0 3.0451661157948617e-12
- O 0 1.9986599875121414e-10
directed O 0 8.61768365001403e-11
mutagenesis O 0 2.940585552835273e-09
. O 0 8.489622308101297e-13

These O 0 4.77674703177472e-13
mutations O 0 3.184709440606781e-12
resulted O 0 4.641395948135063e-11
in O 0 6.794032974015082e-14
the O 0 1.2182128136112302e-13
absence O 0 6.298106567520501e-13
or O 0 3.4952761713592795e-13
a O 0 3.737028048123037e-15
dramatic O 0 3.2263332630511066e-12
decrease O 0 3.8805804815182643e-13
of O 0 1.2361540598714135e-16
CPO O 0 1.7992707057601365e-07
activity O 0 5.231764240581915e-12
. O 0 5.824374186072512e-13

The O 0 1.257932780428803e-14
two O 0 4.2635546336855057e-16
polymorphisms O 0 1.6833178731121001e-12
were O 0 3.811530626708637e-13
localized O 0 3.2702955469511574e-13
in O 0 1.759614047351643e-14
noncoding O 0 1.4916230750561255e-10
part O 0 5.332850318024579e-14
of O 0 1.1583652836916e-17
the O 0 4.489690692295906e-18
gene O 0 2.9875530337761466e-17
1 O 0 1.9389932467049396e-18
) O 0 1.2287716300686942e-18
a O 0 3.614856700962066e-17
C O 0 4.9149774528078893e-11
/ O 0 7.562476686540087e-12
G O 0 1.0932504901361995e-11
polymorphism O 0 8.888223680279458e-14
in O 0 1.3127006920125807e-16
the O 0 8.418242769638376e-16
promotor O 0 7.2786254801116e-10
region O 0 3.636287505912744e-13
, O 0 1.022609642330316e-15
142 O 0 2.0623359994038047e-14
bp O 0 1.2764770794190805e-12
upstream O 0 6.439909335778562e-15
from O 0 1.0293246118249602e-17
the O 0 4.002756064712511e-20
transcriptional O 0 1.0547041177484754e-16
initiation O 0 1.9592700904965745e-17
site O 0 4.217105451734954e-13
( O 0 2.531241495839229e-17
- O 0 1.515472426369402e-12
142C O 0 1.35749723094436e-12
/ O 0 2.6727966628142807e-12
G O 0 1.9610547994514116e-12
) O 0 7.72085172519137e-18
, O 0 2.6585115462456686e-18
and O 0 1.3812408775687246e-16
2 O 0 1.6236910223538142e-17
) O 0 3.7792977458752855e-19
a O 0 1.2771160975717793e-18
6 O 0 6.025269608619959e-17
bp O 0 8.879136372008135e-15
deletion O 0 2.8028137583165547e-16
polymorphism O 0 1.0623003568650553e-14
in O 0 3.382902948754682e-16
the O 0 1.627283064089993e-15
3 O 0 1.8739141979134434e-14
noncoding O 0 4.9062459824000815e-12
part O 0 2.38858420686266e-15
of O 0 3.568792336137968e-17
the O 0 1.1844754150891262e-15
CPO O 0 5.614108483653624e-11
gene O 0 5.070015232161917e-16
, O 0 7.627180303700762e-17
574 O 0 3.043641795302983e-14
bp O 0 1.625932055009452e-13
downstream O 0 2.2698680500303492e-14
of O 0 6.7918038202024364e-18
the O 0 3.2077241474056392e-15
last O 0 2.962388093077223e-13
base O 0 1.4059128032700946e-15
of O 0 7.6235648419999e-19
the O 0 3.6858598995101477e-16
normal O 0 1.3434114491141496e-14
termination O 0 2.1593574909932467e-13
codon O 0 6.815669583619746e-14
( O 0 8.451513165015341e-16
+ O 0 5.266344652032906e-12
574 O 0 6.428950427572744e-11
delATTCTT O 0 4.441925938181157e-09
) O 0 1.868391292375593e-12
. O 0 7.116681376151401e-13

Five O 0 2.139951993385125e-09
intragenic O 0 2.2941016197819408e-07
dimorphisms O 0 6.741579454683233e-07
are O 0 2.763885257814347e-12
now O 0 1.687451041528995e-13
well O 0 1.5197085668876287e-14
characterized O 0 7.867462649240042e-13
and O 0 5.786019450018665e-13
the O 0 6.101557789833095e-15
high O 0 4.555770365989587e-13
degree O 0 3.520950194741371e-17
of O 0 5.020047985189513e-19
allelic O 0 1.1775050877925464e-13
heterogeneity O 0 1.7523546632855491e-12
in O 0 3.1004360320427415e-14
HC B-Disease 0 4.0117694055652464e-08
is O 0 4.4280419310644206e-14
demonstrated O 0 2.437396936843736e-14
with O 0 2.0569910573939965e-16
seven O 0 3.818503141467803e-16
new O 0 4.8533829824813835e-18
different O 0 3.256218970287897e-19
mutations O 0 4.955193364891145e-17
making O 0 5.904629617618285e-17
a O 0 1.0050783102534181e-16
total O 0 9.464121465820952e-17
of O 0 2.538922602363168e-15
nineteen O 0 1.6325480967083195e-09
CPO O 0 0.005234442185610533
gene B-Disease 0 5.550532478082459e-06
defects I-Disease 1 0.9518401026725769
reported O 0 5.5275810595389885e-09
so O 0 2.0305426177286146e-12
far O 0 2.76426342753211e-13
. O 0 1.143022037696645e-13
. O 0 2.4866405809453873e-11

Coincidence O 0 3.254307240352361e-11
of O 0 1.5665553545739512e-15
two O 0 5.1371277701552434e-14
novel O 0 7.369190435820017e-13
arylsulfatase O 0 7.306500404702376e-10
A O 0 1.2840651868076085e-14
alleles O 0 4.6426350177458664e-15
and O 0 1.328794523415902e-13
mutation O 0 7.542355750914977e-15
459 O 0 7.304859299915589e-13
+ O 0 2.5733844851057175e-13
1G O 0 3.725396879872278e-09
> O 0 1.5138005432513424e-11
A O 0 1.45515937082126e-13
within O 0 2.2188497891914328e-16
a O 0 1.5109575645776835e-13
family O 0 1.472798345503179e-07
with O 0 1.3574399417848326e-06
metachromatic B-Disease 1 0.9999990463256836
leukodystrophy I-Disease 1 0.999996542930603
: O 0 7.821897291112809e-14
molecular O 0 4.597848362418032e-16
basis O 0 9.603776684743995e-17
of O 0 2.250973116669358e-16
phenotypic O 0 4.1424863214158114e-13
heterogeneity O 0 3.104954870991605e-08
. O 0 3.804001380558475e-08

In O 0 2.0688455831287256e-13
a O 0 2.916776249781844e-14
family O 0 9.245402186885965e-12
with O 0 6.748842072213171e-14
three O 0 8.528715792410421e-14
siblings O 0 2.516451630407701e-11
, O 0 3.5888607304152394e-17
one O 0 7.497339417309538e-17
developed O 0 3.598565266301271e-14
classical O 0 4.108391848944848e-09
late O 0 0.000956606469117105
infantile O 1 0.9999489784240723
metachromatic B-Disease 1 0.9999973773956299
leukodystrophy I-Disease 1 0.9999847412109375
( O 0 8.166443077328722e-10
MLD B-Disease 1 0.9999867677688599
) O 0 4.6598110786666425e-11
, O 0 1.622289000184629e-13
fatal O 0 7.16795822697236e-09
at O 0 3.943050330690312e-10
age O 0 9.822551626237352e-12
5 O 0 1.2292382687911427e-14
years O 0 8.755332342371552e-14
, O 0 6.884780145280703e-16
with O 0 1.0985187911226324e-13
deficient O 0 8.105757842713501e-08
arylsulfatase O 0 1.940538396638658e-08
A O 0 4.844512638269016e-11
( O 0 3.9388887578875045e-16
ARSA O 0 1.8482703012523416e-07
) O 0 3.660150914313763e-15
activity O 0 4.455386949810515e-15
and O 0 3.833276740732722e-14
increased O 0 1.1999794002765505e-15
galactosylsulfatide O 0 2.101134413123873e-07
( O 0 4.685733138304338e-13
GS O 1 0.9999963045120239
) O 0 2.7143988012151565e-13
excretion O 0 2.995080529075156e-12
. O 0 2.535887081919763e-12

The O 0 6.995771691976904e-13
two O 0 7.264523726492611e-13
other O 0 5.746557201445623e-13
siblings O 0 1.4223981104066752e-08
, O 0 1.1160462744935762e-12
apparently O 0 1.322778886425624e-09
healthy O 0 3.0633796958530815e-14
at O 0 7.571908052818321e-14
12 O 0 1.8516706680262482e-16
( O 0 7.009958256951972e-20
1 O 0 6.369584779366076e-18
/ O 0 1.5310005325140652e-13
2 O 0 1.306292411310569e-15
) O 0 3.702557367355143e-17
and O 0 3.5033085763277625e-15
15 O 0 5.7438470477977806e-18
years O 0 1.4964429170490258e-16
, O 0 3.9412573833676955e-19
respectively O 0 3.3868264980105927e-17
, O 0 5.050403243059428e-16
and O 0 2.777404521647764e-11
their O 0 1.8091075304482729e-09
father O 0 8.751583209232194e-07
, O 0 3.6727424487098537e-13
apparently O 0 1.5305730641235193e-11
healthy O 0 1.2685420189709068e-17
as O 0 6.835521969937089e-18
well O 0 6.058946844509402e-16
, O 0 1.967570715594646e-15
presented O 0 2.6613303574785085e-12
ARSA O 0 0.0006247280398383737
and O 0 3.104528900621517e-07
GS O 1 0.999998927116394
values O 0 6.780873605671811e-12
within O 0 1.618187065955463e-18
the O 0 8.974376544839172e-16
range O 0 4.203297432336939e-11
of O 0 5.723599979384764e-12
MLD B-Disease 1 0.9999912977218628
patients O 0 2.748398513982564e-12
. O 0 2.7075629065176354e-13

Mutation O 0 2.5663080601562305e-12
screening O 0 6.76008251113136e-12
and O 0 5.418537797272083e-13
sequence O 0 1.6313798659943306e-14
analysis O 0 1.7177890374299275e-16
disclosed O 0 8.127218448466915e-15
the O 0 1.777102916608104e-17
involvement O 0 7.569048469588391e-14
of O 0 9.143768972957945e-17
three O 0 1.2968667345526416e-14
different O 0 3.5403882906267668e-15
ARSA O 0 5.518945656035612e-08
mutations O 0 1.6152486317336408e-14
being O 0 2.9870430537674506e-15
the O 0 4.1315864207385304e-18
molecular O 0 1.8632920659416956e-15
basis O 0 9.112157041621925e-16
of O 0 4.933337995792963e-15
intrafamilial O 0 2.5066069042622985e-07
phenotypic O 0 1.8651618877846277e-12
heterogeneity O 0 6.746930836243337e-08
. O 0 3.6529872460278057e-08

The O 0 1.6060847096710518e-10
late O 0 2.5206115878972923e-06
infantile O 1 0.996731162071228
patient O 0 3.474362165434286e-05
inherited O 0 0.003685003612190485
from O 0 3.293775252544151e-10
his O 0 2.0627834373954101e-07
mother O 0 9.229351860540191e-08
the O 0 1.879748222040952e-15
frequent O 0 2.231212610503963e-12
0 O 0 5.7632803592705135e-15
- O 0 4.322817104274179e-11
type O 0 4.441722055263664e-13
mutation O 0 2.2878278590175716e-14
459 O 0 5.6150207096775095e-14
+ O 0 3.08789926679702e-15
1G O 0 6.308161024787262e-12
> O 0 1.0941588753738893e-13
A O 0 1.2867119479273437e-12
, O 0 1.1224464283379754e-12
and O 0 4.4767112239441076e-10
from O 0 8.143673994702449e-13
his O 0 7.534469936842925e-09
father O 0 1.5535924768883547e-09
a O 0 9.897380935923895e-16
novel O 0 1.975913397202038e-14
, O 0 8.171829132699957e-15
single O 0 1.8199062049029102e-12
basepair O 0 2.7482403019973844e-09
microdeletion O 0 3.0548406686203844e-12
of O 0 5.647160749429813e-20
guanine O 0 3.759300633887301e-17
at O 0 1.3499901925498182e-17
nucleotide O 0 3.48287804899576e-17
7 O 0 9.521594768874524e-16
in O 0 5.107592541921486e-18
exon O 0 1.635355940292696e-13
1 O 0 1.0654304044913077e-12
( O 0 1.908819239823667e-14
7delG O 0 3.861599751076028e-08
) O 0 6.815208120070082e-12
. O 0 8.970013967712909e-12

The O 0 1.5256705621080613e-11
two O 0 2.475930571677054e-11
clinically O 0 2.7235850907914028e-08
unaffected O 0 5.7440519896090336e-08
siblings O 0 3.164212669659605e-09
carried O 0 5.319364740352661e-12
the O 0 2.1407119262495096e-16
maternal O 0 4.087703699834355e-12
mutation O 0 2.16612879095821e-15
459 O 0 7.968522760040675e-14
+ O 0 1.0053553482606854e-14
1G O 0 1.7860393719537626e-10
> O 0 1.024243190261842e-12
A O 0 2.3753217275046534e-12
and O 0 2.0135662234799234e-11
, O 0 1.0540696530132905e-14
on O 0 6.516204242856816e-12
their O 0 4.1583823515677076e-13
paternal O 0 2.7242444411434974e-12
allele O 0 2.489683603051386e-14
, O 0 2.6589186431841365e-17
a O 0 4.166340465873734e-19
novel O 0 2.4765984408823436e-17
cytosine O 0 1.3315498877120024e-13
to O 0 2.9530625800828906e-17
thymidine O 0 2.0960360522432643e-14
transition O 0 6.472764473253135e-15
at O 0 1.14999161854544e-16
nucleotide O 0 1.2612421169779018e-16
2435 O 0 8.569759620902576e-14
in O 0 3.6004736017529326e-18
exon O 0 2.632550786792285e-14
8 O 0 6.113002899016395e-13
, O 0 1.2281877150024868e-15
resulting O 0 5.712145350821686e-17
in O 0 7.315722339207931e-20
substitution O 0 8.193291796147968e-18
of O 0 1.051405453814512e-17
alanine O 0 1.4811299756112284e-11
464 O 0 3.1478825622544004e-12
by O 0 4.970414813239288e-13
valine O 0 1.9805912643278134e-07
( O 0 4.810170680822831e-14
A464V O 0 1.1797368637544992e-10
) O 0 9.694159537609881e-13
. O 0 1.931027169763122e-12

The O 0 2.4105977630695108e-12
fathers O 0 2.175840202456314e-10
genotype O 0 5.710877257203428e-11
thus O 0 2.53206770871664e-13
was O 0 4.90788854001778e-10
7delG O 0 3.343814398704126e-07
/ O 0 3.16993506999097e-08
A464V O 0 1.1826640777812258e-09
. O 0 7.330447013287333e-12

Mutation O 0 1.1092034235549164e-10
A464V O 0 4.868757064180329e-10
was O 0 9.484064228404421e-11
not O 0 1.2262275071207862e-13
found O 0 6.635272843322215e-13
in O 0 4.168367294534554e-15
18 O 0 4.934661078197233e-13
unrelated O 0 9.871732320476667e-10
MLD B-Disease 1 0.999996542930603
patients O 0 1.3478948859835249e-11
and O 0 2.4268494115339823e-13
50 O 0 2.2568393280488624e-14
controls O 0 2.5036999140581884e-09
. O 0 3.966736106253421e-10

A464V O 0 2.285923228484421e-09
, O 0 1.8933083724935462e-13
although O 0 2.5038831786758625e-15
clearly O 0 1.150458580397723e-13
modifying O 0 1.8000731114020674e-12
ARSA O 0 0.00012920988956466317
and O 0 4.2332945326961635e-07
GS O 1 0.9999984502792358
levels O 0 4.121562202641371e-09
, O 0 2.9845291277426356e-13
apparently O 0 7.819154212995727e-10
bears O 0 4.1941794546966615e-13
little O 0 4.93007586015485e-18
significance O 0 7.903554415808407e-18
for O 0 5.481629759642705e-19
clinical O 0 9.290814289647986e-16
manifestation O 0 7.486837213556419e-13
of O 0 3.8369142390214106e-13
MLD B-Disease 1 0.9999971389770508
, O 0 1.7554657814194963e-12
mimicking O 0 2.0102479403316664e-10
the O 0 5.480695107820677e-13
frequent O 0 1.2750699340813298e-07
ARSA O 1 0.9586985111236572
pseudodeficiency O 0 9.878843411570415e-05
allele O 0 1.1925724265893223e-06
. O 0 7.660068135351139e-10

Our O 0 8.631291792404738e-10
results O 0 1.5171656045733818e-14
demonstrate O 0 1.0065098753436167e-15
that O 0 5.025513312253258e-17
in O 0 3.774140016262076e-19
certain O 0 2.0055797970903558e-17
genetic O 0 1.2630563261950556e-10
conditions O 0 4.010359599959656e-09
MLD B-Disease 1 0.9999881982803345
- O 0 4.0369235421167105e-07
like O 0 1.605882510302692e-10
ARSA O 0 0.049323514103889465
and O 0 1.0115511486219475e-06
GS O 1 0.9999988079071045
values O 0 1.1834527281762153e-11
need O 0 1.1862196809206494e-17
not O 0 1.0231266457227981e-19
be O 0 1.0664798278615558e-19
paralleled O 0 1.5603170627965417e-15
by O 0 2.5518269375563504e-15
clinical O 0 1.5567819386039239e-12
disease O 0 2.6570118327740033e-10
, O 0 7.490282177021032e-16
a O 0 6.829325957015148e-16
finding O 0 4.458162354906148e-13
with O 0 7.281006526860256e-12
serious O 0 8.851086530370367e-11
diagnostic O 0 7.480845803931047e-12
and O 0 2.0570826292365396e-11
prognostic O 0 2.5404524706118536e-08
implications O 0 1.2462358922604722e-10
. O 0 2.0393620819847413e-11

Moreover O 0 5.07035025076874e-10
, O 0 4.4298012523771857e-13
further O 0 1.4635990715824304e-13
ARSA O 0 3.556235469659441e-06
alleles O 0 1.8095707224330404e-12
functionally O 0 1.1912028308191935e-10
similar O 0 1.231848959859852e-13
to O 0 4.371833841124162e-13
A464V O 0 3.515176344448534e-11
might O 0 6.644622786017296e-12
exist O 0 5.024847623766055e-15
which O 0 7.55941126752771e-14
, O 0 1.335618280131289e-15
together O 0 1.6760614163918719e-12
with O 0 1.295735030772474e-13
0 O 0 1.1035736804639387e-13
- O 0 8.007287277678188e-09
type O 0 1.956468875796702e-10
mutations O 0 1.6673498137720344e-09
, O 0 7.087181536080678e-12
may O 0 2.6175690087670844e-11
cause O 0 8.966456917225418e-12
pathological O 0 4.026330380213494e-10
ARSA O 1 0.9485334753990173
and O 0 0.011020267382264137
GS O 1 0.9999997615814209
levels O 0 2.852560410104843e-09
, O 0 7.821774132522278e-15
but O 0 4.853189112521625e-14
not O 0 1.9977944605152793e-14
clinical O 0 2.120353859939167e-15
outbreak O 0 9.039772104696767e-14
of O 0 1.2682039337109441e-16
the O 0 2.264366992521527e-11
disease O 0 3.0194973188457652e-09
. O 0 4.682391627208737e-13
. O 0 1.438141879889221e-11

Human O 0 8.71444080985384e-06
MLH1 O 1 0.9868139028549194
deficiency O 1 0.9979159235954285
predisposes O 0 0.0001600405084900558
to O 0 6.821229447950827e-08
hematological B-Disease 0 0.48555314540863037
malignancy I-Disease 1 0.9928240776062012
and O 0 1.6805629456939641e-06
neurofibromatosis B-Disease 0 0.0042308601550757885
type I-Disease 0 1.0798189009619819e-08
1 I-Disease 0 2.5507043699413146e-10
. O 0 8.358812531028548e-10

Heterozygous O 0 3.9137869833894e-08
germ O 0 0.00012209074338898063
- O 0 3.878411007463001e-05
line O 0 4.944226716929734e-08
mutations O 0 1.884698126730644e-12
in O 0 4.573373742453813e-17
the O 0 4.633253346996527e-17
DNA O 0 9.672490586254412e-10
mismatch O 0 1.790799686318678e-08
repair O 0 2.787065689346946e-09
genes O 0 4.198588143822235e-10
lead O 0 5.517240708741156e-08
to O 0 4.740940084957401e-09
hereditary B-Disease 1 0.9999594688415527
nonpolyposis I-Disease 1 0.9999710321426392
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999978542327881
. O 0 2.6928973966278136e-06

The O 0 4.6498963013341665e-10
disease O 0 3.868050555411173e-07
susceptibility O 0 1.3709837709541262e-08
of O 0 6.151210861201142e-14
individuals O 0 8.411626972217034e-13
who O 0 1.2409020477832655e-09
constitutionally O 0 2.9074544727336615e-07
lack O 0 1.271069621083809e-11
both O 0 2.52565590647515e-14
wild O 0 4.4144318755989786e-10
- O 0 5.576307012233883e-05
type O 0 1.8143911928447665e-09
alleles O 0 3.308732628160005e-12
is O 0 2.3412450363829995e-12
unknown O 0 2.605998195015502e-10
. O 0 2.1540078748438773e-11

We O 0 1.1948202843781175e-11
have O 0 1.4388907605220199e-15
identified O 0 1.038056495145448e-14
three O 0 1.522220866609185e-14
offspring O 0 1.8707172963483565e-11
in O 0 4.550963182963375e-15
a O 0 1.4058360031654615e-10
hereditary B-Disease 1 0.9999853372573853
nonpolyposis I-Disease 1 0.9999954700469971
colorectal I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
family O 0 0.00016306524048559368
who O 0 2.637051466081175e-08
developed O 0 1.2847348740407938e-09
hematological B-Disease 0 0.0005522583378478885
malignancy I-Disease 0 0.0005348268896341324
at O 0 5.769245081665986e-10
a O 0 2.7964303168557213e-14
very O 0 9.358943605991196e-14
early O 0 2.1407918493476785e-10
age O 0 1.1382771392121072e-09
, O 0 8.897174785652863e-15
and O 0 1.622508686649829e-13
at O 0 4.04975091818343e-14
least O 0 7.949056277136454e-19
two O 0 9.027765163853509e-17
of O 0 6.593098658891071e-17
them O 0 3.681483069783997e-12
displayed O 0 1.1663829901920053e-08
signs O 0 9.257304922627441e-10
of O 0 6.557613034129019e-15
neurofibromatosis B-Disease 0 2.586244249869196e-07
type I-Disease 0 3.084409117004583e-11
1 I-Disease 0 5.106059238618732e-12
( O 0 8.704149190687585e-14
NF1 B-Disease 0 2.902816618188808e-07
) O 0 3.4850948515963154e-11
. O 0 8.810006196791065e-11

DNA O 0 7.305123845245676e-13
sequence O 0 2.272477047033164e-13
analysis O 0 1.2502157597079006e-15
and O 0 3.1497499831824435e-16
allele O 0 2.8781398159807283e-15
- O 0 1.6850966965114428e-13
specific O 0 3.95108047367425e-15
amplification O 0 3.044142937724814e-09
in O 0 3.2482606031623883e-15
two O 0 7.138456221533057e-14
siblings O 0 1.5741853653938875e-10
revealed O 0 1.5861133587091736e-11
a O 0 2.616929889882316e-15
homozygous O 0 1.2402642281250653e-11
MLH1 O 0 1.1191200428584125e-06
mutation O 0 6.16807993569779e-11
( O 0 1.1738880538198632e-13
C676T O 0 1.09401920855845e-09
- O 0 7.07332364981994e-05
- O 0 0.001955375773832202
> O 0 4.495460448339372e-09
Arg226Stop O 0 3.914246008207556e-06
) O 0 1.1938361757501958e-11
. O 0 1.7968486941410955e-12

Thus O 0 2.9082921834677755e-11
, O 0 1.2171113827885976e-14
a O 0 3.124775057913973e-15
homozygous O 0 8.278792928972933e-11
germ O 0 0.00030374733614735305
- O 0 0.0027342166285961866
line O 0 4.0687747969059274e-05
MLH1 O 0 0.0001795990247046575
mutation O 0 1.0537989370007494e-09
and O 0 5.247256795737343e-11
consequent O 0 4.179271151372177e-09
mismatch O 0 2.7451291316538118e-05
repair O 0 0.2166399508714676
deficiency O 1 0.898119330406189
results O 0 8.51136042613436e-14
in O 0 5.768093729872404e-16
a O 0 9.637849871478588e-14
mutator O 0 6.397706329153152e-07
phenotype O 0 5.094672461680716e-10
characterized O 0 2.5207089193735044e-10
by O 0 5.073849673742359e-11
leukemia B-Disease 1 0.9503421187400818
and O 0 0.00021762491087429225
/ O 1 0.9992803931236267
or O 1 0.9966478943824768
lymphoma B-Disease 1 1.0
associated O 0 8.845612455843366e-07
with O 0 9.923383226251303e-10
neurofibromatosis B-Disease 0 3.8363836210919544e-05
type I-Disease 0 3.8093342369371896e-10
1 I-Disease 0 1.0102040731707618e-12
. O 0 4.2818019095614e-12
. O 0 1.793163256769148e-10

Missense O 0 2.3055331155319436e-07
mutations O 0 5.6111164603578345e-09
in O 0 4.1506959002658717e-13
the O 0 7.807942084493615e-15
most O 0 4.728659366231658e-16
ancient O 0 8.697709029783021e-14
residues O 0 2.1828496787890117e-09
of O 0 5.888075417455384e-17
the O 0 3.584486308168483e-15
PAX6 O 0 2.7865326712728233e-10
paired O 0 2.056752121046279e-12
domain O 0 2.6162650604982796e-12
underlie O 0 3.667439962828922e-11
a O 0 2.4818308876523336e-15
spectrum O 0 2.4246230023727833e-10
of O 0 3.3218347777336232e-12
human O 0 3.421552537474781e-05
congenital B-Disease 1 0.9999707937240601
eye I-Disease 1 0.9995455145835876
malformations I-Disease 1 0.9979267120361328
. O 0 2.1987048626215255e-07

Mutations O 0 2.0163114233806567e-10
of O 0 4.269985837216652e-15
the O 0 3.12962004402062e-14
human O 0 1.687287787786873e-12
PAX6 O 0 2.2645767785434145e-06
gene O 0 0.00013994239270687103
underlie O 1 0.9768704175949097
aniridia B-Disease 1 0.9999991655349731
( O 0 4.957711396968989e-08
congenital B-Disease 1 0.9812706708908081
absence I-Disease 0 7.137708202265003e-10
of I-Disease 0 1.0865543829800296e-15
the I-Disease 0 6.984541525874299e-14
iris I-Disease 0 1.3689351874290878e-08
) O 0 1.0251213072853815e-11
, O 0 4.612196380566515e-14
a O 0 1.1359714709689717e-13
rare O 0 1.6343052466893937e-09
dominant O 0 0.0012522233882918954
malformation B-Disease 1 0.9907529354095459
of I-Disease 0 1.8550161406949428e-11
the I-Disease 0 1.0711904696592e-09
eye I-Disease 0 0.0007060266798362136
. O 0 1.6427192051082784e-08

The O 0 4.061509090744035e-14
spectrum O 0 1.1156035947465504e-12
of O 0 5.712499463533197e-15
PAX6 O 0 2.7210097286456403e-08
mutations O 0 4.069694981012617e-08
in O 0 4.536382824937846e-09
aniridia B-Disease 1 0.999998927116394
patients O 0 7.65171190297842e-11
is O 0 4.08749082849037e-17
highly O 0 8.751040658038386e-18
biased O 0 2.6684464100174e-12
, O 0 2.6087381495461248e-14
with O 0 1.602013199831706e-13
92 O 0 5.015072385150532e-11
% O 0 6.629826404530711e-15
of O 0 1.3949552674270577e-16
all O 0 1.370257639993211e-11
reported O 0 4.389361929479918e-10
mutations O 0 3.8879744692840723e-13
leading O 0 2.0926238172847e-11
to O 0 1.8144612331724708e-12
premature O 0 6.239938687285784e-12
truncation O 0 1.0470734522483038e-12
of O 0 1.761659123699494e-14
the O 0 5.844895964793317e-13
protein O 0 2.917798641588476e-11
( O 0 3.3497575569118863e-17
nonsense O 0 9.095531944801338e-14
, O 0 8.796349140048855e-20
splicing O 0 6.492718240149842e-16
, O 0 6.371677629033896e-17
insertions O 0 1.1746456671929417e-12
and O 0 8.687037092273975e-13
deletions O 0 3.0237689522399913e-12
) O 0 3.050146398474174e-13
and O 0 3.832607842202407e-12
just O 0 2.5168439381217933e-12
2 O 0 3.847940236302409e-15
% O 0 6.013873437923239e-19
leading O 0 2.1146328075075093e-17
to O 0 9.50913080313277e-19
substitution O 0 4.532141601332127e-18
of O 0 1.1083636011902955e-18
one O 0 2.8210196833145136e-14
amino O 0 1.8757880041993594e-14
acid O 0 7.507851016775625e-15
by O 0 2.107072806842693e-16
another O 0 5.631369394236418e-13
( O 0 1.3396655306082122e-14
missense O 0 1.1670894806137255e-10
) O 0 9.836537834262415e-12
. O 0 1.3905331747166016e-11

The O 0 9.032321433486128e-15
extraordinary O 0 4.2857643669581055e-16
conservation O 0 6.651986639315456e-17
of O 0 6.306594949870768e-20
the O 0 4.981344928111193e-18
PAX6 O 0 4.3946051360649677e-14
protein O 0 1.0093551648925623e-15
at O 0 3.464434369790441e-16
the O 0 4.135102351932187e-18
amino O 0 1.2173156024321806e-14
acid O 0 4.355950618110428e-14
level O 0 8.504686822949532e-15
amongst O 0 7.844090486067113e-16
vertebrates O 0 4.5800846839097464e-14
predicts O 0 2.2845533798054873e-10
that O 0 3.621064559311549e-11
pathological O 0 1.4890654265187209e-09
missense O 0 3.240349766286954e-09
mutations O 0 1.719310382952699e-08
should O 0 7.83111353541699e-09
in O 0 6.845687076017723e-14
fact O 0 4.093045889198843e-13
be O 0 6.846343153857348e-13
common O 0 2.0512437234887493e-12
even O 0 3.915767363138478e-11
though O 0 5.44821837384496e-13
they O 0 3.6617188231211073e-13
are O 0 2.4316748904718542e-15
hardly O 0 2.8367562205505736e-12
ever O 0 8.262461895225393e-12
seen O 0 1.1831136070838966e-08
in O 0 5.376991213390525e-11
aniridia B-Disease 1 0.9999986886978149
patients O 0 7.654985534344405e-10
. O 0 1.6714100806516918e-12

This O 0 1.727398606099495e-13
indicates O 0 8.595098780926277e-14
that O 0 3.6933918752958105e-15
there O 0 1.935891895125572e-15
is O 0 4.02022631425746e-15
a O 0 5.081776470981791e-13
heavy O 0 5.912511369388085e-07
ascertainment O 0 8.990189144242322e-07
bias O 0 2.819855637881119e-08
in O 0 8.077421063860479e-16
the O 0 6.635183623224299e-17
selection O 0 1.759081132602411e-17
of O 0 1.0673070911921701e-17
patients O 0 1.5377314057140386e-17
for O 0 2.4154449368372677e-19
PAX6 O 0 1.374389859733205e-12
mutation O 0 8.393459538513781e-15
analysis O 0 4.54696799960172e-13
and O 0 1.6582995393532585e-11
that O 0 6.822435953852957e-13
the O 0 3.2561184651336283e-12
missing O 0 1.1636496992650791e-06
PAX6 O 0 9.323965173280158e-07
missense O 0 5.376556089231599e-09
mutations O 0 1.232429491793141e-09
frequently O 0 1.3246146863821195e-06
may O 0 5.867996755171134e-09
underlie O 0 3.127707870476115e-08
phenotypes O 0 2.5456219354680343e-09
distinct O 0 2.523123654452064e-10
from O 0 4.655275720466534e-09
textbook O 0 0.1831444948911667
aniridia B-Disease 1 0.9999836683273315
. O 0 2.0330254812961357e-07

Here O 0 8.171502363651939e-11
we O 0 9.34621195540497e-13
present O 0 2.075887171307158e-15
four O 0 1.3224829590533903e-14
novel O 0 6.974400982955042e-13
PAX6 O 0 6.861561097082358e-09
missense O 0 1.0756614349238802e-10
mutations O 0 1.4607114129372434e-11
, O 0 3.7901517861704814e-13
two O 0 4.626427821570467e-13
in O 0 5.030795658528264e-14
association O 0 3.5476482100176834e-15
with O 0 2.1408539546165228e-13
atypical O 0 2.885860661550055e-09
phenotypes O 0 2.5719433693893734e-08
ectopia B-Disease 0 1.2200795026728883e-05
pupillae I-Disease 0 4.216357410768978e-05
( O 0 1.8050582729911557e-12
displaced B-Disease 0 1.1770555363721513e-10
pupils I-Disease 0 7.142808300386605e-08
) O 0 1.4463338970926998e-07
and O 0 0.01467226818203926
congenital B-Disease 1 0.9998295307159424
nystagmus I-Disease 0 1.0101215366375982e-06
( O 0 8.679331125333034e-14
searching B-Disease 0 1.1747633421599346e-10
gaze I-Disease 0 3.6860157592855103e-07
) O 0 1.3736815775589745e-13
, O 0 1.418635852236741e-14
and O 0 1.62482210303537e-13
two O 0 4.1592051932539884e-14
in O 0 7.43156744130414e-16
association O 0 6.871758684621506e-18
with O 0 8.885633697048727e-17
more O 0 6.592551872653838e-15
recognizable O 0 2.43368685914902e-06
aniridia B-Disease 1 0.9999964237213135
phenotypes O 0 2.2440340785578883e-07
. O 0 3.7650674244993354e-11

Strikingly O 0 1.0677600137398713e-08
, O 0 1.1920978093549195e-11
all O 0 1.4374329363516652e-13
four O 0 4.7574686296578475e-14
mutations O 0 4.654279010265182e-14
are O 0 9.88217669452068e-16
located O 0 1.3969848642477974e-15
within O 0 1.374245576564486e-16
the O 0 1.035746466891696e-14
PAX6 O 0 1.0702136399309836e-10
paired O 0 2.097822133020899e-12
domain O 0 1.074754348018292e-11
and O 0 3.260327424703391e-11
affect O 0 4.824943613049304e-15
amino O 0 6.554408708489556e-16
acids O 0 1.227691141937159e-15
which O 0 8.09604661956842e-14
are O 0 2.7105527873038297e-18
highly O 0 9.050169640257722e-19
conserved O 0 2.1404024945259658e-15
in O 0 2.107596484962333e-15
all O 0 1.393025620494094e-15
known O 0 7.683398277456724e-16
paired O 0 3.1173251913846345e-13
domain O 0 3.698697164516984e-13
proteins O 0 1.8837351383610423e-12
. O 0 2.4085848333160742e-12

Our O 0 1.5666856700846665e-09
results O 0 2.195872945824108e-14
support O 0 2.371613637066624e-16
the O 0 8.07578417268991e-17
hypothesis O 0 2.6954513264004472e-15
that O 0 4.780458607329811e-16
the O 0 1.0934395299964556e-16
under O 0 2.3400091966782307e-15
- O 0 3.737575787060576e-12
representation O 0 1.6295813821132492e-15
of O 0 2.101879859601314e-15
missense O 0 1.4049887642197945e-10
mutations O 0 9.461804256760686e-11
is O 0 8.44659845539164e-12
caused O 0 1.4072899789940863e-10
by O 0 1.6149660276611189e-13
ascertainment O 0 1.7276638573093805e-06
bias O 0 1.918430143632577e-06
and O 0 2.8710233843098898e-11
suggest O 0 6.673597255596551e-15
that O 0 1.602939046018329e-17
a O 0 6.599738272231911e-18
substantial O 0 2.3992491457619795e-16
burden O 0 6.542990593771947e-09
of O 0 1.971769373210891e-13
PAX6 B-Disease 0 0.2292184978723526
- I-Disease 1 0.9891939163208008
related I-Disease 0 8.12887737993151e-05
disease I-Disease 0 4.201153933536261e-05
remains O 0 4.295204469872971e-10
to O 0 1.4449033603706335e-14
be O 0 5.619065164945707e-16
uncovered O 0 5.232447808367624e-10
. O 0 1.3292306437397844e-13
. O 0 2.662273342318028e-13

The O 0 1.4376083060530648e-13
chromosomal O 0 1.4144117876924156e-08
order O 0 4.3477352794363266e-13
of O 0 4.590433184534862e-17
genes O 0 2.4567026473028275e-13
controlling O 0 1.5817411399762782e-12
the O 0 2.7882056692895294e-15
major O 0 1.8396111423188335e-15
histocompatibility O 0 2.8717815885731524e-13
complex O 0 1.3278362072800375e-14
, O 0 3.805357454824212e-16
properdin O 0 5.989101575787359e-12
factor O 0 2.733575898191537e-13
B O 0 3.7771858529822566e-08
, O 0 4.992603119119421e-12
and O 0 4.4601812021483056e-08
deficiency B-Disease 0 9.752877758728573e-07
of I-Disease 0 1.800486402626304e-18
the I-Disease 0 3.5157862186737656e-15
second I-Disease 0 1.6671397335549232e-13
component I-Disease 0 5.615531978764472e-15
of I-Disease 0 8.627405280602535e-18
complement I-Disease 0 2.722705416159654e-13
. O 0 2.4325925388618552e-12

The O 0 5.3434802426994416e-14
relationship O 0 7.174738369608927e-14
of O 0 3.8174633423505993e-19
the O 0 1.4777094382180257e-19
genes O 0 9.317068770679847e-18
coding O 0 1.1066590487962893e-14
for O 0 1.7276437405115423e-19
HLA O 0 5.171060333538724e-15
to O 0 2.235074440598293e-17
those O 0 6.006242800170014e-18
coding O 0 1.6053861189089906e-14
for O 0 2.1683576092663996e-18
properdin O 0 5.080432168708127e-12
Factor O 0 9.436228247351394e-15
B O 0 3.6907799733088e-11
allotypes O 0 4.680478782326247e-10
and O 0 4.7191816426872535e-12
for O 0 2.2889190068602246e-14
deficiency B-Disease 0 3.844848439626958e-09
of I-Disease 0 1.2184553953604508e-19
the I-Disease 0 3.219233154636898e-16
second I-Disease 0 5.4819365870708084e-14
component I-Disease 0 8.870097683427985e-15
of I-Disease 0 1.0549892965364592e-17
complement I-Disease 0 2.94853083734805e-14
( O 0 2.24017979933897e-16
C2 O 0 1.1461461779660453e-09
) O 0 7.883388050259385e-16
was O 0 1.7986308243570642e-13
studied O 0 2.0506695181597397e-15
in O 0 1.7214419331894107e-17
families O 0 3.429669225959368e-15
of O 0 4.9806798748987e-18
patients O 0 5.5684769268522435e-14
with O 0 2.6046602374929506e-11
connective O 0 0.0010633183410391212
tissue O 1 0.9998992681503296
disorders O 1 0.996426522731781
. O 0 1.432152085811822e-08

Patients O 0 1.5549732335085054e-10
were O 0 1.0992733958346823e-13
selected O 0 2.331836705165766e-16
because O 0 8.720258190333409e-16
they O 0 4.510448855942373e-16
were O 0 2.5185976232773273e-15
heterozygous O 0 2.754387243595691e-15
or O 0 1.1194689821675003e-14
homozygous O 0 6.551075654170901e-11
for O 0 1.8244514787824073e-09
C2 B-Disease 1 0.9999992847442627
deficiency I-Disease 1 0.9999982118606567
. O 0 1.2528215131979437e-09

12 O 0 1.3712798258014303e-11
families O 0 7.617014251325507e-14
with O 0 5.2040632253230344e-17
15 O 0 5.35874070591453e-17
matings O 0 9.49511823333804e-12
informative O 0 7.516466338230998e-10
for O 0 3.1876812300879465e-08
C2 B-Disease 1 0.9999996423721313
deficiency I-Disease 1 0.9999997615814209
were O 0 3.639165357949281e-10
found O 0 3.329117884143251e-11
. O 0 3.8323302864462505e-12

Of O 0 2.0267651218344035e-13
57 O 0 6.070083671816384e-13
informative O 0 3.552459433391053e-13
meioses O 0 1.7217369197020105e-10
, O 0 2.78948093033118e-16
two O 0 6.168457467785032e-18
crossovers O 0 1.1614200676494588e-14
were O 0 6.41421865708175e-14
noted O 0 3.3786359144037702e-15
between O 0 6.909228099588952e-14
the O 0 1.1874513461407332e-07
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999974966049194
gene O 0 3.1105156817634204e-15
and O 0 6.166302447222372e-15
the O 0 1.9331605315080322e-16
HLA O 0 1.0931071325881447e-10
- O 0 6.637086613636711e-08
B O 0 5.936292013508648e-10
gene O 0 1.188794563142118e-14
, O 0 1.9428442687647415e-17
with O 0 3.8639468376523734e-21
a O 0 6.77466020877821e-22
recombinant O 0 2.5305727099742223e-19
fraction O 0 6.369515048040437e-17
of O 0 6.12695511984445e-16
0 O 0 2.189041049122098e-13
. O 0 2.3688247544062513e-12

035 O 0 0.0014164051972329617
. O 0 4.439717571358415e-08

A O 0 2.5989408403148673e-09
lod O 0 2.518928886274807e-05
score O 0 1.3632022177745284e-09
of O 0 6.630502442701738e-17
13 O 0 5.415830395687225e-17
was O 0 5.704306325592643e-17
calculated O 0 7.559482022572075e-18
for O 0 5.795563413670362e-20
linkage O 0 9.439780068731807e-10
between O 0 9.366200401927927e-07
C2 B-Disease 1 0.9999997615814209
deficiency I-Disease 1 0.9999996423721313
and O 0 2.268979795716497e-11
HLA O 0 1.737030785875504e-08
- O 0 2.1940579699730733e-06
B O 0 4.586200574863142e-08
at O 0 2.1196030499347207e-14
a O 0 1.28338118938065e-19
maximum O 0 2.5573934516469504e-21
likelihood O 0 2.001937429401366e-21
value O 0 5.099583016673621e-21
of O 0 5.432949930177954e-22
the O 0 1.7291197732288093e-20
recombinant O 0 4.152741875097304e-19
fraction O 0 4.71660205075084e-18
of O 0 5.380124317365761e-17
0 O 0 3.576852423731354e-14
. O 0 5.496555359300881e-13

04 O 0 5.5559405154781416e-05
. O 0 5.960324678255802e-09

18 O 0 3.0881072698996093e-10
families O 0 4.044473089770406e-13
with O 0 1.8056263540601984e-16
21 O 0 3.9150683385261414e-17
informative O 0 1.6588212770898229e-15
matings O 0 4.097617644499563e-12
for O 0 3.089417414536296e-16
both O 0 1.2076857695581412e-14
properdin O 0 8.957508623730348e-10
Factor O 0 1.7218591461497235e-13
B O 0 1.4950096716148664e-10
allotype O 0 7.005820229499804e-11
and O 0 6.663631777446832e-13
HLA O 0 4.218352334106612e-09
- O 0 6.105153715907363e-07
B O 0 1.5342440917720523e-07
were O 0 1.2937576357452407e-12
found O 0 1.7813698649851717e-12
. O 0 8.9717512932741e-14

Of O 0 2.255661342388457e-13
72 O 0 1.9610773508565993e-12
informative O 0 3.788686812195019e-12
meioses O 0 5.603900277151297e-08
, O 0 4.610061789776798e-13
three O 0 2.3484298476684172e-14
recombinants O 0 5.513132173007307e-10
were O 0 1.3613261451266012e-13
found O 0 3.257716243710825e-15
, O 0 4.480466180899868e-19
giving O 0 3.894831612994215e-21
a O 0 6.212841802450965e-22
recombinant O 0 5.414254864774495e-19
fraction O 0 5.576844410643122e-17
of O 0 1.4940994151119895e-15
0 O 0 5.711546686992808e-13
. O 0 2.2816163021410762e-12

042 O 0 3.637089321273379e-05
. O 0 1.231227209075314e-08

A O 0 2.884742167363896e-10
lod O 0 7.971902959980071e-07
score O 0 1.9682065699466733e-10
of O 0 6.274928599356224e-17
16 O 0 4.706811210148417e-16
between O 0 7.006015441625619e-16
HLA O 0 4.0505934717494085e-10
- O 0 3.160806443247566e-07
B O 0 2.3656696157559054e-07
and O 0 1.3960766570564331e-11
Factor O 0 1.0225054445723095e-13
B O 0 2.551092323499482e-11
allotypes O 0 3.259797379945306e-12
was O 0 6.443943414893155e-14
calculated O 0 1.5060014985703333e-15
at O 0 5.996130351745431e-16
a O 0 5.060153837189147e-19
maximum O 0 1.384926656859484e-19
likelihood O 0 2.0588799450022767e-19
value O 0 5.261907841481776e-19
of O 0 3.202812635649779e-20
the O 0 6.277435928549479e-19
recombinant O 0 2.4440490492145045e-18
fraction O 0 1.7192040787602097e-17
of O 0 3.7964548738507735e-16
0 O 0 5.227090800669944e-14
. O 0 1.5715436764429658e-12

04 O 0 7.450548582710326e-05
. O 0 7.054124839811493e-09

A O 0 8.488602615958074e-13
crossover O 0 6.187448123307071e-12
was O 0 4.196168065795369e-11
shown O 0 3.0315227867068473e-13
to O 0 4.65041416833345e-16
have O 0 2.9246893586300357e-16
occurred O 0 4.2807132712656117e-17
between O 0 7.929668714541859e-20
genes O 0 2.9771872199299384e-18
for O 0 2.0857255747948024e-19
Factor O 0 7.891959494290006e-17
B O 0 1.0613597674347108e-12
and O 0 6.949884325804442e-14
HLA O 0 1.541378136238336e-10
- O 0 2.5379437218475687e-08
D O 0 6.747996383893451e-09
, O 0 2.292700606629065e-16
in O 0 1.4720278706325228e-18
which O 0 3.941024922040921e-15
HLA O 0 5.092163496422941e-11
- O 0 2.3313035057981324e-08
D O 0 1.2154255379925871e-09
segregared O 0 9.611643946028092e-12
with O 0 2.8681427625603187e-16
HLA O 0 3.858442731985434e-11
- O 0 4.717043977642277e-10
A O 0 5.964867488827963e-11
and O 0 7.191742201761997e-10
B O 0 2.5712617812700955e-08
. O 0 2.5190805929935223e-13

These O 0 1.1814408826249512e-11
studies O 0 1.4332714973631228e-13
suggest O 0 2.017668055743528e-15
that O 0 3.32022832573757e-18
the O 0 9.265843284802028e-20
genes O 0 1.0429773436404337e-16
for O 0 8.546925073776434e-17
Factor O 0 4.9772214127941083e-11
B O 0 0.1210760772228241
and O 1 0.9994897842407227
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 2.0926863492802729e-16
located O 0 7.051213450563354e-18
outside O 0 1.2093448318161045e-15
those O 0 1.5488050380104085e-17
for O 0 2.691459339115786e-19
HLA O 0 7.933959072408195e-14
, O 0 8.525535903671486e-16
that O 0 1.1090080617414387e-15
the O 0 1.5578361297638135e-16
order O 0 1.3198615614882277e-15
of O 0 1.1669516666040842e-17
genese O 0 1.1116528704502304e-12
is O 0 7.746103894931388e-18
HLA O 0 1.1508882293898882e-14
- O 0 1.5093683681383085e-12
A O 0 1.252566409967737e-12
, O 0 1.129593245113511e-13
- O 0 1.6374995803758452e-10
B O 0 1.1142740063974088e-09
, O 0 6.252927236188649e-15
- O 0 9.619787605386065e-12
D O 0 1.0451027196434204e-11
, O 0 8.45698622208191e-18
Factor O 0 7.431453621251853e-16
B O 0 3.087624045328141e-10
allotype O 0 8.688340358276037e-07
, O 0 4.088351346354102e-08
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999997615814209
, O 0 2.6286817589957813e-18
that O 0 7.943470352309277e-21
the O 0 1.1214916360581083e-20
genes O 0 1.2243851935198492e-14
coding O 0 2.7155243387255723e-08
for O 0 1.64327698115585e-08
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
and O 0 2.586369174384373e-10
Factor O 0 3.8558492878627837e-13
B O 0 1.3897337725055081e-09
allotypes O 0 8.422906122573792e-11
are O 0 5.836795513433017e-17
approximately O 0 6.148089799562139e-18
3 O 0 2.219401022351638e-15
- O 0 1.424531381744032e-09
- O 0 8.128979267496561e-09
5 O 0 1.919693381037882e-13
centimorgans O 0 3.5267812975581236e-11
from O 0 1.1189971113622413e-18
the O 0 2.665872833311931e-19
HLA O 0 1.3843590970151433e-15
- O 0 1.1842094890953357e-14
A O 0 5.2798943263820085e-15
and O 0 2.64566336503555e-14
HLA O 0 9.104579069829644e-13
- O 0 6.818949159666243e-13
B O 0 1.1152875193200847e-14
loci O 0 3.815225322485276e-17
, O 0 7.34293854591488e-17
and O 0 4.160422549005782e-16
that O 0 1.0864798440806712e-15
the O 0 1.0640808201201838e-14
apparent O 0 1.1633429775059767e-09
lack O 0 3.152588443528252e-15
of O 0 5.598260158061151e-19
recombinants O 0 1.934411181583884e-12
between O 0 2.4756728257768968e-17
the O 0 3.95653655699465e-17
Factor O 0 2.293262761220334e-14
B O 0 4.137573061946398e-10
gene O 0 1.567063101504118e-08
and O 0 0.4367160499095917
C2 B-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999995231628418
gene O 0 4.7027402805266405e-11
suggests O 0 9.746892529194362e-12
that O 0 4.541323100990674e-14
these O 0 3.4737278564690374e-14
two O 0 3.978750055116942e-12
genes O 0 4.833063727005538e-09
lie O 0 2.754103434199351e-06
in O 0 1.418637779236696e-15
close O 0 3.074104284930129e-13
proximity O 0 2.6132250524743203e-14
to O 0 1.0747204856739398e-13
one O 0 2.5060932062198615e-13
another O 0 1.1600995771660072e-12
. O 0 6.127040541592521e-11

Distribution O 0 3.887783324441063e-12
of O 0 2.0985691212126872e-13
emerin O 0 1.478858962400409e-06
and O 0 5.930070656745556e-09
lamins O 0 6.045446752978023e-06
in O 0 2.949960696725651e-13
the O 0 2.454413408625733e-12
heart O 0 4.301601741474315e-09
and O 0 6.190631774566357e-13
implications O 0 8.810572019543215e-16
for O 0 1.0403229541419755e-16
Emery B-Disease 0 0.00010032177669927478
- I-Disease 0 0.06128808110952377
Dreifuss I-Disease 1 0.9992223978042603
muscular I-Disease 1 0.7584876418113708
dystrophy I-Disease 0 0.015398264862596989
. O 0 4.842011791517109e-10

Emerin O 0 3.6696681036119116e-06
is O 0 1.4427080190226871e-11
a O 0 8.26923233121675e-14
nuclear O 0 5.785186565909761e-11
membrane O 0 1.7123973137904425e-13
protein O 0 1.3827996039883494e-11
which O 0 1.012086942031587e-11
is O 0 1.0841913982264154e-13
missing O 0 5.64375109146642e-11
or O 0 1.175252251203393e-13
defective O 0 7.047178118835262e-11
in O 0 2.6668038250913595e-15
Emery B-Disease 0 0.000631724891718477
- I-Disease 1 0.9940635561943054
Dreifuss I-Disease 1 0.9998502731323242
muscular I-Disease 1 0.9991255402565002
dystrophy I-Disease 1 0.9942867159843445
( O 0 4.157470812060637e-09
EDMD B-Disease 1 0.9999818801879883
) O 0 2.2476263072945812e-09
. O 0 5.19662021747358e-11

It O 0 2.278147115397644e-11
is O 0 2.69183563921015e-14
one O 0 1.953228499621852e-14
member O 0 1.2448667466459897e-15
of O 0 8.412844390437508e-17
a O 0 4.751667267120785e-13
family O 0 1.9975174847530752e-09
of O 0 9.13607365216236e-15
lamina O 0 8.378422222676818e-08
- O 0 3.8256298129368815e-10
associated O 0 2.98028406966154e-14
proteins O 0 3.929825452412324e-15
which O 0 3.453668633970398e-15
includes O 0 2.813578422110524e-17
LAP1 O 0 8.860650546616e-10
, O 0 1.7354614534321024e-15
LAP2 O 0 1.8274222135516993e-09
and O 0 1.9724512821672757e-12
lamin O 0 1.2290755080357485e-08
B O 0 2.2591978066088814e-08
receptor O 0 4.590322046083006e-12
( O 0 2.7007137303435014e-13
LBR O 0 1.2545822158926967e-08
) O 0 9.307058162350001e-13
. O 0 9.503906342467339e-12

A O 0 5.245245557339295e-11
panel O 0 5.357489452073594e-11
of O 0 1.710662022802391e-15
16 O 0 6.024080533180692e-15
monoclonal O 0 1.783843255401263e-14
antibodies O 0 3.657470160067788e-12
( O 0 3.420586650484638e-16
mAbs O 0 7.50374968324502e-13
) O 0 3.380260311838367e-15
has O 0 2.599498375344296e-15
been O 0 1.7419538286239086e-16
mapped O 0 1.3475394845113842e-12
to O 0 1.829742996725084e-15
six O 0 1.8742669324593363e-19
specific O 0 2.1165494021120182e-21
sites O 0 6.454884454769544e-16
throughout O 0 2.5407510950333837e-17
the O 0 1.3237578965019853e-17
emerin O 0 1.6831716955541948e-14
molecule O 0 6.277340285791153e-19
using O 0 7.583892949629127e-17
phage O 0 2.7675936629251163e-12
- O 0 1.1578563628711347e-11
displayed O 0 1.6899215317042748e-13
peptide O 0 6.061166070831208e-16
libraries O 0 7.026728573559539e-17
and O 0 1.1345455757055638e-15
has O 0 1.3340690337097038e-17
been O 0 9.128081161768632e-18
used O 0 6.349694477074687e-17
to O 0 9.783896255744152e-17
localize O 0 1.0172198500191243e-10
emerin O 0 8.610315127555168e-09
in O 0 1.7589352774993608e-15
human O 0 8.06909140199652e-12
and O 0 1.9275130824780717e-08
rabbit O 1 0.6889944076538086
heart O 0 0.0024297728668898344
. O 0 1.0607238420945464e-09

Several O 0 1.1708737007298103e-13
mAbs O 0 3.892623029466691e-11
against O 0 3.21223794362991e-14
different O 0 1.5819581722637378e-16
emerin O 0 3.2903450797316935e-11
epitopes O 0 1.5267831443566138e-10
did O 0 6.684396959555361e-12
not O 0 1.9456124452282625e-15
recognize O 0 3.3012529748700434e-14
intercalated O 0 2.084404697455522e-12
discs O 0 2.9202919904491864e-06
in O 0 1.0511440676208572e-11
the O 0 1.57823185076289e-10
heart O 0 1.250127752427943e-07
, O 0 1.9017049762183602e-13
though O 0 5.131937491067648e-14
they O 0 1.7870989112373295e-14
recognized O 0 1.0520937961978893e-13
cardiomyocyte O 0 7.179807859358789e-09
nuclei O 0 1.6070093172837474e-11
strongly O 0 5.276255777772465e-13
, O 0 2.707797678639626e-15
both O 0 2.4877171313610405e-15
at O 0 2.563794489207627e-11
the O 0 1.4649460030463635e-12
rim O 0 5.5213233281392604e-05
and O 0 1.4202123921336351e-09
in O 0 6.946806038667531e-15
intranuclear O 0 6.612617675649801e-10
spots O 0 2.3630227982684993e-11
or O 0 2.8157945064694913e-14
channels O 0 1.0693124163907441e-09
. O 0 1.0481455287036923e-10

A O 0 1.6220491963481187e-11
polyclonal O 0 4.961246968804289e-09
rabbit O 0 1.0498351912247017e-06
antiserum O 0 1.7028219190251548e-07
against O 0 1.976204977438556e-09
emerin O 0 4.3161179519302095e-07
did O 0 1.9270590678743815e-10
recognize O 0 1.5031026553632976e-12
both O 0 5.253294527222908e-15
nuclear O 0 9.38618020113191e-12
membrane O 0 6.249016908587649e-15
and O 0 1.4660577710590844e-13
intercalated O 0 6.106727231910188e-15
discs O 0 1.9278190155347374e-11
but O 0 1.0934526193024686e-15
, O 0 1.3319414088519438e-20
after O 0 1.5718971341482005e-20
affinity O 0 3.06870513873431e-19
purification O 0 1.0692433721136465e-16
against O 0 8.011715394652983e-17
a O 0 1.3237781624269928e-17
pure O 0 8.184796021276294e-14
- O 0 1.058265031161909e-08
emerin O 0 2.639426632811137e-08
band O 0 1.7310351069221852e-11
on O 0 9.54277238826573e-13
a O 0 1.5142970216183867e-15
western O 0 1.8951292900422356e-13
blot O 0 9.422909897693899e-06
, O 0 4.256362243996309e-13
it O 0 5.564403104951765e-13
stained O 0 6.559538633155171e-06
only O 0 6.237945002120909e-14
the O 0 2.280060736297839e-14
nuclear O 0 1.3329706227693805e-09
membrane O 0 1.8361646838410683e-12
. O 0 1.3552935683447398e-11

These O 0 2.5508588297196155e-11
results O 0 5.932589624635734e-14
would O 0 4.1609107787965796e-14
not O 0 3.751754562944e-15
be O 0 1.412287996747604e-15
expected O 0 6.139940134925858e-16
if O 0 2.8215993079603197e-15
immunostaining O 0 7.691038778068204e-12
at O 0 4.634071091132652e-15
intercalated O 0 1.980675247024912e-14
discs O 0 4.037413958712932e-09
were O 0 2.6231304454948923e-12
due O 0 1.5219114772372885e-16
to O 0 1.8098259169429057e-16
a O 0 2.7970888743842996e-16
product O 0 2.876088852753894e-14
of O 0 7.099607652300769e-18
the O 0 9.982624637669673e-15
emerin O 0 6.199784435834133e-11
gene O 0 2.163253029398987e-13
and O 0 1.0207922007676729e-10
, O 0 8.579993134158123e-15
therefore O 0 3.127076446431663e-15
, O 0 2.7473145184861176e-15
cast O 0 7.307716172640089e-13
some O 0 1.228547836353968e-16
doubt O 0 3.007898169599154e-16
upon O 0 2.6042869102618854e-19
the O 0 1.3541015448920027e-16
hypothesis O 0 6.806011049881322e-12
that O 0 2.4468155279677717e-10
cardiac B-Disease 0 5.266216612653807e-05
defects I-Disease 1 0.9962122440338135
in O 0 1.4309854412530854e-09
EDMD B-Disease 1 0.9999998807907104
are O 0 2.5746171861129596e-09
caused O 0 7.613729091637822e-11
by O 0 4.670419053668523e-14
absence O 0 2.8593337766946725e-11
of O 0 4.4326728295936493e-14
emerin O 0 2.0902468804706587e-06
from O 0 1.75675771672823e-13
intercalated O 0 1.7372607519217098e-10
discs O 0 3.881807515426772e-06
. O 0 5.639748043573256e-11

Although O 0 3.672464242432394e-12
emerin O 0 1.6073412045791713e-10
was O 0 4.610237430528741e-13
abundant O 0 8.446549022548839e-16
in O 0 3.0662177115065926e-16
the O 0 5.472322847822767e-15
membranes O 0 4.8113393269488824e-09
of O 0 5.562638498153409e-14
cardiomyocyte O 0 2.5936321979003196e-09
nuclei O 0 7.995675302407967e-12
, O 0 4.6986332129217954e-15
it O 0 7.050985500762358e-14
was O 0 2.214024241720125e-10
absent O 0 6.039978413252545e-12
from O 0 1.8457267201980095e-15
many O 0 1.4365105979402353e-15
non O 0 1.096042947699126e-13
- O 0 2.3584155073308466e-08
myocyte O 0 6.772096980967035e-07
cells O 0 1.0142595791018394e-10
in O 0 5.6422246974378865e-14
the O 0 3.57697877394203e-12
heart O 0 7.627591003256384e-07
. O 0 4.123759667074012e-11

This O 0 1.662279924371699e-15
distribution O 0 1.0377713838554022e-14
of O 0 9.908146724683497e-16
emerin O 0 3.86250920136888e-10
was O 0 5.83787629782756e-13
similar O 0 1.4169273020788343e-17
to O 0 1.1838831273007586e-16
that O 0 5.251849383135774e-16
of O 0 1.2085312442625576e-18
lamin O 0 9.192896444076837e-12
A O 0 1.9300835615073536e-13
, O 0 2.3276685089718867e-16
a O 0 9.819111981398494e-18
candidate O 0 2.796768590051119e-16
gene O 0 1.3881301300479668e-14
for O 0 9.347226948632918e-17
an O 0 3.053032002556244e-14
autosomal O 0 3.0681065254611894e-05
form O 0 1.205756490207932e-07
of O 0 3.864027803501813e-06
EDMD B-Disease 1 0.9999978542327881
. O 0 1.5395734465073474e-07

In O 0 3.853210068724411e-13
contrast O 0 2.4055685828722195e-12
, O 0 1.3367358977535437e-13
lamin O 0 2.836221995039523e-07
B1 O 0 0.0017476077191531658
was O 0 6.683119835315665e-09
absent O 0 1.808720256901708e-10
from O 0 1.790524312476026e-14
cardiomyocyte O 0 8.524618233529679e-10
nuclei O 0 2.2252635498154483e-11
, O 0 4.585346791391269e-14
showing O 0 2.7479908973337963e-11
that O 0 1.1999125651418474e-12
lamin O 0 2.2884895756192236e-08
B1 O 0 5.262961622065632e-07
is O 0 1.1930410092984557e-16
not O 0 2.2116307358314987e-18
essential O 0 1.774345013727791e-18
for O 0 1.568154658864281e-19
localization O 0 1.6382592981853406e-13
of O 0 2.045495397549102e-17
emerin O 0 4.36719826968357e-10
to O 0 1.6844507830671845e-13
the O 0 3.988032506226785e-13
nuclear O 0 3.274885429505048e-08
lamina O 0 2.5637678646717177e-09
. O 0 7.554345170246446e-12

Lamin O 0 0.0035886287223547697
B1 O 1 0.9613816738128662
is O 0 2.572632662456442e-10
also O 0 1.9207474499793875e-10
almost O 0 1.4387400125437377e-11
completely O 0 3.49773358720995e-07
absent O 0 4.970835121298478e-08
from O 0 3.5805965397511796e-12
skeletal O 0 0.00019387049542274326
muscle O 0 1.87450126531985e-07
nuclei O 0 4.2922336795925276e-09
. O 0 1.3121557659867555e-11

In O 0 2.5322938190797117e-10
EDMD B-Disease 1 0.9999020099639893
, O 0 1.871599426275187e-14
the O 0 8.730634112326703e-18
additional O 0 3.3217739127121255e-18
absence O 0 2.8708697321944447e-15
of O 0 2.3183019127620303e-16
lamin O 0 2.304434701727587e-06
B1 O 0 0.015599345788359642
from O 0 1.5021345278753984e-11
heart O 0 3.850208031508373e-06
and O 0 4.358033223184066e-08
skeletal O 0 0.0003125851508229971
muscle O 0 1.9965739284089068e-08
nuclei O 0 6.357739890106018e-10
which O 0 3.4916566860054843e-10
already O 0 2.6259464047662107e-10
lack O 0 1.720699320875707e-14
emerin O 0 1.8643207810864482e-10
may O 0 5.542027306634691e-15
offer O 0 4.616891140623678e-20
an O 0 3.8755091908728595e-19
alternative O 0 1.997946926445785e-14
explanation O 0 9.009274988362737e-13
of O 0 1.0126416103762616e-14
why O 0 1.5831039257285795e-10
these O 0 3.7152965708282804e-14
tissues O 0 1.3745314565369315e-12
are O 0 1.1743794176325654e-15
particularly O 0 6.7582929270254555e-15
affected O 0 1.340590151773435e-15
. O 0 3.2060480809612598e-15
. O 0 2.069999336870576e-12

Genetic O 0 5.275593763925945e-12
mapping O 0 5.381190493203292e-10
of O 0 2.240951361650624e-14
the O 0 2.4427413759277317e-13
copper B-Disease 0 1.329933274618611e-09
toxicosis I-Disease 0 8.450120603242794e-10
locus O 0 2.199589035217775e-12
in O 0 1.778705238246513e-15
Bedlington O 0 1.8623091957437055e-10
terriers O 0 2.487526806760343e-08
to O 0 2.4835441862769425e-12
dog O 0 3.96572659155936e-08
chromosome O 0 8.126793460405679e-09
10 O 0 5.779677409410711e-13
, O 0 1.1742898438983932e-15
in O 0 1.8460626481709347e-17
a O 0 2.720980687672455e-14
region O 0 4.723278625856642e-12
syntenic O 0 1.200972121750965e-07
to O 0 1.7655258765375548e-12
human O 0 8.262240717982205e-12
chromosome O 0 1.5115587075342773e-06
region O 0 2.9370525456151597e-10
2p13 O 0 4.100438211196433e-09
- O 0 4.183689394920975e-09
p16 O 0 8.376336846360743e-10
. O 0 1.153507324380687e-11

Abnormal O 0 0.24239423871040344
hepatic B-Disease 1 0.9778101444244385
copper I-Disease 0 2.753164699242916e-05
accumulation I-Disease 0 1.1454124759779916e-08
is O 0 1.3050328097905309e-14
recognized O 0 5.616005978401756e-14
as O 0 1.9785714733266957e-11
an O 0 3.305355846805469e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 5.665783380653933e-12
man O 0 1.3785717012382293e-09
, O 0 1.5196208354501168e-15
mouse O 0 1.4970877870723598e-09
, O 0 1.4042265614189198e-12
rat O 0 1.1968122635153122e-05
and O 0 2.1833589158859468e-08
dog O 0 5.0073907914338633e-05
. O 0 8.512400784255192e-10

The O 0 6.705757368656584e-13
major O 0 9.143443814585428e-12
cause O 0 2.9088013775435684e-08
of O 0 2.572266835296211e-12
hepatic B-Disease 0 0.001376427011564374
copper I-Disease 0 0.00017245672643184662
accumulation I-Disease 0 1.2922895109568344e-07
in O 0 7.067254225411046e-13
man O 0 5.380710987878956e-09
is O 0 3.115659246983975e-14
a O 0 1.372895056645472e-14
dysfunctional O 0 5.135987635185302e-08
ATP7B O 0 2.445059976707853e-07
gene O 0 5.167349215184913e-09
, O 0 4.164405209561295e-10
causing O 0 3.5212055990996305e-06
Wilson B-Disease 0 0.0007132727187126875
disease I-Disease 0 0.0008574278326705098
( O 0 2.893993551744689e-11
WD B-Disease 0 0.4025849997997284
) O 0 2.3146518035588315e-09
. O 0 9.262320355141185e-10

Mutations O 0 2.0558295066308574e-09
in O 0 2.2893481815139394e-13
the O 0 9.860604459420007e-15
ATP7B O 0 4.983379819911704e-10
genes O 0 1.2835614732545353e-13
have O 0 2.107694105509504e-14
also O 0 2.173155564530395e-15
been O 0 7.0583018325475616e-15
demonstrated O 0 3.708582987688343e-15
in O 0 2.4544023726334632e-17
mouse O 0 2.984423019825044e-08
and O 0 2.468383941689467e-09
rat O 0 7.501800428144634e-05
. O 0 2.776927993108913e-11

The O 0 8.162946880940769e-12
ATP7B O 0 1.0277011242010303e-08
gene O 0 5.9107519226331284e-12
has O 0 7.418596119357357e-12
been O 0 5.716230304852674e-14
excluded O 0 1.1016335811444059e-15
in O 0 1.656371790982442e-18
the O 0 2.4405366335384512e-18
much O 0 3.393242574062697e-16
rarer O 0 6.928076276731254e-13
human O 0 1.5238353981428254e-11
copper B-Disease 0 2.1745684080087813e-06
overload I-Disease 0 0.0001532151800347492
disease O 0 2.925622766269953e-07
non B-Disease 0 4.296226222000321e-11
- I-Disease 0 0.0005351236904971302
Indian I-Disease 0 4.401490878080949e-05
childhood I-Disease 1 0.9860126376152039
cirrhosis I-Disease 0 0.004578134045004845
, O 0 1.3672766871063342e-14
indicating O 0 5.695628430696376e-14
genetic O 0 4.727674415144767e-13
heterogeneity O 0 6.312211309200677e-10
. O 0 2.6456234425431546e-10

By O 0 6.2125089415280416e-15
investigating O 0 1.8336508255788891e-13
the O 0 1.7161149075146237e-13
common O 0 3.7120317930572355e-10
autosomal O 0 0.0003600713098421693
recessive O 0 0.00784068088978529
copper B-Disease 0 0.0019116319017484784
toxicosis I-Disease 0 5.1138471462763846e-05
( O 0 4.891850406739742e-14
CT B-Disease 0 3.782648416716938e-09
) O 0 3.309742454063458e-12
in O 0 5.543084403752865e-15
Bedlington O 0 2.3998480980225168e-09
terriers O 0 2.3355703149263718e-07
, O 0 9.097822321890714e-14
we O 0 3.4415823208460263e-15
have O 0 4.625727575065458e-18
identified O 0 5.11761673017471e-18
a O 0 2.539984215887486e-18
new O 0 3.4387065381109795e-16
locus O 0 2.6131144123531236e-11
involved O 0 2.112042528715219e-12
in O 0 4.852602260990713e-12
progressive O 0 0.15655165910720825
liver B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999994039535522
. O 0 2.2754261408408638e-07

We O 0 2.1853959614182017e-12
examined O 0 4.532047073778703e-14
whether O 0 6.0770052693075085e-15
the O 0 6.563197522350267e-14
WD B-Disease 0 2.8843601285188925e-06
gene O 0 1.8612511532012377e-10
ATP7B O 0 2.0699815195257543e-06
was O 0 2.3107545391032325e-11
also O 0 1.5950104205853346e-16
causative O 0 1.1671481385431778e-16
for O 0 2.0001161037083205e-18
CT B-Disease 0 2.730497251912656e-12
by O 0 7.145419727038038e-17
investigating O 0 1.3441086419330346e-14
the O 0 1.8442274718813694e-15
chromosomal O 0 1.1814251621444782e-07
co O 0 6.211958503143933e-09
- O 0 1.262357232634237e-11
localization O 0 2.7766311819221734e-11
of O 0 3.3831869694898084e-16
ATP7B O 0 1.4241157142436123e-09
and O 0 4.050985045187579e-15
C04107 O 0 4.048570988053015e-17
, O 0 4.074654538932135e-21
using O 0 1.0209740051138569e-20
fluorescence O 0 3.807228802067603e-17
in O 0 4.951824196217671e-19
situ O 0 3.8968772471926713e-16
hybridization O 0 1.946237089675215e-14
( O 0 1.1574824338238222e-16
FISH O 0 5.5991798003640625e-11
) O 0 7.51318712105542e-13
. O 0 4.27563193183822e-12

C04107 O 0 1.2571240404213313e-07
is O 0 6.6158402541038885e-12
an O 0 1.5055427878777478e-14
anonymous O 0 1.748543532187341e-10
microsatellite O 0 4.427423846209422e-06
marker O 0 1.3472205182551988e-06
closely O 0 4.197505190650652e-11
linked O 0 1.1527292315127724e-10
to O 0 5.311515116623866e-13
CT B-Disease 0 1.3032762069542514e-07
. O 0 4.963645813815809e-11

However O 0 2.553459388376922e-10
, O 0 6.380620424378813e-12
BAC O 0 1.3562984069181994e-09
clones O 0 2.639756191413767e-10
containing O 0 3.375589391341194e-11
ATP7B O 0 1.9438100196111918e-07
and O 0 1.3417580577417682e-13
C04107 O 0 5.089959046421493e-15
mapped O 0 4.696541549761846e-13
to O 0 8.030537260834362e-16
the O 0 1.8134610117756067e-16
canine O 0 1.1822355316937205e-09
chromosome O 0 4.4919058694858904e-08
regions O 0 4.502980020110181e-12
CFA22q11 O 0 1.5869572322912973e-08
and O 0 6.111968570143844e-12
CFA10q26 O 0 1.0192124921815093e-10
, O 0 1.0686158133439596e-15
respectively O 0 1.3951421440710457e-15
, O 0 9.927096439900352e-17
demonstrating O 0 6.59896814722929e-15
that O 0 6.367365944399961e-13
WD B-Disease 0 1.0524817071200232e-06
cannot O 0 4.800540390551e-13
be O 0 4.233664644230637e-18
homologous O 0 1.055980834628004e-15
to O 0 7.598995759895699e-13
CT B-Disease 0 9.56177999000829e-08
. O 0 1.6588246401494366e-11

The O 0 1.4299074890724434e-13
copper O 0 5.620823251284435e-12
transport O 0 1.431129249395563e-14
genes O 0 4.2563459809637216e-13
CTR1 O 0 3.0807365192231373e-07
and O 0 5.831494315211572e-11
CTR2 O 0 2.3667883652933597e-08
were O 0 1.0445004236525612e-12
also O 0 3.4462578368357516e-16
excluded O 0 5.536588259926188e-18
as O 0 3.632506998154661e-18
candidate O 0 1.1767549976337564e-17
genes O 0 2.3616906460895398e-17
for O 0 7.44946948264436e-18
CT B-Disease 0 1.2496324808264347e-10
since O 0 5.938706557767626e-13
they O 0 1.2524443563316859e-16
both O 0 2.281477608261535e-19
mapped O 0 2.2618317808975608e-12
to O 0 2.1219826026527833e-13
canine O 0 2.402290988356981e-07
chromosome O 0 7.927369006210938e-05
region O 0 2.2758401385658544e-08
CFA11q22 O 0 4.2304822272853926e-05
. O 0 3.0589600297226127e-10

2 O 0 2.086441419635321e-08
- O 0 4.342146439739736e-06
22 O 0 7.408690883003999e-10
. O 0 2.395194979853965e-11

5 O 0 1.4512493429208462e-08
. O 0 8.14020850725683e-10

A O 0 1.3320536080413392e-12
transcribed O 0 6.298498528289898e-11
sequence O 0 1.0433495430464679e-12
identified O 0 9.765203402845035e-12
from O 0 2.4497853019170984e-14
the O 0 1.2556124183730945e-14
C04107 O 0 1.1806081112730737e-10
- O 0 1.0637994929396655e-09
containing O 0 4.546625576029584e-11
BAC O 0 9.706615719529132e-12
was O 0 7.619794010170489e-13
found O 0 1.1964187914036487e-15
to O 0 2.1892691487420464e-18
be O 0 3.3706733667074454e-19
homologous O 0 5.2913413678592195e-17
to O 0 1.46314533720841e-15
a O 0 1.2624642267021122e-17
gene O 0 1.9715088258763155e-14
expressed O 0 9.808190484160385e-16
from O 0 4.4578986671969204e-17
human O 0 1.5634518893826825e-14
chromosome O 0 6.852102218957157e-10
2p13 O 0 1.1380023659524063e-11
- O 0 3.9774299305517236e-12
p16 O 0 4.1298084743623953e-13
, O 0 7.06018732788815e-15
a O 0 1.31603551366548e-15
region O 0 8.241240806103334e-13
devoid O 0 8.318058047906973e-12
of O 0 3.282172227295843e-18
any O 0 7.25495432200782e-17
positional O 0 1.2200766438819066e-11
candidate O 0 1.4305364184896696e-11
genes O 0 2.0541196521506322e-10
. O 0 8.936348327992505e-10

Molecular O 0 4.494913555946889e-12
analysis O 0 6.706777738426165e-14
of O 0 2.0603826633415865e-17
the O 0 5.747685662148394e-17
APC B-Disease 0 1.6229071648295353e-14
gene O 0 1.3117352332713884e-15
in O 0 7.572936446107495e-17
205 O 0 1.4884049184867173e-15
families O 0 7.300715038755217e-15
: O 0 9.046617933502572e-18
extended O 0 6.941852166475514e-15
genotype O 0 1.1804877075860531e-08
- O 0 2.9745915952616997e-08
phenotype O 0 1.9313817906096986e-11
correlations O 0 1.3504218576709803e-11
in O 0 8.184615200917879e-16
FAP B-Disease 0 3.820791339564922e-12
and O 0 5.352249151285892e-15
evidence O 0 4.861740401800313e-18
for O 0 1.3207042733215102e-20
the O 0 2.107029482224135e-19
role O 0 1.5226199408883279e-16
of O 0 9.121741442758873e-19
APC B-Disease 0 2.8516788539920124e-13
amino O 0 3.2450651713688715e-15
acid O 0 3.5984348232273936e-14
changes O 0 1.8245862177905525e-14
in O 0 1.4076638743532044e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999978542327881
predisposition O 0 0.0007886960520409048
. O 0 1.3368712803440985e-09

BACKGROUND O 0 7.323347972487682e-08
/ O 0 9.540057632762e-10
AIMS O 0 1.7538593190605245e-12
The O 0 2.758939304533354e-16
development O 0 8.386035294731097e-15
of O 0 1.5594693938969506e-11
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 1.0277623370413824e-11
a O 0 5.4467841559534494e-17
variable O 0 1.423114877758527e-15
range O 0 9.560015973297809e-11
of O 0 2.5454044254302755e-12
extracolonic O 0 0.042815882712602615
manifestations O 0 1.3838611266692169e-05
in O 0 1.4506238876776933e-08
familial B-Disease 1 0.9999991655349731
adenomatous I-Disease 1 0.999915361404419
polyposis I-Disease 1 0.9999969005584717
( O 0 3.7457795198925226e-10
FAP B-Disease 0 2.2295875368172346e-08
) O 0 1.692819387270894e-12
is O 0 5.089650895835282e-14
the O 0 9.618671520893445e-15
result O 0 9.229642332526933e-14
of O 0 8.960313547983485e-17
the O 0 1.5569631087869462e-12
dominant O 0 2.6718444701145927e-07
inheritance O 0 1.7290333289565751e-06
of O 0 9.100104136905429e-08
adenomatous B-Disease 1 0.9999936819076538
polyposis I-Disease 1 0.9998925924301147
coli I-Disease 1 0.9999964237213135
( O 0 1.539775945635924e-11
APC B-Disease 0 1.9132857520531843e-09
) O 0 7.946412625137178e-13
gene O 0 2.0433257516550007e-11
mutations O 0 4.32181579412827e-09
. O 0 3.224646327737446e-09

In O 0 1.2694812106910092e-13
this O 0 3.4379852366168333e-16
study O 0 8.099319115478269e-18
, O 0 2.609220473929093e-18
direct O 0 1.02649308987013e-18
mutation O 0 1.3982217441090255e-15
analysis O 0 9.480608538622783e-15
of O 0 5.1177558619537415e-17
the O 0 1.263737476040513e-15
APC B-Disease 0 1.037024524412622e-12
gene O 0 3.5707175335009805e-14
was O 0 2.904648526910747e-12
performed O 0 1.9452991192707436e-13
to O 0 6.05867251171361e-15
determine O 0 1.313189140761395e-12
genotype O 0 4.4001749466282547e-10
- O 0 1.7005272745507227e-09
phenotype O 0 4.515089257334237e-12
correlations O 0 1.566863479240954e-11
for O 0 9.10218298302845e-13
nine O 0 1.203122712567506e-09
extracolonic O 0 4.426358657383389e-07
manifestations O 0 5.827405780145511e-10
and O 0 2.0284784323174737e-13
to O 0 1.6741090041779013e-16
investigate O 0 9.73702997571213e-15
the O 0 3.725087001149119e-15
incidence O 0 5.790532497940148e-10
of O 0 2.07382821950084e-16
APC B-Disease 0 6.950730269128513e-11
mutations O 0 3.0410626274124386e-12
in O 0 5.3995006301385887e-14
non O 0 5.11075126663485e-10
- O 0 0.20791120827198029
FAP O 1 0.9996681213378906
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999985694885254
. O 0 1.425131870291807e-07

METHODS O 0 2.1870721379768643e-12
The O 0 3.663363710282698e-15
APC B-Disease 0 1.7518300178542834e-12
gene O 0 6.343797015473385e-14
was O 0 1.3266383651344693e-11
analysed O 0 2.918062926710041e-13
in O 0 2.7128198825676845e-17
190 O 0 5.847406718679745e-16
unrelated O 0 9.860077604926815e-15
FAP B-Disease 0 1.6866910645951805e-10
and O 0 2.1787710524634463e-11
15 O 0 2.0068859768462843e-12
non O 0 3.273002424641902e-10
- O 1 0.9617462754249573
FAP O 1 0.9999010562896729
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
patients O 0 1.6093435611930218e-11
using O 0 7.0783900659246446e-15
denaturing O 0 6.224459614401212e-09
gradient O 0 2.706431190269143e-10
gel O 0 1.58632165181416e-08
electrophoresis O 0 7.61273533100848e-09
, O 0 1.7395120920408146e-14
the O 0 8.20404659167723e-19
protein O 0 2.490060871526093e-16
truncation O 0 2.0868144723091425e-13
test O 0 3.2839152946419203e-13
, O 0 6.444123161736571e-19
and O 0 4.386738345691484e-19
direct O 0 6.584269787982017e-19
sequencing O 0 1.758140508179018e-11
. O 0 1.0433147401567311e-10

RESULTS O 0 8.836398279754576e-10
Chain O 0 2.9809366780542135e-11
terminating O 0 1.8840584474488775e-12
signals O 0 1.607976751749618e-09
were O 0 4.278256622667481e-13
only O 0 2.2027826329732027e-17
identified O 0 1.1096433999793504e-14
in O 0 4.007653804221365e-16
patients O 0 1.5139381178767673e-16
belonging O 0 1.8582799072949959e-16
to O 0 6.3834105441308055e-15
the O 0 1.9548871595391655e-14
FAP B-Disease 0 3.3112821373748602e-09
group O 0 6.412390150117853e-12
( O 0 5.852269084843679e-17
105 O 0 1.3832096817760486e-13
patients O 0 5.1222144845694106e-15
) O 0 1.5361625207012224e-14
. O 0 4.9731863592528125e-12

Amino O 0 7.960562764530721e-10
acid O 0 2.4447478763622854e-11
changes O 0 7.862545216405416e-16
were O 0 2.2502618207519013e-15
identified O 0 3.363245283400512e-14
in O 0 1.1111460258398677e-16
four O 0 2.9727332791565364e-14
patients O 0 1.5143663724409432e-15
, O 0 1.2329987297939933e-16
three O 0 6.116379172344151e-15
of O 0 1.4624311825547562e-15
whom O 0 9.231090284528287e-13
belonged O 0 1.3925070948758722e-12
to O 0 7.278833297815618e-14
the O 0 3.2847219410582496e-14
non O 0 3.2193730103644014e-13
- O 0 1.1612641515057476e-08
FAP O 0 7.628537446180417e-07
group O 0 5.319089169120161e-09
of O 0 2.816563093865909e-10
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
patients O 0 1.1990089809899018e-08
. O 0 1.2803638357872238e-12

Genotype O 0 0.0017483849078416824
- O 0 0.0005772438016720116
phenotype O 0 3.92815913130562e-09
correlations O 0 3.1320987470273565e-10
identified O 0 2.2543918121176176e-10
significant O 0 2.2351555556496955e-13
differences O 0 2.8502014970399614e-08
in O 0 6.004983158945307e-14
the O 0 3.059403384385491e-14
nature O 0 5.029647488427602e-13
of O 0 2.0439597201982852e-16
certain O 0 8.381945311441985e-14
extracolonic O 0 3.541238413617975e-08
manifestations O 0 1.4676232451549254e-11
in O 0 4.866771397003922e-17
FAP B-Disease 0 1.8287689071416757e-12
patients O 0 4.679777094845612e-16
belonging O 0 1.1271466105623995e-16
to O 0 9.452079621926311e-15
three O 0 2.3015447105654077e-14
mutation O 0 7.748138068641719e-12
subgroups O 0 2.2091270479585035e-10
. O 0 1.4470307174718755e-09

CONCLUSIONS O 0 4.277390386331348e-10
Extended O 0 3.590679142906339e-11
genotype O 0 1.6981529427084752e-07
- O 0 4.371928810087411e-07
phenotype O 0 6.496474885819836e-11
correlations O 0 7.335401036590028e-11
made O 0 5.3993646359495884e-11
in O 0 4.369513987288222e-14
this O 0 1.876652951893448e-15
study O 0 3.6586711477549095e-15
may O 0 1.050129601332106e-12
have O 0 1.0821166079627749e-14
the O 0 4.3782693645233396e-16
potential O 0 1.33670464223779e-14
to O 0 3.3018416310046496e-16
determine O 0 2.7431138174028875e-16
the O 0 2.242784425651777e-19
most O 0 5.38748377413336e-22
appropriate O 0 4.1712181819248974e-21
surveillance O 0 3.711866510908374e-15
and O 0 3.758194610690256e-18
prophylactic O 0 4.625924195897062e-17
treatment O 0 1.3449323966943627e-17
regimens O 0 4.672142681012891e-16
for O 0 3.134678220958184e-19
those O 0 3.7280559045688047e-16
patients O 0 6.652084329345798e-18
with O 0 1.4763756146501628e-17
mutations O 0 1.6240784758703164e-13
associated O 0 1.275496982339197e-11
with O 0 1.1446993353203538e-10
life O 0 9.687948931969004e-07
threatening O 0 0.02159673161804676
conditions O 0 6.752979064827969e-09
. O 0 7.51477144400603e-11

This O 0 2.001841414530671e-14
study O 0 2.2121224947056615e-16
also O 0 1.2073758507906527e-16
provided O 0 1.1597043236672009e-18
evidence O 0 1.5449753572104105e-17
for O 0 2.947612100911141e-19
the O 0 3.835305892861164e-16
pathological O 0 5.63144420418632e-13
nature O 0 2.723419507285837e-15
of O 0 1.6731953004732752e-17
amino O 0 6.875810278127517e-14
acid O 0 1.968179986393606e-14
changes O 0 2.748819816801758e-18
in O 0 1.3251725407855735e-17
APC O 0 1.1240703463519242e-12
associated O 0 3.9334249189216814e-15
with O 0 2.9884894684040057e-16
both O 0 6.052389644827351e-15
FAP B-Disease 0 3.0614306645304623e-09
and O 0 4.901480332719643e-10
non O 0 4.136349873729017e-10
- O 0 0.09043098241090775
FAP O 1 0.999750554561615
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999990463256836
patients O 0 6.842284072661187e-09
. O 0 2.6924314421852488e-14
. O 0 4.539576180240257e-13

Inherited B-Disease 1 0.999148964881897
colorectal I-Disease 1 0.9999923706054688
polyposis I-Disease 1 0.999914288520813
and O 0 0.0505707822740078
cancer B-Disease 0 0.00013091714936308563
risk O 0 1.4302241613250999e-09
of O 0 5.693262471798325e-17
the O 0 1.1363392526746695e-14
APC O 0 4.703487599400091e-10
I1307K O 0 1.3542057232529547e-11
polymorphism O 0 1.3187928527003123e-10
. O 0 3.0433388448214416e-11

Germ O 0 0.00011505169095471501
- O 0 9.577707533026114e-05
line O 0 1.109567392632016e-06
and O 0 1.986450717458843e-12
somatic O 0 1.3553492096002318e-13
truncating O 0 1.1849094622151668e-11
mutations O 0 3.291661648113786e-12
of O 0 4.611107405892767e-17
the O 0 1.2546487595769152e-16
APC B-Disease 0 1.408859059146353e-13
gene O 0 1.7916346032632868e-14
are O 0 1.418826508765256e-16
thought O 0 3.0301612659474307e-15
to O 0 4.835649685986125e-15
initiate O 0 1.1203433736284296e-09
colorectal B-Disease 1 0.9999974966049194
tumor I-Disease 0 0.3497970998287201
formation O 0 7.075774192344397e-06
in O 0 1.3551941265177447e-05
familial B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 0.9999911785125732
polyposis I-Disease 1 0.9999998807907104
syndrome I-Disease 1 0.9999984502792358
and O 0 5.51041694052401e-06
sporadic O 0 4.179447205387987e-05
colorectal O 1 0.9999934434890747
carcinogenesis O 0 0.2691573202610016
, O 0 1.942611405070238e-09
respectively O 0 3.908099122096331e-10
. O 0 1.0762032237598973e-10

Recently O 0 2.536760246307779e-10
, O 0 1.1347754604474486e-14
an O 0 1.1232969781660267e-15
isoleucine O 0 2.124014145010733e-06
- O 0 8.132663538162888e-07
- O 0 1.6379860312554229e-07
> O 0 4.66675255297172e-13
lysine O 0 1.6838863203111343e-12
polymorphism O 0 5.734382153149697e-13
at O 0 7.905469627447065e-14
codon O 0 7.971269518482031e-15
1307 O 0 2.1355369729525453e-12
( O 0 4.148186363989306e-17
I1307K O 0 1.15041414504931e-14
) O 0 4.523182408117566e-16
of O 0 2.2444030113153903e-18
the O 0 2.765145144360972e-16
APC B-Disease 0 1.585933261886302e-13
gene O 0 1.8812258710174373e-15
has O 0 2.3917310189650043e-14
been O 0 6.254474871262401e-16
identified O 0 3.8163645420946635e-15
in O 0 4.763490618337286e-17
6 O 0 1.3486392178799905e-13
% O 0 1.0003586162015375e-15
- O 0 2.7385493872600364e-09
7 O 0 1.5203792669282734e-09
% O 0 1.1431129751538621e-14
of O 0 3.337347200745631e-17
the O 0 3.5897852615832115e-13
Ashkenazi O 0 5.984870767861139e-07
Jewish O 0 2.0126785571505934e-08
population O 0 8.953229650721095e-12
. O 0 1.895926471373599e-11

To O 0 6.771981413133954e-12
assess O 0 2.1462354463097633e-12
the O 0 2.0901993176103244e-14
risk O 0 1.7836936693827778e-14
of O 0 1.8198954137556882e-20
this O 0 2.0753445873542326e-19
common O 0 3.0153641694591595e-17
APC B-Disease 0 5.983846231016887e-13
allelic O 0 5.6544911981870616e-12
variant O 0 1.5961604260539275e-09
in O 0 2.1553651918804206e-10
colorectal O 1 0.9999985694885254
carcinogenesis O 0 0.0001859335316112265
, O 0 3.2464336774395974e-11
we O 0 1.2178829451002515e-13
have O 0 5.513933023719279e-17
analyzed O 0 1.3677819210835477e-15
a O 0 9.421328434883379e-17
large O 0 2.2549018672369603e-15
cohort O 0 4.871739123224472e-10
of O 0 5.372582600701205e-15
unselected O 0 1.593429566071336e-08
Ashkenazi O 0 2.5947355197786237e-07
Jewish O 0 5.6701409789639e-08
subjects O 0 2.526622466803019e-08
with O 0 5.127087448174306e-13
adenomatous B-Disease 0 7.754805864124137e-08
polyps I-Disease 0 2.4591554392827675e-05
and O 0 1.3697527556644218e-08
. O 0 3.9211653368731447e-10
or O 0 0.00016526086255908012
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
, I-Disease 0 2.87886034455731e-14
for O 0 1.582565308357691e-19
the O 0 4.530864599902468e-17
APC O 0 1.7781907890590531e-10
I1307K O 0 1.1668485622173819e-11
polymorphism O 0 8.55396517507323e-11
. O 0 2.9879269197730096e-11

The O 0 5.845910235925678e-13
APC O 0 1.3495111972350315e-10
I1307K O 0 8.18227603727184e-12
allele O 0 2.8100889670756857e-12
was O 0 2.121329327475774e-11
identified O 0 1.266751135410582e-12
in O 0 4.808755966394327e-15
48 O 0 8.558419204991556e-15
( O 0 4.956965123724688e-19
10 O 0 1.2087394249432218e-17
. O 0 5.679120330301629e-17
1 O 0 6.652954109759898e-16
% O 0 5.209545447550791e-17
) O 0 8.200018759761495e-17
of O 0 2.6469552127028434e-18
476 O 0 4.180811512960458e-12
patients O 0 9.095218881424033e-14
. O 0 2.9119580553273183e-13

Compared O 0 6.5853984591857095e-12
with O 0 9.446957401936028e-16
the O 0 1.434379754212519e-16
frequency O 0 6.753175275930889e-12
in O 0 3.180381076835323e-16
two O 0 5.91371722235114e-16
separate O 0 5.570279667073885e-15
population O 0 1.3035934996428208e-16
control O 0 1.0346491865305049e-13
groups O 0 1.8521935785222797e-16
, O 0 6.609239930492185e-17
the O 0 1.0553439584958974e-16
APC O 0 1.954006574600431e-11
I1307K O 0 1.0511069011703844e-13
allele O 0 2.491185968449272e-13
is O 0 1.8528667844268897e-14
associated O 0 1.5036259523181113e-14
with O 0 3.593400398202093e-14
an O 0 1.587385957272161e-13
estimated O 0 4.716673232540991e-11
relative O 0 1.3121345121547279e-09
risk O 0 3.909560175596738e-10
of O 0 4.1395910442174836e-15
1 O 0 3.5653652339512343e-12
. O 0 1.0709039210965443e-10

5 O 0 1.452738485063776e-09
- O 0 1.1630201157686315e-07
1 O 0 3.106869275737445e-11
. O 0 4.686077220705798e-11

7 O 0 4.524276953077333e-09
for O 0 1.719898182206414e-11
colorectal B-Disease 1 0.9999871253967285
neoplasia I-Disease 0 0.011956500820815563
( O 0 2.8122778411576732e-11
both O 0 9.966093922342267e-11
P O 0 0.005178479012101889
= O 0 2.5362655264871137e-07
. O 0 3.756782038233375e-11
01 O 0 4.334065994981984e-09
) O 0 2.87038123304717e-12
. O 0 9.68617894225865e-12

Furthermore O 0 5.241615128048771e-11
, O 0 8.312149796588231e-14
compared O 0 7.530396492732693e-15
with O 0 1.0392802036443462e-15
noncarriers O 0 2.063158532905618e-10
, O 0 2.9576749391784863e-16
APC O 0 1.3198176004782652e-13
I1307K O 0 1.473126159359968e-14
carriers O 0 2.872095230050444e-16
had O 0 4.321565823836408e-14
increased O 0 5.9100123300183516e-18
numbers O 0 8.71430566629658e-16
of O 0 3.988954493119542e-16
adenomas B-Disease 0 5.794151093141409e-06
and O 0 0.0011660907184705138
colorectal B-Disease 1 0.9999998807907104
cancers I-Disease 0 0.25658348202705383
per O 0 6.677987589992496e-12
patient O 0 2.362852413728689e-10
( O 0 4.1077726073077137e-13
P O 0 1.3679854419024196e-05
= O 0 1.1211819028744685e-08
. O 0 6.872513409056369e-12
03 O 0 1.3802910203697394e-11
) O 0 1.2927547284069009e-14
, O 0 1.9699356580531597e-16
as O 0 1.0139779795511006e-16
well O 0 1.8714627575091474e-15
as O 0 2.9019196307001824e-15
a O 0 8.864115767347885e-14
younger O 0 2.4232835738047243e-09
age O 0 1.3517799726803226e-11
at O 0 2.7777211954183034e-12
diagnosis O 0 3.8864952922601503e-11
. O 0 3.3005512385664293e-12

We O 0 1.6100051250956399e-13
conclude O 0 5.511728091078458e-16
that O 0 7.016332071312605e-18
the O 0 3.663316167249811e-18
APC O 0 3.988237691487928e-13
I1307K O 0 3.1364444190700586e-14
variant O 0 3.36245332792362e-12
leads O 0 4.9119784628626206e-11
to O 0 1.923121904778835e-11
increased O 0 3.878112761479535e-11
adenoma B-Disease 1 0.9999994039535522
formation O 0 1.610274691365987e-10
and O 0 1.7881859187829363e-11
directly O 0 4.6071735598925915e-15
contributes O 0 9.723180139991575e-16
to O 0 3.1907101142314973e-16
3 O 0 1.12688992252169e-14
% O 0 3.044573372726285e-16
- O 0 1.7396682705506095e-10
4 O 0 2.7069770036636243e-11
% O 0 8.536438276493833e-16
of O 0 4.501336899012285e-17
all O 0 1.9851780809487796e-12
Ashkenazi O 0 0.0002184429467888549
Jewish O 1 0.8260274529457092
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999983310699463
. O 0 4.53130013511327e-08

The O 0 2.2731499842165714e-12
estimated O 0 8.433120738185473e-13
relative O 0 5.152657380630421e-12
risk O 0 1.079771948936381e-11
for O 0 1.963694269311537e-15
carriers O 0 6.050802762481988e-13
may O 0 4.192481729619821e-14
justify O 0 3.069457480180942e-17
specific O 0 1.839136410285496e-20
clinical O 0 1.0510395969994586e-19
screening O 0 2.674449403794399e-19
for O 0 2.1109695680483366e-21
the O 0 5.152361340281052e-20
360 O 0 4.683793089806782e-17
, O 0 4.2529734178718855e-19
000 O 0 3.263370618767666e-18
Americans O 0 6.8403477416307234e-18
expected O 0 2.1844140121366664e-18
to O 0 5.408356322544441e-17
harbor O 0 6.800256294485149e-14
this O 0 3.641342631265223e-19
allele O 0 1.2413858647492481e-15
, O 0 4.1161428428968796e-16
and O 0 1.2818629011447473e-14
genetic O 0 3.731531481921714e-14
testing O 0 2.0830284383228231e-13
in O 0 2.7709301477801472e-17
the O 0 1.477711709862783e-16
setting O 0 1.2608382220224978e-12
of O 0 9.774952487793653e-15
long O 0 5.1692614633225276e-09
- O 0 8.683794305852643e-08
term O 0 2.2692416834502183e-09
- O 0 5.320509366413262e-09
outcome O 0 3.4703387082404835e-13
studies O 0 4.9379350977075964e-14
may O 0 1.6325306449564703e-15
impact O 0 9.265004368564535e-18
significantly O 0 2.3881389216422882e-14
on O 0 3.958935849368572e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
prevention O 0 2.113731767394711e-07
in O 0 4.848095776354843e-16
this O 0 9.694731479666856e-17
population O 0 3.495686126835421e-15
. O 0 1.9835060677264593e-11

Localization O 0 1.4907157452892505e-10
of O 0 6.075240582041023e-16
human O 0 5.124716196379126e-15
BRCA1 O 0 4.822481303179416e-10
and O 0 8.962618980312698e-10
its O 0 1.3897277773011751e-10
loss O 0 1.640463181962204e-10
in O 0 1.212943874808988e-15
high O 0 3.0389435412558896e-10
- O 0 4.391143193060998e-06
grade O 0 7.575973768325639e-07
, O 0 1.755520208368555e-11
non B-Disease 0 6.039420075154567e-10
- I-Disease 0 0.323944628238678
inherited I-Disease 1 0.9998002648353577
breast I-Disease 1 0.9999262094497681
carcinomas I-Disease 1 0.999996542930603
. O 0 8.088538550055091e-08

Although O 0 7.787811736638395e-13
the O 0 2.017343827413187e-16
link O 0 4.683391803712855e-13
between O 0 2.345417120881623e-14
the O 0 5.044824557013869e-14
BRCA1 O 0 2.0073615303317638e-07
tumour B-Disease 1 0.9999972581863403
- O 0 8.755455027653625e-09
suppressor O 0 8.16200884656837e-09
gene O 0 1.7538971519570623e-07
and O 0 7.5593275141727645e-06
hereditary B-Disease 1 0.9999927282333374
breast I-Disease 1 0.9999995231628418
and I-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
is O 0 7.940072904721873e-11
established O 0 1.0208315041806276e-13
, O 0 4.284558954370868e-14
the O 0 8.315090567926156e-16
role O 0 5.770964218651531e-13
, O 0 3.932405091253187e-15
if O 0 6.903632848755318e-17
any O 0 3.538330831054274e-18
, O 0 1.2119118445720975e-16
of O 0 3.251604305426344e-17
BRCA1 O 0 3.3669781629441786e-08
in O 0 3.090381561765554e-10
non B-Disease 0 1.5066495961946202e-07
- I-Disease 1 0.8006561994552612
familial I-Disease 1 0.999843955039978
cancers I-Disease 1 0.9999538660049438
is O 0 5.825572246820343e-10
unclear O 0 2.6027791033556014e-10
. O 0 5.4986974175330605e-12

BRCA1 O 0 3.4717114516524816e-08
mutations O 0 4.317414203924841e-10
are O 0 2.772712072961203e-13
rare O 0 6.409868295864651e-13
in O 0 1.4258605689383697e-13
sporadic B-Disease 0 1.6762504273515333e-08
cancers I-Disease 0 0.0007395907887257636
, O 0 1.885340078500164e-10
but O 0 8.355592884257135e-10
loss O 0 1.423758506924333e-11
of O 0 1.2010687640560583e-16
BRCA1 O 0 1.5279152165703636e-08
resulting O 0 5.734183128325299e-10
from O 0 1.4261984605454248e-12
reduced O 0 1.1324112220850724e-12
expression O 0 3.681146099748789e-12
or O 0 4.065297404265422e-11
incorrect O 0 1.1035511171542112e-08
subcellular O 0 7.918056765809922e-10
localization O 0 2.0069072792505693e-10
is O 0 1.1931144099972912e-15
postulated O 0 2.8001421634613554e-16
to O 0 8.963365328283103e-15
be O 0 2.403335920913804e-15
important O 0 4.5157537174119085e-15
in O 0 6.738658025681743e-13
non B-Disease 0 1.4391969838101204e-09
- I-Disease 0 0.009311851114034653
familial I-Disease 1 0.9999791383743286
breast I-Disease 1 0.9999984502792358
and I-Disease 1 0.9999958276748657
ovarian I-Disease 1 0.9999997615814209
cancers I-Disease 1 0.9999988079071045
. O 0 3.257522962485382e-08

Epigenetic O 0 7.595984357067209e-07
loss O 0 1.268371670448687e-05
, O 0 7.570182328220376e-12
however O 0 1.5520907042237964e-13
, O 0 3.0385648915753774e-15
has O 0 1.0959712717711293e-14
not O 0 4.973204130851079e-16
received O 0 1.777441895223128e-17
general O 0 6.646402839308478e-18
acceptance O 0 1.97564309204791e-13
due O 0 4.1266096713777484e-14
to O 0 3.923324898058621e-15
controversy O 0 1.3434729437061203e-14
regarding O 0 9.363816882998282e-18
the O 0 8.461601062719344e-18
subcellular O 0 1.259719867481579e-13
localization O 0 5.6337299734164625e-14
of O 0 1.7610877900504035e-18
BRCA1 O 0 4.790531374907793e-14
proteins O 0 1.596900237911536e-13
, O 0 2.670775689635977e-14
reports O 0 6.658118067298657e-13
of O 0 2.2178342760970136e-16
which O 0 1.943309749230515e-11
have O 0 5.764322612983319e-12
ranged O 0 4.472643609643168e-12
from O 0 3.5921499975774443e-16
exclusively O 0 6.726981845910432e-14
nuclear O 0 2.1271566452707447e-10
, O 0 2.536835759680956e-19
to O 0 1.271249319077247e-18
conditionally O 0 8.464653674170042e-14
nuclear O 0 1.3271167151329699e-11
, O 0 7.119049291827909e-19
to O 0 9.947827074976033e-18
the O 0 2.4652332770508855e-15
ER O 0 7.604666230065504e-09
/ O 0 6.653192536829056e-13
golgi O 0 9.974308878835103e-11
, O 0 4.434683346997252e-15
to O 0 1.0140016700038441e-15
cytoplasmic O 0 3.8966788129535246e-11
invaginations O 0 3.8690789461170993e-10
into O 0 7.128711446288075e-15
the O 0 3.84986342460915e-15
nucleus O 0 4.716542369338772e-13
. O 0 1.5636024376305957e-12

In O 0 3.4596059198845064e-13
an O 0 6.513981943499477e-15
attempt O 0 1.6290271354080232e-09
to O 0 1.1712947452224842e-11
resolve O 0 2.346279767695414e-11
this O 0 3.537979692884245e-18
issue O 0 5.098762259842307e-15
, O 0 3.0280451129473935e-16
we O 0 8.055301116080289e-15
have O 0 1.1702830604205252e-15
comprehensively O 0 3.120911584719721e-10
characterized O 0 6.89877625512092e-13
19 O 0 2.4715245719149695e-14
anti O 0 1.0968398411748126e-09
- O 0 3.1918368392780394e-08
BRCA1 O 0 5.558548288320253e-09
antibodies O 0 1.0135716710379938e-09
. O 0 4.125394036796903e-12

These O 0 4.321143239099023e-15
reagents O 0 2.256056161385831e-14
detect O 0 6.829466462840439e-13
a O 0 3.7458179207749314e-16
220 O 0 1.1845483869775322e-14
- O 0 9.868841854832056e-12
kD O 0 3.280142216871562e-12
protein O 0 3.7736867870472555e-15
localized O 0 8.098529442543412e-15
in O 0 3.215866670164511e-18
discrete O 0 9.788951740126103e-14
nuclear O 0 1.422810491646942e-08
foci O 0 1.6519149381721832e-09
in O 0 2.716892483152532e-15
all O 0 8.768961526009348e-16
epithelial O 0 7.958759519477443e-13
cell O 0 2.257794022852977e-07
lines O 0 8.759330150098776e-09
, O 0 1.9937060018854723e-14
including O 0 4.1964778298946416e-16
those O 0 9.06103873031007e-14
derived O 0 1.5237168962006255e-14
from O 0 2.8264746446127198e-11
breast B-Disease 0 0.00031392008531838655
malignancies I-Disease 0 0.001359052606858313
. O 0 2.752121641691474e-09

Immunohistochemical O 0 1.4214389921107795e-05
staining O 0 9.54588699642045e-07
of O 0 2.691488254057822e-13
human O 0 9.815640487909061e-12
breast O 0 2.053013758995803e-07
specimens O 0 9.257653671435051e-11
also O 0 6.559702780961629e-11
revealed O 0 3.4348136779271954e-08
BRCA1 O 0 9.93596472653735e-07
nuclear O 0 5.84793212965451e-07
foci O 0 9.730045036349111e-08
in O 0 2.2080326120017119e-13
benign O 0 1.1680725719998009e-06
breast O 0 0.0002354440512135625
, O 0 2.7432074389821537e-09
invasive B-Disease 0 1.4318646890387754e-06
lobular I-Disease 1 0.998542308807373
cancers I-Disease 1 0.9999450445175171
and O 0 3.6507110053207725e-05
low B-Disease 0 0.05273669585585594
- I-Disease 1 0.9986321330070496
grade I-Disease 0 0.019120298326015472
ductal I-Disease 1 0.5487023591995239
carcinomas I-Disease 1 0.9999933242797852
. O 0 2.5192368866555626e-06

Conversely O 0 5.124259905286976e-10
, O 0 2.7022595315909226e-13
BRCA1 O 0 1.1111642855832216e-10
expression O 0 2.1223491714073006e-11
was O 0 7.649530786579817e-09
reduced O 0 9.321506240500543e-12
or O 0 4.467198486124424e-11
undetectable O 0 9.931486744108042e-10
in O 0 5.8169966476865394e-15
the O 0 5.488258502175936e-13
majority O 0 1.608580754491537e-13
of O 0 6.150210515290435e-15
high O 0 6.721188938740852e-09
- O 0 5.901768531657581e-07
grade O 0 6.441378985755364e-09
, O 0 3.423705546498623e-13
ductal B-Disease 0 5.8314562068062514e-09
carcinomas I-Disease 1 0.9999991655349731
, O 0 8.898041331528717e-11
suggesting O 0 2.909819607488373e-10
that O 0 6.935034577854049e-12
absence O 0 1.0172319529679757e-13
of O 0 1.4852054368169214e-16
BRCA1 O 0 6.377366412735341e-10
may O 0 1.4834700308441473e-12
contribute O 0 2.146384383474541e-18
to O 0 1.7804763576694422e-16
the O 0 1.9384701045983366e-16
pathogenesis O 0 1.8513910836261832e-13
of O 0 6.841936031804402e-19
a O 0 5.235204590152186e-17
significant O 0 1.20374750575175e-16
percentage O 0 2.2901726348667495e-10
of O 0 4.784041543991202e-13
sporadic B-Disease 0 1.3091949995214236e-06
breast I-Disease 1 0.5637425780296326
cancers I-Disease 0 0.07796048372983932
. O 0 7.118321487808998e-10
. O 0 6.547131170542286e-10

